GeneCard,Gene Name,Locus,Disorders
A2M,alpha-2-macroglobulin ,12p13.3-p12.3,
,,,Emphysema due to alpha-2-macroglobulin deficiency
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,
A4GALT,"alpha 1,4-galactosyltransferase ",22q13.2,
,,,"Blood group, P system [MIM:111400]"
,,,
A4GNT,"alpha-1,4-N-acetylglucosaminyltransferase ",?,
,,,mutations
,,,
AA1,Alopecia areata 1 ,18p11.3-p11.2,
,,,Alopecia areata 1
,,,
AA2,Alopecia areata 2 ,16q11-q22,
,,,Alopecia areata 2
,,,
AAA1,"aortic aneurysm, familial abdominal 1 ",19q13,
,,,"Aortic aneurysm, familial abdominal 1"
,,,
AAA2,"Aortic aneurysm, familial abdominal 2 ",4q31,
,,,"Aortic aneurysm, familial abdominal 2"
,,,
AAA3,"Aneurysm, familial abdominal 3 ",9p21,
,,,"Aneurysm, familial abdominal 3"
,,,
AAAS,"achalasia, adrenocortical insufficiency, alacrimia ",12q13,
,,,Achalasia-addisonianism-alacrimia syndrome [MIM:231550]
,,,
AADACL2,arylacetamide deacetylase-like 2 ,?,
,,,mutations
,,,
AADAC,arylacetamide deacetylase ,3q21.3-q25.2,
,,,mutations
,,,
AANAT,aralkylamine N-acetyltransferase ,17q25,
,,,"Delayed sleep phase syndrome, susceptibility to"
,,,
AARS2,"alanyl-tRNA synthetase 2, mitochondrial (putative) ",6p21.1,
,,,mutations
,,,
AARS,alanyl-tRNA synthetase ,16q22,
,,,"Charcot-Marie-Tooth disease, axonal, type 2N [MIM:613287]"
,,,
AASS,aminoadipate-semialdehyde synthase ,7q31.3,
,,,Hyperlysinemia [MIM:238700]
,,,Saccharopinuria [MIM:268700]
,,,
AAT1,"Aortic aneurysm, familial thoracic 1 ",11q23.3-q24,
,,,"Aortic aneurysm, familial thoracic 1"
,,,
AAT2,"Aortic aneurysm, familial thoracic 2 ",5q13-q14,
,,,"Aortic aneurysm, familial thoracic 2"
,,,
ABAT,4-aminobutyrate aminotransferase ,16p13.3,
,,,GABA-transaminase deficiency [MIM:613163]
,,,
ABCA10,"ATP-binding cassette, sub-family A (ABC1), member 10 ",17q24.2,
,,,mutations
,,,
ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12 ",2q34,
,,,"Ichthyosis, lamellar 2 [MIM:601277]"
,,,"Ichthyosis, harlequin [MIM:242500]"
,,,
ABCA13,"ATP-binding cassette, sub-family A (ABC1), member 13 ",7p12.3,
,,,mutations
,,,
ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1 ",9q22-q31,
,,,Tangier disease [MIM:205400]
,,,"HDL deficiency, type 2 [MIM:604091]"
,,,"Coronary artery disease in familial hypercholesterolemia, protection against [MIM:143890]"
,,,
ABCA2,"ATP-binding cassette, sub-family A (ABC1), member 2 ",9q34,
,,,mutations
,,,
ABCA3,"ATP-binding cassette, sub-family A (ABC1), member 3 ",16p13.3,
,,,"Surfactant metabolism dysfunction, pulmonary, 3 [MIM:610921]"
,,,
ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4 ",1p22.1,
,,,Stargardt disease-1 [MIM:248200]
,,,Retinitis pigmentosa-19 [MIM:601718]
,,,Cone-rod dystrophy 3 [MIM:604116]
,,,"Macular degeneration, age-related, 2 [MIM:153800]"
,,,Fundus flavimaculatus [MIM:248200]
,,,"Retinal dystrophy, early-onset severe [MIM:248200]"
,,,
ABCA7,"ATP-binding cassette, sub-family A (ABC1), member 7 ",19p13.3,
,,,mutations
,,,
ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11 ",2q24,
,,,"Cholestasis, progressive familial intrahepatic 2 [MIM:601847]"
,,,"Cholestasis, benign recurrent intrahepatic, 2 [MIM:605479]"
,,,
ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1 ",7q21.1,
,,,Colchicine resistance
,,,Inflammatory bowel disease 13 [MIM:612244]
,,,
ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4 ",7q21.1,
,,,"Cholestasis, progressive familial intrahepatic 3 [MIM:602347]"
,,,"Cholestasis, familial intrahepatic, of pregnancy [MIM:147480]"
,,,Gallbladder disease 1 [MIM:600803]
,,,
ABCB6,"ATP-binding cassette, sub-family B (MDR/TAP), member 6 ",2q36,
,,,mutations
,,,
ABCB7,"ATP-binding cassette, sub-family B (MDR/TAP), member 7 ",Xq13.1-q13.3,
,,,"Anemia, sideroblastic, with ataxia [MIM:301310]"
,,,
ABCC11,"ATP-binding cassette, sub-family C (CFTR/MRP), member 11 ",16q12.1,
,,,"Earwax, wet/dry [MIM:117800]"
,,,"Axillary odor, variation in [MIM:117800]"
,,,"Colostrum secretion, variation in [MIM:117800]"
,,,
ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1 ",16p13.1,
,,,mutations
,,,
ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2 ",10q24,
,,,Dubin-Johnson syndrome [MIM:237500]
,,,
ABCC3,"ATP-binding cassette, sub-family C (CFTR/MRP), member 3 ",17q22,
,,,mutations
,,,
ABCC4,"ATP-binding cassette, sub-family C (CFTR/MRP), member 4 ",13q32,
,,,mutations
,,,
ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6 ",16p13.1,
,,,Pseudoxanthoma elasticum [MIM:264800]
,,,"Pseudoxanthoma elasticum, forme fruste [MIM:177850]"
,,,
ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8 ",11p15.1,
,,,"Hyperinsulinemic hypoglycemia, familial, 1 [MIM:256450]"
,,,"Hypoglycemia of infancy, leucine-sensitive [MIM:240800]"
,,,"Diabetes mellitus, transient neonatal 2 [MIM:610374]"
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,"Diabetes mellitus, permanent neonatal [MIM:606176]"
,,,
ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9 ",12p12.1,
,,,"Cardiomyopathy, dilated, 1O [MIM:608569]"
,,,
ABCD1,"ATP-binding cassette, sub-family D (ALD), member 1 ",Xq28,
,,,Adrenoleukodystrophy [MIM:300100]
,,,Adrenomyeloneuropathy [MIM:300100]
,,,
ABCD3,"ATP-binding cassette, sub-family D (ALD), member 3 ",1p22-p21,
,,,Zellweger syndrome-2
,,,
ABCG1,"ATP-binding cassette, sub-family G (WHITE), member 1 ",21q22.3,
,,,mutations
,,,
ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 ",4q22,
,,,mutations
,,,
ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5 ",2p21,
,,,Sitosterolemia [MIM:210250]
,,,
ABCG8,"ATP-binding cassette, sub-family G (WHITE), member 8 ",2p21,
,,,Sitosterolemia [MIM:210250]
,,,Gallbladder disease 4 [MIM:611465]
,,,
ABHD12,abhydrolase domain containing 12 ,20p11.21,
,,,"Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract [MIM:612674]"
,,,
ABHD5,abhydrolase domain containing 5 ,3p21,
,,,Chanarin-Dorfman syndrome [MIM:275630]
,,,
ABI3BP,"ABI family, member 3 (NESH) binding protein ",3q12,
,,,mutations
,,,
ABL1,"c-abl oncogene 1, non-receptor tyrosine kinase ",9q34.1,
,,,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib"
,,,
ABL2,v-abl Abelson murine leukemia viral oncogene homolog 2 ,1q24-q25,
,,,"Leukemia, acute myeloid, with eosinophilia"
,,,
ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) ",9q34,
,,,"Blood group, ABO system"
,,,
ABP1,amiloride binding protein 1 (amine oxidase (copper-containing)) ,7q31-q32,
,,,mutations
,,,
ACAA1,acetyl-CoA acyltransferase 1 ,3p23-p22,
,,,pseudo Zellweger syndrome with abundant peroxisomes and normal plasmalogen biosynthesis (ACAA deficiency)
,,,
ACACA,acetyl-CoA carboxylase alpha ,17q21,
,,,Acetyl-CoA carboxylase deficiency
,,,
ACACB,acetyl-CoA carboxylase beta ,12q24.1,
,,,mutations
,,,
ACAD8,"acyl-CoA dehydrogenase family, member 8 ",11q25,
,,,Isobutyryl-CoA dehydrogenase deficiency [MIM:611283]
,,,
ACAD9,"acyl-CoA dehydrogenase family, member 9 ",3q26,
,,,ACAD9 deficiency [MIM:611126]
,,,
ACADL,"acyl-CoA dehydrogenase, long chain ",2q34-q35,
,,,"Acyl-CoA dehydrogenase, long chain, deficiency of [MIM:201460]"
,,,
ACADM,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain ",1p31,
,,,"Acyl-CoA dehydrogenase, medium chain, deficiency of [MIM:201450]"
,,,
ACADSB,"acyl-CoA dehydrogenase, short/branched chain ",10q25-q26,
,,,2-methylbutyrylglycinuria [MIM:610006]
,,,
ACADS,"acyl-CoA dehydrogenase, C-2 to C-3 short chain ",12q22-qter,
,,,"Acyl-CoA dehydrogenase, short-chain, deficiency of [MIM:201470]"
,,,
ACADVL,"acyl-CoA dehydrogenase, very long chain ",17p13,
,,,VLCAD deficiency [MIM:201475]
,,,
ACAN,aggrecan ,15q26.1,
,,,"Spondyloepiphyseal dysplasia, Kimberley type [MIM:608361]"
,,,"Spondyloepimetaphyseal dysplasia, aggrecan type [MIM:612813]"
,,,"Osteochondritis dissecans, short stature, and early-onset osteoarthritis [MIM:165800]"
,,,
ACAT1,acetyl-CoA acetyltransferase 1 ,11q22.3-q23.1,
,,,Alpha-methylacetoacetic aciduria [MIM:203750]
,,,
ACAT2,acetyl-CoA acetyltransferase 2 ,6q25.3-q26,
,,,ACAT2 deficiency
,,,
ACBD5,acyl-CoA binding domain containing 5 ,?,
,,,mutations
,,,
ACBD6,acyl-CoA binding domain containing 6 ,?,
,,,mutations
,,,
ACCS,1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) ,11p11,
,,,mutations
,,,
ACE,angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ,17q23,
,,,"Myocardial infarction, susceptibility to"
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,Microvascular complications of diabetes 3 [MIM:612624]
,,,"Angiotensin I-converting enzyme, benign serum increase"
,,,"SARS, progression of"
,,,Renal tubular dysgenesis [MIM:267430]
,,,
ACF,Asymmetric crying facies (Cayler cardiofacial syndrome) ,22q11,
,,,Cayler cardiofacial syndrome
,,,
ACHE,acetylcholinesterase ,7q22,
,,,"Blood group, Yt system [MIM:112100]"
,,,
ACHM1,achromatopsia (rod monochromacy) 1 ,8q21-q22,
,,,Achromatopsia-3 [MIM:262300]
,,,"Macular degeneration, juvenile [MIM:248200]"
,,,
ACLS,acrocallosal syndrome ,7p13,
,,,Greig cephalopolysyndactyly syndrome [MIM:175700]
,,,Pallister-Hall syndrome [MIM:146510]
,,,"Polydactyly, preaxial, type IV [MIM:174700]"
,,,"Polydactyly, postaxial, types A1 and B [MIM:174200]"
,,,Acrocallosal syndrome [MIM:200990]
,,,"Hypothalamic hamartomas, somatic [MIM:241800]"
,,,
ACLY,ATP citrate lyase ,17q21.1,
,,,mutations
,,,
ACO2,"aconitase 2, mitochondrial ",22q11.21-q13.31,
,,,mutations
,,,
ACOX1,"acyl-CoA oxidase 1, palmitoyl ",17q25,
,,,Peroxisomal acyl-CoA oxidase deficiency [MIM:264470]
,,,
ACP2,"acid phosphatase 2, lysosomal ",11p12-p11,
,,,Lysosomal acid phosphatase deficiency [MIM:200950]
,,,
ACP5,"acid phosphatase 5, tartrate resistant ",19p13.3-p13.1,
,,,mutations
,,,
ACRPS,Acropectoral syndrome ,7q36,
,,,Acropectoral syndrome
,,,
ACRPV,Acropectorovertebral dysplasia (F syndrome) ,2q36,
,,,Acropectorovertebral dysplasia
,,,
ACR,acrosin ,22q13.3,
,,,Male infertility due to acrosin deficiency
,,,
ACSF3,acyl-CoA synthetase family member 3 ,?,
,,,mutations
,,,
ACSL4,acyl-CoA synthetase long-chain family member 4 ,Xq22.3,
,,,"Mental retardation, X-linked nonspecific, 63 [MIM:300387]"
,,,
ACSL5,acyl-CoA synthetase long-chain family member 5 ,10q25.1-q25.2,
,,,mutations
,,,
ACSL6,acyl-CoA synthetase long-chain family member 6 ,5q31,
,,,Myelodysplastic syndrome
,,,"Myelogenous leukemia, acute"
,,,
ACSM2B,acyl-CoA synthetase medium-chain family member 2B ,?,
,,,mutations
,,,
ACSM3,acyl-CoA synthetase medium-chain family member 3 ,16p13.11,
,,,"Hypertension, essential"
,,,
ACTA1,"actin, alpha 1, skeletal muscle ",1q42.1,
,,,"Myopathy, nemaline, 3 [MIM:161800]"
,,,"Myopathy, actin, congenital, with excess of thin myofilaments [MIM:161800]"
,,,"Myopathy, actin, congenital, with cores"
,,,"Myopathy, congenital, with fiber-type disproportion 1 [MIM:255310]"
,,,
ACTA2,"actin, alpha 2, smooth muscle, aorta ",10q22-q24,
,,,"Aortic aneurysm, familial thoracic 6 [MIM:611788]"
,,,
ACTB,"actin, beta ",7p22-p12,
,,,"Dystonia, juvenile-onset [MIM:607371]"
,,,
ACTC1,"actin, alpha, cardiac muscle 1 ",15q14,
,,,"Cardiomyopathy, dilated, 1R [MIM:613424]"
,,,"Cardiomyopathy, familial hypertrophic, 11 [MIM:612098]"
,,,Atrial septal defect 5 [MIM:612794]
,,,Left ventricular noncompaction 4 [MIM:613424]
,,,
ACTD,Acetabular dysplasia ,13q22,
,,,Acetabular dysplasia
,,,
ACTG1,"actin, gamma 1 ",17q25.3,
,,,"Deafness, autosomal dominant 20/26 [MIM:604717]"
,,,
ACTN2,"actinin, alpha 2 ",1q42-q43,
,,,"Cardiomyopathy, dilated, 1AA [MIM:612158]"
,,,
ACTN3,"actinin, alpha 3 ",11q13-q14,
,,,Alpha-actinin-3 deficiency
,,,Sprinting performance
,,,
ACTN4,"actinin, alpha 4 ",19q13,
,,,"Glomerulosclerosis, focal segmental, 1 [MIM:603278]"
,,,
ACT,actin-like protein (ACT) gene ,17p13-p12,
,,,mutations
,,,
ACVR1B,"activin A receptor, type IB ",12q13,
,,,"Pancreatic cancer, somatic"
,,,
ACVR1C,"activin A receptor, type IC ",2q24.1,
,,,mutations
,,,
ACVR1,"activin A receptor, type I ",2q23-q24,
,,,Fibrodysplasia ossificans progressiva [MIM:135100]
,,,
ACVR2B,"activin A receptor, type IIB ",3p22-p21.3,
,,,"Heterotaxy, visceral, 4, autosomal"
,,,
ACVRL1,activin A receptor type II-like 1 ,12q11-q14,
,,,"Telangiectasia, hereditary hemorrhagic, type 2 [MIM:600376]"
,,,
ACY1,aminoacylase 1 ,3p21.1,
,,,Aminoacylase 1 deficiency [MIM:609924]
,,,
AD10,Alzheimer disease-10 ,7q36,
,,,Alzheimer disease-10 [MIM:104300]
,,,
AD11,Alzheimer disease-11 ,9p22.1,
,,,Alzheimer disease-11
,,,
AD12,Alzheimer disease 12 ,8p12-q22,
,,,Alzheimer disease 12
,,,
AD13,Alzheimer disease-13 ,1q21,
,,,Alzheimer disease-13
,,,
AD14,Alzheimer disease 14 ,1q25,
,,,Alzheimer disease-14
,,,
AD15,Alzheimer disease-15 ,3q22-q24,
,,,Alzheimer disease-15
,,,
AD16,Alzheimer disease 16 ,Xq21.3,
,,,Alzheimer disease 16
,,,
AD5,Alzheimer disease 5 ,12p11.23-q13.12,
,,,Alzheimer disease-5 [MIM:104300]
,,,
AD6,Alzheimer disease 6 ,10q24,
,,,Alzheimer disease 6 [MIM:104300]
,,,
AD7,Alzheimer disease 7 ,10p13,
,,,Alzheimer disease-7
,,,
AD8,Alzheimer disease 8 ,20p,
,,,Alzheimer disease 8 [MIM:104300]
,,,
AD9,Alzheimer disease 9 ,19p13.2,
,,,"Alzheimer disease 9, late onset, susceptibility to [MIM:104300]"
,,,
ADAM10,ADAM metallopeptidase domain 10 ,15q21.3-q23,
,,,mutations
,,,
ADAM12,ADAM metallopeptidase domain 12 ,10q26.3,
,,,mutations
,,,
ADAM17,ADAM metallopeptidase domain 17 ,2p25,
,,,mutations
,,,
ADAM19,ADAM metallopeptidase domain 19 ,5q32-q33,
,,,mutations
,,,
ADAM33,ADAM metallopeptidase domain 33 ,20p13,
,,,mutations
,,,
ADAM7,ADAM metallopeptidase domain 7 ,8p12,
,,,mutations
,,,
ADAM9,ADAM metallopeptidase domain 9 ,8p11.23,
,,,Cone-rod dystrophy 9 [MIM:612775]
,,,
ADAMTS10,"ADAM metallopeptidase with thrombospondin type 1 motif, 10 ",19p13.3-p13.2,
,,,"Weill-Marchesani syndrome, recessive [MIM:277600]"
,,,
ADAMTS13,"ADAM metallopeptidase with thrombospondin type 1 motif, 13 ",9q34,
,,,"Thrombotic thrombocytopenic purpura, familial [MIM:274150]"
,,,
ADAMTS16,"ADAM metallopeptidase with thrombospondin type 1 motif, 16 ",5p15,
,,,mutations
,,,
ADAMTS17,"ADAM metallopeptidase with thrombospondin type 1 motif, 17 ",15q24,
,,,Weill-Marchesani-like syndrome [MIM:613195]
,,,
ADAMTS18,"ADAM metallopeptidase with thrombospondin type 1 motif, 18 ",16q23,
,,,mutations
,,,
ADAMTS2,"ADAM metallopeptidase with thrombospondin type 1 motif, 2 ",5q23,
,,,"Ehlers-Danlos syndrome, type VIIC [MIM:225410]"
,,,
ADAMTSL2,ADAMTS-like 2 ,9q34.2,
,,,Geleophysic dysplasia [MIM:231050]
,,,
ADAMTSL3,ADAMTS-like 3 ,15q25.2,
,,,mutations
,,,
ADAMTSL4,ADAMTS-like 4 ,1q21,
,,,"Ectopia lentis, isolated, autosomal recessive [MIM:225100]"
,,,
ADARB1,"adenosine deaminase, RNA-specific, B1 ",21q22.3,
,,,mutations
,,,
ADAR,"adenosine deaminase, RNA-specific ",1q21.3,
,,,Dyschromatosis symmetrica hereditaria [MIM:127400]
,,,
ADA,adenosine deaminase ,20q13.11,
,,,Severe combined immunodeficiency due to ADA deficiency [MIM:102700]
,,,"Adenosine deaminase deficiency, partial [MIM:102700]"
,,,
ADCK3,aarF domain containing kinase 3 ,1q42.2,
,,,Coenzyme Q10 deficiency [MIM:607426]
,,,"Spinocerebellar ataxia, autosomal recessive 9 [MIM:612016]"
,,,
ADCY10,adenylate cyclase 10 (soluble) ,1q24,
,,,"Hypercalciuria, absorptive, susceptibility to [MIM:143870]"
,,,
ADCY3,adenylate cyclase 3 ,2p24-p22,
,,,mutations
,,,
ADCY5,adenylate cyclase 5 ,3q13.2-q21,
,,,mutations
,,,
ADCY6,adenylate cyclase 6 ,12q12-q13,
,,,mutations
,,,
ADCY9,adenylate cyclase 9 ,16p13.3,
,,,mutations
,,,
ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary) ,18p11,
,,,mutations
,,,
ADC,arginine decarboxylase ,?,
,,,mutations
,,,
ADD1,adducin 1 (alpha) ,4p16.3,
,,,"Hypertension, essential, salt-sensitive [MIM:145500]"
,,,
ADFN,albinism-deafness syndrome ,Xq26.3-q27.1,
,,,Albinism-deafness syndrome
,,,
ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide ",4q22,
,,,"Alcoholism, susceptibility to [MIM:103780]"
,,,
ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide ",4q22,
,,,"Alcohol dependence, protection against [MIM:103780]"
,,,"Parkinson disease, susceptibility to [MIM:168600]"
,,,
ADH4,"alcohol dehydrogenase 4 (class II), pi polypeptide ",4q22,
,,,mutations
,,,
ADH5,"alcohol dehydrogenase 5 (class III), chi polypeptide ",4q21-q25,
,,,mutations
,,,
ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide ",4q23-q24,
,,,mutations
,,,
ADHD1,"Attention deficit-hyperactivity disorder, susceptibility to, 1 ",16p13,
,,,Attention deficit-hyperactivity disorder [MIM:143465]
,,,
ADHD2,"Attention deficit-hyperactivity disorder, susceptibility to, 2 ",17p11,
,,,Attention deficit-hyperactivity disorder [MIM:143465]
,,,
ADHD3,"Attention deficit-hyperactivity disorder, susceptibility to, 2 ",6q12,
,,,Attention deficit-hyperactivity disorder [MIM:143465]
,,,
ADHD4,"Attention deficit-hyperactivity disorder, susceptibility to, 4 ",5p13,
,,,Attention deficit-hyperactivity disorder [MIM:143465]
,,,
ADHD5,"Attention deficit-hyperactivity disorder, susceptibility to, 5 ",2q21.1,
,,,"Attention deficit-hyperactivity disorder, susceptibility to, 5"
,,,
ADHD6,"Attention deficit-hyperactivity disorder, susceptibility to, 6 ",13q12.11,
,,,"Attention deficit-hyperactivity disorder, susceptibility to, 6"
,,,
ADIPOQ,"adiponectin, C1Q and collagen domain containing ",3q27,
,,,Adiponectin deficiency [MIM:612556]
,,,
ADIPOR1,adiponectin receptor 1 ,1p36.13-q41,
,,,mutations
,,,
ADIPQTL4,"Adiponectin, serum level of, QTL4 ",11q23-q24,
,,,"Adiponectin, serum level of, QTL4"
,,,
ADK,adenosine kinase ,10q11-q24,
,,,mutations
,,,
ADM,adrenomedullin ,11p15.4,
,,,mutations
,,,
ADNP,activity-dependent neuroprotector homeobox ,?,
,,,mutations
,,,
ADORA1,adenosine A1 receptor ,1q32.1,
,,,mutations
,,,
ADORA2A,adenosine A2a receptor ,22q11.2,
,,,mutations
,,,
ADORA3,adenosine A3 receptor ,1p21-p13,
,,,mutations
,,,
ADRA1A,adrenoceptor alpha 1A ,8p21,
,,,mutations
,,,
ADRA2A,adrenoceptor alpha 2A ,10q24-q26,
,,,mutations
,,,
ADRA2B,adrenoceptor alpha 2B ,2q11.2,
,,,mutations
,,,
ADRA2C,adrenoceptor alpha 2C ,4p16.1,
,,,"Congestive heart failure and beta-blocker response, modifier of"
,,,
ADRB1,adrenoceptor beta 1 ,10q24-q26,
,,,Resting heart rate [MIM:607276]
,,,"Congestive heart failure and beta-blocker response, modifier of (3) 19"
,,,
ADRB2,"adrenoceptor beta 2, surface ",5q32-q34,
,,,"Asthma, nocturnal, susceptibility to [MIM:600807]"
,,,"Obesity, susceptibility to [MIM:601665]"
,,,"Beta-2-adrenoreceptor agonist, reduced response to (3) 18"
,,,
ADRB3,adrenoceptor beta 3 ,8p12-p11.2,
,,,"Obesity, susceptibility to [MIM:601665]"
,,,
ADRBK2,"adrenergic, beta, receptor kinase 2 ",22q11,
,,,mutations
,,,
ADSL,adenylosuccinate lyase ,22q13.1,
,,,Adenylosuccinase deficiency [MIM:103050]
,,,
AFA1,"Alopecia, androgenetic ",3q26,
,,,"Alopecia, androgenetic"
,,,
AFD1,"acrofacial dysostosis 1, Nager type ",9q32,
,,,"Acrofacial dysostosis, Nager type"
,,,
AFF2,"AF4/FMR2 family, member 2 ",Xq28,
,,,"Mental retardation, X-linked, FRAXE type [MIM:309548]"
,,,
AFF3,"AF4/FMR2 family, member 3 ",2q11.2-q12,
,,,mutations
,,,
AFG3L2,AFG3 ATPase family gene 3-like 2 (S. cerevisiae) ,18p11,
,,,Spinocerebellar ataxia 28 [MIM:610246]
,,,
AFP,alpha-fetoprotein ,4q11-q13,
,,,"AFP deficiency, congenital"
,,,Hereditary persistence of alpha-fetoprotein
,,,
AGA2,"Alopecia, androgenetic, 2 ",Xq11-q12,
,,,"Alopecia, androgenetic, 2"
,,,
AGA3,"Alopecia, androgenetic, 3 ",20p11.22,
,,,"Alopecia, androgenetic, 3"
,,,
AGA,aspartylglucosaminidase ,4q32-q33,
,,,Aspartylglucosaminuria [MIM:208400]
,,,
AGBL4,ATP/GTP binding protein-like 4 ,?,
,,,mutations
,,,
AGER,advanced glycosylation end product-specific receptor ,6p21.3,
,,,mutations
,,,
AGGF1,angiogenic factor with G patch and FHA domains 1 ,5q13.3,
,,,mutations
,,,
AGK,acylglycerol kinase ,7q34,
,,,mutations
,,,
AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase ",1p21,
,,,Glycogen storage disease IIIa [MIM:232400]
,,,Glycogen storage disease IIIb [MIM:232400]
,,,
AGMX2,"agammaglobulinemia, X-linked 2 (with growth hormone deficiency) ",Xp22,
,,,"Agammaglobulinemia, X-linked 2"
,,,
AGPAT2,"1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) ",9q34.3,
,,,"Lipodystrophy, congenital generalized, type 1 [MIM:608594]"
,,,
AGPS,alkylglycerone phosphate synthase ,2q31,
,,,"Rhizomelic chondrodysplasia punctata, type 3 [MIM:600121]"
,,,
AGRN,agrin ,1pter-p32,
,,,"Myasthenia, limb-girdle, familial [MIM:254300]"
,,,
AGRP,agouti related protein homolog (mouse) ,16q22,
,,,"Obesity, late-onset [MIM:601665]"
,,,"Leanness, inherited"
,,,
AGSPX,Angio serpiginosum ,Xp11.3-q12,
,,,Angio serpiginosum
,,,
AGTR1,"angiotensin II receptor, type 1 ",3q21-q25,
,,,"Hypertension, essential [MIM:145500]"
,,,Renal tubular dysgenesis [MIM:267430]
,,,
AGTR2,"angiotensin II receptor, type 2 ",Xq22-q23,
,,,"Mental retardation, X-linked-88"
,,,
AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8) ",1q42-q43,
,,,"Hypertension, essential, susceptibility to [MIM:145500]"
,,,"Preeclampsia, susceptibility to"
,,,Renal tubular dysgenesis [MIM:267430]
,,,
AGXT2L1,alanine-glyoxylate aminotransferase 2-like 1 ,?,
,,,mutations
,,,
AGXT2,alanine--glyoxylate aminotransferase 2 ,5p13,
,,,mutations
,,,
AGXT,alanine-glyoxylate aminotransferase ,2q36-q37,
,,,"Hyperoxaluria, primary, type 1 [MIM:259900]"
,,,
AHCY,adenosylhomocysteinase ,20cen-q13.1,
,,,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase
,,,
AHI1,Abelson helper integration site 1 ,6q23.3,
,,,Joubert syndrome-3 [MIM:608629]
,,,
AHRR,aryl-hydrocarbon receptor repressor ,5p15.3,
,,,mutations
,,,
AHR,aryl hydrocarbon receptor ,7p15,
,,,mutations
,,,
AHSG,alpha-2-HS-glycoprotein ,3q27,
,,,mutations
,,,
AHSP,alpha hemoglobin stabilizing protein ,16p11.2,
,,,mutations
,,,
AICDA,activation-induced cytidine deaminase ,12p13,
,,,"Immunodeficiency with hyper-IgM, type 2 [MIM:605258]"
,,,
AIC,Aicardi syndrome ,Xp22,
,,,Aicardi syndrome
,,,
AIF1,allograft inflammatory factor 1 ,6p21.3,
,,,mutations
,,,
AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1 ",Xq25-q26,
,,,Combined oxidative phosphorylation deficiency 6 [MIM:300816]
,,,
AIH3,"amelogenesis imperfecta 3, hypomaturation or hypoplastic type ",Xq22-q28,
,,,"Amelogenesis imperfecta-3, hypoplastic type"
,,,
AIMP1,aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 ,4q24,
,,,mutations
,,,
AIPL1,aryl hydrocarbon receptor interacting protein-like 1 ,17p13.1,
,,,Leber congenital amaurosis 4 [MIM:604393]
,,,"Retinitis pigmentosa, juvenile"
,,,Cone-rod dystrophy
,,,
AIP,aryl hydrocarbon receptor interacting protein ,11q13.3,
,,,"Pituitary adenoma, growth hormone-secreting [MIM:102200]"
,,,"Pituitary adenoma, prolactin-secreting [MIM:600634]"
,,,"Pituitary adenoma, ACTH-secreting [MIM:219090]"
,,,
AIRE,autoimmune regulator ,21q22.3,
,,,"Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia [MIM:240300]"
,,,
AIR,Acute insulin response (2) ,1p31,
,,,Acute insulin response
,,,
AIS2,autoimmune susceptibility 2 ,7,
,,,"Autoimmune disease, susceptibility to, 2"
,,,
AIS3,autoimmune susceptibility 3 (vitiligo specific) ,8,
,,,"Autoimmune disease, susceptibility to, 3"
,,,
AIS4,"autoimmune disease, susceptibility to, 4 ",4q13-q21,
,,,"Autoimmune disease, susceptibility to, 4"
,,,
AIS,Adolescent idiopathic scoliosis ,19p13.3,
,,,"Scoliosis, idiopathic 1"
,,,
AITD1,"Autoimmune thyroid disease, susceptibility to, 1 ",6p11,
,,,"Autoimmune thyroid disease, susceptibility to, 1"
,,,
AITD2,"Autoimmune thyroid disease, susceptibility to, 2 ",5q31-q33,
,,,"Autoimmune thyroid disease, susceptibility to, 2"
,,,
AITD4,"Autoimmune thyroid disease, susceptibility to, 4 ",10q,
,,,"Autoimmune thyroid disease, susceptibility to, 4"
,,,
AK1,adenylate kinase 1 ,9q34.1,
,,,Hemolytic anemia due to adenylate kinase deficiency [MIM:612631]
,,,
AK2,adenylate kinase 2 ,1p34,
,,,Reticular dysgenesis [MIM:267500]
,,,
AKAP10,A kinase (PRKA) anchor protein 10 ,17p11.1,
,,,"Cardiac conduction defect, susceptibility to [MIM:115080]"
,,,
AKAP13,A kinase (PRKA) anchor protein 13 ,15q24-q25,
,,,mutations
,,,
AKAP2,A kinase (PRKA) anchor protein 2 ,9q31-q33,
,,,mutations
,,,
AKAP9,A kinase (PRKA) anchor protein (yotiao) 9 ,7q21-q22,
,,,Long QT syndrome-11 [MIM:611820]
,,,
AKR1B1,"aldo-keto reductase family 1, member B1 (aldose reductase) ",7q35,
,,,mutations
,,,
AKR1C2,"aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) ",10p15-p14,
,,,"Obesity, hyperphagia, and developmental delay"
,,,
AKR1C3,"aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) ",10p15-p14,
,,,mutations
,,,
AKR1C4,"aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) ",10p15-p14,
,,,mutations
,,,
AKR1D1,"aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) ",7q32-q33,
,,,"Bile acid synthesis defect, congenital, 2 [MIM:235555]"
,,,
AKR7A2,"aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) ",?,
,,,mutations
,,,
AKR7A3,"aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) ",?,
,,,mutations
,,,
AKT1,v-akt murine thymoma viral oncogene homolog 1 ,14q32.3,
,,,"Breast cancer, somatic [MIM:114480]"
,,,"Colorectal cancer, somatic [MIM:114500]"
,,,"Ovarian cancer, somatic [MIM:604370]"
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,
AKT2,v-akt murine thymoma viral oncogene homolog 2 ,19q13.1-q13.2,
,,,"Diabetes mellitus, type II [MIM:125853]"
,,,
AKT3,"v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) ",1q44,
,,,mutations
,,,
ALAD,aminolevulinate dehydratase ,9q34,
,,,"Porphyria, acute hepatic [MIM:612740]"
,,,"Lead poisoning, susceptibility to [MIM:612740]"
,,,
ALAS2,"aminolevulinate, delta-, synthase 2 ",Xp11.21,
,,,"Anemia, sideroblastic, X-linked [MIM:300751]"
,,,"Protoporphyria, erythropoietic, X-linked dominant [MIM:300752]"
,,,
ALB,albumin ,4q11-q13,
,,,Analbuminemia
,,,Dysalbuminemic hyperthyroxinemia
,,,Dysalbuminemic hyperzincemia [MIM:194470]
,,,
ALCAM,activated leukocyte cell adhesion molecule ,3q13.1-q13.2,
,,,mutations
,,,
ALDH16A1,"aldehyde dehydrogenase 16 family, member A1 ",19q13.33,
,,,mutations
,,,
ALDH18A1,"aldehyde dehydrogenase 18 family, member A1 ",10q24.3,
,,,"Mental retardation, joint hypermobility and skin laxity, with or without metabolic abnormalities [MIM:612652]"
,,,
ALDH1A1,"aldehyde dehydrogenase 1 family, member A1 ",9q21,
,,,mutations
,,,
ALDH1A2,"aldehyde dehydrogenase 1 family, member A2 ",15,
,,,mutations
,,,
ALDH2,aldehyde dehydrogenase 2 family (mitochondrial) ,12q24.2,
,,,"Alcohol sensitivity, acute [MIM:610251]"
,,,"Hangover, susceptibility to [MIM:610251]"
,,,"Sublingual nitroglycerin, susceptibility to poor response to"
,,,"Esophageal cancer, alcohol-related, susceptibility to (3) 4"
,,,
ALDH3A2,"aldehyde dehydrogenase 3 family, member A2 ",17p11.2,
,,,Sjogren-Larsson syndrome [MIM:270200]
,,,
ALDH4A1,"aldehyde dehydrogenase 4 family, member A1 ",1p36,
,,,"Hyperprolinemia, type II [MIM:239510]"
,,,
ALDH5A1,"aldehyde dehydrogenase 5 family, member A1 ",6p22,
,,,Succinic semialdehyde dehydrogenase deficiency [MIM:271980]
,,,
ALDH6A1,"aldehyde dehydrogenase 6 family, member A1 ",14q24.3,
,,,Methylmalonate semialdehyde dehydrogenase deficiency
,,,
ALDH7A1,"aldehyde dehydrogenase 7 family, member A1 ",5q31,
,,,"Epilepsy, pyridoxine-dependent [MIM:266100]"
,,,
ALDOA,"aldolase A, fructose-bisphosphate ",16p11.2,
,,,Glycogen storage disease XII [MIM:611881]
,,,
ALDOB,"aldolase B, fructose-bisphosphate ",9q22.3,
,,,Fructose intolerance [MIM:229600]
,,,
ALG10B,"asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog B (yeast) ",?,
,,,mutations
,,,
ALG10,"asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe) ",12p11.1,
,,,"Acquired long QT syndrome, reduced susceptibility to [MIM:152427]"
,,,
ALG11,"asparagine-linked glycosylation 11, alpha-1,2-mannosyltransferase homolog (yeast) ",13q14.3,
,,,"Congenital disorder of glycosylation, type Ip [MIM:613661]"
,,,
ALG12,"asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae) ",22q13.33,
,,,"Congenital disorder of glycosylation, type Ig [MIM:607143]"
,,,
ALG1,"asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae) ",16p13.3,
,,,"Congenital disorder of glycosylation, type Ik [MIM:608540]"
,,,
ALG2,"asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae) ",9q22,
,,,"Congenital disorder of glycosylation, type Ii [MIM:607906]"
,,,
ALG3,"asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae) ",3q27,
,,,"Congenital disorder of glycosylation, type Id [MIM:601110]"
,,,
ALG6,"asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae) ",1p22.3,
,,,"Congenital disorder of glycosylation, type Ic [MIM:603147]"
,,,
ALG8,"asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae) ",11pter-p15.5,
,,,"Congenital disorder of glycosylation, type Ih [MIM:608104]"
,,,
ALG9,"asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae) ",11q23,
,,,"Congenital disorder of glycosylation, type Il [MIM:608776]"
,,,
ALK,anaplastic lymphoma receptor tyrosine kinase ,2p23,
,,,"Neuroblastoma, susceptibility to, 3 [MIM:613014]"
,,,
ALL1,"Leukemia, acute lymphocytic, susceptibility to, 1 ",10q21,
,,,"Leukemia, acute lymphocytic, susceptibility to, 1"
,,,
ALL2,"Leukemia, acute lymphoblastic, susceptibility to, 2 ",7p12.2,
,,,"Leukemia, acute lymphoblastic, susceptibility to, 2"
,,,
ALMS1,Alstrom syndrome 1 ,2p13,
,,,Alstrom syndrome [MIM:203800]
,,,
ALOX12B,"arachidonate 12-lipoxygenase, 12R type ",17p13.1,
,,,"Ichthyosiform erythroderma, congenital, nonbullous, 1 [MIM:242100]"
,,,
ALOX12,arachidonate 12-lipoxygenase ,17p13.1,
,,,mutations
,,,
ALOX15,arachidonate 15-lipoxygenase ,17p13.3,
,,,mutations
,,,
ALOX5AP,arachidonate 5-lipoxygenase-activating protein ,13q12,
,,,"Stroke, susceptibility to [MIM:601367]"
,,,
ALOX5,arachidonate 5-lipoxygenase ,10q11.2,
,,,"Atherosclerosis, susceptibility to"
,,,"Asthma, diminished response to antileukotriene treatment in [MIM:600807]"
,,,
ALOXE3,arachidonate lipoxygenase 3 ,17p13.1,
,,,"Ichthyosiform erythroderma, congenital, nonbullous, 1 [MIM:242100]"
,,,
ALPL,"alkaline phosphatase, liver/bone/kidney ",1p36.1-p34,
,,,"Hypophosphatasia, infantile [MIM:241500]"
,,,"Hypophosphatasia, childhood [MIM:241510]"
,,,Odontohypophosphatasia [MIM:146300]
,,,"Hypophosphatasia, adult [MIM:146300]"
,,,
ALPQTL1,"Alkaline phosphatase, plasma level of, QTL1 ",9q34.13,
,,,"Alkaline phosphatase, plasma level of, QTL1"
,,,
ALPQTL2,"Alkaline phosphatase, plasma level of, QTL 2 ",1p36,
,,,"Alkaline phosphatase, plasma level of, QTL 2"
,,,
ALPQTL3,"Alkaline phosphatase, plasma level of, QTL3 ",6p22,
,,,"Alkaline phosphatase, plasma level of, QTL3"
,,,
ALPQTL4,"Alkaline phosphatase, plasma level of, QTL4 ",10q21,
,,,"Alkaline phosphatase, plasma level of, QTL4"
,,,
ALS2CL,ALS2 C-terminal like ,3p21.31,
,,,mutations
,,,
ALS2,amyotrophic lateral sclerosis 2 (juvenile) ,2q33,
,,,"Amyotrophic lateral sclerosis, juvenile [MIM:205100]"
,,,"Primary lateral sclerosis, juvenile [MIM:606353]"
,,,"Spastic paralysis, infantile onset ascending [MIM:607225]"
,,,
ALS3,amyotrophic lateral sclerosis 3 (autosomal dominant) ,18q21,
,,,Amyotrophic lateral sclerosis 3
,,,
ALS5,amyotrophic lateral sclerosis 5 ,15q15.1-q21.1,
,,,"Amyotrophic lateral sclerosis-5, juvenile recessive"
,,,
ALS7,amyotrophic lateral sclerosis 7 ,20p13,
,,,Amyotrophic lateral sclerosis 7
,,,
ALX1,ALX homeobox 1 ,12q21.3-q22,
,,,Frontonasal dysplasia 3 [MIM:613456]
,,,
ALX3,ALX homeobox 3 ,1p21-p13,
,,,Frontorhiny [MIM:136760]
,,,
ALX4,ALX homeobox 4 ,11p11.2,
,,,Parietal foramina 2 [MIM:609597]
,,,Frontonasal dysplasia 2 [MIM:613451]
,,,
AMACR,alpha-methylacyl-CoA racemase ,5p13.2-q11.1,
,,,Alpha-methylacyl-CoA racemase deficiency
,,,"Bile acid synthesis defect, congenital, 4 [MIM:214950]"
,,,
AMCD2B,"arthrogryposis multiplex congenita, distal, type 2B ",11p15.5,
,,,"Arthyrgryposis, distal, type 2B [MIM:601680]"
,,,
AMCN,"arthrogryposis multiplex congenita, neurogenic ",5q35,
,,,"Arthrogryposis multiplex congenita, neurogenic"
,,,
AMELX,"amelogenin, X-linked ",Xp22.3-p22.1,
,,,"Amelogenesis imperfecta, hypoplastic/hypomaturation type [MIM:301200]"
,,,
AMELY,"amelogenin, Y-linked ",Yp11,
,,,mutations
,,,
AMHR2,"anti-Mullerian hormone receptor, type II ",12q13,
,,,"Persistent Mullerian duct syndrome, type II [MIM:261550]"
,,,
AMH,anti-Mullerian hormone ,19p13.3-p13.2,
,,,"Persistent Mullerian duct syndrome, type I [MIM:261550]"
,,,
AMLCR2,acute myeloid leukemia chromosome region 2 ,16q22,
,,,"Leukemia, acute myelogenous [MIM:601626]"
,,,
AMMEC,"Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis ",Xq22.3,
,,,"Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis"
,,,
AMN,amnionless homolog (mouse) ,14q32,
,,,"Megaloblastic anemia-1, Norwegian type [MIM:261100]"
,,,
AMPD1,adenosine monophosphate deaminase 1 ,1p21-p13,
,,,Myoadenylate deaminase deficiency
,,,
AMPD3,adenosine monophosphate deaminase 3 ,11pter-p13,
,,,"AMP deaminase deficiency, erythrocytic [MIM:612874]"
,,,
AMRS,Alopecia-mental retardation syndrome ,3q26.3-q27.3,
,,,Alopecia with mental retardation syndrome 1
,,,
AMT,aminomethyltransferase ,3p21.2-p21.1,
,,,Glycine encephalopathy [MIM:605899]
,,,
ANAPC1,anaphase promoting complex subunit 1 ,?,
,,,mutations
,,,
ANBC,Aneurysmal bone cysts ,16q22,
,,,Aneurysmal bone cysts
,,,
ANCR,Angelman syndrome chromosome region ,15q11-q13,
,,,Angelman syndrome [MIM:105830]
,,,
ANC,Anal canal carcinoma ,11q22-qter,
,,,Anal canal carcinoma
,,,
ANGPT1,angiopoietin 1 ,8q22,
,,,mutations
,,,
ANGPTL3,angiopoietin-like 3 ,1p31,
,,,"Hypobetalipoproteinemia, familial, 2 [MIM:605019]"
,,,
ANGPTL4,angiopoietin-like 4 ,19p13.3,
,,,"Reduced triglycerides, susceptibility to"
,,,
ANGPTL5,angiopoietin-like 5 ,11q22,
,,,mutations
,,,
ANG,"angiogenin, ribonuclease, RNase A family, 5 ",14q11.2,
,,,Amyotrophic lateral sclerosis 9 [MIM:611895]
,,,
ANIB10,"Aneurysm, intracranial berry, 10 ",8q12.1,
,,,"Aneurysm, intracranial berry, 10"
,,,
ANIB1,"aneurysm, intracranial berry 1 ",7q11.2,
,,,"Aneurysm, intracranial berry, 1"
,,,
ANIB2,"aneurysm, intracranial berry 2 ",19q13,
,,,"Aneurysm, intracranial berry, 2"
,,,
ANIB3,"aneurysm, intracranial berry 3 ",1p36.13-p34.3,
,,,"Aneurysm, intracranial berry, 3"
,,,
ANIB4,"aneurysm, intracranial berry 4 ",5p15.2-p14.3,
,,,"Aneurysm, intracranial berry, 4"
,,,
ANIB5,"Aneurysm, intracranial berry, 5 ",2p15-q14,
,,,"Aneurysm, intracranial berry, 5"
,,,
ANIB6,"Aneurysm, intracranial berry, 6 ",9p21,
,,,"Aneurysm, intracranial berry, 6"
,,,
ANIB7,"Aneurysm, intracranial berry, 7 ",11q24-q25,
,,,"Aneurysm, intracranial berry, 7"
,,,
ANIB8,"Aneurysm, intracranial berry, 8 ",14q23,
,,,"Aneurysm, intracranial berry, 8"
,,,
ANIB9,"Aneurysm, intracranial berry, 9 ",2q33.1,
,,,"Aneurysm, intracranial berry, 9"
,,,
ANIC,"Anosmia, isolated congenital ",18p11.23-q12.2,
,,,"Anosmia, isolated congenital"
,,,
ANK1,"ankyrin 1, erythrocytic ",8p11.2,
,,,"Spherocytosis, type 1 [MIM:182900]"
,,,
ANK2,"ankyrin 2, neuronal ",4q25-q27,
,,,Long QT syndrome-4 [MIM:600919]
,,,"Cardiac arrhythmia, ankyrin-B-related [MIM:600919]"
,,,
ANK3,"ankyrin 3, node of Ranvier (ankyrin G) ",10q21,
,,,mutations
,,,
ANKH,"ankylosis, progressive homolog (mouse) ",5p15.2-p14.1,
,,,Craniometaphyseal dysplasia [MIM:123000]
,,,Chondrocalcinosis 2 [MIM:118600]
,,,
ANKK1,ankyrin repeat and kinase domain containing 1 ,11q23.2,
,,,"Dopamine receptor D2, reduced brain density of"
,,,
ANKRD11,ankyrin repeat domain 11 ,16q24.3,
,,,mutations
,,,
ANKRD1,ankyrin repeat domain 1 (cardiac muscle) ,?,
,,,mutations
,,,
ANKRD26,ankyrin repeat domain 26 ,10p12.1,
,,,mutations
,,,
ANKS1A,ankyrin repeat and sterile alpha motif domain containing 1A ,6p21.3,
,,,mutations
,,,
ANKS1B,ankyrin repeat and sterile alpha motif domain containing 1B ,12q23.1,
,,,mutations
,,,
ANMA,Anisomastia ,16q13-q21,
,,,Anisomastia
,,,
ANO10,anoctamin 10 ,3p22.1,
,,,mutations
,,,
ANO5,anoctamin 5 ,11p14.3,
,,,Gnathodiaphyseal dysplasia [MIM:166260]
,,,"Muscular dystrophy, limb-girdle, type 2L [MIM:611307]"
,,,Miyoshi muscular dystrophy 3 [MIM:613319]
,,,
ANO6,anoctamin 6 ,12q12,
,,,Scott syndrome [MIM:262890]
,,,
ANO7,anoctamin 7 ,2q37.3,
,,,mutations
,,,
ANON1,"Anorexia nervosa, susceptibility to, 1 ",1p,
,,,"Anorexia nervosa, susceptibility to"
,,,
ANOP1,"anophthalmos 1 (with mental retardation, without limb anomalies or dental or urogenital abnormalities) ",Xq27-q28,
,,,"Microphthalmia, syndromic 4"
,,,
ANTXR1,anthrax toxin receptor 1 ,2p13.1,
,,,"Hemangioma, capillary infantile, susceptibility to [MIM:602089]"
,,,
ANTXR2,anthrax toxin receptor 2 ,4q21,
,,,"Fibromatosis, juvenile hyaline [MIM:228600]"
,,,"Hyalinosis, infantile systemic [MIM:236490]"
,,,
ANXA11,annexin A11 ,10q22.3-q23.1,
,,,mutations
,,,
ANXA5,annexin A5 ,4q26-q28,
,,,mutations
,,,
AN,blood group Ahonen ,?,
,,,mutations
,,,
AOAH,acyloxyacyl hydrolase (neutrophil) ,7p14-p12,
,,,mutations
,,,
AOCH,"Acromegaloid features, overgrowth, cleft palate, and hernia ",11,
,,,"Acromegaloid features, overgrowth, cleft palate, and hernia"
,,,
AOMS1,Abdominal obesity-metabolic syndrome QTL1 ,3q27,
,,,Abdominal obesity-metabolic syndrome
,,,
AOMS2,abdominal obesity-metabolic syndrome QTL2 ,17p12,
,,,Abdominal obesity-metabolic syndrome
,,,
AP1S1,"adaptor-related protein complex 1, sigma 1 subunit ",7q22.1,
,,,mutations
,,,
AP1S2,"adaptor-related protein complex 1, sigma 2 subunit ",Xp22,
,,,"Mental retardation, X-linked 59 [MIM:300630]"
,,,
AP3B1,"adaptor-related protein complex 3, beta 1 subunit ",5q14.1,
,,,Hermansky-Pudlak syndrome 2 [MIM:608233]
,,,
AP3B2,"adaptor-related protein complex 3, beta 2 subunit ",15q,
,,,mutations
,,,
AP4B1,"adaptor-related protein complex 4, beta 1 subunit ",1p13.2,
,,,mutations
,,,
AP4E1,"adaptor-related protein complex 4, epsilon 1 subunit ",15q21.2,
,,,mutations
,,,
AP4M1,"adaptor-related protein complex 4, mu 1 subunit ",7q22.1,
,,,"Cerebral palsy, spastic quadriplegic, 3 [MIM:612936]"
,,,
AP4S1,"adaptor-related protein complex 4, sigma 1 subunit ",14q12,
,,,mutations
,,,
AP5Z1,"adaptor-related protein complex 5, zeta 1 subunit ",7p22.1,
,,,"Spastic paraplegia 48, autosomal recessive [MIM:613647]"
,,,
APAF1,apoptotic peptidase activating factor 1 ,12q23,
,,,mutations
,,,
APBA2,"amyloid beta (A4) precursor protein-binding, family A, member 2 ",15q,
,,,mutations
,,,
APBB1,"amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) ",11p15,
,,,mutations
,,,
APBB2,"amyloid beta (A4) precursor protein-binding, family B, member 2 ",4p14,
,,,"Alzheimer disease, late-onset [MIM:104300]"
,,,
APBB3,"amyloid beta (A4) precursor protein-binding, family B, member 3 ",5q31,
,,,mutations
,,,
APCDD1,adenomatosis polyposis coli down-regulated 1 ,18p11,
,,,mutations
,,,
APCS,"amyloid P component, serum ",1q21-q23,
,,,"Amyloidosis, secondary, susceptibility to"
,,,
APC,adenomatous polyposis coli ,5q21-q22,
,,,Adenomatous polyposis coli [MIM:175100]
,,,"Gastric cancer, somatic [MIM:613659]"
,,,"Adenoma, periampullary, somatic"
,,,"Hepatoblastoma, somatic [MIM:114550]"
,,,"Desmoid disease, hereditary [MIM:135290]"
,,,Gardner syndrome
,,,"Colorectal cancer, somatic [MIM:114500]"
,,,Brain tumor-polyposis syndrome 2
,,,
APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1 ,14q12,
,,,mutations
,,,
APH1A,anterior pharynx defective 1 homolog A (C. elegans) ,1p36.13-q31.3,
,,,mutations
,,,
APH1B,anterior pharynx defective 1 homolog B (C. elegans) ,15q22.2,
,,,mutations
,,,
APLNR,apelin receptor ,11q12,
,,,mutations
,,,
APMR2,Alopecia with mental retardation syndrome 2 ,3q26.2-q26.31,
,,,Alopecia with mental retardation syndrome 2
,,,
APOA1,apolipoprotein A-I ,11q23,
,,,"ApoA-I and apoC-III deficiency, combined"
,,,Hypoalphalipoproteinemia [MIM:604091]
,,,"Corneal clouding, autosomal recessive"
,,,"Amyloidosis, 3 or more types [MIM:105200]"
,,,
APOA2,apolipoprotein A-II ,1q21-q23,
,,,Apolipoprotein A-II deficiency
,,,"Hypercholesterolemia, familial, modification of [MIM:143890]"
,,,
APOA4,apolipoprotein A-IV ,11q23,
,,,mutations
,,,
APOA5,apolipoprotein A-V ,11q23,
,,,"Hypertriglyceridemia, susceptibility to [MIM:145750]"
,,,"Hyperchylomicronemia, late-onset [MIM:144650]"
,,,
APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B ",22q13,
,,,mutations
,,,
APOBEC3G,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G ",22q12-q13.2,
,,,mutations
,,,
APOBEC3H,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H ",22q13.1,
,,,mutations
,,,
APOB,apolipoprotein B (including Ag(x) antigen) ,2p24,
,,,Hypobetalipoproteinemia
,,,"Hypobetalipoproteinemia, normotriglyceridemic"
,,,"Hypercholesterolemia, due to ligand-defective apo B [MIM:144010]"
,,,
APOC1,apolipoprotein C-I ,19q13.2,
,,,mutations
,,,
APOC2,apolipoprotein C-II ,19q13.2,
,,,"Hyperlipoproteinemia, type Ib [MIM:207750]"
,,,
APOC3,apolipoprotein C-III ,11q23,
,,,Apolipoprotein C3 deficiency
,,,
APOC4,apolipoprotein C-IV ,19q13.2,
,,,mutations
,,,
APOD,apolipoprotein D ,3q26.2-qter,
,,,mutations
,,,
APOE,apolipoprotein E ,19q13.2,
,,,"Hyperlipoproteinemia, type III"
,,,Myocardial infarction susceptibility
,,,Sea-blue histiocyte disease [MIM:269600]
,,,Alzheimer disease-2 [MIM:104310]
,,,"Macular degeneration, age-related [MIM:603075]"
,,,Lipoprotein glomerulopathy [MIM:611771]
,,,
APOH,apolipoprotein H (beta-2-glycoprotein I) ,17q23-qter,
,,,deficiency of production of apo-H dependent antiphospholipid autoantibody
,,,
APOL1,"apolipoprotein L, 1 ",22q12.3,
,,,"Glomerulosclerosis, focal segmental, 4, susceptibility to [MIM:612551]"
,,,"End-stage renal disease, nondiabetic, susceptibility to [MIM:612551]"
,,,
APOL2,"apolipoprotein L, 2 ",22q12.3,
,,,Schizophrenia [MIM:181500]
,,,
APOL3,"apolipoprotein L, 3 ",22q12.3,
,,,mutations
,,,
APOL4,"apolipoprotein L, 4 ",22q12.3,
,,,Schizophrenia [MIM:181500]
,,,
APOM,apolipoprotein M ,?,
,,,mutations
,,,
APP,amyloid beta (A4) precursor protein ,21q21,
,,,"Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants [MIM:605714]"
,,,"Alzheimer disease 1, familial [MIM:104300]"
,,,"Dementia, early-onset progressive, autosomal recessive"
,,,
APRT,adenine phosphoribosyltransferase ,16q24.3,
,,,"Urolithiasis, 2,8-dihydroxyadenine"
,,,
APTX,aprataxin ,9p13.3,
,,,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia [MIM:208920]"
,,,Coenzyme Q10 deficiency [MIM:607426]
,,,
AQP1,aquaporin 1 (Colton blood group) ,7p14,
,,,"Blood group, Colton [MIM:110450]"
,,,Aquaporin-1 deficiency
,,,
AQP2,aquaporin 2 (collecting duct) ,12q13,
,,,"Diabetes insipidus, nephrogenic [MIM:125800]"
,,,
AQP3,aquaporin 3 (Gill blood group) ,9p13,
,,,Blood group GIL [MIM:607457]
,,,
AQP4,aquaporin 4 ,18q11.2-q12.1,
,,,mutations
,,,
AQP5,aquaporin 5 ,12q13,
,,,mutations
,,,
AQP7,aquaporin 7 ,9p13,
,,,mutations
,,,
AQP9,aquaporin 9 ,15q22,
,,,"Glycerol release during exercise, defective"
,,,
ARCC1,Age-related cortical cataract 1 ,6p12-q12,
,,,"Cataract, age-related cortical, susceptibility to"
,,,
ARCODS,Ariculocondylar syndrome ,1p21.1-q23.3,
,,,Ariculocondylar syndrome
,,,
ARC,activity-regulated cytoskeleton-associated protein ,8q24,
,,,mutations
,,,
ARF4,ADP-ribosylation factor 4 ,3p14.1,
,,,mutations
,,,
ARFGEF2,ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) ,20q13.13,
,,,Periventricular heterotopia with microcephaly [MIM:608097]
,,,
ARG1,"arginase, liver ",6q23,
,,,Argininemia [MIM:207800]
,,,
ARHGAP24,Rho GTPase activating protein 24 ,4q21,
,,,mutations
,,,
ARHGAP26,Rho GTPase activating protein 26 ,5q31,
,,,"Leukemia, juvenile myelomonocytic [MIM:607785]"
,,,
ARHGAP31,Rho GTPase activating protein 31 ,3q13.3,
,,,mutations
,,,
ARHGAP6,Rho GTPase activating protein 6 ,Xp22.3,
,,,mutations
,,,
ARHGAP9,Rho GTPase activating protein 9 ,12q14,
,,,"Coronary artery spasm 3, susceptibility to"
,,,
ARHGEF10,Rho guanine nucleotide exchange factor (GEF) 10 ,8p23,
,,,"Slowed nerve conduction velocity, AD [MIM:608236]"
,,,
ARHGEF11,Rho guanine nucleotide exchange factor (GEF) 11 ,?,
,,,mutations
,,,
ARHGEF12,Rho guanine nucleotide exchange factor (GEF) 12 ,11q23.3,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
ARHGEF6,Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 ,Xq26,
,,,"Mental retardation, X-linked nonspecific, type 46 [MIM:300436]"
,,,
ARHGEF7,Rho guanine nucleotide exchange factor (GEF) 7 ,13q34,
,,,mutations
,,,
ARHGEF9,Cdc42 guanine nucleotide exchange factor (GEF) 9 ,Xq22.1,
,,,"Epileptic encephalopathy, early infantile, 8 [MIM:300607]"
,,,
ARHI1,Age-related hearing impairment 1 ,8q24.13-q24.22,
,,,Age-related hearing impairment 1
,,,
ARHI2,Age-related hearing impairment 2 ,3p26.1-p25.1,
,,,Age-related hearing impairment 2
,,,
ARID1A,AT rich interactive domain 1A (SWI-like) ,1p36.1-p35,
,,,mutations
,,,
ARID1B,AT rich interactive domain 1B (SWI1-like) ,?,
,,,mutations
,,,
ARL11,ADP-ribosylation factor-like 11 ,13q14.3,
,,,mutations
,,,
ARL13B,ADP-ribosylation factor-like 13B ,3q11.2,
,,,Joubert syndrome 8 [MIM:612291]
,,,
ARL6IP5,ADP-ribosylation-like factor 6 interacting protein 5 ,3p14,
,,,mutations
,,,
ARL6,ADP-ribosylation factor-like 6 ,3p12-q13,
,,,Bardet-Biedl syndrome 3 [MIM:209900]
,,,"Bardet-Biedl syndrome 1, modifier of [MIM:209900]"
,,,Retinitis pigmentosa 55 [MIM:613575]
,,,
ARMS2,age-related maculopathy susceptibility 2 ,10q26.13,
,,,"Macular degeneration, age-related, 8"
,,,
ARNT,aryl hydrocarbon receptor nuclear translocator ,1q21,
,,,"Leukemia, acute myeloblastic"
,,,
ARPC3,"actin related protein 2/3 complex, subunit 3, 21kDa ",?,
,,,mutations
,,,
ARSA,arylsulfatase A ,22q13.31-qter,
,,,Metachromatic leukodystrophy [MIM:250100]
,,,
ARSB,arylsulfatase B ,5q11-q13,
,,,Mucopolysaccharidosis type VI (Maroteaux-Lamy) [MIM:253200]
,,,
ARSE,arylsulfatase E (chondrodysplasia punctata 1) ,Xp22.3,
,,,"Chondrodysplasia punctata, X-linked recessive [MIM:302950]"
,,,
ARSF,arylsulfatase F ,Xp22.3,
,,,mutations
,,,
ART4,ADP-ribosyltransferase 4 (Dombrock blood group) ,12p13-p12,
,,,"Blood group, Dombrock"
,,,
ARVCF,armadillo repeat gene deleted in velocardiofacial syndrome ,22q11,
,,,mutations
,,,
ARVD1,arrhythmogenic right ventricular dysplasia 1 ,14q12-q22,
,,,Arrhythmogenic right ventricular dysplasia-3
,,,
ARVD3,arrhythmogenic right ventricular dysplasia 3 ,14q12-q22,
,,,Arrhythmogenic right ventricular dysplasia-3
,,,
ARVD4,arrhythmogenic right ventricular dysplasia 4 ,2q32.1-q32.3,
,,,Arrhythmogenic right ventricular dysplasia-4
,,,
ARVD5,arrhythmogenic right ventricular dysplasia 5 ,3p25,
,,,"Arrhythmogenic right ventricular dysplasia, familial, 5 [MIM:604400]"
,,,
ARVD6,arrhythmogenic right ventricular dysplasia 6 ,10p14-p12,
,,,Arrhythmogenic right ventricular dysplasia-6
,,,
ARVD7,"Arrhythmogenic right ventricular dysplasia, familial, 7 ",10q22.3,
,,,Arrhythmogenic right ventricular dysplasia-7
,,,
ARX,aristaless related homeobox ,Xp22.13,
,,,"Epileptic encephalopathy, early infantile, 1 [MIM:308350]"
,,,"Lissencephaly, X-linked 2 [MIM:300215]"
,,,"Mental retardation, X-linked 36/43/54 [MIM:300419]"
,,,Proud syndrome [MIM:300004]
,,,Partington syndrome [MIM:309510]
,,,Hydranencephaly with abnormal genitalia [MIM:300215]
,,,
AR,androgen receptor ,Xq11-q12,
,,,Androgen insensitivity [MIM:300068]
,,,Spinal and bulbar muscular atrophy of Kennedy [MIM:313200]
,,,"Androgen insensitivity, partial, with or without breast cancer [MIM:312300]"
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,"Hypospadias 1, X-linked [MIM:300633]"
,,,
AS3MT,arsenic (+3 oxidation state) methyltransferase ,10q24,
,,,mutations
,,,
ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1 ,8p22-p21.3,
,,,Farber lipogranulomatosis [MIM:228000]
,,,
ASAH2,N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 ,?,
,,,mutations
,,,
ASB10,ankyrin repeat and SOCS box containing 10 ,?,
,,,mutations
,,,
ASCC1,activating signal cointegrator 1 complex subunit 1 ,?,
,,,mutations
,,,
ASCC3,activating signal cointegrator 1 complex subunit 3 ,?,
,,,mutations
,,,
ASCL1,achaete-scute complex homolog 1 (Drosophila) ,12q22-q23,
,,,"Central hypoventilation syndrome, congenital [MIM:209880]"
,,,Haddad syndrome [MIM:209880]
,,,
ASD1,atrial septal defect 1 ,5p,
,,,"Atrial septal defect, secundum type"
,,,
ASIP,agouti signaling protein ,20q11.2,
,,,"Skin/hair/eye pigmentation 9, dark/light hair [MIM:611742]"
,,,
ASL,argininosuccinate lyase ,7cen-q11.2,
,,,Argininosuccinic aciduria [MIM:207900]
,,,
ASMTL,acetylserotonin O-methyltransferase-like ,Xpter-p22.32,
,,,mutations
,,,
ASMT,acetylserotonin O-methyltransferase ,Xpter-p22.32,
,,,mutations
,,,
ASNS,asparagine synthetase (glutamine-hydrolyzing) ,7q21-q31,
,,,mutations
,,,
ASPA,aspartoacylase ,17pter-p13,
,,,Canavan disease [MIM:271900]
,,,
ASPG1,"Asperger syndrome, susceptibility to, 1 ",3q25-q27,
,,,Asperger syndrome susceptibility 1
,,,
ASPG2,"Asperger syndrome, susceptibility to, 2 ",17p13,
,,,Asperger syndrome susceptibility 2
,,,
ASPG3,"Asperger syndrome, susceptibility to, 3 ",1q21-q22,
,,,Asperger syndrome susceptibility 3
,,,
ASPG4,"Asperger syndrome, susceptibility to, 4 ",3p24-p21,
,,,Asperger syndrome susceptibility 4
,,,
ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila) ",1q31,
,,,"Microcephaly, primary autosomal recessive, 5, with or without simplified gyral pattern [MIM:608716]"
,,,
ASPN,asporin ,9q21.3-q22,
,,,Osteoarthritis susceptibility 3 [MIM:607850]
,,,Lumbar disc degeneration [MIM:603932]
,,,
ASPRV1,"aspartic peptidase, retroviral-like 1 ",2p13.1,
,,,mutations
,,,
ASPSCR1,"alveolar soft part sarcoma chromosome region, candidate 1 ",17q25,
,,,Alveolar soft-part sarcoma [MIM:606243]
,,,
ASRT3,"Asthma-related traits, susceptibility to, 3 ",2p16,
,,,"Asthma-related traits, susceptibility to, 3"
,,,
ASRT4,"Asthma-related traits, susceptibility to, 4 ",1p31,
,,,"Asthma-related traits, susceptibility to, 4"
,,,
ASRT6,"Asthma-related traits, susceptibility to, 6 ",17q21,
,,,"Asthma-related traits, susceptibility to, 6"
,,,
ASRT8,"Asthma-related traits, susceptibility to, 8 ",9q33,
,,,"Asthma-related traits, susceptibility to, 8"
,,,
ASS1,argininosuccinate synthase 1 ,9q34.1,
,,,Citrullinemia [MIM:215700]
,,,
ASTN2,astrotactin 2 ,9q33.1,
,,,mutations
,,,
ASXL1,additional sex combs like 1 (Drosophila) ,20q11.21,
,,,mutations
,,,
ATCAY,"ataxia, cerebellar, Cayman type ",19p13.3,
,,,"Ataxia, cerebellar, Cayman type [MIM:601238]"
,,,
ATD,asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome) ,15q13,
,,,Asphyxiating thoracic dystrophy 1
,,,
ATF1,activating transcription factor 1 ,12q13,
,,,mutations
,,,
ATF3,activating transcription factor 3 ,1q32.3,
,,,mutations
,,,
ATF5,activating transcription factor 5 ,19q13.3,
,,,mutations
,,,
ATF6,activating transcription factor 6 ,1q22-q23,
,,,mutations
,,,
ATFB1,"Atrial fibrillation, familial 1 ",10q22-q24,
,,,"Atrial fibrillation, familial, 1"
,,,
ATFB2,familial atrial fibrillation 2 ,6q14-q16,
,,,"Atrial fibrillation, familial, 2"
,,,
ATFB5,"Atrial fibrillation, familial, 5 ",4q25,
,,,"Atrial fibrillation, familial, 5"
,,,
ATFB8,"Atrial fibrillation, familial, 8 ",16q22,
,,,"Atrial fibrillation, familial, 8"
,,,
ATG16L1,autophagy related 16-like 1 (S. cerevisiae) ,2q37.1,
,,,Inflammatory bowel disease 10 [MIM:611081]
,,,
ATG7,autophagy related 7 ,?,
,,,mutations
,,,
ATHS,atherosclerosis susceptibility (lipoprotein associated) ,19p13.3-p13.2,
,,,"Atherosclerosis, susceptibility to"
,,,
ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase ,2q35,
,,,AICA-ribosiduria due to ATIC deficiency [MIM:608688]
,,,
ATL1,atlastin GTPase 1 ,14q11-q21,
,,,Spastic paraplegia-3A [MIM:182600]
,,,
ATM,ataxia telangiectasia mutated ,11q22.3,
,,,Ataxia-telangiectasia [MIM:208900]
,,,"Lymphoma, B-cell non-Hodgkin, somatic"
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,"Lymphoma, mantle cell"
,,,"T-cell prolymphocytic leukemia, sporadic"
,,,
ATN1,atrophin 1 ,12p13.31,
,,,Dentatorubro-pallidoluysian atrophy [MIM:125370]
,,,
ATOD3,"Dermatitis, atopic, 3 ",20p,
,,,"Dermatitis, atopic, susceptibility to, 3"
,,,
ATOD5,"Dermatitis, atopic, 5 ",13q12-q14,
,,,"Dermatitis, atopic, susceptibility to, 5"
,,,
ATOD6,"Dermatitis, atopic, 6 ",5q31-q33,
,,,"Dermatitis, atopic, susceptibility to, 6"
,,,
ATOD7,"Dermatitis, atopic, susceptibility to, 7 ",11q13.5,
,,,"Dermatitis, atopic, susceptibility to, 7"
,,,
ATOD,"Dermatitis, atopic ",3q21,
,,,"Dermatitis, atopic, susceptibility to, 1"
,,,
ATOH7,atonal homolog 7 (Drosophila) ,10q21.3-q22.1,
,,,mutations
,,,
ATP10A,"ATPase, class V, type 10A ",15q11-q13,
,,,mutations
,,,
ATP10D,"ATPase, class V, type 10D ",?,
,,,mutations
,,,
ATP13A2,ATPase type 13A2 ,1p36,
,,,Parkinson disease 9 [MIM:606693]
,,,
ATP13A4,ATPase type 13A4 ,?,
,,,mutations
,,,
ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide ",1q21-q23,
,,,"Migraine, familial hemiplegic, 2 [MIM:602481]"
,,,Alternating hemiplegia of childhood [MIM:104290]
,,,"Migraine, familial basilar [MIM:602481]"
,,,
ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide ",19q12-q13.2,
,,,Dystonia-12 [MIM:128235]
,,,
ATP1B1,"ATPase, Na+/K+ transporting, beta 1 polypeptide ",1q22-q25,
,,,Blood pressure regulation QTL [MIM:145500]
,,,
ATP2A1,"ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 ",16p12,
,,,Brody myopathy [MIM:601003]
,,,
ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 ",12q23-q24.1,
,,,Darier disease [MIM:124200]
,,,Acrokeratosis verruciformis [MIM:101900]
,,,
ATP2A3,"ATPase, Ca++ transporting, ubiquitous ",17p13.3,
,,,mutations
,,,
ATP2B2,"ATPase, Ca++ transporting, plasma membrane 2 ",3p26-p25,
,,,"Deafness, autosomal recessive 12, modifier of [MIM:601386]"
,,,
ATP2B4,"ATPase, Ca++ transporting, plasma membrane 4 ",1q25-q32,
,,,mutations
,,,
ATP2C1,"ATPase, Ca++ transporting, type 2C, member 1 ",3q21-q24,
,,,Hailey-Hailey disease [MIM:169600]
,,,
ATP5E,"ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit ",20q13.3,
,,,mutations
,,,
ATP5SL,ATP5S-like ,?,
,,,mutations
,,,
ATP6AP2,"ATPase, H+ transporting, lysosomal accessory protein 2 ",Xp11.4,
,,,"Mental retardation, X-linked, with epilepsy [MIM:300423]"
,,,
ATP6V0A1,"ATPase, H+ transporting, lysosomal V0 subunit a1 ",17q21,
,,,mutations
,,,
ATP6V0A2,"ATPase, H+ transporting, lysosomal V0 subunit a2 ",12q24.3,
,,,"Cutis laxa, autosomal recessive, type II [MIM:219200]"
,,,Wrinkly skin syndrome [MIM:278250]
,,,
ATP6V0A4,"ATPase, H+ transporting, lysosomal V0 subunit a4 ",7q33-q34,
,,,"Renal tubular acidosis, distal, autosomal recessive [MIM:602722]"
,,,
ATP6V1B1,"ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 ",2cen-q13,
,,,Renal tubular acidosis with deafness [MIM:267300]
,,,
ATP7A,"ATPase, Cu++ transporting, alpha polypeptide ",Xq12-q13,
,,,Menkes disease [MIM:309400]
,,,Occipital horn syndrome [MIM:304150]
,,,"Spinal muscular atrophy, distal, X-linked 3 [MIM:300489]"
,,,
ATP7B,"ATPase, Cu++ transporting, beta polypeptide ",13q14.3-q21.1,
,,,Wilson disease [MIM:277900]
,,,
ATP8A2,"ATPase, aminophospholipid transporter, class I, type 8A, member 2 ",13q12,
,,,mutations
,,,
ATP8B1,"ATPase, aminophospholipid transporter, class I, type 8B, member 1 ",18q21,
,,,"Cholestasis, progressive familial intrahepatic 1 [MIM:211600]"
,,,"Cholestasis, benign recurrent intrahepatic [MIM:243300]"
,,,
ATPAF2,ATP synthase mitochondrial F1 complex assembly factor 2 ,17p11.2,
,,,"ATP synthase deficiency, nuclear-encoded [MIM:604273]"
,,,
ATPLS,"antiphospholipid syndrome, familial ",6p21.3,
,,,"Antiphospholipid syndrome, familial"
,,,
ATRNL1,attractin-like 1 ,10q26,
,,,mutations
,,,
ATRX,alpha thalassemia/mental retardation syndrome X-linked ,Xq13,
,,,Alpha-thalassemia/mental retardation syndrome [MIM:301040]
,,,"Alpha-thalassemia myelodysplasia syndrome, somatic [MIM:300448]"
,,,"Mental retardation-hypotonic facies syndrome, X-linked [MIM:309580]"
,,,
ATR,ataxia telangiectasia and Rad3 related ,3q22-q24,
,,,Seckel syndrome 1 [MIM:210600]
,,,
ATXN10,ataxin 10 ,22q13,
,,,Spinocerebellar ataxia-10 [MIM:603516]
,,,
ATXN1,ataxin 1 ,6p23,
,,,Spinocerebellar ataxia-1 [MIM:164400]
,,,
ATXN2,ataxin 2 ,12q24,
,,,Spinocerebellar ataxia-2 [MIM:183090]
,,,
ATXN3L,ataxin 3-like ,?,
,,,mutations
,,,
ATXN3,ataxin 3 ,14q24.3-q31,
,,,Machado-Joseph disease [MIM:109150]
,,,
ATXN7,ataxin 7 ,3p21.1-p12,
,,,Spinocerebellar ataxia-7 [MIM:164500]
,,,
ATXN8OS,ATXN8 opposite strand (non-protein coding) ,13q21,
,,,Spinocerebellar ataxia 8 [MIM:608768]
,,,
ATXN8,ataxin 8 ,13q21,
,,,Spinocerebellar ataxia 8 [MIM:608768]
,,,
AUH,AU RNA binding protein/enoyl-CoA hydratase ,9,
,,,"3-methylglutaconic aciduria, type I [MIM:250950]"
,,,
AUNX1,"auditory neuropathy, X-linked recessive 1 ",Xq23-q27.3,
,,,"Deafness, X-linked 5"
,,,
AURKA,aurora kinase A ,20q13.2-q13.3,
,,,"Colon cancer, susceptibility to [MIM:114500]"
,,,
AURKC,aurora kinase C ,19q13.43,
,,,"Male infertility with large-headed, multiflagellar, polyploid spermatozoa [MIM:243060]"
,,,
AUTS11,"Autism, susceptibility to, 11 ",1q41-q42,
,,,Autism susceptibility 11
,,,
AUTS12,"autism, susceptibility to, 12 ",21p13-q11,
,,,Autism susceptibility 12
,,,
AUTS13,"autism, susceptibility to, 13 ",12q14.2,
,,,Autism susceptibility 13
,,,
AUTS14,"autism, susceptibility to, 14 ",16p11.2,
,,,Autism susceptibility 14
,,,
AUTS1,autism susceptibility 1 ,7q22,
,,,Autism susceptibility 1
,,,
AUTS2,autism susceptibility candidate 2 ,7q11.2,
,,,mutations
,,,
AUTS3,"Autism, susceptibility to, 3 ",13q14.2-q14.1,
,,,Autism susceptibility 3
,,,
AUTS5,"Autism, susceptibility to, 5 ",2q,
,,,Autism susceptibility 5
,,,
AUTS6,"Autism, susceptibility to, 6 ",17q11,
,,,Autism susceptibility 6
,,,
AUTS7,"Autism, susceptibility to, 7 ",17q21,
,,,Autism susceptibility 7
,,,
AUTS8,"Autism, susceptibility to, 8 ",3q25-q27,
,,,Autism susceptibility 8
,,,
AUTSX4,"Autism, X-linked, susceptibility to, 4 ",Xp22.11,
,,,"Autism susceptibility, X-linked 4"
,,,
AVPR1A,arginine vasopressin receptor 1A ,12q14-q15,
,,,mutations
,,,
AVPR1B,arginine vasopressin receptor 1B ,1q32,
,,,mutations
,,,
AVPR2,arginine vasopressin receptor 2 ,Xq28,
,,,"Diabetes insipidus, nephrogenic [MIM:304800]"
,,,Nephrogenic syndrome of inappropriate antidiuresis [MIM:300539]
,,,
AVP,arginine vasopressin ,20p13,
,,,"Diabetes insipidus, neurohypophyseal [MIM:125700]"
,,,
AVSD1,atrioventricular septal defect 1 ,1p31-p21,
,,,Atrioventricular canal defect [MIM:600309]
,,,
AXIN1,axin 1 ,16p13.3,
,,,"Hepatocellular carcinoma, somatic [MIM:114550]"
,,,Caudal duplication anomaly [MIM:607864]
,,,
AXIN2,axin 2 ,17q24,
,,,Colorectal cancer [MIM:114500]
,,,Oligodontia-colorectal cancer syndrome [MIM:608615]
,,,
AXL,AXL receptor tyrosine kinase ,19q13.1-q13.2,
,,,mutations
,,,
AZF1,azoospermia factor 1 ,?,
,,,mutations
,,,
AZON,"Azoospremia, nonobstructive ",6p21.3,
,,,"Azoospremia, nonobstructive"
,,,
B2M,beta-2-microglobulin ,15q21-q22,
,,,"Hypoproteinemia, hypercatabolic [MIM:241600]"
,,,
B3GALNT1,"beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) ",3q25,
,,,"Blood group, P system [MIM:111400]"
,,,"Urinary tract infection, susceptibility to"
,,,
B3GALT6,"UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 ",?,
,,,mutations
,,,
B3GALTL,"beta 1,3-galactosyltransferase-like ",13q12.3,
,,,Peters-plus syndrome [MIM:261540]
,,,
B3GAT3,"beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) ",11q12-q13,
,,,mutations
,,,
B3GNT1,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 ",11,
,,,mutations
,,,
B3GNT3,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 ",19p,
,,,mutations
,,,
B4GALNT2,"beta-1,4-N-acetyl-galactosaminyl transferase 2 ",17q21.2,
,,,"Blood group, Sd system"
,,,"Blood group, Cad system"
,,,
B4GALT1,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 ",9p13,
,,,"Congenital disorder of glycosylation, type IId [MIM:607091]"
,,,
B4GALT7,"xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 ",5q35.2-q35.3,
,,,"Ehlers-Danlos syndrome, progeroid form [MIM:130070]"
,,,
B6QTL1,Vitamin B6 plasma level QTL 1 ,1p36.12,
,,,Vitamin B6 plasma level QTL 1
,,,
B9D1,B9 protein domain 1 ,?,
,,,mutations
,,,
B9D2,B9 protein domain 2 ,19q13.2,
,,,mutations
,,,
BAALC,"brain and acute leukemia, cytoplasmic ",8q22.3,
,,,mutations
,,,
BAAT,bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) ,9q22.3,
,,,"Hypercholanemia, familial [MIM:607748]"
,,,
BACE1,beta-site APP-cleaving enzyme 1 ,11q23.3,
,,,mutations
,,,
BAG3,BCL2-associated athanogene 3 ,10q25.2-q26.2,
,,,"Myopathy, myofibrillar, BAG3-related [MIM:612954]"
,,,
BAG6,BCL2-associated athanogene 6 ,6p21.3,
,,,mutations
,,,
BANF1,barrier to autointegration factor 1 ,11,
,,,mutations
,,,
BANK1,B-cell scaffold protein with ankyrin repeats 1 ,4q22-q24,
,,,"Systemic lupus erythematosus, association with [MIM:152700]"
,,,
BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) ,3p21.3,
,,,mutations
,,,
BARD1,BRCA1 associated RING domain 1 ,2q34-q35,
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,
BAS,"Beta-adrenergic stimulation, response to ",21,
,,,mutations
,,,
BAX,BCL2-associated X protein ,19q13.3-q13.4,
,,,Colorectal cancer
,,,T-cell acute lymphoblastic leukemia
,,,
BBS10,Bardet-Biedl syndrome 10 ,12q21.2,
,,,Bardet-Biedl syndrome 10 [MIM:209900]
,,,
BBS12,Bardet-Biedl syndrome 12 ,4q27,
,,,Bardet-Biedl syndrome 12 [MIM:209900]
,,,
BBS1,Bardet-Biedl syndrome 1 ,11q13,
,,,Bardet-Biedl syndrome 1 [MIM:209900]
,,,
BBS2,Bardet-Biedl syndrome 2 ,16q21,
,,,Bardet-Biedl syndrome 2 [MIM:209900]
,,,
BBS4,Bardet-Biedl syndrome 4 ,15q22.3-q23,
,,,Bardet-Biedl syndrome 4 [MIM:209900]
,,,
BBS5,Bardet-Biedl syndrome 5 ,2q31,
,,,Bardet-Biedl syndrome 5 [MIM:209900]
,,,
BBS7,Bardet-Biedl syndrome 7 ,4q27,
,,,Bardet-Biedl syndrome 7 [MIM:209900]
,,,
BBS9,Bardet-Biedl syndrome 9 ,7p14,
,,,Bardet-Biedl syndrome 9 [MIM:209900]
,,,
BCAM,basal cell adhesion molecule (Lutheran blood group) ,19q13.2,
,,,"Blood group, Lutheran system [MIM:111200]"
,,,"Blood group, Auberger system [MIM:111200]"
,,,"Blood group, Lutheran null [MIM:247420]"
,,,
BCAP31,B-cell receptor-associated protein 31 ,Xq28,
,,,mutations
,,,
BCAT1,"branched chain amino-acid transaminase 1, cytosolic ",12p12,
,,,Hyperleucinemia-isoleucinemia or hypervalinemia
,,,
BCAT2,"branched chain amino-acid transaminase 2, mitochondrial ",19q13,
,,,Hypervalinemia or hyperleucine-isoleucinemia
,,,
BCC1,"Basal cell carcinoma, susceptibility to, 1 ",1p36,
,,,"Basal cell carcinoma, susceptibility to, 1"
,,,
BCC2,"Basal cell carcinoma, susceptibility to, 2 ",1q42,
,,,"Basal cell carcinoma, susceptibility to, 2"
,,,
BCC3,"Basal cell carcinoma, susceptibility to, 3 ",5p15.33,
,,,"Basal cell carcinoma, susceptibility to, 3"
,,,
BCC4,"Basal cell carcinoma, susceptibility to, 4 ",12q13,
,,,"Basal cell carcinoma, susceptibility to, 4"
,,,
BCC5,"Basal cell carcinoma, susceptibility to, 5 ",9p21,
,,,"Basal cell carcinoma, susceptibility to, 5"
,,,
BCC6,"Basal cell carcinoma, susceptibility to, 6 ",7q32,
,,,"Basal cell carcinoma, susceptibility to, 6"
,,,
BCHE,butyrylcholinesterase ,3q26.1-q26.2,
,,,"Apnea, postanesthetic"
,,,
BCKDHA,"branched chain keto acid dehydrogenase E1, alpha polypeptide ",19q13.1-q13.2,
,,,"Maple syrup urine disease, type Ia [MIM:248600]"
,,,
BCKDHB,"branched chain keto acid dehydrogenase E1, beta polypeptide ",6q14,
,,,"Maple syrup urine disease, type Ib [MIM:248600]"
,,,
BCL10,B-cell CLL/lymphoma 10 ,1p22,
,,,"Lymphoma, MALT"
,,,"Lymphoma, follicular"
,,,Mesothelioma
,,,Germ cell tumor
,,,Sezary syndrome
,,,Colon cancer
,,,
BCL11A,B-cell CLL/lymphoma 11A (zinc finger protein) ,2p16.1,
,,,mutations
,,,
BCL2A1,BCL2-related protein A1 ,15q24.3,
,,,mutations
,,,
BCL2L11,BCL2-like 11 (apoptosis facilitator) ,2q12-q13,
,,,mutations
,,,
BCL2L2,BCL2-like 2 ,14q11.2-q12,
,,,mutations
,,,
BCL2,B-cell CLL/lymphoma 2 ,18q21.3,
,,,"Leukemia/lymphoma, B-cell, 2"
,,,
BCL3,B-cell CLL/lymphoma 3 ,19q13,
,,,"Leukemia/lymphoma, B-cell, 3"
,,,
BCL5,B-cell CLL/lymphoma 5 ,17q22,
,,,"B cell prolymphocytic acute agressive leukemia with translocation t(8;17)(q24;q22),see MYC"
,,,
BCL6,B-cell CLL/lymphoma 6 ,3q27,
,,,"Lymphoma, B-cell"
,,,
BCL7A,B-cell CLL/lymphoma 7A ,12q24.1,
,,,"B-cell non-Hodgkin lymphoma, high-grade"
,,,
BCL9,B-cell CLL/lymphoma 9 ,1q21,
,,,"B-cell CLL ,chronic lymphocytic leukemia with translocation t(1;14)(q21;q32),t(1;22)(q21;q11)"
,,,
BCMO1,"beta-carotene 15,15'-monooxygenase 1 ",16q21-q23,
,,,"Hypercarotenemia and vitamin A deficiency, autosomal dominant [MIM:115300]"
,,,
BCORL1,BCL6 corepressor-like 1 ,Xq25-q26.1,
,,,mutations
,,,
BCOR,BCL6 corepressor ,Xp11.4,
,,,"Microphthalmia, syndromic 2 [MIM:300166]"
,,,
BCPR,Breast cancer-related regulator of TP53 ,17p13.3,
,,,Breast cancer
,,,
BCR,breakpoint cluster region ,22q11.21,
,,,"Leukemia, chronic myeloid [MIM:608232]"
,,,"Leukemia, acute lymphocytic [MIM:613065]"
,,,
BCS1L,BCS1-like (S. cerevisiae) ,2q33,
,,,Mitochondrial complex III deficiency [MIM:124000]
,,,GRACILE syndrome [MIM:603358]
,,,Leigh syndrome [MIM:256000]
,,,Bjornstad syndrome [MIM:262000]
,,,
BDA1B,"Brachydactyly, type A1, locus B ",5p13.3-p13.2,
,,,"Brachydactyly, type A1 [MIM:112500]"
,,,
BDET,"Bleeding disorder, east Texas type ",1q23,
,,,"Bleeding disorder, east Texas type"
,,,
BDKRB2,bradykinin receptor B2 ,14q32.1-q32.2,
,,,mutations
,,,
BDNF,brain-derived neurotrophic factor ,11p13,
,,,"Memory impairment, susceptibility to"
,,,"Central hypoventilation syndrome, congenital [MIM:209880]"
,,,"Obsessive-compulsive disorder, protection against [MIM:164230]"
,,,"Bulimia nervosa, age of onset of weight loss in [MIM:607499]"
,,,"Anorexia nervosa, susceptibility to [MIM:606788]"
,,,
BEAN1,"brain expressed, associated with NEDD4, 1 ",16q21,
,,,Spinocerebellar ataxia 31 [MIM:117210]
,,,
BEST1,bestrophin 1 ,11q13,
,,,Best macular dystrophy [MIM:153700]
,,,"Maculopathy, bull's-eye"
,,,"Vitelliform macular dystrophy, adult-onset [MIM:608161]"
,,,Bestrophinopathy [MIM:611809]
,,,Vitreoretinochoroidopathy [MIM:193220]
,,,"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma [MIM:193220]"
,,,Retinitis pigmentosa-50 [MIM:613194]
,,,"Retinitis pigmentosa, concentric [MIM:613194]"
,,,
BEX4,"brain expressed, X-linked 4 ",Xq22.2,
,,,mutations
,,,
BFHD,Beukes familial hip dysplasia ,4q35,
,,,"Hip dysplasia, Beukes type"
,,,
BFIC2,Benign familial infantile convulsions-2 ,16p12-q12,
,,,"Convulsions, benign familial infantile, 2"
,,,
BFIC4,"Convulsions, benign familial infantile, 4 ",1p36.12-p35.1,
,,,"Convulsions, benign familial infantile, 4"
,,,
BFIC,benign familial infantile convulsions ,19q,
,,,"Convulsions, benign familial infantile"
,,,
BFSP1,"beaded filament structural protein 1, filensin ",20p12.1-p11.23,
,,,"Cataract, cortical, juvenile-onset [MIM:611391]"
,,,
BFSP2,"beaded filament structural protein 2, phakinin ",3q21-q25,
,,,"Cataract, juvenile-onset [MIM:604219]"
,,,"Cataract, congenital [MIM:604219]"
,,,"Cataract, autosomal dominant, multiple types 1 [MIM:611597]"
,,,
BHLHA9,"basic helix-loop-helix family, member a9 ",?,
,,,mutations
,,,
BHLHE41,"basic helix-loop-helix family, member e41 ",12p12.1-p11.23,
,,,Short sleeper [MIM:612975]
,,,
BHMT,betaine--homocysteine S-methyltransferase ,5q13.1-q13.2,
,,,mutations
,,,
BICC1,bicaudal C homolog 1 (Drosophila) ,?,
,,,mutations
,,,
BICD1,bicaudal D homolog 1 (Drosophila) ,12p11.2-p11.1,
,,,mutations
,,,
BIN1,bridging integrator 1 ,2q14,
,,,"Myopathy, centronuclear, autosomal recessive [MIM:255200]"
,,,
BIRC5,baculoviral IAP repeat containing 5 ,17q25,
,,,mutations
,,,
BLK,B lymphoid tyrosine kinase ,8p23-p22,
,,,"Maturity-onset diabetes of the young, type 11 [MIM:613375]"
,,,
BLMH,bleomycin hydrolase ,17q11.2,
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,
BLM,"Bloom syndrome, RecQ helicase-like ",15q26.1,
,,,Bloom syndrome [MIM:210900]
,,,
BLNK,B-cell linker ,10q23.2,
,,,Agammaglobulinemia 4 [MIM:613502]
,,,
BLOC1S3,"biogenesis of lysosomal organelles complex-1, subunit 3 ",19q13,
,,,Hermansky-Pudlak syndrome 8 [MIM:203300]
,,,
BLVRA,biliverdin reductase A ,7p14-cen,
,,,mutations
,,,
BMI1,BMI1 polycomb ring finger oncogene ,10p13,
,,,mutations
,,,
BMIQ13,Body mass index QTL13 ,2q14.1,
,,,Body mass index QTL13
,,,
BMIQ14,Body mass index QTL14 ,16q12.2,
,,,Body mass index QTL14
,,,
BMIQ15,Body mass index QTL 15 ,17q23.2-q25.1,
,,,Body mass index QTL 15
,,,
BMIQ1,body mass index QTL 1 ,7q32.3,
,,,Body mass index QTL1
,,,
BMIQ2,body mass index QTL 2 ,13q14,
,,,Body mass index QTL2
,,,
BMIQ3,body mass index QTL 3 ,6q23-q25,
,,,Body mass index QTL3
,,,
BMIQ5,body mass index QTL 5 ,16p13,
,,,Body mass index QTL5
,,,
BMIQ6,body mass index QTL 6 ,20pter-p11.2,
,,,Body mass index QTL6
,,,
BMIQ8,body mass index quantitative trait locus 8 ,10p,
,,,"Obesity, susceptibility to, BMIQ8"
,,,
BMND10,Bone mineral density QTL 10 ,8q24,
,,,Bone mineral density QTL 10
,,,
BMND11,Bone mineral density QTL 11 ,6q25,
,,,Bone mineral density QTL 11
,,,
BMND13,Bone mineral density QTL 13 ,16q23,
,,,Bone mineral density QTL 13
,,,
BMND14,Bone mineral density QTL 14 ,1p33-p32,
,,,Bone mineral density QTL 14
,,,
BMND2,Bone mineral density variation 2 ,1q21-q23,
,,,Bone mineral density QTL 2
,,,
BMND3,Bone mineral density variability 3 ,1p36,
,,,Bone mineral density QTL 3
,,,
BMND4,Bone mineral density variation QTL 4 ,Xq27,
,,,Bone mineral density QTL 4
,,,
BMND5,Bone mineral density variation QTL 5 ,11q23,
,,,Bone mineral density QTL 5
,,,
BMND6,Bone mineral density QTL 6 ,21q22.13-qter,
,,,Bone mineral density QTL 6
,,,
BMND7,Osteoporosis ,20p12.3,
,,,Osteoporosis [MIM:166710]
,,,
BMND8,Osteoporosis ,11p12,
,,,Osteoporosis [MIM:166710]
,,,
BMND9,Bone mineral density QTL 9 ,13q14,
,,,Bone mineral density QTL 9
,,,
BMP10,bone morphogenetic protein 10 ,?,
,,,mutations
,,,
BMP15,bone morphogenetic protein 15 ,Xp11.2,
,,,Ovarian dysgenesis 2 [MIM:300510]
,,,Premature ovarian failure 4 [MIM:300510]
,,,
BMP1,bone morphogenetic protein 1 ,8p21,
,,,mutations
,,,
BMP2K,BMP2 inducible kinase ,?,
,,,mutations
,,,
BMP2,bone morphogenetic protein 2 ,20p12,
,,,"HFE hemochromatosis, modifier of [MIM:235200]"
,,,
BMP4,bone morphogenetic protein 4 ,14q22-q23,
,,,"Microphthalmia, syndromic 6 [MIM:607932]"
,,,Orofacial cleft 11 [MIM:600625]
,,,
BMP5,bone morphogenetic protein 5 ,6p12.1,
,,,mutations
,,,
BMP7,bone morphogenetic protein 7 ,20q13.1-q13.3,
,,,mutations
,,,
BMPER,BMP binding endothelial regulator ,?,
,,,mutations
,,,
BMPR1A,"bone morphogenetic protein receptor, type IA ",10q22.3,
,,,"Polyposis, juvenile intestinal [MIM:174900]"
,,,"Polyposis syndrome, hereditary mixed, 2 [MIM:610069]"
,,,"Juvenile polyposis syndrome, infantile form [MIM:174900]"
,,,
BMPR1B,"bone morphogenetic protein receptor, type IB ",4q23-q24,
,,,"Brachydactyly, type A2 [MIM:112600]"
,,,"Chrondrodysplasia, acromesomelic, with genital anomalies [MIM:609441]"
,,,
BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase) ",2q33,
,,,"Pulmonary hypertension, familial primary [MIM:178600]"
,,,Pulmonary venoocclusive disease [MIM:265450]
,,,"Pulmonary hypertension, primary, fenfluramine-associated [MIM:178600]"
,,,
BNC2,basonuclin 2 ,9p22.1,
,,,mutations
,,,
BOLA3,bolA homolog 3 (E. coli) ,2p13.1,
,,,mutations
,,,
BOP,"Polymicrogyria, bilateral occipital ",6q16.3-q22.1,
,,,"Polymicrogyria, bilateral occipital"
,,,
BOS2,Branchiootic syndrome 2 ,1q31,
,,,Branchiootic syndrome 2
,,,
BP10,Blood pressure QTL 10 ,17q21.2,
,,,"Osteogenesis imperfecta, type VI [MIM:610698]"
,,,
BP28,Blood pressure QTL 28 ,3q27,
,,,Adiponectin deficiency [MIM:612556]
,,,
BP4,Blood pressure QTL 4 ,19q13.1-q13.2,
,,,"Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities [MIM:613177]"
,,,
BP50,Blood pressure QTL 50 ,17q25.1,
,,,"Nephrolithiasis/osteoporosis, hypophosphatemic, 2 [MIM:612287]"
,,,
BP51,Blood pressure QTL 51 ,6p21.3-p21.2,
,,,Major depressive disorder and accelerated response to antidepressant drug treatment [MIM:608516]
,,,
BPGM,"2,3-bisphosphoglycerate mutase ",?,
,,,erythrocytosis
,,,
BPIFA1,"BPI fold containing family A, member 1 ",20q11,
,,,mutations
,,,
BPI,bactericidal/permeability-increasing protein ,20q11.23-q12,
,,,mutations
,,,
BPPV,"vestibulopathy, familial ",6q,
,,,"Vestibulopathy, familial"
,,,
BRAF,v-raf murine sarcoma viral oncogene homolog B1 ,7q34,
,,,"Melanoma, malignant, somatic"
,,,"Colorectal cancer, somatic"
,,,"Adenocarcinoma of lung, somatic [MIM:211980]"
,,,"Nonsmall cell lung cancer, somatic"
,,,Cardiofaciocutaneous syndrome [MIM:115150]
,,,Noonan syndrome 7 [MIM:613706]
,,,LEOPARD syndrome 3 [MIM:613707]
,,,
BRAP,BRCA1 associated protein ,12q24,
,,,mutations
,,,
BRAT1,BRCA1-associated ATM activator 1 ,?,
,,,mutations
,,,
BRCA1,"breast cancer 1, early onset ",17q21,
,,,"Breast-ovarian cancer, familial, 1 [MIM:604370]"
,,,"Pancreatic cancer, susceptibility to, 4 (3) 11"
,,,
BRCA2,"breast cancer 2, early onset ",13q12.3,
,,,"Breast-ovarian cancer, familial, 2 [MIM:612555]"
,,,"Fanconi anemia, complementation group D1 [MIM:605724]"
,,,Prostate cancer [MIM:176807]
,,,"Breast cancer, male, susceptibility to [MIM:114480]"
,,,Wilms tumor [MIM:194070]
,,,Medulloblastoma [MIM:155255]
,,,Glioblastoma 3 [MIM:613029]
,,,Pre-B-cell acute lymphoblastic leukemia
,,,Pancreatic cancer [MIM:613347]
,,,
BRCA3,breast cancer 3 ,13q21,
,,,"Breast cancer, type 3"
,,,
BRCATA,"Breast cancer, 11;22 translocation associated ",11q23,
,,,"Breast cancer, 11:22 translocation associated"
,,,
BRCC3,"BRCA1/BRCA2-containing complex, subunit 3 ",?,
,,,mutations
,,,
BRD1,bromodomain containing 1 ,22q13,
,,,mutations
,,,
BRIP1,BRCA1 interacting protein C-terminal helicase 1 ,17q22,
,,,"Breast cancer, early-onset [MIM:114480]"
,,,"Fanconi anemia, complementation group J [MIM:609054]"
,,,
BRKS,"Telopeptide lysyl hydroxylase, bone-specific ",17p12,
,,,Bruck syndrome 1
,,,
BRSK2,BR serine/threonine kinase 2 ,?,
,,,mutations
,,,
BRV2,"Vertigo, benign recurrent, 2 ",22q12,
,,,"Vertigo, benign recurrent, 2"
,,,
BRWD1,bromodomain and WD repeat domain containing 1 ,?,
,,,mutations
,,,
BRWD3,bromodomain and WD repeat domain containing 3 ,Xq13,
,,,"Mental retardation, X-linked 93 [MIM:300659]"
,,,
BSCL2,Berardinelli-Seip congenital lipodystrophy 2 (seipin) ,11q13,
,,,"Lipodystrophy, congenital generalized, type 2 [MIM:269700]"
,,,Silver spastic paraplegia syndrome [MIM:270685]
,,,"Neuropathy, distal hereditary motor, type V [MIM:600794]"
,,,
BSG,basigin (Ok blood group) ,19p13.3,
,,,"Blood group, OK [MIM:111380]"
,,,
BSND,"Bartter syndrome, infantile, with sensorineural deafness (Barttin) ",1p31,
,,,"Bartter syndrome, type 4a [MIM:602522]"
,,,Sensorineural deafness with mild renal dysfunction [MIM:602522]
,,,
BST1,bone marrow stromal cell antigen 1 ,4p15.32,
,,,mutations
,,,
BSZQTL2,Bone size QTL ,5q,
,,,Bone size QTL
,,,
BSZQTL3,Bone size quantitative trait locus 3 ,8q24,
,,,Bone size quantitative trait locus 3
,,,
BSZQTL,Bone size QTL ,17q23,
,,,Bone size QTL
,,,
BTAF1,"BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae) ",10q22-q23,
,,,mutations
,,,
BTBD9,BTB (POZ) domain containing 9 ,6p21,
,,,mutations
,,,
BTC,betacellulin ,4q13-q21,
,,,mutations
,,,
BTD,biotinidase ,3p25,
,,,Biotinidase deficiency [MIM:253260]
,,,
BTK,Bruton agammaglobulinemia tyrosine kinase ,Xq21.3-q22,
,,,"Agammaglobulinemia, X-linked 1 [MIM:300755]"
,,,Agammaglobulinemia and isolated hormone deficiency [MIM:307200]
,,,
BTLA,B and T lymphocyte associated ,?,
,,,mutations
,,,
BTN1A1,"butyrophilin, subfamily 1, member A1 ",6p22.1,
,,,mutations
,,,
BTN2A1,"butyrophilin, subfamily 2, member A1 ",6p22.1,
,,,mutations
,,,
BTNL2,butyrophilin-like 2 (MHC class II associated) ,6p21.3,
,,,"Sarcoidosis, susceptibility to, 2 [MIM:612387]"
,,,
BTRC,beta-transducin repeat containing E3 ubiquitin protein ligase ,10q24-q25,
,,,mutations
,,,
BTS1,bladder tumor susceptibility 1 ,9q34.3,
,,,Joubert syndrome-1
,,,
BUB1B,budding uninhibited by benzimidazoles 1 homolog beta (yeast) ,15q15,
,,,Colorectal cancer [MIM:114500]
,,,Mosaic variegated aneuploidy syndrome [MIM:257300]
,,,Premature chromatid separation trait [MIM:176430]
,,,
BUB1,budding uninhibited by benzimidazoles 1 homolog (yeast) ,2q14,
,,,Colorectal cancer with chromosomal instability
,,,
BULN,"Bulimia nervosa, susceptibility to ",10p,
,,,"Bulimia nervosa, susceptibility to"
,,,
BWQTL2,Birth weight QTL 2 ,3q25.3,
,,,Birth weight QTL 2
,,,
BZX,Bazex syndrome ,Xq24-q27,
,,,Bazex syndrome
,,,
C10orf11,chromosome 10 open reading frame 11 ,?,
,,,mutations
,,,
C10orf137,chromosome 10 open reading frame 137 ,?,
,,,mutations
,,,
C10orf2,chromosome 10 open reading frame 2 ,10q24,
,,,"Progressive external ophthalmoplegia, autosomal dominant, 3 [MIM:609286]"
,,,Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) [MIM:271245]
,,,
C11orf65,chromosome 11 open reading frame 65 ,?,
,,,mutations
,,,
C11orf93,chromosome 11 open reading frame 93 ,?,
,,,mutations
,,,
C12orf10,chromosome 12 open reading frame 10 ,?,
,,,mutations
,,,
C12orf57,chromosome 12 open reading frame 57 ,?,
,,,mutations
,,,
C12orf65,chromosome 12 open reading frame 65 ,12q24.31,
,,,Combined oxidative phosphorylation deficiency 7 [MIM:613559]
,,,
C15orf62,chromosome 15 open reading frame 62 ,?,
,,,mutations
,,,
C17orf53,chromosome 17 open reading frame 53 ,?,
,,,mutations
,,,
C18orf26,chromosome 18 open reading frame 26 ,?,
,,,mutations
,,,
C19orf12,chromosome 19 open reading frame 12 ,?,
,,,mutations
,,,
C19orf48,chromosome 19 open reading frame 48 ,?,
,,,mutations
,,,
C1GALT1C1,C1GALT1-specific chaperone 1 ,Xq23,
,,,Tn syndrome [MIM:300622]
,,,
C1GALT1,"core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 ",7p14-p13,
,,,mutations
,,,
C1QA,"complement component 1, q subcomponent, A chain ",1p36.3-p34.1,
,,,"C1q deficiency, type A"
,,,
C1QB,"complement component 1, q subcomponent, B chain ",1p36.3-p34.1,
,,,"C1q deficiency, type B"
,,,
C1QC,"complement component 1, q subcomponent, C chain ",1p36.3-p34.1,
,,,"C1q deficiency, type C"
,,,
C1QTNF5,C1q and tumor necrosis factor related protein 5 ,11q23.3,
,,,"Retinal degeneration, late-onset, autosomal dominant [MIM:605670]"
,,,
C1R,"complement component 1, r subcomponent ",?,
,,,lupus systemic-like syndrome
,,,
C1S,"complement component 1, s subcomponent ",12p13,
,,,"C1r/C1s deficiency, combined"
,,,"C1s deficiency, isolated"
,,,
C1orf227,chromosome 1 open reading frame 227 ,?,
,,,mutations
,,,
C21orf91,chromosome 21 open reading frame 91 ,?,
,,,mutations
,,,
C22DDELS,"Chromosome 22q11.2 deletion syndrome, distal ",22q11.2,
,,,"Chromosome 22q11.2 deletion syndrome, distal"
,,,
C2orf42,chromosome 2 open reading frame 42 ,?,
,,,mutations
,,,
C2orf56,chromosome 2 open reading frame 56 ,?,
,,,mutations
,,,
C2orf71,chromosome 2 open reading frame 71 ,2p24.1-p23.1,
,,,Retinitis pigmentosa 54 [MIM:613428]
,,,
C2,complement component 2 ,?,
,,,"Henoch-Schonlein purpura susceptibility,lupus systemic discoid syndrome,polymyositis susceptibility (C2 deficiency,type I)"
,,,
C3AR1,complement component 3a receptor 1 ,?,
,,,mutations
,,,
C3,complement component 3 ,19p13.3-p13.2,
,,,C3 deficiency
,,,"Macular degeneration, age-related, 9 [MIM:611378]"
,,,"Hemolytic uremic syndrome, atypical, susceptibility to, 5 [MIM:612925]"
,,,
C4A,complement component 4A (Rodgers blood group) ,6p21.3,
,,,C4 deficiency
,,,"Blood group, Rodgers"
,,,"Systemic lupus erythematosus, susceptibility to or protection against [MIM:152700]"
,,,
C4BPA,"complement component 4 binding protein, alpha ",1q32,
,,,mutations
,,,
C4B,complement component 4B (Chido blood group) ,6p21.3,
,,,C4 deficiency
,,,
C5orf42,chromosome 5 open reading frame 42 ,?,
,,,mutations
,,,
C5,complement component 5 ,9q34.1,
,,,C5 deficiency [MIM:609536]
,,,"Liver fibrosis, susceptibility to"
,,,
C6orf15,chromosome 6 open reading frame 15 ,?,
,,,mutations
,,,
C6,complement component 6 ,5p13,
,,,C6 deficiency [MIM:612446]
,,,Combined C6/C7 deficiency
,,,
C7orf10,chromosome 7 open reading frame 10 ,7p14,
,,,mutations
,,,
C7,complement component 7 ,5p13,
,,,C7 deficiency [MIM:610102]
,,,
C8A,"complement component 8, alpha polypeptide ",1p32,
,,,"C8 deficiency, type I"
,,,
C8B,"complement component 8, beta polypeptide ",1p32,
,,,"C8 deficiency, type II"
,,,
C8orf37,chromosome 8 open reading frame 37 ,?,
,,,mutations
,,,
C9orf72,chromosome 9 open reading frame 72 ,?,
,,,mutations
,,,
C9,complement component 9 ,5p13,
,,,C9 deficiency
,,,C9 deficiency with dermatomyositis
,,,
CA12,carbonic anhydrase XII ,15q22,
,,,"Hyperchlorhidrosis, isolated [MIM:143860]"
,,,
CA1,carbonic anhydrase I ,8q22,
,,,mutations
,,,
CA2,carbonic anhydrase II ,8q22,
,,,"Osteopetrosis, autosomal recessive 3, with renal tubular acidosis [MIM:259730]"
,,,
CA4,carbonic anhydrase IV ,17q23,
,,,Retinitis pigmentosa-17 [MIM:600852]
,,,
CA6,carbonic anhydrase VI ,1p36.33-p36.22,
,,,mutations
,,,
CA8,carbonic anhydrase VIII ,8q11-q12,
,,,Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3 [MIM:613227]
,,,
CABIN1,calcineurin binding protein 1 ,22q11.2,
,,,mutations
,,,
CABP4,calcium binding protein 4 ,11q13.1,
,,,"Night blindness, congenital stationary, type 2B [MIM:610427]"
,,,
CACD,central areolar choroidal dystrophy ,17p,
,,,"Choroidal dystrophy, central areolar"
,,,
CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ",19p13,
,,,"Hemiplegic migraine, familial [MIM:141500]"
,,,"Episodic ataxia, type 2 [MIM:108500]"
,,,Spinocerebellar ataxia-6 [MIM:183086]
,,,"Cerebellar ataxia, pure"
,,,
CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit ",12p13.3,
,,,Timothy syndrome [MIM:601005]
,,,Brugada syndrome 3 [MIM:611875]
,,,
CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit ",3p14.3,
,,,mutations
,,,
CACNA1E,"calcium channel, voltage-dependent, R type, alpha 1E subunit ",1q25-q31,
,,,mutations
,,,
CACNA1F,"calcium channel, voltage-dependent, L type, alpha 1F subunit ",Xp11.23,
,,,"Night blindness, congenital stationary, X-linked, type 2A [MIM:300071]"
,,,"Cone-rod dystrophy, X-linked, 3 [MIM:300476]"
,,,Aland Island eye disease [MIM:300600]
,,,
CACNA1G,"calcium channel, voltage-dependent, T type, alpha 1G subunit ",17q22,
,,,mutations
,,,
CACNA1H,"calcium channel, voltage-dependent, T type, alpha 1H subunit ",16p13.3,
,,,"Epilepsy, idiopathic generalized, susceptibility to, 6 [MIM:611942]"
,,,"Epilepsy, childhood absence, susceptibility to, 6 [MIM:611942]"
,,,
CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit ",1q32,
,,,"Hypokalemic periodic paralysis, type 1 [MIM:170400]"
,,,Malignant hyperthermia susceptibility 5 [MIM:601887]
,,,"Thyrotoxic periodic paralysis, susceptibility to, 1 [MIM:188580]"
,,,
CACNA2D1,"calcium channel, voltage-dependent, alpha 2/delta subunit 1 ",7q21-q22,
,,,mutations
,,,
CACNA2D3,"calcium channel, voltage-dependent, alpha 2/delta subunit 3 ",3p21.1,
,,,mutations
,,,
CACNA2D4,"calcium channel, voltage-dependent, alpha 2/delta subunit 4 ",12p13.3,
,,,Retinal cone dystrophy 4 [MIM:610478]
,,,
CACNB2,"calcium channel, voltage-dependent, beta 2 subunit ",10p12,
,,,Brugada syndrome 4 [MIM:611876]
,,,
CACNB4,"calcium channel, voltage-dependent, beta 4 subunit ",2q22-q23,
,,,"Epilepsy, juvenile myoclonic, susceptibility to, 6 [MIM:607682]"
,,,"Epilepsy, idiopathic generalized, susceptibility to, 9 [MIM:607682]"
,,,"Episodic ataxia, type 5 (3) 2"
,,,
CACNG2,"calcium channel, voltage-dependent, gamma subunit 2 ",22q13.1,
,,,mutations
,,,
CADM1,cell adhesion molecule 1 ,11q23.2,
,,,mutations
,,,
CALCA,calcitonin-related polypeptide alpha ,11p15.2-p15.1,
,,,mutations
,,,
CALCR,calcitonin receptor ,7q21.3,
,,,"Osteoporosis, postmenopausal, susceptibility [MIM:166710]"
,,,
CALHM1,calcium homeostasis modulator 1 ,10q24.33,
,,,mutations
,,,
CALM1,"calmodulin 1 (phosphorylase kinase, delta) ",14q24-q31,
,,,mutations
,,,
CALM3,"calmodulin 3 (phosphorylase kinase, delta) ",19q13.2-q13.3,
,,,mutations
,,,
CALR3,calreticulin 3 ,19p13.12,
,,,mutations
,,,
CALR,calreticulin ,19p13.2,
,,,mutations
,,,
CAMK4,calcium/calmodulin-dependent protein kinase IV ,5q21-q23,
,,,mutations
,,,
CAMKK1,"calcium/calmodulin-dependent protein kinase kinase 1, alpha ",?,
,,,mutations
,,,
CAMKK2,"calcium/calmodulin-dependent protein kinase kinase 2, beta ",?,
,,,mutations
,,,
CAMPD1,Camptodactyly 1 ,3q11.2-q13.12,
,,,Camptodactyly 1
,,,
CAMP,cathelicidin antimicrobial peptide ,3p21.3,
,,,mutations
,,,
CAMTA1,calmodulin binding transcription activator 1 ,1p36,
,,,mutations
,,,
CANDF1,"candidiasis, familial 1 ",2p22.3-p21,
,,,"Candidiasis, familial chronic mucocutaneous, autosomal dominant, with or without thyroid disease"
,,,
CANDN1,"candidiasis, nail 1 (with ICAM1 deficiency) ",11p13-q12,
,,,"Candidiasis, familial chronic nail, with ICAM1 deficiency"
,,,
CANT1,calcium activated nucleotidase 1 ,17q25.3,
,,,Desbuquois dysplasia [MIM:251450]
,,,
CAPN10,calpain 10 ,2q37.3,
,,,"Diabetes mellitus, noninsulin-dependent 1 [MIM:601283]"
,,,
CAPN13,calpain 13 ,?,
,,,mutations
,,,
CAPN3,"calpain 3, (p94) ",15q15.1-q21.1,
,,,"Muscular dystrophy, limb-girdle, type 2A [MIM:253600]"
,,,
CAQ14,Circulating adiponectin QTL on chromosome 14 ,14p11.2-q13,
,,,"Adiponectin, serum level of, QTL3"
,,,
CAQ5,Circulating adiponectin QTL on chromosome 5 ,5p15.2-p14,
,,,"Adiponectin, serum level of, QTL2"
,,,
CARD14,"caspase recruitment domain family, member 14 ",?,
,,,mutations
,,,
CARD8,"caspase recruitment domain family, member 8 ",19q13.3,
,,,mutations
,,,
CARD9,"caspase recruitment domain family, member 9 ",9q34.3,
,,,"Candidiasis, familial chronic mucocutaneous, autosomal recessive [MIM:212050]"
,,,
CARTPT,CART prepropeptide ,5q13.2,
,,,"Obesity, susceptibility to [MIM:601665]"
,,,
CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family) ,Xp11.4,
,,,Mental retardation and microcephaly with pontine and cerebellar hypoplasia [MIM:300749]
,,,FG syndrome 4 [MIM:300422]
,,,
CASP10,"caspase 10, apoptosis-related cysteine peptidase ",2q33-q34,
,,,"Autoimmune lymphoproliferative syndrome, type II [MIM:603909]"
,,,"Non-Hodgkin lymphoma, somatic [MIM:605027]"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,
CASP12,caspase 12 (gene/pseudogene) ,11q22.3,
,,,"Sepsis, susceptibility to"
,,,
CASP1,"caspase 1, apoptosis-related cysteine peptidase ",11q22.2-q22.3,
,,,mutations
,,,
CASP2,"caspase 2, apoptosis-related cysteine peptidase ",7q35,
,,,mutations
,,,
CASP3,"caspase 3, apoptosis-related cysteine peptidase ",4q35,
,,,mutations
,,,
CASP5,"caspase 5, apoptosis-related cysteine peptidase ",11q22.2-q22.3,
,,,mutations
,,,
CASP8,"caspase 8, apoptosis-related cysteine peptidase ",2q33,
,,,"Autoimmune lymphoproliferative syndrome, type IIB [MIM:607271]"
,,,"Hepatocellular carcinoma, somatic [MIM:114550]"
,,,"Breast cancer, protection against [MIM:114480]"
,,,"Lung cancer, protection against [MIM:211980]"
,,,
CASP9,"caspase 9, apoptosis-related cysteine peptidase ",1p36.3-p36.1,
,,,mutations
,,,
CASQ2,calsequestrin 2 (cardiac muscle) ,1p13.3-p11,
,,,"Ventricular tachycardia, catecholaminergic polymorphic, 2 [MIM:611938]"
,,,
CASR,calcium-sensing receptor ,3q13.3-q21,
,,,"Hypocalciuric hypercalcemia, type I [MIM:145980]"
,,,"Hyperparathyroidism, neonatal [MIM:239200]"
,,,"Hypocalcemia, autosomal dominant [MIM:146200]"
,,,"Hypocalcemia, autosomal dominant, with Bartter syndrome"
,,,"Epilepsy, idiopathic generalized, susceptibility to, 8 [MIM:612899]"
,,,
CAST,calpastatin ,5q15-q21,
,,,mutations
,,,
CATC3,"Cataract, autosomal recessive congenital 3 ",1p34.3-p32.2,
,,,"Cataract, autosomal recessive congenital 3"
,,,
CATCN1,"cataract, congenital nuclear, autosomal recessive ",19q13,
,,,"Cataract, congenital nuclear, 1"
,,,
CATM,"cataract, congenital, with microphthalmia ",16p13.3,
,,,Microphthalmia with cataract 1
,,,
CATSPER1,"cation channel, sperm associated 1 ",11q13.1,
,,,"Male infertility, nonsyndromic, autosomal recessive [MIM:612997]"
,,,
CATSPER2,"cation channel, sperm associated 2 ",?,
,,,mutations
,,,
CATSPER3,"cation channel, sperm associated 3 ",?,
,,,mutations
,,,
CATSPER4,"cation channel, sperm associated 4 ",?,
,,,mutations
,,,
CAT,catalase ,11p13,
,,,Acatalasemia
,,,
CAV1,"caveolin 1, caveolae protein, 22kDa ",7q31.1,
,,,"Lipodystrophy, congenital generalized, type 3 [MIM:612526]"
,,,
CAV3,caveolin 3 ,3p25,
,,,"Muscular dystrophy, limb-girdle, type IC [MIM:607801]"
,,,Rippling muscle disease [MIM:606072]
,,,"Creatine phosphokinase, elevated serum [MIM:123320]"
,,,"Myopathy, distal, with decreased caveolin 3"
,,,"Cardiomyopathy, familial hypertrophic [MIM:192600]"
,,,Long QT syndrome-9 [MIM:611818]
,,,
CBFB,"core-binding factor, beta subunit ",16q22,
,,,"Myeloid leukemia, acute, M4Eo subtype"
,,,
CBLB,"Cbl proto-oncogene, E3 ubiquitin protein ligase B ",3q,
,,,mutations
,,,
CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase ",11q23.3,
,,,Noonan syndrome-like disorder [MIM:613563]
,,,
CBR1,carbonyl reductase 1 ,21q22.12,
,,,mutations
,,,
CBR3,carbonyl reductase 3 ,21q22.2,
,,,mutations
,,,
CBS,cystathionine-beta-synthase ,21q22.3,
,,,"Homocystinuria, B6-responsive and nonresponsive types [MIM:236200]"
,,,"Thrombosis, hyperhomocysteinemic [MIM:236200]"
,,,
CBX2,chromobox homolog 2 ,17q25,
,,,"46XY gonadal dysgenesis, complete, CBS2-related [MIM:613080]"
,,,
CBX4,chromobox homolog 4 ,?,
,,,mutations
,,,
CC2D1A,coiled-coil and C2 domain containing 1A ,19p13.12,
,,,"Mental retardation, autosomal recessive 3 [MIM:608443]"
,,,
CC2D2A,coiled-coil and C2 domain containing 2A ,4p15.3,
,,,Joubert syndrome 9 [MIM:612285]
,,,"Meckel syndrome, type 6 [MIM:612284]"
,,,COACH syndrome [MIM:216360]
,,,
CCA1,"cataract, congenital, cerulean type, 1 ",17q24,
,,,"Cataract, cerulean, type 1"
,,,
CCAL1,"chondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) ",8q,
,,,Chondrocalcinosis with early-onset osteoarthritis
,,,
CCBE1,collagen and calcium binding EGF domains 1 ,18q21.32,
,,,Hennekam lymphangiectasia-lymphedema syndrome [MIM:235510]
,,,
CCDC103,coiled-coil domain containing 103 ,?,
,,,mutations
,,,
CCDC14,coiled-coil domain containing 14 ,?,
,,,mutations
,,,
CCDC22,coiled-coil domain containing 22 ,?,
,,,mutations
,,,
CCDC28B,coiled-coil domain containing 28B ,?,
,,,mutations
,,,
CCDC39,coiled-coil domain containing 39 ,?,
,,,mutations
,,,
CCDC40,coiled-coil domain containing 40 ,?,
,,,mutations
,,,
CCDC50,coiled-coil domain containing 50 ,3q28,
,,,"Deafness, autosomal dominant 44 [MIM:607453]"
,,,
CCDC6,coiled-coil domain containing 6 ,10q21,
,,,Thyroid papillary carcinoma [MIM:188550]
,,,
CCDC88C,coiled-coil domain containing 88C ,?,
,,,mutations
,,,
CCDC8,coiled-coil domain containing 8 ,?,
,,,mutations
,,,
CCHCR1,coiled-coil alpha-helical rod protein 1 ,6p21.3,
,,,mutations
,,,
CCKAR,cholecystokinin A receptor ,4p15.2-p15.1,
,,,mutations
,,,
CCKBR,cholecystokinin B receptor ,11p15.5-p15.4,
,,,mutations
,,,
CCK,cholecystokinin ,3pter-p21,
,,,mutations
,,,
CCL11,chemokine (C-C motif) ligand 11 ,17q21.1-q21.2,
,,,"HIV1, resistance to [MIM:609423]"
,,,"Asthma, susceptibility to [MIM:600807]"
,,,
CCL13,chemokine (C-C motif) ligand 13 ,17q11.2,
,,,mutations
,,,
CCL17,chemokine (C-C motif) ligand 17 ,16q13,
,,,mutations
,,,
CCL22,chemokine (C-C motif) ligand 22 ,16q13,
,,,mutations
,,,
CCL26,chemokine (C-C motif) ligand 26 ,7q11.2,
,,,mutations
,,,
CCL2,chemokine (C-C motif) ligand 2 ,17q11.2-q12,
,,,"HIV-1, resistance to [MIM:609423]"
,,,"Spina bifida, susceptibility to [MIM:182940]"
,,,"Coronary artery disease, modifier of"
,,,"Mycobacterium tuberculosis, susceptibility to [MIM:607948]"
,,,
CCL3L1,chemokine (C-C motif) ligand 3-like 1 ,17q11.2,
,,,"HIV/AIDS, susceptibility to [MIM:609423]"
,,,
CCL3,chemokine (C-C motif) ligand 3 ,17q12,
,,,"HIV infection, resistance to [MIM:609423]"
,,,
CCL4L1,chemokine (C-C motif) ligand 4-like 1 ,17q12,
,,,mutations
,,,
CCL5,chemokine (C-C motif) ligand 5 ,17q11.2-q12,
,,,"HIV-1 disease, delayed progression of"
,,,"HIV-1 disease, rapid progression of"
,,,
CCL7,chemokine (C-C motif) ligand 7 ,17q11.2-q12,
,,,mutations
,,,
CCM2,cerebral cavernous malformation 2 ,7p13,
,,,Cerebral cavernous malformations-2 [MIM:603284]
,,,
CCNA2,cyclin A2 ,4q27,
,,,mutations
,,,
CCND1,cyclin D1 ,11q13,
,,,"Colorectal cancer, susceptibility to [MIM:114500]"
,,,"von Hippel-Lindau disease, modification of [MIM:193300]"
,,,
CCNP,"Cataract, congenital, nuclear progressive ",2p12,
,,,"Cataract, nuclear progressive"
,,,
CCPSO,"Cataract, central pouch-like, with sutural opacities ",15q21-q22,
,,,"Cataract, central saccular, with sutural opacities"
,,,
CCR1,chemokine (C-C motif) receptor 1 ,3p21,
,,,mutations
,,,
CCR2,chemokine (C-C motif) receptor 2 ,3p21,
,,,"HIV infection, susceptibility/resistance to"
,,,
CCR3,chemokine (C-C motif) receptor 3 ,3p21.3,
,,,mutations
,,,
CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene) ,3p21,
,,,"HIV infection, susceptibility/resistance to"
,,,"West nile virus, susceptibility to [MIM:610379]"
,,,"Hepatitis C virus, resistance to [MIM:609532]"
,,,"Diabetes mellitus, insulin-dependent, 22 [MIM:612522]"
,,,
CCR6,chemokine (C-C motif) receptor 6 ,6q27,
,,,mutations
,,,
CCR7,chemokine (C-C motif) receptor 7 ,17q12-q21.2,
,,,mutations
,,,
CCRL2,chemokine (C-C motif) receptor-like 2 ,3p21,
,,,mutations
,,,
CCT5,"chaperonin containing TCP1, subunit 5 (epsilon) ",5p15.2,
,,,"Neuropathy, hereditary sensory, with spastic paraplegia [MIM:256840]"
,,,
CCT,"cataract, congenital, total ",Xp22.13,
,,,Nance-Horan syndrome [MIM:302350]
,,,"Cataract, congenital, X-linked [MIM:302200]"
,,,
CCV,"cataract, congenital, Volkmann type ",1pter-p36.13,
,,,"Cataract, congenital, Volkmann type"
,,,
CD109,CD109 molecule ,6q13,
,,,mutations
,,,
CD14,CD14 molecule ,5q31.1,
,,,mutations
,,,
CD151,CD151 molecule (Raph blood group) ,11p15.5,
,,,Nephropathy with pretibial epidermolysis bullosa and deafness [MIM:609057]
,,,"Blood group, Raph [MIM:179620]"
,,,
CD177,CD177 molecule ,19q13.2,
,,,mutations
,,,
CD19,CD19 molecule ,16p11.2,
,,,"Immunodeficiency, common variable, 3 [MIM:613493]"
,,,
CD1A,CD1a molecule ,1q21-q23,
,,,mutations
,,,
CD1E,CD1e molecule ,1q21-q23,
,,,mutations
,,,
CD207,"CD207 molecule, langerin ",2p13,
,,,Birbeck granule deficiency [MIM:613393]
,,,
CD209,CD209 molecule ,19p13.3,
,,,"Dengue fever, protection against"
,,,"HIV type 1, susceptibility to [MIM:609423]"
,,,"Mycobacterium tuberculosis, susceptibility to [MIM:607948]"
,,,
CD226,CD226 molecule ,18q22.3,
,,,mutations
,,,
CD22,CD22 molecule ,19q13.1,
,,,mutations
,,,
CD244,"CD244 molecule, natural killer cell receptor 2B4 ",1q22,
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,
CD247,CD247 molecule ,1q22-q23,
,,,Immunodeficiency due to defect in CD3-zeta [MIM:610163]
,,,
CD24,CD24 molecule ,6q21,
,,,"Multiple sclerosis, susceptibility to [MIM:126200]"
,,,
CD27,CD27 molecule ,12p13,
,,,mutations
,,,
CD2AP,CD2-associated protein ,6p12,
,,,"Glomerulosclerosis, focal segmental, 3 [MIM:607832]"
,,,
CD320,CD320 molecule ,19p13.2,
,,,Methylmalonic aciduria due to transcobalamin receptor defect [MIM:613646]
,,,
CD36,CD36 molecule (thrombospondin receptor) ,7q11.2,
,,,Macrothrombocytopenia
,,,Platelet glycoprotein IV deficiency [MIM:608404]
,,,"Malaria, cerebral, susceptibility to [MIM:611162]"
,,,"Malaria, cerebral, reduced risk of [MIM:611162]"
,,,"Coronary heart disease, susceptibility to, 7 [MIM:610938]"
,,,
CD38,CD38 molecule ,4p15,
,,,mutations
,,,
CD3D,"CD3d molecule, delta (CD3-TCR complex) ",11q23,
,,,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive [MIM:608971]"
,,,
CD3EAP,"CD3e molecule, epsilon associated protein ",19q13.2-q13.3,
,,,mutations
,,,
CD3E,"CD3e molecule, epsilon (CD3-TCR complex) ",11q23,
,,,Immunodeficiency due to defect in CD3-epsilon
,,,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive [MIM:608971]"
,,,
CD3G,"CD3g molecule, gamma (CD3-TCR complex) ",11q23,
,,,Immunodeficiency due to defect in CD3-gamma
,,,
CD40LG,CD40 ligand ,Xq26,
,,,"Immunodeficiency, X-linked, with hyper-IgM [MIM:308230]"
,,,
CD40,"CD40 molecule, TNF receptor superfamily member 5 ",20q12-q13.2,
,,,"Immunodeficiency with hyper-IgM, type 3 [MIM:606843]"
,,,
CD44,CD44 molecule (Indian blood group) ,11pter-p13,
,,,"Blood group, Indian system"
,,,
CD46,"CD46 molecule, complement regulatory protein ",1q32,
,,,"Hemolytic uremic syndrome, atypical, susceptibility to, 2 [MIM:612922]"
,,,
CD4,CD4 molecule ,12pter-p12,
,,,CD4+ lymphocyte deficiency
,,,"Lupus erythematosus, susceptibility to (2) 6"
,,,
CD55,"CD55 molecule, decay accelerating factor for complement (Cromer blood group) ",1q32,
,,,Blood group Cromer
,,,
CD58,CD58 molecule ,1p13,
,,,mutations
,,,
CD59,"CD59 molecule, complement regulatory protein ",11p13,
,,,CD59 deficiency [MIM:612300]
,,,
CD5,CD5 molecule ,11q13,
,,,mutations
,,,
CD72,CD72 molecule ,9p,
,,,mutations
,,,
CD79A,"CD79a molecule, immunoglobulin-associated alpha ",19q13.2,
,,,Agammaglobulinemia 3 [MIM:613501]
,,,
CD79B,"CD79b molecule, immunoglobulin-associated beta ",17q23,
,,,Agammaglobulinemia 6 [MIM:612692]
,,,
CD81,CD81 molecule ,11p,
,,,"Immunodeficiency, common variable, 6 [MIM:613496]"
,,,
CD82,CD82 molecule ,11p11.2,
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
CD86,CD86 molecule ,3q21,
,,,mutations
,,,
CD8A,CD8a molecule ,2p12,
,,,"CD8 deficiency, familial [MIM:608957]"
,,,
CD96,CD96 molecule ,3q13.13,
,,,C syndrome [MIM:211750]
,,,C-like syndrome [MIM:605039]
,,,
CDAGS,"Craniosynostosis, anal anomalies, and porokeratosis syndrome ",22q12-q13,
,,,CDAGS syndrome
,,,
CDAN1,codanin 1 ,15q15,
,,,"Anemia, congenital dyserythropoietic, type I [MIM:224120]"
,,,
CDAN3,"congenital dyserythropoietic anemia, type III ",15q21,
,,,"Dyserythropoietic anemia, congenital, type III"
,,,
CDA,cytidine deaminase ,1p36.2-p35,
,,,mutations
,,,
CDB2,corneal dystrophy of Bowman layer type II (Thiel-Behnke) ,10q24,
,,,"Corneal dystrophy, Thiel-Behnke type"
,,,
CDC42BPB,CDC42 binding protein kinase beta (DMPK-like) ,?,
,,,mutations
,,,
CDC6,cell division cycle 6 homolog (S. cerevisiae) ,17q21.3,
,,,mutations
,,,
CDC73,"cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) ",1q25-q31,
,,,Hyperparathyroidism-jaw tumor syndrome [MIM:145001]
,,,"Hyperparathyroidism, familial primary [MIM:145000]"
,,,Parathyroid adenoma with cystic changes [MIM:145001]
,,,Parathyroid carcinoma [MIM:608266]
,,,
CDH12,"cadherin 12, type 2 (N-cadherin 2) ",5p14-p13,
,,,mutations
,,,
CDH13,"cadherin 13, H-cadherin (heart) ",16q24.2-q24.3,
,,,mutations
,,,
CDH15,"cadherin 15, type 1, M-cadherin (myotubule) ",16q24.3,
,,,"Mental retardation, autosomal dominant 3 [MIM:612580]"
,,,
CDH1,"cadherin 1, type 1, E-cadherin (epithelial) ",16q22.1,
,,,"Endometrial carcinoma, somatic [MIM:608089]"
,,,"Ovarian carcinoma, somatic [MIM:167000]"
,,,"Breast cancer, lobular [MIM:114480]"
,,,"Gastric cancer, familial diffuse, with or without cleft lip and/or palate [MIM:137215]"
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
CDH23,cadherin-related 23 ,10q21-q22,
,,,"Usher syndrome, type 1D [MIM:601067]"
,,,"Deafness, autosomal recessive 12 [MIM:601386]"
,,,"Usher syndrome, type 1D/F digenic [MIM:601067]"
,,,
CDH3,"cadherin 3, type 1, P-cadherin (placental) ",16q22.1,
,,,"Hypotrichosis, congenital, with juvenile macular dystrophy [MIM:601553]"
,,,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy [MIM:225280]"
,,,
CDH5,"cadherin 5, type 2 (vascular endothelium) ",16q22.1,
,,,mutations
,,,
CDH8,"cadherin 8, type 2 ",16q21-q22.1,
,,,mutations
,,,
CDHR1,cadherin-related family member 1 ,10q23.1,
,,,Cone-rod dystrophy 15 [MIM:613660]
,,,
CDK11A,cyclin-dependent kinase 11A ,1p36.3,
,,,mutations
,,,
CDK4,cyclin-dependent kinase 4 ,12q14,
,,,Melanoma [MIM:609048]
,,,
CDK5R1,"cyclin-dependent kinase 5, regulatory subunit 1 (p35) ",?,
,,,mutations
,,,
CDK5RAP2,CDK5 regulatory subunit associated protein 2 ,9q33.3,
,,,"Microcephaly, primary autosomal recessive, 3 [MIM:604804]"
,,,
CDK5RAP3,CDK5 regulatory subunit associated protein 3 ,17q21.31,
,,,mutations
,,,
CDK7,cyclin-dependent kinase 7 ,5q13.2,
,,,mutations
,,,
CDKAL1,CDK5 regulatory subunit associated protein 1-like 1 ,6p22.3,
,,,"Diabetes mellitus, noninsulin-dependent, susceptibility to [MIM:125853]"
,,,
CDKL3,cyclin-dependent kinase-like 3 ,5q31,
,,,mutations
,,,
CDKL5,cyclin-dependent kinase-like 5 ,Xp22,
,,,"Epileptic encephalopathy, early infantile, 2 [MIM:300672]"
,,,Angelman syndrome-like [MIM:105830]
,,,
CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1) ",6p21.2,
,,,mutations
,,,
CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1) ",12p13,
,,,"Multiple endocrine neoplasia, type IV [MIM:610755]"
,,,
CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2) ",11p15.5,
,,,Beckwith-Wiedemann syndrome [MIM:130650]
,,,
CDKN2A,cyclin-dependent kinase inhibitor 2A ,9p21,
,,,"Melanoma, cutaneous malignant, 2 [MIM:155601]"
,,,Li-Fraumeni syndrome [MIM:151623]
,,,Melanoma and neural system tumor syndrome [MIM:155755]
,,,Pancreatic cancer/melanoma syndrome [MIM:606719]
,,,"Orolaryngeal cancer, multiple"
,,,
CDKN2B-AS1,CDKN2B antisense RNA 1 ,9p21,
,,,mutations
,,,
CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) ",9p21,
,,,mutations
,,,
CDKN2C,"cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) ",1p32,
,,,mutations
,,,
CDON,Cdon homolog (mouse) ,?,
,,,mutations
,,,
CDSN,corneodesmosin ,6p21.3,
,,,Hypotrichosis simplex of scalp [MIM:146520]
,,,
CDT1,chromatin licensing and DNA replication factor 1 ,?,
,,,mutations
,,,
CEACAM16,carcinoembryonic antigen-related cell adhesion molecule 16 ,?,
,,,mutations
,,,
CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha ",19q13.1,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
CEBPE,"CCAAT/enhancer binding protein (C/EBP), epsilon ",14q11.2,
,,,Specific granule deficiency [MIM:245480]
,,,
CECR,cat eye syndrome chromosome region ,22q11,
,,,Cat eye syndrome
,,,
CELIAC10,"Celiac disease, susceptibility to, 10 ",3q25-q26,
,,,"Celiac disease, susceptibility to, 10"
,,,
CELIAC11,"Celiac disease, susceptibility to, 11 ",3q28,
,,,"Celiac disease, susceptibility to, 11"
,,,
CELIAC12,"Celiac disease, susceptibility to, 12 ",6q25.3,
,,,"Celiac disease, susceptibility to, 12"
,,,
CELIAC13,"Celiac disease, susceptibility to, 13 ",12q24,
,,,"Celiac disease, susceptibility to, 13"
,,,
CELIAC2,celiac disease 2 ,5q31-q33,
,,,"Celiac disease, susceptibility to, 2"
,,,
CELIAC5,"Celiac disease, susceptibility to, 5 ",15q11-q13,
,,,"Celiac disease, susceptibility to, 5"
,,,
CELIAC6,"Celiac disease, susceptibility to, 6 ",4q27,
,,,"Celiac disease, susceptibility to, 6"
,,,"Autoimmune disease, susceptibility to, 5"
,,,
CELIAC7,"Celiac disease, susceptibility to, 7 ",1q31,
,,,"Celiac disease, susceptibility to, 7"
,,,
CELIAC8,"Celiac disease, susceptibility to, 8 ",2q11-q12,
,,,"Celiac disease, susceptibility to, 8"
,,,
CELIAC9,"Celiac disease, susceptibility to, 9 ",3p21,
,,,"Celiac disease, susceptibility to, 9"
,,,
CELSR1,"cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) ",22q13.3,
,,,mutations
,,,
CEL,carboxyl ester lipase (bile salt-stimulated lipase) ,9q34.3,
,,,"Maturity-onset diabetes of the young, type VIII [MIM:609812]"
,,,
CENPJ,centromere protein J ,13q12.2,
,,,"Microcephaly, primary autosomal recessive, 6 [MIM:608393]"
,,,Seckel syndrome 4 [MIM:613676]
,,,
CEP135,centrosomal protein 135kDa ,?,
,,,mutations
,,,
CEP152,centrosomal protein 152kDa ,15q21.1,
,,,"Microcephaly, primary autosomal recessive, 4 [MIM:604321]"
,,,
CEP290,centrosomal protein 290kDa ,12q21.3,
,,,Joubert syndrome 5 [MIM:610188]
,,,Senior-Loken syndrome 6 [MIM:610189]
,,,Leber congenital amaurosis 10 [MIM:611755]
,,,Meckel syndrome type 4 [MIM:611134]
,,,Bardet-Biedl syndrome 14 [MIM:209900]
,,,
CEP41,centrosomal protein 41kDa ,?,
,,,mutations
,,,
CEP57,centrosomal protein 57kDa ,?,
,,,mutations
,,,
CEP63,centrosomal protein 63kDa ,?,
,,,mutations
,,,
CEP68,centrosomal protein 68kDa ,?,
,,,mutations
,,,
CER1,"cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis) ",9p22,
,,,mutations
,,,
CERKL,ceramide kinase-like ,2q31.2-q32.3,
,,,Retinitis pigmentosa-26 [MIM:608380]
,,,
CES1,carboxylesterase 1 ,16q13-q22.1,
,,,Carboxylesterase 1 deficiency
,,,
CES2,carboxylesterase 2 ,?,
,,,mutations
,,,
CETP,"cholesteryl ester transfer protein, plasma ",16q21,
,,,CETP deficiency [MIM:607322]
,,,Hyperalphalipoproteinemia [MIM:143470]
,,,High density lipoprotein cholesterol level QTL 10
,,,
CFB,complement factor B ,6p21.3,
,,,"Macular degeneration, age-related, reduced risk of [MIM:603075]"
,,,"Hemolytic uremic syndrome, atypical, susceptibility to, 4 [MIM:612924]"
,,,
CFC1,"cripto, FRL-1, cryptic family 1 ",2q21.1,
,,,"Heterotaxy, visceral, 2, autosomal [MIM:605376]"
,,,Double-outlet right ventricle [MIM:217095]
,,,"Transposition of the great arteries, dextro-looped 2"
,,,
CFD,complement factor D (adipsin) ,19p13.3,
,,,Complement factor D deficiency
,,,
CFHR1,complement factor H-related 1 ,1q31-q32.1,
,,,"Macular degeneration, age-related, reduced risk of [MIM:603075]"
,,,"Hemolytic uremic syndrome, atypical, susceptibility to [MIM:235400]"
,,,
CFHR2,complement factor H-related 2 ,1q31-q32.1,
,,,mutations
,,,
CFHR3,complement factor H-related 3 ,1q31-q32.1,
,,,"Macular degeneration, age-related, reduced risk of [MIM:603075]"
,,,"Hemolytic uremic syndrome, atypical, susceptibility to [MIM:235400]"
,,,
CFHR5,complement factor H-related 5 ,1q32,
,,,mutations
,,,
CFH,complement factor H ,1q32,
,,,"Hemolytic uremic syndrome, atypical, susceptibility to, 1 [MIM:235400]"
,,,Membranoproliferative glomerulonephritis with CFH deficiency [MIM:609814]
,,,"Macular degeneration, age-related, 4 [MIM:610698]"
,,,Complement factor H deficiency [MIM:609814]
,,,Basal laminar drusen [MIM:126700]
,,,
CFI,complement factor I ,4q25,
,,,Complement factor I deficiency [MIM:610984]
,,,"Hemolytic uremic syndrome, atypical, susceptibility to, 3 [MIM:612923]"
,,,
CFL2,cofilin 2 (muscle) ,14q12,
,,,Nemaline myopathy 7 [MIM:610687]
,,,
CFLAR,CASP8 and FADD-like apoptosis regulator ,2q33,
,,,mutations
,,,
CFM1,cystic fibrosis modifier 1 ,19q13.2-q13.4,
,,,"Meconium ileus in cystic fibrosis, susceptibility to"
,,,
CFP,complement factor properdin ,Xp11.4-p11.23,
,,,"Properdin deficiency, X-linked [MIM:312060]"
,,,
CFSS,craniofacioskeletal syndrome ,Xq26-q27,
,,,Craniofacioskeletal syndrome
,,,
CFTDX,"Myopathy, congenital, with fiber-type disproportion, X-linked ",Xq13.1-q22.1,
,,,"Myopathy, congenital, with fiber-type disproportion, X-linked"
,,,
CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) ",7q31.2,
,,,Cystic fibrosis [MIM:219700]
,,,Congenital bilateral absence of vas deferens [MIM:277180]
,,,Sweat chloride elevation without CF
,,,"Pancreatitis, idiopathic [MIM:167800]"
,,,"Hypertrypsinemia, neonatal"
,,,"Bronchiectasis with or without elevated sweat chloride 1, modifier of [MIM:211400]"
,,,
CGA,"glycoprotein hormones, alpha polypeptide ",6q12-q21,
,,,mutations
,,,
CGB,"chorionic gonadotropin, beta polypeptide ",19q13.32,
,,,mutations
,,,
CGF1,"cognitive function 1, social ",Xq,
,,,Social cognition
,,,
CHAT,choline O-acetyltransferase ,10q11.2,
,,,"Myasthenic syndrome, congenital, associated with episodic apnea [MIM:254210]"
,,,
CHD1L,chromodomain helicase DNA binding protein 1-like ,1q21,
,,,mutations
,,,
CHD2,chromodomain helicase DNA binding protein 2 ,15q26,
,,,mutations
,,,
CHD3,chromodomain helicase DNA binding protein 3 ,17p13,
,,,mutations
,,,
CHD6,chromodomain helicase DNA binding protein 6 ,?,
,,,mutations
,,,
CHD7,chromodomain helicase DNA binding protein 7 ,8q12.1,
,,,CHARGE syndrome [MIM:214800]
,,,"Scoliosis, idiopathic 3 [MIM:608765]"
,,,Kallmann syndrome 5 [MIM:612370]
,,,Hypogonadotropic hypogonadism [MIM:146110]
,,,
CHD8,chromodomain helicase DNA binding protein 8 ,14q11.2,
,,,mutations
,,,
CHDH,choline dehydrogenase ,?,
,,,mutations
,,,
CHDM,Chordoma ,7q33,
,,,Chordoma
,,,
CHDS1,"Coronary heart disease, susceptibility to, 1 ",16pter-p13,
,,,"Coronary heart disease, susceptibility to"
,,,
CHDS2,"Coronary heart disease, susceptibility to, 2 ",2q21.1-q22,
,,,"Coronary heart disease, susceptibility to, 2"
,,,
CHDS3,"Coronary heart disease, susceptibility to, 3 ",Xq23-q26,
,,,"Coronary heart disease, susceptibility to, 3"
,,,
CHDS4,"Coronary heart disease, susceptibility to, 4 ",14q32,
,,,"Coronary heart disease, susceptibility to, 4"
,,,
CHDS8,"Coronary heart disease, susceptibility to, 8 ",9p21,
,,,"Coronary heart disease, susceptibility to, 8"
,,,
CHDS9,"Coronary heart disease, suscpetibility to, 9 ",8p22,
,,,"Coronary heart disease, susceptibility to, 9"
,,,
CHED1,corneal endothelial dystrophy 1 (autosomal dominant) ,20p11.2-q11.2,
,,,"Congenital hereditary endothelial dystrophy of cornea, autosomal dominant"
,,,
CHEK2,checkpoint kinase 2 ,22q12.1,
,,,Li-Fraumeni syndrome [MIM:609265]
,,,"Osteosarcoma, somatic [MIM:259500]"
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,"Prostate cancer, familial, susceptibility to [MIM:176807]"
,,,"Breast and colorectal cancer, susceptibility to"
,,,
CHFR,"checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase ",12q24.33,
,,,mutations
,,,
CHGA,chromogranin A (parathyroid secretory protein 1) ,14q32,
,,,mutations
,,,
CHGB,chromogranin B (secretogranin 1) ,20pter-p12,
,,,mutations
,,,
CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39) ,1q32.1,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,"Asthma-related traits, susceptibility to, 7 [MIM:611960]"
,,,
CHI3L2,chitinase 3-like 2 ,?,
,,,mutations
,,,
CHIA,"chitinase, acidic ",1p21.3-p13.1,
,,,mutations
,,,
CHIC2,cysteine-rich hydrophobic domain 2 ,4q11-q12,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
CHIT1,chitinase 1 (chitotriosidase) ,1q31-q32,
,,,Chitotriosidase deficiency
,,,
CHKB,choline kinase beta ,22q13,
,,,mutations
,,,
CHL1,cell adhesion molecule with homology to L1CAM (close homolog of L1) ,3p26.1,
,,,mutations
,,,
CHMP2B,charged multivesicular body protein 2B ,3p11.2,
,,,"Dementia, familial, nonspecific [MIM:600795]"
,,,"Amyotrophic lateral sclerosis, CHMP2B-related"
,,,
CHMP4B,charged multivesicular body protein 4B ,20q11.21,
,,,"Cataract, posterior polar, 3 [MIM:605387]"
,,,
CHMRQ,"Cerebellar hypoplasia, mental retardation, and quadrupedal locomotion ",17p,
,,,"Cerebellar hypoplasia, mental retardation, and quadrupedal locomotion 2"
,,,
CHM,choroideremia (Rab escort protein 1) ,Xq21.2,
,,,Choroideremia [MIM:303100]
,,,
CHN1,chimerin (chimaerin) 1 ,2q31-q32.1,
,,,Duane retraction syndrome 2 [MIM:604356]
,,,
CHNG3,"Hypothyroidism, congenital, nongoitrous, 3 ",15q25.3-q26.1,
,,,"Hypothyroidism, congenital, nongoitrous, 3"
,,,
CHRDL1,chordin-like 1 ,Xq22.1-q23,
,,,mutations
,,,
CHRFAM7A,"CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion ",?,
,,,mutations
,,,
CHRM1,"cholinergic receptor, muscarinic 1 ",11q13,
,,,mutations
,,,
CHRM2,"cholinergic receptor, muscarinic 2 ",7q35-q36,
,,,mutations
,,,
CHRM3,"cholinergic receptor, muscarinic 3 ",1q41-q44,
,,,mutations
,,,
CHRNA1,"cholinergic receptor, nicotinic, alpha 1 (muscle) ",2q24-q32,
,,,"Myasthenic syndrome, slow-channel congenital [MIM:601462]"
,,,"Myasthenic syndrome, fast-channel congenital [MIM:608930]"
,,,"Multiple pterygium syndrome, lethal type [MIM:253290]"
,,,
CHRNA2,"cholinergic receptor, nicotinic, alpha 2 (neuronal) ",8p21,
,,,"Epilepsy, nocturnal frontal lobe, type 4 [MIM:610353]"
,,,
CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal) ",15q25.1,
,,,Lung cancer susceptibility 2 [MIM:612052]
,,,
CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal) ",20q13.2-q13.3,
,,,"Epilepsy, nocturnal frontal lobe, 1 [MIM:600513]"
,,,"Nicotine addiction, susceptibility to [MIM:188890]"
,,,
CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal) ",15q25.1,
,,,Lung cancer susceptibility 2 [MIM:612052]
,,,
CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal) ",15q14,
,,,"Schizophrenia, neurophysiologic defect in"
,,,
CHRNA9,"cholinergic receptor, nicotinic, alpha 9 (neuronal) ",4p15.1-p14,
,,,mutations
,,,
CHRNB1,"cholinergic receptor, nicotinic, beta 1 (muscle) ",17p12-p11,
,,,"Myasthenic syndrome, slow-channel congenital [MIM:601462]"
,,,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [MIM:608931]"
,,,
CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal) ",1q21,
,,,"Epilepsy, nocturnal frontal lobe, 3 [MIM:605375]"
,,,
CHRNB4,"cholinergic receptor, nicotinic, beta 4 (neuronal) ",15q24,
,,,mutations
,,,
CHRND,"cholinergic receptor, nicotinic, delta (muscle) ",2q33-q34,
,,,"Myasthenic syndrome, slow-channel congenital [MIM:601462]"
,,,"Myasthenic syndrome, fast-channel congenital [MIM:608930]"
,,,"Multiple pterygium syndrome, lethal type [MIM:253290]"
,,,
CHRNE,"cholinergic receptor, nicotinic, epsilon (muscle) ",17p13-p12,
,,,"Myasthenic syndrome, slow-channel congenital [MIM:601462]"
,,,"Myasthenic syndrome, fast-channel congenital [MIM:608930]"
,,,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [MIM:608931]"
,,,
CHRNG,"cholinergic receptor, nicotinic, gamma (muscle) ",2q33-q34,
,,,"Myasthenia gravis, neonatal transient"
,,,Escobar syndrome [MIM:265000]
,,,"Multiple pterygium syndrome, lethal type [MIM:253290]"
,,,
CHST14,carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 ,15q14,
,,,"Ehlers-Danlos syndrome, musculocontractural type [MIM:601776]"
,,,
CHST3,carbohydrate (chondroitin 6) sulfotransferase 3 ,10q22.1,
,,,Spondyloepiphyseal dysplasia with congenital joint dislocations [MIM:143095]
,,,
CHST6,carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 ,16q22,
,,,Macular corneal dystrophy [MIM:217800]
,,,
CHST8,carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 ,19q13.1,
,,,mutations
,,,
CHSY1,chondroitin sulfate synthase 1 ,15q26.3,
,,,mutations
,,,
CHUK,conserved helix-loop-helix ubiquitous kinase ,10q24,
,,,Cocoon syndrome [MIM:613630]
,,,
CIC,capicua homolog (Drosophila) ,19q13.2,
,,,mutations
,,,
CIDEA,cell death-inducing DFFA-like effector a ,?,
,,,mutations
,,,
CIDEC,cell death-inducing DFFA-like effector c ,3p25,
,,,mutations
,,,
CIHL,"hearing loss, cisplatin-induced, susceptibility to ",6p22.3,
,,,"Hearing loss, cisplatin-induced, susceptibility to"
,,,
CIITA,"class II, major histocompatibility complex, transactivator ",16p13,
,,,"Bare lymphocyte syndrome, type II, complementation group A [MIM:209920]"
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,
CILD2,"ciliary dyskinesia, primary 2 ",19q13.3-qter,
,,,"Ciliary dyskinesia, primary, 2"
,,,
CILD4,"Ciliary dyskinesia, primary, 4 ",15q13.1-q15.1,
,,,"Ciliary dyskinesia, primary, 4"
,,,
CILD5,"Ciliary dyskinesia, primary, 5 ",16p12.2-p12.1,
,,,"Ciliary dyskinesia, primary, 5"
,,,
CILD8,"Ciliary dyskinesia, primary, 8 ",15q24-q25,
,,,"Ciliary dyskinesia, primary, 8"
,,,
CILP,"cartilage intermediate layer protein, nucleotide pyrophosphohydrolase ",15q22,
,,,"Lumbar disc disease, susceptibility to [MIM:603932]"
,,,
CIMT,Carotid intimal medial thickness ,12q24,
,,,Carotid intimal medial thickness
,,,
CINN,"Cinnamon odor, pleasantness of ",4q32.3,
,,,"Cinnamon odor, pleasantness of"
,,,
CIRH1A,"cirrhosis, autosomal recessive 1A (cirhin) ",16q22,
,,,"Cirrhosis, North American Indian childhood type [MIM:604901]"
,,,
CISD2,CDGSH iron sulfur domain 2 ,4q22-q24,
,,,Wolfram syndrome 2 [MIM:604928]
,,,
CISH,cytokine inducible SH2-containing protein ,3p21.3,
,,,"Tuberculosis, susceptibility to [MIM:607948]"
,,,"Malaria, susceptibility to [MIM:611162]"
,,,"Bacteremia, susceptibility to (3) 9"
,,,
CITED2,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 ",6q23.3,
,,,mutations
,,,
CKBE,"creatine kinase, ectopic expression ",14q32,
,,,"Creatine kinase, brain type, ectopic expression of"
,,,
CKM,"creatine kinase, muscle ",19q13,
,,,mutations
,,,
CLA3,cerebellar ataxia 3 (cerebellar parenchyma disorder 1) ,20q11-q13,
,,,"Spinocerebellar ataxia, autosomal recessive 6"
,,,
CLAM,cerebellar atrophy with progressive microcephaly ,7q11-q21,
,,,Cerebellar atrophy with progressive microcephaly
,,,
CLCA1,chloride channel accessory 1 ,1p31-p22,
,,,mutations
,,,
CLCA2,chloride channel accessory 2 ,1p31-p22,
,,,mutations
,,,
CLCF1,cardiotrophin-like cytokine factor 1 ,11q13.3,
,,,Cold-induced sweating syndrome 1 [MIM:610313]
,,,
CLCN1,"chloride channel, voltage-sensitive 1 ",7q35,
,,,"Myotonia congenita, recessive [MIM:255700]"
,,,"Myotonia congenita, dominant [MIM:160800]"
,,,"Myotonia levior, recessive"
,,,
CLCN2,"chloride channel, voltage-sensitive 2 ",3q26,
,,,"Epilepsy, juvenile myoclonic, susceptibility to, 8 [MIM:607628]"
,,,"Epilepsy, juvenile absence, susceptibility to, 2 [MIM:607628]"
,,,"Epilepsy, idiopathic generalized, susceptibility to, 11 [MIM:607628]"
,,,
CLCN5,"chloride channel, voltage-sensitive 5 ",Xp11.22,
,,,Dent disease [MIM:300009]
,,,"Nephrolithiasis, type I [MIM:310468]"
,,,Hypophosphatemic rickets [MIM:300554]
,,,"Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis [MIM:308990]"
,,,
CLCN7,"chloride channel, voltage-sensitive 7 ",16p13,
,,,"Osteopetrosis, autosomal recessive 4 [MIM:611490]"
,,,"Osteopetrosis, autosomal dominant 2 [MIM:166600]"
,,,
CLCNKA,"chloride channel, voltage-sensitive Ka ",1p36,
,,,"Bartter syndrome, type 4b, digenic [MIM:613090]"
,,,
CLCNKB,"chloride channel, voltage-sensitive Kb ",1p36,
,,,"Bartter syndrome, type 3 [MIM:607364]"
,,,"Bartter syndrome, type 4, digenic [MIM:602522]"
,,,
CLDN14,claudin 14 ,21q22.3,
,,,"Deafness, autosomal recessive 29"
,,,
CLDN16,claudin 16 ,3q27,
,,,"Hypomagnesemia, primary [MIM:248250]"
,,,
CLDN19,claudin 19 ,1p34.2,
,,,"Hypomagnesemia, renal, with ocular involvement [MIM:248190]"
,,,
CLDN1,claudin 1 ,3q28-q29,
,,,"Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis [MIM:607626]"
,,,
CLEC11A,"C-type lectin domain family 11, member A ",?,
,,,mutations
,,,
CLEC2D,"C-type lectin domain family 2, member D ",12p13,
,,,mutations
,,,
CLEC4M,"C-type lectin domain family 4, member M ",19p13.3,
,,,"SARS infection, protection against"
,,,
CLEC7A,"C-type lectin domain family 7, member A ",12p13.2-p12.3,
,,,"Candidiasis, familial chronic mucocutaneous, autosomal dominant [MIM:613108]"
,,,
CLF,cholesterol-lowering factor ,13q,
,,,Cholesterol level QTL 1
,,,
CLIC2,chloride intracellular channel 2 ,?,
,,,mutations
,,,
CLK2,CDC-like kinase 2 ,1p31,
,,,mutations
,,,
CLLS1,"Leukemia, chronic lymphocytic, susceptibility to, 1 ",11q13.3,
,,,"Leukemia, chronic lymphocytic, susceptibility to, 1"
,,,
CLLS3,"Leukemia, chronic lymphocytic, susceptibility to, 3 ",9q34.1,
,,,"Leukemia, chronic lymphocytic, susceptibility to, 3"
,,,
CLLS4,"Leukemia, chronic lymphocytic susceptibility to, 4 ",6p25,
,,,"Leukemia, chronic lymphocytic susceptibility to, 4"
,,,
CLLS5,"Leukemia, chronic lymphocytic susceptiblity to, 5 ",11q24.1,
,,,"Leukemia, chronic lymphocytic susceptibility to, 5"
,,,
CLMP,CXADR-like membrane protein ,11q24.1,
,,,mutations
,,,
CLN3,"ceroid-lipofuscinosis, neuronal 3 ",16p12.1,
,,,"Ceroid-lipofuscinosis, neuronal-3, juvenile [MIM:204200]"
,,,
CLN5,"ceroid-lipofuscinosis, neuronal 5 ",13q21.1-q32,
,,,"Ceroid-lipofuscinosis, neuronal-5, variant late infantile [MIM:256731]"
,,,
CLN6,"ceroid-lipofuscinosis, neuronal 6, late infantile, variant ",15q21-q23,
,,,"Ceroid-lipofuscinosis, neuronal-6, variant late infantile [MIM:601780]"
,,,
CLN8,"ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) ",8p23,
,,,"Ceroid lipofuscinosis, neuronal 8 [MIM:600143]"
,,,"Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant [MIM:610003]"
,,,
CLNK,cytokine-dependent hematopoietic cell linker ,?,
,,,mutations
,,,
CLOCK,clock homolog (mouse) ,4q12,
,,,mutations
,,,
CLPS,"colipase, pancreatic ",6pter-p21.1,
,,,mutations
,,,
CLPTM1,cleft lip and palate associated transmembrane protein 1 ,?,
,,,mutations
,,,
CLQTL2,Cholesterol level QTL 2 ,2p24-p22,
,,,Cholesterol level QTL 2
,,,
CLRN1,clarin 1 ,3q21-q25,
,,,"Usher syndrome, type 3 [MIM:276902]"
,,,
CLSTN2,calsyntenin 2 ,?,
,,,mutations
,,,
CLTCL1,"clathrin, heavy chain-like 1 ",22q11.2,
,,,mutations
,,,
CLUL1,clusterin-like 1 (retinal) ,?,
,,,mutations
,,,
CLU,clusterin ,8p21-p12,
,,,mutations
,,,
CLYBL,citrate lyase beta like ,13q32,
,,,mutations
,,,
CMA1,"chymase 1, mast cell ",14q11.2,
,,,mutations
,,,
CMAL,"Capillary malformations, hereditary ",5q13-q22,
,,,"Capillary malformations, hereditary"
,,,
CMD1B,"cardiomyopathy, dilated 1B (autosomal dominant) ",9q13,
,,,"Cardiomyopathy, dilated 1B"
,,,
CMD1D,"cardiomyopathy, dilated 1D (autosomal dominant) ",1q32,
,,,"Cardiomyopathy, familial hypertrophic, 2 [MIM:115195]"
,,,"Cardiomyopathy, dilated, 1D [MIM:601494]"
,,,"Cardiomyopathy, familial restrictive, 3 [MIM:612422]"
,,,Left ventricular noncompaction 6 [MIM:601494]
,,,
CMD1F,"cardiomyopathy, dilated 1F (autosomal dominant) ",6q23,
,,,"Cardiomyopathy, dilated, 1F"
,,,
CMD1H,"cardiomyopathy, dilated 1H (autosomal dominant) ",2q14-q22,
,,,"Cardiomyopathy, dilated, 1H"
,,,
CMD1K,"cardiomyopathy, dilated 1K (autosomal dominant) ",6q12-q16,
,,,"Cardiomyopathy, dilated, 1K"
,,,
CMD1Q,"cardiomyopathy, dilated 1Q (autosomal dominant) ",7q22.3-q31.1,
,,,"Cardiomyopathy, dilated, 1Q"
,,,
CMD2A,"cardiomyopathy, dilated 2A (autosomal recessive) ",19q13.4,
,,,"Cardiomyopathy, familial hypertrophic, 7 [MIM:613690]"
,,,"Cardiomyopathy, familial restrictive [MIM:115210]"
,,,"Cardiomyopathy, dilated, 2A [MIM:611880]"
,,,"Cardiomyopathy, dilated, 1FF [MIM:613286]"
,,,
CMDR,"Craniometaphyseal dysplasia, autosomal recessive ",6q21-q22,
,,,"Craniometaphyseal dysplasia, autosomal recessive"
,,,
CMM4,"Melanoma, cutaneous malignant, 4 ",1p22,
,,,"Melanoma, cutaneous malignant, 4"
,,,
CMM7,"Melanoma, cutaneous malignant, susceptibility to, 7 ",20q11.2,
,,,"Melanoma, cutaneous malignant, susceptibility to, 7"
,,,
CMM,cutaneous malignant melanoma/dysplastic nevus ,1p36,
,,,"Malignant melanoma, cutaneous"
,,,
CMPK1,"cytidine monophosphate (UMP-CMP) kinase 1, cytosolic ",1p32,
,,,mutations
,,,
CMT1A,"Charcot-Marie-Tooth neuropathy 1A (greatly reduced nerve conduction velocity, hereditary motor sensory neuropathy Ia) ",17p11.2,
,,,"Charcot-Marie-Tooth disease, type 1A [MIM:118220]"
,,,Dejerine-Sottas disease [MIM:145900]
,,,"Neuropathy, recurrent, with pressure palsies [MIM:162500]"
,,,"Charcot-Marie-Tooth disease, type 1E [MIM:118300]"
,,,Roussy-Levy syndrome [MIM:180800]
,,,
CMT2B,Charcot-Marie-Tooth neuropathy 2B ,3q21,
,,,"Charcot-Marie-Tooth disease, type 2B [MIM:600882]"
,,,
CMT2G,"Charcot-Marie-Tooth disease, axonal, type 2G ",12q12-q13.3,
,,,"Charcot-Marie-Tooth disease, axonal, type 2G"
,,,
CMTDI2,"Charcot-Marie-Tooth disease, dominant intermediate 2 ",10q24.1-q25.1,
,,,"Charcot-Marie-Tooth disease, dominant intermediate 2"
,,,
CMTX2,"Charcot-Marie-Tooth neuropathy, X-linked 2 (recessive) ",Xp22.2,
,,,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 2"
,,,
CMTX3,"Charcot-Marie-Tooth neuropathy, X-linked 3 (dominant) ",Xq26,
,,,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 3"
,,,
CNBP,"CCHC-type zinc finger, nucleic acid binding protein ",3q13.3-q24,
,,,"Myotonic dystrophy, type 2 [MIM:602668]"
,,,
CNC,"Carney complex, multiple neoplasia and lentiginosis ",2p16,
,,,"Carney complex, type II"
,,,
CNDP1,carnosine dipeptidase 1 (metallopeptidase M20 family) ,18q22.3,
,,,mutations
,,,
CND,Corneal dermoids ,Xq24-qter,
,,,Dermoids of cornea
,,,
CNGA1,cyclic nucleotide gated channel alpha 1 ,4p12-cen,
,,,Retinitis pigmentosa-49
,,,
CNGA3,cyclic nucleotide gated channel alpha 3 ,2q11,
,,,Achromatopsia-2 [MIM:216900]
,,,
CNGB1,cyclic nucleotide gated channel beta 1 ,16q13,
,,,Retinitis pigmentosa-45 [MIM:268000]
,,,
CNGB3,cyclic nucleotide gated channel beta 3 ,8q21-q22,
,,,Achromatopsia-3 [MIM:262300]
,,,"Macular degeneration, juvenile [MIM:248200]"
,,,
CNKSR1,connector enhancer of kinase suppressor of Ras 1 ,?,
,,,mutations
,,,
CNKSR2,connector enhancer of kinase suppressor of Ras 2 ,Xp22.12,
,,,mutations
,,,
CNNM2,cyclin M2 ,10q24.33,
,,,mutations
,,,
CNNM4,cyclin M4 ,2q11.2,
,,,Jalili syndrome [MIM:217080]
,,,
CNOT3,"CCR4-NOT transcription complex, subunit 3 ",19q13.4,
,,,mutations
,,,
CNOT4,"CCR4-NOT transcription complex, subunit 4 ",7q22-qter,
,,,mutations
,,,
CNPY3,canopy 3 homolog (zebrafish) ,6pter-p12,
,,,mutations
,,,
CNR1,cannabinoid receptor 1 (brain) ,6q14-q15,
,,,mutations
,,,
CNR2,cannabinoid receptor 2 (macrophage) ,1p36,
,,,mutations
,,,
CNSN,Carnosinemia (carnosinase) ,18q21.3,
,,,Carnosinemia
,,,
CNTF,ciliary neurotrophic factor ,11q12.2,
,,,mutations
,,,
CNTN1,contactin 1 ,12q11-q12,
,,,"Myopathy, congenital, Compton-North [MIM:612540]"
,,,
CNTN4,contactin 4 ,3p26-p25,
,,,mutations
,,,
CNTNAP2,contactin associated protein-like 2 ,7q35-q36,
,,,Cortical dysplasia-focal epilepsy syndrome [MIM:610042]
,,,Autism susceptibility 15 [MIM:612100]
,,,Pitt-Hopkins like syndrome 1 [MIM:610042]
,,,
CNTNAP4,contactin associated protein-like 4 ,?,
,,,mutations
,,,
COCH,"coagulation factor C homolog, cochlin (Limulus polyphemus) ",14q12-q13,
,,,"Deafness, autosomal dominant 9 [MIM:601369]"
,,,
COD2,cone dystrophy 2 (X-linked) ,Xq27,
,,,"Cone dystrophy, progressive X-linked, 2"
,,,
CODA,Cavitary optic disc anomalies ,12q,
,,,Cavitary optic disc anomalies
,,,
COG1,component of oligomeric golgi complex 1 ,17q25.1,
,,,"Congenital disorder of glycosylation, type IIg [MIM:611209]"
,,,
COG4,component of oligomeric golgi complex 4 ,16q22.1,
,,,"Congenital disorder of glycosylation, type IIj [MIM:613489]"
,,,
COG5,component of oligomeric golgi complex 5 ,7q31,
,,,"Congenital disorder of glycosylation, type IIi [MIM:613612]"
,,,
COG6,component of oligomeric golgi complex 6 ,13q13.3,
,,,mutations
,,,
COG7,component of oligomeric golgi complex 7 ,16p,
,,,"Congenital disorder of glycosylation, type IIe [MIM:608779]"
,,,
COG8,component of oligomeric golgi complex 8 ,16q22.1,
,,,"Congenital disorder of glycosylation, type IIh [MIM:611182]"
,,,
COL10A1,"collagen, type X, alpha 1 ",6q21-q22.3,
,,,"Metaphyseal chondrodysplasia, Schmid type"
,,,"Spondylometaphyseal dysplasia, Japanese type"
,,,
COL11A1,"collagen, type XI, alpha 1 ",1p21,
,,,"Stickler syndrome, type II [MIM:604841]"
,,,Marshall syndrome [MIM:154780]
,,,"Lumbar disc herniation, susceptibility to [MIM:603932]"
,,,
COL11A2,"collagen, type XI, alpha 2 ",6p21.3,
,,,"Stickler syndrome, type III [MIM:184840]"
,,,Otospondylomegaepiphyseal dysplasia [MIM:215150]
,,,Weissenbacher-Zweymuller syndrome [MIM:277610]
,,,"Deafness, autosomal dominant 13 [MIM:601868]"
,,,"Deafness, autosomal recessive 53 [MIM:609706]"
,,,
COL12A1,"collagen, type XII, alpha 1 ",?,
,,,mutations
,,,
COL17A1,"collagen, type XVII, alpha 1 ",10q24.3,
,,,"Epidermolysis bullosa, junctional, non-Herlitz type [MIM:226650]"
,,,
COL18A1,"collagen, type XVIII, alpha 1 ",21q22.3,
,,,"Knobloch syndrome, type 1 [MIM:267750]"
,,,
COL1A1,"collagen, type I, alpha 1 ",17q21.31-q22,
,,,"Osteogenesis imperfecta, type I [MIM:166200]"
,,,OI type II [MIM:166210]
,,,OI type III [MIM:259420]
,,,OI type IV [MIM:166220]
,,,"Ehlers-Danlos syndrome, type I [MIM:130000]"
,,,"Ehlers-Danlos syndrome, type VIIA [MIM:130060]"
,,,Osteoporosis [MIM:166710]
,,,Caffey disease [MIM:114000]
,,,Bone mineral density variation QTL
,,,
COL1A2,"collagen, type I, alpha 2 ",7q22.1,
,,,"Ehlers-Danlos syndrome, type VIIB [MIM:130060]"
,,,"Osteogenesis imperfecta, type IV [MIM:166220]"
,,,"Osteogenesis imperfecta, type III [MIM:259420]"
,,,"Osteogenesis imperfecta, type II [MIM:166210]"
,,,"Osteoporosis, postmenopausal [MIM:166710]"
,,,"Ehlers-Danlos syndrome, cardiac valvular form [MIM:225320]"
,,,
COL25A1,"collagen, type XXV, alpha 1 ",4q25,
,,,mutations
,,,
COL2A1,"collagen, type II, alpha 1 ",12q13.11-q13.2,
,,,"Stickler syndrome, type I [MIM:108300]"
,,,Kniest dysplasia [MIM:156550]
,,,"Achondrogenesis-hypochondrogenesis, type II [MIM:200610]"
,,,SED congenita [MIM:183900]
,,,SMED Strudwick type [MIM:184250]
,,,"Epiphyseal dysplasia, multiple, with myopia and deafness [MIM:132450]"
,,,Spondyloperipheral dysplasia [MIM:271700]
,,,"SED, Namaqualand type"
,,,Osteoarthritis with mild chondrodysplasia [MIM:604864]
,,,Vitreoretinopathy with phalangeal epiphyseal dysplasia
,,,"Platyspondylic skeletal dysplasia, Torrance type [MIM:151210]"
,,,Otospondylomegaepiphyseal dysplasia [MIM:215150]
,,,Avascular necrosis of the femoral head [MIM:608805]
,,,Legg-Calve-Perthes disease [MIM:150600]
,,,"Stickler sydrome, type I, nonsyndromic ocular [MIM:609508]"
,,,
COL3A1,"collagen, type III, alpha 1 ",2q31,
,,,"Ehlers-Danlos syndrome, type IV [MIM:130050]"
,,,"Ehlers-Danlos syndrome, type III [MIM:130020]"
,,,
COL4A1,"collagen, type IV, alpha 1 ",13q34,
,,,Porencephaly [MIM:175780]
,,,Brain small vessel disease with hemorrhage [MIM:607595]
,,,"Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps [MIM:611773]"
,,,Brain small vessel disease with Axenfeld-Rieger anomaly [MIM:607595]
,,,
COL4A2,"collagen, type IV, alpha 2 ",13q34,
,,,mutations
,,,
COL4A3,"collagen, type IV, alpha 3 (Goodpasture antigen) ",2q36-q37,
,,,"Alport syndrome, autosomal recessive [MIM:203780]"
,,,"Hematuria, benign familial [MIM:141200]"
,,,
COL4A4,"collagen, type IV, alpha 4 ",2q36-q37,
,,,"Alport syndrome, autosomal recessive [MIM:203780]"
,,,"Hematuria, familial benign"
,,,
COL4A5,"collagen, type IV, alpha 5 ",Xq22.3,
,,,Alport syndrome [MIM:301050]
,,,
COL4A6,"collagen, type IV, alpha 6 ",Xq22.3,
,,,"Leiomyomatosis, diffuse, with Alport syndrome [MIM:308940]"
,,,
COL5A1,"collagen, type V, alpha 1 ",9q34.2-q34.3,
,,,"Ehlers-Danlos syndrome, type II [MIM:130010]"
,,,"Ehlers-Danlos syndrome, type I [MIM:130000]"
,,,
COL5A2,"collagen, type V, alpha 2 ",2q31,
,,,"Ehlers-Danlos syndrome, type I [MIM:130000]"
,,,
COL6A1,"collagen, type VI, alpha 1 ",21q22.3,
,,,Bethlem myopathy [MIM:158810]
,,,Ullrich congenital muscular dystrophy [MIM:254090]
,,,Ossification of the posterior longitudinal spinal ligaments [MIM:602475]
,,,
COL6A2,"collagen, type VI, alpha 2 ",21q22.3,
,,,Bethlem myopathy [MIM:158810]
,,,Ullrich congenital muscular dystrophy [MIM:254090]
,,,"Myosclerosis, congenital [MIM:255600]"
,,,
COL6A3,"collagen, type VI, alpha 3 ",2q37,
,,,Bethlem myopathy [MIM:158810]
,,,Ullrich congenital muscular dystrophy [MIM:254090]
,,,
COL6A5,"collagen, type VI, alpha 5 ",3q21,
,,,mutations
,,,
COL7A1,"collagen, type VII, alpha 1 ",3p21.3,
,,,"Epidermolysis bullosa dystrophica, AD [MIM:131750]"
,,,"Epidermolysis bullosa dystrophica, AR [MIM:226600]"
,,,"Epidermolysis bullosa, pretibial [MIM:131850]"
,,,"EBD, Bart type [MIM:132000]"
,,,"EBD, localisata variant"
,,,Transient bullous of the newborn [MIM:131705]
,,,Epidermolysis bullosa pruriginosa [MIM:604129]
,,,"Toenail dystrophy, isolated [MIM:607523]"
,,,EBD inversa [MIM:226600]
,,,
COL8A2,"collagen, type VIII, alpha 2 ",1p34.3-p32.3,
,,,"Corneal dystrophy, Fuchs endothelial, 1 [MIM:136800]"
,,,"Corneal dystrophy polymorphous posterior, 2 [MIM:609140]"
,,,
COL9A1,"collagen, type IX, alpha 1 ",6q13,
,,,"Epiphyseal dysplasia, multiple, 6"
,,,
COL9A2,"collagen, type IX, alpha 2 ",1p33-p32.2,
,,,"Epiphyseal dysplasia, multiple, 2 [MIM:600204]"
,,,"Intervertebral disc disease, susceptibility to [MIM:603932]"
,,,
COL9A3,"collagen, type IX, alpha 3 ",20q13.3,
,,,"Epiphyseal dysplasia, multiple, 3 [MIM:600969]"
,,,"Epiphyseal dysplasia, multiple, with myopathy"
,,,"Intervertebral disc disease, susceptibility to [MIM:603932]"
,,,
COLEC11,collectin sub-family member 11 ,2p25.3,
,,,mutations
,,,
COLQ,collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase ,3p25,
,,,Endplate acetylcholinesterase deficiency [MIM:603034]
,,,
COMA,Cogan-type congential oculomotor apraxia ,2q13,
,,,"Oculomotor apraxia, congenital, Cogan-type"
,,,
COMMD1,copper metabolism (Murr1) domain containing 1 ,2p16-p13,
,,,mutations
,,,
COMP,cartilage oligomeric matrix protein ,19p13.1,
,,,Pseudoachondroplasia [MIM:177170]
,,,"Epiphyseal dysplasia, multiple 1 [MIM:132400]"
,,,
COMT,catechol-O-methyltransferase ,22q11.2,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,"Panic disorder, susceptibility to [MIM:167870]"
,,,
COPD,"Pulmonary disease, chronic obstructive, severe early-onset ",2q,
,,,"Pulmonary disease, chronic obstructive, severe early-onset"
,,,
COPS4,COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis) ,Xq27-q28,
,,,"Microphthalmia, syndromic 4"
,,,
COPS8,COP9 constitutive photomorphogenic homolog subunit 8 (Arabidopsis) ,6q21,
,,,"Microphthalmia, syndromic 8"
,,,
COP,clathrin-ordered protein ,7p11.2,
,,,mutations
,,,
COQ2,"coenzyme Q2 homolog, prenyltransferase (yeast) ",4q21-q22,
,,,Coenzyme Q10 deficiency [MIM:607426]
,,,
COQ4,coenzyme Q4 homolog (S. cerevisiae) ,9q34.13,
,,,mutations
,,,
COQ5,"coenzyme Q5 homolog, methyltransferase (S. cerevisiae) ",?,
,,,mutations
,,,
COQ6,"coenzyme Q6 homolog, monooxygenase (S. cerevisiae) ",?,
,,,mutations
,,,
COQ9,coenzyme Q9 homolog (S. cerevisiae) ,16q13,
,,,Coenzyme Q10 deficiency [MIM:607426]
,,,
CORD1,cone rod dystrophy 1 (autosomal dominant) ,18q21.1-q21.3,
,,,Cone-rod retinal dystrophy-1
,,,
CORD8,cone rod dystrophy 8 ,1q12-q24,
,,,Cone-rod dystrophy 8
,,,
CORIN,"corin, serine peptidase ",4p13-p12,
,,,mutations
,,,
CORO1A,"coronin, actin binding protein, 1A ",16p11.2,
,,,mutations
,,,
COX10,"COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast) ",17p12-p11.2,
,,,"Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency"
,,,
COX15,"COX15 homolog, cytochrome c oxidase assembly protein (yeast) ",10q24,
,,,"Cardiomyopathy, hypertrophic, early-onset fatal"
,,,Leigh syndrome due to cytochrome c oxidase deficiency [MIM:256000]
,,,
COX4I1,cytochrome c oxidase subunit IV isoform 1 ,16q22-qter,
,,,mutations
,,,
COX4I2,cytochrome c oxidase subunit IV isoform 2 (lung) ,20q11.21,
,,,"Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis [MIM:612714]"
,,,
COX6B1,cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) ,19q13.1,
,,,Cytochrome c oxidase deficiency [MIM:220110]
,,,
COX7A1,cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) ,19q13.12,
,,,mutations
,,,
COX7A2,cytochrome c oxidase subunit VIIa polypeptide 2 (liver) ,6q12,
,,,mutations
,,,
CPA4,carboxypeptidase A4 ,7q32,
,,,mutations
,,,
CPA6,carboxypeptidase A6 ,?,
,,,mutations
,,,
CPAT1,"cerebral palsy, ataxic 1 ",9p12-q12,
,,,"Cerebral palsy, ataxic, autosomal recessive"
,,,
CPB2,carboxypeptidase B2 (plasma) ,13q14.11,
,,,mutations
,,,
CPE,carboxypeptidase E ,4q32.3,
,,,mutations
,,,
CPLX2,complexin 2 ,5q35.2,
,,,mutations
,,,
CPN1,"carboxypeptidase N, polypeptide 1 ",10q24.2,
,,,Carboxypeptidase N deficiency [MIM:212070]
,,,
CPOX,coproporphyrinogen oxidase ,3q12,
,,,Coproporphyria [MIM:121300]
,,,Harderoporphyria [MIM:121300]
,,,
CPO,carboxypeptidase O ,?,
,,,"coproporphyria,hereditary acute hepatic porphyria characterized by cutaneous photosensibility and neurological disturbances with an overproduction of coproporphyrin,including harderoporphyria"
,,,
CPROTQ,C-reactive protein QTL ,10q23-q24,
,,,C-reactive protein QTL
,,,
CPS1,"carbamoyl-phosphate synthase 1, mitochondrial ",2q35,
,,,Carbamoylphosphate synthetase I deficiency [MIM:237300]
,,,"Pulmonary hypertension, familial persistent, of the newborn [MIM:265380]"
,,,Venoocclusive disease after bone marrow transplantation (3) 1
,,,
CPT1A,carnitine palmitoyltransferase 1A (liver) ,11q13,
,,,"CPT deficiency, hepatic, type IA [MIM:255120]"
,,,
CPT1B,carnitine palmitoyltransferase 1B (muscle) ,22q13,
,,,mutations
,,,
CPT2,carnitine palmitoyltransferase 2 ,1p32,
,,,Myopathy due to CPT II deficiency [MIM:255110]
,,,"CPT deficiency, hepatic, type II [MIM:600649]"
,,,"CPT II deficiency, lethal neonatal [MIM:608836]"
,,,
CPZ,carboxypeptidase Z ,?,
,,,mutations
,,,
CP,ceruloplasmin (ferroxidase) ,3q23-q24,
,,,"Hypoceruloplasminemia, hereditary [MIM:604290]"
,,,Cerebellar ataxia [MIM:604290]
,,,"Hemosiderosis, systemic, due to aceruloplasminemia [MIM:604290]"
,,,
CR1,complement component (3b/4b) receptor 1 (Knops blood group) ,1q32,
,,,CR1 deficiency
,,,?SLE susceptibility
,,,"Blood group, Knops system [MIM:607486]"
,,,"Malaria, severe, resistance to [MIM:611162]"
,,,
CR2,complement component (3d/Epstein Barr virus) receptor 2 ,1q32,
,,,"Systemic lupus erythematosus, susceptibility to, 9 [MIM:610927]"
,,,
CRAC1,colorectal adenoma and carcinoma 1 ,15q15.3-q22.1,
,,,"Polyposis syndrome, mixed hereditary 1"
,,,"Colorectal cancer, susceptibility to, 4"
,,,
CRADD,CASP2 and RIPK1 domain containing adaptor with death domain ,12q21.33-q23.1,
,,,mutations
,,,
CRAT,carnitine O-acetyltransferase ,9q34.1,
,,,Carnitine acetyltransferase deficiency
,,,
CRB1,crumbs homolog 1 (Drosophila) ,1q31-q32.1,
,,,"Retinitis pigmentosa-12, autosomal recessive [MIM:600105]"
,,,Leber congenital amaurosis 8
,,,Pigmented paravenous chorioretinal atrophy [MIM:172870]
,,,
CRBN,cereblon ,3p26.2,
,,,"Mental retardation, autosomal recessive 2A [MIM:607417]"
,,,
CRCL,Creatinine clearance QTL ,3p,
,,,Creatinine clearance QTL
,,,
CRCS10,"Colorectal cancer, susceptibility to, 10 ",19q13.1,
,,,"Colorectal cancer, susceptibility to, 10"
,,,
CRCS11,"Colorectal cancer, susceptibility to, 11 ",20p12.3,
,,,"Colorectal cancer, susceptibility to, 11"
,,,
CRCS2,"Colorectal cancer, susceptibility to, 2 ",8q24,
,,,"Colorectal cancer, susceptibility to, 2"
,,,
CRCS5,"Colorectal cancer, susceptibility to, 5 ",10p14,
,,,"Colorectal cancer, susceptibility to, 5"
,,,
CRCS6,"colorectal cancer, susceptibility to, 6 ",8q23,
,,,"Colorectal cancer, susceptibility to, 6"
,,,
CRCS7,"colorectal cancer, susceptibility to, 7 ",11q23,
,,,"Colorectal cancer, susceptibility to, 7"
,,,
CRCS8,"Colorectal cancer, susceptibility to, 8 ",14q22.2,
,,,"Colorectal cancer, susceptibility to, 8"
,,,
CRCS9,"colorectal cancer, susceptibility to, 9 ",16q22.1,
,,,"Colorectal cancer, susceptibility to, 9"
,,,
CREB1,cAMP responsive element binding protein 1 ,2q32.3-q34,
,,,"Histiocytoma, angiomatoid fibrous, somatic [MIM:612160]"
,,,
CREB3L3,cAMP responsive element binding protein 3-like 3 ,19p13.3,
,,,mutations
,,,
CREBBP,CREB binding protein ,16p13.3,
,,,Rubinstein-Taybi syndrome [MIM:180849]
,,,
CRELD1,cysteine-rich with EGF-like domains 1 ,3p25.3,
,,,"Atrioventricular septal defect, susceptibility to, 2 [MIM:606217]"
,,,"Atrioventricular septal defect, partial, with heterotaxy syndrome [MIM:606217]"
,,,
CRHR1,corticotropin releasing hormone receptor 1 ,17q12-q22,
,,,mutations
,,,
CRH,corticotropin releasing hormone ,8q13,
,,,congenital isolated adrenocorticotropic hormone (ACTH) deficiency (?CRH or ? SGKL defect)
,,,
CRIPT,cysteine-rich PDZ-binding protein ,?,
,,,mutations
,,,
CRISP2,cysteine-rich secretory protein 2 ,6p12,
,,,mutations
,,,
CRKL,v-crk sarcoma virus CT10 oncogene homolog (avian)-like ,22q11,
,,,mutations
,,,
CRK,v-crk sarcoma virus CT10 oncogene homolog (avian) ,17p13.3,
,,,mutations
,,,
CRLF1,cytokine receptor-like factor 1 ,19p12,
,,,Cold-induced sweating syndrome [MIM:272430]
,,,Crisponi syndrome [MIM:601378]
,,,
CRP,"C-reactive protein, pentraxin-related ",1q21-q23,
,,,mutations
,,,
CRSA,"Craniosynostosis, Adelaide type ",4p16,
,,,"Craniosynostosis, Adelaide type"
,,,
CRTAP,cartilage associated protein ,3p22,
,,,"Osteogenesis imperfecta, type IIB [MIM:610854]"
,,,"Osteogenesis imperfecta, type VII [MIM:610682]"
,,,
CRTC1,CREB regulated transcription coactivator 1 ,19p13,
,,,Mucoepidermoid salivary gland carcinoma
,,,
CRX,cone-rod homeobox ,19q13.3,
,,,Cone-rod retinal dystrophy-2 [MIM:120970]
,,,Leber congenital amaurosis 7
,,,"Retinitis pigmentosa, late-onset dominant [MIM:268000]"
,,,
CRYAA,"crystallin, alpha A ",21q22.3,
,,,"Cataract, zonular central nuclear, autosomal dominant"
,,,"Cataract, congenital, autosomal recessive"
,,,"Cataract, autosomal dominant nuclear"
,,,
CRYAB,"crystallin, alpha B ",11q22.3-q23.1,
,,,"Myopathy, cardioskeletal, desmin-related, with cataract [MIM:608810]"
,,,"Cataract, posterior polar 2"
,,,
CRYBA1,"crystallin, beta A1 ",17q11.1-q12,
,,,"Cataract, congenital zonular, with sutural opacities [MIM:600881]"
,,,
CRYBA4,"crystallin, beta A4 ",22q11.2-q13.1,
,,,"Cataract, lamellar 2 [MIM:610425]"
,,,Microphthalmia with cataract 4 [MIM:610426]
,,,
CRYBB1,"crystallin, beta B1 ",22q11.2-q12.1,
,,,"Cataract, pulverulent"
,,,"Cataract, congenital nuclear, autosomal recessive 3 [MIM:611544]"
,,,
CRYBB2,"crystallin, beta B2 ",22q11.2-q12.2,
,,,"Cataract, cerulean, type 2 [MIM:601547]"
,,,"Cataract, sutural, with punctate and cerulean opacities [MIM:607133]"
,,,"Cataract, Coppock-like [MIM:604307]"
,,,
CRYBB3,"crystallin, beta B3 ",22q11.2-q12.2,
,,,"Cataract, congenital nuclear, 2 [MIM:609741]"
,,,
CRYGB,"crystallin, gamma B ",2q33-q35,
,,,mutations
,,,
CRYGC,"crystallin, gamma C ",2q33-q35,
,,,"Cataract, Coppock-like [MIM:604307]"
,,,"Cataract, variable zonular pulverulent"
,,,
CRYGD,"crystallin, gamma D ",2q33-q35,
,,,"Cataracts, punctate, progressive juvenile-onset"
,,,"Cataract, crystalline aculeiform [MIM:115700]"
,,,"Cataract, congenital, cerulean type, 3 [MIM:608983]"
,,,"Cataract, nonnuclear polymorphic congenital [MIM:601286]"
,,,
CRYGEP,"crystallin, gamma E, pseudogene ",?,
,,,mutations
,,,
CRYGS,"crystallin, gamma S ",3q27,
,,,"Cataract, progressive polymorphic cortical"
,,,
CRYM,"crystallin, mu ",16p13.11-p12.3,
,,,"Deafness, autosomal dominant 40"
,,,
CSAG1,chondrosarcoma associated gene 1 ,?,
,,,mutations
,,,
CSDE1,"cold shock domain containing E1, RNA-binding ",1p22,
,,,mutations
,,,
CSE,"choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity) ",1p,
,,,"Choreoathetosis/spasticity, episodic"
,,,
CSF1R,colony stimulating factor 1 receptor ,5q33.2-q33.3,
,,,"Myeloid malignancy, predisposition to"
,,,
CSF1,colony stimulating factor 1 (macrophage) ,1p21-p13,
,,,mutations
,,,
CSF2RA,"colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) ",Xp22.32,
,,,Pulmonary alveolar proteinosis [MIM:300770]
,,,
CSF2RB,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) ",22q12.2-q13.1,
,,,mutations
,,,
CSF2,colony stimulating factor 2 (granulocyte-macrophage) ,5q31.1,
,,,mutations
,,,
CSF3R,colony stimulating factor 3 receptor (granulocyte) ,1p35-p34.3,
,,,"Neutrophilia, hereditary [MIM:162830]"
,,,
CSGALNACT1,chondroitin sulfate N-acetylgalactosaminyltransferase 1 ,?,
,,,mutations
,,,
CSH1,chorionic somatomammotropin hormone 1 (placental lactogen) ,17q22-q24,
,,,Placental lactogen deficiency
,,,
CSMD1,CUB and Sushi multiple domains 1 ,8p23,
,,,mutations
,,,
CSMD3,CUB and Sushi multiple domains 3 ,8q23.3,
,,,mutations
,,,
CSNK1A1L,"casein kinase 1, alpha 1-like ",?,
,,,mutations
,,,
CSNK1D,"casein kinase 1, delta ",17q25,
,,,mutations
,,,
CSNK1E,"casein kinase 1, epsilon ",22q12-q13,
,,,mutations
,,,
CSNK2A1P,"casein kinase 2, alpha 1 polypeptide pseudogene ",?,
,,,mutations
,,,
CSNK2A2,"casein kinase 2, alpha prime polypeptide ",16p13.3-p13.2,
,,,mutations
,,,
CSRP3,cysteine and glycine-rich protein 3 (cardiac LIM protein) ,11p15.1,
,,,"Cardiomyopathy, dilated, 1M [MIM:607482]"
,,,"Cardiomyopathy, familial hypertrophic, 12 [MIM:612124]"
,,,
CST3,cystatin C ,20p11.2,
,,,Cerebral amyloid angiopathy [MIM:105150]
,,,"Macular degeneration, age-related, 11 [MIM:611953]"
,,,
CSTA,cystatin A (stefin A) ,3q21,
,,,mutations
,,,
CSTB,cystatin B (stefin B) ,21q22.3,
,,,"Epilepsy, progressive myoclonic 1 [MIM:254800]"
,,,
CSTF2T,"cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant ",10q22-q23,
,,,mutations
,,,
CS,citrate synthase ,12q13.2-q13.3,
,,,mutations
,,,
CTAA1,"cataract, anterior polar 1 ",14q24-qter,
,,,"Cataract, anterior polar-1"
,,,
CTAA2,"cataract, anterior polar 2 ",17p13,
,,,"Cataract, anterior polar-2"
,,,
CTC1,CTS telomere maintenance complex component 1 ,17p13.1,
,,,mutations
,,,
CTDP1,"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 ",18q23,
,,,"Congenital cataracts, facial dysmorphism, and neuropathy [MIM:604168]"
,,,
CTEPH1,"Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to ",6p21.3,
,,,"Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to"
,,,
CTF1,cardiotrophin 1 ,16p11.2-p11.1,
,,,mutations
,,,
CTGF,connective tissue growth factor ,6q23.1,
,,,mutations
,,,
CTHM,cono-truncal heart malformation ,22q11.2,
,,,Conotruncal anomaly face syndrome [MIM:217095]
,,,DiGeorge syndrome [MIM:188400]
,,,Velocardiofacial syndrome [MIM:192430]
,,,
CTHRC1,collagen triple helix repeat containing 1 ,8q22.3,
,,,mutations
,,,
CTH,cystathionase (cystathionine gamma-lyase) ,1p31.1,
,,,Cystathioninuria [MIM:219500]
,,,"Homocysteine, total plasma, elevated"
,,,
CTLA4,cytotoxic T-lymphocyte-associated protein 4 ,2q33,
,,,"Graves disease, susceptibility to, 4"
,,,"Hypothyroidism, autoimmune [MIM:140300]"
,,,"Diabetes mellitus, insulin-dependent, susceptibility to [MIM:601388]"
,,,"Celiac disease, susceptibility to, 3 [MIM:609755]"
,,,
CTNNA3,"catenin (cadherin-associated protein), alpha 3 ",10q21,
,,,mutations
,,,
CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa ",3p22-p21.3,
,,,Colorectal cancer
,,,Hepatoblastoma
,,,Pilomatricoma [MIM:132600]
,,,Ovarian cancer [MIM:167000]
,,,Hepatocellular carcinoma [MIM:114550]
,,,
CTNND1,"catenin (cadherin-associated protein), delta 1 ",11q11,
,,,mutations
,,,
CTNND2,"catenin (cadherin-associated protein), delta 2 ",5p15.2,
,,,Mental retardation in cri-du-chat syndrome [MIM:123450]
,,,
CTNS,"cystinosin, lysosomal cystine transporter ",17p13,
,,,"Cystinosis, nephropathic [MIM:219800]"
,,,"Cystinosis, ocular nonnephropathic [MIM:219750]"
,,,"Cystinosis, late-onset juvenile or adolescent nephropathic [MIM:219900]"
,,,"Cystinosis, atypical nephropathic"
,,,
CTPL1,"cataract, pulverulent (autosomal recessive, early-onset) ",9q13-q22,
,,,"Cataract, autosomal recessive, early-onset, pulverulent"
,,,
CTPP5,"Cataract, posterior polar, 5 ",14q22-q23,
,,,"Cataract, posterior polar, 5"
,,,
CTPP,"Cataract, posterior polar ",1pter-p36.1,
,,,"Cataract, posterior polar"
,,,
CTRC,chymotrypsin C (caldecrin) ,1p36.21,
,,,"Pancreatitis, chronic, susceptibility to [MIM:167800]"
,,,
CTSA,cathepsin A ,20q13.1,
,,,Galactosialidosis [MIM:256540]
,,,
CTSB,cathepsin B ,8p22,
,,,mutations
,,,
CTSC,cathepsin C ,11q14.1-q14.3,
,,,Papillon-Lefevre syndrome [MIM:245000]
,,,Haim-Munk syndrome [MIM:245010]
,,,"Periodontitis, juvenile [MIM:170650]"
,,,
CTSD,cathepsin D ,11p15.5,
,,,"Ceroid lipofuscinosis, neuronal, 10 [MIM:610127]"
,,,
CTSG,cathepsin G ,14q11.2,
,,,mutations
,,,
CTSK,cathepsin K ,1q21,
,,,Pycnodysostosis [MIM:265800]
,,,
CTSZ,cathepsin Z ,20q13,
,,,mutations
,,,
CTTNBP2,cortactin binding protein 2 ,7q31,
,,,mutations
,,,
CUBN,cubilin (intrinsic factor-cobalamin receptor) ,10p12.1,
,,,"Megaloblastic anemia-1, Finnish type [MIM:261100]"
,,,
CUL3,cullin 3 ,2q36,
,,,mutations
,,,
CUL4B,cullin 4B ,Xq23,
,,,"Mental retardation, X-linked, syndromic 15 (Cabezas type) [MIM:300354]"
,,,
CUL5,cullin 5 ,11q22-q23,
,,,mutations
,,,
CUL7,cullin 7 ,6p21.1,
,,,3-M syndrome [MIM:273750]
,,,
CVMRF,cubitus valgus with mental retardation and unusual facies ,X,
,,,Cubitus valgus with mental retardation and unusual facies
,,,
CX3CR1,chemokine (C-X3-C motif) receptor 1 ,3pter-p21,
,,,Rapid progression to AIDS from HIV1 infection [MIM:609423]
,,,"Coronary artery disease, resistance to [MIM:607339]"
,,,"Macular degeneration, age-related, susceptibility to [MIM:603075]"
,,,
CXCL10,chemokine (C-X-C motif) ligand 10 ,4q21,
,,,mutations
,,,
CXCL11,chemokine (C-X-C motif) ligand 11 ,4q21.2,
,,,mutations
,,,
CXCL12,chemokine (C-X-C motif) ligand 12 ,10q11.1,
,,,"AIDS, resistance to [MIM:609423]"
,,,
CXCL16,chemokine (C-X-C motif) ligand 16 ,17p13,
,,,mutations
,,,
CXCL5,chemokine (C-X-C motif) ligand 5 ,4q12-q13,
,,,mutations
,,,
CXCR1,chemokine (C-X-C motif) receptor 1 ,2q35,
,,,"AIDS, slow progression to [MIM:609423]"
,,,
CXCR3,chemokine (C-X-C motif) receptor 3 ,Xq13,
,,,mutations
,,,
CXCR4,chemokine (C-X-C motif) receptor 4 ,2q21,
,,,WHIM syndrome [MIM:193670]
,,,"Myelokathexis, isolated"
,,,
CYB5A,cytochrome b5 type A (microsomal) ,18q23,
,,,"Methemoglobinemia, type IV [MIM:250790]"
,,,
CYB5R3,cytochrome b5 reductase 3 ,22q13.31-qter,
,,,"Methemoglobinemia, type I [MIM:250800]"
,,,"Methemoglobinemia, type II [MIM:250800]"
,,,
CYBA,"cytochrome b-245, alpha polypeptide ",16q24,
,,,"Chronic granulomatous disease, autosomal, due to deficiency of CYBA [MIM:233690]"
,,,
CYBB,"cytochrome b-245, beta polypeptide ",Xp21.1,
,,,"Chronic granulomatous disease, X-linked [MIM:306400]"
,,,
CYBRD1,cytochrome b reductase 1 ,?,
,,,mutations
,,,
CYCS,"cytochrome c, somatic ",7p15.2,
,,,Thrombocytopenia 4 [MIM:612004]
,,,
CYLD,cylindromatosis (turban tumor syndrome) ,16q12-q13,
,,,"Cylindromatosis, familial [MIM:132700]"
,,,Brooke-Spiegler syndrome [MIM:605041]
,,,"Trichoepithelioma, multiple familial, 1 [MIM:601606]"
,,,
CYMD,cystoid macular dystrophy ,7p21-p15,
,,,"Macular dystrophy, dominant cystoid"
,,,
CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1 ",15q23-q24,
,,,Lipoid congenital adrenal hyperplasia [MIM:201710]
,,,"Adrenal insufficiency, congenital with or without 46, XY sex reversal"
,,,
CYP11B1,"cytochrome P450, family 11, subfamily B, polypeptide 1 ",8q21,
,,,"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency [MIM:202010]"
,,,"Aldosteronism, glucocorticoid-remediable [MIM:103900]"
,,,
CYP11B2,"cytochrome P450, family 11, subfamily B, polypeptide 2 ",8q21,
,,,"Hypoaldosteronism, congenital, due to CMO II deficiency [MIM:610600]"
,,,"Hypoaldosteronism, congenital, due to CMO I deficiency [MIM:203400]"
,,,"Low renin hypertension, susceptibility to"
,,,Aldosterone to renin ratio raised
,,,
CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1 ",10q24.3,
,,,"17-alpha-hydroxylase/17,20-lyase deficiency [MIM:202110]"
,,,"17,20-lyase deficiency, isolated [MIM:202110]"
,,,
CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1 ",15q21.1,
,,,Aromatase deficiency [MIM:613546]
,,,Aromatase excess syndrome [MIM:139300]
,,,
CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1 ",15q24.1,
,,,mutations
,,,
CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2 ",15q24.1,
,,,mutations
,,,
CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1 ",2p22-p21,
,,,"Glaucoma 3A, primary congenital [MIM:231300]"
,,,Peters anomaly [MIM:604229]
,,,"Glaucoma, early-onset, digenic"
,,,"Glaucoma, primary open angle, adult-onset [MIM:137760]"
,,,"Glaucoma, primary open angle, juvenile-onset [MIM:137750]"
,,,
CYP21A2,"cytochrome P450, family 21, subfamily A, polypeptide 2 ",?,
,,,"adrenal hyperplasia III,female pseudohermaphroditism,with/without salt losing;cryptic non classic and latent forms,hirsutism hyperandrogenic women,virilization with advanced somatic growth,skeletal age and false precocious puberty in male (21-OH deficiency),sometimes with uniparental disomy"
,,,
CYP24A1,"cytochrome P450, family 24, subfamily A, polypeptide 1 ",20q13.2-q13.3,
,,,mutations
,,,
CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1 ",10q23-q24,
,,,mutations
,,,
CYP26B1,"cytochrome P450, family 26, subfamily B, polypeptide 1 ",?,
,,,mutations
,,,
CYP27A1,"cytochrome P450, family 27, subfamily A, polypeptide 1 ",2q33-qter,
,,,Cerebrotendinous xanthomatosis [MIM:213700]
,,,
CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1 ",12q13.1-q13.3,
,,,"Vitamin D-dependent rickets, type I [MIM:264700]"
,,,
CYP2A13,"cytochrome P450, family 2, subfamily A, polypeptide 13 ",19q13.2,
,,,mutations
,,,
CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6 ",19q13.2,
,,,Coumarin resistance [MIM:122700]
,,,"Nicotine addiction, protection from [MIM:188890]"
,,,"Lung cancer, resistance to [MIM:211980]"
,,,
CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6 ",19q13.2,
,,,mutations
,,,
CYP2C18,"cytochrome P450, family 2, subfamily C, polypeptide 18 ",?,
,,,mutations
,,,
CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19 ",10q24.1-q24.3,
,,,Mephenytoin poor metabolizer [MIM:609535]
,,,Opremazole poor metabolizer [MIM:609535]
,,,Proguanil poor metabolizer [MIM:609535]
,,,"Clopidogrel, impaired responsiveness to [MIM:609535]"
,,,
CYP2C8,"cytochrome P450, family 2, subfamily C, polypeptide 8 ",10q23.3,
,,,"Rhabdomyolysis, cerivastatin-induced"
,,,
CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9 ",10q24,
,,,Tolbutamide poor metabolizer
,,,Warfarin sensitivity [MIM:122700]
,,,
CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6 ",22q13.1,
,,,Debrisoquine sensitivity [MIM:608902]
,,,Codeine sensitivity [MIM:608902]
,,,
CYP2D7P1,"cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1 ",?,
,,,mutations
,,,
CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1 ",10q24.3-qter,
,,,mutations
,,,
CYP2F1,"cytochrome P450, family 2, subfamily F, polypeptide 1 ",19q13.2,
,,,mutations
,,,
CYP2G1P,"cytochrome P450, family 2, subfamily G, polypeptide 1 pseudogene ",?,
,,,mutations
,,,
CYP2G2P,"cytochrome P450, family 2, subfamily G, polypeptide 2 pseudogene ",?,
,,,mutations
,,,
CYP2J2,"cytochrome P450, family 2, subfamily J, polypeptide 2 ",1p31.3-p31.2,
,,,mutations
,,,
CYP2R1,"cytochrome P450, family 2, subfamily R, polypeptide 1 ",11p15.2,
,,,Rickets due to defect in vitamin D 25-hydroxylation [MIM:600081]
,,,
CYP2W1,"cytochrome P450, family 2, subfamily W, polypeptide 1 ",?,
,,,mutations
,,,
CYP3A43,"cytochrome P450, family 3, subfamily A, polypeptide 43 ",7q22.1,
,,,mutations
,,,
CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4 ",7q22.1,
,,,mutations
,,,
CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5 ",7q22.1,
,,,"Hypertension, salt-sensitive essential, susceptibility to [MIM:145500]"
,,,
CYP3A7,"cytochrome P450, family 3, subfamily A, polypeptide 7 ",7q22.1,
,,,mutations
,,,
CYP46A1,"cytochrome P450, family 46, subfamily A, polypeptide 1 ",14q32.1,
,,,mutations
,,,
CYP4A11,"cytochrome P450, family 4, subfamily A, polypeptide 11 ",1p33,
,,,mutations
,,,
CYP4A22,"cytochrome P450, family 4, subfamily A, polypeptide 22 ",?,
,,,mutations
,,,
CYP4B1,"cytochrome P450, family 4, subfamily B, polypeptide 1 ",1p34-p12,
,,,mutations
,,,
CYP4F12,"cytochrome P450, family 4, subfamily F, polypeptide 12 ",19p13.1,
,,,mutations
,,,
CYP4F22,"cytochrome P450, family 4, subfamily F, polypeptide 22 ",19p13.12,
,,,"Ichthyosis, lamellar, 3 [MIM:604777]"
,,,
CYP4F2,"cytochrome P450, family 4, subfamily F, polypeptide 2 ",?,
,,,mutations
,,,
CYP4F3,"cytochrome P450, family 4, subfamily F, polypeptide 3 ",19p13.2,
,,,mutations
,,,
CYP4V2,"cytochrome P450, family 4, subfamily V, polypeptide 2 ",4q35.1,
,,,Bietti crystalline corneoretinal dystrophy [MIM:210370]
,,,
CYP7A1,"cytochrome P450, family 7, subfamily A, polypeptide 1 ",8q11-q12,
,,,mutations
,,,
CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1 ",8q21.3,
,,,"Bile acid synthesis defect, congenital, 3"
,,,Spastic paraplegia-5A [MIM:270800]
,,,
CYSLTR1,cysteinyl leukotriene receptor 1 ,Xq13-q21,
,,,mutations
,,,
CYSLTR2,cysteinyl leukotriene receptor 2 ,13q14,
,,,mutations
,,,
D13S25,Disrupted in B-cell neoplasia ,13q14,
,,,"Leukemia, chronic lymphocytic, susceptibility to, 2"
,,,
D2HGDH,D-2-hydroxyglutarate dehydrogenase ,2q37.3,
,,,D-2-hydroxyglutaric aciduria [MIM:600721]
,,,
DAG1,dystroglycan 1 (dystrophin-associated glycoprotein 1) ,3p21,
,,,mutations
,,,
DAOA,D-amino acid oxidase activator ,13q34,
,,,Schizophrenia [MIM:181500]
,,,
DAO,D-amino-acid oxidase ,12q24,
,,,Schizophrenia [MIM:181500]
,,,
DAPK1,death-associated protein kinase 1 ,9q34.1,
,,,mutations
,,,
DARC,"Duffy blood group, chemokine receptor ",1q23.2,
,,,"Blood group, Duffy system [MIM:110700]"
,,,"Malaria, vivax, protection against [MIM:611162]"
,,,White blood cell count QTL [MIM:611862]
,,,
DARS2,"aspartyl-tRNA synthetase 2, mitochondrial ",1q25.1,
,,,Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation [MIM:611105]
,,,
DAZ1,deleted in azoospermia 1 ,Yq11,
,,,Sertoli-cell-only syndrome
,,,
DAZ2,deleted in azoospermia 2 ,Yq11.2,
,,,mutations
,,,
DAZL,deleted in azoospermia-like ,3p24,
,,,"Spermatogenic failure, susceptibility to"
,,,
DBA2,Diamond-Blackfan anemia 2 ,8p23.3-p22,
,,,Diamond-Blackfan anemia 2
,,,
DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase) ,9q34,
,,,"Dopamine-beta-hydroxylase activity levels, plasma"
,,,Dopamine beta-hydroxylase deficiency [MIM:223360]
,,,
DBI,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) ",2q12-q21,
,,,mutations
,,,
DBT,dihydrolipoamide branched chain transacylase E2 ,1p31,
,,,"Maple syrup urine disease, type II [MIM:248600]"
,,,
DCAF13,DDB1 and CUL4 associated factor 13 ,?,
,,,mutations
,,,
DCAF17,DDB1 and CUL4 associated factor 17 ,2q22.3-q35,
,,,Woodhouse-Sakati syndrome [MIM:241080]
,,,
DCC,deleted in colorectal carcinoma ,18q21.3,
,,,Colorectal cancer
,,,"Mirror movements, congenital [MIM:157600]"
,,,
DCDC2,doublecortin domain containing 2 ,6p22.1,
,,,mutations
,,,
DCK,deoxycytidine kinase ,4q13.3-q21.1,
,,,mutations
,,,
DCLK1,doublecortin-like kinase 1 ,13q13,
,,,mutations
,,,
DCLRE1C,DNA cross-link repair 1C ,10p,
,,,"Severe combined immunodeficiency, Athabascan type [MIM:602450]"
,,,Omenn syndrome [MIM:603554]
,,,
DCN,decorin ,12q21.3,
,,,"Corneal dystrophy, congenital stromal [MIM:610048]"
,,,
DCP1B,DCP1 decapping enzyme homolog B (S. cerevisiae) ,12p13.33,
,,,mutations
,,,
DCR,Down syndrome chromosome region ,21q22.3,
,,,Down syndrome
,,,
DCTD,dCMP deaminase ,4q35,
,,,mutations
,,,
DCTN1,dynactin 1 ,2p13,
,,,"Neuropathy, distal hereditary motor, type VIIB [MIM:607641]"
,,,"Amyotrophic lateral sclerosis, susceptibility to [MIM:105400]"
,,,Perry syndrome [MIM:168605]
,,,
DCXR,dicarbonyl/L-xylulose reductase ,17q25.3,
,,,Pentosuria [MIM:260800]
,,,
DCX,doublecortin ,Xq22.3-q23,
,,,"Lissencephaly, X-linked [MIM:300067]"
,,,"Subcortical laminal heteropia, X-linked [MIM:300067]"
,,,
DDAH1,dimethylarginine dimethylaminohydrolase 1 ,1p22,
,,,mutations
,,,
DDAH2,dimethylarginine dimethylaminohydrolase 2 ,6p21.3,
,,,mutations
,,,
DDB1,"damage-specific DNA binding protein 1, 127kDa ",11q12-q13,
,,,"Xeroderma pigmentosum, group E, subtype 2"
,,,
DDB2,"damage-specific DNA binding protein 2, 48kDa ",11p12-p11,
,,,"Xeroderma pigmentosum, group E, DDB-negative subtype [MIM:278740]"
,,,
DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase) ,7p11,
,,,Aromatic L-amino acid decarboxylase deficiency [MIM:608643]
,,,
DDIT3,DNA-damage-inducible transcript 3 ,12q13.1-q13.2,
,,,Myxoid liposarcoma [MIM:613488]
,,,
DDOST,dolichyl-diphosphooligosaccharide--protein glycosyltransferase ,1p36.1,
,,,mutations
,,,
DDR1,discoidin domain receptor tyrosine kinase 1 ,6p21.3,
,,,mutations
,,,
DDR2,discoidin domain receptor tyrosine kinase 2 ,1q12-qter,
,,,"Spondylometaepiphyseal dysplasia, short limb-hand type [MIM:271665]"
,,,
DDX11,DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 ,12p11,
,,,Warsaw breakage syndrome [MIM:613398]
,,,
DDX20,DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 ,1p21.1-p13.2,
,,,mutations
,,,
DDX25,DEAD (Asp-Glu-Ala-Asp) box helicase 25 ,11q24,
,,,mutations
,,,
DDX39B,DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B ,6p21.3,
,,,mutations
,,,
DDX3Y,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked ",Yq11,
,,,mutations
,,,
DDX53,DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 ,?,
,,,mutations
,,,
DDX58,DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 ,?,
,,,mutations
,,,
DDX5,DEAD (Asp-Glu-Ala-Asp) box helicase 5 ,17q23-q25,
,,,mutations
,,,
DEAF1,deformed epidermal autoregulatory factor 1 (Drosophila) ,?,
,,,mutations
,,,
Dec-01,deleted in esophageal cancer 1 ,9q32,
,,,Esophageal squamous cell carcinoma [MIM:133239]
,,,
DECR1,"2,4-dienoyl CoA reductase 1, mitochondrial ",8q21.3,
,,,DECR deficiency
,,,
DEFB126,"defensin, beta 126 ",?,
,,,mutations
,,,
DEFB1,"defensin, beta 1 ",8p23.1,
,,,mutations
,,,
DEFB4A,"defensin, beta 4A ",8p23.1,
,,,mutations
,,,
DEK,DEK oncogene ,6p23,
,,,"Leukemia, acute nonlymphocytic"
,,,
DEL11P13,"Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome ",11p13,
,,,"Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome"
,,,
DEL11P15P14,Chromosome 11p15-p14 deletion syndrome ,11p15-p14,
,,,Chromosome 11p15-p14 deletion syndrome
,,,
DEL14Q11Q22,Chromosome 14q11-q22 deletion syndrome ,14q11-q22,
,,,Chromosome 14q11-q22 deletion syndrome
,,,
DEL15Q15.3,Deafness and male infertility ,15q15.3,
,,,Deafness and male infertility
,,,
DEL15Q24,Chromosome 15q24 deletion syndrome ,15q24,
,,,Chromosome 15q24 deletion syndrome
,,,
DEL15Q26QTER,Chromosome 15q26-qter deletion syndrome ,15q26-qter,
,,,Chromosome 15q26-qter deletion syndrome
,,,
DEL16P12.1P11.2,Chromosome 16p12.2-p11.2 deletion syndrome ,16q12.2-p11.2,
,,,Chromosome 16p12.2-p11.2 deletion syndrome
,,,
DEL17Q11.2,chromosome 17q11.2 deletion syndrome ,17q11.2,
,,,"Chromosome 17q11.2 deletion syndrome, 1.4Mb"
,,,
DEL17Q21.31,Microdeletion 17q21.31 syndrome ,17q21.31,
,,,Chromosome 17q21.31 microdeletion syndrome
,,,
DEL17Q23.1Q23.2,Chromosome 17q23.1-q23.2 deletion syndrome ,17q23.1-q23.2,
,,,Chromosome 17q23.1-q23.2 deletion syndrome
,,,
DEL18P,Chromosome 18p deletion syndrome ,18p,
,,,Chromosome 18p deletion syndrome
,,,
DEL18Q,Chromosome 18q deletion syndrome ,18q,
,,,Chromosome 18q deletion syndrome
,,,
DEL19P13.13,Chromosome 19p13.13 deletion syndrome ,19p13.13,
,,,Chromosome 19p13.13 deletion syndrome
,,,Chromosome 19p13.13 duplication syndrome
,,,
DEL19Q13.11,Chromosome 19q13.11 deletion syndrome ,19q13.11,
,,,Chromosome 19q13.11 deletion syndrome
,,,
DEL1P32P31,Chromosome 1p32-p31 deletion syndrome ,1p32-p31,
,,,Chromosome 1p32-p31 deletion syndrome
,,,
DEL1P36,Chromosome 1p36 deletion syndrome ,1p36,
,,,Chromosome 1p36 deletion syndrome
,,,
DEL1Q21,Chromosome 1q21.1 deletion syndrome ,1q21.1,
,,,Chromosome 1q21.1 deletion syndrome
,,,
DEL1Q41Q42,Chromosome 1q41-q42 deletion syndrome ,1q41-q42,
,,,Chromosome 1q41-q42 deletion syndrome
,,,
DEL1Q42Q44,Chromosome 1q42-q44 deletion syndrome ,1q42-q44,
,,,Chromosome 1q42-q44 deletion syndrome
,,,
DEL2P12P11.2,Chromosome 2p12-p11.2 deletion syndrome ,2p12-p11.2,
,,,Chromosome 2p12-p11.2 deletion syndrome
,,,
DEL2P16.1-P15,Chromosome 2p16.1-p15 deletion syndrome ,2p16.1-p15,
,,,Chromosome 2p16.1-p15 deletion syndrome
,,,
DEL2P21,Hypotonia-cystinuria syndrome ,2p21,
,,,Hypotonia-cystinuria syndrome
,,,
DEL2Q31,Chromosome 2q31.2 deletion syndrome ,2q31.2,
,,,Chromosome 2q31.2 deletion syndrome
,,,
DEL2Q32Q33,Chromosome 2q32-q33 deletion syndrome ,2q32-q33,
,,,Chromosome 2q32-q33 deletion syndrome
,,,
DEL4Q21,Chromosome 4q21 deletion syndrome ,4q21,
,,,Chromosome 4q21 deletion syndrome
,,,
DEL6PTER,Chromosome 6pter deletion syndrome ,6pter-p24,
,,,Chromosome 6pter-p24 deletion syndrome
,,,
DEL6Q11Q14,Chromosome 6q11-q14 deletion syndrome ,6q11-q14,
,,,Chromosome 6q11-q14 deletion syndrome
,,,
DEL6Q24Q25,Chromosome 6q25-q25 deletion syndrome ,6q24-q25,
,,,Chromosome 6q25-q25 deletion syndrome
,,,
DEL8Q13,Mesomelia-synostoses syndrome ,8q13,
,,,Mesomelia-synostoses syndrome
,,,
DEL9P,Chromosome 9p deletion syndrome ,9p,
,,,Chromosome 9p deletion syndrome
,,,
DELXP11.3,Chromosome Xp11.3 deletion syndrome ,Xp11.3,
,,,Chromosome Xp11.3 deletion syndrome
,,,
DELXP21,Chromosome Xp21 deletion syndrome ,Xp21,
,,,Chromosome Xp21 deletion syndrome
,,,
DELXQ28,Chromosome Xq28 microdeletion syndrome ,Xq28,
,,,Chromosome Xq28 microdeletion syndrome
,,,
DEM1,defects in morphology 1 homolog (S. cerevisiae) ,?,
,,,mutations
,,,
DER22T11-22,Emanuel syndrome ,22q11.2,
,,,Emanuel syndrome
,,,
DER22T8-22,Supernumerary der(22)t(8-22) syndrome ,22q11.2,
,,,Supernumerary der(22)t(8-22) syndrome
,,,
DES,desmin ,2q35,
,,,"Myopathy, desmin-related, cardioskeletal [MIM:601419]"
,,,"Cardiomyopathy, dilated, 1I [MIM:604765]"
,,,"Scapuloperoneal syndrome, neurogenic, Kaeser type [MIM:181400]"
,,,
DEXI,Dexi homolog (mouse) ,?,
,,,mutations
,,,
DFCTRPS,"Deafness, cataract, retinitis pigmentosa, and sperm abnormalities ",X,
,,,"Deafness, cataract, retinitis pigmentosa, and sperm abnormalities"
,,,
DFN4,"deafness, X-linked 4, congenital sensorineural ",Xp21.2,
,,,"Deafness, X-linked 3"
,,,
DFN6,"deafness, X-linked 6, sensorineural ",Xp22,
,,,"Deafness, X-linked 4"
,,,
DFNA16,"deafness, autosomal dominant 16 ",2q23-q24.3,
,,,"Deafness, autosomal dominant 16"
,,,
DFNA18,"deafness, autosomal dominant 18 ",3q22,
,,,"Deafness, autosomal dominant 18"
,,,
DFNA21,"deafness, autosomal dominant 21 ",6p21.3,
,,,"Deafness, autosomal dominant 21"
,,,
DFNA24,"deafness, autosomal dominant 24 ",4q35-qter,
,,,"Deafness, autosomal dominant 24"
,,,
DFNA27,"deafness, autosomal dominant 27 ",4q12-q13.1,
,,,"Deafness, autosomal dominant 27"
,,,
DFNA30,"deafness, autosomal dominant 30 ",15q25-q26,
,,,"Deafness, autosomal dominant 30"
,,,
DFNA31,"deafness, autosomal dominant 31 ",6p21.3,
,,,"Deafness, autosomal dominant 31"
,,,
DFNA40,"deafness, autosomal dominant 40 ",16p13.11-p12.3,
,,,"Deafness, autosomal dominant 40"
,,,
DFNA41,"deafness, autosomal dominant 41 ",12q24.32-qter,
,,,"Deafness, autosomal dominant 41"
,,,
DFNA43,"deafness, autosomal dominant 43 ",2p12,
,,,"Deafness, autosomal dominant 43"
,,,
DFNA47,"deafness, autosomal dominant 47 ",9p22-p21,
,,,"Deafness, autosomal dominant 47"
,,,
DFNA49,"deafness, autosomal dominant 49 ",1q21-q23,
,,,"Deafness, autosomal dominant 49"
,,,
DFNA52,"deafness, autosomal dominant 52 ",4q28,
,,,"Deafness, autosomal dominant 52"
,,,
DFNA53,"deafness, autosomal dominant 53 ",14q11.2-q12,
,,,"Deafness, autosomal dominant 53"
,,,
DFNA59,"deafness, autosomal dominant 59 ",11p14.2-q12.3,
,,,"Deafness, autosomal dominant 59"
,,,
DFNA5,"deafness, autosomal dominant 5 ",7p15,
,,,"Deafness, autosomal dominant 5 [MIM:600994]"
,,,
DFNA7,"deafness, autosomal dominant 7 ",1q21-q23,
,,,"Deafness, autosomal dominant 7"
,,,
DFNB13,"deafness, autosomal recessive 13 ",7q34-q36,
,,,"Deafness, autosomal recessive 13"
,,,
DFNB14,"deafness, autosomal recessive 14 ",7q31,
,,,"Deafness, autosomal recessive 14"
,,,
DFNB17,"deafness, autosomal recessive 17 ",7q31,
,,,"Deafness, autosomal recessive 17"
,,,
DFNB20,"deafness, autosomal recessive 20 ",11q25-qter,
,,,"Deafness, autosomal recessive 20"
,,,
DFNB26,"deafness, autosomal recessive 26 ",4q31,
,,,"Deafness, autosomal recessive 26"
,,,
DFNB27,"deafness, autosomal recessive 27 ",2q23-q31,
,,,"Deafness, autosomal recessive 27"
,,,
DFNB31,"deafness, autosomal recessive 31 ",9q32-q34,
,,,"Deafness, autosomal recessive 31 [MIM:607084]"
,,,"Usher syndrome, type IID [MIM:611383]"
,,,
DFNB33,"deafness, autosomal recessive 33 ",10p11.23-q21.1,
,,,"Deafness, autosomal recessive 33"
,,,
DFNB38,"deafness, autosomal recessive 38 ",6q26-q27,
,,,"Deafness, autosomal recessive 38"
,,,
DFNB40,"deafness, autosomal recessive 40 ",22q11.21-q12.1,
,,,"Deafness, autosomal recessive 40"
,,,
DFNB44,"deafness, autosomal recessive 44 ",7p14.1-q11.22,
,,,"Deafness, autosomal recessive 44"
,,,
DFNB45,"deafness, autosomal recessive 45 ",1q43-q44,
,,,"Deafness, autosomal recessive 45"
,,,
DFNB46,"deafness, autosomal recessive 46 ",18p11.32-p11.31,
,,,"Deafness, neurosensory, autosomal recessive 46"
,,,
DFNB47,"deafness, autosomal recessive 47 ",2p25.1-p24.3,
,,,"Deafness, neurosensory, autosomal recessive 47"
,,,
DFNB51,"deafness, autosomal recessive 51 ",11p13-p12,
,,,"Deafness, autosomal recessive 51"
,,,
DFNB55,"deafness, autosomal recessive 55 ",4q12-q13.2,
,,,"Deafness, autosomal recessive 55"
,,,
DFNB59,"deafness, autosomal recessive 59 ",2q31.1-q31.3,
,,,"Deafness, autosomal recessive 59 [MIM:610220]"
,,,
DFNB5,"deafness, autosomal recessive 5 ",14q12,
,,,"Deafness, autosomal recessive 5"
,,,
DFNB62,"deafness, autosomal recessive 62 ",12p13.2-p11.23,
,,,"Deafness, autosomal recessive 62"
,,,
DFNB65,"deafness, autosomal recessive 65 ",20q13.2-q13.3,
,,,"Deafness, autosomal recessive 65"
,,,
DFNB66,"deafness, autosomal recessive 66 ",6p22.3-p21.2,
,,,"Deafness, autosomal recessive 66"
,,,
DFNB71,"deafness, autosomal recessive 71 ",8p22-p21.3,
,,,"Deafness, autosomal recessive 71"
,,,
DFNB74,"deafness, autosomal recessive 74 ",12q14.3,
,,,"Deafness, autosomal recessive 74 [MIM:613718]"
,,,
DFNB83,"deafness, autosomal recessive 83 ",9p23-p21.2,
,,,"Deafness, autosomal recessive 83"
,,,
DFNB85,"deafness, autosomal recessive 85 ",17p12-q11.2,
,,,"Deafness, autosomal recessive 85"
,,,
DFNM1,"deafness (recessive, nonsyndromic) modifier 1 ",1q24,
,,,"Deafness, nonsyndromic, modifier 1"
,,,
DFNY1,"deafness, Y-linked 1 ",Y,
,,,"Deafness, Y-linked 1"
,,,
DGAT1,diacylglycerol O-acyltransferase 1 ,8qter,
,,,mutations
,,,
DGCR14,DiGeorge syndrome critical region gene 14 ,22q11.2,
,,,mutations
,,,
DGCR2,DiGeorge syndrome critical region gene 2 ,22q11.2,
,,,mutations
,,,
DGCR5,DiGeorge syndrome critical region gene 5 (non-protein coding) ,?,
,,,mutations
,,,
DGCR,DiGeorge syndrome chromosome region ,22q11.2,
,,,Conotruncal anomaly face syndrome [MIM:217095]
,,,DiGeorge syndrome [MIM:188400]
,,,Velocardiofacial syndrome [MIM:192430]
,,,
DGKD,"diacylglycerol kinase, delta 130kDa ",2q37.1,
,,,mutations
,,,
DGS2,DiGeorge syndrome/velocardiofacial syndrome complex 2 ,10p14-p13,
,,,DiGeorge syndrome/velocardiofacial syndrome complex-2
,,,
DGUOK,deoxyguanosine kinase ,2p13,
,,,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) [MIM:251880]
,,,
DHCR24,24-dehydrocholesterol reductase ,1p33-p31.1,
,,,Desmosterolosis [MIM:602398]
,,,
DHCR7,7-dehydrocholesterol reductase ,11q12-q13,
,,,Smith-Lemli-Opitz syndrome [MIM:270400]
,,,
DHDDS,dehydrodolichyl diphosphate synthase ,1p35,
,,,mutations
,,,
DHFRP1,dihydrofolate reductase pseudogene 1 ,5q11.2-q13.2,
,,,"Anemia, megaloblastic, due to DHFR deficiency"
,,,
DHFR,dihydrofolate reductase ,5q11.2-q13.2,
,,,"Anemia, megaloblastic, due to DHFR deficiency"
,,,
DHH,desert hedgehog ,12q13.1,
,,,"46XY partial gonadal dysgenesis, with minifascicular neuropathy [MIM:607080]"
,,,46XY complete gonadal dysgenesis [MIM:233420]
,,,
DHODH,dihydroorotate dehydrogenase (quinone) ,16q22,
,,,Miller syndrome [MIM:264750]
,,,
DHOF,"dermal hypoplasia, focal ",Xp11.23,
,,,Focal dermal hypoplasia [MIM:305600]
,,,
DHRS4L1,dehydrogenase/reductase (SDR family) member 4 like 1 ,?,
,,,mutations
,,,
DHS,dehydrated hereditary stomatocytosis ,16q23-q24,
,,,Dehydrated hereditary stomatocytosis
,,,"Pseudohyperkalemia, familial [MIM:177720]"
,,,"Dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema [MIM:603528]"
,,,
DHX16,DEAH (Asp-Glu-Ala-His) box polypeptide 16 ,6p21.3,
,,,mutations
,,,
DHX36,DEAH (Asp-Glu-Ala-His) box polypeptide 36 ,3q25.2,
,,,mutations
,,,
DHX37,DEAH (Asp-Glu-Ala-His) box polypeptide 37 ,?,
,,,mutations
,,,
DIABLO,"diablo, IAP-binding mitochondrial protein ",12,
,,,mutations
,,,
DIAPH1,diaphanous homolog 1 (Drosophila) ,5q31,
,,,"Deafness, autosomal dominant 1 [MIM:124900]"
,,,
DIAPH2,diaphanous homolog 2 (Drosophila) ,Xq22,
,,,Premature ovarian failure [MIM:300511]
,,,
DIAPH3,diaphanous homolog 3 (Drosophila) ,?,
,,,mutations
,,,
DICER1,"dicer 1, ribonuclease type III ",14q31,
,,,Pleuropulmonary blastoma [MIM:601200]
,,,
DIH1,diaphragmatic hernia 1 ,15q26.1,
,,,"Hernia, congenital diaphragmatic 1"
,,,
DIH2,"Hernia, congenital diaphragmatic 2 ",8p23.1,
,,,"Hernia, congenital diaphragmatic 2"
,,,
DIO1,"deiodinase, iodothyronine, type I ",1p33-p32,
,,,mutations
,,,
DIO2,"deiodinase, iodothyronine, type II ",14q24.3,
,,,mutations
,,,
DIP2A,DIP2 disco-interacting protein 2 homolog A (Drosophila) ,21q22.3,
,,,mutations
,,,
DIP2B,DIP2 disco-interacting protein 2 homolog B (Drosophila) ,12q13.12,
,,,"Mental retardation, FRA12A type [MIM:136630]"
,,,
DIP2C,DIP2 disco-interacting protein 2 homolog C (Drosophila) ,10p15.3,
,,,mutations
,,,
DIRAS3,"DIRAS family, GTP-binding RAS-like 3 ",1p31,
,,,Ovarian cancer
,,,
DIRC2,disrupted in renal carcinoma 2 ,3q21,
,,,Renal cell carcinoma [MIM:144700]
,,,
DIRC3,disrupted in renal carcinoma 3 ,?,
,,,mutations
,,,
DIS3L2,DIS3 mitotic control homolog (S. cerevisiae)-like 2 ,?,
,,,mutations
,,,
DISC1,disrupted in schizophrenia 1 ,1q42.1,
,,,"Schizophrenia, susceptibility to [MIM:604906]"
,,,"Schizoaffective disorder, susceptibility to [MIM:181500]"
,,,
DISC2,disrupted in schizophrenia 2 (non-protein coding) ,1q42.1,
,,,Schizophrenia [MIM:181500]
,,,
DISP1,dispatched homolog 1 (Drosophila) ,1q42,
,,,mutations
,,,
DKBI,"Dyskeratosis, hereditary benign intraepithelial ",4q35,
,,,"Dyskeratosis, hereditary benign intraepithelial"
,,,
DKC1,"dyskeratosis congenita 1, dyskerin ",Xq28,
,,,Dyskeratosis congenita-1 [MIM:305000]
,,,Hoyeraal-Hreidarsson syndrome [MIM:300240]
,,,
DKK2,dickkopf 2 homolog (Xenopus laevis) ,?,
,,,mutations
,,,
DKK3,dickkopf 3 homolog (Xenopus laevis) ,?,
,,,mutations
,,,
DLAT,dihydrolipoamide S-acetyltransferase ,11q23.1,
,,,Pyruvate dehydrogenase E2 deficiency [MIM:245348]
,,,
DLC1,deleted in liver cancer 1 ,8p22-p21.3,
,,,"Colorectal cancer, somatic"
,,,
DLD,dihydrolipoamide dehydrogenase ,7q31-q32,
,,,"Maple syrup urine disease, type III [MIM:248600]"
,,,Leigh syndrome [MIM:256000]
,,,
DLEC1,deleted in lung and esophageal cancer 1 ,3p22-p21.3,
,,,Lung cancer [MIM:211980]
,,,Esophageal cancer [MIM:133239]
,,,
DLG3,"discs, large homolog 3 (Drosophila) ",Xq13.1,
,,,"Mental retardation, X-linked-90"
,,,
DLG5,"discs, large homolog 5 (Drosophila) ",10q23,
,,,mutations
,,,
DLGAP2,"discs, large (Drosophila) homolog-associated protein 2 ",8p,
,,,mutations
,,,
DLGAP3,"discs, large (Drosophila) homolog-associated protein 3 ",?,
,,,mutations
,,,
DLL1,delta-like 1 (Drosophila) ,?,
,,,mutations
,,,
DLL3,delta-like 3 (Drosophila) ,19q13,
,,,"Spondylocostal dysostosis, autosomal recessive, 1 [MIM:277300]"
,,,
DLX3,distal-less homeobox 3 ,17q21.3-q22,
,,,Trichodontoosseous syndrome [MIM:190320]
,,,"Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism [MIM:104510]"
,,,
DLX5,distal-less homeobox 5 ,7q22,
,,,mutations
,,,
DLX6,distal-less homeobox 6 ,7q22,
,,,mutations
,,,
DM1,dystrophia myotonica 1 (includes dystrophia myotonia protein kinase) ,19p13.1,
,,,Pseudoachondroplasia [MIM:177170]
,,,"Epiphyseal dysplasia, multiple 1 [MIM:132400]"
,,,
DMBT1,deleted in malignant brain tumors 1 ,10q25.3-q26.1,
,,,mutations
,,,
DMC1,"DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) ",?,
,,,mutations
,,,
DMD,dystrophin ,Xp21.2,
,,,Duchenne muscular dystrophy [MIM:310200]
,,,Becker muscular dystrophy [MIM:300376]
,,,"Cardiomyopathy, dilated, 3B [MIM:302045]"
,,,
DMGDH,dimethylglycine dehydrogenase ,5q12.2-q12.3,
,,,Dimethylglycine dehydrogenase deficiency [MIM:605850]
,,,
DMP1,dentin matrix acidic phosphoprotein 1 ,4q21,
,,,"Hypophosphatemic rickets, AR [MIM:241520]"
,,,
DMPK,dystrophia myotonica-protein kinase ,19q13.2-q13.3,
,,,Myotonic dystrophy [MIM:160900]
,,,
DMRT1,doublesex and mab-3 related transcription factor 1 ,9p24.3,
,,,mutations
,,,
DMXL1,Dmx-like 1 ,5q21-q22,
,,,mutations
,,,
DNAAF1,"dynein, axonemal, assembly factor 1 ",16q24.1,
,,,"Ciliary dyskinesia, primary, 13 [MIM:613193]"
,,,
DNAAF2,"dynein, axonemal, assembly factor 2 ",14q21.3,
,,,"Ciliary dyskinesia, primary, 10 [MIM:612518]"
,,,
DNAAF3,"dynein, axonemal, assembly factor 3 ",?,
,,,mutations
,,,
DNAH11,"dynein, axonemal, heavy chain 11 ",7p21,
,,,"Ciliary dyskinesia, primary, 7, with out without situs inversus [MIM:611884]"
,,,
DNAH5,"dynein, axonemal, heavy chain 5 ",5p15-p14,
,,,"Ciliary dyskinesia, primary, 3, with or without situs inversus [MIM:608644]"
,,,
DNAH9,"dynein, axonemal, heavy chain 9 ",17p12,
,,,mutations
,,,
DNAI1,"dynein, axonemal, intermediate chain 1 ",9p21-p13,
,,,"Ciliary dyskinesia, primary, 1, with our without situs inversus [MIM:244400]"
,,,
DNAI2,"dynein, axonemal, intermediate chain 2 ",17q25,
,,,"Ciliary dyskinesia, primary, 9, with our without situs inversus [MIM:612444]"
,,,
DNAJA4,"DnaJ (Hsp40) homolog, subfamily A, member 4 ",?,
,,,mutations
,,,
DNAJB2,"DnaJ (Hsp40) homolog, subfamily B, member 2 ",2q32-34,
,,,mutations
,,,
DNAJB6,"DnaJ (Hsp40) homolog, subfamily B, member 6 ",?,
,,,mutations
,,,
DNAJC19,"DnaJ (Hsp40) homolog, subfamily C, member 19 ",3q26.3,
,,,"3-methylglutaconic aciduria, type V [MIM:610198]"
,,,
DNAJC5,"DnaJ (Hsp40) homolog, subfamily C, member 5 ",?,
,,,mutations
,,,
DNAJC6,"DnaJ (Hsp40) homolog, subfamily C, member 6 ",1p32.1-p31.3,
,,,mutations
,,,
DNAL1,"dynein, axonemal, light chain 1 ",14q24.3,
,,,mutations
,,,
DNASE1L3,deoxyribonuclease I-like 3 ,3p21.1-p14.3,
,,,mutations
,,,
DNASE1,deoxyribonuclease I ,16p13.3,
,,,"Systemic lupus erythematosus, susceptibility to [MIM:152700]"
,,,
DNASE2,"deoxyribonuclease II, lysosomal ",19p13.2-q13.4,
,,,mutations
,,,
DND1,dead end homolog 1 (zebrafish) ,5q31.3,
,,,mutations
,,,
DNM1L,dynamin 1-like ,12p11.21,
,,,"Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission"
,,,
DNM1,dynamin 1 ,9q34,
,,,mutations
,,,
DNM2,dynamin 2 ,19p13.2,
,,,"Charcot-Marie-Tooth disease, dominant intermediate B [MIM:606482]"
,,,"Myopathy, centronuclear [MIM:160150]"
,,,"Charcot-Marie-Tooth disease, axonal, type 2M [MIM:606482]"
,,,
DNMT1,DNA (cytosine-5-)-methyltransferase 1 ,19p13.3-p13.2,
,,,mutations
,,,
DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha ,2p23,
,,,mutations
,,,
DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta ,20q11.2,
,,,Immunodeficiency-centromeric instability-facial anomalies syndrome [MIM:242860]
,,,
DNMT3L,DNA (cytosine-5-)-methyltransferase 3-like ,21q22.3,
,,,mutations
,,,
DOC2A,"double C2-like domains, alpha ",16p11.2,
,,,mutations
,,,
DOCK3,dedicator of cytokinesis 3 ,3p14,
,,,mutations
,,,
DOCK6,dedicator of cytokinesis 6 ,?,
,,,mutations
,,,
DOCK8,dedicator of cytokinesis 8 ,9p24,
,,,"Mental retardation, autosomal dominant 2"
,,,"Hyper-IgE recurrent infection syndrome, autosomal recessive [MIM:243700]"
,,,
DOCK9,dedicator of cytokinesis 9 ,13q32.3,
,,,mutations
,,,
DOK7,docking protein 7 ,4p16.2,
,,,"Myasthenia, limb-girdle, familial [MIM:254300]"
,,,Fetal akinesia deformation sequence [MIM:208150]
,,,
DOLK,dolichol kinase ,9q34.11,
,,,"Congenital disorder of glycosylation, type Im [MIM:610768]"
,,,
DOM3Z,dom-3 homolog Z (C. elegans) ,6p21.3,
,,,mutations
,,,
DPAGT1,dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) ,11q23.3,
,,,"Congenital disorder of glycosylation, type Ij [MIM:608093]"
,,,
DPM1,"dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit ",20q13.13,
,,,"Congenital disorder of glycosylation, type Ie [MIM:608799]"
,,,
DPM3,dolichyl-phosphate mannosyltransferase polypeptide 3 ,1q12-q21,
,,,"Congenital disorder of glycosylation, type Io [MIM:612937]"
,,,
DPP6,dipeptidyl-peptidase 6 ,7q36.2,
,,,"Ventricular fibrillation, paroxysmal familial, 2 [MIM:612956]"
,,,
DPY19L2,dpy-19-like 2 (C. elegans) ,?,
,,,mutations
,,,
DPYD,dihydropyrimidine dehydrogenase ,1p22,
,,,Dihydropyrimidine dehydrogenase deficiency [MIM:274270]
,,,5-fluorouracil toxicity [MIM:274270]
,,,
DPYSL2,dihydropyrimidinase-like 2 ,8p21,
,,,mutations
,,,
DPYS,dihydropyrimidinase ,8q22,
,,,Dihydropyrimidinuria [MIM:222748]
,,,
DRD1,dopamine receptor D1 ,5q35.1,
,,,mutations
,,,
DRD2,dopamine receptor D2 ,11q23.1,
,,,"Dystonia, myoclonic [MIM:159900]"
,,,
DRD3,dopamine receptor D3 ,3q13.3,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,"Essential tremor, susceptibility to [MIM:190300]"
,,,
DRD4,dopamine receptor D4 ,11p15.5,
,,,Autonomic nervous system dysfunction
,,,Novelty seeking personality [MIM:601696]
,,,Attention deficit-hyperactivity disorder [MIM:143465]
,,,
DRD5,dopamine receptor D5 ,4p16.1-p15.3,
,,,"Blepharospasm, primary benign [MIM:606798]"
,,,"Dystonia, primary cervical"
,,,"Attention deficit-hyperactivity disorder, susceptibility to [MIM:143465]"
,,,
DROSHA,"drosha, ribonuclease type III ",5p14-p13,
,,,mutations
,,,
DRP2,dystrophin related protein 2 ,Xq22,
,,,mutations
,,,
DSAP2,disseminated superficial actinic porokeratosis 2 ,15q25.1-q26.1,
,,,"Porokeratosis, disseminated superficial actinic, 2"
,,,
DSAP3,"Porokeratosis, disseminated superficial actinic, 3 ",1p31.3-p31.1,
,,,"Porokeratosis, disseminated superficial actinic, 3"
,,,
DSAP4,"Porokeratosis, disseminated superficial actinic, 4 ",18p11.3,
,,,"Porokeratosis, disseminated superficial actinic, 4"
,,,
DSC2,desmocollin 2 ,18q12.1,
,,,"Arrhythmogenic right ventricular dysplasia, familial, 11 [MIM:610476]"
,,,
DSC3,desmocollin 3 ,18q12.1,
,,,Hypotrichosis and recurrent skin vesicles [MIM:613102]
,,,
DSCAM,Down syndrome cell adhesion molecule ,21q22.2-q22.3,
,,,mutations
,,,
DSCR8,Down syndrome critical region gene 8 ,21q22.2,
,,,mutations
,,,
DSG1,desmoglein 1 ,18q12.1-q12.2,
,,,Keratosis palmoplantaris striata I [MIM:148700]
,,,
DSG2,desmoglein 2 ,18q12.1-q12.2,
,,,"Arrhythmogenic right ventricular dysplasia, familial, 10 [MIM:610193]"
,,,"Cardiomyopathy, dilated, 1BB [MIM:612877]"
,,,
DSG4,desmoglein 4 ,18q12,
,,,"Hypotrichosis, localized, autosomal recessive [MIM:607903]"
,,,
DSPP,dentin sialophosphoprotein ,4q21.3,
,,,"Dentinogenesis imperfecta, Shields type II [MIM:125490]"
,,,"Deafness, autosomal dominant 36, with dentinogenesis [MIM:605594]"
,,,"Dentinogenesis imperfecta, Shields type III [MIM:125500]"
,,,"Dentin dysplasia, type II [MIM:125420]"
,,,
DSP,desmoplakin ,6p24,
,,,Keratosis palmoplantaris striata II [MIM:612908]
,,,Dilated cardiomyopathy with woolly hair and keratoderma [MIM:605676]
,,,Arrhythmogenic right ventricular dysplasia 8 [MIM:607450]
,,,Skin fragility-woolly hair syndrome [MIM:607655]
,,,"Epidermolysis bullosa, lethal acantholytic [MIM:609638]"
,,,
DST,dystonin ,6p12-p11,
,,,mutations
,,,
DTNA,"dystrobrevin, alpha ",18q12.1-q12.2,
,,,"Left ventricular noncompaction 1, with or without congenital heart defects [MIM:604169]"
,,,
DTNBP1,dystrobrevin binding protein 1 ,6p22.3,
,,,Schizophrenia [MIM:181500]
,,,Hermansky-Pudlak syndrome 7 [MIM:203300]
,,,
DUH2,Dyschromatosis universalis hereditaria 2 ,12q21-q23,
,,,Dyschromatosis universalis hereditaria 2
,,,
DUH,Dyschromatosis universalis hereditaria ,6q24.2-q25.2,
,,,Dyschromatosis universalis hereditaria 1
,,,
DUOX2,dual oxidase 2 ,15q15.3,
,,,Thryoid dyshormonogenesis 6 [MIM:607200]
,,,
DUOXA2,dual oxidase maturation factor 2 ,15q15,
,,,Thyroid dyshormonogenesis 5 [MIM:274900]
,,,
DUP16P13.3,Chromosome 16p13.3 duplication syndrome ,16p13.3,
,,,Chromosome 16p13.3 duplication syndrome
,,,
DUP17P13.3,Chromosome 17p13.3 duplication syndrome ,17p13.3,
,,,Chromosome 17p13.3 duplication syndrome
,,,
DUP17Q21.31,Chromosome 17q21.31 duplication syndrome ,17q21.31,
,,,Chromosome 17q21.31 duplication syndrome
,,,
DUP17Q23.1Q23.2,Chromosome 17q23.1-q23.2 duplication syndrome ,17q23.1-q23.2,
,,,Chromosome 17q23.1-q23.2 duplication syndrome
,,,
DUP18PDEL18Q,Chromosome 18 pericentric inversion ,18q22,
,,,Chromosome 18 pericentric inversion
,,,
DUP1Q21,Chromosome 1q21.1 duplication syndrome ,1q21.1,
,,,Chromosome 1q21.1 duplication syndrome
,,,
DUP22Q11.2,Chromosome 22q11.2 microduplication syndrome ,22q11.2,
,,,Chromosome 22q11.2 microduplication syndrome
,,,
DUP2Q31.1,Chromosome 2q31.1 duplication syndrome ,2q31.1,
,,,Chromosome 2q31.1 duplication syndrome
,,,
DUP3Q29,chromosome 3q29 microduplication syndrome ,3q29,
,,,Chromosome 3q29 microduplication syndrome
,,,
DUP5P13,Chromosome 5p13 duplication syndrome ,5p13,
,,,Chromosome 5p13 duplication syndrome
,,,
DUP7Q11.23,Chromosome 7q11.23 duplication syndrome ,7q11.23,
,,,Chromosome 7q11.23 duplication syndrome
,,,
DUPC1,Dupuytren contracture 1 ,16q11.1-q22,
,,,Dupuytren contracture 1
,,,
DUPXP11.23P11.22,Chromosome Xp11.23-p11.22 duplication syndrome ,Xp11.23-p11.22,
,,,Chromosome Xp11.23-p11.22 duplication syndrome
,,,
DUPXQ28,Chromosome Xq28 duplication syndrome ,Xq28,
,,,Chromosome Xq28 duplication syndrome
,,,
DURS1,Duane retraction syndrome 1 ,8q13,
,,,Duane syndrome
,,,
DUSP23,dual specificity phosphatase 23 ,?,
,,,mutations
,,,
DUX4,double homeobox 4 ,4q35,
,,,mutations
,,,
DYM,dymeclin ,18q12-q21.1,
,,,Dyggve-Melchior-Clausen disease [MIM:223800]
,,,Smith-McCort dysplasia [MIM:607326]
,,,
DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1 ",14q32,
,,,mutations
,,,
DYNC2H1,"dynein, cytoplasmic 2, heavy chain 1 ",11q13.5,
,,,Asphyxiating thoracic dystrophy 3 [MIM:613091]
,,,"Short rib-polydactyly syndrome, type III [MIM:263510]"
,,,"Short rib-polydactyly syndrome, type II, digenic [MIM:263520]"
,,,
DYRK1A,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A ,21q22.1,
,,,mutations
,,,
DYSF,"dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) ",2p13.3-p13.1,
,,,"Muscular dystrophy, limb-girdle, type 2B [MIM:253601]"
,,,Miyoshi myopathy [MIM:254130]
,,,"Myopathy, distal, with anterior tibial onset [MIM:606768]"
,,,
DYT10,dystonia 10 ,16p11.2-q12.1,
,,,Paroxysmal kinesigenic choreoathetosis
,,,
DYT13,"dystonia 13, torsion ",1p36.32-p36.13,
,,,"Dystonia 13, torsion"
,,,
DYT15,"dystonia 15, myoclonic ",18p11,
,,,"Dystonia-15, myoclonic"
,,,
DYT17,dystonia 17 ,20p11.2-q13.12,
,,,"Dystonia-17, primary torsion"
,,,
DYT7,"dystonia 7, torsion (autosomal dominant) ",18p,
,,,"Dystonia-7, torsion"
,,,
DYX1C1,dyslexia susceptibility 1 candidate 1 ,15q21,
,,,"Dyslexia, susceptibility to, 1 [MIM:127700]"
,,,
DYX1,dyslexia susceptibility 1 ,?,
,,,mutations
,,,
DYX2,dyslexia susceptibility 2 ,6p22.2,
,,,"Dyslexia, susceptibility to, 2 [MIM:600202]"
,,,
DYX3,dyslexia susceptibility 3 ,2p16-p15,
,,,"Dyslexia, susceptibility to, 3"
,,,
DYX5,dyslexia susceptibility 5 ,3p12-q13,
,,,"Dyslexia, susceptibility to, 5"
,,,
DYX6,dyslexia susceptibility 6 ,18p11.2,
,,,"Dyslexia, susceptibility to, 6"
,,,
DYX8,dyslexia susceptibility 8 ,1p36-p34,
,,,"Dyslexia, susceptibility to, 8"
,,,
DYX9,dyslexia susceptibility 9 ,Xq27.3,
,,,"Dyslexia, susceptibility to, 9"
,,,
EA3,"Episodic ataxia, type 3 ",1q42,
,,,"Episodic ataxia, type 3"
,,,
EA7,"Episodic ataxia, type 7 ",19q13,
,,,"Episodic ataxia, type 7"
,,,
EARS2,"glutamyl-tRNA synthetase 2, mitochondrial (putative) ",16p13.1-p11.2,
,,,mutations
,,,
EBAG9,"estrogen receptor binding site associated, antigen, 9 ",8q23,
,,,mutations
,,,
EBP,emopamil binding protein (sterol isomerase) ,Xp11.23-p11.22,
,,,"Chondrodysplasia punctata, X-linked dominant [MIM:302960]"
,,,
ECA1,"epilepsy, childhood absence 1 ",8q24,
,,,"Epilepsy, childhood absence, 1"
,,,
ECD,ecdysoneless homolog (Drosophila) ,Xq25,
,,,"Corneal dystrophy, endothelial, X-linked"
,,,
ECE1,endothelin converting enzyme 1 ,1p36.1,
,,,"Hirschsprung disease, cardiac defects, and autonomic dysfunction"
,,,"Hypertension, essential, susceptibility to [MIM:145500]"
,,,
ECI1,enoyl-CoA delta isomerase 1 ,16p13.3,
,,,mutations
,,,
ECM1,extracellular matrix protein 1 ,1q21,
,,,Lipoid proteinosis [MIM:247100]
,,,
ECM2,"extracellular matrix protein 2, female organ and adipocyte specific ",9q22.3,
,,,mutations
,,,
ECSIT,ECSIT homolog (Drosophila) ,19p13.2,
,,,mutations
,,,
ECT,centralopathic epilepsy ,11p13,
,,,Centrotemporal epilepsy
,,,
EDA2R,ectodysplasin A2 receptor ,Xq12,
,,,mutations
,,,
EDARADD,EDAR-associated death domain ,1q42.2-q43,
,,,"Ectodermal dysplasia, anhidrotic, autosomal recessive [MIM:224900]"
,,,"Ectodermal dysplasia, anhidrotic, autosomal dominant [MIM:129490]"
,,,
EDAR,ectodysplasin A receptor ,2q11-q13,
,,,"Ectodermal dysplasia, hypohidrotic, autosomal dominant [MIM:129490]"
,,,"Ectodermal dysplasia, hypohidrotic, autosomal recessive [MIM:224900]"
,,,"Hair morphology 1, hair thickness [MIM:612630]"
,,,
EDA,ectodysplasin A ,Xq12-q13.1,
,,,"Ectodermal dysplasia, anhidrotic, X-linked [MIM:305100]"
,,,"Tooth agenesis, selective, X-linked 1 [MIM:313500]"
,,,
EDN1,endothelin 1 ,6p24-p23,
,,,High density lipoprotein cholesterol level QTL 7
,,,
EDN2,endothelin 2 ,1p34,
,,,mutations
,,,
EDN3,endothelin 3 ,20q13.2-q13.3,
,,,"Waardenburg syndrome, type 4B [MIM:613265]"
,,,"Central hypoventilation syndrome, congenital [MIM:209880]"
,,,"Hirschsprung disease, susceptibility to, 4 [MIM:613712]"
,,,
EDNRA,endothelin receptor type A ,4q31.2,
,,,"Migraine, resistance to [MIM:157300]"
,,,
EDNRB,endothelin receptor type B ,13q22,
,,,"Hirschsprung disease, susceptibility to, 2 [MIM:600155]"
,,,ABCD syndrome [MIM:600501]
,,,"Waardenburg syndrome, type 4A [MIM:277580]"
,,,
EDS8,"Ehlers-Danlos syndrome, type VIII ",12p13,
,,,"Ehlers-Danlos syndrome, type VIII"
,,,
EDSS2,Ectodermal dysplasia-syndactyly syndrome 2 ,7p21.2-p14.3,
,,,Ectodermal dysplasia-syndactyly syndrome 2
,,,
EEC1,"ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome 1 ",7q11.2-q21.3,
,,,EEC syndrome-1
,,,
EEF1B2,eukaryotic translation elongation factor 1 beta 2 ,2q33-q34,
,,,mutations
,,,
EEF2K,eukaryotic elongation factor-2 kinase ,16,
,,,mutations
,,,
EE,"Esophagitis, eosinophilic ",17q11.2,
,,,"Esophagitis, eosinophilic, 1"
,,,
EFCAB5,EF-hand calcium binding domain 5 ,?,
,,,mutations
,,,
EFEMP1,EGF containing fibulin-like extracellular matrix protein 1 ,2p16,
,,,Doyne honeycomb degeneration of retina [MIM:126600]
,,,
EFEMP2,EGF containing fibulin-like extracellular matrix protein 2 ,11q13,
,,,"Cutis laxa, autosomal recessive, type I [MIM:219100]"
,,,
EFHC1,EF-hand domain (C-terminal) containing 1 ,6p12-p11,
,,,"Myoclonic epilepsy, juvenile, susceptibility to, 1 [MIM:254770]"
,,,"Epilepsy, juvenile absence, susceptibility to, 1 [MIM:607631]"
,,,
EFHC2,EF-hand domain (C-terminal) containing 2 ,Xp11.3,
,,,mutations
,,,
EFNB1,ephrin-B1 ,Xq12,
,,,Craniofrontonasal dysplasia [MIM:304110]
,,,
EFR3A,EFR3 homolog A (S. cerevisiae) ,8q24.2,
,,,mutations
,,,
EFTUD2,elongation factor Tu GTP binding domain containing 2 ,17q21.31,
,,,mutations
,,,
EGFR,epidermal growth factor receptor ,7p12.3-p12.1,
,,,"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in [MIM:211980]"
,,,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in [MIM:211980]"
,,,"Nonsmall cell lung cancer, susceptibility to [MIM:211980]"
,,,
EGF,epidermal growth factor ,4q25,
,,,"Hypomagnesemia 4, renal [MIM:611718]"
,,,
EGID-100124696,transient erythroblastopenia of childhood ,19q13.2,
,,,Transient erythroblastopenia of childhood
,,,
EGID-100505381,Miyoshi muscular dystrophy 2 ,8q22.3,
,,,Miyoshi muscular dystrophy 2
,,,
EGI,"epilepsy, generalized, idiopathic ",8q24,
,,,"Epilepsy, idiopathic generalized, susceptibility to, 1"
,,,
EGLN1,egl nine homolog 1 (C. elegans) ,1q42-q43,
,,,"Erythrocytosis, familial, 3 [MIM:609820]"
,,,
EGR2,early growth response 2 ,10q21.1-q22.1,
,,,"Neuropathy, congenital hypomyelinating, 1 [MIM:605253]"
,,,"Charcot-Marie-Tooth disease, type 1D [MIM:607678]"
,,,Dejerine-Sottas neuropathy [MIM:145900]
,,,
EGR3,early growth response 3 ,8p23-p21,
,,,mutations
,,,
EHBP1,EH domain binding protein 1 ,2p15,
,,,"Prostate cancer, hereditary, 12 [MIM:611868]"
,,,
EHD2,EH-domain containing 2 ,19q13.3,
,,,mutations
,,,
EHMT1,euchromatic histone-lysine N-methyltransferase 1 ,9q34.3,
,,,Kleefstra syndrome [MIM:610253]
,,,
EHMT2,euchromatic histone-lysine N-methyltransferase 2 ,?,
,,,mutations
,,,
EIF2AK3,eukaryotic translation initiation factor 2-alpha kinase 3 ,2p12,
,,,Wolcott-Rallison syndrome [MIM:226980]
,,,
EIF2B1,"eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa ",12,
,,,Leukoencephalopathy with vanishing white matter [MIM:603896]
,,,
EIF2B2,"eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa ",14q24,
,,,Leukoencephalopathy with vanishing white matter [MIM:603896]
,,,Ovarioleukodystrophy [MIM:603896]
,,,
EIF2B3,"eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa ",1p34.1,
,,,Leukoencephalopathy with vanishing white matter [MIM:603896]
,,,
EIF2B4,"eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa ",2p23.3,
,,,Leukoencephaly with vanishing white matter [MIM:603896]
,,,Ovarioleukodystrophy [MIM:603896]
,,,
EIF2B5,"eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa ",3q27,
,,,Leukoencephalopathy with vanishing white matter [MIM:603896]
,,,Ovarioleukodystrophy [MIM:603896]
,,,
EIF2C1,"eukaryotic translation initiation factor 2C, 1 ",1p35-p34,
,,,mutations
,,,
EIF2C2,"eukaryotic translation initiation factor 2C, 2 ",8q24,
,,,mutations
,,,
EIF3H,"eukaryotic translation initiation factor 3, subunit H ",8q24.11,
,,,mutations
,,,
EIF4E,eukaryotic translation initiation factor 4E ,4q21-q25,
,,,mutations
,,,
EIF4G1,"eukaryotic translation initiation factor 4 gamma, 1 ",3q27,
,,,mutations
,,,
EIG2,"Epilepsy, idiopathic generalized, susceptibility to 2 ",14q23,
,,,"Epilepsy, idiopathic generalized, susceptibility to, 2"
,,,
EIG3,"Epilepsy, idiopathic generalized, susceptibility to 3 ",9q32-q33,
,,,"Epilepsy, idiopathic generalized, susceptibility to, 3"
,,,
EIG4,"Epilepsy, idiopathic generalized, susceptibility to 4 ",10q25-q26,
,,,"Epilepsy, idiopathic generalized, susceptibility to 4"
,,,
EIG5,"Epilepsy, idiopathic generalized, susceptibility to, 5 ",10p11.22,
,,,"Epilepsy, idiopathic generalized, susceptibility to, 5"
,,,
EJM1,"epilepsy, juvenile myoclonic 1 ",6p12-p11,
,,,"Myoclonic epilepsy, juvenile, susceptibility to, 1 [MIM:254770]"
,,,"Epilepsy, juvenile absence, susceptibility to, 1 [MIM:607631]"
,,,
EJM2,"epilepsy, juvenile myoclonic 2 ",15q14,
,,,"Epilepsy, idiopathic generalized, susceptibility to, 7"
,,,"Epilepsy, juvenile myoclonic"
,,,
EJM3,"Epilepsy, juvenile myoclonic 3 ",6p21,
,,,"Epilepsy, juvenile myoclonic 3"
,,,
EJM4,"Myoclonic epilepsy, juvenile, 4 ",5q12-q14,
,,,"Myoclonic epilepsy, juvenile, 4"
,,,
EKD2,Episodic kinesigenic dyskinesia 2 ,16q13-q22.1,
,,,Episodic kinesigenic dyskinesia 2
,,,
EKV3,erythrokeratodermia variabilis 3 (Kamouraska type) ,7q22,
,,,Erythrokeratodermia variabilis 3
,,,
ELAC2,elaC homolog 2 (E. coli) ,17p11,
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
ELANE,"elastase, neutrophil expressed ",19p13.3,
,,,"Hematopoiesis, cyclic [MIM:162800]"
,,,"Neutropenia, severe congenital, autosomal dominant 1 [MIM:202700]"
,,,
ELAVL2,"ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) ",9p21,
,,,mutations
,,,
ELAVL4,"ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 ",1p34,
,,,"Neuropathy, paraneoplastic sensory"
,,,
ELF4,E74-like factor 4 (ets domain transcription factor) ,Xq26,
,,,mutations
,,,
ELK1,"ELK1, member of ETS oncogene family ",Xp11.2,
,,,mutations
,,,
ELL,elongation factor RNA polymerase II ,19p13.1,
,,,mutations
,,,
ELN,elastin ,7q11.2,
,,,Supravalvar aortic stenosis [MIM:185500]
,,,"Cutis laxa, AD [MIM:123700]"
,,,
ELOVL4,ELOVL fatty acid elongase 4 ,6q14,
,,,Stargardt disease 3 [MIM:600110]
,,,"Macular dystrophy, autosomal dominant, chromosome 6-linked [MIM:600110]"
,,,
ELP2,elongator acetyltransferase complex subunit 2 ,?,
,,,mutations
,,,
ELP4,elongator acetyltransferase complex subunit 4 ,11p13,
,,,mutations
,,,
EMB,embigin ,Xq27.1-q27.2,
,,,Hemophilia B [MIM:306900]
,,,Warfarin sensitivity [MIM:122700]
,,,"Thrombophilia, X-linked, due to factor IX defect [MIM:300807]"
,,,
EMD,emerin ,Xq28,
,,,Emery-Dreifuss muscular dystrophy [MIM:310300]
,,,
EME1,essential meiotic endonuclease 1 homolog 1 (S. pombe) ,17q21.3,
,,,mutations
,,,
EMG1,EMG1 nucleolar protein homolog (S. cerevisiae) ,12p13,
,,,Bowen-Conradi syndrome [MIM:211180]
,,,
EMWX,"episodic muscle weakness, X-linked ",Xp22.3,
,,,"Episodic muscle weakness, X-linked"
,,,
EMX2,empty spiracles homeobox 2 ,10q26.1,
,,,Schizencephaly [MIM:269160]
,,,
EN2,engrailed homeobox 2 ,7q36,
,,,Autism susceptibility 10 [MIM:611016]
,,,
ENAM,enamelin ,4q21,
,,,"Amelogenesis imperfecta, type IB [MIM:104500]"
,,,"Amelogenesis imperfecta, type IC [MIM:204650]"
,,,
ENDO1,"Endometriosis, susceptibility to, 1 ",10q26,
,,,"Endometriosis, susceptibility to, 1"
,,,
ENFL2,"Epilepsy, nocturnal frontal lobe, type 2 ",15q24,
,,,"Epilepsy, nocturnal frontal lobe, type 2"
,,,
ENG,endoglin ,9q34.1,
,,,"Telangiectasia, hereditary hemorrhagic, type 1 [MIM:187300]"
,,,
ENO1,"enolase 1, (alpha) ",1pter-p36.13,
,,,Enolase deficiency
,,,
ENO3,"enolase 3 (beta, muscle) ",17pter-p12,
,,,Glycogen storage disease XIII [MIM:612932]
,,,
ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1 ,6q22-q23,
,,,Ossification of posterior longitudinal ligament of spine [MIM:602475]
,,,"Diabetes mellitus, non-insulin-dependent, susceptibility to [MIM:125853]"
,,,"Obesity, susceptibility to [MIM:601665]"
,,,"Arterial calcification, generalized, of infancy [MIM:208000]"
,,,"Hypophosphatemic rickets, autosomal recessive, 2 [MIM:613312]"
,,,
ENSA,endosulfine alpha ,1q21.2,
,,,mutations
,,,
ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1 ,10q24,
,,,mutations
,,,
ENUR1,"enuresis, nocturnal 1 ",13q13-q14.3,
,,,"Enuresis, nocturnal, 1"
,,,
ENUR2,"enuresis, nocturnal 2 ",12q13-q21,
,,,"Enuresis, nocturnal, 2"
,,,
EOE2,"Esophagitis, eosinophilic, 2 ",5q22,
,,,"Esophagitis, eosinophilic, 2"
,,,
EOMES,eomesodermin ,3p21.3-p21.2,
,,,mutations
,,,
EOS,"eosinophilia, familial ",5q31-q33,
,,,"Eosinophilia, familial"
,,,
EP300,E1A binding protein p300 ,22q13,
,,,Colorectal cancer [MIM:114500]
,,,Rubinstein-Taybi syndrome 2 [MIM:613684]
,,,
EPAS1,endothelial PAS domain protein 1 ,2p21-p16,
,,,"Erythrocytosis, familial, 4 [MIM:611783]"
,,,
EPB41L1,erythrocyte membrane protein band 4.1-like 1 ,?,
,,,mutations
,,,
EPB41,"erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) ",1p36.2-p34,
,,,Elliptocytosis-1 [MIM:611804]
,,,
EPB42,erythrocyte membrane protein band 4.2 ,15q15,
,,,"Spherocytosis, hereditary, type 5 [MIM:612690]"
,,,
EPC2,enhancer of polycomb homolog 2 (Drosophila) ,2q23.1,
,,,mutations
,,,
EPCAM,epithelial cell adhesion molecule ,2p21,
,,,"Diarrhea 5, with tufting enteropathy, congenital [MIM:613217]"
,,,"Colorectal cancer, hereditary nonpolyposis, type I [MIM:613244]"
,,,
EPHA2,EPH receptor A2 ,1p36.1,
,,,"Cataract, posterior polar, 1 [MIM:613020]"
,,,
EPHA3,EPH receptor A3 ,3p11.2,
,,,mutations
,,,
EPHA5,EPH receptor A5 ,4q13,
,,,mutations
,,,
EPHA7,EPH receptor A7 ,?,
,,,mutations
,,,
EPHB2,EPH receptor B2 ,1p36.1-p35,
,,,"Prostate cancer, progression and metastasis of [MIM:603688]"
,,,
EPHB6,EPH receptor B6 ,7q33-q35,
,,,mutations
,,,
EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic) ",1q42.1,
,,,Fetal hydantoin syndrome
,,,Diphenylhydantoin toxicity
,,,"Hypercholanemia, familial [MIM:607748]"
,,,"Preeclampsia, susceptibility to [MIM:189800]"
,,,
EPHX2,"epoxide hydrolase 2, cytoplasmic ",8p21-p12,
,,,"Hypercholesterolemia, familial, due to LDLR defect, modifier of [MIM:143890]"
,,,
EPM2A,"epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) ",6q24,
,,,"Epilepsy, progressive myoclonic 2A (Lafora) [MIM:254780]"
,,,
EPOLM,"epilepsy, occipitotemporal lobe, and migraine with aura ",9q21-q22,
,,,"Epilepsy, occipitotemporal lobe, and migraine with aura"
,,,
EPOR,erythropoietin receptor ,19p13.3-p13.2,
,,,"Erythrocytosis, familial [MIM:133100]"
,,,
EPO,erythropoietin ,7q21,
,,,Microvascular complications of diabetes 2 [MIM:612623]
,,,
EPPS,"Epilepsy, partial, with pericentral spikes ",4p15,
,,,"Epilepsy, partial, with pericentral spikes"
,,,
EPRPDC,"Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp ",16p12-p11.2,
,,,"Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp"
,,,
EPX,eosinophil peroxidase ,17q23.1,
,,,Eosinophil peroxidase deficiency [MIM:261500]
,,,
ERAP1,endoplasmic reticulum aminopeptidase 1 ,5q15,
,,,mutations
,,,
ERAP2,endoplasmic reticulum aminopeptidase 2 ,5q15,
,,,mutations
,,,
ERBB2,"v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) ",17q21.1,
,,,"Adenocarcinoma of lung, somatic [MIM:211980]"
,,,"Glioblastoma, somatic [MIM:137800]"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,"Ovarian cancer, somatic"
,,,
ERBB3,v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) ,12q13,
,,,Lethal congenital contractural syndrome 2 [MIM:607598]
,,,
ERBB4,v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) ,2q33.3-q34,
,,,mutations
,,,
ERC2,ELKS/RAB6-interacting/CAST family member 2 ,15q13.1,
,,,"Skin/hair/eye pigmentation 1, blue/nonblue eyes [MIM:227220]"
,,,"Skin/hair/eye pigmentation 1, blond/brown hair [MIM:227220]"
,,,
ERCC1,"excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) ",19q13.2-q13.3,
,,,Cerebrooculofacioskeletal syndrome 4 [MIM:610758]
,,,
ERCC2,"excision repair cross-complementing rodent repair deficiency, complementation group 2 ",19q13.2-q13.3,
,,,"Xeroderma pigmentosum, group D [MIM:278730]"
,,,Trichothiodystrophy [MIM:601675]
,,,Cerebrooculofacioskeletal syndrome 2 [MIM:610756]
,,,
ERCC3,"excision repair cross-complementing rodent repair deficiency, complementation group 3 ",2q21,
,,,"Xeroderma pigmentosum, group B [MIM:610651]"
,,,Trichothiodystrophy [MIM:601675]
,,,
ERCC4,"excision repair cross-complementing rodent repair deficiency, complementation group 4 ",16p13.3-p13.13,
,,,"Xeroderma pigmentosum, group F [MIM:278760]"
,,,XFE progeroid syndrome [MIM:610965]
,,,
ERCC5,"excision repair cross-complementing rodent repair deficiency, complementation group 5 ",13q33,
,,,"Xeroderma pigmentosum, group G [MIM:278780]"
,,,Cerebrooculofacioskeletal syndrome 3
,,,
ERCC6,"excision repair cross-complementing rodent repair deficiency, complementation group 6 ",10q11,
,,,"Cockayne syndrome, type B [MIM:133540]"
,,,Cerebrooculofacioskeletal syndrome 1 [MIM:214150]
,,,De Sanctis-Cacchione syndrome [MIM:278800]
,,,"Macular degeneration, age-related, susceptibility to 5"
,,,Lung cancer [MIM:211980]
,,,UV-sensitive syndrome [MIM:600630]
,,,
ERCC8,"excision repair cross-complementing rodent repair deficiency, complementation group 8 ",5q12,
,,,"Cockayne syndrome, type A [MIM:216400]"
,,,
ERF,Ets2 repressor factor ,19q13.1,
,,,mutations
,,,
ERLIN2,ER lipid raft associated 2 ,8p11.2,
,,,mutations
,,,
ERMAP,erythroblast membrane-associated protein (Scianna blood group) ,1p34,
,,,"Blood group, Scianna system [MIM:111750]"
,,,"Blood group, Radin [MIM:111620]"
,,,
ESAM,endothelial cell adhesion molecule ,?,
,,,mutations
,,,
ESCO2,establishment of cohesion 1 homolog 2 (S. cerevisiae) ,8p21.1,
,,,Roberts syndrome [MIM:268300]
,,,SC phocomelia syndrome [MIM:269000]
,,,
ESPN,espin ,1p36.3-p36.1,
,,,"Deafness, autosomal recessive 36 [MIM:609006]"
,,,"Deafness, neurosensory, without vestibular involvement, autosomal dominant"
,,,
ESR1,estrogen receptor 1 ,6q25.1,
,,,Breast cancer
,,,Estrogen resistance
,,,"HDL response to hormone replacement, augmented"
,,,"Migraine, susceptibility to [MIM:157300]"
,,,"Atherosclerosis, susceptibility to"
,,,"Myocardial infarction, susceptibility to [MIM:608446]"
,,,
ESR2,estrogen receptor 2 (ER beta) ,14q,
,,,mutations
,,,
ESRRB,estrogen-related receptor beta ,14q24.3,
,,,"Deafness, autosomal recessive 35 [MIM:608565]"
,,,
ESRRG,estrogen-related receptor gamma ,1q41,
,,,mutations
,,,
ETFA,"electron-transfer-flavoprotein, alpha polypeptide ",15q23-q25,
,,,"Glutaricaciduria, type IIA [MIM:231680]"
,,,
ETFB,"electron-transfer-flavoprotein, beta polypeptide ",19q13.3,
,,,"Glutaricaciduria, type IIB [MIM:231680]"
,,,
ETFDH,electron-transferring-flavoprotein dehydrogenase ,4q32-qter,
,,,"Glutaricaciduria, type IIC [MIM:231680]"
,,,
ETHE1,ethylmalonic encephalopathy 1 ,19q13.32,
,,,Ethylmalonic encephalopathy [MIM:602473]
,,,
ETL2,"epilepsy, familial temporal lobe ",12q22-q23.3,
,,,"Epilepsy, familial temporal lobe"
,,,
ETM2,essential tremor 2 ,2p25-p22,
,,,"Tremor, hereditary essential, 2"
,,,
ETS1,v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) ,11q23.3,
,,,mutations
,,,
ETV6,ets variant 6 ,12p13,
,,,"Leukemia, acute myeloid, somatic [MIM:601626]"
,,,
EVC2,Ellis van Creveld syndrome 2 ,4p16,
,,,Ellis-van Creveld syndrome [MIM:225500]
,,,
EVC,Ellis van Creveld syndrome ,4p16,
,,,Ellis-van Creveld syndrome [MIM:225500]
,,,Weyers acrodental dysostosis [MIM:193530]
,,,
EVI5,ecotropic viral integration site 5 ,1p22,
,,,mutations
,,,
EVR3,exudative vitreoretinopathy 3 ,11p13-p12,
,,,Exudative vitreoretinopathy-3
,,,
EWSR1,Ewing sarcoma breakpoint region 1 ,22q12,
,,,Ewing sarcoma [MIM:612219]
,,,Neuroepithelioma [MIM:612219]
,,,
EXO1,exonuclease 1 ,1q42-q43,
,,,mutations
,,,
EXOC4,exocyst complex component 4 ,7q31,
,,,mutations
,,,
EXT1,exostosin 1 ,8q24.11-q24.13,
,,,"Exostoses, multiple, type 1 [MIM:133700]"
,,,Chondrosarcoma [MIM:215300]
,,,
EXT2,exostosin 2 ,11p12-p11,
,,,"Exostoses, multiple, type 2 [MIM:133701]"
,,,
EXT3,exostoses (multiple) 3 ,19p,
,,,"Exostoses, multiple, type 3"
,,,
EXTL3,exostoses (multiple)-like 3 ,8p21,
,,,mutations
,,,
EYA1,eyes absent homolog 1 (Drosophila) ,8q13.3,
,,,Branchiootorenal syndrome [MIM:113650]
,,,Branchiootic syndrome
,,,Anterior segment anomalies and cataract
,,,Branchiootorenal syndrome with cataract [MIM:113650]
,,,Otofaciocervical syndrome [MIM:166780]
,,,
EYA4,eyes absent homolog 4 (Drosophila) ,6q23,
,,,"Deafness, autosomal dominant 10 [MIM:601316]"
,,,"Cardiomyopathy, dilated, 1J [MIM:605362]"
,,,
EYS,eyes shut homolog (Drosophila) ,6q12,
,,,Retinitis pigmentosa-25 [MIM:602772]
,,,
EZH2,enhancer of zeste homolog 2 (Drosophila) ,7q35,
,,,mutations
,,,
F10,coagulation factor X ,?,
,,,bleeding diathesis (FX deficiency)
,,,
F11,coagulation factor XI ,4q35,
,,,"Factor XI deficiency, autosomal recessive [MIM:612416]"
,,,"Factor XI deficiency, autosomal dominant [MIM:612416]"
,,,
F12,coagulation factor XII (Hageman factor) ,5q33-qter,
,,,Factor XII deficiency [MIM:234000]
,,,"Angioedema, hereditary, type III [MIM:610618]"
,,,
F13A1,"coagulation factor XIII, A1 polypeptide ",6p25-p24,
,,,Factor XIIIA deficiency [MIM:613225]
,,,
F13B,"coagulation factor XIII, B polypeptide ",1q31-q32.1,
,,,Factor XIIIB deficiency [MIM:613235]
,,,
F2RL1,coagulation factor II (thrombin) receptor-like 1 ,5q13,
,,,mutations
,,,
F2R,coagulation factor II (thrombin) receptor ,5q13,
,,,mutations
,,,
F2,coagulation factor II (thrombin) ,11p11-q12,
,,,Hypoprothrombinemia [MIM:613679]
,,,Dysprothrombinemia [MIM:613679]
,,,"Thrombosis, susceptibility to [MIM:188050]"
,,,"Stroke, ischemic, susceptibility to [MIM:601367]"
,,,
F3,"coagulation factor III (thromboplastin, tissue factor) ",1p22-p21,
,,,mutations
,,,
F5,"coagulation factor V (proaccelerin, labile factor) ",1q23,
,,,Factor V deficiency [MIM:227400]
,,,"Thrombophilia, susceptibility to, due to factor V Leiden [MIM:188055]"
,,,"Stroke, ischemic, susceptibility to [MIM:601367]"
,,,Budd-Chiari syndrome [MIM:600880]
,,,"Thrombophilia, susceptibility to, due to activated protein C resistance [MIM:188055]"
,,,
F7,coagulation factor VII (serum prothrombin conversion accelerator) ,?,
,,,hypoproconvertinemia
,,,
F8,"coagulation factor VIII, procoagulant component ",?,
,,,mutations
,,,
F9,coagulation factor IX ,Xq27.1-q27.2,
,,,Hemophilia B [MIM:306900]
,,,Warfarin sensitivity [MIM:122700]
,,,"Thrombophilia, X-linked, due to factor IX defect [MIM:300807]"
,,,
FA2H,fatty acid 2-hydroxylase ,16q23,
,,,"Leukodystrophy, dysmyelinating, and spastic paraparesis with or without dystonia [MIM:612443]"
,,,
FAAH2,fatty acid amide hydrolase 2 ,Xp11,
,,,mutations
,,,
FAAH,fatty acid amide hydrolase ,1p35-p34,
,,,"Drug addiction, susceptibility to"
,,,
FABP1,"fatty acid binding protein 1, liver ",2p11,
,,,mutations
,,,
FABP2,"fatty acid binding protein 2, intestinal ",4q28-q31,
,,,"insulin resistance,increased fatty oxidation in Pima Indian population (FABP2 polymorphism,A94T)"
,,,
FABP3,"fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) ",1p33-p31,
,,,mutations
,,,
FABP4,"fatty acid binding protein 4, adipocyte ",8q21,
,,,mutations
,,,
FABP6,"fatty acid binding protein 6, ileal ",5q23-q35,
,,,mutations
,,,
FABP7,"fatty acid binding protein 7, brain ",6q22-q23,
,,,mutations
,,,
FADD,Fas (TNFRSF6)-associated via death domain ,11q13.3,
,,,mutations
,,,
FADS2,fatty acid desaturase 2 ,11q12-q13.1,
,,,mutations
,,,
FAF2,Fas associated factor family member 2 ,5q12.1,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,Leigh syndrome [MIM:256000]
,,,
FAH,fumarylacetoacetate hydrolase (fumarylacetoacetase) ,?,
,,,"tyrosinemia I,hepatorenal"
,,,
FAM120A,family with sequence similarity 120A ,9q22.31,
,,,mutations
,,,
FAM123B,family with sequence similarity 123B ,Xq11.1,
,,,Osteopathia striata with cranial sclerosis [MIM:300373]
,,,
FAM126A,"family with sequence similarity 126, member A ",7p15.3,
,,,"Leukodystrophy, hypomyelinating, 5 [MIM:610532]"
,,,
FAM134B,"family with sequence similarity 134, member B ",5p15.1,
,,,"Neuropathy, hereditary sensory and autonomic, type IIB [MIM:613115]"
,,,
FAM154A,"family with sequence similarity 154, member A ",?,
,,,mutations
,,,
FAM161A,"family with sequence similarity 161, member A ",2p15,
,,,Retinitis pigmentosa 28 [MIM:606068]
,,,
FAM175A,"family with sequence similarity 175, member A ",4q21.2,
,,,mutations
,,,
FAM188A,"family with sequence similarity 188, member A ",10p13,
,,,mutations
,,,
FAM20A,"family with sequence similarity 20, member A ",17q24.2,
,,,mutations
,,,
FAM20C,"family with sequence similarity 20, member C ",7p22,
,,,Raine syndrome [MIM:259775]
,,,
FAM27L,family with sequence similarity 27-like ,?,
,,,mutations
,,,
FAM47B,"family with sequence similarity 47, member B ",?,
,,,mutations
,,,
FAM58A,"family with sequence similarity 58, member A ",Xq28,
,,,STAR syndrome [MIM:300707]
,,,
FAM75C1,"family with sequence similarity 75, member C1 ",?,
,,,mutations
,,,
FAM83H,"family with sequence similarity 83, member H ",8q24.3,
,,,"Amelogenesis imperfecta, type 3 [MIM:130900]"
,,,
FAM8A1,"family with sequence similarity 8, member A1 ",?,
,,,mutations
,,,
FAM91A1,"family with sequence similarity 91, member A1 ",?,
,,,mutations
,,,
FAME3,"Epilepsy, familial adult myoclonic, 3 ",5p15.31-p15.1,
,,,"Epilepsy, familial adult myoclonic, 3"
,,,
FANCA,"Fanconi anemia, complementation group A ",16q24.3,
,,,"Fanconi anemia, complementation group A [MIM:227650]"
,,,
FANCB,"Fanconi anemia, complementation group B ",Xp22.31,
,,,"Fanconi anemia, complementation group B [MIM:300514]"
,,,
FANCC,"Fanconi anemia, complementation group C ",?,
,,,"Fanconi anemia,autosomal recessive,complementation group C,characterized by progressive bone marrow failure (pancytopenia),often associated with skeletal abnormalities,radial hypoplasia and vertebral defect and an increased cancer risk with spontaneous chromosomal breakage exacerbated by exposure to DNA cross-linking agents"
,,,
FANCD2,"Fanconi anemia, complementation group D2 ",?,
,,,mutations
,,,
FANCE,"Fanconi anemia, complementation group E ",?,
,,,mutations
,,,
FANCF,"Fanconi anemia, complementation group F ",?,
,,,mutations
,,,
FANCG,"Fanconi anemia, complementation group G ",9p13,
,,,"Fanconi anemia, complementation group G"
,,,
FANCI,"Fanconi anemia, complementation group I ",15q25-q26,
,,,"Fanconi anemia, complementation group I [MIM:609053]"
,,,
FANCL,"Fanconi anemia, complementation group L ",2p16.1,
,,,"Fanconi anemia, complementation group L"
,,,
FANCM,"Fanconi anemia, complementation group M ",14q21.3,
,,,"Fanconi anemia, complementation group M"
,,,
FAR1,fatty acyl CoA reductase 1 ,?,
,,,"familial amyloidosis,renal,Ostertag type (FGA deposit)"
,,,
FAR2,fatty acyl CoA reductase 2 ,?,
,,,"familial amyloidosis,renal,Ostertag type (lysozyme deposit)"
,,,
FARS2,"phenylalanyl-tRNA synthetase 2, mitochondrial ",6p25.1,
,,,mutations
,,,
FASLG,"Fas ligand (TNF superfamily, member 6) ",1q23,
,,,"Systemic lupus erythematosus, susceptibility [MIM:152700]"
,,,
FASN,fatty acid synthase ,17q25,
,,,mutations
,,,
FASTKD2,FAST kinase domains 2 ,2q33.3,
,,,Mitochondrial complex IV deficiency [MIM:220110]
,,,
FAS,"Fas (TNF receptor superfamily, member 6) ",10q24.1,
,,,Autoimmune lymphoproliferative syndrome [MIM:601859]
,,,"Squamous cell carcinoma, burn scar-related, somatic"
,,,"Autoimmune lymphoproliferative syndrome, type IA [MIM:601859]"
,,,
FBLIM1,filamin binding LIM protein 1 ,1p36.13,
,,,mutations
,,,
FBLN1,fibulin 1 ,22q13.3,
,,,"Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses [MIM:608180]"
,,,
FBLN5,fibulin 5 ,14q32.1,
,,,"Cutis laxa, autosomal recessive [MIM:219100]"
,,,"Cutis laxa, autosomal dominant [MIM:123700]"
,,,"Macular degeneration, age-related, 3 [MIM:608895]"
,,,
FBN1,fibrillin 1 ,15q21.1,
,,,Marfan syndrome [MIM:154700]
,,,Shprintzen-Goldberg syndrome [MIM:182212]
,,,"Ectopia lentis, familial [MIM:129600]"
,,,MASS syndrome [MIM:604308]
,,,"Weill-Marchesani syndrome, dominant [MIM:608328]"
,,,"Aortic aneurysm, ascending, and dissection"
,,,Stiff skin syndrome [MIM:184900]
,,,
FBN2,fibrillin 2 ,5q23-q31,
,,,"Contractural arachnodactyly, congenital [MIM:121050]"
,,,
FBN3,fibrillin 3 ,?,
,,,mutations
,,,
FBP1,"fructose-1,6-bisphosphatase 1 ",9q22.2-q22.3,
,,,"Fructose-1,6-bidphosphatase deficiency [MIM:229700]"
,,,
FBXL6,F-box and leucine-rich repeat protein 6 ,?,
,,,mutations
,,,
FBXO10,F-box protein 10 ,9p13.1,
,,,mutations
,,,
FBXO18,"F-box protein, helicase, 18 ",10p15.1,
,,,mutations
,,,
FBXO33,F-box protein 33 ,14q13.3,
,,,Bone mineral density QTL 12 [MIM:612560]
,,,
FBXO7,F-box protein 7 ,22q12-q13,
,,,"Parkinson disease 15, autosomal recessive [MIM:260300]"
,,,
FBXW11,F-box and WD repeat domain containing 11 ,5q35.1,
,,,mutations
,,,
FBXW4,F-box and WD repeat domain containing 4 ,10q24,
,,,mutations
,,,
FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase ",4q31.3,
,,,mutations
,,,
FCAR,"Fc fragment of IgA, receptor for ",19q13.4,
,,,mutations
,,,
FCER1A,"Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide ",1q23,
,,,mutations
,,,
FCER2,"Fc fragment of IgE, low affinity II, receptor for (CD23) ",19p13.3,
,,,mutations
,,,
FCGR1A,"Fc fragment of IgG, high affinity Ia, receptor (CD64) ",1q21.2-q21.3,
,,,"IgG receptor I, phagocytic, familial deficiency of"
,,,
FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32) ",1q21-q23,
,,,"Lupus nephritis, susceptibility to"
,,,
FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor (CD32) ",1q22,
,,,"Systemic lupus erythematosus, susceptibility to [MIM:152700]"
,,,"Malaria, resistance to [MIM:611162]"
,,,
FCGR2C,"Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) ",1q23,
,,,"Thrombocytopenic purpura, autoimmune [MIM:188030]"
,,,
FCGR3A,"Fc fragment of IgG, low affinity IIIa, receptor (CD16a) ",1q23,
,,,"Lupus erythematosus, systemic, susceptibility [MIM:152700]"
,,,"Neutropenia, alloimmune neonatal"
,,,"Viral infections, recurrent"
,,,
FCGR3B,"Fc fragment of IgG, low affinity IIIb, receptor (CD16b) ",1q23,
,,,"autoimmune thyroiditis,recurrent bacterial infections in some FCGR3B deficient people"
,,,
FCGRT,"Fc fragment of IgG, receptor, transporter, alpha ",19q13.3,
,,,mutations
,,,
FCMTE1,familial cortical myoclonic tremor with epilepsy 1 ,8q24,
,,,"Epilepsy, myoclonic, benign adult familial"
,,,
FCMTE2,familial cortical myoclonic tremor with epilepsy 2 ,2p11.1-q12.2,
,,,"Epilepsy, myoclonic, benign adult familial, type 2"
,,,
FCMTE3,familial cortical myoclonic tremor with epilepsy 3 ,5p15.31-p15.1,
,,,"Epilepsy, familial adult myoclonic, 3"
,,,
FCN2,ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) ,9q34,
,,,mutations
,,,
FCN3,ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen) ,1p36.11,
,,,mutations
,,,
FCP1,F-cell production 1 ,Xp22.2,
,,,Fetal hemoglobin quantitative trait locus 3
,,,
FCRL3,Fc receptor-like 3 ,1q21.2-q22,
,,,mutations
,,,
FDFT1,farnesyl-diphosphate farnesyltransferase 1 ,8p23.1-p22,
,,,mutations
,,,
Feb-10,"Febrile convulsions, familial, 10 ",3q26.2-q26.33,
,,,"Febrile convulsions, familial, 10"
,,,
Feb-01,febrile convulsions 1 ,8q13-q21,
,,,"Convulsions, familial febrile, 1"
,,,
Feb-02,febrile convulsions 2 ,19p13.3,
,,,"Convulsions, familial febrile, 2"
,,,
Feb-04,febrile convulsions 4 ,5q14.3,
,,,"Convulsions, familial febrile, 4 [MIM:604352]"
,,,"Usher syndrome, type IIC [MIM:605472]"
,,,
Feb-05,febrile convulsions 5 ,6q22-q24,
,,,"Febrile convulsions, familial, 5"
,,,
Feb-06,febrile convulsions 6 ,18p11.2,
,,,"Febrile convulsions, familial, 6"
,,,
Feb-07,febrile convulsions 7 ,21q22,
,,,"Febrile convulsions, familial, 7"
,,,
Feb-09,"Febrile convulsions, familial, 9 ",3p24.2-p23,
,,,"Febrile convulsions, familial, 9"
,,,
FECD2,"corneal dystrophy, Fuchs endothelial 2 ",13pter-q12.13,
,,,"Corneal dystrophy, Fuchs endothelial, late onset 1"
,,,
FECD3,"Corneal dystrophy, Fuchs endothelial, 3 ",18q21.2-q21.3,
,,,"Corneal dystrophy, Fuchs endothelial, 3"
,,,
FECD5,"Corneal dystrophy, Fuchs endothelial, 5 ",5q33.1-q35.2,
,,,"Corneal dystrophy, Fuchs endothelial, 5"
,,,
FECD7,"Corneal dystrophy, Fuchs endothelial, 7 ",9p24.1-p22.1,
,,,"Corneal dystrophy, Fuchs endothelial, 7"
,,,
FECH,ferrochelatase ,18q21.3,
,,,"Protoporphyria, erythropoietic, autosomal dominant [MIM:177000]"
,,,"Protoporphyria, erythropoietic, autosomal recessive [MIM:177000]"
,,,
FEM1A,fem-1 homolog a (C. elegans) ,?,
,,,mutations
,,,
FEN1,flap structure-specific endonuclease 1 ,11q12,
,,,mutations
,,,
FEOM3,"fibrosis of extraocular muscles, congenital, 3 ",16q24.2-q24.3,
,,,"Fibrosis of extraocular muscles, congenital, 3"
,,,"Fibrosis, congenital, of vertically acting extraocular muscles"
,,,
FERMT1,fermitin family member 1 ,20p13,
,,,Kindler syndrome [MIM:173650]
,,,
FERMT3,fermitin family member 3 ,11q12,
,,,"Leukocyte adhesion deficiency, type III [MIM:612840]"
,,,
FES,feline sarcoma oncogene ,15q26.1,
,,,mutations
,,,
FEV,FEV (ETS oncogene family) ,2q36,
,,,mutations
,,,
FEZF2,FEZ family zinc finger 2 ,3p14.2,
,,,mutations
,,,
FFAR1,free fatty acid receptor 1 ,19q13.1,
,,,mutations
,,,
FGA,fibrinogen alpha chain ,4q28,
,,,"Dysfibrinogenemia, alpha type, causing bleeding diathesis"
,,,"Dysfibrinogenemia, alpha type, causing recurrent thrombosis"
,,,"Amyloidosis, hereditary renal [MIM:105200]"
,,,"Afibrinogenemia, congenital [MIM:202400]"
,,,
FGB,fibrinogen beta chain ,4q28,
,,,"Dysfibrinogenemia, beta type"
,,,"Afibrinogenemia, congenital [MIM:202400]"
,,,"Thrombophilia, dysfibrinogenemic"
,,,
FGD1,"FYVE, RhoGEF and PH domain containing 1 ",Xp11.21,
,,,Aarskog-Scott syndrome [MIM:305400]
,,,"Mental retardation, X-linked syndromic 16"
,,,
FGD3,"FYVE, RhoGEF and PH domain containing 3 ",8q11.2-q13.2,
,,,Glucocorticoid deficiency 3
,,,
FGD4,"FYVE, RhoGEF and PH domain containing 4 ",12p11.2,
,,,"Charcot-Marie-Tooth disease, type 4H [MIM:609311]"
,,,
FGF10,fibroblast growth factor 10 ,5p13-p12,
,,,Aplasia of lacrimal and salivary glands [MIM:180920]
,,,LADD syndrome [MIM:149730]
,,,
FGF14,fibroblast growth factor 14 ,13q34,
,,,Spinocerebellar ataxia-27 [MIM:609307]
,,,
FGF1,fibroblast growth factor 1 (acidic) ,5q31,
,,,mutations
,,,
FGF20,fibroblast growth factor 20 ,8p22-p21.3,
,,,mutations
,,,
FGF23,fibroblast growth factor 23 ,12p13.3,
,,,"Hypophosphatemic rickets, autosomal dominant [MIM:193100]"
,,,"Osteomalacia, tumor-induced"
,,,"Tumoral calcinosis, hyperphosphatemic, familial [MIM:211900]"
,,,
FGF2,fibroblast growth factor 2 (basic) ,4q25-q27,
,,,mutations
,,,
FGF3,fibroblast growth factor 3 ,11q13,
,,,"Deafness, congenital with inner ear agenesis, microtia, and microdontia [MIM:610706]"
,,,
FGF8,fibroblast growth factor 8 (androgen-induced) ,10q24,
,,,Kallmann syndrome 6 [MIM:612702]
,,,
FGF9,fibroblast growth factor 9 (glia-activating factor) ,13q11-q12,
,,,Multiple synostoses syndrome 3 [MIM:612961]
,,,
FGFBP1,fibroblast growth factor binding protein 1 ,4p15.3,
,,,mutations
,,,
FGFR1OP,FGFR1 oncogene partner ,6q27,
,,,Myeloproliferative disorder
,,,
FGFR1,fibroblast growth factor receptor 1 ,8p11.2-p11.1,
,,,Pfeiffer syndrome [MIM:101600]
,,,Jackson-Weiss syndrome [MIM:123150]
,,,Kallmann syndrome 2 [MIM:147950]
,,,Hypogonadotropic hypogonadism [MIM:146110]
,,,Osteoglophonic dysplasia [MIM:166250]
,,,Trigonocephaly [MIM:190440]
,,,
FGFR2,fibroblast growth factor receptor 2 ,10q26,
,,,Crouzon syndrome [MIM:123500]
,,,Jackson-Weiss syndrome [MIM:123150]
,,,Beare-Stevenson cutis gyrata syndrome [MIM:123790]
,,,Pfeiffer syndrome [MIM:101600]
,,,Apert syndrome [MIM:101200]
,,,Saethre-Chotzen syndrome [MIM:101400]
,,,"Craniosynostosis, nonspecific"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,Craniofacial-skeletal-dermatologic dysplasia
,,,Antley-Bixler syndrome [MIM:207410]
,,,Scaphocephaly and Axenfeld-Rieger anomaly
,,,LADD syndrome [MIM:149730]
,,,"Scaphocephaly, maxillary retrusion, and mental retardation [MIM:609579]"
,,,
FGFR3,fibroblast growth factor receptor 3 ,4p16.3,
,,,Achondroplasia [MIM:100800]
,,,Hypochondroplasia [MIM:146000]
,,,"Thanatophoric dysplasia, type I [MIM:187600]"
,,,Crouzon syndrome with acanthosis nigricans [MIM:612247]
,,,Muenke syndrome [MIM:602849]
,,,"Bladder cancer, somatic [MIM:109800]"
,,,"Colorectal cancer, somatic [MIM:109800]"
,,,"Cervical cancer, somatic [MIM:603956]"
,,,LADD syndrome [MIM:149730]
,,,CATSHL syndrome [MIM:610474]
,,,"Nevus, keratinocytic, nonepidermolytic [MIM:162900]"
,,,"Thanatophoric dysplasia, type II [MIM:187601]"
,,,
FGFR4,fibroblast growth factor receptor 4 ,5q35.1-qter,
,,,Cancer progression/metastasis
,,,
FGFRL1,fibroblast growth factor receptor-like 1 ,4p16,
,,,mutations
,,,
FGG,fibrinogen gamma chain ,4q28,
,,,"Dysfibrinogenemia, gamma type"
,,,"Hypofibrinogenemia, gamma type"
,,,"Thrombophilia, dysfibrinogenemic"
,,,
FGQTL1,Fasting plasma glucose level QTL 1 ,2q24-q32,
,,,Fasting plasma glucose level QTL 1
,,,
FGQTL2,Fasting plasma glucose level QTL2 ,7p15-p13,
,,,Fasting plasma glucose level QTL 2
,,,Birth weight QTL 1
,,,
FGQTL3,Fasting plasma glucose level QTL3 ,11q21-q22,
,,,Fasting plasma glucose level QTL 3
,,,
FGQTL4,Fasting plasma glucose level QTL 4 ,7p21.2,
,,,Fasting plasma glucose level QTL 4
,,,
FGQTL6,Fasting plasma glucose level QTL 6 ,3q21,
,,,Fasting plasma glucose level QTL 6
,,,Birth weight QTL 3
,,,"Plasma glucose, 2-hour, QTL 1"
,,,
FGS2,FG syndrome 2 ,Xq28,
,,,FG syndrome 2
,,,
FGS3,FG syndrome 3 ,Xp22.3,
,,,FG syndrome 3
,,,
FGS5,FG syndrome 5 ,Xq22.3,
,,,FG syndrome 5
,,,
FHA2,"Hyperaldosteronism, familial, type II ",7p22,
,,,"Hyperaldosteronism, familial, type II"
,,,
FHASD,Foveal hypoplasia and anterior segment dysgenesis ,16q23.2-q24.2,
,,,Foveal hypoplasia and anterior segment dysgenesis
,,,
FHL1,four and a half LIM domains 1 ,Xq27.2,
,,,"Scapuloperoneal myopathy, X-linked dominant [MIM:300695]"
,,,"Myopathy, X-linked, with postural muscle atrophy [MIM:300696]"
,,,"Myopathy, reducing body, X-linked, severe early-onset [MIM:300717]"
,,,"Myopathy, reducing body, X-linked, childhood-onset [MIM:300718]"
,,,Emery-Dreifuss muscular dystrophy 6 [MIM:300696]
,,,
FHL2,four and a half LIM domains 2 ,2q12-q14,
,,,mutations
,,,
FHQTL,Fetal hemoglobin QTL on chromosome 8 ,8q,
,,,Fetal hemoglobin quantitative trait locus 4
,,,
FH,fumarate hydratase ,1q42.1,
,,,Fumarase deficiency [MIM:606812]
,,,Multiple cutaneous and uterine leiomyomata [MIM:150800]
,,,Leiomyomatosis and renal cell cancer [MIM:605839]
,,,
FIG4,"FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) ",6q21,
,,,"Charcot-Marie-Tooth disease, type 4J [MIM:611228]"
,,,Amyotrophic lateral sclerosis 11 [MIM:612577]
,,,
FIGLA,folliculogenesis specific basic helix-loop-helix ,2p12,
,,,Premature ovarian failure 6 [MIM:612310]
,,,
FIMG1,"myasthenia gravis, familial infantile, 1 ",17p13,
,,,"Myasthenia, familial infantile, 1"
,,,
FIP1L1,FIP1 like 1 (S. cerevisiae) ,4q12,
,,,mutations
,,,
FKBP10,"FK506 binding protein 10, 65 kDa ",17q21.2,
,,,"Osteogenesis imperfecta, type VI [MIM:610698]"
,,,
FKBP14,"FK506 binding protein 14, 22 kDa ",?,
,,,mutations
,,,
FKBP5,FK506 binding protein 5 ,6p21.3-p21.2,
,,,Major depressive disorder and accelerated response to antidepressant drug treatment [MIM:608516]
,,,
FKBP6,"FK506 binding protein 6, 36kDa ",7q11.23,
,,,mutations
,,,
FKBPL,FK506 binding protein like ,?,
,,,mutations
,,,
FKRP,fukutin related protein ,19q13.3,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5 [MIM:613153]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5 [MIM:606612]"
,,,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 [MIM:607155]"
,,,
FKTN,fukutin ,9q31,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 [MIM:253800]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4 [MIM:613152]"
,,,"Cardiomyopathy, dilated, 1X [MIM:611615]"
,,,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 [MIM:611588]"
,,,
FL1,"Follicular lymphoma, susceptibility to, 1 ",6p21.33,
,,,"Follicular lymphoma, susceptibility to, 1"
,,,
FLCN,folliculin ,17p11.2,
,,,Birt-Hogg-Dube syndrome [MIM:135150]
,,,"Pneumothorax, primary spontaneous [MIM:173600]"
,,,"Renal carcinoma, chromophobe, somatic [MIM:144700]"
,,,"Colorectal cancer, somatic [MIM:114500]"
,,,
FLD1,"Fatty liver disease 1, susceptiblity to ",22q13,
,,,"Fatty liver disease, nonalcoholic, susceptibility to, 1"
,,,
FLG,filaggrin ,1q21,
,,,Ichthyosis vulgaris [MIM:146700]
,,,"Dermatitis, atopic, susceptibility to, 2 [MIM:605803]"
,,,
FLNA,"filamin A, alpha ",Xq28,
,,,"Heterotopia, periventricular [MIM:300049]"
,,,"Otopalatodigital syndrome, type I [MIM:311300]"
,,,"Otopalatodigital syndrome, type II [MIM:304120]"
,,,"Intestinal pseudoobstruction, neuronal [MIM:300048]"
,,,Melnick-Needles syndrome [MIM:309350]
,,,Frontometaphyseal dysplasia [MIM:305620]
,,,"Heterotopia, periventricular, ED variant [MIM:300537]"
,,,FG syndrome 2 [MIM:300321]
,,,"Cardiac valvular dysplasia, X-linked [MIM:314400]"
,,,Terminal osseous dysplasia [MIM:300244]
,,,
FLNB,"filamin B, beta ",3p14.3,
,,,Spondylocarpotarsal synostosis syndrome [MIM:272460]
,,,Larsen syndrome [MIM:150250]
,,,"Atelostogenesis, type I [MIM:108720]"
,,,"Atelosteogenesis, type III [MIM:108721]"
,,,Boomerang dysplasia [MIM:112310]
,,,
FLNC,"filamin C, gamma ",7q32,
,,,"Myopathy, myofibrillar, filamin C-related [MIM:609524]"
,,,
FLT1,fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) ,13q12,
,,,mutations
,,,
FLT3,fms-related tyrosine kinase 3 ,13q12,
,,,"Leukemia, acute myeloid, reduced survival in"
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,"Leukemia, acute lymphoblastic"
,,,
FLT4,fms-related tyrosine kinase 4 ,5q35.3,
,,,"Lymphedema, hereditary I [MIM:153100]"
,,,"Hemangioma, capillary infantile, somatic [MIM:602089]"
,,,
FLVCR1,feline leukemia virus subgroup C cellular receptor 1 ,1q31.3,
,,,"Ataxia, posterior column, with retinitis pigmentosa [MIM:609033]"
,,,
FLVCR2,"feline leukemia virus subgroup C cellular receptor family, member 2 ",14q24.3,
,,,Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome [MIM:225790]
,,,
FMN1,formin 1 ,15q13-q14,
,,,mutations
,,,
FMN2,formin 2 ,1q23-q32,
,,,mutations
,,,
FMO1,flavin containing monooxygenase 1 ,1q23-q25,
,,,mutations
,,,
FMO2,flavin containing monooxygenase 2 (non-functional) ,1q23-q25,
,,,mutations
,,,
FMO3,flavin containing monooxygenase 3 ,1q23-q25,
,,,Trimethylaminuria [MIM:602079]
,,,
FMO4,flavin containing monooxygenase 4 ,1q23-q25,
,,,mutations
,,,
FMO5,flavin containing monooxygenase 5 ,1q21.1,
,,,mutations
,,,
FMO6P,flavin containing monooxygenase 6 pseudogene ,?,
,,,mutations
,,,
FMR1,fragile X mental retardation 1 ,Xq27.3,
,,,Fragile X syndrome [MIM:300624]
,,,Fragile X tremor/ataxia syndrome [MIM:300623]
,,,
FMTLE,"Epilepsy, familial mesial temporal lobe ",4q13.2-q21.3,
,,,"Epilepsy, familial mesial temporal lobe"
,,,
FN1,fibronectin 1 ,2q34,
,,,Glomerulopathy with fibronectin deposits 2 [MIM:601894]
,,,
FN3K,fructosamine 3 kinase ,?,
,,,mutations
,,,
FND,frontonasal dysplasia ,Xq12,
,,,Craniofrontonasal dysplasia [MIM:304110]
,,,
FOLH1,folate hydrolase (prostate-specific membrane antigen) 1 ,11p11.2,
,,,mutations
,,,
FOLR1,folate receptor 1 (adult) ,11q13.3-q13.5,
,,,Neurodegeneration due to cerebral folate transport deficiency [MIM:613068]
,,,
FOXA1,forkhead box A1 ,14q13,
,,,mutations
,,,
FOXA2,forkhead box A2 ,20p11,
,,,mutations
,,,
FOXA3,forkhead box A3 ,19q13.2-q13.4,
,,,mutations
,,,
FOXC1,forkhead box C1 ,6p25,
,,,"Iridogoniodysgenesis, type 1 [MIM:601631]"
,,,Rieger or Axenfeld anomalies [MIM:602482]
,,,"Axenfeld-Rieger syndrome, type 3 [MIM:602482]"
,,,Iris hypoplasia and glaucoma [MIM:601631]
,,,
FOXC2,"forkhead box C2 (MFH-1, mesenchyme forkhead 1) ",16q24.3,
,,,Lymphedema-distichiasis syndrome [MIM:153400]
,,,Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus [MIM:153400]
,,,
FOXD3,forkhead box D3 ,1p31,
,,,"Autoimmune disease, susceptibility to, 1 [MIM:607836]"
,,,
FOXD4,forkhead box D4 ,9p1-q1,
,,,mutations
,,,
FOXE1,forkhead box E1 (thyroid transcription factor 2) ,9q22,
,,,Bamforth-Lazarus syndrome [MIM:241850]
,,,
FOXE3,forkhead box E3 ,1p32,
,,,Anterior segment mesenchymal dysgenesis [MIM:107250]
,,,"Aphakia, congenital primary [MIM:610256]"
,,,
FOXF1,forkhead box F1 ,16q24,
,,,Alveolar capillary dysplasia with misalignment of pulmonary veins [MIM:265380]
,,,
FOXF2,forkhead box F2 ,6p25.3,
,,,mutations
,,,
FOXG1,forkhead box G1 ,14q13,
,,,"Rett syndrome, congenital variant [MIM:613454]"
,,,
FOXH1,forkhead box H1 ,8q24.3,
,,,mutations
,,,
FOXI1,forkhead box I1 ,5q34,
,,,Enlarged vestibular aqueduct [MIM:600791]
,,,
FOXL2,forkhead box L2 ,3q23,
,,,"Blepharophimosis, epicanthus inversus, and ptosis, type 1 [MIM:110100]"
,,,"Blepharophimosis, epicanthus inversus, and ptosis, type 2 [MIM:110100]"
,,,Premature ovarian failure 3 [MIM:608996]
,,,
FOXN1,forkhead box N1 ,17q11-q12,
,,,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy [MIM:601705]"
,,,
FOXO1,forkhead box O1 ,13q14.1,
,,,"Rhabdomyosarcoma, alveolar [MIM:268220]"
,,,
FOXP1,forkhead box P1 ,3p14.1,
,,,Mental retardation with language impairment and autistic features [MIM:613670]
,,,
FOXP2,forkhead box P2 ,7q31,
,,,Speech-language disorder-1 [MIM:602081]
,,,
FOXP3,forkhead box P3 ,Xp11.23-q13.3,
,,,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked [MIM:304790]"
,,,"Diabetes mellitus, type I, susceptibility to [MIM:222100]"
,,,
FOXRED1,FAD-dependent oxidoreductase domain containing 1 ,11q24.2,
,,,Mitochondrial complex 1 deficiency [MIM:252010]
,,,Leigh syndrome [MIM:256000]
,,,
FPEVF,"Epilepsy, partial, with variable foci ",22q11-q12,
,,,"Epilepsy, partial, with variable foci"
,,,
FPGS,folylpolyglutamate synthase ,9cen-q34,
,,,mutations
,,,
FPR1,formyl peptide receptor 1 ,19q13.4,
,,,mutations
,,,
FPR2,formyl peptide receptor 2 ,19q13.3-q13.4,
,,,mutations
,,,
FRA10A,"fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) ",?,
,,,mutations
,,,
FRAS1,Fraser syndrome 1 ,4q21,
,,,Fraser syndrome [MIM:219000]
,,,
FRAXA,"fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) ",Xq27.3,
,,,Fragile X syndrome [MIM:300624]
,,,Fragile X tremor/ataxia syndrome [MIM:300623]
,,,
FRAXE,"fragile site, folic acid type, rare, fra(X)(q28) E ",Xq28,
,,,"Mental retardation, X-linked, FRAXE type [MIM:309548]"
,,,
FRAXF,"fragile site, folic acid type, rare, fra(X)(q28) F ",Xq28,
,,,mutations
,,,
FRDA2,Friedreich ataxia 2 ,9p23-p11,
,,,Friedreich ataxia 2
,,,
FREM1,FRAS1 related extracellular matrix 1 ,9p22.3,
,,,Bifid nose with or without anorectal and renal anomalies [MIM:608980]
,,,
FREM2,FRAS1 related extracellular matrix protein 2 ,13q13.3,
,,,Fraser syndrome [MIM:219000]
,,,
FREM3,FRAS1 related extracellular matrix 3 ,4q31.2,
,,,mutations
,,,
FRK,fyn-related kinase ,6q21-q22.3,
,,,mutations
,,,
FRMD6,FERM domain containing 6 ,?,
,,,mutations
,,,
FRMD7,FERM domain containing 7 ,Xq26.2,
,,,"Nystagmus 1, congenital, X-linked [MIM:310700]"
,,,
FRMPD4,FERM and PDZ domain containing 4 ,?,
,,,mutations
,,,
FRTS,Fanconi renotubular syndrome ,15q15.3,
,,,Fanconi renotubular syndrome 1
,,,
FRY,furry homolog (Drosophila) ,?,
,,,mutations
,,,
FRZB,frizzled-related protein ,2q31-q33,
,,,Osteoarthritis susceptibility 1 [MIM:165720]
,,,
FSCB,fibrous sheath CABYR binding protein ,14q21.3,
,,,mutations
,,,
FSCN2,"fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) ",17q25,
,,,Retinitis pigmentosa-30 [MIM:607921]
,,,
FSGS2,focal segmental glomerulosclerosis 2 ,11q21-q22,
,,,"Glomerulosclerosis, focal segmental, 2 [MIM:603965]"
,,,
FSHB,"follicle stimulating hormone, beta polypeptide ",11p13,
,,,"Follicle-stimulating hormone deficiency, isolated [MIM:229070]"
,,,
FSHMD1A,facioscapulohumeral muscular dystrophy 1A ,4q35,
,,,Facioscapulohumeral muscular dystrophy-1A
,,,
FSHR,follicle stimulating hormone receptor ,2p21-p16,
,,,Ovarian dysgenesis 1 [MIM:233300]
,,,Ovarian response to FSH stimulation [MIM:276400]
,,,Ovarian hyperstimulation syndrome [MIM:608115]
,,,
FSI,fasting glucose and specific insulin levels ,6q22-q24,
,,,Fasting insulin level quantitative trait locus 1
,,,
FSTL3,follistatin-like 3 (secreted glycoprotein) ,19p13,
,,,B cell chronic leukemia with a translocation t(11;19)(p13;q13) juxtaposing CCND1 and FSTL3 with an expression of the FSTL3 in hematopoietic cells
,,,
FST,follistatin ,5q11.2,
,,,Polycystic ovary syndrome [MIM:184700]
,,,
FTCD,formiminotransferase cyclodeaminase ,21q22.3,
,,,Glutamate formiminotransferase deficiency [MIM:229100]
,,,
FTH1,"ferritin, heavy polypeptide 1 ",11q12-q13,
,,,"Iron overload, autosomal dominant"
,,,
FTHL17,"ferritin, heavy polypeptide-like 17 ",X,
,,,mutations
,,,
FTL,"ferritin, light polypeptide ",19q13.3-q13.4,
,,,Hyperferritinemia-cataract syndrome [MIM:600886]
,,,Neurodegeneration with brain iron accumulation 3 [MIM:606159]
,,,
FTO,fat mass and obesity associated ,16q12.2,
,,,"Growth retardation, developmental delay, coarse facies, and early death [MIM:612938]"
,,,
FTSJ1,FtsJ RNA methyltransferase homolog 1 (E. coli) ,Xp11.23,
,,,"Mental retardation, X-linked-9 [MIM:309549]"
,,,
FTX,"FTX transcript, XIST regulator (non-protein coding) ",X,
,,,"Thrombocytosis, familial X-linked"
,,,
FUCA1,"fucosidase, alpha-L- 1, tissue ",1p34,
,,,Fucosidosis [MIM:230000]
,,,
FURIN,furin (paired basic amino acid cleaving enzyme) ,15q25-q26,
,,,mutations
,,,
FUS,fused in sarcoma ,16p11.2,
,,,"Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia [MIM:608030]"
,,,
FUT1,"fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) ",19q13.3,
,,,Bombay phenotype
,,,
FUT2,fucosyltransferase 2 (secretor status included) ,19q13.3,
,,,"Norwalk virus infection, resistance to"
,,,Bombay phenotype
,,,Vitamin B12 plasma level QTL1 [MIM:612542]
,,,
FUT3,"fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) ",19p13.3,
,,,"Blood group, Lewis"
,,,
FUT6,"fucosyltransferase 6 (alpha (1,3) fucosyltransferase) ",19p13.3,
,,,Fucosyltransferase-6 deficiency
,,,
FUT7,"fucosyltransferase 7 (alpha (1,3) fucosyltransferase) ",9,
,,,mutations
,,,
FUT8,"fucosyltransferase 8 (alpha (1,6) fucosyltransferase) ",14q23,
,,,mutations
,,,
FUZ,fuzzy homolog (Drosophila) ,19q13,
,,,mutations
,,,
FWS,Forsythe-Wakeling syndrome ,1p33-p31.1,
,,,Forsythe-Wakeling syndrome
,,,
FXN,frataxin ,9q13,
,,,Friedreich ataxia [MIM:229300]
,,,Friedreich ataxia with retained reflexes [MIM:229300]
,,,
FXYD2,FXYD domain containing ion transport regulator 2 ,11q23,
,,,"Hypomagnesemia-2, renal [MIM:154020]"
,,,
FYCO1,FYVE and coiled-coil domain containing 1 ,?,
,,,mutations
,,,
FZD1,frizzled family receptor 1 ,7q21,
,,,mutations
,,,
FZD3,frizzled family receptor 3 ,8p21,
,,,mutations
,,,
FZD4,frizzled family receptor 4 ,11q14-q21,
,,,Exudative vitreoretinopathy [MIM:133780]
,,,Retinopathy of prematurity [MIM:133780]
,,,
FZD6,frizzled family receptor 6 ,8q22.3-q23.1,
,,,mutations
,,,
FZD9,frizzled family receptor 9 ,7q11.23,
,,,mutations
,,,
G6PC2,"glucose-6-phosphatase, catalytic, 2 ",2q24-q32,
,,,mutations
,,,
G6PC3,"glucose 6 phosphatase, catalytic, 3 ",17q21,
,,,"Neutropenia, severe congenital, autosomal recessive 4 [MIM:612541]"
,,,Darsun syndrome [MIM:612541]
,,,
G6PC,"glucose-6-phosphatase, catalytic subunit ",?,
,,,mutations
,,,
G6PD,glucose-6-phosphate dehydrogenase ,Xq28,
,,,G6PD deficiency
,,,Favism
,,,Hemolytic anemia due to G6PD deficiency
,,,
GAA,"glucosidase, alpha; acid ",17q25.2-q25.3,
,,,Glycogen storage disease II [MIM:232300]
,,,
GAB2,GRB2-associated binding protein 2 ,11q13.4-q13.5,
,,,mutations
,,,
GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1 ",?,
,,,mutations
,,,
GABBR2,"gamma-aminobutyric acid (GABA) B receptor, 2 ",9q22.1,
,,,"Nicotine dependence, susceptibility to [MIM:188890]"
,,,"Nicotine dependence, protection against [MIM:188890]"
,,,
GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1 ",5q34-q35,
,,,"Epilepsy, juvenile myoclonic, susceptibility to, 5 [MIM:611136]"
,,,"Epilepsy, childhood absence, susceptibility to, 4 [MIM:611136]"
,,,
GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2 ",4p13-p12,
,,,"Alcoholism, susceptibility to [MIM:103780]"
,,,
GABRA6,"gamma-aminobutyric acid (GABA) A receptor, alpha 6 ",5q31.1-q35,
,,,mutations
,,,
GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3 ",15q11.2-q12,
,,,Insomnia
,,,"Epilepsy, childhood absence, susceptibility to, 5 [MIM:612269]"
,,,
GABRD,"gamma-aminobutyric acid (GABA) A receptor, delta ",1p36.3,
,,,"Generalized epilepsy with febrile seizures plus, type 5, susceptibility to [MIM:604233]"
,,,"Epilepsy, idiopathic generalized, 10 [MIM:613060]"
,,,"Epilepsy, juvenile myoclonic, susceptibility to [MIM:613060]"
,,,
GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2 ",5q31.1-q33.1,
,,,"Epilepsy, generalized, with febrile seizures plus, type 3 [MIM:604233]"
,,,"Epilepsy, childhood absence, susceptibility to, 2 [MIM:607681]"
,,,"Febrilel, convulsions, familial, 8 [MIM:611277]"
,,,"Myoclonic epilepsy, severe, of infancy [MIM:607208]"
,,,
GABRR2,"gamma-aminobutyric acid (GABA) A receptor, rho 2 ",6q14-q21,
,,,mutations
,,,
GAD1,"glutamate decarboxylase 1 (brain, 67kDa) ",2q31,
,,,"Cerebral palsy, spastic, symmetric, autosomal recessive [MIM:603513]"
,,,
GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) ",10p11.23,
,,,mutations
,,,
GADD45B,"growth arrest and DNA-damage-inducible, beta ",19p13.3,
,,,mutations
,,,
GAK,cyclin G associated kinase ,4p16,
,,,mutations
,,,
GAL3ST3,galactose-3-O-sulfotransferase 3 ,11q13,
,,,mutations
,,,
GALC,galactosylceramidase ,14q31,
,,,Krabbe disease [MIM:245200]
,,,
GALE,UDP-galactose-4-epimerase ,1p36-p35,
,,,Galactose epimerase deficiency [MIM:230350]
,,,
GALK1,galactokinase 1 ,17q24,
,,,Galactokinase deficiency with cataracts [MIM:230200]
,,,
GALNS,galactosamine (N-acetyl)-6-sulfate sulfatase ,16q24.3,
,,,Mucopolysaccharidosis IVA [MIM:253000]
,,,
GALNT12,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) ,9q22,
,,,"Colorectal cancer, susceptibility to, 1 [MIM:608812]"
,,,
GALNT2,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) ,1q41-q42,
,,,mutations
,,,
GALNT3,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) ,2q24-q31,
,,,"Tumoral calcinosis, hyperphosphatemic, familial [MIM:211900]"
,,,
GALNT9,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) ,?,
,,,mutations
,,,
GALNTL4,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 ,?,
,,,mutations
,,,
GALNTL5,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 ,?,
,,,mutations
,,,
GALP,galanin-like peptide ,?,
,,,mutations
,,,
GALT,galactose-1-phosphate uridylyltransferase ,9p13,
,,,Galactosemia [MIM:230400]
,,,
GAMT,guanidinoacetate N-methyltransferase ,19p13.3,
,,,GAMT deficiency [MIM:612736]
,,,
GAN,gigaxonin ,16q24.1,
,,,Giant axonal neuropathy-1 [MIM:256850]
,,,
GAP43,growth associated protein 43 ,3q13,
,,,mutations
,,,
GARS,glycyl-tRNA synthetase ,7p15,
,,,"Charcot-Marie-Tooth disease, type 2D [MIM:601472]"
,,,"Neuropathy, distal hereditary motor, type V [MIM:600794]"
,,,
GAS1,growth arrest-specific 1 ,9q21.3-q22.1,
,,,mutations
,,,
GAS2L2,growth arrest-specific 2 like 2 ,?,
,,,mutations
,,,
GAS6,growth arrest-specific 6 ,13q34,
,,,mutations
,,,
GATA1,GATA binding protein 1 (globin transcription factor 1) ,Xp11.23,
,,,Dyserythropoietic anemia with thrombocytopenia [MIM:300367]
,,,Macrothrombocytopenia [MIM:300367]
,,,"Leukemia, megakaryoblastic, with or without Down syndrome [MIM:190685]"
,,,"Leukemia, megakaryoblastic, of Down syndrome [MIM:190685]"
,,,"Thrombocytopenia with beta-thalassemia, X-linked [MIM:314050]"
,,,"Anemia, X-linked, without thrombocytopenia"
,,,
GATA2,GATA binding protein 2 ,3q21,
,,,mutations
,,,
GATA3,GATA binding protein 3 ,10p15,
,,,"Hypoparathyroidism, sensorineural deafness, and renal dysplasia [MIM:146255]"
,,,
GATA4,GATA binding protein 4 ,8p23.1-p22,
,,,Atrial septal defect-2 [MIM:607941]
,,,
GATA6,GATA binding protein 6 ,18q11.1-q11.2,
,,,mutations
,,,
GATAD1,GATA zinc finger domain containing 1 ,?,
,,,mutations
,,,
GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase) ,15q15.3,
,,,AGAT deficiency [MIM:612718]
,,,
GBA3,"glucosidase, beta, acid 3 (cytosolic) ",4p15.31,
,,,mutations
,,,
GBA,"glucosidase, beta, acid ",1q21,
,,,"Gaucher disease, type I [MIM:230800]"
,,,"Gaucher disease, type II [MIM:230900]"
,,,"Gaucher disease, type III [MIM:231000]"
,,,"Gaucher disease, type IIIC [MIM:231005]"
,,,"Gaucher disease, perinatal lethal [MIM:608013]"
,,,
GBD2,gallbladder disease 2 ,1p36.21,
,,,Gallbladder disease 2
,,,
GBD3,gallbladder disease 3 ,1p34.3,
,,,Gallbladder disease 3
,,,
GBE1,"glucan (1,4-alpha-), branching enzyme 1 ",3p12,
,,,Glycogen storage disease IV [MIM:232500]
,,,
GBGT1,"globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 ",9q34,
,,,mutations
,,,
GCCD3,glucocorticoid deficiency 3 ,8q11.2-q13.2,
,,,Glucocorticoid deficiency 3
,,,
GCDH,glutaryl-CoA dehydrogenase ,19p13.2,
,,,"Glutaricaciduria, type I [MIM:231670]"
,,,
GCGR,glucagon receptor ,17q25,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
GCG,glucagon ,2q36-q37,
,,,Hyperproglucagonemia
,,,
GCH1,GTP cyclohydrolase 1 ,14q22.1-q22.2,
,,,"Dystonia, DOPA-responsive, with or without hyperphenylalainemia [MIM:233910]"
,,,"Hyperpehnylalaninemia, BH4-deficient, B [MIM:233910]"
,,,
GCKR,glucokinase (hexokinase 4) regulator ,2p23.3-p23.2,
,,,Fasting plasma glucose level QTL 5 [MIM:613463]
,,,
GCK,glucokinase (hexokinase 4) ,7p15-p13,
,,,"MODY, type II [MIM:125851]"
,,,"Diabetes mellitus, noninsulin-dependent, late onset [MIM:125853]"
,,,"Diabetes mellitus, gestational [MIM:125851]"
,,,"Hyperinsulinemic hypoglycemia, familial, 3 [MIM:602485]"
,,,"Diabetes mellitus, permanent neonatal [MIM:606176]"
,,,
GCLC,"glutamate-cysteine ligase, catalytic subunit ",6p12,
,,,Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency [MIM:230450]
,,,"Myocardial infarction, susceptibility to [MIM:608446]"
,,,
GCLM,"glutamate-cysteine ligase, modifier subunit ",1p22.1,
,,,"Myocardial infarction, susceptibility to"
,,,
GCM2,glial cells missing homolog 2 (Drosophila) ,6p24.2,
,,,"Hypoparathyroidism, familial isolated [MIM:146200]"
,,,
GCNT2,"glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) ",6p24-p23,
,,,"Blood group, Ii [MIM:110800]"
,,,Adult i phenotype with congenital cataract [MIM:110800]
,,,Adult i phenotype without cataract [MIM:110800]
,,,
GCSH,glycine cleavage system protein H (aminomethyl carrier) ,16q24,
,,,Glycine encephalopathy [MIM:605899]
,,,
GC,group-specific component (vitamin D binding protein) ,4q12,
,,,"Graves disease, susceptibility to, 3"
,,,
GDAP1,ganglioside induced differentiation associated protein 1 ,8q13-q21.1,
,,,"Charcot-Marie-Tooth disease, type 4A [MIM:214400]"
,,,"Charcot-Marie-Tooth disease, axonal, with vocal cord paresis [MIM:607706]"
,,,"Charcot-Marie-Tooth disease, axonal, type 2K [MIM:607831]"
,,,"Charcot-Marie-Tooth disease, recessive intermediate, A [MIM:608340]"
,,,
GDF15,growth differentiation factor 15 ,19p13.2-p13.1,
,,,mutations
,,,
GDF1,growth differentiation factor 1 ,19p12,
,,,"Transposition of great arteries, dextro-looped 3"
,,,Double-outlet right ventricle [MIM:217095]
,,,Tetralogy of Fallot [MIM:187500]
,,,
GDF3,growth differentiation factor 3 ,12p13.1,
,,,"Klippel-Feil syndrome 3, autosomal dominant [MIM:613702]"
,,,Microphthalmia with coloboma 6 [MIM:613703]
,,,"Microphthalmia, isolated 7 [MIM:613704]"
,,,
GDF5,growth differentiation factor 5 ,20q11.2,
,,,"Acromesomelic dysplasia, Hunter-Thompson type [MIM:201250]"
,,,"Brachydactyly, type C [MIM:113100]"
,,,"Chondrodysplasia, Grebe type [MIM:200700]"
,,,Fibular hypoplasia and complex brachydactyly [MIM:228900]
,,,"Brachydactyly, type A2 [MIM:112600]"
,,,"Symphalangism, proximal [MIM:185800]"
,,,Multiple synostoses syndrome 2 [MIM:610017]
,,,Osteoarthritis [MIM:612400]
,,,
GDF6,growth differentiation factor 6 ,8q22.1,
,,,"Klippel-Feil syndrome 1, autosomal dominant [MIM:118100]"
,,,"Microphthalmia, isolated 4 [MIM:613094]"
,,,"Microphthalmia with coloboma 6, digenic [MIM:613703]"
,,,
GDF9,growth differentiation factor 9 ,?,
,,,mutations
,,,
GDI1,GDP dissociation inhibitor 1 ,Xq28,
,,,"Mental retardation, X-linked nonspecific [MIM:309541]"
,,,
GDNF,glial cell derived neurotrophic factor ,5p13.1-p12,
,,,Central hypoventilation syndrome [MIM:209880]
,,,"Pheochromocytoma, modifier of [MIM:171300]"
,,,"Hirschsprung disease, susceptibility to, 3 [MIM:613711]"
,,,
GEFSP4,"Epilepsy, generalized, with febrile seizures plus, type 4 ",2p24,
,,,"Epilepsy, generalized, with febrile seizures plus, type 4"
,,,
GEFSP6,"Generalized epilepsy with febrile seizures plus, type 6 ",8p23-p21,
,,,"Generalized epilepsy with febrile seizures plus, type 6"
,,,
GEMIN4,gem (nuclear organelle) associated protein 4 ,?,
,,,mutations
,,,
GEM,GTP binding protein overexpressed in skeletal muscle ,8q13-q21,
,,,mutations
,,,
GER,Gastroesophageal reflux ,13q14,
,,,Gastroesophageal reflux
,,,
GEVQ1,"gene expression, variation in, quantitative trait locus ",14q32,
,,,"Gene expression, variation in, QTL"
,,,
GEVQ2,"gene expression, variation in, quantitative trait locus ",20q13,
,,,"Gene expression, variation in, QTL"
,,,
GFAP,glial fibrillary acidic protein ,17q21,
,,,Alexander disease [MIM:203450]
,,,
GFER,"growth factor, augmenter of liver regeneration ",16p13.3-p13.12,
,,,"Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay [MIM:613076]"
,,,
GFI1B,growth factor independent 1B transcription repressor ,9q34.13,
,,,mutations
,,,
GFI1,growth factor independent 1 transcription repressor ,1p22,
,,,"Neutropenia, severe congenital, autosomal dominant 2 [MIM:613107]"
,,,"Neutropenia, nonimmune chronic idiopathic, of adults [MIM:607847]"
,,,
GFM1,"G elongation factor, mitochondrial 1 ",3q25.1-q26.2,
,,,Combined oxidative phosphorylation deficiency 1 [MIM:609060]
,,,
GFPT1,glutamine--fructose-6-phosphate transaminase 1 ,2p13,
,,,mutations
,,,
GFPT2,glutamine-fructose-6-phosphate transaminase 2 ,5q34-q35,
,,,mutations
,,,
GFRA1,GDNF family receptor alpha 1 ,10q26,
,,,mutations
,,,
GGCX,gamma-glutamyl carboxylase ,2p12,
,,,Vitamin K-dependent coagulation defect [MIM:277450]
,,,Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency [MIM:610842]
,,,
GGH,"gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) ",8q12.3,
,,,mutations
,,,
GGT2,gamma-glutamyltransferase 2 ,22q11.1,
,,,"Gamma-glutamyltransferase, familial high serum"
,,,
GGT5,gamma-glutamyltransferase 5 ,22q11.2,
,,,mutations
,,,
GGT6,gamma-glutamyltransferase 6 ,17p13.2,
,,,glutathionuria
,,,
GH1,growth hormone 1 ,17q22-q24,
,,,"Growth hormone deficiency, isolated, type IA [MIM:262400]"
,,,"Growth hormone deficiency, isolated, type IB [MIM:612781]"
,,,"Growth hormone deficiency, isolated, type II [MIM:173100]"
,,,Kowarski syndrome [MIM:262650]
,,,
GH2,growth hormone 2 ,17q22-q24,
,,,mutations
,,,
GHRHR,growth hormone releasing hormone receptor ,7p15-p14,
,,,"Growth hormone deficiency, isolated, type IB [MIM:612781]"
,,,
GHRH,growth hormone releasing hormone ,20q11.2,
,,,Isolated growth hormone deficiency due to defect in GHRF
,,,Gigantism due to GHRF hypersecretion
,,,
GHRL,ghrelin/obestatin prepropeptide ,3p26-p25,
,,,"Obesity, susceptibility to [MIM:601665]"
,,,
GHR,growth hormone receptor ,5p13-p12,
,,,Laron dwarfism [MIM:262500]
,,,Short stature [MIM:604271]
,,,"Hypercholesterolemia, familial, modification of [MIM:143890]"
,,,Increased responsiveness to growth hormone
,,,
GHSR,growth hormone secretagogue receptor ,3q26.3,
,,,Short stature [MIM:604271]
,,,
GIF,gastric intrinsic factor (vitamin B synthesis) ,11q13,
,,,Intrinsic factor deficiency [MIM:261000]
,,,
GIGYF2,GRB10 interacting GYF protein 2 ,2q37.1,
,,,Parkinson disease 11 [MIM:607688]
,,,
GIMAP8,"GTPase, IMAP family member 8 ",?,
,,,mutations
,,,
GINGF2,"gingival fibromatosis, hereditary, 2 ",5q13-q22,
,,,"Fibromatosis, gingival, 2"
,,,
GINGF3,"Fibromatosis, gingival, 3 ",2p23.3-p22.3,
,,,"Fibromatosis, gingival, 3"
,,,
GINGF4,"gingival fibromatosis, hereditary, 4 ",11p15,
,,,"Fibromatosis, gingival, 4"
,,,
GIPC3,"GIPC PDZ domain containing family, member 3 ",?,
,,,mutations
,,,
GIPR,gastric inhibitory polypeptide receptor ,19q13.3,
,,,"Plasma glucose, 2-hour, QTL 2"
,,,
GIP,gastric inhibitory polypeptide ,17q21.3-q22,
,,,mutations
,,,
GIT1,G protein-coupled receptor kinase interacting ArfGAP 1 ,17p11.2,
,,,mutations
,,,
GJA1,"gap junction protein, alpha 1, 43kDa ",6q21-q23.2,
,,,Oculodentodigital dysplasia [MIM:164200]
,,,"Syndactyly, type III [MIM:186100]"
,,,Hypoplastic left heart syndrome [MIM:241550]
,,,Atrioventricular septal defect [MIM:600309]
,,,"Oculodentodigital dysplasia, autosomal recessive [MIM:257850]"
,,,Hallermann-Streiff syndrome [MIM:234100]
,,,
GJA3,"gap junction protein, alpha 3, 46kDa ",13q11,
,,,"Cataract, zonular pulverulent-3 [MIM:601885]"
,,,
GJA4,"gap junction protein, alpha 4, 37kDa ",1p35.1,
,,,mutations
,,,
GJA5,"gap junction protein, alpha 5, 40kDa ",1q21.1,
,,,Atrial fibrillation [MIM:608583]
,,,
GJA8,"gap junction protein, alpha 8, 50kDa ",1q21.1,
,,,"Cataract, zonular pulverulent-1 [MIM:116200]"
,,,"Cataract, nuclear progressive"
,,,Cataract-microcornea syndrome [MIM:116150]
,,,"Cataract, nuclear pulverulent"
,,,
GJB1,"gap junction protein, beta 1, 32kDa ",Xq13.1,
,,,"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1 [MIM:302800]"
,,,
GJB2,"gap junction protein, beta 2, 26kDa ",13q11-q12,
,,,"Deafness, autosomal recessive 1A [MIM:220290]"
,,,"Deafness, autosomal dominant 3A [MIM:601544]"
,,,Vohwinkel syndrome [MIM:124500]
,,,"Keratoderma, palmoplantar, with deafness [MIM:148350]"
,,,Keratitis-ichthyosis-deafness syndrome [MIM:148210]
,,,Hystrix-like ichthyosis with deafness [MIM:602540]
,,,Bart-Pumphrey syndrome [MIM:149200]
,,,
GJB3,"gap junction protein, beta 3, 31kDa ",1p35.1,
,,,Erythrokeratodermia variabilis et progressiva [MIM:133200]
,,,"Deafness, autosomal dominant 2B [MIM:612644]"
,,,"Deafness, autosomal recessive"
,,,"Deafness, autosomal dominant, with peripheral neuropathy"
,,,"Deafness, digenic, GJB2/GJB3 [MIM:220290]"
,,,
GJB4,"gap junction protein, beta 4, 30.3kDa ",1p35.1,
,,,Erythrokeratodermia variabilis with erythema gyratum repens [MIM:133200]
,,,
GJB6,"gap junction protein, beta 6, 30kDa ",13q12,
,,,"Deafness, autosomal dominant 3B [MIM:612643]"
,,,"Ectodermal dysplasia, hidrotic [MIM:129500]"
,,,"Deafness, autosomal recessive 1B [MIM:612645]"
,,,"Deafness, digenic GJB2/GJB6 [MIM:220290]"
,,,
GJC2,"gap junction protein, gamma 2, 47kDa ",1q41-q42,
,,,"Leukodystrophy, hypomyelinating, 2 [MIM:608804]"
,,,"Spastic paraplegia, 44 [MIM:613206]"
,,,"Lymphedema, hereditary, IC [MIM:613480]"
,,,
GJC3,"gap junction protein, gamma 3, 30.2kDa ",7q22.1,
,,,mutations
,,,
GJD2,"gap junction protein, delta 2, 36kDa ",15q14,
,,,mutations
,,,
GK,glycerol kinase ,Xp21.3-p21.2,
,,,Glycerol kinase deficiency [MIM:307030]
,,,
GLA,"galactosidase, alpha ",Xq22,
,,,Fabry disease [MIM:301500]
,,,"Fabry disease, cardiac variant [MIM:301500]"
,,,
GLB1,"galactosidase, beta 1 ",3p21.33,
,,,"GM1-gangliosidosis, type I [MIM:230500]"
,,,"GM1-gangliosidosis, type II [MIM:230600]"
,,,"GM1-gangliosidosis, type III [MIM:230650]"
,,,Mucopolysaccharidosis type IVB (Morquio) [MIM:253010]
,,,
GLC1B,"glaucoma 1, open angle, B (adult-onset) ",2cen-q13,
,,,"Glaucoma 1B, primary open angle, adult onset [MIM:137760]"
,,,
GLC1C,"glaucoma 1, open angle, C ",3q21-q24,
,,,"Glaucoma 1C, primary open angle"
,,,
GLC1D,"glaucoma 1, open angle, D (adult-onset) ",8q23,
,,,"Glaucoma 1D, primary open angle"
,,,
GLC1F,"glaucoma 1, open angle, F (adult-onset) ",7q35-q36,
,,,Glaucoma 1F
,,,
GLC1I,"glaucoma 1, open angle, I ",15q11-q13,
,,,"Glaucoma 1, open angle, I"
,,,
GLC1J,"glaucoma 1, open angle, J (juvenile-onset) ",9q22,
,,,"Glaucoma, primary open angle, juvenile-onset, 2"
,,,
GLC1K,"glaucoma 1, open angle, K (juvenile-onset) ",20p12,
,,,"Glaucoma 1K, primary open angle, juvenile-onset"
,,,
GLC1M,"glaucoma 1, open angle, M (juvenile-onset) ",5q22.1-q32,
,,,"Glaucoma 1, open angle, M"
,,,
GLC3B,"glaucoma 3, primary infantile, B ",1p36.2-p36.1,
,,,"Glaucoma 3, primary infantile, B"
,,,
GLC3C,"glaucoma 3, primary congenital, C ",14q24.3,
,,,"Glaucoma 3, primary congenital, C"
,,,
GLCCI1,glucocorticoid induced transcript 1 ,?,
,,,mutations
,,,
GLDC,glycine dehydrogenase (decarboxylating) ,9p22,
,,,Glycine encephalopathy [MIM:605899]
,,,
GLE1,GLE1 RNA export mediator homolog (yeast) ,9q34,
,,,Lethal congenital contracture syndrome 1 [MIM:253310]
,,,"Arthrogryposis, lethal, with anterior horn cell disease [MIM:611890]"
,,,
GLI1,GLI family zinc finger 1 ,12q13.2-q13.3,
,,,mutations
,,,
GLI2,GLI family zinc finger 2 ,2q14,
,,,Pituitary anomalies with holoprosencephaly-like features
,,,Holoprosencephaly-9 [MIM:610829]
,,,
GLI3,GLI family zinc finger 3 ,7p13,
,,,Greig cephalopolysyndactyly syndrome [MIM:175700]
,,,Pallister-Hall syndrome [MIM:146510]
,,,"Polydactyly, preaxial, type IV [MIM:174700]"
,,,"Polydactyly, postaxial, types A1 and B [MIM:174200]"
,,,Acrocallosal syndrome [MIM:200990]
,,,"Hypothalamic hamartomas, somatic [MIM:241800]"
,,,
GLIS2,GLIS family zinc finger 2 ,16p13.3,
,,,Nephronophthisis 7 [MIM:611498]
,,,
GLIS3,GLIS family zinc finger 3 ,9p24.3-p23,
,,,"Diabetes mellitus, neonatal, with congenital hypothyroidism [MIM:610199]"
,,,
GLM1,"Glioma, familial, 1 ",15q23-q26.3,
,,,Glioma susceptibility 4
,,,
GLM5,Glioma susceptibility 5 ,9p21.3,
,,,Glioma susceptibility 5
,,,
GLM6,Glioma susceptibility 6 ,20q13.33,
,,,Glioma susceptibility 6
,,,
GLM8,Glioma susceptibility 8 ,5p15.33,
,,,Glioma susceptibility 8
,,,
GLMN,"glomulin, FKBP associated protein ",1p22-p21,
,,,Glomuvenous malformations [MIM:138000]
,,,
GLO1,glyoxalase I ,6p21.3-p21.2,
,,,glyoxalase I deficiency
,,,
GLP1R,glucagon-like peptide 1 receptor ,6p21,
,,,mutations
,,,
GLRA1,"glycine receptor, alpha 1 ",5q32,
,,,"Startle disease/hyperekplexia, autosomal dominant [MIM:149400]"
,,,"Startle disease, autosomal recessive"
,,,Hyperekplexia and spastic paraparesis
,,,
GLRB,"glycine receptor, beta ",4q31.3,
,,,"Hyperekplexia, autosomal recessive [MIM:149400]"
,,,
GLRX5,glutaredoxin 5 ,14q32,
,,,"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive [MIM:205950]"
,,,
GLS,glutaminase ,2q32-q34,
,,,mutations
,,,
GLTSCR1,glioma tumor suppressor candidate region gene 1 ,19q13.3,
,,,mutations
,,,
GLUD1,glutamate dehydrogenase 1 ,10q23.3,
,,,Hyperinsulinism-hyperammonemia syndrome [MIM:606762]
,,,
GLUD2,glutamate dehydrogenase 2 ,Xq25,
,,,mutations
,,,
GLUL,glutamate-ammonia ligase ,1q31,
,,,"Glutamine deficiency, congenital [MIM:610015]"
,,,
GLYCTK,glycerate kinase ,3p21,
,,,mutations
,,,
GM2A,GM2 ganglioside activator ,5q31.3-q33.1,
,,,"GM2-gangliosidosis, AB variant [MIM:272750]"
,,,
GMIP,GEM interacting protein ,19p12-p11,
,,,mutations
,,,
GMPS,guanine monphosphate synthetase ,3q24,
,,,"Leukemia, acute myelogenous [MIM:601626]"
,,,
GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 ",3p21,
,,,Pituitary ACTH-secreting adenoma
,,,"Ventricular tachycardia, idiopathic [MIM:192605]"
,,,
GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide ",9q21,
,,,Bleeding diathesis due to GNAQ deficiency
,,,
GNAS-AS1,GNAS antisense RNA 1 ,20q13.2,
,,,"Pseudohypoparathyroidism, type IB [MIM:603233]"
,,,
GNAS,GNAS complex locus ,20q13.2,
,,,Pseudohypoparathyroidism Ia [MIM:103580]
,,,McCune-Albright syndrome [MIM:174800]
,,,Pseudohypoparathyroidism Ic [MIM:612462]
,,,"Osseous heteroplasia, progressive [MIM:166350]"
,,,Pseudohypoparathyroidism Ib [MIM:603233]
,,,"Prolonged bleeding time, brachydactyly and mental retardation"
,,,Acromegaly [MIM:102200]
,,,Pseudopseudohypoparathyroidism [MIM:612463]
,,,
GNAT1,"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 ",3p21,
,,,"Night blindness, congenital stationary, autosomal dominant 3 [MIM:610444]"
,,,
GNAT2,"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 ",1p13,
,,,Achromatopsia-4
,,,
GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like ",22q11.2,
,,,mutations
,,,
GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3 ",12p13,
,,,"Hypertension, essential, susceptibility to [MIM:145500]"
,,,
GNB5,"guanine nucleotide binding protein (G protein), beta 5 ",15,
,,,mutations
,,,
GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase ,9p13.3,
,,,Sialuria [MIM:269921]
,,,"Inclusion body myopathy, autosomal recessive [MIM:600737]"
,,,Nonaka myopathy [MIM:605820]
,,,
GNMT,glycine N-methyltransferase ,6p12,
,,,Glycine N-methyltransferase deficiency [MIM:606664]
,,,
GNPAT,glyceronephosphate O-acyltransferase ,1q42,
,,,"Chondrodysplasia punctata, rhizomelic, type 2 [MIM:222765]"
,,,
GNPTAB,"N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits ",12q23.3,
,,,Mucolipidosis III alpha/beta [MIM:252600]
,,,Mucolipidosis II alpha/beta [MIM:252500]
,,,
GNPTG,"N-acetylglucosamine-1-phosphate transferase, gamma subunit ",16p,
,,,Mucolipidosis III gamma [MIM:252605]
,,,
GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) ,8p21-p11.2,
,,,Hypogonadotropic hypogonadism due to GNRH deficiency [MIM:227200]
,,,
GNRHR,gonadotropin-releasing hormone receptor ,4q21.2,
,,,Hypogonadotropic hypogonadism
,,,Fertile eunuch syndrome [MIM:228300]
,,,
GNS,glucosamine (N-acetyl)-6-sulfatase ,12q14,
,,,Mucopolysaccharidosis type IIID [MIM:252940]
,,,
GOA1,"Osteoarthritis, generalized, without dysplasia, susceptibility to ",2q33.3,
,,,Osteoarthritis susceptibility 4
,,,
GOLGA3,golgin A3 ,12,
,,,mutations
,,,
GOLGA5,golgin A5 ,14q,
,,,"Thyroid carcinoma, papillary [MIM:188550]"
,,,
GON4L,gon-4-like (C. elegans) ,?,
,,,mutations
,,,
GOPC,golgi-associated PDZ and coiled-coil motif containing ,6q21,
,,,Globozoospermia [MIM:102530]
,,,
GORAB,"golgin, RAB6-interacting ",1q24.2,
,,,Geroderma osteodysplasticum [MIM:231070]
,,,
GOSR2,golgi SNAP receptor complex member 2 ,17q21,
,,,mutations
,,,
GOT1,"glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) ",10q24.1-q25.1,
,,,mutations
,,,
GP1BA,"glycoprotein Ib (platelet), alpha polypeptide ",17pter-p12,
,,,"Bernard-Soulier syndrome, type A [MIM:231200]"
,,,"von Willebrand disease, platelet-type [MIM:177820]"
,,,"Nonarteritic anterior ischemic optic neuropathy, susceptibility to [MIM:258660]"
,,,"Bernard-Soulier syndrome, benign autosomal dominant [MIM:153670]"
,,,
GP1BB,"glycoprotein Ib (platelet), beta polypeptide ",22q11.2,
,,,"Bernard-Soulier syndrome, type B [MIM:231200]"
,,,"Giant platelet disorder, isolated"
,,,
GP2,glycoprotein 2 (zymogen granule membrane) ,16p12.3,
,,,mutations
,,,
GP6,glycoprotein VI (platelet) ,19q13.4,
,,,mutations
,,,
GP9,glycoprotein IX (platelet) ,3q21,
,,,"Bernard-Soulier syndrome, type C [MIM:231200]"
,,,
GPAM,"glycerol-3-phosphate acyltransferase, mitochondrial ",10q24-q26,
,,,mutations
,,,
GPANK1,G patch domain and ankyrin repeats 1 ,6p21.3,
,,,mutations
,,,
GPAT2,"glycerol-3-phosphate acyltransferase 2, mitochondrial ",9q34.3,
,,,"Lipodystrophy, congenital generalized, type 1 [MIM:608594]"
,,,
GPATCH8,G patch domain containing 8 ,?,
,,,mutations
,,,
GPBAR1,G protein-coupled bile acid receptor 1 ,2q35,
,,,mutations
,,,
GPC3,glypican 3 ,Xq26,
,,,"Simpson-Golabi-Behmel syndrome, type 1 [MIM:312870]"
,,,"Wilms tumor, somatic [MIM:194070]"
,,,
GPC4,glypican 4 ,Xq26,
,,,mutations
,,,
GPC6,glypican 6 ,13q32,
,,,Omodysplasia 1 [MIM:258315]
,,,
GPD1L,glycerol-3-phosphate dehydrogenase 1-like ,3p22.3,
,,,Brugada syndrome 2 [MIM:611777]
,,,
GPD1,glycerol-3-phosphate dehydrogenase 1 (soluble) ,12q12-q13,
,,,mutations
,,,
GPD2,glycerol-3-phosphate dehydrogenase 2 (mitochondrial) ,2q24.1,
,,,"Diabetes, type 2, susceptibility to [MIM:125853]"
,,,
GPDS1,glaucoma-related pigment dispersion syndrome 1 ,7q35-q36,
,,,Pigment dispersion syndrome
,,,
GPHN,gephyrin ,14q24,
,,,"Molybdenum cofactor deficiency, type C [MIM:252150]"
,,,Hyperekplexia [MIM:149400]
,,,
GPIHBP1,glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 ,8q24.3,
,,,mutations
,,,
GPI,glucose-6-phosphate isomerase ,19q13.1,
,,,"Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency [MIM:613470]"
,,,
GPR12,G protein-coupled receptor 12 ,13q12,
,,,mutations
,,,
GPR139,G protein-coupled receptor 139 ,?,
,,,mutations
,,,
GPR143,G protein-coupled receptor 143 ,Xp22.3,
,,,"Ocular albinism, type I, Nettleship-Falls type [MIM:300500]"
,,,"Nystagmus 6, congenital, X-linked [MIM:300814]"
,,,
GPR179,G protein-coupled receptor 179 ,?,
,,,mutations
,,,
GPR1,G protein-coupled receptor 1 ,2q33.3,
,,,mutations
,,,
GPR33,G protein-coupled receptor 33 (gene/pseudogene) ,?,
,,,mutations
,,,
GPR55,G protein-coupled receptor 55 ,2q37,
,,,mutations
,,,
GPR56,G protein-coupled receptor 56 ,16q13,
,,,"Polymicrogyria, bilateral frontoparietal [MIM:606854]"
,,,
GPR68,G protein-coupled receptor 68 ,14q31,
,,,mutations
,,,
GPR77,G protein-coupled receptor 77 ,19q13.4,
,,,mutations
,,,
GPR98,G protein-coupled receptor 98 ,5q14.3,
,,,"Convulsions, familial febrile, 4 [MIM:604352]"
,,,"Usher syndrome, type IIC [MIM:605472]"
,,,
GPS1,G protein pathway suppressor 1 ,17q25.3,
,,,mutations
,,,
GPSC,"gliosis, familial progressive subcortical ",17q21-q22,
,,,"Gliosis, familial progressive subcortical"
,,,
GPSM2,G-protein signaling modulator 2 ,1p13.1,
,,,"Deafness, autosomal recessive 82 [MIM:613557]"
,,,
GPT,glutamic-pyruvate transaminase (alanine aminotransferase) ,8q24.3,
,,,mutations
,,,
GPX1,glutathione peroxidase 1 ,3p21.3,
,,,Hemolytic anemia due to glutathione peroxidase deficiency
,,,
GPX4,glutathione peroxidase 4 ,19p13.3,
,,,mutations
,,,
GRB10,growth factor receptor-bound protein 10 ,7p12-p11.2,
,,,mutations
,,,
GRD1,"Graves disease, susceptiblity to, 1 ",14q31,
,,,"Graves disease, susceptibility to, 1"
,,,
GRD2,"Graves disease, susceptibility to, 2 ",20q13.11,
,,,"Graves disease, susceptibility to, 2"
,,,
GRDX,"Graves disease, susceptibility to, X-linked ",Xp11,
,,,"Graves disease, susceptibility to, X-linked"
,,,
GREM1,gremlin 1 ,15q13-q15,
,,,mutations
,,,
GRHL2,grainyhead-like 2 (Drosophila) ,8q22,
,,,"Deafness, autosomal dominant 28 [MIM:608641]"
,,,
GRHPR,glyoxylate reductase/hydroxypyruvate reductase ,9cen,
,,,"Hyperoxaluria, primary, type II [MIM:260000]"
,,,
GRIA3,"glutamate receptor, ionotropic, AMPA 3 ",Xq25-q26,
,,,"Mental retardation, X-linked 94 [MIM:300699]"
,,,
GRID1,"glutamate receptor, ionotropic, delta 1 ",10q22,
,,,mutations
,,,
GRIK1,"glutamate receptor, ionotropic, kainate 1 ",21q22,
,,,mutations
,,,
GRIK2,"glutamate receptor, ionotropic, kainate 2 ",6q21,
,,,"Mental retardation, autosomal recessive, 6 [MIM:611092]"
,,,
GRIK3,"glutamate receptor, ionotropic, kainate 3 ",1p34-p33,
,,,mutations
,,,
GRIK4,"glutamate receptor, ionotropic, kainate 4 ",11q22.3,
,,,mutations
,,,
GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1 ",9q34.3,
,,,mutations
,,,
GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A ",16p13,
,,,mutations
,,,
GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B ",12p12,
,,,mutations
,,,
GRIN3A,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3A ",9q31.1,
,,,mutations
,,,
GRIP1,glutamate receptor interacting protein 1 ,12q14.3,
,,,mutations
,,,
GRK1,G protein-coupled receptor kinase 1 ,13q34,
,,,Oguchi disease-2 [MIM:613411]
,,,
GRK4,G protein-coupled receptor kinase 4 ,4p16.3,
,,,mutations
,,,
GRK5,G protein-coupled receptor kinase 5 ,10q24-qter,
,,,mutations
,,,
GRM1,"glutamate receptor, metabotropic 1 ",6q24,
,,,mutations
,,,
GRM3,"glutamate receptor, metabotropic 3 ",7q21.1-q21.2,
,,,mutations
,,,
GRM5,"glutamate receptor, metabotropic 5 ",?,
,,,mutations
,,,
GRM6,"glutamate receptor, metabotropic 6 ",5q35,
,,,"Night blindness, congenital stationary, type 1B [MIM:257270]"
,,,
GRM7,"glutamate receptor, metabotropic 7 ",3p26.1-p25.2,
,,,mutations
,,,
GRM8,"glutamate receptor, metabotropic 8 ",7q31.3-q32.1,
,,,mutations
,,,
GRN,granulin ,17q21.32,
,,,Frontotemporal lobar degeneration with ubiquitin-positive inclusions [MIM:607485]
,,,
GRPR,gastrin-releasing peptide receptor ,Xp22.3-p21.2,
,,,mutations
,,,
GRXCR1,"glutaredoxin, cysteine rich 1 ",4p13,
,,,"Deafness, autosomal recessive 25 [MIM:613285]"
,,,
GSC,goosecoid homeobox ,14q32.1,
,,,mutations
,,,
GSDMA,gasdermin A ,17q12,
,,,mutations
,,,
GSDMB,gasdermin B ,17q21,
,,,mutations
,,,
GSK3B,glycogen synthase kinase 3 beta ,3q13.3,
,,,mutations
,,,
GSM1,geniospasm 1 ,9q13-q21,
,,,Geniospasm
,,,
GSN,gelsolin ,9q34,
,,,"Amyloidosis, Finnish type [MIM:105120]"
,,,
GSPT1,G1 to S phase transition 1 ,16p13.1,
,,,mutations
,,,
GSPT2,G1 to S phase transition 2 ,Xp11.23-p11.21,
,,,mutations
,,,
GSR,glutathione reductase ,8p21.1,
,,,Hemolytic anemia due to glutathione reductase deficiency
,,,
GSS,glutathione synthetase ,20q11.2,
,,,Hemolytic anemia due to glutathione synthetase deficiency [MIM:231900]
,,,Glutathione synthetase deficiency [MIM:266130]
,,,
GSTA1,glutathione S-transferase alpha 1 ,6p12.2,
,,,mutations
,,,
GSTA2,glutathione S-transferase alpha 2 ,6p12.2,
,,,mutations
,,,
GSTA3,glutathione S-transferase alpha 3 ,6p12.2,
,,,mutations
,,,
GSTK1,glutathione S-transferase kappa 1 ,?,
,,,mutations
,,,
GSTM1,glutathione S-transferase mu 1 ,1p13.3,
,,,mutations
,,,
GSTM3,glutathione S-transferase mu 3 (brain) ,1p13.3,
,,,mutations
,,,
GSTM4,glutathione S-transferase mu 4 ,1p13.3,
,,,mutations
,,,
GSTO1,glutathione S-transferase omega 1 ,10q24-q25,
,,,mutations
,,,
GSTO2,glutathione S-transferase omega 2 ,10q24-q25,
,,,mutations
,,,
GSTP1,glutathione S-transferase pi 1 ,11q13,
,,,mutations
,,,
GSTT1,glutathione S-transferase theta 1 ,22q11.2,
,,,mutations
,,,
GSTT2B,glutathione S-transferase theta 2B (gene/pseudogene) ,?,
,,,mutations
,,,
GSTT2,glutathione S-transferase theta 2 ,22q11.2,
,,,mutations
,,,
GSTZ1,glutathione S-transferase zeta 1 ,14q24.3,
,,,"Tyrosinemia, type Ib"
,,,
GTF2E1,"general transcription factor IIE, polypeptide 1, alpha 56kDa ",?,
,,,mutations
,,,
GTF2H1,"general transcription factor IIH, polypeptide 1, 62kDa ",11p15.1-p14,
,,,mutations
,,,
GTF2H5,"general transcription factor IIH, polypeptide 5 ",6q25.3,
,,,"Trichothiodystrophy, complementation group A [MIM:601675]"
,,,
GTF2IRD1,GTF2I repeat domain containing 1 ,7q11.23,
,,,mutations
,,,
GTF2IRD2,GTF2I repeat domain containing 2 ,?,
,,,mutations
,,,
GTS,Gilles de la Tourette syndrome ,11q23,
,,,Tourette syndrome
,,,
GUCA1A,guanylate cyclase activator 1A (retina) ,6p21.1,
,,,Cone dystrophy-3 [MIM:602093]
,,,Cone-rod dystrophy 14 [MIM:602093]
,,,
GUCA1B,guanylate cyclase activator 1B (retina) ,6p21.1,
,,,Retinitis pigmentosa-48
,,,
GUCY2C,guanylate cyclase 2C (heat stable enterotoxin receptor) ,12p12,
,,,mutations
,,,
GUCY2D,"guanylate cyclase 2D, membrane (retina-specific) ",17p13.1,
,,,Leber congenital amaurosis 1 [MIM:204000]
,,,Cone-rod dystrophy 6 [MIM:601777]
,,,
GULOP,"gulonolactone (L-) oxidase, pseudogene ",8p21.1,
,,,Scurvy
,,,
GUSB,"glucuronidase, beta ",7q21.11,
,,,Mucopolysaccharidosis VII [MIM:253220]
,,,
GUST,"Gustavson mental retardation syndrome (with microcephaly, optic ",Xq26,
,,,Gustavson syndrome
,,,
GYG1,glycogenin 1 ,3q24-q25.1,
,,,Glycogen storage disease XV [MIM:613507]
,,,
GYLTL1B,glycosyltransferase-like 1B ,11p11.2,
,,,mutations
,,,
GYPA,glycophorin A (MNS blood group) ,4q28.2-q31.1,
,,,"Blood group, MN"
,,,"Malaria, resistance to [MIM:611162]"
,,,
GYPB,glycophorin B (MNS blood group) ,4q28-q31,
,,,"Blood group, Ss"
,,,
GYPC,glycophorin C (Gerbich blood group) ,2q14-q21,
,,,"Malaria, resistance to [MIM:611162]"
,,,"Blood group, Gerbich"
,,,
GYPE,glycophorin E (MNS blood group) ,4q28-q31,
,,,mutations
,,,
GYS1,glycogen synthase 1 (muscle) ,19q13.3,
,,,"Glycogen storage disease 0, muscle [MIM:611556]"
,,,
GYS2,glycogen synthase 2 (liver) ,12p12.2,
,,,"Glycogen storage disease, type 0 [MIM:240600]"
,,,
GZMB,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) ",14q11.2,
,,,mutations
,,,
H19,"H19, imprinted maternally expressed transcript (non-protein coding) ",11p15.5,
,,,Beckwith-Wiedemann syndrome [MIM:130650]
,,,Silver-Russell syndrome [MIM:180860]
,,,Wilms tumor 2 [MIM:194071]
,,,
H2BFWT,"H2B histone family, member W, testis-specific ",?,
,,,mutations
,,,
H6PD,hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) ,1p36,
,,,Cortisone reductase deficiency [MIM:604931]
,,,
HABP2,hyaluronan binding protein 2 ,10q25-q26,
,,,"Carotid stenosis, susceptibility to"
,,,"Venous thromboembolism, susceptibility to [MIM:188050]"
,,,
HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 ,6q21,
,,,mutations
,,,
HADHA,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit ",2p23,
,,,LCHAD deficiency [MIM:609016]
,,,Trifunctional protein deficiency [MIM:609015]
,,,"HELLP syndrome, maternal, of pregnancy [MIM:609016]"
,,,"Fatty liver, acute, of pregnancy [MIM:609016]"
,,,
HADHB,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit ",2p23,
,,,Trifunctional protein deficiency [MIM:609015]
,,,
HADH,hydroxyacyl-CoA dehydrogenase ,4q22-q26,
,,,3-hydroxyacyl-CoA dehydrogenase deficiency [MIM:231530]
,,,"Hyperinsulinemic hypoglycemia, familial, 4 [MIM:609975]"
,,,
HAGH,hydroxyacylglutathione hydrolase ,16p13,
,,,Glyoxalase II deficiency
,,,
HAL,histidine ammonia-lyase ,12q22-q23,
,,,Histidinemia [MIM:235800]
,,,
HAMP,hepcidin antimicrobial peptide ,19q13,
,,,"Hemochromatosis, type 2B [MIM:613313]"
,,,
HAND1,heart and neural crest derivatives expressed 1 ,?,
,,,mutations
,,,
HAND2,heart and neural crest derivatives expressed 2 ,4q33,
,,,mutations
,,,
HARS2,"histidyl-tRNA synthetase 2, mitochondrial ",5q31.3,
,,,mutations
,,,
HARS,histidyl-tRNA synthetase ,5q31.3,
,,,mutations
,,,
HAS1,hyaluronan synthase 1 ,19q13.3-q13.4,
,,,mutations
,,,
HAVCR1,hepatitis A virus cellular receptor 1 ,5q33.2,
,,,"Atopy, resistance to [MIM:147050]"
,,,
HAX1,HCLS1 associated protein X-1 ,1q21.3,
,,,"Neutropenia, severe congenital, autosomal recessive 3 [MIM:610738]"
,,,
HBA1,"hemoglobin, alpha 1 ",16pter-p13.3,
,,,"Thalassemias, alpha- [MIM:604131]"
,,,"Methemoglobinemias, alpha-"
,,,"Erythremias, alpha-"
,,,"Heinz body anemias, alpha- [MIM:140700]"
,,,
HBA2,"hemoglobin, alpha 2 ",16pter-p13.3,
,,,"Thalassemia, alpha- [MIM:604131]"
,,,Hemoglobin H disease
,,,Heinz body anemia [MIM:140700]
,,,Erythrocytosis
,,,Hypochromic microcytic anemia
,,,
HBBP1,"hemoglobin, beta pseudogene 1 ",11p15.5,
,,,Sickle cell anemia [MIM:603903]
,,,"Thalassemias, beta- [MIM:604131]"
,,,"Erythremias, beta-"
,,,"Methemoglobinemias, beta-"
,,,"Heinz body anemias, beta- [MIM:140700]"
,,,"Thalassemia-beta, dominant inclusion-body [MIM:603902]"
,,,Hereditary persistence of fetal hemoglobin
,,,
HBB,"hemoglobin, beta ",11p15.5,
,,,Sickle cell anemia [MIM:603903]
,,,"Thalassemias, beta- [MIM:604131]"
,,,"Erythremias, beta-"
,,,"Methemoglobinemias, beta-"
,,,"Heinz body anemias, beta- [MIM:140700]"
,,,"Thalassemia-beta, dominant inclusion-body [MIM:603902]"
,,,Hereditary persistence of fetal hemoglobin
,,,
HBD,"hemoglobin, delta ",11p15.5,
,,,"Thalassemia, delta-"
,,,Thalassemia due to Hb Lepore
,,,
HBE1,"hemoglobin, epsilon 1 ",11p15.5,
,,,mutations
,,,
HBEGF,heparin-binding EGF-like growth factor ,5q23,
,,,"Diphtheria, susceptibility to"
,,,
HBG1,"hemoglobin, gamma A ",11p15.5,
,,,Fetal hemoglobin quantitative trait locus 1 [MIM:141749]
,,,
HBG2,"hemoglobin, gamma G ",11p15.5,
,,,Fetal hemoglobin quantitative trait locus 1 [MIM:141749]
,,,
HBHR,"alpha-thalassemia/mental retardation syndrome, type 1 ",16pter-p13.3,
,,,"Alpha-thalassemia/mental retardation syndrome, type 1"
,,,
HBM,"hemoglobin, mu ",16p13.3,
,,,mutations
,,,
HBS1L,HBS1-like (S. cerevisiae) ,6q24,
,,,mutations
,,,
HCA1,"Hypercalciuria, absorptive, 1 ",4q33-qter,
,,,"Hypercalciuria, absorptive"
,,,
HCCS,holocytochrome c synthase ,Xp22,
,,,"Microphthalmia, syndromic 7 [MIM:309801]"
,,,
HCHGQ1,Hematocrit/hemoglobin quantitative trait locus 1 ,6q23,
,,,Hematocrit/hemoglobin quantitative trait locus 1
,,,
HCHGQ2,Hematocrit/hemoglobin quantitative trait locus 2 ,9q,
,,,Hematocrit/hemoglobin quantitative trait locus 2
,,,
HCHGQ3,Hematocrit/hemoglobin quantitative trait locus 3 ,22q12-q13,
,,,Hematocrit/hemoglobin quantitative trait locus 3
,,,
HCK,hemopoietic cell kinase ,20q11-q12,
,,,mutations
,,,
HCL3,hair color 3 (brown) ,15q11.2-q12,
,,,"Albinism, oculocutaneous, type II [MIM:203200]"
,,,"Albinism, brown oculocutaneous [MIM:203200]"
,,,"Skin/hair/eye pigmentation 1, blue/nonblue eyes [MIM:227220]"
,,,"Skin/hair/eye pigmentation 1, blond/brown hair [MIM:227220]"
,,,
HCLS1,hematopoietic cell-specific Lyn substrate 1 ,3q13,
,,,mutations
,,,
HCN1,hyperpolarization activated cyclic nucleotide-gated potassium channel 1 ,?,
,,,mutations
,,,
HCN2,hyperpolarization activated cyclic nucleotide-gated potassium channel 2 ,19p13.3,
,,,mutations
,,,
HCN4,hyperpolarization activated cyclic nucleotide-gated potassium channel 4 ,15q24-q25,
,,,Sick sinus syndrome 2 [MIM:163800]
,,,Brugada syndrome 8 [MIM:613123]
,,,
HCP5,HLA complex P5 (non-protein coding) ,6p21.3,
,,,mutations
,,,
HCRTR1,hypocretin (orexin) receptor 1 ,?,
,,,mutations
,,,
HCRTR2,hypocretin (orexin) receptor 2 ,?,
,,,mutations
,,,
HCRT,hypocretin (orexin) neuropeptide precursor ,17q21,
,,,Narcolepsy 1 [MIM:161400]
,,,
HDAC4,histone deacetylase 4 ,2q37.2,
,,,Brachydacytly-mental retardation syndrome [MIM:600430]
,,,
HDAC9,histone deacetylase 9 ,7p21-p15,
,,,mutations
,,,
HDC,histidine decarboxylase ,15q21-q22,
,,,mutations
,,,
HDGFRP2,hepatoma-derived growth factor-related protein 2 ,?,
,,,mutations
,,,
HDLBP,high density lipoprotein binding protein ,2q37,
,,,mutations
,,,
HDLC2,High density lipoprotein cholesterol level QTL on chromsome 8 ,8q23,
,,,High density lipoprotein cholesterol level QTL 2
,,,
HDLC3,"High density lipoprotein cholesterol, low serum, 3 ",16q24.1,
,,,"High density lipoprotein cholesterol, low serum, 3"
,,,
HDLCQ1,high density lipoprotein cholesterol level QTL 1 ,9p,
,,,High density lipoprotein cholesterol level QTL 1
,,,
HDLCQ4,High density lipoprotein cholesterol level QTL 4 ,4q32.3,
,,,High density lipoprotein cholesterol level QTL 4
,,,
HDLCQ5,High density lipoprotein cholesterol level QTL 5 ,3q24-q26,
,,,High density lipoprotein cholesterol level QTL 5
,,,
HDPA,"Hodgkin disease, susceptibility, pseudoautosomal ",Xpter-p22.32,
,,,"Hodgkin disease susceptibility, pseudoautosomal"
,,,
HDX,highly divergent homeobox ,Xq27.2-q27.3,
,,,"Panhypopituitarism, X-linked"
,,,
HELQ,"helicase, POLQ-like ",4q21,
,,,mutations
,,,
HEMC,"hemangioma, capillary, hereditary ",5q31-q33,
,,,"Hemangioma, capillary infantile"
,,,
HEPACAM,hepatic and glial cell adhesion molecule ,11q24,
,,,mutations
,,,
HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2 ,15q13.1,
,,,"Skin/hair/eye pigmentation 1, blue/nonblue eyes [MIM:227220]"
,,,"Skin/hair/eye pigmentation 1, blond/brown hair [MIM:227220]"
,,,
HES6,hairy and enhancer of split 6 (Drosophila) ,2q37.3,
,,,mutations
,,,
HES7,hairy and enhancer of split 7 (Drosophila) ,17p13.2,
,,,"Spondylocostal dysostosis 4, autosomal recessive [MIM:613686]"
,,,
HESX1,HESX homeobox 1 ,3p21.2-p21.1,
,,,Septooptic dysplasia [MIM:182230]
,,,"Pituitary hormone deficiency, combined, 5 [MIM:182230]"
,,,Growth hormone deficiency with pituitary anomalies [MIM:182230]
,,,
HEXA,hexosaminidase A (alpha polypeptide) ,15q23-q24,
,,,Tay-Sachs disease [MIM:272800]
,,,"GM2-gangliosidosis, several forms [MIM:272800]"
,,,Hex A pseudodeficiency [MIM:272800]
,,,
HEXB,hexosaminidase B (beta polypeptide) ,5q13,
,,,"Sandhoff disease, infantile, juvenile, and adult forms [MIM:268800]"
,,,
HEY1,hairy/enhancer-of-split related with YRPW motif 1 ,?,
,,,mutations
,,,
HEY,"hairy ears, Y-linked ",Yq,
,,,"Hairy ears, Y-linked"
,,,
HFE2,hemochromatosis type 2 (juvenile) ,1q21,
,,,"Hemochromatosis, type 2A [MIM:602390]"
,,,
HFE,hemochromatosis ,6p21.3,
,,,Hemochromatosis [MIM:235200]
,,,Microvascular complications of diabetes 7 [MIM:612635]
,,,"Porphyria variegata, susceptibility to [MIM:176200]"
,,,"Porphyria cutanea tarda, susceptibility to [MIM:176100]"
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,Transferrin serum level QTL [MIM:190000]
,,,
HFM,Hemifacial microsomia ,14q32,
,,,Hemifacial microsomia
,,,
HGD,"homogentisate 1,2-dioxygenase ",3q21-q23,
,,,Alkaptonuria [MIM:203500]
,,,
HGF,hepatocyte growth factor (hepapoietin A; scatter factor) ,7q21.1,
,,,"Deafness, autosomal recessive 39 [MIM:608265]"
,,,
HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase ,8p11.1,
,,,Mucopolysaccharidosis type IIIC (Sanfilippo C) [MIM:252930]
,,,
HHC2,hypocalciuric hypercalcemia 2 ,19p13.3,
,,,"Hypocalciuric hypercalcemia, type II"
,,,
HHC3,hypocalciuric hypercalcemia 3 (Oklahoma type) ,19q13,
,,,"Hypercalciuric hypercalcemia, type III"
,,,
HHEX,hematopoietically expressed homeobox ,10q24,
,,,mutations
,,,
HHIP,hedgehog interacting protein ,4q28-q32,
,,,mutations
,,,
HHT4,"Telangiectasia, hereditary hemorrhagic, type 4 ",7p14,
,,,"Telangiectasia, hereditary hemorrhagic, type 4"
,,,
HIBCH,3-hydroxyisobutyryl-CoA hydrolase ,2q32.2,
,,,3-hydroxyisobutryl-CoA hydrolase deficiency [MIM:250620]
,,,
HIF1AN,"hypoxia inducible factor 1, alpha subunit inhibitor ",10q24,
,,,mutations
,,,
HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) ",14q21-q24,
,,,mutations
,,,
HIGD2A,"HIG1 hypoxia inducible domain family, member 2A ",?,
,,,mutations
,,,
HIP1,huntingtin interacting protein 1 ,7q11.23,
,,,"Prostate cancer, progression of [MIM:176807]"
,,,
HIST1H2AE,"histone cluster 1, H2ae ",6p21.3,
,,,mutations
,,,
HIST3H3,"histone cluster 3, H3 ",1q42,
,,,mutations
,,,
HK1,hexokinase 1 ,10q22,
,,,Hemolytic anemia due to hexokinase deficiency [MIM:235700]
,,,
HK2,hexokinase 2 ,2p12,
,,,mutations
,,,
HLA-A,"major histocompatibility complex, class I, A ",6p21.3,
,,,"Severe cutaneous adverse reaction, susceptibiliyt to [MIM:608579]"
,,,
HLA-B,"major histocompatibility complex, class I, B ",6p21.3,
,,,"Spondyloarthropathy, susceptibility to, 1 [MIM:106300]"
,,,"Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to [MIM:608579]"
,,,"Abacavir hypersensitivity, susceptibility to"
,,,"Synovitis, chronic, susceptibility to"
,,,Drug-induced liver injury due to flucloxacillin
,,,
HLA-C,"major histocompatibility complex, class I, C ",6p21.3,
,,,Psoriasis susceptibility 1 [MIM:177900]
,,,"HIV-1 viremia, susceptibility to [MIM:609423]"
,,,
HLA-DMB,"major histocompatibility complex, class II, DM beta ",6p21.3,
,,,mutations
,,,
HLA-DOA,"major histocompatibility complex, class II, DO alpha ",6p21.3,
,,,mutations
,,,
HLA-DPB1,"major histocompatibility complex, class II, DP beta 1 ",6p21.3,
,,,"Beryllium disease, chronic, susceptibility to"
,,,
HLA-DPB2,"major histocompatibility complex, class II, DP beta 2 (pseudogene) ",?,
,,,mutations
,,,
HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1 ",6p21.3,
,,,"Celiac disease, susceptibility to [MIM:212750]"
,,,
HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1 ",6p21.3,
,,,"Creutzfeldt-Jakob disease, variant, resistance to [MIM:123400]"
,,,"Multiple sclerosis, susceptibility to [MIM:126200]"
,,,"Celiac disease, susceptibility to [MIM:212750]"
,,,
HLA-DRA,"major histocompatibility complex, class II, DR alpha ",6p21.3,
,,,mutations
,,,
HLA-DRB1,"major histocompatibility complex, class II, DR beta 1 ",6p21.3,
,,,"Pemphigoid, susceptibility to"
,,,"Sarcoidosis, susceptibility l, 1 [MIM:181000]"
,,,"Multiple sclerosis, susceptibility to [MIM:126200]"
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,
HLA-DRB4,"major histocompatibility complex, class II, DR beta 4 ",?,
,,,mutations
,,,
HLA-DRB5,"major histocompatibility complex, class II, DR beta 5 ",6p21.3,
,,,mutations
,,,
HLA-E,"major histocompatibility complex, class I, E ",6p21.3,
,,,mutations
,,,
HLA-G,"major histocompatibility complex, class I, G ",6p21.3,
,,,"Asthma, susceptibility to [MIM:600807]"
,,,
HLA-H,"major histocompatibility complex, class I, H (pseudogene) ",6p21.3,
,,,Hemochromatosis [MIM:235200]
,,,Microvascular complications of diabetes 7 [MIM:612635]
,,,"Porphyria variegata, susceptibility to [MIM:176200]"
,,,"Porphyria cutanea tarda, susceptibility to [MIM:176100]"
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,Transferrin serum level QTL [MIM:190000]
,,,
HLCS,holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) ,21q22.1,
,,,Holocarboxylase synthetase deficiency [MIM:253270]
,,,
HLF,hepatic leukemia factor ,17q22,
,,,"acute lymphoblastic leukemia,preB-cell,with t(17;19)(q22;p13) translocation (see TCF3),associated with CDNK2A and/or CDKN2B deletion"
,,,
HLN2,Huntington-like neurodegenerative disorder 2 ,4p15.3,
,,,Huntington disease-like 3
,,,
HLX,H2.0-like homeobox ,1q41-q42.1,
,,,mutations
,,,
HMBS,hydroxymethylbilane synthase ,11q23.3,
,,,"Porphyria, acute intermittent [MIM:176000]"
,,,"Porphyria, acute intermittent, nonerythroid variant [MIM:176000]"
,,,
HMCN1,hemicentin 1 ,1q24-q25,
,,,"Macular degeneration, age-related, 1 [MIM:603075]"
,,,
HMGA1,high mobility group AT-hook 1 ,6p21,
,,,Lipoma
,,,
HMGA2,high mobility group AT-hook 2 ,12q14.3,
,,,mutations
,,,
HMGCL,3-hydroxymethyl-3-methylglutaryl-CoA lyase ,?,
,,,"defective ketogenesis characterized by recurrent non ketotic hypoglycemia with acidosis,hyperammonemia and hydroxymethylglutaricaciduria"
,,,
HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase ,5q13.3-q14,
,,,"Statins, attenuated cholesterol lowering by"
,,,Low density lipoprotein cholesterol level QTL 3
,,,
HMGCS2,3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) ,1p13-p12,
,,,HMG-CoA synthase-2 deficiency [MIM:605911]
,,,
HMHA1,histocompatibility (minor) HA-1 ,19p13.3,
,,,mutations
,,,
HMMR,hyaluronan-mediated motility receptor (RHAMM) ,5q33.2,
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,
HMN7A,"Motor neuronopathy, distal hereditary, type VIIA ",2q14,
,,,"Motor neuronopathy, distal hereditary, with vocal cord paralysis"
,,,
HMNJ,"Distal hereditary motor neuropathy, Jerash type ",9p21.1-p12,
,,,"Neuropathy, distal hereditary motor, Jerash type"
,,,
HMOX1,heme oxygenase (decycling) 1 ,22q12,
,,,Heme oxygenase-1 deficiency
,,,"Pulmonary disease, chronic obstructive, susceptibility to [MIM:606963]"
,,,
HMOX2,heme oxygenase (decycling) 2 ,16p13.3,
,,,mutations
,,,
HMSD,histocompatibility (minor) serpin domain containing ,18q21.3,
,,,mutations
,,,
HMSNO,"Neuropathy, hereditary motor and sensory, Okinawa type ",3q13.1,
,,,"Neuropathy, hereditary motor and sensory, Okinawa type"
,,,
HMX1,H6 family homeobox 1 ,4p16.1,
,,,Oculoauricular syndrome [MIM:612109]
,,,
HMX2,H6 family homeobox 2 ,10q25.2-q26.3,
,,,mutations
,,,
HN1,hematological and neurological expressed 1 ,Xq12,
,,,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance [MIM:300486]"
,,,
HNF1A,HNF1 homeobox A ,12q24.2,
,,,"MODY, type III [MIM:600496]"
,,,"Diabetes mellitus, noninsulin-dependent, 2 [MIM:125853]"
,,,"Diabetes mellitus, insulin-dependent [MIM:222100]"
,,,Hepatic adenoma [MIM:142330]
,,,Renal cell carcinoma [MIM:144700]
,,,"Diabetes mellitus, insulin-dependent, 20 [MIM:612520]"
,,,
HNF1B,HNF1 homeobox B ,17q12,
,,,Renal cysts and diabetes syndrome [MIM:137920]
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,Renal cell carcinoma [MIM:144700]
,,,
HNF4A,"hepatocyte nuclear factor 4, alpha ",20q12-q13.1,
,,,"MODY, type I [MIM:125850]"
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
HNMT,histamine N-methyltransferase ,2q22,
,,,"Asthma, susceptibility to [MIM:600807]"
,,,
HNP1,Hypertensive nephropathy ,9q31-q32,
,,,Hypertensive nephropathy
,,,
HNRNPH3,heterogeneous nuclear ribonucleoprotein H3 (2H9) ,10q22,
,,,mutations
,,,
HNRNPU,heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) ,?,
,,,mutations
,,,
HOGA1,4-hydroxy-2-oxoglutarate aldolase 1 ,10q24.2,
,,,"Hyperoxaluria, primary, type III [MIM:613616]"
,,,
HOMER2,homer homolog 2 (Drosophila) ,15q24.3,
,,,mutations
,,,
HOXA10,homeobox A10 ,7p15-p14.2,
,,,mutations
,,,
HOXA11,homeobox A11 ,7p15-p14.2,
,,,Radioulnar synostosis with amegakaryocytic thrombocytopenia [MIM:605432]
,,,
HOXA13,homeobox A13 ,7p15-p14.2,
,,,Hand-foot-uterus syndrome [MIM:140000]
,,,Guttmacher syndrome [MIM:176305]
,,,
HOXA1,homeobox A1 ,7p15.3,
,,,Bosley-Salih-Alorainy syndrome [MIM:601536]
,,,Athabaskan brainstem dysgenesis syndrome [MIM:601536]
,,,
HOXA2,homeobox A2 ,7p15-p14,
,,,"Microtia, hearing impairment, and cleft palate [MIM:612290]"
,,,
HOXA4,homeobox A4 ,7p15-p14.2,
,,,mutations
,,,
HOXB13,homeobox B13 ,17q21.2,
,,,mutations
,,,
HOXB6,homeobox B6 ,17q21-q22,
,,,mutations
,,,
HOXD10,homeobox D10 ,2q31-q32,
,,,"Vertical talus, congenital [MIM:192950]"
,,,"Charcot-Marie-Tooth disease, foot deformity of"
,,,
HOXD13,homeobox D13 ,2q31-q32,
,,,"Synpolydactyly, type II [MIM:186000]"
,,,"Brachydactyly, type E [MIM:113300]"
,,,"Brachydactyly, type D [MIM:113200]"
,,,Synpolydactyly with foot anomalies [MIM:186000]
,,,"Syndactyly, type V [MIM:186300]"
,,,Brachydactyly-syndactyly syndrome [MIM:610713]
,,,VACTERL association [MIM:192350]
,,,
HOXD4,homeobox D4 ,2q31-q32,
,,,"Leukemia, acute lymphoblastic, susceptibility to"
,,,
HPC10,"Prostate cancer, hereditary, 10 ",8q24,
,,,"Prostate cancer, hereditary, 10"
,,,
HPC14,"Prostate cancer, hereditary, 14 ",11q13,
,,,"Prostate cancer, hereditary, 14"
,,,
HPC15,"Prostate cancer, hereditary, 15 ",19q13.4,
,,,"Prostate cancer, hereditary, 15"
,,,
HPC1,hereditary prostate cancer 1 ,1q25,
,,,"Prostate cancer 1, 176807 [MIM:601518]"
,,,
HPC3,"Prostate cancer, hereditary, 3 ",20q13,
,,,"Prostate cancer, susceptibility to, 3 [MIM:176807]"
,,,
HPC4,"Prostate cancer, hereditary, 4 ",7p11-q21,
,,,"Prostate cancer, susceptibility to, 4 [MIM:176807]"
,,,
HPC5,"prostate cancer, hereditary, 5 ",3p26,
,,,"Prostate cancer, hereditary, 5 [MIM:176807]"
,,,
HPC6,"Prostate cancer, susceptibility to ",22q12.3,
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
HPC7,"Prostate cancer, hereditary, 7 ",15q12,
,,,"Prostate cancer, hereditary, 7"
,,,
HPC9,"Prostate cancer, hereditary, 9 ",17q21-q22,
,,,"Prostate cancer, hereditary, 9"
,,,
HPCQTL19,Prostate cancer aggressiveness quantitative trait locus on chromosome 19 ,19q,
,,,Prostate cancer aggressiveness QTL [MIM:176807]
,,,
HPCX2,"Prostate cancer, hereditary, X-linked 2 ",Xp11.22,
,,,"Prostate cancer, hereditary, X-linked 2"
,,,
HPCX,"hereditary prostate cancer, X-linked ",Xq27-q28,
,,,"Prostate cancer, hereditary, X-linked 1"
,,,
HPD,4-hydroxyphenylpyruvate dioxygenase ,12q24-qter,
,,,"Tyrosinemia, type III [MIM:276710]"
,,,Hawkinsinuria [MIM:140350]
,,,
HPE1,"holoprosencephaly 1, alobar ",21q22.3,
,,,Holoprosencephaly-1
,,,
HPE6,holoprosencephaly 6 ,2q37.1-q37.3,
,,,Holoprosencephaly-6
,,,
HPE8,holoprosencephaly 8 ,14q13,
,,,Holoprosencephaly-8
,,,
HPFH2,"hereditary persistence of fetal hemoglobin, heterocellular, Indian type ",7q36,
,,,Fetal hemoglobin QTL5
,,,
HPFH,"hereditary persistence of fetal hemoglobin, heterocellular ",6q22.3-q23.1,
,,,Fetal hemoglobin quantitative trait locus 2
,,,
HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD) ,4q34-q35,
,,,Cranioosteoarthropathy [MIM:259100]
,,,"Hypertrophic osteoarthropathy, primary, autosomal recessive [MIM:259100]"
,,,"Digital clubbing, isolated congenital [MIM:119900]"
,,,
HPLH1,hemophagocytic lymphohistiocytosis 1 ,9q21.3-q22,
,,,"Hemophagocytic lymphohistiocytosis, familial, 1"
,,,
HPP1,"hyperpigmentation, progressive, 1 ",19pter-p13.1,
,,,"Hyperpigmentation, familial progressive"
,,,
HPRHP,Hypophosphatemic rickets and hyperparathyroidism ,13q13.1,
,,,Hypophosphatemic rickets and hyperparathyroidism
,,,
HPRT1,hypoxanthine phosphoribosyltransferase 1 ,Xq26-q27.2,
,,,Lesch-Nyhan syndrome [MIM:300322]
,,,HPRT-related gout [MIM:300323]
,,,
HPS1,Hermansky-Pudlak syndrome 1 ,10q23.1,
,,,Hermansky-Pudlak syndrome 1 [MIM:203300]
,,,
HPS3,Hermansky-Pudlak syndrome 3 ,3q24,
,,,Hermansky-Pudlak syndrome 3 [MIM:203300]
,,,
HPS4,Hermansky-Pudlak syndrome 4 ,22q11.2-q12.2,
,,,Hermansky-Pudlak syndrome 4 [MIM:203300]
,,,
HPS5,Hermansky-Pudlak syndrome 5 ,11p15-p13,
,,,Hermansky-Pudlak syndrome 5 [MIM:203300]
,,,
HPS6,Hermansky-Pudlak syndrome 6 ,10q24.32,
,,,Hermansky-Pudlak syndrome 6 [MIM:203300]
,,,
HPSE2,heparanase 2 ,10q23-q24,
,,,Urofacial syndrome [MIM:236730]
,,,
HPSE,heparanase ,4q21.3,
,,,mutations
,,,
HPT,hypoparathyroidism ,Xq26-q27,
,,,"Hypoparathyroidism, X-linked"
,,,
HP,haptoglobin ,16q22.1,
,,,Anhaptoglobinemia
,,,Hypohaptoglobinemia
,,,
HRAS,v-Ha-ras Harvey rat sarcoma viral oncogene homolog ,11p15.5,
,,,"Bladder cancer, somatic [MIM:109800]"
,,,Costello syndrome [MIM:218040]
,,,"Thyroid carcinoma, follicular, somatic [MIM:188470]"
,,,
HRC,histidine rich calcium binding protein ,19q13.3,
,,,mutations
,,,
HRG,histidine-rich glycoprotein ,3q27,
,,,Thrombophilia due to HRG deficiency [MIM:613116]
,,,Thrombophilia due to elevated HRG [MIM:613116]
,,,
HRH2,histamine receptor H2 ,?,
,,,mutations
,,,
HRH3,histamine receptor H3 ,?,
,,,mutations
,,,
HRM2,"hair, curly ",1q21.3,
,,,"Hair, curly"
,,,
HRPT3,Hyperparathyroidism 3 ,2p14-p13.3,
,,,Hyperparathyroidism 3
,,,
HR,hairless homolog (mouse) ,8p21.2,
,,,Alopecia universalis [MIM:203655]
,,,Atrichia with papular lesions [MIM:209500]
,,,"Hypotrichosis, hereditary, Marie Unna type, 1 [MIM:146550]"
,,,
HS1BP3,HCLS1 binding protein 3 ,2p24.1,
,,,mutations
,,,
HS6ST1,heparan sulfate 6-O-sulfotransferase 1 ,2q21,
,,,mutations
,,,
HSCR5,"Hirschsprung disease, susceptibility to, 5 ",9q31,
,,,"Hirschsprung disease, susceptibility to, 5"
,,,
HSCR9,"Hirschsprung disease, susceptibility to, 9 ",4q31.3-q32.3,
,,,"Hirschsprung disease, susceptibility to, 9"
,,,
HSCRM2,Hirschsprung disease modifier 2 ,16q23,
,,,"Hirschsprung disease, susceptibility to, 8"
,,,
HSCRS2,"Hirschsprung disease, short-segment, 2 ",3p21,
,,,"Hirschsprung disease, susceptibility to, 6"
,,,
HSCRS3,"Hirschsprung disease, short-segment, 3 ",19q12,
,,,"Hirschsprung disease, susceptibility to, 7"
,,,
HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1 ,1q32-q41,
,,,Cortisone reductase deficiency [MIM:604931]
,,,
HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2 ,?,
,,,"hypertension,hyporeninemia,hypoaldosteronemia,hypokalemic metabolic alkalosis and apparent mineralocorticoid excess,including a severe form associated with failure to thrive,poor growth,nephrocalcinosis and sudden fatality (type I) and a mild form characterized by low-renin hypertension (type II)"
,,,
HSD17B10,hydroxysteroid (17-beta) dehydrogenase 10 ,Xp11.2,
,,,17-beta-hydroxysteroid dehydrogenase X deficiency [MIM:300438]
,,,"Mental retardation, X-linked syndromic 10 [MIM:300220]"
,,,"Mental retardation, X-linked 17/31, microduplication [MIM:300705]"
,,,
HSD17B1,hydroxysteroid (17-beta) dehydrogenase 1 ,17q12-q21,
,,,hirsutism with amenorrhea and polycystic ovarian disease
,,,
HSD17B2,hydroxysteroid (17-beta) dehydrogenase 2 ,16q24.1-q24.2,
,,,mutations
,,,
HSD17B3,hydroxysteroid (17-beta) dehydrogenase 3 ,9q22,
,,,"Pseudohermaphroditism, male, with gynecomastia [MIM:264300]"
,,,
HSD17B4,hydroxysteroid (17-beta) dehydrogenase 4 ,5q2,
,,,D-bifunctional protein deficiency [MIM:261515]
,,,
HSD3B1,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 ",1p13.1,
,,,mutations
,,,
HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 ",?,
,,,"adrenal hyperplasia II (3-beta-hydroxysteroid dehydrogenase deficiency),male pseudohermaphroditism,with or without salt losing"
,,,
HSD3B7,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 ",16p12-p11.2,
,,,"Cholestasis, progressive familial intrahepatic 4 [MIM:607765]"
,,,
HSF4,heat shock transcription factor 4 ,16q21-q22.1,
,,,"Cataract, Marner type [MIM:116800]"
,,,"Cataract, lamellar [MIM:116800]"
,,,
HSFY1,"heat shock transcription factor, Y-linked 1 ",Yq11.2,
,,,mutations
,,,
HSN1B,"Hereditary sensory neuropathy, type IB ",3p24-p22,
,,,HSN I with cough and gastroesophageal reflux
,,,
HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1 ",14q32.2,
,,,mutations
,,,
HSP90B1,"heat shock protein 90kDa beta (Grp94), member 1 ",12q23.3,
,,,mutations
,,,
HSPA1A,heat shock 70kDa protein 1A ,6p21.3,
,,,mutations
,,,
HSPA1B,heat shock 70kDa protein 1B ,6p21.3,
,,,mutations
,,,
HSPA1L,heat shock 70kDa protein 1-like ,6p21.3,
,,,mutations
,,,
HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) ",9q34,
,,,mutations
,,,
HSPA8,heat shock 70kDa protein 8 ,11q23.3-q25,
,,,mutations
,,,
HSPA9,heat shock 70kDa protein 9 (mortalin) ,5q31.1,
,,,mutations
,,,
HSPB1,heat shock 27kDa protein 1 ,7q11.23,
,,,"Neuropathy, distal hereditary motor, type IIB [MIM:608634]"
,,,"Charcot-Marie-Tooth disease, axonal, type 2F [MIM:606595]"
,,,
HSPB3,heat shock 27kDa protein 3 ,5q11.2,
,,,"Neuronopathy, distal hereditary motor, type IIC [MIM:613376]"
,,,
HSPB6,"heat shock protein, alpha-crystallin-related, B6 ",19q13.13,
,,,mutations
,,,
HSPB7,"heat shock 27kDa protein family, member 7 (cardiovascular) ",1p36.23-p34.3,
,,,mutations
,,,
HSPB8,heat shock 22kDa protein 8 ,12q24,
,,,"Neuropathy, distal hereditary motor, type IIA [MIM:158590]"
,,,"Charcot-Marie-Tooth disease, axonal, type 2L [MIM:608673]"
,,,
HSPD1,heat shock 60kDa protein 1 (chaperonin) ,2q33.1,
,,,Spastic paraplegia-13 [MIM:605280]
,,,"Leukodystrophy, hypomyelinating, 4 [MIM:612233]"
,,,
HSPG2,heparan sulfate proteoglycan 2 ,1p36.1,
,,,"Schwartz-Jampel syndrome, type 1 [MIM:255800]"
,,,"Dyssegmental dysplasia, Silverman-Handmaker type [MIM:224410]"
,,,
HSR,"Hand skill, relative ",2p12-q22,
,,,Handedness
,,,
HTC2,"hypertrichosis 2 (generalized, congenital) ",Xq24-q27.1,
,,,"Hypertrichosis, congenital generalized"
,,,
HTGH,"Hypertrichosis terminalis, generalized, with or without gingival hyperplasia ",17q24.2-q24.3,
,,,"Hypertrichosis terminalis, generalized, with or without gingival hyperplasia"
,,,
HTGS,"Hypertriglyceridemia, familial ",15q11.2-q13.1,
,,,"Hypertriglyceridemia, susceptibility to"
,,,
HTN3,histatin 3 ,4q13,
,,,mutations
,,,
HTNB,hypertension with brachydactyly ,12p12.2-p11.2,
,,,Hypertension with brachydactyly
,,,
HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled ",5q11.2-q13,
,,,mutations
,,,
HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled ",6q13,
,,,mutations
,,,
HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled ",13q14-q21,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,"Obsessive-compulsive disorder, susceptibility to [MIM:164230]"
,,,"Seasonal affective disorder, susceptibility to [MIM:608516]"
,,,"Alcohol dependence, susceptibility to [MIM:103780]"
,,,"Anorexia nervosa, susceptibility to [MIM:606788]"
,,,"Major depressive disorder, response to citalopram therapy in [MIM:608516]"
,,,
HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled ",2q36.3-q37.1,
,,,mutations
,,,
HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled ",Xq24,
,,,mutations
,,,
HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic ",11q23.1-q23.2,
,,,mutations
,,,
HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic ",11q23.1,
,,,mutations
,,,
HTR3C,"5-hydroxytryptamine (serotonin) receptor 3C, ionotropic ",3q27,
,,,mutations
,,,
HTR3E,"5-hydroxytryptamine (serotonin) receptor 3E, ionotropic ",3q27,
,,,mutations
,,,
HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled ",7q36.1,
,,,mutations
,,,
HTR6,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled ",1p36-p35,
,,,mutations
,,,
HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled ",10q21-q24,
,,,mutations
,,,
HTRA1,HtrA serine peptidase 1 ,10q25.3-q26.2,
,,,"Macular degeneration, age-related, 7 [MIM:610149]"
,,,"Macular degeneration, age-related, neovascular type [MIM:610149]"
,,,
HTRA2,HtrA serine peptidase 2 ,2p12,
,,,Parkinson disease 13 [MIM:610297]
,,,
HTT,huntingtin ,4p16.3,
,,,Huntington disease [MIM:143100]
,,,
HTX2,heterotaxy 2 (autosomal dominant) ,2q21.1,
,,,"Heterotaxy, visceral, 2, autosomal [MIM:605376]"
,,,Double-outlet right ventricle [MIM:217095]
,,,"Transposition of the great arteries, dextro-looped 2"
,,,
HTX3,"Heterotaxy, visceral, 3 ",6q21,
,,,"Heterotaxy, visceral"
,,,
HT,Hashimoto thyroiditis ,8q23-q24,
,,,Hashimoto thyroiditis
,,,
HUS1B,HUS1 checkpoint homolog b (S. pombe) ,6p25.3-p25.1,
,,,mutations
,,,
HUWE1,"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase ",Xp11.2,
,,,"Mental retardation, X-linked syndromic, Turner type [MIM:300706]"
,,,
HVCN1,hydrogen voltage-gated channel 1 ,?,
,,,mutations
,,,
HWE1,"Epilepsy, hot water, 1 ",10q21.3-q22.3,
,,,"Epilepsy, hot water, 1"
,,,
HWE2,"Epilepsy, hot water, 2 ",4q24-q28,
,,,"Epilepsy, hot water, 2"
,,,
HYAL1,hyaluronoglucosaminidase 1 ,3p21.3-p21.2,
,,,Mucopolysaccharidosis type IX [MIM:601492]
,,,
HYALP,"Hypoalphalipoproteinemia, primary ",11q23.3,
,,,"Hypoalphalipoproteinemia, primary"
,,,
HYD2,"hypodontia, autosomal recessive (2) ",16q12.1,
,,,"Tooth agenesis, selective, 2"
,,,
HYDIN2,"HYDIN2, axonemal central pair apparatus protein (pseudogene) ",1q21.1,
,,,mutations
,,,
HYLS1,hydrolethalus syndrome 1 ,11q24.2,
,,,Hydrolethalus syndrome [MIM:236680]
,,,
HYMAI,hydatidiform mole associated and imprinted (non-protein coding) ,6q24,
,,,6q24-Related Transient Neonatal
,,,
HYPLIP2,"hyperlipidemia, combined, 2 ",11p,
,,,"Hyperlipidemia, combined, 2"
,,,
HYT1,"Hypertension, essential, susceptibility to, 1 ",17q,
,,,"Hypertension, essential, susceptibility to, 1 [MIM:145500]"
,,,
HYT2,"Hypertension, essential, susceptibility to, 2 ",15q,
,,,"Hypertension, essential, susceptibility to, 2 [MIM:145500]"
,,,
HYT3,"Hypertension, essential, susceptibility to, 3 ",2p25-p24,
,,,"Hypertension, essential, susceptibility to, 3 [MIM:145500]"
,,,
HYT4,"Hypertension, essential, susceptibility to, 4 ",12p12.2-p12.1,
,,,"Hypertension, essential, susceptibility to, 4 [MIM:145500]"
,,,
HYT5,"Hypertension, essential, susceptibility to, 5 ",20q11-q13,
,,,"Hypertension, essential, susceptibility to, 5 [MIM:145500]"
,,,
HYT6,"Hypertension, essential, susceptibility to, 6 ",5p13-q12,
,,,"Hypertension, essential, susceptibility to, 6 [MIM:145500]"
,,,
HYT7,"Hypertension, essential, susceptibility to, 7 ",3p14.1-q12.3,
,,,"Hypertension, essential, susceptibility to, 7"
,,,
HYT8,"hypertension, essential, susceptibility to, 8 ",18q21.2,
,,,"Hypertension, essential, susceptibility to, 8"
,,,
IAPP,islet amyloid polypeptide ,12p12.3-p12.1,
,,,mutations
,,,
IBD11,Inflammatory bowel disease 11 ,7q22,
,,,Inflammatory bowel disease 11
,,,
IBD12,Inflammatory bowel disease 12 ,3p21.3,
,,,Inflammatory bowel disease 12
,,,
IBD15,Inflammatory bowel disease-15 ,10q21,
,,,Inflammatory bowel disease 15
,,,
IBD16,Inflammatory bowel disease-16 ,9q32,
,,,Inflammatory bowel disease 16
,,,
IBD18,Inflammatory bowel disease-18 ,5p13.1,
,,,Inflammatory bowel disease 18
,,,
IBD19,Inflammatory bowel disease 19 ,5q33.1,
,,,Inflammatory bowel disease 19
,,,
IBD20,Inflammatory bowel disease-20 ,10q23-q24,
,,,Inflammatory bowel disease 20
,,,
IBD21,Inflammatory bowel disease-21 ,18p11,
,,,Inflammatory bowel disease 21
,,,
IBD22,Inflammatory bowel disease-22 ,17q21.2,
,,,Inflammatory bowel disease 22
,,,
IBD23,Inflammatory bowel disease-23 ,1q32.1,
,,,Inflammatory bowel disease 23
,,,
IBD24,Inflammatory bowel disease-24 ,20q13,
,,,Inflammatory bowel disease 24
,,,
IBD26,Inflammatory bowel disease-26 ,12q15,
,,,Inflammatory bowel disease 26
,,,
IBD27,Inflammatory bowel disease-27 ,13q13.3,
,,,Inflammatory bowel disease 27
,,,
IBD2,inflammatory bowel disease 2 ,12p13.2-q24.1,
,,,Inflammatory bowel disease 2
,,,
IBD3,inflammatory bowel disease 3 ,6p21.3,
,,,Inflammatory bowel disease 3
,,,
IBD4,inflammatory bowel disease 4 ,14q11-q12,
,,,Inflammatory bowel disease 4
,,,
IBD5,inflammatory bowel disease 5 ,5q31,
,,,Inflammatory bowel disease 5
,,,
IBD6,inflammatory bowel disease 6 ,19p13,
,,,Inflammatory bowel disease 6
,,,
IBD7,inflammatory bowel disease 7 ,1p36,
,,,Inflammatory bowel disease 7
,,,
IBD8,inflammatory bowel disease 8 ,16p,
,,,Inflammatory bowel disease 8
,,,
IBD9,inflammatory bowel disease 9 ,3p26,
,,,Inflammatory bowel disease 9
,,,
IBGC1,idiopathic basal ganglia calcification 1 ,14q,
,,,"Basal ganglia calcification, idiopathic"
,,,
IBSP,integrin-binding sialoprotein ,4q21-q25,
,,,mutations
,,,
ICAM1,intercellular adhesion molecule 1 ,19p13.3-p13.2,
,,,"Malaria, cerebral, susceptibility to [MIM:611162]"
,,,
ICAM4,intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) ,?,
,,,mutations
,,,
ICAM5,"intercellular adhesion molecule 5, telencephalin ",19p13.2,
,,,mutations
,,,
ICCA,infantile convulsions and paroxysmal choreoathetosis ,16p12-q12,
,,,"Convulsions, infantile and paroxysmal choreoathetosis"
,,,
ICK,intestinal cell (MAK-like) kinase ,6p12.3,
,,,Endocrine-cerebroosteodysplasia [MIM:612651]
,,,
ICOS,inducible T-cell co-stimulator ,2q33,
,,,"Immunodeficiency, common variable, 1 [MIM:607594]"
,,,
ICR1,"ichthyosis congenita I, erythromatous lamellar ichthyosis, ichthyosiform erythroderma ",?,
,,,"congenital ichthyosis,autosomal recessive 1,including lamellar ichthyosis (LI) and non bullous congenital ichthyosiformis erythroderma,large,thick brownish scales"
,,,
ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein ",1p36.13-p36.12,
,,,mutations
,,,
IDDM11,insulin-dependent diabetes mellitus 11 ,14q24.3-q31,
,,,"Diabetes mellitus, insulin-dependent, 11"
,,,
IDDM12,insulin-dependent diabetes mellitus 12 ,2q33,
,,,"Graves disease, susceptibility to, 4"
,,,"Hypothyroidism, autoimmune [MIM:140300]"
,,,"Diabetes mellitus, insulin-dependent, susceptibility to [MIM:601388]"
,,,"Celiac disease, susceptibility to, 3 [MIM:609755]"
,,,
IDDM13,insulin-dependent diabetes mellitus 13 ,2q34,
,,,"Diabetes mellitus, insulin-dependent, 13"
,,,
IDDM15,insulin-dependent diabetes mellitus 15 ,6q21,
,,,"Diabetes mellitus, insulin-dependent, 15"
,,,
IDDM17,insulin-dependent diabetes mellitus 17 ,10q25,
,,,"Diabetes mellitus, insulin-dependent, 17"
,,,
IDDM18,insulin-dependent diabetes mellitus 18 ,5q31.1-q33.1,
,,,"Diabetes mellitus, insulin-dependent, 18"
,,,
IDDM23,"Diabetes mellitus, insulin-dependent, 23 ",4q27,
,,,"Diabetes mellitus, insulin-dependent, 23"
,,,
IDDM24,"Diabetes mellitus, insulin-dependent, 24 ",10q23.31,
,,,"Diabetes mellitus, insulin-dependent, 24"
,,,
IDDM2,insulin-dependent diabetes mellitus 2 ,?,
,,,"diabetes mellitus,insulin-dependent 2,associated to ILPR,VNTR,affecting susceptibility in HLA-DR4 patients,second contributor (10%) to the family clustering"
,,,
IDDM3,insulin-dependent diabetes mellitus 3 ,15q26,
,,,"Diabetes mellitus, insulin-dependent, 3"
,,,
IDDM4,insulin-dependent diabetes mellitus 4 ,11q13,
,,,"Diabetes mellitus, insulin-dependent, 4"
,,,
IDDM5,insulin-dependent diabetes mellitus 5 ,6q25,
,,,"Diabetes mellitus, insulin-dependent, 5 [MIM:600320]"
,,,
IDDM6,insulin-dependent diabetes mellitus 6 ,18q21,
,,,"Diabetes mellitus, insulin-dependent, 6"
,,,
IDDM7,insulin-dependent diabetes mellitus 7 ,2q31,
,,,"Diabetes mellitus, insulin-dependent, 7"
,,,
IDDM8,insulin-dependent diabetes mellitus 8 ,6q25-q27,
,,,"Diabetes mellitus, insulin-dependent, 8"
,,,
IDDMX,"Diabetes mellitus, insulin-dependent, X-linked, susceptibility to ",Xp11,
,,,"Diabetes mellitus, insulin-dependent, X-linked"
,,,
IDE,insulin-degrading enzyme ,10q23-q25,
,,,mutations
,,,
IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble ",2q33.3,
,,,mutations
,,,
IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial ",15q26.1,
,,,D-2-hydrosyglutaric aciduria 2 [MIM:613657]
,,,
IDH3B,isocitrate dehydrogenase 3 (NAD+) beta ,20p13,
,,,Retinitis pigmentosa-46
,,,
IDO1,"indoleamine 2,3-dioxygenase 1 ",8p12-p11,
,,,mutations
,,,
IDS,iduronate 2-sulfatase ,Xq28,
,,,Mucopolysaccharidosis II [MIM:309900]
,,,
IDUA,"iduronidase, alpha-L- ",4p16.3,
,,,Mucopolysaccharidosis Ih [MIM:607014]
,,,Mucopolysaccharidosis Is [MIM:607016]
,,,Mucopolysaccharidosis Ih/s [MIM:607015]
,,,
IER3IP1,immediate early response 3 interacting protein 1 ,?,
,,,mutations
,,,
IFI30,"interferon, gamma-inducible protein 30 ",19p13.11,
,,,mutations
,,,
IFI44L,interferon-induced protein 44-like ,?,
,,,mutations
,,,
IFIH1,interferon induced with helicase C domain 1 ,2q24,
,,,mutations
,,,
IFITM3,interferon induced transmembrane protein 3 ,11,
,,,mutations
,,,
IFNA10,"interferon, alpha 10 ",9p22,
,,,mutations
,,,
IFNA17,"interferon, alpha 17 ",9p22,
,,,mutations
,,,
IFNA1,"interferon, alpha 1 ",9p22,
,,,"Interferon, alpha, deficiency"
,,,
IFNA2,"interferon, alpha 2 ",9p22,
,,,mutations
,,,
IFNAR1,"interferon (alpha, beta and omega) receptor 1 ",21q22.1,
,,,mutations
,,,
IFNAR2,"interferon (alpha, beta and omega) receptor 2 ",21q22.1,
,,,"Hepatitis B virus, susceptibility to [MIM:610424]"
,,,
IFNGR1,interferon gamma receptor 1 ,6q23-q24,
,,,"Mycobacterial infection, atypical, familial disseminated [MIM:209950]"
,,,"BCG infection, generalized familial [MIM:209950]"
,,,"H. pylori infection, susceptibility to [MIM:600263]"
,,,"Tuberculosis, susceptibility to [MIM:607948]"
,,,"Mycobacterium tuberculosis infection, protection against [MIM:600263]"
,,,"Hepatitis B virus infection, susceptibility to [MIM:610424]"
,,,
IFNGR2,interferon gamma receptor 2 (interferon gamma transducer 1) ,21q22.1-q22.2,
,,,"Mycobacterial infection, atypical, familial disseminated [MIM:209950]"
,,,
IFNG,"interferon, gamma ",12q14,
,,,"TSC2 angiomyolipomas, renal, modifier of [MIM:613254]"
,,,Aplastic anemia [MIM:609135]
,,,"Tuberculosis, protection against [MIM:607948]"
,,,"AIDS, rapid progression to [MIM:609423]"
,,,"Hepatitis C virus, response to therapy of [MIM:609532]"
,,,
IFRD1,interferon-related developmental regulator 1 ,7q22-q31,
,,,mutations
,,,
IFT122,intraflagellar transport 122 homolog (Chlamydomonas) ,3q21,
,,,Cranioectodermal dysplasia [MIM:218330]
,,,
IFT140,intraflagellar transport 140 homolog (Chlamydomonas) ,?,
,,,mutations
,,,
IFT43,intraflagellar transport 43 homolog (Chlamydomonas) ,?,
,,,mutations
,,,
IFT80,intraflagellar transport 80 homolog (Chlamydomonas) ,3q24-q26,
,,,Asphyxiating thoracic dystrophy 2 [MIM:611263]
,,,
IGAD1,immunoglobulin A (IgA) deficiency susceptibility 1 ,6p21.3,
,,,Immunoglobulin A deficiency
,,,
IGAN,IgA nephropathy ,6q22-q23,
,,,"Nephropathy, IgA type"
,,,
IGBP1,immunoglobulin (CD79A) binding protein 1 ,Xq13.1-q13.3,
,,,"Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia [MIM:300472]"
,,,
IGES,"immunoglobulin E concentration, serum ",5q31.1,
,,,Allergy and asthma susceptibility
,,,
IGF1R,insulin-like growth factor 1 receptor ,15q25-q26,
,,,"Insulin-like growth factor I, resistance to [MIM:270450]"
,,,
IGF1,insulin-like growth factor 1 (somatomedin C) ,12q22-q24.1,
,,,Growth retardation with deafness and mental retardation due to IGF1 deficiency [MIM:608747]
,,,
IGF2BP2,insulin-like growth factor 2 mRNA binding protein 2 ,3q28,
,,,"Diabetes mellitus, noninsulin-dependent, susceptibility to [MIM:125853]"
,,,
IGF2R,insulin-like growth factor 2 receptor ,6q26,
,,,Hepatocellular carcinoma
,,,
IGF2,insulin-like growth factor 2 (somatomedin A) ,11p15.5,
,,,Intrauterine and postnatal growth retardation
,,,
IGFALS,"insulin-like growth factor binding protein, acid labile subunit ",16p13.3,
,,,"Acid-labile subunit, deficiency of"
,,,
IGFBP1,insulin-like growth factor binding protein 1 ,7p14-p12,
,,,mutations
,,,
IGFBP3,insulin-like growth factor binding protein 3 ,7p14-p12,
,,,mutations
,,,
IGFBP5,insulin-like growth factor binding protein 5 ,2q33-q36,
,,,mutations
,,,
IGFBP7,insulin-like growth factor binding protein 7 ,4q12,
,,,mutations
,,,
IGHA1,immunoglobulin heavy constant alpha 1 ,14q32.33,
,,,mutations
,,,
IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker) ,14q32.33,
,,,"infections,recurrent"
,,,
IGHG2,immunoglobulin heavy constant gamma 2 (G2m marker) ,14q32.33,
,,,"IgG2 deficiency, selective"
,,,
IGHG4,immunoglobulin heavy constant gamma 4 (G4m marker) ,14q32.33,
,,,"immunoglobulin,gamma 4 deficiency"
,,,
IGHMBP2,immunoglobulin mu binding protein 2 ,11q13.2-q13.4,
,,,"Neuronopathy, distal hereditary motor, type VI [MIM:604320]"
,,,
IGHM,immunoglobulin heavy constant mu ,14q32.33,
,,,Agammaglobulinemia 1 [MIM:601495]
,,,
IGKC,immunoglobulin kappa constant ,2p12,
,,,Kappa light chain deficiency
,,,
IGKV@,immunoglobulin kappa variable cluster ,2p12,
,,,mutations
,,,
IGLL1,immunoglobulin lambda-like polypeptide 1 ,22q11.21,
,,,Agammaglobulinemia 2 [MIM:613500]
,,,
IHH,Indian hedgehog ,2q33-q35,
,,,Acrocapitofemoral dysplasia [MIM:607778]
,,,"Brachydactyly, type A1 [MIM:112500]"
,,,
IHPS2,"Pyloric stenosis, infantile hypertrophic, 2 ",16p13-p12,
,,,"Pyloric stenosis, infantile hypertrophic, 2"
,,,
IHPS3,"Pyloric stenosis, infantile hypertrophic, 3 ",11q14-q22,
,,,"Pyloric stenosis, infantile hypertrophic, 3"
,,,
IHPS4,"Pyloric stenosis, infantile hypertrophic, 4 ",Xq23,
,,,"Pyloric stenosis, infantile hypertrophic, 4"
,,,
IHPS5,"Pyloric stenosis, infantile hypertrophic, 5 ",16q24.3,
,,,"Pyloric stenosis, infantile hypertrophic, 5"
,,,
IH,Hemihypertrophy ,11p15,
,,,Hemihypertrophy
,,,
IKBIP,IKBKB interacting protein ,12q23,
,,,mutations
,,,
IKBKAP,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein ",9q31,
,,,"Dysautonomia, familial [MIM:223900]"
,,,
IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma ",Xq28,
,,,"Incontinentia pigmenti, type II [MIM:308300]"
,,,"Ectodermal dysplasia, hypohidrotic, with immune deficiency [MIM:300291]"
,,,"Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency [MIM:300301]"
,,,"Immunodeficiency, isolated [MIM:300584]"
,,,"Atypical mycobacteriosis, familial [MIM:300636]"
,,,"Invasive pneumococcal disease, recurrent isolated, 2 [MIM:300640]"
,,,
IKZF1,IKAROS family zinc finger 1 (Ikaros) ,7p12,
,,,"Leukemia, acute lymphoblastic"
,,,
IL10RA,"interleukin 10 receptor, alpha ",11q23.3,
,,,"Inflammatory bowel disease 28, early onset, autosomal recessive [MIM:613148]"
,,,
IL10RB,"interleukin 10 receptor, beta ",21q22.1,
,,,"Hepatitis B virus, susceptibility to [MIM:610424]"
,,,"Inflammatory bowel disease 25, early onset, autosomal recessive [MIM:612567]"
,,,
IL10,interleukin 10 ,1q31-q32,
,,,"HIV-1, susceptibility to"
,,,"Graft-versus-host disease, protection against"
,,,"Rheumatoid arthritis, progression of [MIM:180300]"
,,,
IL11RA,"interleukin 11 receptor, alpha ",9p13,
,,,mutations
,,,
IL12A,"interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) ",3p12-q13.2,
,,,mutations
,,,
IL12B,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) ",5q31.1-q33.1,
,,,"BCG and salmonella infection, disseminated [MIM:209950]"
,,,"Asthma, susceptibility to [MIM:600807]"
,,,
IL12RB1,"interleukin 12 receptor, beta 1 ",19p13.1,
,,,"Mycobacterial and salmonella infections, susceptibility to [MIM:209950]"
,,,
IL12RB2,"interleukin 12 receptor, beta 2 ",1p31.2,
,,,mutations
,,,
IL13,interleukin 13 ,5q31,
,,,"Asthma, susceptibility to [MIM:600807]"
,,,"Allergic rhinitis, susceptibility to [MIM:607154]"
,,,
IL16,interleukin 16 ,15q26.1,
,,,mutations
,,,
IL17A,interleukin 17A ,6p12.2,
,,,mutations
,,,
IL17F,interleukin 17F ,6p12,
,,,mutations
,,,
IL17RA,interleukin 17 receptor A ,22q11.22-q11.23,
,,,mutations
,,,
IL17RB,interleukin 17 receptor B ,3p21.1,
,,,mutations
,,,
IL17REL,interleukin 17 receptor E-like ,?,
,,,mutations
,,,
IL18R1,interleukin 18 receptor 1 ,2q12,
,,,mutations
,,,
IL18RAP,interleukin 18 receptor accessory protein ,2q12,
,,,mutations
,,,
IL18,interleukin 18 (interferon-gamma-inducing factor) ,11q22.2-q22.3,
,,,mutations
,,,
IL19,interleukin 19 ,1q32,
,,,mutations
,,,
IL1A,"interleukin 1, alpha ",2q14,
,,,mutations
,,,
IL1B,"interleukin 1, beta ",2q14,
,,,Gastric cancer risk after H. pylori infection [MIM:137215]
,,,
IL1R1,"interleukin 1 receptor, type I ",2q12,
,,,mutations
,,,
IL1RAPL1,interleukin 1 receptor accessory protein-like 1 ,Xp22.1-p21.3,
,,,"Mental retardation, X-linked, 21/34 [MIM:300143]"
,,,
IL1RN,interleukin 1 receptor antagonist ,2q14.2,
,,,Gastric cancer risk after H. pylori infection [MIM:137215]
,,,Microvascular complications of diabetes 4 [MIM:612628]
,,,Interleukin 1 receptor antagonist deficiency [MIM:612852]
,,,
IL20RA,"interleukin 20 receptor, alpha ",6q23,
,,,mutations
,,,
IL20RB,interleukin 20 receptor beta ,?,
,,,mutations
,,,
IL21R,interleukin 21 receptor ,16p11,
,,,"Lymphoma, diffuse large B-cell"
,,,"IgE, elevated level of [MIM:147050]"
,,,
IL21,interleukin 21 ,4q26-q27,
,,,mutations
,,,
IL23R,interleukin 23 receptor ,1p31.3,
,,,"Inflammatory bowel disease 17, protection against [MIM:612261]"
,,,"Psoriasis, protection against [MIM:177900]"
,,,
IL28B,"interleukin 28B (interferon, lambda 3) ",19q13.13,
,,,"Hepatitis C virus infection, response to therapy of [MIM:609532]"
,,,
IL2RA,"interleukin 2 receptor, alpha ",10p15.1,
,,,"Interleukin-2 receptor, alpha chain, deficiency of [MIM:606367]"
,,,"Diabetes, mellitus, insulin-dependent, susceptibility to, 10 [MIM:601942]"
,,,
IL2RG,"interleukin 2 receptor, gamma ",Xq13,
,,,"Severe combined immunodeficiency, X-linked [MIM:300400]"
,,,"Combined immunodeficiency, X-linked, moderate [MIM:312863]"
,,,
IL2,interleukin 2 ,4q26-q27,
,,,Severe combined immunodeficiency due to IL2 deficiency
,,,
IL31RA,interleukin 31 receptor A ,5q11.2,
,,,mutations
,,,
IL36RN,interleukin 36 receptor antagonist ,2q12.1,
,,,mutations
,,,
IL3,"interleukin 3 (colony-stimulating factor, multiple) ",5q31.1,
,,,"leukemia,acute,lymphoblastic,preB cell,with translocation t(5;14)(q31;q32)"
,,,
IL4R,interleukin 4 receptor ,16p12.1-p11.2,
,,,"Atopy, susceptibility to [MIM:147050]"
,,,"AIDS, slow progression to [MIM:609423]"
,,,
IL4,interleukin 4 ,5q31.1,
,,,mutations
,,,
IL5,"interleukin 5 (colony-stimulating factor, eosinophil) ",5q31.1,
,,,mutations
,,,
IL6R,interleukin 6 receptor ,1q21.3,
,,,mutations
,,,
IL6,"interleukin 6 (interferon, beta 2) ",7p21,
,,,"Rheumatoid arthritis, systemic juvenile [MIM:604302]"
,,,"Kaposi sarcoma, susceptibility to [MIM:148000]"
,,,"Diabetes, susceptibility to, 222100 [MIM:125853]"
,,,"Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to [MIM:108010]"
,,,Crohn disease-associated growth failure [MIM:266600]
,,,
IL7R,interleukin 7 receptor ,5p13,
,,,"Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type [MIM:608971]"
,,,
IL7,interleukin 7 ,8q12-q13,
,,,mutations
,,,
IL8,interleukin 8 ,4q12-q13,
,,,mutations
,,,
IL9R,interleukin 9 receptor ,Xq28,
,,,mutations
,,,
IL9,interleukin 9 ,5q31.1,
,,,mutations
,,,
ILDR1,immunoglobulin-like domain containing receptor 1 ,3q21.1,
,,,mutations
,,,
ILK,integrin-linked kinase ,11p15.5-p15.4,
,,,mutations
,,,
IMAGE,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies ",X,
,,,IMAGE syndrome
,,,
IMMP2L,IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) ,7q31,
,,,mutations
,,,
IMMT,"inner membrane protein, mitochondrial ",2p11.2,
,,,mutations
,,,
IMPA2,inositol(myo)-1(or 4)-monophosphatase 2 ,18p11.2,
,,,mutations
,,,
IMPAD1,inositol monophosphatase domain containing 1 ,?,
,,,mutations
,,,
IMPDH1,IMP (inosine 5'-monophosphate) dehydrogenase 1 ,7q31.3-q32,
,,,Retinitis pigmentosa-10 [MIM:180105]
,,,Leber congenital amaurosis 11
,,,
IMPDH2,IMP (inosine 5'-monophosphate) dehydrogenase 2 ,3p21.2,
,,,"IMPDH2 enzyme activity, variation in"
,,,
IMPG2,interphotoreceptor matrix proteoglycan 2 ,3q11.2,
,,,Retinitis pigmentosa 56 [MIM:613581]
,,,"Maculopathy, IMPG2-related [MIM:613581]"
,,,
INDX,"Immunoneurologic syndrome X-linked, of Wood, Black, and Norbury ",Xq26-qter,
,,,Wood neuroimmunologic syndrome
,,,
INF2,"inverted formin, FH2 and WH2 domain containing ",14q32.33,
,,,"Glomerulosclerosis, focal segmental, 5 [MIM:613237]"
,,,
ING1,"inhibitor of growth family, member 1 ",13q34,
,,,"Squamous cell carcinoma, head and neck [MIM:275355]"
,,,
INHA,"inhibin, alpha ",2q33-q36,
,,,mutations
,,,
INLNE,"Ichthyosis, nonlamellar and nonerythrodermic, congenital, autosomal recessive ",19p13.2-p13.1,
,,,"Ichthyosis, nonlamellar and nonerythrodermic, congenital"
,,,
INMT,indolethylamine N-methyltransferase ,7p15.3-p15.2,
,,,mutations
,,,
INPP4A,"inositol polyphosphate-4-phosphatase, type I, 107kDa ",2q11.2,
,,,mutations
,,,
INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa ",9q34.3,
,,,"Mental retardation, truncal obesity, retinal dystrophy, and micropenis [MIM:610156]"
,,,Joubert syndrome 1 [MIM:213300]
,,,
INSIG1,insulin induced gene 1 ,7q36,
,,,mutations
,,,
INSIG2,insulin induced gene 2 ,2q14.1,
,,,mutations
,,,
INSL3,insulin-like 3 (Leydig cell) ,19p13.2,
,,,"Cryptorchidism, idiopathic [MIM:219050]"
,,,
INSL6,insulin-like 6 ,9p24,
,,,mutations
,,,
INSR,insulin receptor ,19p13.2,
,,,Leprechaunism [MIM:246200]
,,,Rabson-Mendenhall syndrome [MIM:262190]
,,,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans [MIM:610549]"
,,,"Hyperinsulinemic hypoglycemia, familial, 5 [MIM:609968]"
,,,
INS,insulin ,11p15.5,
,,,"Hyperproinsulinemia, familial, with or without diabetes"
,,,"Maturity-onset diabetes of the young, type 10 [MIM:613370]"
,,,"Diabetes mellitus, permanent neonatal [MIM:606176]"
,,,"Diabetes mellitus, type 1 [MIM:125852]"
,,,"Diabetes mellitus, insulin-dependent, 2 [MIM:125852]"
,,,
INTLQ1,Intelligence QTL1 ,4p16-q34,
,,,Intelligence QTL1
,,,
INTLQ2,Intelligence QTL3 ,2q24.1-q31.1,
,,,Intelligence QTL3
,,,
INTLQ3,Intelligence QTL3 ,6p25.3-p22.3,
,,,Intelligence QTL3
,,,
INTS6,integrator complex subunit 6 ,13q14.12-q14.2,
,,,Nonsmall cell lung cancer
,,,
INVS,inversin ,9q31,
,,,"Nephronophthisis 2, infantile [MIM:602088]"
,,,
IPOX,"Intestinal pseudoobstruction, neuronal, primary idiopathic ",Xq28,
,,,"Intestinal pseudoobstruction, neuronal, X-linked"
,,,
IQCB1,IQ motif containing B1 ,3q21.1,
,,,Senior-Loken syndrome 5 [MIM:609254]
,,,
IQGAP1,IQ motif containing GTPase activating protein 1 ,15q26,
,,,mutations
,,,
IQGAP2,IQ motif containing GTPase activating protein 2 ,5q11-q13,
,,,mutations
,,,
IQGAP3,IQ motif containing GTPase activating protein 3 ,?,
,,,mutations
,,,
IQSEC2,IQ motif and Sec7 domain 2 ,Xp11.22,
,,,"Mental retardation, X-linked 1 [MIM:309530]"
,,,
IRAK1,interleukin-1 receptor-associated kinase 1 ,Xq28,
,,,mutations
,,,
IRAK3,interleukin-1 receptor-associated kinase 3 ,12q14.3,
,,,Asthma susceptibility 5 [MIM:611064]
,,,
IRAK4,interleukin-1 receptor-associated kinase 4 ,12q12,
,,,IRAK4 deficiency [MIM:607676]
,,,"Invasive pneumococcal disease, recurrent isolated, 1 [MIM:610799]"
,,,
IRF1,interferon regulatory factor 1 ,5q31.1,
,,,"Myelodysplastic syndrome, preleukemic"
,,,"Myelogenous leukemia, acute"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,"Nonsmall cell lung cancer, somatic [MIM:211980]"
,,,
IRF2,interferon regulatory factor 2 ,4q35.1,
,,,mutations
,,,
IRF4,interferon regulatory factor 4 ,6p25-p23,
,,,Multiple myeloma
,,,
IRF5,interferon regulatory factor 5 ,7q32,
,,,Inflammatory bowel disease 14 [MIM:612245]
,,,"Systemic lupus erythematosus, susceptibility to, 10 [MIM:612251]"
,,,
IRF6,interferon regulatory factor 6 ,1q32-q41,
,,,van der Woude syndrome [MIM:119300]
,,,Popliteal pterygium syndrome [MIM:119500]
,,,Orofacial cleft 6 [MIM:608864]
,,,
IRF7,interferon regulatory factor 7 ,?,
,,,mutations
,,,
IRF8,interferon regulatory factor 8 ,?,
,,,mutations
,,,
IRG1,immunoresponsive 1 homolog (mouse) ,11q13.4-q13.5,
,,,"Osteopetrosis, recessive 1 [MIM:259700]"
,,,
IRGM,"immunity-related GTPase family, M ",5q33.1,
,,,"Mycobacterium tuberculosis, protection against [MIM:607948]"
,,,
IRS1,insulin receptor substrate 1 ,2q36,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,"Coronary artery disease, susceptibility to (3) 1"
,,,
IRS2,insulin receptor substrate 2 ,13q34,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
IRS4,insulin receptor substrate 4 ,?,
,,,mutations
,,,
IRX4,iroquois homeobox 4 ,5p15.3,
,,,mutations
,,,
IRX5,iroquois homeobox 5 ,16q11.2-q13,
,,,mutations
,,,
IS2,"Scoliosis, idiopathic 2 ",17p11.2,
,,,"Scoliosis, idiopathic 2"
,,,
IS4,"Scoliosis, idiopathic, susceptibility to, 4 ",9q31.2-q34.2,
,,,"Scoliosis, idiopathic, susceptibility to, 4"
,,,
ISCU,iron-sulfur cluster scaffold homolog (E. coli) ,12q24.1,
,,,"Myopathy with lactic acidosis, hereditary [MIM:255125]"
,,,
ISL1,ISL LIM homeobox 1 ,5q,
,,,mutations
,,,
ISPD,isoprenoid synthase domain containing ,?,
,,,mutations
,,,
IST1,increased sodium tolerance 1 homolog (yeast) ,7p21,
,,,Saethre-Chotzen syndrome [MIM:101400]
,,,Saethre-Chotzen syndrome with eyelid anomalies [MIM:101400]
,,,"Craniosynostosis, type 1 [MIM:123100]"
,,,
ISYNA1,inositol-3-phosphate synthase 1 ,19p13.1,
,,,mutations
,,,
ITC1,"hypertrichosis universalis congenita, Ambras type ",8q22,
,,,"Hypertrichosis universalis congenita, Ambras type"
,,,
ITCH,itchy E3 ubiquitin protein ligase ,20q11.22-q11.23,
,,,"Autoimmune disease, syndromic multisystem [MIM:613385]"
,,,
ITGA11,"integrin, alpha 11 ",15q23,
,,,mutations
,,,
ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) ",17q21.32,
,,,"Glanzmann thrombasthenia, type A [MIM:273800]"
,,,"Thrombocytopenia, neonatal alloimmune"
,,,
ITGA2,"integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) ",5q23-q31,
,,,Neonatal alloimmune thrombocytopenia
,,,Glycoprotein Ia deficiency
,,,
ITGA3,"integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) ",17,
,,,mutations
,,,
ITGA4,"integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) ",2q31-q32,
,,,mutations
,,,
ITGA6,"integrin, alpha 6 ",2q31.1,
,,,"Epidermolysis bullosa, junctional, with pyloric stenosis [MIM:226730]"
,,,
ITGA7,"integrin, alpha 7 ",12q13,
,,,"Muscular dystrophy, congenital, due to ITGA7 deficiency [MIM:613204]"
,,,
ITGA9,"integrin, alpha 9 ",3p21.3,
,,,mutations
,,,
ITGAE,"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) ",?,
,,,mutations
,,,
ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit) ",16p11.2,
,,,"Systemic lupus erythematous, association with susceptibility to, 6 [MIM:609939]"
,,,
ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) ",21q22.3,
,,,Leukocyte adhesion deficiency [MIM:116920]
,,,
ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) ",17q21.32,
,,,"Glanzmann thrombasthenia, type B"
,,,
ITGB4,"integrin, beta 4 ",17q11-qter,
,,,"Epidermolysis bullosa, junctional, with pyloric atresia [MIM:226730]"
,,,"Epidermolysis bullosa, junctional, non-Herlitz type [MIM:226650]"
,,,Epidermolysis bullosa of hands and feet [MIM:131800]
,,,
ITIH1,inter-alpha-trypsin inhibitor heavy chain 1 ,3p21.2-p21.1,
,,,mutations
,,,
ITIH3,inter-alpha-trypsin inhibitor heavy chain 3 ,3p21.2-p21.1,
,,,mutations
,,,
ITIH4,"inter-alpha-trypsin inhibitor heavy chain family, member 4 ",3p21.2-p14.1,
,,,"Hypercholesterolemia, susceptibility to [MIM:143890]"
,,,
ITK,IL2-inducible T-cell kinase ,5q32,
,,,"Lymphoproliferative syndrome, EBV-associated, autosomal, 1 [MIM:613011]"
,,,
ITM2B,integral membrane protein 2B ,13q14,
,,,"Dementia, familial British [MIM:176500]"
,,,"Dementia, familial Danish [MIM:117300]"
,,,
ITPA,inosine triphosphatase (nucleoside triphosphate pyrophosphatase) ,20p,
,,,Inosine triphosphatase deficiency
,,,
ITPKC,inositol-trisphosphate 3-kinase C ,19q13.2,
,,,"Kawasaki disease, susceptibility to [MIM:611775]"
,,,
ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1 ",3p26-p25,
,,,Spinocerebellar ataxia 15 [MIM:606658]
,,,
ITPR3,"inositol 1,4,5-trisphosphate receptor, type 3 ",6pter-p21,
,,,"Diabetes, type 1, susceptibility to [MIM:222100]"
,,,
ITSN2,intersectin 2 ,2p25,
,,,mutations
,,,
ITS,Insulinoma tumor suppressor gene locus ,22q12.1-q12.2,
,,,Insulinoma
,,,
IVD,isovaleryl-CoA dehydrogenase ,15q14-q15,
,,,Isovaleric acidemia [MIM:243500]
,,,
IV,"inversus situs, viscerum ",?,
,,,mutations
,,,
IYD,iodotyrosine deiodinase ,6q24-q25,
,,,Thyroid dyshormonogenesis 4 [MIM:274800]
,,,
JAG1,jagged 1 ,20p12,
,,,Alagille syndrome [MIM:118450]
,,,Tetralogy of Fallot [MIM:187500]
,,,"Deafness, congenital heart defects, and posterior embryotoxon"
,,,
JAG2,jagged 2 ,14q32,
,,,mutations
,,,
JAK2,Janus kinase 2 ,9p24,
,,,Polycythemia vera [MIM:263300]
,,,"Thrombocythemia, essential [MIM:187950]"
,,,"Myelofibrosis, idiopathic [MIM:254450]"
,,,Budd-Chiari syndrome [MIM:600880]
,,,"Leukemia, acute myelogenous [MIM:601626]"
,,,Myeloproliferative disorder with erythrocytosis
,,,
JAK3,Janus kinase 3 ,19p13.1,
,,,"SCID, autosomal recessive, T-negative/B-positive type"
,,,
JAM3,junctional adhesion molecule 3 ,11q25,
,,,"Hemorrhagic destruction of the brain, subependymal calcification, and cataracts [MIM:613730]"
,,,
JAWAD,Microcephaly with digital anomalies ,18p11.22-q11.2,
,,,Microcephaly with digital anomalies
,,,
JAZF1,JAZF zinc finger 1 ,7p15,
,,,Endometrial stromal tumors
,,,
JBS,Jacobsen syndrome ,11q23,
,,,Jacobsen syndrome
,,,
JMJD1C,jumonji domain containing 1C ,?,
,,,mutations
,,,
JPD,juvenile periodontitis ,11q14.1-q14.3,
,,,Papillon-Lefevre syndrome [MIM:245000]
,,,Haim-Munk syndrome [MIM:245010]
,,,"Periodontitis, juvenile [MIM:170650]"
,,,
JPH2,junctophilin 2 ,20q12,
,,,mutations
,,,
JPH3,junctophilin 3 ,16q24.3,
,,,Huntington disease-like 2 [MIM:606438]
,,,
JRK,jerky homolog (mouse) ,8q24,
,,,mutations
,,,
JUN,jun proto-oncogene ,1p32-p31,
,,,mutations
,,,
JUP,junction plakoglobin ,17q21,
,,,Naxos disease [MIM:601214]
,,,"Arrhythmogenic right ventricular dysplasia, familial, 12 [MIM:611528]"
,,,
KAL1,Kallmann syndrome 1 sequence ,?,
,,,"Kallmann syndrome 1,characterized by hypogonadotropic hypogonadism and anosmia,maybe associated with renal agenesis of olfactory lobes and ataxia,synkinesia,nystagmus,visual defects,clubfoot,cleft palate,including rare cases of sporadic isolated GNRH deficiency"
,,,
KALRN,"kalirin, RhoGEF kinase ",?,
,,,mutations
,,,
KANK1,KN motif and ankyrin repeat domains 1 ,9p24.3,
,,,"Cerebral palsy, spastic quadriplegic [MIM:612900]"
,,,
KANSL1,KAT8 regulatory NSL complex subunit 1 ,17q21.31,
,,,mutations
,,,
KARS,lysyl-tRNA synthetase ,16q22.2-q22.3,
,,,"Charcot-Marie-Tooth disease, recessive intermediate, B [MIM:613641]"
,,,
KAT6B,K(lysine) acetyltransferase 6B ,10q22,
,,,mutations
,,,
KATNAL2,katanin p60 subunit A-like 2 ,?,
,,,mutations
,,,
KAZA,"Kala-azar (visceral leishmaniasis), susceptibility to ",22q12,
,,,"Kala-azar, susceptibility to"
,,,
KBTBD13,kelch repeat and BTB (POZ) domain containing 13 ,15q22.31,
,,,Nemaline myopathy 6 [MIM:609273]
,,,
KCNA1,"potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) ",12p13,
,,,Episodic ataxia/myokymia syndrome [MIM:160120]
,,,
KCNA3,"potassium voltage-gated channel, shaker-related subfamily, member 3 ",1p21-p13.3,
,,,mutations
,,,
KCNA5,"potassium voltage-gated channel, shaker-related subfamily, member 5 ",12p13,
,,,"Atrial fibrillation, familial, 7 [MIM:612240]"
,,,
KCNAB2,"potassium voltage-gated channel, shaker-related subfamily, beta member 2 ",1p36.3,
,,,mutations
,,,
KCNC3,"potassium voltage-gated channel, Shaw-related subfamily, member 3 ",19q13.3-q13.4,
,,,Spinocerebellar ataxia-13 [MIM:605259]
,,,
KCND2,"potassium voltage-gated channel, Shal-related subfamily, member 2 ",7q31,
,,,mutations
,,,
KCND3,"potassium voltage-gated channel, Shal-related subfamily, member 3 ",1p13.3-p13.2,
,,,mutations
,,,
KCNE1L,KCNE1-like ,Xq22.3,
,,,mutations
,,,
KCNE1,"potassium voltage-gated channel, Isk-related family, member 1 ",21q22.1-q22.2,
,,,Jervell and Lange-Nielsen syndrome 2 [MIM:612347]
,,,Long QT syndrome-5 [MIM:613695]
,,,
KCNE2,"potassium voltage-gated channel, Isk-related family, member 2 ",21q22.1,
,,,Long QT syndrome-6 [MIM:613693]
,,,"Atrial fibrillation, familial, 4 [MIM:611493]"
,,,
KCNE3,"potassium voltage-gated channel, Isk-related family, member 3 ",11q13-q14,
,,,Brugada syndrome 6 [MIM:613119]
,,,
KCNE4,"potassium voltage-gated channel, Isk-related family, member 4 ",2q35-q36,
,,,mutations
,,,
KCNH2,"potassium voltage-gated channel, subfamily H (eag-related), member 2 ",7q35-q36,
,,,Long QT syndrome-2 [MIM:613688]
,,,"Long QT syndrome-2, acquired, susceptibility to [MIM:613688]"
,,,Short QT syndrome-1 [MIM:609620]
,,,
KCNIP4,Kv channel interacting protein 4 ,4p15.3,
,,,mutations
,,,
KCNJ10,"potassium inwardly-rectifying channel, subfamily J, member 10 ",1q23.2,
,,,SESAME syndrome [MIM:612780]
,,,
KCNJ11,"potassium inwardly-rectifying channel, subfamily J, member 11 ",11p15.1,
,,,"Hyperinsulinemic hypoglycemia, familial, 2 [MIM:601820]"
,,,"Diabetes, permanent neonatal [MIM:606176]"
,,,"Diabetes mellitus, permanent neonatal, with neurologic features [MIM:606176]"
,,,"Diabetes mellitus, type 2, susceptibility to [MIM:125853]"
,,,"Diabetes mellitus, transient neonatal, 3 [MIM:610582]"
,,,
KCNJ13,"potassium inwardly-rectifying channel, subfamily J, member 13 ",2q37,
,,,Snowflake vitreoretinal degeneration [MIM:193230]
,,,
KCNJ15,"potassium inwardly-rectifying channel, subfamily J, member 15 ",21q22.2,
,,,mutations
,,,
KCNJ18,"potassium inwardly-rectifying channel, subfamily J, member 18 ",17p11.2,
,,,"Thyrotoxic periodic paralysis, susceptibility to, 2 [MIM:613239]"
,,,
KCNJ1,"potassium inwardly-rectifying channel, subfamily J, member 1 ",11q24,
,,,"Bartter syndrome, type 2 [MIM:241200]"
,,,
KCNJ2,"potassium inwardly-rectifying channel, subfamily J, member 2 ",17q23.1-q24.2,
,,,Long QT syndrome-7 [MIM:170390]
,,,Short QT syndrome-3 [MIM:609622]
,,,
KCNJ3,"potassium inwardly-rectifying channel, subfamily J, member 3 ",2q24.1,
,,,mutations
,,,
KCNJ5,"potassium inwardly-rectifying channel, subfamily J, member 5 ",11q24,
,,,Long QT syndrome 13 [MIM:613485]
,,,
KCNJ6,"potassium inwardly-rectifying channel, subfamily J, member 6 ",21q22.1,
,,,mutations
,,,
KCNJ8,"potassium inwardly-rectifying channel, subfamily J, member 8 ",12p11.23,
,,,Prinzmetal angina
,,,
KCNJ9,"potassium inwardly-rectifying channel, subfamily J, member 9 ",1q21-q23,
,,,mutations
,,,
KCNK18,"potassium channel, subfamily K, member 18 ",10q25.3,
,,,"Migraine, with or without aura, susceptibility to, 13 [MIM:613656]"
,,,
KCNK6,"potassium channel, subfamily K, member 6 ",19q13.1,
,,,mutations
,,,
KCNK9,"potassium channel, subfamily K, member 9 ",8q24.1-q24.3,
,,,Birk-Barel mental retardation dysmorphism syndrome [MIM:612292]
,,,
KCNMA1,"potassium large conductance calcium-activated channel, subfamily M, alpha member 1 ",10q22.3,
,,,Generalized epilepsy and paroxysmal dyskinesia [MIM:609446]
,,,
KCNMB1,"potassium large conductance calcium-activated channel, subfamily M, beta member 1 ",5q34,
,,,"Hypertension, diastolic, resistance to [MIM:608622]"
,,,
KCNMB3,"potassium large conductance calcium-activated channel, subfamily M beta member 3 ",3q26.3-q27.1,
,,,mutations
,,,
KCNN3,"potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 ",1q21.3,
,,,mutations
,,,
KCNQ1OT1,KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) ,11p15.5,
,,,Beckwith-Wiedemann syndrome [MIM:130650]
,,,
KCNQ1,"potassium voltage-gated channel, KQT-like subfamily, member 1 ",11p15.5,
,,,Long QT syndrome-1 [MIM:192500]
,,,Jervell and Lange-Nielsen syndrome [MIM:220400]
,,,"Atrial fibrillation, familial, 3 [MIM:607554]"
,,,Short QT syndrome-2 [MIM:609621]
,,,"Long QT syndrome 1, acquired, susceptibility to [MIM:192500]"
,,,
KCNQ2,"potassium voltage-gated channel, KQT-like subfamily, member 2 ",20q13.3,
,,,"Seizures, benign neonatal, 1 [MIM:121200]"
,,,Myokymia [MIM:121200]
,,,"Epileptic encephalopathy, early infantile, 7 [MIM:613720]"
,,,
KCNQ3,"potassium voltage-gated channel, KQT-like subfamily, member 3 ",8q24,
,,,"Epilepsy, benign neonatal, type 2 [MIM:121201]"
,,,
KCNQ4,"potassium voltage-gated channel, KQT-like subfamily, member 4 ",1p34,
,,,"Deafness, autosomal dominant 2A [MIM:600101]"
,,,
KCNS1,"potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 ",?,
,,,mutations
,,,
KCNS3,"potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 ",2p24,
,,,mutations
,,,
KCNV2,"potassium channel, subfamily V, member 2 ",9p24.2,
,,,Retinal cone dystrophy 3B [MIM:610356]
,,,
KCTD13,potassium channel tetramerisation domain containing 13 ,16p11.2,
,,,mutations
,,,
KCTD7,potassium channel tetramerisation domain containing 7 ,7q11.21,
,,,"Epilepsy, progressive myoclonic 3 [MIM:611726]"
,,,
KDM4C,lysine (K)-specific demethylase 4C ,9p24.1,
,,,mutations
,,,
KDM5A,lysine (K)-specific demethylase 5A ,12p11,
,,,mutations
,,,
KDM5C,lysine (K)-specific demethylase 5C ,Xp11.22-p11.21,
,,,"Mental retardation, X-linked, syndromic, JARID1C-related [MIM:300534]"
,,,
KDM6A,lysine (K)-specific demethylase 6A ,Xp11.2,
,,,mutations
,,,
KDM6B,lysine (K)-specific demethylase 6B ,17p13.1,
,,,mutations
,,,
KDR,kinase insert domain receptor (a type III receptor tyrosine kinase) ,4q12,
,,,"Hemangioma, capillary infantile, somatic [MIM:602089]"
,,,"Hemangioma, capillary infantile, susceptibility to [MIM:602089]"
,,,
KDSR,3-ketodihydrosphingosine reductase ,18q21.3,
,,,"Lymphoma/leukemia, B-cell, variant"
,,,
KEL,"Kell blood group, metallo-endopeptidase ",?,
,,,mutations
,,,
KERA,keratocan ,12q22,
,,,"Cornea plana congenita, recessive [MIM:217300]"
,,,
KFM,Klippel-Feil malformation ,5q11.2,
,,,"Klippel-Feil syndrome 2, autosomal recessive"
,,,
KFSD,keratosis follicularis spinulosa decalvans ,Xp22.1,
,,,Keratosis follicularis spinulosa decalvans [MIM:308800]
,,,
KHK,ketohexokinase (fructokinase) ,?,
,,,fructosuria
,,,
KIAA0100,KIAA0100 ,?,
,,,mutations
,,,
KIAA0182,KIAA0182 ,?,
,,,mutations
,,,
KIAA0196,KIAA0196 ,8q24.13,
,,,Spastic paraplegia-8 [MIM:603563]
,,,
KIAA0226,KIAA0226 ,?,
,,,mutations
,,,
KIAA0232,KIAA0232 ,?,
,,,mutations
,,,
KIAA0317,KIAA0317 ,?,
,,,mutations
,,,
KIAA0319,KIAA0319 ,6p22.2,
,,,"Dyslexia, susceptibility to, 2 [MIM:600202]"
,,,
KIAA0513,KIAA0513 ,16q24.1,
,,,mutations
,,,
KIAA1033,KIAA1033 ,?,
,,,mutations
,,,
KIAA1199,KIAA1199 ,15q24,
,,,"Deafness, nonsyndromic"
,,,
KIAA1279,KIAA1279 ,10q22.1,
,,,Goldberg-Shprintzen megacolon syndrome [MIM:609460]
,,,
KIAA1377,KIAA1377 ,?,
,,,mutations
,,,
KIAA1432,KIAA1432 ,?,
,,,mutations
,,,
KIAA1462,KIAA1462 ,?,
,,,mutations
,,,
KIF11,kinesin family member 11 ,10q24.1,
,,,mutations
,,,
KIF17,kinesin family member 17 ,?,
,,,mutations
,,,
KIF18A,kinesin family member 18A ,?,
,,,mutations
,,,
KIF1A,kinesin family member 1A ,2q37,
,,,mutations
,,,
KIF1B,kinesin family member 1B ,1p36.2,
,,,"Charcot-Marie-Tooth disease, type 2A1 [MIM:118210]"
,,,Pheochromocytoma [MIM:171300]
,,,"Neuroblastoma, susceptibility to, 1 [MIM:256700]"
,,,
KIF21A,kinesin family member 21A ,12q12,
,,,"Fibrosis of extraocular muscles, congenital, 1 [MIM:135700]"
,,,"Fibrosis of extraocular muscles, congenital, 3B [MIM:135700]"
,,,
KIF22,kinesin family member 22 ,16p11.2,
,,,mutations
,,,
KIF5A,kinesin family member 5A ,12q13,
,,,Spastic paraplegia 10 [MIM:604187]
,,,
KIF5B,kinesin family member 5B ,10p12-cen,
,,,mutations
,,,
KIF6,kinesin family member 6 ,?,
,,,mutations
,,,
KIF7,kinesin family member 7 ,?,
,,,mutations
,,,
KIFAP3,kinesin-associated protein 3 ,1q24.2,
,,,mutations
,,,
KIR2DL1,"killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 ",19q13.4,
,,,mutations
,,,
KIR2DL2,"killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 ",19q13.4,
,,,mutations
,,,
KIR2DL3,"killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 ",19q13.4,
,,,mutations
,,,
KIR2DL4,"killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 ",19q13.4,
,,,mutations
,,,
KIR2DL5A,"killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A ",19p13.3,
,,,mutations
,,,
KIR2DS3,"killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 ",19q13.4,
,,,mutations
,,,
KIR3DL1,"killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 ",19q13.4,
,,,"AIDS, delayed/rapid progression to [MIM:609423]"
,,,
KIR3DL2,"killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 ",19q13.4,
,,,mutations
,,,
KIR3DS1,"killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 ",19q13.4,
,,,"AIDS, delayed/rapid progression to [MIM:609423]"
,,,
KIRREL3,kin of IRRE like 3 (Drosophila) ,11q24.2,
,,,"Mental retardation, autosomal dominant 4 [MIM:612581]"
,,,
KISS1R,KISS1 receptor ,19p13.3,
,,,Hypogonadotropic hypogonadism [MIM:146110]
,,,"Precocious puberty, central [MIM:176400]"
,,,
KISS1,KiSS-1 metastasis-suppressor ,1q32,
,,,mutations
,,,
KITLG,KIT ligand ,12q22,
,,,"Skin/hair/eye pigmentation 7, blond/brown hair [MIM:611664]"
,,,"Hyperpigmentation, familial progressive [MIM:145250]"
,,,
KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog ,4q12,
,,,Piebaldism
,,,Mast cell leukemia
,,,Mastocytosis with associated hematologic disorder
,,,Germ cell tumors [MIM:273300]
,,,"Gastrointestinal stromal tumor, somatic [MIM:606764]"
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
KLB,klotho beta ,4p14,
,,,mutations
,,,
KLF10,Kruppel-like factor 10 ,?,
,,,mutations
,,,
KLF11,Kruppel-like factor 11 ,2p25,
,,,"Maturity-onset diabetes of the young, type VII [MIM:610508]"
,,,
KLF1,Kruppel-like factor 1 (erythroid) ,19p13.13-p13.12,
,,,Blood group--Lutheran inhibitor [MIM:111150]
,,,Hereditary persistence of fetal hemoglobin [MIM:613566]
,,,"Anemia, dyserythropoietic congenital, type IV [MIM:613673]"
,,,
KLF5,Kruppel-like factor 5 (intestinal) ,?,
,,,mutations
,,,
KLF6,Kruppel-like factor 6 ,10p15,
,,,"Prostate cancer, somatic [MIM:176807]"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,
KLF7,Kruppel-like factor 7 (ubiquitous) ,2q32,
,,,mutations
,,,
KLHDC8B,kelch domain containing 8B ,3p21.31,
,,,Hodgkin lymphoma [MIM:236000]
,,,
KLHL10,kelch-like 10 (Drosophila) ,?,
,,,mutations
,,,
KLHL3,kelch-like 3 (Drosophila) ,5q31,
,,,mutations
,,,
KLHL7,kelch-like 7 (Drosophila) ,7p15.3,
,,,Retinitis pigmentosa-42 [MIM:612943]
,,,
KLHL9,kelch-like 9 (Drosophila) ,?,
,,,mutations
,,,
KLK12,kallikrein-related peptidase 12 ,19q13.4,
,,,mutations
,,,
KLK15,kallikrein-related peptidase 15 ,19q13.4,
,,,mutations
,,,
KLK1,kallikrein 1 ,19q13.4,
,,,"Kallikrein, decreased urinary activity of"
,,,
KLK3,kallikrein-related peptidase 3 ,19q13.4,
,,,mutations
,,,
KLK4,kallikrein-related peptidase 4 ,19q13.4,
,,,"Amelogenesis imperfecta, type IIA1 [MIM:204700]"
,,,
KLK7,kallikrein-related peptidase 7 ,?,
,,,mutations
,,,
KLKB1,"kallikrein B, plasma (Fletcher factor) 1 ",4q35,
,,,Fletcher factor deficiency [MIM:612423]
,,,
KLRK1,"killer cell lectin-like receptor subfamily K, member 1 ",12p13.2-p12.3,
,,,mutations
,,,
KL,klotho ,13q12,
,,,"Coronary artery disease, susceptibility to"
,,,"Tumoral calcinosis, hyperphosphatemic [MIM:211900]"
,,,
KMS,Kabuki mental retardation syndrome ,Xp22.3,
,,,Kallmann syndrome
,,,
KNG1,kininogen 1 ,3q27,
,,,Kininogen deficiency [MIM:228960]
,,,High molecular weight kininogen deficiency [MIM:228960]
,,,
KPNA1,karyopherin alpha 1 (importin alpha 5) ,3q21,
,,,mutations
,,,
KRAS,v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ,12p12.1,
,,,Lung cancer [MIM:211980]
,,,Bladder cancer [MIM:109800]
,,,"Breast cancer, somatic [MIM:114480]"
,,,"Pancreatic carcinoma, somatic [MIM:260350]"
,,,Gastric cancer [MIM:137215]
,,,"Leukemia, acute myelogenous"
,,,Noonan syndrome 3 [MIM:609942]
,,,Cardiofaciocutaneous syndrome [MIM:115150]
,,,
KRIT1,"KRIT1, ankyrin repeat containing ",7q11.2-q21,
,,,Cerebral cavernous malformations-1 [MIM:116860]
,,,Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations [MIM:116860]
,,,Cavernous malformations of CNS and retina [MIM:116860]
,,,
KRT10,keratin 10 ,17q21-q22,
,,,Epidermolytic hyperkeratosis [MIM:113800]
,,,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis [MIM:607602]"
,,,Ichthyosis with confetti [MIM:609165]
,,,
KRT12,keratin 12 ,17q12,
,,,Meesmann corneal dystrophy [MIM:122100]
,,,
KRT13,keratin 13 ,17q21-q22,
,,,White sponge nevus [MIM:193900]
,,,
KRT14,keratin 14 ,17q12-q21,
,,,"Epidermolysis bullosa simplex, Dowling-Meara type [MIM:131760]"
,,,"Epidermolysis bullosa simplex, Koebner type [MIM:131900]"
,,,"Epidermolysis bullosa simplex, recessive [MIM:601001]"
,,,Naegeli-Franceschetti-Jadassohn syndrome [MIM:161000]
,,,Dermatopathia pigmentosa reticularis [MIM:125595]
,,,"Epidermolysis bullosa simplex, Weber-Cockayne type [MIM:131800]"
,,,
KRT16,keratin 16 ,17q12-q21,
,,,"Pachyonychia congenita, Jadassohn-Lewandowsky type [MIM:167200]"
,,,"Palmoplantar keratoderma, nonepidermolytic [MIM:600962]"
,,,"Palmoplantar verrucous nevus, unilateral [MIM:144200]"
,,,"Palmoplantar keratoderma, nonepidermolytic, focal [MIM:613000]"
,,,
KRT17,keratin 17 ,17q12-q21,
,,,"Pachyonychia congenita, Jackson-Lawler type [MIM:167210]"
,,,Steatocystoma multiplex [MIM:184500]
,,,
KRT18,keratin 18 ,12q13,
,,,"Cirrhosis, cryptogenic"
,,,"Cirrhosis, noncryptogenic, susceptibility to [MIM:215600]"
,,,
KRT1,keratin 1 ,12q13,
,,,Epidermolytic hyperkeratosis [MIM:113800]
,,,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis [MIM:607602]"
,,,"Ichthyosis histrix, Curth-Macklin Palmoplantar keratoderma, nonepidermolytic [MIM:600962]"
,,,"Plamoplantar keratoderma, epidermolytic [MIM:144200]"
,,,Keratosis palmoplantaris striata III [MIM:607654]
,,,
KRT2,keratin 2 ,12q11-q13,
,,,Ichthyosis bullosa of Siemens [MIM:146800]
,,,
KRT31,keratin 31 ,17q12-q21,
,,,mutations
,,,
KRT37,keratin 37 ,17q12-q21,
,,,mutations
,,,
KRT38,keratin 38 ,17q12-q21,
,,,mutations
,,,
KRT3,keratin 3 ,12q13,
,,,Meesmann corneal dystrophy [MIM:122100]
,,,
KRT4,keratin 4 ,12q13,
,,,White sponge nevus [MIM:193900]
,,,
KRT5,keratin 5 ,12q13,
,,,"Epidermolysis bullosa simplex, Dowling-Meara type [MIM:131760]"
,,,"Epidermolysis bullosa simplex, Koebner type [MIM:131900]"
,,,"Epidermolysis bullosa simplex, Weber-Cockayne type [MIM:131800]"
,,,Epidermolysis bullosa simplex with mottled pigmentation [MIM:131960]
,,,Dowling-Degos disease [MIM:179850]
,,,Epidermolysis bullosa simplex with migratory circinate erythema [MIM:609352]
,,,
KRT6A,keratin 6A ,12q13,
,,,"Pachyonychia congenita, Jadassohn-Lewandowsky type [MIM:167200]"
,,,
KRT6B,keratin 6B ,12q13,
,,,"Pachyonychia congenita, Jackson-Lawler type [MIM:167210]"
,,,
KRT6C,keratin 6C ,12q13.13,
,,,mutations
,,,
KRT74,keratin 74 ,12q13,
,,,"Woolly hair, autosomal dominant [MIM:194300]"
,,,
KRT75,keratin 75 ,12q13,
,,,"Pseudofolliculitis barbae, susceptibility to [MIM:612318]"
,,,
KRT81,keratin 81 ,12q13,
,,,Monilethrix [MIM:158000]
,,,
KRT83,keratin 83 ,12q13,
,,,Monilethrix [MIM:158000]
,,,
KRT85,keratin 85 ,12q13,
,,,"Ectodermal dysplasia, 'pure' hair-nail type [MIM:602032]"
,,,
KRT86,keratin 86 ,12q13,
,,,Monilethrix [MIM:158000]
,,,
KRT8,keratin 8 ,12q13,
,,,"Cirrhosis, cryptogenic"
,,,"Cirrhosis, noncryptogenic, susceptibility to [MIM:215600]"
,,,
KRT9,keratin 9 ,17q12-q21,
,,,Epidermolytic palmoplantar keratoderma [MIM:144200]
,,,
KRTAP1-1,keratin associated protein 1-1 ,17q12-q21,
,,,mutations
,,,
KTCN2,Keratoconus 2 ,16q22.3-q23.1,
,,,Keratoconus 2
,,,
KTCN3,Keratoconus 3 ,3p14-q13,
,,,Keratoconus 3
,,,
KTCN4,Keratoconus 4 ,2p24,
,,,Keratoconus 4
,,,
KTWS,Klippel-Trenaunay-Weber syndrome ,8q22.3,
,,,Klippel-Trenaunay-Weber syndrome
,,,
KWE,keratolytic winter erythema (Oudtshoorn skin disease) ,8p23-p22,
,,,Keratolytic winter erythema
,,,
KYNU,kynureninase ,?,
,,,mutations
,,,
KYPSC1,Kyphoscoliosis 1 ,5p13,
,,,Kyphoscoliosis 1
,,,
L1CAM,L1 cell adhesion molecule ,Xq28,
,,,Hydrocephalus due to aqueductal stenosis [MIM:307000]
,,,MASA syndrome [MIM:303350]
,,,CRASH syndrome [MIM:303350]
,,,Hydrocephalus with Hirschsprung disease and cleft palate [MIM:142623]
,,,Hydrocephalus with congenital idiopathic intestinal pseudoobstruction [MIM:307000]
,,,"Corpus callosum, partial agenesis of [MIM:304100]"
,,,
L2HGDH,L-2-hydroxyglutarate dehydrogenase ,14q22.1,
,,,L-2-hydroxyglutaric aciduria [MIM:236792]
,,,
L3MBTL1,l(3)mbt-like 1 (Drosophila) ,20q12,
,,,mutations
,,,
LAG5,Leukocyte antigen group 5 ,4,
,,,"Neutropenia, neonatal alloimmune"
,,,
LALL,Lymphomatous acute lymphoblastic leukemia ,9p22-p21,
,,,"Leukemia, acute lymphoblastic"
,,,
LAMA1,"laminin, alpha 1 ",18p11.31,
,,,mutations
,,,
LAMA2,"laminin, alpha 2 ",6q22-q23,
,,,"Muscular dystrophy, congenital merosin-deficient [MIM:607855]"
,,,"Muscular dystrophy, congenital, due to partial LAMA2 deficiency [MIM:607855]"
,,,
LAMA3,"laminin, alpha 3 ",18q11.2,
,,,"Epidermolysis bullosa, junctional, Herlitz type [MIM:226700]"
,,,"Epidermolysis bullosa, generalized atrophic benign [MIM:226650]"
,,,Laryngoonychocutaneous syndrome [MIM:245660]
,,,
LAMA4,"laminin, alpha 4 ",6q21,
,,,mutations
,,,
LAMA5,"laminin, alpha 5 ",20q13.2-q13.3,
,,,mutations
,,,
LAMB1,"laminin, beta 1 ",7q31.1-q31.3,
,,,"Cutis laxa, marfanoid neonatal type"
,,,
LAMB2,"laminin, beta 2 (laminin S) ",3p21,
,,,"Nephrosis, congenital, with or without ocular abnormalities [MIM:609049]"
,,,Pierson syndrome [MIM:609049]
,,,
LAMB3,"laminin, beta 3 ",1q32,
,,,"Epidermolysis bullosa, junctional, Herlitz type [MIM:226700]"
,,,"Epidermolysis bullosa, junctional, non-Herlitz type [MIM:226650]"
,,,
LAMC1,"laminin, gamma 1 (formerly LAMB2) ",1q31,
,,,mutations
,,,
LAMC2,"laminin, gamma 2 ",1q25-q31,
,,,"Epidermolysis bullosa, junctional, Herlitz type [MIM:226700]"
,,,"Epidermolysis bullosa, junctional, non-Herlitz type [MIM:226650]"
,,,
LAMC3,"laminin, gamma 3 ",9q33-q34,
,,,mutations
,,,
LAMP2,lysosomal-associated membrane protein 2 ,Xq24,
,,,Glycogen storage disease IIb [MIM:300257]
,,,
LAMTOR2,"late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 ",1q22,
,,,Immunodeficiency due to defect in MAPBP-interacting protein [MIM:610798]
,,,
LAP,Laryngeal adductor paralysis ,6p21.3-p21.2,
,,,Laryngeal adductor paralysis
,,,
LARGE,like-glycosyltransferase ,22q12.3-q13.1,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6 [MIM:613154]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6 [MIM:608840]"
,,,
LARS2,"leucyl-tRNA synthetase 2, mitochondrial ",3p21.3,
,,,mutations
,,,
LAT,linker for activation of T cells ,16p11.2,
,,,mutations
,,,
LBMQTL1,Lean body mass QTL 1 ,8q23,
,,,Lean body mass QTL 1
,,,
LBP,lipopolysaccharide binding protein ,20q11.23-q12,
,,,mutations
,,,
LBR,lamin B receptor ,1q42.1,
,,,Pelger-Huet anomaly [MIM:169400]
,,,HEM skeletal dysplasia [MIM:215140]
,,,Reynolds syndrome [MIM:613471]
,,,
LCA10,lung carcinoma-associated protein 10 ,12q21.3,
,,,Joubert syndrome 5 [MIM:610188]
,,,Senior-Loken syndrome 6 [MIM:610189]
,,,Leber congenital amaurosis 10 [MIM:611755]
,,,Meckel syndrome type 4 [MIM:611134]
,,,Bardet-Biedl syndrome 14 [MIM:209900]
,,,
LCA5,Leber congenital amaurosis 5 ,6q14.1,
,,,Leber congenital amaurosis 5 [MIM:604537]
,,,
LCA9,Leber congenital amaurosis 9 ,1p36,
,,,Leber congenital amaurosis 9
,,,
LCAT,lecithin-cholesterol acyltransferase ,16q22.1,
,,,Norum disease [MIM:245900]
,,,Fish-eye disease [MIM:136120]
,,,
LCE3B,late cornified envelope 3B ,1q21,
,,,mutations
,,,
LCE3C,late cornified envelope 3C ,1q21,
,,,mutations
,,,
LCE5A,late cornified envelope 5A ,1q21,
,,,mutations
,,,
LCK,lymphocyte-specific protein tyrosine kinase ,1p35-p34.3,
,,,SCID due to LCK deficiency
,,,
LCN10,lipocalin 10 ,9q34,
,,,mutations
,,,
LCO,liver cancer oncogene ,2q14-q21,
,,,Hepatocellular carcinoma
,,,
LCRB,"locus control region, beta ",11p15.5,
,,,"Thalassemia, Hispanic gamma-delta-beta [MIM:604131]"
,,,
LCS1,lymphedema-cholestasis syndrome 1 ,15q,
,,,Cholestasis-lymphedema syndrome
,,,
LCT,lactase ,2q21,
,,,"Lactase deficiency, congenital [MIM:223000]"
,,,
LDB3,LIM domain binding 3 ,10q22.2-q23.3,
,,,"Myopathy, myofibrillar, ZASP-related [MIM:609452]"
,,,"Cardiomyopathy, dilated 1C [MIM:601493]"
,,,"Left ventricular noncompaction 3, with or without dilated cardiomyopathy [MIM:601493]"
,,,
LDHA,lactate dehydrogenase A ,11p15.4,
,,,Glycogen storage disease XI [MIM:612933]
,,,
LDHB,lactate dehydrogenase B ,12p12.2-p12.1,
,,,Lactate dehydrogenase-B deficiency
,,,
LDLRAP1,low density lipoprotein receptor adaptor protein 1 ,1p36-p35,
,,,"Hypercholesterolemia, familial, autosomal recessive [MIM:603813]"
,,,
LDLR,low density lipoprotein receptor ,19p13.2,
,,,"Hypercholesterolemia, familial [MIM:143890]"
,,,LDL cholesterol level QTL2
,,,
LECD,"Corneal dystrophy, Lisch epithelial ",Xp22.3,
,,,"Corneal dystrophy, Lisch epithelial"
,,,
LEF1,lymphoid enhancer-binding factor 1 ,4q23-q25,
,,,"Sebaceous tumors, somatic"
,,,
LEFTY2,left-right determination factor 2 ,1q42.1,
,,,Left-right axis malformations
,,,
LEMD3,LEM domain containing 3 ,12q14,
,,,Osteopoikilosis [MIM:166700]
,,,Buschke-Ollendorff syndrome [MIM:166700]
,,,Melorheostosis with osteopoikilosis [MIM:155950]
,,,
LEPRE1,leucine proline-enriched proteoglycan (leprecan) 1 ,1p34,
,,,"Osteogenesis imperfecta, type VIII [MIM:610915]"
,,,
LEPREL1,leprecan-like 1 ,?,
,,,mutations
,,,
LEPR,leptin receptor ,1p31,
,,,"Obesity, morbid, with hypogonadism"
,,,
LEP,leptin ,7q31.3,
,,,"Obesity, severe, due to leptin deficiency"
,,,"Obesity, morbid, with hypogonadism"
,,,
LETM1,leucine zipper-EF-hand containing transmembrane protein 1 ,4p16.3,
,,,mutations
,,,
LFNG,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase ,7p22,
,,,"Spondylocostal dysostosis, autosomal recessive 3 [MIM:609813]"
,,,
LFS3,Li-Fraumeni syndrome 3 ,1q23,
,,,Li-Fraumeni syndrome 3
,,,
LGALS13,"lectin, galactoside-binding, soluble, 13 ",19q13.1,
,,,mutations
,,,
LGALS2,"lectin, galactoside-binding, soluble, 2 ",22q13.1,
,,,"Myocardial infarction, susceptibility to"
,,,
LGALS3,"lectin, galactoside-binding, soluble, 3 ",14q21-q22,
,,,mutations
,,,
LGI1,"leucine-rich, glioma inactivated 1 ",10q24,
,,,"Epilepsy, partial, with auditory features [MIM:600512]"
,,,
LGMD1D,limb girdle muscular dystrophy 1D (autosomal dominant) ,7q,
,,,"Muscular dystrophy, limb-girdle, type 1D"
,,,
LGMD1F,limb girdle muscular dystrophy 1F (autosomal dominant) ,7q32.1-q32.2,
,,,"Muscular dystrophy, limb-girdle, type 1F"
,,,
LGMD1G,limb girdle muscular dystrophy 1G (autosomal dominant) ,4q21,
,,,"Limb-girdle muscular dystrophy, type 1G"
,,,
LGMD1H,limb girdle muscular dystrophy 1H (autosomal dominant) ,3p25.1-p23,
,,,"Muscular dystrophy, limb-girdle, type 1H"
,,,
LGMD2L,limb girdle muscular dystrophy 2L (autosomal recessive) ,11p14.3,
,,,Gnathodiaphyseal dysplasia [MIM:166260]
,,,"Muscular dystrophy, limb-girdle, type 2L [MIM:611307]"
,,,Miyoshi muscular dystrophy 3 [MIM:613319]
,,,
LGR4,leucine-rich repeat containing G protein-coupled receptor 4 ,11p14-p13,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,
LGV1,longevity 1 ,4q25,
,,,Longevity 1
,,,
LHB,luteinizing hormone beta polypeptide ,19q13.32,
,,,"Hypogonadism, hypergonadotropic"
,,,Male pseudohermaphroditism due to defective LH
,,,
LHCGR,luteinizing hormone/choriogonadotropin receptor ,2p21,
,,,"Precocious puberty, male [MIM:176410]"
,,,Leydig cell hypoplasia with pseudohermaphroditism [MIM:238320]
,,,Leydig cell hypoplasia with hypergonadotropic hypogonadism [MIM:238320]
,,,"Luteinizing hormone resistance, female [MIM:238320]"
,,,"Leydig cell adenoma, somatic, with precocious puberty [MIM:176410]"
,,,
LHFPL5,lipoma HMGIC fusion partner-like 5 ,6p21.3,
,,,"Deafness, autosomal recessive 67 [MIM:610265]"
,,,
LHX1,LIM homeobox 1 ,17q12,
,,,mutations
,,,
LHX3,LIM homeobox 3 ,9q34.3,
,,,"Pituitary hormone deficiency, combined, 3 [MIM:221750]"
,,,
LHX4,LIM homeobox 4 ,1q25,
,,,"Pituitary hormone deficiency, combined, 4 [MIM:262700]"
,,,
LHX8,LIM homeobox 8 ,1p31.1,
,,,mutations
,,,
LI5,Lamellar ichthyosis 5 ,17p13.2-p13.1,
,,,"Ichthyosis, lamellar, 5"
,,,
LIAS,lipoic acid synthetase ,4p14,
,,,mutations
,,,
LIFR,leukemia inhibitory factor receptor alpha ,5p13.1,
,,,Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome [MIM:601559]
,,,
LIF,leukemia inhibitory factor ,22q12.1-q12.2,
,,,mutations
,,,
LIG1,"ligase I, DNA, ATP-dependent ",19q13.2-q13.3,
,,,DNA ligase I deficiency
,,,
LIG3,"ligase III, DNA, ATP-dependent ",17q11.2-q12,
,,,mutations
,,,
LIG4,"ligase IV, DNA, ATP-dependent ",13q22-q34,
,,,LIG4 syndrome [MIM:606593]
,,,"Multiple myeloma, resistance to [MIM:254500]"
,,,
LILRA3,"leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 ",19q13.4,
,,,mutations
,,,
LIM2,"lens intrinsic membrane protein 2, 19kDa ",19q13.4,
,,,"Cataract, cortical pulverulent, late-onset"
,,,
LIMK1,LIM domain kinase 1 ,7q11.23,
,,,mutations
,,,
LIN28A,lin-28 homolog A (C. elegans) ,1p36.11,
,,,mutations
,,,
LIN28B,lin-28 homolog B (C. elegans) ,6q21,
,,,mutations
,,,
LINS,lines homolog (Drosophila) ,?,
,,,mutations
,,,
LIPA,"lipase A, lysosomal acid, cholesterol esterase ",10q23.31,
,,,Wolman disease [MIM:278000]
,,,Cholesteryl ester storage disease [MIM:278000]
,,,
LIPC,"lipase, hepatic ",15q21-q23,
,,,Hepatic lipase deficiency
,,,High density lipoprotein cholesterol level QTL 12 [MIM:612797]
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
LIPE,"lipase, hormone-sensitive ",19q13.1-q13.2,
,,,mutations
,,,
LIPG,"lipase, endothelial ",18q21.1,
,,,mutations
,,,
LIPH,"lipase, member H ",3q27-q28,
,,,"Hypotrichosis, localized, autosomal recessive 2 [MIM:604379]"
,,,"Woolly hair, autosomal recessive 2 with or without hypotrichosis [MIM:604379]"
,,,
LIPI,"lipase, member I ",21q11.2,
,,,"Hypertriglyceridemia, susceptibility to [MIM:145750]"
,,,
LIPN,"lipase, family member N ",?,
,,,mutations
,,,
LITAF,lipopolysaccharide-induced TNF factor ,16p13.3-p12,
,,,"Charcot-Marie-Tooth disease, type 1C [MIM:601098]"
,,,
LKMCD,Leukoencephalopathy with metaphyseal chondrodysplasia ,Xq25-q27,
,,,Leukoencephalopathy with metaphyseal chondrodysplasia
,,,
LLGL1,lethal giant larvae homolog 1 (Drosophila) ,17p12-p11.2,
,,,mutations
,,,
LMAN1,"lectin, mannose-binding, 1 ",18q21.3-q22,
,,,Combined factor V and VIII deficiency [MIM:227300]
,,,
LMBR1,limb region 1 homolog (mouse) ,7q36,
,,,Acheiropody [MIM:200500]
,,,"Polydactyly, preaxial type II [MIM:174500]"
,,,"Triphalangeal thumb, type I [MIM:174500]"
,,,Triphalangeal thumb-polysyndactyly syndrome [MIM:174500]
,,,"Syndactyly, type IV [MIM:186200]"
,,,
LMBRD1,LMBR1 domain containing 1 ,6q13,
,,,"Methylmalonic aciduria and homocystinuria, cblF type [MIM:277380]"
,,,
LMF1,lipase maturation factor 1 ,16p13.3,
,,,"Lipase deficiency, combined [MIM:246650]"
,,,
LMNA,lamin A/C ,1q21.2,
,,,"Emery-Dreifuss muscular dystrophy, AD [MIM:181350]"
,,,"Cardiomyopathy, dilated, 1A [MIM:115200]"
,,,"Lipodystrophy, familial partial [MIM:151660]"
,,,"Emery-Dreifuss muscular dystrophy, AR [MIM:181350]"
,,,"Charcot-Marie-Tooth disease, type 2B1 [MIM:605588]"
,,,"Muscular dystrophy, limb-girdle, type 1B [MIM:159001]"
,,,Mandibuloacral dysplasia [MIM:248370]
,,,Hutchinson-Gilford progeria [MIM:176670]
,,,"Restrictive dermopathy, lethal [MIM:275210]"
,,,"Heart-hand syndrome, Slovenian type [MIM:610140]"
,,,
LMNB1,lamin B1 ,5q23.3-q31.1,
,,,"Leukodystrophy, adult-onset, autosomal dominant [MIM:169500]"
,,,
LMNB2,lamin B2 ,19p13.3,
,,,"Lipodystrophy, partial, acquired [MIM:608709]"
,,,
LMO1,LIM domain only 1 (rhombotin 1) ,11p15,
,,,"Leukemia, T-cell acute lymphoblastic"
,,,
LMO2,LIM domain only 2 (rhombotin-like 1) ,11p13,
,,,"Leukemia, acute T-cell"
,,,
LMPH1B,"Lymphedema, hereditary, IB ",6q16.2-q22.1,
,,,"Lymphedema, hereditary, IB"
,,,
LMTK3,lemur tyrosine kinase 3 ,?,
,,,mutations
,,,
LMX1B,"LIM homeobox transcription factor 1, beta ",9q34.1,
,,,Nail-patella syndrome [MIM:161200]
,,,
LNCR1,Lung cancer 1 ,6q23-q25,
,,,Lung cancer susceptibility
,,,
LNCR3,Lung cancer susceptibility 3 ,5p15.33,
,,,Lung cancer susceptibility 3
,,,
LNCR4,Lung cancer susceptibility 4 ,6p21.33,
,,,Lung cancer susceptibility 4
,,,
LNX2,ligand of numb-protein X 2 ,13q12.2,
,,,mutations
,,,
LOAS,"Leber optic atrophy, susceptibility to ",Xp11,
,,,"Leber optic atrophy, susceptibility to"
,,,
LOC344967,acyl-CoA thioesterase 7 pseudogene ,4p14-p11,
,,,mutations
,,,
LOC619540,keratosis palmoplantaris papulosa ,15q22-q24,
,,,"Keratoderma, palmoplantar, punctate type 1"
,,,
LOC643714,uncharacterized LOC643714 ,?,
,,,mutations
,,,
LOR,loricrin ,1q21,
,,,Vohwinkel syndrome with ichthyosis [MIM:604117]
,,,
LOXHD1,lipoxygenase homology domains 1 ,18q12-q21,
,,,"Deafness, autosomal recessive 77 [MIM:613079]"
,,,
LOXL1,lysyl oxidase-like 1 ,15q22,
,,,"Exfoliation syndrome, susceptibility to [MIM:177650]"
,,,
LOXL2,lysyl oxidase-like 2 ,8p21.3-p21.2,
,,,mutations
,,,
LOX,lysyl oxidase ,5q23.3-q31.2,
,,,mutations
,,,
LPAR1,lysophosphatidic acid receptor 1 ,9q31.3,
,,,mutations
,,,
LPAR6,lysophosphatidic acid receptor 6 ,13q14.12-q14.2,
,,,"Hypotrichosis, localized, autosomal recessive, 3 [MIM:611452]"
,,,"Woolly hair, autosomal recessive 1 [MIM:278150]"
,,,
LPA,"lipoprotein, Lp(a) ",6q27,
,,,"Coronary artery disease, susceptibility to"
,,,"LPA deficiency, congenital"
,,,
LPIN1,lipin 1 ,2p21,
,,,"Myoglobinuria, acute recurrent, autosomal recessive [MIM:268200]"
,,,
LPIN2,lipin 2 ,18p,
,,,Majeed syndrome [MIM:609628]
,,,
LPIN3,lipin 3 ,20q,
,,,mutations
,,,
LPL,lipoprotein lipase ,8p22,
,,,Lipoprotein lipase deficiency [MIM:238600]
,,,"Combined hyperlipidemia, familial [MIM:144250]"
,,,High density lipoprotein cholesterol level QTL 11
,,,
LPP,LIM domain containing preferred translocation partner in lipoma ,3q28,
,,,Lipoma
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
LPRS1,"Leprosy, susceptibility to 1 ",10p13,
,,,"Leprosy, paucibacillary type, susceptibility to"
,,,
LPRS6,"Leprosy, susceptiblity to, 6 ",13q14.11,
,,,"Leprosy, susceptiblity to, 6"
,,,
LPSA,"Oncogene liposarcoma (DNA segment, single copy, expressed, probes ",19p13.2-q13.3,
,,,Liposarcoma
,,,
LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) ,4q31,
,,,"Retinal dystrophy, early-onset severe [MIM:613341]"
,,,Leber congenital amaurosis 14 [MIM:613341]
,,,"Retinitis pigmentosa, juvenile [MIM:613341]"
,,,
LRCH1,leucine-rich repeats and calponin homology (CH) domain containing 1 ,13q14,
,,,mutations
,,,
LRFN5,leucine rich repeat and fibronectin type III domain containing 5 ,14q21.2,
,,,mutations
,,,
LRP1,low density lipoprotein receptor-related protein 1 ,12q13.1-q13.3,
,,,mutations
,,,
LRP2,low density lipoprotein receptor-related protein 2 ,2q24-q31,
,,,Donnai-Barrow syndrome [MIM:222448]
,,,
LRP4,low density lipoprotein receptor-related protein 4 ,11p12-p11.2,
,,,Cenani-Lenz syndactyly syndrome [MIM:212780]
,,,
LRP5,low density lipoprotein receptor-related protein 5 ,11q13.4,
,,,Osteoporosis-pseudoglioma syndrome [MIM:259770]
,,,Bone mineral density variability 1 [MIM:601884]
,,,"Osteopetrosis, AD type I [MIM:607634]"
,,,"Hyperostosis, endosteal [MIM:144750]"
,,,"van Buchem disease, type 2 [MIM:607636]"
,,,Osteosclerosis [MIM:144750]
,,,Osteoporosis [MIM:166710]
,,,Exudative vitreoretinopathy 4 [MIM:601813]
,,,
LRP6,low density lipoprotein receptor-related protein 6 ,12p13.3-p11.2,
,,,"Coronary artery disease, autosomal dominant, 2 [MIM:610947]"
,,,
LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor ",1p34,
,,,"Myocardial infarction, susceptibility to [MIM:608446]"
,,,
LRPAP1,low density lipoprotein receptor-related protein associated protein 1 ,4p16.3,
,,,mutations
,,,
LRPPRC,leucine-rich pentatricopeptide repeat containing ,2p21-p16,
,,,"Leigh syndrome, French-Canadian type [MIM:220111]"
,,,
LRRC4,leucine rich repeat containing 4 ,?,
,,,mutations
,,,
LRRC8A,"leucine rich repeat containing 8 family, member A ",9q34.13,
,,,Agammaglobulinemia 5 [MIM:613506]
,,,
LRRK2,leucine-rich repeat kinase 2 ,12q12,
,,,Parkinson disease-8 [MIM:607060]
,,,
LRSAM1,leucine rich repeat and sterile alpha motif containing 1 ,9q33.3-q34.11,
,,,mutations
,,,
LRSL,Larsen-like syndrome ,6p25,
,,,Larsen-like syndrome
,,,
LRTOMT,leucine rich transmembrane and 0-methyltransferase domain containing ,11q13.3-q13.4,
,,,"Deafness, autosomal recessive 63 [MIM:611451]"
,,,
LSL,"Leptin, serum levels of ",2p21,
,,,Leptin serum levels QTL1
,,,
LTA,"lymphotoxin alpha (TNF superfamily, member 1) ",6p21.3,
,,,"Myocardial infarction, susceptibility to"
,,,"Psoriatic arthritis, susceptibility to [MIM:607507]"
,,,"Leprosy, susceptibility to, 4 [MIM:610988]"
,,,
LTBP1,latent transforming growth factor beta binding protein 1 ,2p12-q22,
,,,mutations
,,,
LTBP2,latent transforming growth factor beta binding protein 2 ,14q24,
,,,"Glaucoma 3, primary congenital, D [MIM:613086]"
,,,
LTBP3,latent transforming growth factor beta binding protein 3 ,11q12,
,,,"Tooth agenesis, selective, 6 [MIM:613097]"
,,,
LTBP4,latent transforming growth factor beta binding protein 4 ,19q13.1-q13.2,
,,,"Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities [MIM:613177]"
,,,
LTC4S,leukotriene C4 synthase ,5q35,
,,,Leukotriene C4 synthase deficiency
,,,
LTF,lactotransferrin ,3p21.31,
,,,mutations
,,,
LTK,leukocyte receptor tyrosine kinase ,15q15.1-q21.1,
,,,mutations
,,,
LTN1,listerin E3 ubiquitin protein ligase 1 ,21q22.11,
,,,mutations
,,,
LUM,lumican ,12q21.3-q22,
,,,mutations
,,,
LVG2,longevity 2 ,6q21,
,,,Longevity 2
,,,
LVNC2,"noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2 ",11p15,
,,,Left ventricular noncompaction 2
,,,
LY96,lymphocyte antigen 96 ,?,
,,,mutations
,,,
LYL1,lymphoblastic leukemia derived sequence 1 ,19p13.2-p13.1,
,,,"Leukemia, T-cell acute lymphoblastoid"
,,,
LYN,v-yes-1 Yamaguchi sarcoma viral related oncogene homolog ,8q13-qter,
,,,mutations
,,,
LYST,lysosomal trafficking regulator ,1q42.1-q42.2,
,,,Chediak-Higashi syndrome [MIM:214500]
,,,
LYZ,lysozyme ,12q15,
,,,"Amyloidosis, renal [MIM:105200]"
,,,
LZTFL1,leucine zipper transcription factor-like 1 ,3p21.3,
,,,mutations
,,,
LZTS1,"leucine zipper, putative tumor suppressor 1 ",8p22,
,,,Esophageal squamous cell carcinoma [MIM:133239]
,,,
MAA,microphthalmia or anophthalmia and associated anomalies ,Xq27-q28,
,,,"Microphthalmia, syndromic 1"
,,,
MACROD2,MACRO domain containing 2 ,20p12,
,,,mutations
,,,
MACST,Macrostomia ,1p34-p32,
,,,Macrostomia
,,,
MAD1L1,MAD1 mitotic arrest deficient-like 1 (yeast) ,7p22,
,,,"Lymphoma, somatic"
,,,"Prostate cancer, somatic [MIM:176807]"
,,,
MAD2L1,MAD2 mitotic arrest deficient-like 1 (yeast) ,4q27,
,,,mutations
,,,
MADD,MAP-kinase activating death domain ,11p11.2,
,,,mutations
,,,
MAFB,v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) ,20q11.2-q13.1,
,,,mutations
,,,
MAFD1,major affective disorder 1 ,18p,
,,,Major affective disorder 1
,,,
MAFD2,major affective disorder 2 ,Xq28,
,,,Major affective disorder 2
,,,
MAFD3,"Major affective disorder 3, early onset ",21q22.13,
,,,"Major affective disorder 3, early onset"
,,,
MAFD4,Major affective disorder 4 ,16p12,
,,,Major affective disorder 4
,,,
MAFD5,Major affective disorder 5 ,2q22-q24,
,,,Major affective disorder 5
,,,
MAFD6,Major affective disorder 6 ,6q23-q24,
,,,Major affective disorder 6
,,,
MAFD8,"Major affective disorder-8, susceptibility to ",10q21,
,,,"Major affective disorder-8, susceptibility to"
,,,
MAFD9,"Major affective disorder-9, susceptibility to ",12p13.3,
,,,"Major affective disorder-9, susceptibility to"
,,,
MAF,v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) ,16q22-q23,
,,,"Cataract, pulverulent or cerulean, with or without microcornea"
,,,
MAGEE2,"melanoma antigen family E, 2 ",Xq13.1,
,,,mutations
,,,
MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2 ",7q21,
,,,mutations
,,,
MAGT1,magnesium transporter 1 ,Xq13.1-q13.2,
,,,"Mental retardation, X-linked 95 [MIM:300716]"
,,,
MAG,myelin associated glycoprotein ,19q13.1,
,,,mutations
,,,
MAK,male germ cell-associated kinase ,6q22,
,,,mutations
,,,
MALL,"mal, T-cell differentiation protein-like ",2q13,
,,,mutations
,,,
MALT1,mucosa associated lymphoid tissue lymphoma translocation gene 1 ,18q21,
,,,MALT lymphoma
,,,
MAL,"mal, T-cell differentiation protein ",2cen-q13,
,,,mutations
,,,
MAML2,mastermind-like 2 (Drosophila) ,11q21,
,,,Mucoepidermoid salivary gland carcinoma
,,,
MAMLD1,mastermind-like domain containing 1 ,Xq28,
,,,"Hypospadias 2, X-linked [MIM:300758]"
,,,
MAN1A2,"mannosidase, alpha, class 1A, member 2 ",1p13,
,,,mutations
,,,
MAN1B1,"mannosidase, alpha, class 1B, member 1 ",?,
,,,mutations
,,,
MAN2B1,"mannosidase, alpha, class 2B, member 1 ",19cen-q12,
,,,"Mannosidosis, alpha-, types I and II [MIM:248500]"
,,,
MANBA,"mannosidase, beta A, lysosomal ",4q22-q25,
,,,"Mannosidosis, beta [MIM:248510]"
,,,
MAOA,monoamine oxidase A ,Xp11.23,
,,,Brunner syndrome [MIM:300615]
,,,
MAOB,monoamine oxidase B ,Xp11.23,
,,,monoamine oxidase deficiency
,,,
MAP2K1,mitogen-activated protein kinase kinase 1 ,15q21,
,,,Cardiofaciocutaneous syndrome [MIM:115150]
,,,
MAP2K2,mitogen-activated protein kinase kinase 2 ,19p13.3,
,,,Cardiofaciocutaneous syndrome [MIM:115150]
,,,
MAP2K3,mitogen-activated protein kinase kinase 3 ,17q11.2,
,,,mutations
,,,
MAP2K4,mitogen-activated protein kinase kinase 4 ,17p11.2,
,,,mutations
,,,
MAP2,microtubule-associated protein 2 ,2q34-q35,
,,,mutations
,,,
MAP3K15,mitogen-activated protein kinase kinase kinase 15 ,Xp22.12,
,,,mutations
,,,
MAP3K1,"mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase ",5q11.2,
,,,mutations
,,,
MAP3K8,mitogen-activated protein kinase kinase kinase 8 ,10p11.2,
,,,"Lung cancer, somatic [MIM:211980]"
,,,
MAP4K5,mitogen-activated protein kinase kinase kinase kinase 5 ,14,
,,,mutations
,,,
MAP6,microtubule-associated protein 6 ,?,
,,,mutations
,,,
MAP7D3,MAP7 domain containing 3 ,?,
,,,mutations
,,,
MAPK10,mitogen-activated protein kinase 10 ,4q21.3,
,,,"Epileptic encephalopathy, Lennox-Gastaut type [MIM:606369]"
,,,
MAPK8IP1,mitogen-activated protein kinase 8 interacting protein 1 ,11p12-p11.2,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
MAPT,microtubule-associated protein tau ,17q21.1,
,,,"Dementia, frontotemporal, with or without parkinsonism [MIM:600274]"
,,,Pick disease [MIM:172700]
,,,"Supranuclear palsy, progressive [MIM:601104]"
,,,"Supranuclear palsy, progressive atypical [MIM:260540]"
,,,"Parkinson disease, susceptibility to [MIM:168600]"
,,,Tauopathy and respiratory failure (3) 11
,,,
MARS2,"methionyl-tRNA synthetase 2, mitochondrial ",2q33.1,
,,,mutations
,,,
MARVELD2,MARVEL domain containing 2 ,5q13.1,
,,,"Deafness, autosomal recessive 49 [MIM:610153]"
,,,
MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) ,3q27-q28,
,,,mutations
,,,
MASP2,mannan-binding lectin serine peptidase 2 ,1p36.3-p36.2,
,,,MASP2 deficiency
,,,
MAST4,microtubule associated serine/threonine kinase family member 4 ,?,
,,,mutations
,,,
MASTL,microtubule associated serine/threonine kinase-like ,10p12.1,
,,,Thrombocytopenia-2 [MIM:188000]
,,,
MAT1A,"methionine adenosyltransferase I, alpha ",10q22,
,,,"Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency [MIM:250850]"
,,,"Methionine adenosyltransferase deficiency, autosomal recessive [MIM:250850]"
,,,
MATN3,matrilin 3 ,2p24-p23,
,,,"Epiphyseal dysplasia, multiple, 5 [MIM:607078]"
,,,Osteoarthritis susceptibility 2 [MIM:140600]
,,,Spondyloepimetaphyseal dysplasia [MIM:608728]
,,,
MATR3,matrin 3 ,5q31.2,
,,,"Myopathy, distal 2 [MIM:606070]"
,,,
MAVS,mitochondrial antiviral signaling protein ,20p13,
,,,mutations
,,,
MAX,MYC associated factor X ,14q23,
,,,mutations
,,,
MA,"Migraine with aura, susceptibility to ",6p21.3,
,,,"Malaria, cerebral, susceptibility to [MIM:611162]"
,,,"Septic shock, susceptibility to"
,,,"Asthma, susceptibility to [MIM:600807]"
,,,"Dementia, vascular, susceptibility to"
,,,"Migraine without aura, susceptibility to [MIM:157300]"
,,,
MBD1,methyl-CpG binding domain protein 1 ,18q21.1,
,,,mutations
,,,
MBD3,methyl-CpG binding domain protein 3 ,19p13.3,
,,,mutations
,,,
MBD4,methyl-CpG binding domain protein 4 ,3q21-q22,
,,,mutations
,,,
MBD5,methyl-CpG binding domain protein 5 ,2q23.1,
,,,"Mental retardation, autosomal dominant 1 [MIM:156200]"
,,,
MBL2,"mannose-binding lectin (protein C) 2, soluble ",10q11.2-q21,
,,,Mannose-binding protein deficiency
,,,"Diabetes mellitus, gestational, susceptibility to"
,,,"Meningococcal disease, susceptibility to"
,,,"Chronic infections, due to MBL deficiency"
,,,"Preterm delivery, susceptibility to (3) 14"
,,,
MBS1,Moebius syndrome 1 ,13q12.2-q13,
,,,Moebius syndrome
,,,
MBS2,Moebius syndrome 2 ,3q21-q22,
,,,"Facial paresis, hereditary congenital, 1"
,,,
MBS3,Moebius syndrome 3 ,10q21.3-q22.1,
,,,Moebius syndrome-3
,,,
MBTPS2,"membrane-bound transcription factor peptidase, site 2 ",Xp22.12-p22.11,
,,,"Ichthyosis follicularis, atrichia, and photophobia syndrome [MIM:308205]"
,,,
MB,myoglobin ,22q11.2-q13,
,,,mutations
,,,
MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) ,16q24.3,
,,,"Skin/hair/eye pigmentation 2, red hair/fair skin [MIM:266300]"
,,,"Skin/hair/eye pigmentation 2, blond hair/fair skin [MIM:266300]"
,,,Melanoma susceptibility 5 [MIM:613099]
,,,"Analgesia from kappa-opioid receptor agonist, female-specific [MIM:613098]"
,,,"Oculocutaneous albinism, type II, modifier of,0 [MIM:203200]"
,,,UV-induced skin damage [MIM:266300]
,,,
MC2R,melanocortin 2 receptor (adrenocorticotropic hormone) ,18p11.2,
,,,"Glucocorticoid deficiency, due to ACTH unresponsiveness [MIM:202200]"
,,,
MC3R,melanocortin 3 receptor ,20q13.2,
,,,"Obesity, severe, susceptibility to, BMIQ9 [MIM:602025]"
,,,"Mycobacterium tuberculosis, protection against [MIM:607948]"
,,,
MC4R,melanocortin 4 receptor ,18q22,
,,,"Obesity, autosomal dominant [MIM:601665]"
,,,
MCCC1,methylcrotonoyl-CoA carboxylase 1 (alpha) ,3q25-q27,
,,,3-Methylcrotonyl-CoA carboxylase 1 deficiency [MIM:210200]
,,,
MCCC2,methylcrotonoyl-CoA carboxylase 2 (beta) ,5q12-q13,
,,,3-Methylcrotonyl-CoA carboxylase 2 deficiency [MIM:210210]
,,,
MCC,mutated in colorectal cancers ,5q21,
,,,Colorectal cancer
,,,
MCDR1,"macular dystrophy, retinal, 1 (North Carolina type) ",6q14-q16.2,
,,,"Macular dystrophy, North Carolina type"
,,,
MCDR3,"macular dystrophy, retinal 3 ",5p15.33-p13.1,
,,,"Macular dystrophy, retinal, 3"
,,,
MCEE,methylmalonyl CoA epimerase ,2p13.3,
,,,Methylmalonyl-CoA epimerase deficiency [MIM:251120]
,,,
MCF2L2,MCF.2 cell line derived transforming sequence-like 2 ,?,
,,,mutations
,,,
MCFD2,multiple coagulation factor deficiency 2 ,2p21-p16.3,
,,,"Factor V and factor VIII, combined deficiency of [MIM:613625]"
,,,
MCHR1,melanin-concentrating hormone receptor 1 ,22q13.3,
,,,mutations
,,,
MCI2,"Myocardial infarction, susceptiblity to, 2 ",13q12,
,,,"Myocardial infarction, susceptibility to, 2"
,,,
MCKD1,medullary cystic kidney disease 1 (autosomal dominant) ,1q21,
,,,Medullary cystic kidney disease 1
,,,
MCKD2,medullary cystic kidney disease 2 (autosomal dominant) ,16p12.3,
,,,"Hyperuricemic nephropathy, familial juvenile 1 [MIM:162000]"
,,,Medullary cystic kidney disease 2 [MIM:603860]
,,,Glomerulocystic kidney disease with hyperuricemia and isosthenuria [MIM:609886]
,,,
MCL1,myeloid cell leukemia sequence 1 (BCL2-related) ,1q21,
,,,mutations
,,,
MCM3AP,minichromosome maintenance complex component 3 associated protein ,21q22.3,
,,,mutations
,,,
MCM4,minichromosome maintenance complex component 4 ,8q11.2,
,,,mutations
,,,
MCM5,minichromosome maintenance complex component 5 ,22q13.1,
,,,mutations
,,,
MCM6,minichromosome maintenance complex component 6 ,2q21,
,,,Lactase persistance/nonpersistance [MIM:223100]
,,,
MCOLN1,mucolipin 1 ,19p13.3-p13.2,
,,,Mucolipidosis IV [MIM:252650]
,,,
MCOP,"microphthalmia, autosomal recessive ",14q32,
,,,"Microphthalmia, isolated 1"
,,,
MCOR,"microcoria, congenital ",13q31-q32,
,,,"Microcoria, congenital"
,,,
MCPH1,microcephalin 1 ,8p23,
,,,"Microcephaly, primary autosomal recessive, 1 [MIM:251200]"
,,,Premature chromosome condensation with microcephaly and mental retardation [MIM:606858]
,,,
MCS,Miles-Carpenter X-linked mental retardation syndrome ,Xq13-q22,
,,,"Mental retardation, X-linked, syndromic-4, with congenital contractures and low fingertip arches"
,,,
MDC1B,"Muscular dystrophy, congenital, 1B ",1q42,
,,,"Muscular dystrophy, congenital, 1B"
,,,
MDD1,Major depressive disorder ,12q22-q23.2,
,,,Major depressive disorder 1 [MIM:608516]
,,,
MDD2,Major depressive disorder 2 ,15q25.3-q26.2,
,,,Major depressive disorder 2 [MIM:608516]
,,,
MDH1,"malate dehydrogenase 1, NAD (soluble) ",2p16,
,,,mutations
,,,
MDM2,"Mdm2, p53 E3 ubiquitin protein ligase homolog (mouse) ",12q14.3-q15,
,,,"Accelerated tumor formation, susceptibility to"
,,,
MDM4,Mdm4 p53 binding protein homolog (mouse) ,1q32,
,,,mutations
,,,
MDN1,"MDN1, midasin homolog (yeast) ",?,
,,,mutations
,,,
MDNS,Mammary-digital-nail syndrome ,22q12.3-q13.1,
,,,Mammary-digital-nail syndrome
,,,
MDP1,magnesium-dependent phosphatase 1 ,2p12-p11.2,
,,,"Surfactant metabolism dysfunction, pulmonary, 1 [MIM:265120]"
,,,
MDRV,"muscular dystrophy, with rimmed vacuoles ",19p13.3,
,,,Muscular dystrophy with rimmed vacuoles
,,,
ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial ",18q21,
,,,"Epilepsy, idiopathic generalized, susceptibility to [MIM:600669]"
,,,"Opioid dependence, susceptibility to [MIM:610064]"
,,,
MEB,muscle-eye-brain disease ,1p34-p33,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 [MIM:253280]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3 [MIM:613151]"
,,,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3 [MIM:613157]"
,,,
MECOM,MDS1 and EVI1 complex locus ,3q26,
,,,3q21q26 syndrome
,,,
MECP2,methyl CpG binding protein 2 (Rett syndrome) ,Xq28,
,,,Rett syndrome [MIM:312750]
,,,"Mental retardation, X-linked, syndromic 13 [MIM:300055]"
,,,"Rett syndrome, preserved speech variant [MIM:312750]"
,,,"Encephalopathy, neonatal severe [MIM:300673]"
,,,"Autism susceptibility, X-linked 3 [MIM:300496]"
,,,Angelman syndrome [MIM:105830]
,,,"Mental retardation, X-linked, Lubs type [MIM:300260]"
,,,
MED12,mediator complex subunit 12 ,Xq13,
,,,Opitz-Kaveggia syndrome [MIM:305450]
,,,Lujan-Fryns syndrome [MIM:309520]
,,,
MED13L,mediator complex subunit 13-like ,12q24,
,,,"Transposition of the great arteries, dextro-looped 1 [MIM:608808]"
,,,
MED13,mediator complex subunit 13 ,17q22-q23,
,,,mutations
,,,
MED17,mediator complex subunit 17 ,11q21,
,,,"Microcephaly, postnatal progressive, with seizures and brain atrophy [MIM:613668]"
,,,
MED23,mediator complex subunit 23 ,?,
,,,mutations
,,,
MED25,mediator complex subunit 25 ,19q13.3,
,,,"Charcot-Marie-Tooth disease, type 2B2 [MIM:605589]"
,,,
MEF2A,myocyte enhancer factor 2A ,15q26,
,,,"Coronary artery disease, autosomal dominant, 1 [MIM:608320]"
,,,
MEF2C,myocyte enhancer factor 2C ,5q14,
,,,"Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations [MIM:613443]"
,,,Chromosome 5q14.3 deletion syndrome [MIM:613443]
,,,
MEFV,Mediterranean fever ,16p13,
,,,"Familial Mediterranean fever, AR [MIM:249100]"
,,,"Familial Mediterranean fever, AD [MIM:134610]"
,,,
MEGF10,multiple EGF-like-domains 10 ,5q23.2,
,,,mutations
,,,
MEGF11,multiple EGF-like-domains 11 ,15q22.31,
,,,mutations
,,,
MEHMO,"mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly and obesity syndrome ",Xp22.13-p21.1,
,,,MEHMO syndrome
,,,
MEIS1,Meis homeobox 1 ,2p14-p13,
,,,mutations
,,,
MEIS2,Meis homeobox 2 ,15q14-q25,
,,,mutations
,,,
MEN1,multiple endocrine neoplasia I ,11q13,
,,,Multiple endocrine neoplasia 1 [MIM:131100]
,,,Carcinoid tumor of lung
,,,"Parathyroid adenoma, somatic"
,,,"Lipoma, somatic"
,,,"Angiofibroma, somatic"
,,,"Adrenal adenoma, somatic"
,,,
MENAQ1,"Menarche, age at, QTL ",22q13,
,,,"Menarche, age at, QTL"
,,,
MENAQ2,"Menarche, age at, QTL2 ",6q21,
,,,"Menarche, age at, QTL2"
,,,
MENAQ3,"Menarche, age at, QTL3 ",9q31.2,
,,,"Menarche, age at, QTL3"
,,,
MENOQ1,"menopause, natural, age at, QTL ",Xp21.3,
,,,"Menopause, natural, age at, QTL1"
,,,
MENOQ2,"Menopause, natural, age at, QTL2 ",19q13.4,
,,,"Menopause, natural, age at, QTL2"
,,,
MENOQ3,"Menopause, natural, age at, QTL3 ",20p12.3,
,,,"Menopause, natural, age at, QTL3"
,,,
MENOQ4,"Menopause, natural, age at, QTL4 ",5q35.2,
,,,"Menopause, natural, age at, QTL4"
,,,
MEP1B,"meprin A, beta ",18q12.2-q12.3,
,,,mutations
,,,
MERTK,c-mer proto-oncogene tyrosine kinase ,2q14.1,
,,,Retinitis pigmentosa-38 [MIM:268000]
,,,
MESDC2,mesoderm development candidate 2 ,15,
,,,mutations
,,,
MESP2,mesoderm posterior 2 homolog (mouse) ,15q26.1,
,,,"Spondylocostal dysostosis, autosomal recessive 2 [MIM:608681]"
,,,
MEST,mesoderm specific transcript homolog (mouse) ,7q32,
,,,mutations
,,,
MET,met proto-oncogene (hepatocyte growth factor receptor) ,7q31,
,,,"Renal cell carcinoma, papillary, familial and sporadic [MIM:605074]"
,,,"Hepatocellular carcinoma, childhood type [MIM:114550]"
,,,Autism suseptibility 9 [MIM:611015]
,,,
MFF,mitochondrial fission factor ,?,
,,,mutations
,,,
MFGE8,milk fat globule-EGF factor 8 protein ,15q25,
,,,mutations
,,,
MFHAS1,malignant fibrous histiocytoma amplified sequence 1 ,8p23.1,
,,,Malignant fibrous histiocytoma
,,,
MFI2,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 ,3q29,
,,,mutations
,,,
MFN2,mitofusin 2 ,1p36.2,
,,,"Charcot-Marie-Tooth disease, type 2A2 [MIM:609260]"
,,,Hereditary motor and sensory neuropathy VI [MIM:601152]
,,,
MFRP,membrane frizzled-related protein ,11q23,
,,,"Microphthalmia, isolated 5 [MIM:611040]"
,,,
MFSD2A,major facilitator superfamily domain containing 2A ,?,
,,,mutations
,,,
MFSD8,major facilitator superfamily domain containing 8 ,4q28.1-q28.2,
,,,"Ceroid lipofuscinosis, neuronal, 7 [MIM:610951]"
,,,
MFT2,"Trichoepithelioma, multiple familial, 2 ",9p21,
,,,"Trichoepithelioma, multiple familial, 2"
,,,
MGAM,maltase-glucoamylase (alpha-glucosidase) ,7q34,
,,,diarrhea in children associated with starch malabsorption and small intestinal glucoamylase deficiency
,,,
MGAT1,"mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase ",5q35,
,,,mutations
,,,
MGAT2,"mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase ",14q21,
,,,"Congenital disorder of glycosylation, type IIa [MIM:212066]"
,,,
MGAT4C,"mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) ",12q21,
,,,mutations
,,,
MGC1,megalocornea 1 (X-linked) ,Xq21.3-q22,
,,,"Megalocornea, X-linked"
,,,
MGCT,male germ cell tumor ,12q22,
,,,Male germ cell tumor
,,,
MGEA5,meningioma expressed antigen 5 (hyaluronidase) ,10q24.1-q24.3,
,,,mutations
,,,
MGLL,monoglyceride lipase ,3p21.3,
,,,mutations
,,,
MGMT,O-6-methylguanine-DNA methyltransferase ,10q26,
,,,mutations
,,,
MGP,matrix Gla protein ,12p13.1-p12.3,
,,,Keutel syndrome [MIM:245150]
,,,Natural teeth remaining intact
,,,
MGR12,"Migraine, with or without aura, susceptibility to, 12 ",10q22-q23,
,,,"Migraine, with or without aura, susceptibility to, 12"
,,,
MGR2,"Migraine, familial typical, susceptibility to ",Xq,
,,,"Migraine, familial typical, susceptibility to, 1"
,,,
MGR3,"Migraine, familial, with or without aura, susceptibility to ",6p21.1-p12.2,
,,,"Migraine with or without aura, susceptibility to, 3"
,,,
MGR4,"Migraine, susceptibility to, 4 ",14q21.2-q22.3,
,,,"Migraine without aura, susceptibility to, 4"
,,,
MGR5,"Migraine with or without aura, susceptibility to, 5 ",19p13,
,,,"Migraine with or without aura, susceptibility to, 5"
,,,
MGR7,"Migraine with aura, susceptibility to, 7 ",15q11.2-q12,
,,,"Migraine with aura, susceptibility to, 7"
,,,
MGR8,"Migraine, susceptibility to, 8 ",5q21,
,,,"Migraine, susceptibility to, 8"
,,,
MGR9,"Migraine with aura, susceptibility to, 9 ",11q24,
,,,"Migraine with aura, susceptibility to, 9"
,,,
MGR,"Migraine, several forms ",1q31,
,,,"Migraine, familial hemiplegic"
,,,"Migraine with or without aura, susceptibility to"
,,,
MGST2,microsomal glutathione S-transferase 2 ,4q28-q31,
,,,mutations
,,,
MGST3,microsomal glutathione S-transferase 3 ,1q23,
,,,mutations
,,,
MGS,Mungen syndrome ,8q23-q24,
,,,Mungen syndrome
,,,
MHAC,microhydranencephaly ,16p13.3-p12.1,
,,,Microhydranencephaly
,,,
MHB,"myopathy, hyaline body, autosomal recessive ",3p22.2-p21.32,
,,,"Myopathy, hyaline body"
,,,
MHS2,malignant hyperthermia susceptibility 2 ,17q11.2-q24,
,,,Malignant hyperthermia susceptibility 2
,,,
MHS3,Malignant hyperthermia susceptibility 3 ,7q21-q22,
,,,Malignant hyperthermia susceptibility 3
,,,
MHS4,malignant hyperthermia susceptibility 4 ,3q13.1,
,,,Malignant hyperthermia susceptibility 4
,,,
MHS6,malignant hyperthermia susceptibility 6 ,5p,
,,,Malignant hyperthermia susceptibility 6
,,,
MHW1,Mental health wellness 1 ,4p,
,,,Mental health wellness-1
,,,
MHW2,Mental health wellness 2 ,4q,
,,,Mental health wellness-2
,,,
MIA3,"melanoma inhibitory activity family, member 3 ",1q42,
,,,mutations
,,,
MIAT,myocardial infarction associated transcript (non-protein coding) ,22q12.1,
,,,"Myocardial infarction, susceptibility to"
,,,
MICA,MHC class I polypeptide-related sequence A ,6p21.3,
,,,mutations
,,,
MICB,MHC class I polypeptide-related sequence B ,6p21.3,
,,,mutations
,,,
MICRODEL15Q13.3,Chromosome 15q13.3 microdeletion syndrome ,15q13.3,
,,,Chromosome 15q13.3 microdeletion syndrome
,,,
MICRODEL3Q29,Chromosome 3q29 microdeletion syndrome ,3q29,
,,,Chromosome 3q29 microdeletion syndrome
,,,
MID1,midline 1 (Opitz/BBB syndrome) ,Xp22,
,,,"Opitz G syndrome, type I [MIM:300000]"
,,,
MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor) ,22q11.2,
,,,"Rheumatoid arthritis, systemic juvenile, susceptibility to [MIM:604302]"
,,,
MIIP,migration and invasion inhibitory protein ,?,
,,,mutations
,,,
MINPP1,multiple inositol-polyphosphate phosphatase 1 ,10q23,
,,,"Thyroid carcinoma, follicular [MIM:188470]"
,,,
MIPOL1,mirror-image polydactyly 1 ,14q13,
,,,Mirror-image polydactyly [MIM:135750]
,,,
MIP,major intrinsic protein of lens fiber ,12q13,
,,,"Cataract, polymorphic and lamellar [MIM:604219]"
,,,
MIR106B,microRNA 106b ,7q22,
,,,mutations
,,,
MIR124-1,microRNA 124-1 ,8p23.1,
,,,mutations
,,,
MIR125A,microRNA 125a ,19q13.33,
,,,mutations
,,,
MIR126,microRNA 126 ,9q34.3,
,,,mutations
,,,
MIR140,microRNA 140 ,16q22.1,
,,,mutations
,,,
MIR146A,microRNA 146a ,5q33.3,
,,,mutations
,,,
MIR16-1,microRNA 16-1 ,13q14.3,
,,,mutations
,,,
MIR17HG,miR-17-92 cluster host gene (non-protein coding) ,13q31.3,
,,,mutations
,,,
MIR17,microRNA 17 ,13q31.3,
,,,mutations
,,,
MIR182,microRNA 182 ,7q32.2,
,,,mutations
,,,
MIR184,microRNA 184 ,15q25.1,
,,,mutations
,,,
MIR191,microRNA 191 ,?,
,,,mutations
,,,
MIR196A2,microRNA 196a-2 ,12q13,
,,,mutations
,,,
MIR206,microRNA 206 ,6p12.2,
,,,mutations
,,,
MIR24-1,microRNA 24-1 ,9q22.32,
,,,mutations
,,,
MIR27A,microRNA 27a ,19p13.12,
,,,mutations
,,,
MIR2861,microRNA 2861 ,9q34.11,
,,,Bone mineral density QTL 15 [MIM:613418]
,,,
MIR30C1,microRNA 30c-1 ,?,
,,,mutations
,,,
MIR34B,microRNA 34b ,?,
,,,mutations
,,,
MIR502,microRNA 502 ,?,
,,,mutations
,,,
MIR510,microRNA 510 ,?,
,,,mutations
,,,
MIR890,microRNA 890 ,?,
,,,mutations
,,,
MIR892B,microRNA 892b ,?,
,,,mutations
,,,
MIR934,microRNA 934 ,?,
,,,mutations
,,,
MIR96,microRNA 96 ,7q32.2,
,,,"Deafness, autosomal dominant 50 [MIM:613074]"
,,,
MIRLET7E,microRNA let-7e ,?,
,,,mutations
,,,
MITF,microphthalmia-associated transcription factor ,3p14.1-p12.3,
,,,"Waardenburg syndrome, type 2A [MIM:193510]"
,,,"Waardenburg syndrome/ocular albinism, digenic [MIM:103470]"
,,,Tietz albinism-deafness syndrome [MIM:103500]
,,,
MKKS,McKusick-Kaufman syndrome ,20p12,
,,,McKusick-Kaufman syndrome [MIM:236700]
,,,Bardet-Biedl syndrome 6 [MIM:209900]
,,,
MKL1,megakaryoblastic leukemia (translocation) 1 ,22q13,
,,,"Megakaryoblastic leukemia, acute"
,,,
MKS1,"Meckel syndrome, type 1 ",17q23,
,,,"Meckel syndrome, type 1 [MIM:249000]"
,,,Bardet-Biedl syndrome 13 [MIM:209900]
,,,
MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1 ,22q13.33,
,,,Megalencephalic leukoencephalopathy with subcortical cysts [MIM:604004]
,,,
MLF1,myeloid leukemia factor 1 ,3q25.1,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
MLH1,"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) ",3p21.3,
,,,"Colorectal cancer, hereditary nonpolyposis, type 2 [MIM:609310]"
,,,Mismatch repair cancer syndrome [MIM:276300]
,,,Muir-Torre syndrome [MIM:158320]
,,,
MLH3,mutL homolog 3 (E. coli) ,14q24.3,
,,,"Colorectal cancer, somatic [MIM:114500]"
,,,"Colon cancer, hereditary nonpolyposis, type 7"
,,,Endometrial cancer [MIM:608089]
,,,
MLL2,myeloid/lymphoid or mixed-lineage leukemia 2 ,12q12-q14,
,,,Kabuki syndrome [MIM:147920]
,,,
MLL3,myeloid/lymphoid or mixed-lineage leukemia 3 ,7q36,
,,,mutations
,,,
MLL5,"myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila) ",7q22,
,,,mutations
,,,
MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 ",10p12,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,"Leukemia, acute T-cell lymphoblastic"
,,,
MLLT11,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 ",1q21,
,,,"Leukemia, acute myelomonocytic"
,,,
MLLT3,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 ",9p22,
,,,mutations
,,,
MLL,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) ",11q23,
,,,"Leukemia, myeloid/lymphoid or mixed-lineage"
,,,
MLPH,melanophilin ,2q37,
,,,"Griscelli syndrome, type 3 [MIM:609227]"
,,,
MLXIPL,MLX interacting protein-like ,7q11.23,
,,,mutations
,,,
MLYCD,malonyl-CoA decarboxylase ,16q24,
,,,Malonyl-CoA decarboxylase deficiency [MIM:248360]
,,,
MMAA,methylmalonic aciduria (cobalamin deficiency) cblA type ,4q31.1-q31.2,
,,,"Methylmalonic aciduria, vitamin B12-responsive [MIM:251100]"
,,,
MMAB,methylmalonic aciduria (cobalamin deficiency) cblB type ,12q24,
,,,"Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type [MIM:251110]"
,,,
MMACHC,"methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria ",1p34.1,
,,,"Methylmalonic aciduria and homocystinuria, cblC type [MIM:277400]"
,,,
MMADHC,"methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria ",2q23.2,
,,,"Homocystinuria, cblD type, variant 1 [MIM:277410]"
,,,"Methylmalonic aciduria, cblD type, variant 2 [MIM:277410]"
,,,"Methylmalonic aciduria and homocystinuria, cblD type [MIM:277410]"
,,,
MMDFS,Multiple mitochondrial dysfunctions syndrome ,2p14-p13,
,,,Multiple mitochondrial dysfunctions syndrome
,,,
MMDK,"Mesomelic dysplasia, Kantaputra type ",2q24-q32,
,,,"Mesomelic dysplasia, Kantaputra type"
,,,
MMEDF,Macrocephaly with multiple epiphyseal dysplasia and distinctive facies ,15q26.1,
,,,Macrocephaly with multiple epiphyseal dysplasia and distinctive facies
,,,
MMEL1,membrane metallo-endopeptidase-like 1 ,?,
,,,mutations
,,,
MME,membrane metallo-endopeptidase ,3q21-q27,
,,,Neutral endopeptidase deficiency
,,,"Membranous glomerulonephritis, antenatal"
,,,
MMP10,matrix metallopeptidase 10 (stromelysin 2) ,11q22.3-q23,
,,,mutations
,,,
MMP12,matrix metallopeptidase 12 (macrophage elastase) ,11q22.2-q22.3,
,,,mutations
,,,
MMP13,matrix metallopeptidase 13 (collagenase 3) ,11q22.3,
,,,"Spondyloepimetaphyseal dysplasia, Missouri type [MIM:602111]"
,,,Metaphyseal anadysplasia 1 [MIM:602111]
,,,
MMP14,matrix metallopeptidase 14 (membrane-inserted) ,14q11-q12,
,,,mutations
,,,
MMP1,matrix metallopeptidase 1 (interstitial collagenase) ,11q22-q23,
,,,"COPD, rate of decline of lung function in [MIM:606963]"
,,,"Epidermolysis bullosa dystrophica, autosomal recessive, modifier of [MIM:226600]"
,,,
MMP20,matrix metallopeptidase 20 ,11q22.3-q23,
,,,"Amelogenesis imperfecta, type IIA2 [MIM:612529]"
,,,
MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) ",16q13,
,,,Torg-Winchester syndrome [MIM:259600]
,,,
MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase) ",11q23,
,,,"Coronary heart disease, susceptibility to, 6"
,,,
MMP7,"matrix metallopeptidase 7 (matrilysin, uterine) ",11q21-q22,
,,,mutations
,,,
MMP8,matrix metallopeptidase 8 (neutrophil collagenase) ,11q21-q22,
,,,mutations
,,,
MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) ",20q11.2-q13.1,
,,,Metaphyseal anadysplasia 2 [MIM:613073]
,,,
MMRFCGU,"Microcephaly, mental retardation, and distinctive facies, with cardiac and genitourinary malformations ",16p13.3,
,,,"Microcephaly, mental retardation, and distinctive facies, with cardiac and genitourinary malformations"
,,,
MMS,"Malignant mesothelioma, susceptibility to ",9p,
,,,"Malignant mesothelioma, susceptibility to"
,,,
MMVP1,myxomatous mitral valve prolapse 1 ,16p12.1-p11.2,
,,,"Mitral valve prolapse, myxomatous 1"
,,,
MMVP2,myxomatous mitral valve prolapse 2 ,11p15.4,
,,,"Mitral valve prolapse, myxomatous 2"
,,,
MMVP3,"Mitral valve prolapse, myxomatous 3 ",13q31.3-q32.1,
,,,"Mitral valve prolapse, myxomatous 3"
,,,
MN1,meningioma (disrupted in balanced translocation) 1 ,22q12.3-qter,
,,,Meningioma [MIM:607174]
,,,
MNDEC,Microtia with nasolacrimal duct imperforation and eye coloboma ,4p16-p15,
,,,Microtia with nasolacrimal duct imperforation and eye coloboma
,,,
MNG1,multinodular goitre 1 ,14q,
,,,"Goiter, multinodular, 1"
,,,
MNG2,multinodular goiter 2 ,Xp22,
,,,"Goiter, multinodular, 2"
,,,
MNG3,Multinodular goiter-3 ,3q26.1-q26.3,
,,,"Goiter, multinodular, 3"
,,,
MNRI,"meningioma, radiation-induced ",1p11,
,,,"Meningioma, radiation-induced"
,,,
MNX1,motor neuron and pancreas homeobox 1 ,7q36,
,,,Currarino syndrome [MIM:176450]
,,,
MOCOS,molybdenum cofactor sulfurase ,18q12.2,
,,,mutations
,,,
MOCS1,molybdenum cofactor synthesis 1 ,6p21.3,
,,,"Molybdenum cofactor deficiency, type A [MIM:252150]"
,,,
MOCS2,molybdenum cofactor synthesis 2 ,5q11,
,,,"Molybdenum cofactor deficiency, type B [MIM:252150]"
,,,
MOGS,mannosyl-oligosaccharide glucosidase ,2p13-p12,
,,,"Congenital disorder of glycosylation, type IIb [MIM:606056]"
,,,
MOG,myelin oligodendrocyte glycoprotein ,6p21.3,
,,,mutations
,,,
MOK,MOK protein kinase ,14q32,
,,,mutations
,,,
MOPCB1,"Microphthalmia, colobomatous, 1 ",X,
,,,Microphthalmia with coloboma 1
,,,
MOPCB2,"Microphthalmia, colobomatous, 2 ",15q12-q15,
,,,Microphthalmia with coloboma 2
,,,
MPD3,"Myopathy, distal 3 ",8p22-q11,
,,,"Myopathy, distal 3"
,,,
MPDMRS,Martin-Probst deafness-mental retardation syndrome ,Xq11-q21,
,,,Martin-Probst deafness-mental retardation syndrome
,,,
MPDU1,mannose-P-dolichol utilization defect 1 ,17p13.1-p12,
,,,"Congenital disorder of glycosylation, type If [MIM:609180]"
,,,
MPDZ,multiple PDZ domain protein ,9p24-p22,
,,,mutations
,,,
MPFD,myopathy with fiber type disproportion ,9p13-p12,
,,,Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia [MIM:167320]
,,,
MPG,N-methylpurine-DNA glycosylase ,16pter-p13.3,
,,,mutations
,,,
MPHOSPH8,M-phase phosphoprotein 8 ,13q12.11,
,,,mutations
,,,
MPI,mannose phosphate isomerase ,15q22-qter,
,,,"Congenital disorder of glycosylation, type Ib [MIM:602579]"
,,,
MPLKIP,M-phase specific PLK1 interacting protein ,7p14,
,,,"Trichothiodystrophy, nonphotosensitive 1 [MIM:234050]"
,,,
MPL,myeloproliferative leukemia virus oncogene ,1p34,
,,,"Thrombocytopenia, congenital amegakaryocytic [MIM:604498]"
,,,"Thrombycytosis, susceptibility to [MIM:187950]"
,,,"Thrombocythemia, essential [MIM:187950]"
,,,
MPO,myeloperoxidase ,17q23.1,
,,,Myeloperoxidase deficiency [MIM:254600]
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,"Lung cancer, protection against, in smokers (3) 11"
,,,
MPP3,"membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) ",17q12-q21,
,,,mutations
,,,
MPP6,"membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) ",7p21-p15,
,,,mutations
,,,
MPP7,"membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) ",10p12.1,
,,,mutations
,,,
MPST,mercaptopyruvate sulfurtransferase ,22q11.2-qter,
,,,mutations
,,,
MPV17,MpV17 mitochondrial inner membrane protein ,2p23-p21,
,,,Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) [MIM:256810]
,,,
MPVQTL1,Mean platelet volume QTL1 ,12q24.31,
,,,Mean platelet volume QTL1
,,,
MPVQTL2,Mean platelet volume QTL2 ,3p21-p13,
,,,Mean platelet volume QTL2
,,,
MPVQTL3,Mean platelet volume QTL3 ,17q11.2,
,,,Mean platelet volume QTL3
,,,
MPZ,myelin protein zero ,1q22,
,,,"Charcot-Marie-Tooth disease, type 1B [MIM:118200]"
,,,Dejerine-Sottas syndrome [MIM:145900]
,,,"Neuropathy, congenital hypomyelinating [MIM:605253]"
,,,"Charcot-Marie-Tooth disease, type 2J [MIM:607736]"
,,,Roussy-Levy syndrome [MIM:180800]
,,,"Charcot-Marie-Tooth disease, type 2I [MIM:607677]"
,,,"Charcot-Marie-Tooth disease, dominant intermediate 3 [MIM:607791]"
,,,
MR1,"major histocompatibility complex, class I-related ",1q25.3,
,,,mutations
,,,
MRAP,melanocortin 2 receptor accessory protein ,21q22.1,
,,,Glucocorticoid deficiency 2 [MIM:607398]
,,,
MRC1,"mannose receptor, C type 1 ",10p13,
,,,mutations
,,,
MRE11A,MRE11 meiotic recombination 11 homolog A (S. cerevisiae) ,11q21,
,,,Ataxia-telangiectasia-like disorder [MIM:604391]
,,,
MROS,Melkersson-Rosenthal syndrome ,9p11,
,,,Melkersson-Rosenthal syndrome
,,,
MRPL3,mitochondrial ribosomal protein L3 ,?,
,,,mutations
,,,
MRPL48,mitochondrial ribosomal protein L48 ,11q13.2,
,,,mutations
,,,
MRPS16,mitochondrial ribosomal protein S16 ,10q22.1,
,,,Combined oxidative phosphorylation deficiency 2 [MIM:610498]
,,,
MRPS22,mitochondrial ribosomal protein S22 ,3q23,
,,,Combined oxidative phosphorylation deficiency 5 [MIM:611719]
,,,
MRRF,mitochondrial ribosome recycling factor ,9q32-q34.1,
,,,mutations
,,,
MRSD,mental retardation-skeletal dysplasia ,Xq28,
,,,Mental retardation-skeletal dysplasia
,,,
MRSS,"Mental retardation, X-linked, with short stature ",Xq24,
,,,"Mental retardation, X-linked, with short stature"
,,,
MRST,"Mental retardation, severe, with spasticity and tapetoretinal ",15q24,
,,,"Mental retardation, severe, with spasticity and tapetoretinal degeneration"
,,,
MRT10,"mental retardation, non-syndromic, autosomal recessive, 10 ",16p12-q12,
,,,"Mental retardation, autosomal recessive, 10"
,,,
MRT11,"mental retardation, non-syndromic, autosomal recessive, 11 ",19q13.2-q13.3,
,,,"Mental retardation, autosomal recessive, 11"
,,,
MRT12,"mental retardation, non-syndromic, autosomal recessive, 12 ",1p34-p33,
,,,"Mental retardation, autosomal recessive, 12"
,,,
MRT4,"mental retardation, non-syndromic, autosomal recessive, 4 ",1p21.1-p13.3,
,,,"Mental retardation, autosomal recessive, 4"
,,,
MRT5,"mental retardation, non-syndromic, autosomal recessive, 5 ",5p15-p14,
,,,"Mental retardation, autosomal recessive, 5"
,,,
MRT8,"mental retardation, non-syndromic, autosomal recessive, 8 ",10q22,
,,,"Mental retardation, autosomal recessive, 8"
,,,
MRT9,"mental retardation, non-syndromic, autosomal recessive, 9 ",14q11.2-q12,
,,,"Mental retardation, autosomal recessive, 9"
,,,
MRX14,"mental retardation, X-linked 14 ",Xp11.3-q13.3,
,,,"Mental retardation, X-linked 14"
,,,
MRX17,"mental retardation, X-linked 17 ",Xp11.2,
,,,17-beta-hydroxysteroid dehydrogenase X deficiency [MIM:300438]
,,,"Mental retardation, X-linked syndromic 10 [MIM:300220]"
,,,"Mental retardation, X-linked 17/31, microduplication [MIM:300705]"
,,,
MRX1,"mental retardation, X-linked 1 (non-dysmorphic) ",Xp11.3-q21.1,
,,,"Mental retardation, X-linked, 1"
,,,
MRX20,"mental retardation, X-linked 20 ",Xp11-q21,
,,,"Mental retardation, X-linked 20"
,,,
MRX23,"mental retardation, X-linked 23 ",Xq23-q24,
,,,"Mental retardation, X-linked 23, nonspecific"
,,,
MRX27,"mental retardation, X-linked 27 ",Xq23-q24,
,,,"Mental retardation, X-linked 23, nonspecific"
,,,
MRX2,"mental retardation, X-linked 2 (non-dysmorphic) ",Xp22.3,
,,,"Mental retardation, X-linked, 2"
,,,
MRX31,"mental retardation, X-linked 31 ",Xp11.2,
,,,17-beta-hydroxysteroid dehydrogenase X deficiency [MIM:300438]
,,,"Mental retardation, X-linked syndromic 10 [MIM:300220]"
,,,"Mental retardation, X-linked 17/31, microduplication [MIM:300705]"
,,,
MRX35,"mental retardation, X-linked 35 ",Xq23-q24,
,,,"Mental retardation, X-linked 23, nonspecific"
,,,
MRX42,"mental retardation, X-linked 42 ",Xq26,
,,,"Mental retardation, X-linked nonspecific, 42"
,,,
MRX49,"mental retardation, X-linked 49 ",Xp22.3,
,,,"Mental retardation, X-linked-49"
,,,
MRX4,"mental retardation, X-linked 4 ",?,
,,,"mental retardation,X-linked 4,with scoliosis and spotty abdominal hypopigmentation,slight facial asymetry and clinodactyly,may be several genes in the interval"
,,,
MRX50,"mental retardation, X-linked 50 ",Xp11.3-p11.21,
,,,"Mental retardation, X-linked nonspecific, type 50"
,,,
MRX52,"mental retardation, X-linked 52 ",Xp11.21-q22.3,
,,,"Mental retardation, X-linked 52"
,,,
MRX53,"mental retardation, X-linked 53 ",Xq22.2-q26,
,,,"Mental retardation, X-linked-53"
,,,
MRX77,"mental retardation, X-linked 77 ",Xq12-q21.3,
,,,"Mental retardation, X-linked 77"
,,,
MRX78,"mental retardation, X-linked 78 ",Xp11.4-p11.23,
,,,"Mental retardation, X-linked 78"
,,,
MRX80,"mental retardation, X-linked 80 ",Xq23-q24,
,,,"Mental retardation, X-linked 23, nonspecific"
,,,
MRX81,"mental retardation, X-linked 81 ",Xp11.2-q12,
,,,"Mental retardation, X-linked 81"
,,,
MRX82,"mental retardation, X-linked 82 ",Xq24-q25,
,,,"Mental retardation, X-linked 82"
,,,
MRX84,"mental retardation, X-linked 84 ",Xp11.3-q22.3,
,,,"Mental retardation, X-linked 84"
,,,
MRXS11,"mental retardation, X-linked, syndromic 11 ",Xq26-q27,
,,,"Mental retardation, X-linked, Shashi type"
,,,
MRXS12,"Mental retardation, X-linked, syndromic 12 ",Xp11,
,,,"Mental retardation, X-linked, syndromic 12"
,,,
MRXS5,"mental retardation, X-linked, syndromic 5 ",Xq25-q27,
,,,"Mental retardation, X-linked, syndromic-5, with Dandy-Walker malformation, basal ganglia disease, and seizures"
,,,
MRXS7,"mental retardation, X-linked, syndromic 7 ",Xp11.3-q22,
,,,"Mental retardation, X-linked, syndromic 7"
,,,
MRXSAB,Abidi X-linked mental retardation syndrome ,Xq13.2,
,,,"Mental retardation syndrome, X-linked, Abidi type"
,,,
MRXSA,Armfield X-linked mental retardation syndrome ,Xq28,
,,,"Mental retardation syndrome, X-linked, Armfield type"
,,,
MRXSL,Lubs X-linked mental retardation syndrome ,Xq28,
,,,"Mental retardation syndrome, X-linked, Lubs type"
,,,
MS2,"Multiple sclerosis, susceptibility to, 2 ",10p15.1,
,,,"Multiple sclerosis, susceptibility to, 2"
,,,
MS3,"Multiple sclerosis, susceptibility to, 3 ",5p13.2,
,,,"Multiple sclerosis, susceptibility to, 3"
,,,
MS4A12,"membrane-spanning 4-domains, subfamily A, member 12 ",11q12-q13,
,,,mutations
,,,
MS4A1,"membrane-spanning 4-domains, subfamily A, member 1 ",11q13,
,,,"Immunodeficiency, common variable, 5 [MIM:613495]"
,,,
MS4A2,"membrane-spanning 4-domains, subfamily A, member 2 ",11q13,
,,,"Atopy, susceptibility to [MIM:147050]"
,,,
MS4A3,"membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) ",11q12-q13,
,,,mutations
,,,
MS4A6A,"membrane-spanning 4-domains, subfamily A, member 6A ",11q12-q13,
,,,mutations
,,,
MS4A6E,"membrane-spanning 4-domains, subfamily A, member 6E ",11q12-q13.1,
,,,mutations
,,,
MS4,"Multiple sclerosis, susceptiblity to, 4 ",1p36,
,,,"Multiple sclerosis, susceptibility to, 4"
,,,
MSH2,"mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) ",2p22-p21,
,,,"Colorectal cancer, hereditary nonpolyposis, type 1 [MIM:120435]"
,,,Muir-Torre syndrome [MIM:158320]
,,,Mismatch repair cancer syndrome [MIM:276300]
,,,
MSH3,mutS homolog 3 (E. coli) ,5q11-q12,
,,,Endometrial carcinoma
,,,
MSH4,mutS homolog 4 (E. coli) ,1p31,
,,,mutations
,,,
MSH5,mutS homolog 5 (E. coli) ,?,
,,,mutations
,,,
MSH6,mutS homolog 6 (E. coli) ,2p16,
,,,"Colorectal cancer, hereditary nonpolyposis, type 5"
,,,"Endometrial cancer, familial [MIM:608089]"
,,,Mismatch repair cancer syndrome [MIM:276300]
,,,
MSMB,"microseminoprotein, beta- ",10q11.2,
,,,"Prostate cancer, hereditary, 13 [MIM:611928]"
,,,
MSMO1,methylsterol monooxygenase 1 ,4q32-q34,
,,,mutations
,,,
MSR1,macrophage scavenger receptor 1 ,8p22,
,,,"Prostate cancer, hereditary [MIM:176807]"
,,,
MSRB3,methionine sulfoxide reductase B3 ,12q14.3,
,,,"Deafness, autosomal recessive 74 [MIM:613718]"
,,,
MSSE,multiple self-healing squamous epithelioma ,9q31,
,,,"Epithelioma, self-healing, squamous 1, Ferguson-Smith type"
,,,Basal cell carcinoma
,,,
MST1R,macrophage stimulating 1 receptor (c-met-related tyrosine kinase) ,3p21.3,
,,,mutations
,,,
MST1,macrophage stimulating 1 (hepatocyte growth factor-like) ,3p21,
,,,mutations
,,,
MSTN,myostatin ,2q32.2,
,,,Muscle hypertrophy
,,,
MSX1,msh homeobox 1 ,4p16.1,
,,,"Tooth agenesis, selective, 1, with or without orofacial cleft [MIM:106600]"
,,,Witkop syndrome [MIM:189500]
,,,Orofacial cleft 5 [MIM:608874]
,,,
MSX2,msh homeobox 2 ,5q34-q35,
,,,"Craniosynostosis, type 2 [MIM:604757]"
,,,Parietal foramina 1 [MIM:168500]
,,,Parietal foramina with cleidocranial dysplasia [MIM:168550]
,,,
MT-ATP6,mitochondrially encoded ATP synthase 6 ,?,
,,,mutations
,,,
MT-ATP8,mitochondrially encoded ATP synthase 8 ,?,
,,,mutations
,,,
MT-CO1,mitochondrially encoded cytochrome c oxidase I ,?,
,,,mutations
,,,
MT-CO2,mitochondrially encoded cytochrome c oxidase II ,?,
,,,mutations
,,,
MT-CO3,mitochondrially encoded cytochrome c oxidase III ,?,
,,,mutations
,,,
MT-CYB,mitochondrially encoded cytochrome b ,?,
,,,mutations
,,,
MT-ND1,mitochondrially encoded NADH dehydrogenase 1 ,?,
,,,mutations
,,,
MT-ND2,mitochondrially encoded NADH dehydrogenase 2 ,?,
,,,mutations
,,,
MT-ND3,mitochondrially encoded NADH dehydrogenase 3 ,?,
,,,mutations
,,,
MT-ND4L,mitochondrially encoded NADH dehydrogenase 4L ,?,
,,,mutations
,,,
MT-ND4,mitochondrially encoded NADH dehydrogenase 4 ,?,
,,,mutations
,,,
MT-ND5,mitochondrially encoded NADH dehydrogenase 5 ,?,
,,,mutations
,,,
MT-ND6,mitochondrially encoded NADH dehydrogenase 6 ,?,
,,,mutations
,,,
MT-RNR1,mitochondrially encoded 12S RNA ,?,
,,,Mitochondrial
,,,
MT-RNR2,mitochondrially encoded 16S RNA ,?,
,,,mutations
,,,
MT-TA,mitochondrially encoded tRNA alanine ,?,
,,,mutations
,,,
MT-TC,mitochondrially encoded tRNA cysteine ,?,
,,,mutations
,,,
MT-TD,mitochondrially encoded tRNA aspartic acid ,?,
,,,mutations
,,,
MT-TE,mitochondrially encoded tRNA glutamic acid ,?,
,,,mutations
,,,
MT-TF,mitochondrially encoded tRNA phenylalanine ,?,
,,,mutations
,,,
MT-TG,mitochondrially encoded tRNA glycine ,?,
,,,mutations
,,,
MT-TH,mitochondrially encoded tRNA histidine ,?,
,,,mutations
,,,
MT-TI,mitochondrially encoded tRNA isoleucine ,?,
,,,mutations
,,,
MT-TK,mitochondrially encoded tRNA lysine ,?,
,,,mutations
,,,
MT-TL1,mitochondrially encoded tRNA leucine 1 (UUA/G) ,?,
,,,mutations
,,,
MT-TL2,mitochondrially encoded tRNA leucine 2 (CUN) ,?,
,,,mutations
,,,
MT-TM,mitochondrially encoded tRNA methionine ,?,
,,,mutations
,,,
MT-TN,mitochondrially encoded tRNA asparagine ,?,
,,,mutations
,,,
MT-TP,mitochondrially encoded tRNA proline ,?,
,,,mutations
,,,
MT-TQ,mitochondrially encoded tRNA glutamine ,?,
,,,mutations
,,,
MT-TR,mitochondrially encoded tRNA arginine ,?,
,,,mutations
,,,
MT-TS1,mitochondrially encoded tRNA serine 1 (UCN) ,?,
,,,Mitochondrial
,,,
MT-TS2,mitochondrially encoded tRNA serine 2 (AGU/C) ,?,
,,,mutations
,,,
MT-TT,mitochondrially encoded tRNA threonine ,?,
,,,mutations
,,,
MT-TV,mitochondrially encoded tRNA valine ,?,
,,,mutations
,,,
MT-TW,mitochondrially encoded tRNA tryptophan ,?,
,,,mutations
,,,
MT-TY,mitochondrially encoded tRNA tyrosine ,?,
,,,mutations
,,,
MT1A,metallothionein 1A ,16q13,
,,,mutations
,,,
MT2A,metallothionein 2A ,16q13,
,,,mutations
,,,
MTAP,methylthioadenosine phosphorylase ,9p21,
,,,mutations
,,,
MTBS1,"mycobacterium tuberculosis, susceptibility to infection by, 1 ",2q35,
,,,"Tuberculosis, susceptibility to"
,,,
MTBS2,"Mycobacterium tuberculosis, susceptibility to, 2 ",8q12-q13,
,,,"Mycobacterium tuberculosis, susceptibility to, 2"
,,,
MTBS3,"Mycobacterium tuberculosis, susceptibility to, 3 ",19q13.31-q33,
,,,"Mycobacterium tuberculosis, susceptibility to, 3"
,,,
MTCH2,mitochondrial carrier 2 ,11q12.1,
,,,mutations
,,,
MTCP1,mature T-cell proliferation 1 ,Xq28,
,,,"prolymphocytic leukemia (T-PLL),with translocation t(X;14)(q28;q11) and breakpoint at MTCP1 locus"
,,,
MTFMT,mitochondrial methionyl-tRNA formyltransferase ,15q22.31,
,,,mutations
,,,
MTHFD1L,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like ,?,
,,,mutations
,,,
MTHFD1,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase ",14q24,
,,,"Spina bifida, folate-sensitive, susceptibility to [MIM:601634]"
,,,"Abruptio placentae, susceptibility to"
,,,
MTHFR,methylenetetrahydrofolate reductase (NAD(P)H) ,1p36.3,
,,,Homocystinuria due to MTHFR deficiency [MIM:236250]
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,"Vascular disease, susceptibility to"
,,,"Neural tube defects, susceptibility to [MIM:601634]"
,,,"Thromboembolism, susceptibility to [MIM:188050]"
,,,
MTHFS,"5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) ",?,
,,,mutations
,,,
MTM1,myotubularin 1 ,Xq28,
,,,"Myotubular myopathy, X-linked [MIM:310400]"
,,,
MTMR14,myotubularin related protein 14 ,3p25.3,
,,,"Centronuclear myopathy, autosomal, modifier of [MIM:160150]"
,,,
MTMR2,myotubularin related protein 2 ,11q22,
,,,"Charcot-Marie-Tooth disease, type 4B1 [MIM:601382]"
,,,
MTMR9,myotubularin related protein 9 ,8p23-p22,
,,,mutations
,,,
MTNR1A,melatonin receptor 1A ,4q35.1,
,,,mutations
,,,
MTNR1B,melatonin receptor 1B ,11q21-q22,
,,,mutations
,,,
MTPAP,mitochondrial poly(A) polymerase ,10p11.23,
,,,"Ataxia, spastic, 4 [MIM:613672]"
,,,
MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase ,5p15.3-p15.2,
,,,"Homocystinuria-megaloblastic anemia, cbl E type [MIM:236270]"
,,,"Neural tube defects, folate-sensitive, susceptibility to [MIM:601634]"
,,,
MTR,5-methyltetrahydrofolate-homocysteine methyltransferase ,1q43,
,,,"Methylcobalamin deficiency, cblG type [MIM:250940]"
,,,"Neural tube defects, folate-sensitive, susceptibility to [MIM:601634]"
,,,"Down syndrome, susceptibility to [MIM:190685]"
,,,
MTTP,microsomal triglyceride transfer protein ,4q22-q24,
,,,Abetalipoproteinemia [MIM:200100]
,,,"Metabolic syndrome, protection against [MIM:605552]"
,,,
MTUS1,microtubule associated tumor suppressor 1 ,?,
,,,mutations
,,,
MTX3,metaxin 3 ,Xq26,
,,,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 3"
,,,
MUC13,"mucin 13, cell surface associated ",3q13.3,
,,,mutations
,,,
MUC1,"mucin 1, cell surface associated ",1q21,
,,,mutations
,,,
MUC2,"mucin 2, oligomeric mucus/gel-forming ",11p15.5,
,,,mutations
,,,
MUC3A,"mucin 3A, cell surface associated ",7q22,
,,,mutations
,,,
MUC4,"mucin 4, cell surface associated ",3q29,
,,,mutations
,,,
MUC5B,"mucin 5B, oligomeric mucus/gel-forming ",11p15,
,,,mutations
,,,
MUC6,"mucin 6, oligomeric mucus/gel-forming ",11p15.5-p15.4,
,,,mutations
,,,
MUC7,"mucin 7, secreted ",4q13-q21,
,,,"Asthma, protection against [MIM:600807]"
,,,
MUHH2,"Hypotrichosis, hereditary, Marie Unna type, 2 ",1p21.1-q21.3,
,,,"Hypotrichosis, hereditary, Marie Unna type, 2"
,,,
MURC,muscle-related coiled-coil protein ,?,
,,,mutations
,,,
MUSK,"muscle, skeletal, receptor tyrosine kinase ",9q31.3-q32,
,,,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [MIM:608931]"
,,,
MUSQTL1,Musical aptitude QTL 1 ,4q22,
,,,Musical aptitude QTL 1
,,,
MUSTQTL1,Muscle strength quantitative trait locus 1 ,14q24.3,
,,,Muscle strength quantitative trait locus 1
,,,
MUTYH,mutY homolog (E. coli) ,1p34.3-p32.1,
,,,"Adenomas, multiple colorectal [MIM:608456]"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,"Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas [MIM:132600]"
,,,
MUT,methylmalonyl CoA mutase ,6p21,
,,,"Methylmalonic aciduria, mut(0) type [MIM:251000]"
,,,
MVK,mevalonate kinase ,12q24,
,,,Mevalonic aciduria [MIM:610377]
,,,Hyper-IgD syndrome [MIM:260920]
,,,
MX1,"myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) ",21q22.3,
,,,mutations
,,,
MXI1,MAX interactor 1 ,10q25,
,,,Neurofibrosarcoma
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
MYAS1,Myasthenia gravis with thymus hyperplasia ,6p21.3,
,,,Myasthenia gravis with thymus hyperplasia
,,,
MYBL2,v-myb myeloblastosis viral oncogene homolog (avian)-like 2 ,20q13.1,
,,,mutations
,,,
MYBPC1,"myosin binding protein C, slow type ",12,
,,,mutations
,,,
MYBPC3,"myosin binding protein C, cardiac ",11p11.2,
,,,"Cardiomyopathy, familial hypertrophic, 4 [MIM:115197]"
,,,"Cardiomyopathy, dilated [MIM:115200]"
,,,
MYB,v-myb myeloblastosis viral oncogene homolog (avian) ,6q22,
,,,T-cell acute lymphoblastic leukemia
,,,
MYCL1,"v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) ",1p34.3,
,,,mutations
,,,
MYCN,"v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) ",2p24.1,
,,,Feingold syndrome [MIM:164280]
,,,Microcephaly and digital abnormalities with normal intelligence [MIM:602585]
,,,
MYC,v-myc myelocytomatosis viral oncogene homolog (avian) ,8q24.12-q24.13,
,,,Burkitt lymphoma [MIM:113970]
,,,
MYD88,myeloid differentiation primary response gene (88) ,3p22-p21.3,
,,,"Pyogenic bacterial infections, recurrent, due to MYD88 deficiency [MIM:612260]"
,,,
MYF6,myogenic factor 6 (herculin) ,12q21,
,,,"Myopathy, centronuclear [MIM:160150]"
,,,Becker muscular dystrophy modifier [MIM:300376]
,,,
MYH11,"myosin, heavy chain 11, smooth muscle ",16p13.13-p13.12,
,,,"Aortic aneurysm, familial thoracic 4 [MIM:132900]"
,,,
MYH13,"myosin, heavy chain 13, skeletal muscle ",17p13.1-p12,
,,,mutations
,,,
MYH14,"myosin, heavy chain 14, non-muscle ",19q13.33,
,,,"Deafness, autosomal dominant 4 [MIM:600652]"
,,,
MYH15,"myosin, heavy chain 15 ",3q13.13,
,,,mutations
,,,
MYH2,"myosin, heavy chain 2, skeletal muscle, adult ",17p13.1,
,,,Inclusion body myopathy-3 [MIM:605637]
,,,
MYH3,"myosin, heavy chain 3, skeletal muscle, embryonic ",17p13.1,
,,,"Arthrogryposis, distal, type 2A [MIM:193700]"
,,,"Arthrogryposis, distal, type 2B [MIM:601680]"
,,,
MYH6,"myosin, heavy chain 6, cardiac muscle, alpha ",14q12,
,,,"Cardiomyopathy, familial hypertrophic, 14 [MIM:613251]"
,,,Atrial septal defect 3
,,,"Cardiomyopathy, dilated, 1EE [MIM:613252]"
,,,
MYH7,"myosin, heavy chain 7, cardiac muscle, beta ",14q12,
,,,"Cardiomyopathy, familial hypertrophic, 1 [MIM:192600]"
,,,"Cardiomyopathy, dilated, 1S [MIM:613426]"
,,,"Myopathy, myosin storage [MIM:608358]"
,,,Laing distal myopathy [MIM:160500]
,,,"Scapuloperoneal syndrome, myopathic type [MIM:181430]"
,,,Left ventricular noncompaction 5 [MIM:613426]
,,,
MYH8,"myosin, heavy chain 8, skeletal muscle, perinatal ",17p13.1,
,,,Carney complex variant [MIM:608837]
,,,Trismus-pseudocamptodactyly syndrome [MIM:158300]
,,,
MYH9,"myosin, heavy chain 9, non-muscle ",22q11.2,
,,,May-Hegglin anomaly [MIM:155100]
,,,Fechtner syndrome [MIM:153640]
,,,Sebastian syndrome [MIM:605249]
,,,"Deafness, autosomal dominant 17 [MIM:603622]"
,,,Epstein syndrome [MIM:153650]
,,,Macrothrombocytopenia and progressive sensorineural deafness [MIM:600208]
,,,
MYL2,"myosin, light chain 2, regulatory, cardiac, slow ",12q23-q24.3,
,,,"Cardiomyopathy, familial hypertrophic, 10 [MIM:608758]"
,,,
MYL3,"myosin, light chain 3, alkali; ventricular, skeletal, slow ",3p,
,,,"Cardiomyopathy, familial hypertrophic, 8 [MIM:608751]"
,,,
MYLIP,myosin regulatory light chain interacting protein ,6p23-p22.3,
,,,mutations
,,,
MYLK2,myosin light chain kinase 2 ,20q13.3,
,,,"Cardiomyopathy, hypertrophic, midventricular, digenic [MIM:192600]"
,,,
MYLK,myosin light chain kinase ,3q21,
,,,mutations
,,,
MYMY1,moyamoya disease 1 ,3p26-p24.2,
,,,Moyamoya disease
,,,
MYMY3,moyamoya disease 3 ,8q23,
,,,Moyamoya disease 3
,,,
MYO15A,myosin XVA ,17p11.2,
,,,"Deafness, autosomal recessive 3 [MIM:600316]"
,,,
MYO18B,myosin XVIIIB ,22q12.1,
,,,mutations
,,,
MYO1A,myosin IA ,12q13-q15,
,,,"Deafness, autosomal dominant 48 [MIM:607841]"
,,,
MYO1C,myosin IC ,17p13,
,,,mutations
,,,
MYO1E,myosin IE ,15q21-q22,
,,,mutations
,,,
MYO1F,myosin IF ,19p13.3-p13.2,
,,,mutations
,,,
MYO3A,myosin IIIA ,10p11.1,
,,,"Deafness, autosomal recessive 30 [MIM:607101]"
,,,
MYO5A,"myosin VA (heavy chain 12, myoxin) ",15q21,
,,,"Griscelli syndrome, type 1 [MIM:214450]"
,,,
MYO5B,myosin VB ,18q21,
,,,Microvillus inclusion disease [MIM:251850]
,,,
MYO6,myosin VI ,6q13,
,,,"Deafness, autosomal dominant 22 [MIM:606346]"
,,,"Deafness, autosomal recessive 37 [MIM:607821]"
,,,"Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy [MIM:606346]"
,,,
MYO7A,myosin VIIA ,11q13.5,
,,,"Usher syndrome, type 1B [MIM:276900]"
,,,"Deafness, autosomal recessive 2, neurosensory [MIM:600060]"
,,,"Deafness, autosomal dominant 11, neurosensory [MIM:601317]"
,,,
MYO7B,myosin VIIB ,2q21.1,
,,,mutations
,,,
MYO9B,myosin IXB ,19p13.1,
,,,"Celiac disease, susceptibility to, 4 [MIM:609753]"
,,,
MYOCD,myocardin ,17p11.2,
,,,mutations
,,,
MYOC,"myocilin, trabecular meshwork inducible glucocorticoid response ",1q24.3-q25.2,
,,,"Glaucoma 1A, primary open angle, juvenile-onset [MIM:137750]"
,,,"Glaucoma 1A, primary open angle, recessive"
,,,"Glaucoma, early-onset, digenic"
,,,
MYOM1,"myomesin 1, 185kDa ",?,
,,,mutations
,,,
MYOT,myotilin ,5q31,
,,,"Muscular dystrophy, limb-girdle, type 1A [MIM:159000]"
,,,Myotilinopathy [MIM:609200]
,,,"Myopathy, spheroid body [MIM:182920]"
,,,
MYOZ2,myozenin 2 ,4q26-q27,
,,,mutations
,,,
MYP10,myopia 10 ,8p23,
,,,Myopia 10
,,,
MYP11,"myopia 11 (high grade, autosomal dominant) ",4q22-q27,
,,,Myopia 11
,,,
MYP12,"myopia 12 (high grade, autosomal dominant) ",2q37.1,
,,,Myopia 12
,,,
MYP13,myopia 13 ,Xq23-q27.2,
,,,Myopia 13
,,,
MYP15,myopia 15 ,10q21.1,
,,,Myopia 15
,,,
MYP16,myopia 16 ,5p15.33-p15.2,
,,,Myopia 16
,,,
MYP17,myopia 17 ,7p15,
,,,Myopia 17
,,,
MYP1,myopia 1 (X-linked) ,Xq28,
,,,Myopia-1
,,,Bornholm eye disease
,,,
MYP2,"myopia 2 (high grade, autosomal dominant) ",18p11.31,
,,,Myopia-2
,,,
MYP3,"myopia 3 (high grade, autosomal dominant) ",12q21-q23,
,,,Myopia-3
,,,
MYP4,"myopia 4 (high grade, autosomal dominant) ",7p15,
,,,Myopia 17
,,,
MYP5,"myopia 5 (high grade, autosomal dominant) ",17q21-q22,
,,,Myopia 5
,,,
MYP6,myopia 6 ,22q12,
,,,Myopia-6
,,,
MYP7,myopia 7 ,11p13,
,,,Myopia 7
,,,
MYP8,myopia 8 ,3q26,
,,,Myopia 8
,,,
MYP9,myopia 9 ,4q12,
,,,Myopia 9
,,,
MYPN,myopalladin ,?,
,,,mutations
,,,
MYT1L,myelin transcription factor 1-like ,2p24,
,,,mutations
,,,
MYT1,myelin transcription factor 1 ,20q13.3,
,,,mutations
,,,
NAA10,"N(alpha)-acetyltransferase 10, NatA catalytic subunit ",Xq28,
,,,mutations
,,,
NAFLD2,"Fatty liver disease, nonalcoholic, susceptibility to, 2 ",11q23,
,,,"Fatty liver disease, nonalcoholic, susceptibility to, 2"
,,,
NAGA,"N-acetylgalactosaminidase, alpha- ",22q11,
,,,"Schindler disease, type I [MIM:609241]"
,,,Kanzaki disease [MIM:609242]
,,,"Schindler disease, type III [MIM:609241]"
,,,
NAGLU,"N-acetylglucosaminidase, alpha ",17q21,
,,,Mucopolysaccharidosis type IIIB (Sanfilippo B) [MIM:252920]
,,,
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase ,16p13.3,
,,,mutations
,,,
NAGS,N-acetylglutamate synthase ,17q21.31,
,,,N-acetylglutamate synthase deficiency [MIM:237310]
,,,
NAIP,"NLR family, apoptosis inhibitory protein ",5q12.2-q13.3,
,,,mutations
,,,
NAMPT,nicotinamide phosphoribosyltransferase ,7q22.2,
,,,mutations
,,,
NAMSD,"neuropathy, axonal, motor-sensory with deafness and mental retardation (Cowchock syndrome) ",Xq24-q26.1,
,,,Cowchock syndrome
,,,
NAPRT1,nicotinate phosphoribosyltransferase domain containing 1 ,8q24.3,
,,,mutations
,,,
NARS2,"asparaginyl-tRNA synthetase 2, mitochondrial (putative) ",11q14.1,
,,,mutations
,,,
NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase) ,8p23.1-p21.3,
,,,mutations
,,,
NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase) ,8p23.1-p21.3,
,,,"Acetylation, slow [MIM:243400]"
,,,
NAT8L,"N-acetyltransferase 8-like (GCN5-related, putative) ",?,
,,,mutations
,,,
NAV2,neuron navigator 2 ,11p15.1,
,,,mutations
,,,
NA,neuroacanthocytosis ,Yq11,
,,,mutations
,,,
NBAS,neuroblastoma amplified sequence ,2p24-p23,
,,,mutations
,,,
NBEAL2,neurobeachin-like 2 ,?,
,,,mutations
,,,
NBEAP1,neurobeachin pseudogene 1 ,15q11-q13,
,,,"Lymphoma, diffuse large cell"
,,,
NBEA,neurobeachin ,13q13.2,
,,,mutations
,,,
NBLST4,"Neuroblastoma, susceptibility to, 4 ",6p22,
,,,"Neuroblastoma, susceptibility to, 4"
,,,
NBLST5,"Neuroblastoma, susceptibility to, 5 ",2q35,
,,,"Neuroblastoma, susceptibility to, 5"
,,,
NBLST6,"Neuroblastoma, susceptibility to, 6 ",1q21.1,
,,,"Neuroblastoma, susceptibility to, 6"
,,,
NBN,nibrin ,8q21,
,,,Nijmegen breakage syndrome [MIM:251260]
,,,"Leukemia, acute lymphoblastic"
,,,
NBPF1,"neuroblastoma breakpoint family, member 1 ",1p36.2,
,,,mutations
,,,
NCALD,neurocalcin delta ,8q22.2,
,,,mutations
,,,
NCAM1,neural cell adhesion molecule 1 ,11q23.1,
,,,mutations
,,,
NCAN,neurocan ,19p12,
,,,mutations
,,,
NCAPD2,"non-SMC condensin I complex, subunit D2 ",?,
,,,mutations
,,,
NCF1,neutrophil cytosolic factor 1 ,7q11.23,
,,,Chronic granulomatous disease due to deficiency of NCF-1 [MIM:233700]
,,,
NCF2,neutrophil cytosolic factor 2 ,1q25,
,,,Chronic granulomatous disease due to deficiency of NCF-2 [MIM:233710]
,,,
NCF4,"neutrophil cytosolic factor 4, 40kDa ",22q13.1,
,,,mutations
,,,
NCKAP1,NCK-associated protein 1 ,2q32.1-q32.2,
,,,mutations
,,,
NCL,nucleolin ,2q12-qter,
,,,mutations
,,,
NCOA1,nuclear receptor coactivator 1 ,2p23,
,,,mutations
,,,
NCOA3,nuclear receptor coactivator 3 ,20q12,
,,,mutations
,,,
NCOA4,nuclear receptor coactivator 4 ,10q11.2,
,,,"Thyroid carcinoma, papillary [MIM:188550]"
,,,
NCR3,natural cytotoxicity triggering receptor 3 ,6p21.3,
,,,"Malaria, mild, susceptibility to [MIM:609148]"
,,,
NCS1,neuronal calcium sensor 1 ,9q34,
,,,mutations
,,,
NCSTN,nicastrin ,1q22-q23,
,,,"Acne inversa, familial, 1 [MIM:142690]"
,,,
NDE1,nudE nuclear distribution E homolog 1 (A. nidulans) ,16p13.1,
,,,mutations
,,,
NDIC,"Nail dysplasia, isolated congenital ",17p13,
,,,"Nail dysplasia, isolated congenital"
,,,
NDN,necdin homolog (mouse) ,15q11-q13,
,,,Prader-Willi syndrome [MIM:176270]
,,,
NDOR1,NADPH dependent diflavin oxidoreductase 1 ,9q34.3,
,,,mutations
,,,
NDP,Norrie disease (pseudoglioma) ,Xp11.4,
,,,Norrie disease [MIM:310600]
,,,"Exudative vitreoretinopathy, X-linked [MIM:305390]"
,,,
NDRG1,N-myc downstream regulated 1 ,8q24.3,
,,,"Charcot-Marie-Tooth disease, type 4D [MIM:601455]"
,,,
NDST1,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 ,5q32-q33.3,
,,,mutations
,,,
NDUFA10,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa ",2q37.3,
,,,mutations
,,,
NDUFA11,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa ",19p13.3,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFA12,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 ",?,
,,,mutations
,,,
NDUFA13,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 ",19p13.2-p13.1,
,,,"Thyroid carcinoma, Hurthle cell [MIM:607464]"
,,,
NDUFA1,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa ",Xq24,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFA2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa ",5q31.2,
,,,Leigh syndrome due to mitochondrial complex I deficiency [MIM:256000]
,,,
NDUFA4,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa ",?,
,,,mutations
,,,
NDUFA6,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa ",22q13.1,
,,,mutations
,,,
NDUFA8,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa ",9q33.2-q34.11,
,,,mutations
,,,
NDUFA9,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa ",12p,
,,,mutations
,,,
NDUFAF1,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 ",15q13.3,
,,,mutations
,,,
NDUFAF2,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 ",5q12.1,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,Leigh syndrome [MIM:256000]
,,,
NDUFAF3,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 ",3p21.31,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFAF4,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 4 ",6q16.1,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFAF5,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 ",20p12.1,
,,,Mitochondrial complex 1 deficiency [MIM:252010]
,,,
NDUFAF6,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 ",8q22.1,
,,,Leigh syndrome due to mitochondrial complex I deficiency [MIM:256000]
,,,
NDUFB1,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa ",?,
,,,mutations
,,,
NDUFB3,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa ",2q31.3,
,,,mutations
,,,
NDUFB6,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa ",?,
,,,mutations
,,,
NDUFB9,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa ",8q13.3,
,,,mutations
,,,
NDUFC2,"NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa ",?,
,,,mutations
,,,
NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) ",2q33-q34,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFS2,"NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) ",1q23,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFS3,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) ",11p11.11,
,,,Leigh syndrome [MIM:256000]
,,,
NDUFS4,"NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) ",5q11.1,
,,,Leigh syndrome [MIM:256000]
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFS5,"NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) ",1p34.2-p33,
,,,mutations
,,,
NDUFS6,"NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) ",5pter-p15.33,
,,,"Complex I, mitochondrial respiratory chain, deficiency of [MIM:252010]"
,,,
NDUFS7,"NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) ",19p13,
,,,Leigh syndrome [MIM:256000]
,,,
NDUFS8,"NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) ",11q13,
,,,Leigh syndrome [MIM:256000]
,,,
NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa ",11q13,
,,,Leigh syndrome [MIM:256000]
,,,Alexander disease [MIM:203450]
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa ",18p11.31-p11.2,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NDUFV3,"NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa ",21q22.3,
,,,mutations
,,,
NEBL,nebulette ,10p13-p12,
,,,mutations
,,,
NEB,nebulin ,2q22,
,,,"Nemaline myopathy 2, autosomal recessive [MIM:256030]"
,,,
NEDD4L,"neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase ",18q21,
,,,mutations
,,,
NEDD9,"neural precursor cell expressed, developmentally down-regulated 9 ",6p25-p24,
,,,mutations
,,,
NEDE,"nephropathy, progressive, with deafness ",11q24,
,,,"Nephropathy, progressive, with deafness"
,,,
NEFH,"neurofilament, heavy polypeptide ",22q12.2,
,,,"Amyotrophic lateral sclerosis, susceptibility to [MIM:105400]"
,,,
NEFL,"neurofilament, light polypeptide ",8p21,
,,,"Charcot-Marie-Tooth disease, type 2E [MIM:607684]"
,,,"Charcot-Marie-Tooth disease, type 1F [MIM:607734]"
,,,
NEFM,"neurofilament, medium polypeptide ",8p21,
,,,mutations
,,,
NEGR1,neuronal growth regulator 1 ,1p31.1,
,,,mutations
,,,
NEIL1,nei endonuclease VIII-like 1 (E. coli) ,?,
,,,mutations
,,,
NEIL2,nei endonuclease VIII-like 2 (E. coli) ,?,
,,,mutations
,,,
NEK1,NIMA (never in mitosis gene a)-related kinase 1 ,4q33,
,,,"Short rib-polydactyly syndorme, type II [MIM:253520]"
,,,
NEK8,NIMA (never in mitosis gene a)- related kinase 8 ,17q11.1,
,,,Nephronophthisis 9
,,,
NELF,nasal embryonic LHRH factor ,9q34.3,
,,,Hypogonadotropic hypogonadism [MIM:146110]
,,,
NELL1,NEL-like 1 (chicken) ,11p15.2-p15.1,
,,,mutations
,,,
NES,nestin ,?,
,,,mutations
,,,
NEU1,sialidase 1 (lysosomal sialidase) ,6p21.3,
,,,"Sialidosis, type I [MIM:256550]"
,,,"Sialidosis, type II [MIM:256550]"
,,,
NEU2,sialidase 2 (cytosolic sialidase) ,2q37,
,,,mutations
,,,
NEUROD1,neuronal differentiation 1 ,2q32,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,Maturity-onset diabetes of the young 6 [MIM:606394]
,,,
NEUROG3,neurogenin 3 ,10q21.3,
,,,"Diarrhea 4, malabsorptive, congenital [MIM:610370]"
,,,
NEXN,nexilin (F actin binding protein) ,1p32-p31,
,,,"Cardiomyopathy, dilated, 1CC [MIM:613122]"
,,,
NF1,neurofibromin 1 ,17q11.2,
,,,"Neurofibromatosis, type 1 [MIM:162200]"
,,,"Leukemia, juvenile myelomonocytic [MIM:607785]"
,,,"Melanoma, desmoplastic neurotrophic"
,,,"Neurofibromatosis, familial spinal [MIM:162210]"
,,,Neurofibromatosis-Noonan syndrome [MIM:601321]
,,,Watson syndrome [MIM:193520]
,,,
NF2,neurofibromin 2 (merlin) ,22q12.2,
,,,"Neurofibromatosis, type 2 [MIM:101000]"
,,,"Meningioma, NF2-related, somatic [MIM:607174]"
,,,Schwannomatosis [MIM:162091]
,,,
NFATC4,"nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 ",14,
,,,mutations
,,,
NFE2L2,nuclear factor (erythroid-derived 2)-like 2 ,2q31,
,,,mutations
,,,
NFIA,nuclear factor I/A ,1p31.3-p31.2,
,,,mutations
,,,
NFIX,nuclear factor I/X (CCAAT-binding transcription factor) ,19p13.3,
,,,mutations
,,,
NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 ,4q23-q24,
,,,mutations
,,,
NFKB2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) ,10q24,
,,,"lymphoma,B cell,non Hodgkin,associated with breakpoint in t(10;14)(q24;q32) translocation"
,,,
NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha ",14q13,
,,,"Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency [MIM:612132]"
,,,
NFKBIL1,nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 ,6p21.3,
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,
NFU1,NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae) ,2p15-p13,
,,,mutations
,,,
NGFR,nerve growth factor receptor ,17q21-q22,
,,,mutations
,,,
NGF,nerve growth factor (beta polypeptide) ,1p13.1,
,,,"Neuropathy, hereditary sensory and autonomic, type V [MIM:608654]"
,,,
NHEJ1,nonhomologous end-joining factor 1 ,2q35,
,,,"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation [MIM:611291]"
,,,
NHLRC1,NHL repeat containing 1 ,6p22.3,
,,,"Epilepsy, progressive myoclonic 2B (Lafora) [MIM:254780]"
,,,
NHP2,NHP2 ribonucleoprotein homolog (yeast) ,5q35.3,
,,,Dyskeratosis congenita [MIM:224230]
,,,
NHS,Nance-Horan syndrome (congenital cataracts and dental anomalies) ,Xp22.13,
,,,Nance-Horan syndrome [MIM:302350]
,,,"Cataract, congenital, X-linked [MIM:302200]"
,,,
NID1,nidogen 1 ,1q43,
,,,mutations
,,,
NIDDM2,"non-insulin-dependent diabetes mellitus (common, type 2) 2 ",12q24.2,
,,,"Diabetes mellitus, noninsulin-dependent, 2"
,,,
NIDDM3,Noninsulin-dependent diabetes mellitus 3 ,20q12-q13.1,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
NIDDM4,"Diabetes mellitus, noninsulin-dependent ",5q34-q35.2,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
NINJ1,ninjurin 1 ,9q22,
,,,mutations
,,,
NIPA1,non imprinted in Prader-Willi/Angelman syndrome 1 ,15q11.1,
,,,Spastic paraplegia-6 [MIM:600363]
,,,
NIPAL4,NIPA-like domain containing 4 ,5q33,
,,,"Ichthyosis, congenital, autosomal recessive [MIM:612281]"
,,,
NIPBL,Nipped-B homolog (Drosophila) ,5p13.1,
,,,Cornelia de Lange syndrome 1 [MIM:122470]
,,,
NIPSNAP1,nipsnap homolog 1 (C. elegans) ,22q12,
,,,mutations
,,,
NIPSNAP3A,nipsnap homolog 3A (C. elegans) ,?,
,,,mutations
,,,
NKAIN2,Na+/K+ transporting ATPase interacting 2 ,6q21,
,,,mutations
,,,
NKCD,"Natural killer cell deficiency, familial isolated ",8p11.23-q11.21,
,,,"Natural killer cell deficiency, familial isolated"
,,,
NKX2-1,NK2 homeobox 1 ,14q13,
,,,"Goiter, familial, due to TTF-1 defect"
,,,"Chorea, hereditary benign [MIM:118700]"
,,,"Choreoathetosis, hypothyroidism, and neonatal respiratory distress [MIM:610978]"
,,,
NKX2-3,NK2 homeobox 3 ,10q24.2,
,,,mutations
,,,
NKX2-5,NK2 homeobox 5 ,5q34,
,,,Atrial septal defect with atrioventricular conduction defects [MIM:108900]
,,,Tetrology of Fallot [MIM:187500]
,,,"Atrioventricular block, second-degree"
,,,"Hypothyroidism, congenital nongoitrous, 5 [MIM:225250]"
,,,
NKX2-6,NK2 homeobox 6 ,8p21,
,,,Persistent truncus arteriosus [MIM:217095]
,,,
NKX3-1,NK3 homeobox 1 ,8p21,
,,,mutations
,,,
NKX3-2,NK3 homeobox 2 ,4p16.1,
,,,Spondylo-megaepiphyseal-metaphyseal dysplasia [MIM:613330]
,,,
NLGN1,neuroligin 1 ,3q26.3,
,,,mutations
,,,
NLGN2,neuroligin 2 ,17,
,,,mutations
,,,
NLGN3,neuroligin 3 ,Xq13,
,,,"Autism susceptibility, X-linked 1 [MIM:300425]"
,,,"Asperger syndrome susceptibility, X-linked 1 [MIM:300494]"
,,,
NLGN4X,"neuroligin 4, X-linked ",Xp22.33,
,,,"Autism susceptibility, X-linked 2 [MIM:300495]"
,,,"Asperger syndrome susceptibility, X-linked 2 [MIM:300497]"
,,,"Mental retardation, X-linked [MIM:300495]"
,,,
NLGN4Y,"neuroligin 4, Y-linked ",Yq11.2,
,,,mutations
,,,
NLRP12,"NLR family, pyrin domain containing 12 ",19q13.4,
,,,Familial cold autoinflammatory syndrome 2 [MIM:611762]
,,,
NLRP14,"NLR family, pyrin domain containing 14 ",11p15.4,
,,,mutations
,,,
NLRP1,"NLR family, pyrin domain containing 1 ",17p13,
,,,Vitiligo-associated multiple autoimmune disease susceptibility 1 [MIM:606579]
,,,
NLRP2,"NLR family, pyrin domain containing 2 ",19q13.4,
,,,mutations
,,,
NLRP3,"NLR family, pyrin domain containing 3 ",1q44,
,,,"Cold-induced autoinflammatory syndrome, familial [MIM:120100]"
,,,Muckle-Wells syndrome [MIM:191900]
,,,CINCA syndrome [MIM:607115]
,,,
NLRP7,"NLR family, pyrin domain containing 7 ",19q13.4,
,,,Hydatidiform mole [MIM:231090]
,,,
NLRX1,NLR family member X1 ,11q23.3,
,,,mutations
,,,
NMB,neuromedin B ,15q22-qter,
,,,mutations
,,,
NME1,NME/NM23 nucleoside diphosphate kinase 1 ,17q21.3,
,,,Neuroblastoma [MIM:256700]
,,,
NME8,NME/NM23 family member 8 ,7p14-p13,
,,,"Ciliary dyskinesia, primary, 6 [MIM:610852]"
,,,
NMSR,"Neuropathy, hereditary motor and sensory, Russe type ",10q23.2,
,,,"Neuropathy, motor and sensory, Russe type"
,,,
NMS,neuromedin S ,2q33,
,,,Mitochondrial complex III deficiency [MIM:124000]
,,,GRACILE syndrome [MIM:603358]
,,,Leigh syndrome [MIM:256000]
,,,Bjornstad syndrome [MIM:262000]
,,,
NMT2,N-myristoyltransferase 2 ,10p13,
,,,mutations
,,,
NMTC1,Nonmedullary thyroid carcinoma 1 ,2q21,
,,,"Thyroid carcinoma, nonmedullary, 1"
,,,
NMU,neuromedin U ,?,
,,,mutations
,,,
NM,neutrophil migration ,7q22-qter,
,,,mutations
,,,
NNMT,nicotinamide N-methyltransferase ,11q23.1,
,,,Homocysteine plasma level
,,,
NNO1,nanophthalmos 1 ,11p,
,,,Nanophthalmos-1
,,,
NNO3,nanophthalmos 3 ,2q11-q14,
,,,Nanophthalmos 3
,,,
NOBOX,NOBOX oogenesis homeobox ,7q35,
,,,Premature ovarian failure 5 [MIM:611548]
,,,
NOD1,nucleotide-binding oligomerization domain containing 1 ,7p15-p14,
,,,mutations
,,,
NOD2,nucleotide-binding oligomerization domain containing 2 ,16q12,
,,,Inflammatory bowel disease 1 [MIM:266600]
,,,Blau syndrome [MIM:186580]
,,,"Psoriatic arthritis, susceptibility to [MIM:607507]"
,,,"Sarcoidosis, early-onset [MIM:609464]"
,,,
NODAL,nodal homolog (mouse) ,10q22.1,
,,,"Heterotaxy, visceral, 5 [MIM:270100]"
,,,
NOG,noggin ,17q22,
,,,"Symphalangism, proximal [MIM:185800]"
,,,"Synostoses syndrome, multiple, 1 [MIM:186500]"
,,,Tarsal-carpal coalition syndrome [MIM:186570]
,,,Stapes ankylosis with broad thumb and toes [MIM:184460]
,,,"Brachydactyly, type B2 [MIM:611377]"
,,,
NOP10,NOP10 ribonucleoprotein homolog (yeast) ,15q14-q15,
,,,"Dyskeratosis congenita, autosomal recessive [MIM:224230]"
,,,
NOP56,NOP56 ribonucleoprotein homolog (yeast) ,?,
,,,mutations
,,,
NOS1AP,nitric oxide synthase 1 (neuronal) adaptor protein ,1q23.3,
,,,mutations
,,,
NOS1,nitric oxide synthase 1 (neuronal) ,12q24.2-q24.31,
,,,mutations
,,,
NOS2,"nitric oxide synthase 2, inducible ",17cen-q11.2,
,,,"Hypertension, susceptibility to [MIM:145500]"
,,,"Malaria, resistance to [MIM:611162]"
,,,
NOS3,nitric oxide synthase 3 (endothelial cell) ,7q36,
,,,"Coronary artery spasm 1, susceptibility to"
,,,"Alzheimer disease, late-onset, susceptibility to [MIM:104300]"
,,,"Hypertension, susceptibility to [MIM:145500]"
,,,"Hypertension, pregnancy-induced [MIM:189800]"
,,,Placental abruption
,,,"Ischemic stroke, susceptibility to [MIM:601367]"
,,,
NOTCH1,notch 1 ,9q34.3,
,,,Aortic valve disease [MIM:109730]
,,,"Leukemia, T-cell acute lymphoblastic"
,,,
NOTCH2,notch 2 ,1p13-p11,
,,,Alagille syndrome 2 [MIM:610205]
,,,
NOTCH3,notch 3 ,19p13.2-p13.1,
,,,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy [MIM:125310]
,,,
NOTCH4,notch 4 ,6p21.3,
,,,mutations
,,,
NPAS2,neuronal PAS domain protein 2 ,2q13,
,,,mutations
,,,
NPAS3,neuronal PAS domain protein 3 ,14q13,
,,,mutations
,,,
NPAT,"nuclear protein, ataxia-telangiectasia locus ",11q22.3,
,,,mutations
,,,
NPC1L1,"NPC1 (Niemann-Pick disease, type C1, gene)-like 1 ",7p13,
,,,"Ezetimibe, nonresponse to"
,,,
NPC1,"Niemann-Pick disease, type C1 ",18q11-q12,
,,,"Niemann-Pick disease, type C1 [MIM:257220]"
,,,"Niemann-Pick disease, type D [MIM:257220]"
,,,
NPC2,"Niemann-Pick disease, type C2 ",14q24.3,
,,,"Niemann-pick disease, type C2 [MIM:607625]"
,,,
NPCA1,Nasopharyngeal carcinoma 1 ,4p15.1-q12,
,,,Nasopharyngeal carcinoma 1
,,,
NPCA2,"Nasopharyngeal carcinoma, susceptibility to, 2 ",6p21.3,
,,,"Nasopharyngeal carcinoma, susceptibility to, 2"
,,,
NPFFR2,neuropeptide FF receptor 2 ,4q13.2-q13.3,
,,,mutations
,,,
NPHP1,nephronophthisis 1 (juvenile) ,2q13,
,,,"Nephronophthisis 1, juvenile [MIM:256100]"
,,,Senior-Loken syndrome-1 [MIM:266900]
,,,Joubert syndrome 4 [MIM:609583]
,,,
NPHP3,nephronophthisis 3 (adolescent) ,3q22,
,,,Nephronophthisis 3 [MIM:604387]
,,,Renal-hepatic-pancreatic dysplasia [MIM:208540]
,,,Meckel syndrome 7 [MIM:267010]
,,,
NPHP4,nephronophthisis 4 ,1p36,
,,,Nephronophthisis 4 [MIM:606966]
,,,Senior-Loken syndrome 4 [MIM:606996]
,,,
NPHS1,"nephrosis 1, congenital, Finnish type (nephrin) ",19q13.1,
,,,"Nephrotic syndrome, type 1 [MIM:256300]"
,,,
NPHS2,"nephrosis 2, idiopathic, steroid-resistant (podocin) ",1q25-q31,
,,,"Nephrotic syndrome, type 2 [MIM:600995]"
,,,
NPL,N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) ,1q25,
,,,mutations
,,,
NPM1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin) ",5q35,
,,,"Leukemia, acute promyelocytic, NPM/RARA type"
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
NPPA,natriuretic peptide A ,1p36.2,
,,,"Atrial fibrillation, familial, 6 [MIM:612201]"
,,,
NPPB,natriuretic peptide B ,1p36.2,
,,,mutations
,,,
NPPC,natriuretic peptide C ,2q24-qter,
,,,mutations
,,,
NPR1,natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) ,1q21-q22,
,,,mutations
,,,
NPR2,natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) ,9p21-p12,
,,,"Acromesomelic dysplasia, Maroteaux type [MIM:602875]"
,,,
NPR3,natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) ,5p14-p12,
,,,"Hypertension, salt-resistant"
,,,
NPSR1,neuropeptide S receptor 1 ,7p15-p14,
,,,"Asthma, susceptibility to, 2 [MIM:608584]"
,,,
NPTN,neuroplastin ,15q22,
,,,mutations
,,,
NPY1R,neuropeptide Y receptor Y1 ,4q31.3-q32,
,,,mutations
,,,
NPY2R,neuropeptide Y receptor Y2 ,4q31,
,,,mutations
,,,
NPY,neuropeptide Y ,7p15.1,
,,,mutations
,,,
NQO1,"NAD(P)H dehydrogenase, quinone 1 ",16q22.1,
,,,"Benzene toxicity, susceptibility to"
,,,"Leukemia, post-chemotherapy, susceptibility to"
,,,"Breast cancer, poor survival after chemotherapy for (3) 8"
,,,
NQO2,"NAD(P)H dehydrogenase, quinone 2 ",6p25,
,,,Breast cancer susceptibility [MIM:114480]
,,,
NR0B1,"nuclear receptor subfamily 0, group B, member 1 ",Xp21.3-p21.2,
,,,"Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism [MIM:300200]"
,,,Dosage-sensitive sex reversal [MIM:300018]
,,,
NR0B2,"nuclear receptor subfamily 0, group B, member 2 ",1p36.1,
,,,"Obesity, mild, early-onset [MIM:601665]"
,,,
NR1H2,"nuclear receptor subfamily 1, group H, member 2 ",19q13.3,
,,,mutations
,,,
NR1H3,"nuclear receptor subfamily 1, group H, member 3 ",?,
,,,mutations
,,,
NR1H4,"nuclear receptor subfamily 1, group H, member 4 ",12q,
,,,mutations
,,,
NR1I2,"nuclear receptor subfamily 1, group I, member 2 ",3q13-q21,
,,,mutations
,,,
NR1I3,"nuclear receptor subfamily 1, group I, member 3 ",?,
,,,mutations
,,,
NR2E1,"nuclear receptor subfamily 2, group E, member 1 ",6q21,
,,,mutations
,,,
NR2E3,"nuclear receptor subfamily 2, group E, member 3 ",15q23,
,,,Enhanced S-cone syndrome [MIM:268100]
,,,Retinitis pigmentosa-37 [MIM:611131]
,,,
NR2F1,"nuclear receptor subfamily 2, group F, member 1 ",5q14,
,,,mutations
,,,
NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) ",5q31,
,,,Cortisol resistance
,,,
NR3C2,"nuclear receptor subfamily 3, group C, member 2 ",4q31.1,
,,,"Pseudohypoaldosteronism type I, autosomal dominant [MIM:177735]"
,,,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy [MIM:605115]"
,,,
NR4A2,"nuclear receptor subfamily 4, group A, member 2 ",2q22-q23,
,,,mutations
,,,
NR4A3,"nuclear receptor subfamily 4, group A, member 3 ",9q22,
,,,"Chondrosarcoma, extraskeletal myxoid [MIM:612237]"
,,,
NR5A1,"nuclear receptor subfamily 5, group A, member 1 ",9q33,
,,,"46XY gonadal dysgenesis, complete or partial, with or without adrenal failure [MIM:612965]"
,,,Premature ovarian failure 7 [MIM:612964]
,,,Adrenocortical insufficiency
,,,
NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog ,1p13.2,
,,,Colorectal cancer [MIM:114500]
,,,"Thyroid carcinoma, follicular [MIM:188470]"
,,,Autoimmune lymphoproliferative syndrome type IV
,,,Noonan syndrome 6 [MIM:613224]
,,,
NRCLP3,Narcolepsy 3 ,21q11.2,
,,,Narcolepsy 3
,,,
NRCLP4,Narcolepsy 4 ,22q13,
,,,Narcolepsy 4
,,,
NRCLP5,Narcolepsy 5 ,14q11.2,
,,,Narcolepsy 5
,,,
NRCLP,"Narcolepsy, HLA-associated ",4p13-q21,
,,,Narcolepsy 2
,,,
NRG1,neuregulin 1 ,8p22-p11,
,,,"Schizophrenia, susceptibility to [MIM:603013]"
,,,
NRG3,neuregulin 3 ,10q22,
,,,mutations
,,,
NRIP1,nuclear receptor interacting protein 1 ,21q11,
,,,mutations
,,,
NRL,neural retina leucine zipper ,14q11.1-q11.2,
,,,Retinitis pigmentosa-27
,,,"Retinal degeneration, autosomal recessive, clumped pigment type"
,,,
NRP2,neuropilin 2 ,2q34,
,,,mutations
,,,
NRTN,neurturin ,19p13.3,
,,,mutations
,,,
NRXN1,neurexin 1 ,2p16.3,
,,,Pitt-Hopkins-like syndrome 2
,,,
NRXN2,neurexin 2 ,11q13,
,,,mutations
,,,
NRXN3,neurexin 3 ,14q24.3-q31.1,
,,,mutations
,,,
NSD1,nuclear receptor binding SET domain protein 1 ,5q35,
,,,Sotos syndrome [MIM:117550]
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,Weaver syndrome [MIM:277590]
,,,Beckwith-Wiedemann syndrome [MIM:130650]
,,,
NSDHL,NAD(P) dependent steroid dehydrogenase-like ,Xq28,
,,,CHILD syndrome [MIM:308050]
,,,CK syndrome [MIM:300831]
,,,
NSUN2,"NOP2/Sun RNA methyltransferase family, member 2 ",5p15.31,
,,,mutations
,,,
NSUN7,"NOP2/Sun domain family, member 7 ",?,
,,,mutations
,,,
NT5C1B,"5'-nucleotidase, cytosolic IB ",?,
,,,mutations
,,,
NT5C3,"5'-nucleotidase, cytosolic III ",7p15-p14,
,,,"Anemia, hemolytic, due to UMPH1 deficiency [MIM:266120]"
,,,
NT5E,"5'-nucleotidase, ecto (CD73) ",6q14-q21,
,,,Calcification of joints and arteries [MIM:211800]
,,,
NTF3,neurotrophin 3 ,12p13,
,,,mutations
,,,
NTF4,neurotrophin 4 ,19q13.3,
,,,"Glaucoma 1, open angle, 1O [MIM:613100]"
,,,
NTHL1,nth endonuclease III-like 1 (E. coli) ,16p13.3-p13.2,
,,,mutations
,,,
NTNG1,netrin G1 ,1p13.3,
,,,mutations
,,,
NTRK1,"neurotrophic tyrosine kinase, receptor, type 1 ",1q21-q22,
,,,"Insensitivity to pain, congenital, with anhidrosis [MIM:256800]"
,,,"Medullary thyroid carcinoma, familial [MIM:155240]"
,,,
NTRK2,"neurotrophic tyrosine kinase, receptor, type 2 ",9q22.1,
,,,"Obesity, hyperphagia, and developmental delay"
,,,
NTRK3,"neurotrophic tyrosine kinase, receptor, type 3 ",15q25,
,,,mutations
,,,
NTS,neurotensin ,12q21,
,,,mutations
,,,
NUAK1,"NUAK family, SNF1-like kinase, 1 ",?,
,,,mutations
,,,
NUBPL,nucleotide binding protein-like ,14q12,
,,,Mitochondrial complex I deficiency [MIM:252010]
,,,
NUDC,nuclear distribution C homolog (A. nidulans) ,?,
,,,mutations
,,,
NUDT1,nudix (nucleoside diphosphate linked moiety X)-type motif 1 ,7p22,
,,,mutations
,,,
NUDT6,nudix (nucleoside diphosphate linked moiety X)-type motif 6 ,?,
,,,mutations
,,,
NUMA1,nuclear mitotic apparatus protein 1 ,11q13,
,,,"Leukemia, acute promyelocytic, NUMA/RARA type"
,,,
NUMBL,numb homolog (Drosophila)-like ,19q13.13-q13.2,
,,,mutations
,,,
NUMB,numb homolog (Drosophila) ,14q24.3,
,,,mutations
,,,
NUP155,nucleoporin 155kDa ,5p13,
,,,mutations
,,,
NUP214,nucleoporin 214kDa ,9q34.1,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,"Leukemia, T-cell acute lymphoblastic"
,,,
NUP62,nucleoporin 62kDa ,19q13.33,
,,,"Striatonigral degeneration, infantile [MIM:271930]"
,,,
NUP98,nucleoporin 98kDa ,11p15,
,,,"Leukemia, lymphocytic, acute T-cell"
,,,
NXF3,nuclear RNA export factor 3 ,Xq21.3-q22.3,
,,,mutations
,,,
NXF5,nuclear RNA export factor 5 ,X,
,,,mutations
,,,
NXNL1,nucleoredoxin-like 1 ,?,
,,,mutations
,,,
NYS2,"nystagmus 2, congenital autosomal dominant ",6p12,
,,,"Nystagmus-2, autosomal dominant"
,,,
NYS3,"nystagmus 3, congenital autosomal dominant ",7p11.2,
,,,"Nystagmus 3, congenital"
,,,
NYS4,"nystagmus 4, congenital autosomal dominant ",13q31-q33,
,,,"Nystagmus 4, congenital"
,,,
NYS5,"Nystagmus 5, infantile periodic alternating ",Xp11.4,
,,,"Nystagmus 5, congenital, X-linked"
,,,
NYX,nyctalopin ,Xp11.4,
,,,"Night blindness, congenital stationary, type 1 [MIM:310500]"
,,,
O3FAR1,omega-3 fatty acid receptor 1 ,?,
,,,mutations
,,,
OA1,Osteoarthritis QTL 1 ,Xp22.3,
,,,Ocular albinism with sensorineural deafness
,,,
OA2,Osteoarthritis QTL 2 ,Xp11.23,
,,,"Night blindness, congenital stationary, X-linked, type 2A [MIM:300071]"
,,,"Cone-rod dystrophy, X-linked, 3 [MIM:300476]"
,,,Aland Island eye disease [MIM:300600]
,,,
OA4,Osteoarthritis QTL 4 ,17q23-q24,
,,,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 [MIM:610131]"
,,,
OA5,Osteoarthritis QTL 5 ,11q23,
,,,"Hypertriglyceridemia, susceptibility to [MIM:145750]"
,,,"Hyperchylomicronemia, late-onset [MIM:144650]"
,,,
OAS1,"2'-5'-oligoadenylate synthetase 1, 40/46kDa ",12q24.2,
,,,"Viral infection, susceptibility to"
,,,"Diabetes mellitus, type 1, susceptibility to [MIM:222100]"
,,,
OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa ",12q24.2,
,,,mutations
,,,
OASD,ocular albinism and sensorineural deafness ,Xp22.3,
,,,Ocular albinism with sensorineural deafness
,,,
OAT,ornithine aminotransferase ,10q26,
,,,Gyrate atrophy of choroid and retina with or without ornithinemia [MIM:258870]
,,,
OAZ1,ornithine decarboxylase antizyme 1 ,19p13.3,
,,,mutations
,,,
OB10Q,"Obesity, susceptibility to, on chromosome 10q ",10q,
,,,"Obesity, susceptibility to, BMIQ10"
,,,
OB4,"Obesity, susceptibility to, on chromosome 4 ",4p15-p14,
,,,"Obesity, susceptibility to, BMIQ7"
,,,
OBSCN,"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF ",?,
,,,mutations
,,,
OBSL1,obscurin-like 1 ,2q35,
,,,Three M syndrome 2 [MIM:612921]
,,,
OCA2,oculocutaneous albinism II ,15q11.2-q12,
,,,"Albinism, oculocutaneous, type II [MIM:203200]"
,,,"Albinism, brown oculocutaneous [MIM:203200]"
,,,"Skin/hair/eye pigmentation 1, blue/nonblue eyes [MIM:227220]"
,,,"Skin/hair/eye pigmentation 1, blond/brown hair [MIM:227220]"
,,,
OCD1,obsessive-compulsive disorder 1 ,17q11.1-q12,
,,,Anxiety-related personality traits [MIM:607834]
,,,Obsessive-compulsive disorder 1 [MIM:164230]
,,,
OCLN,occludin ,5q13.1,
,,,Band-like calcification with simplified gyration and polymicrogyria [MIM:251290]
,,,
OCRL,oculocerebrorenal syndrome of Lowe ,Xq26.1,
,,,Lowe syndrome [MIM:309000]
,,,Dent disease 2 [MIM:300555]
,,,
ODC1,ornithine decarboxylase 1 ,2p25,
,,,"Colonic adenoma recurrence, reduced risk of [MIM:114500]"
,,,
ODCP,ornithine decarboxylase pseudogene ,2p25,
,,,"Colonic adenoma recurrence, reduced risk of [MIM:114500]"
,,,
ODPF,"Osseous dysplasia, digital, with facial pigmentary defects and multiple frenula ",Xq27.3-q28,
,,,"Osseous dysplasia, digital, with facial pigmentary defects and multiple frenula"
,,,
ODS1,"Opioid dependence, susceptibility to, 1 ",17,
,,,"Opioid dependence, susceptibility to, 1"
,,,
ODZ4,"odz, odd Oz/ten-m homolog 4 (Drosophila) ",?,
,,,mutations
,,,
OFC12,Orofacial cleft 12 ,8q24.31,
,,,Orofacial cleft 12
,,,
OFC1,orofacial cleft 1 ,6p24.3,
,,,Orofacial cleft-1
,,,
OFC2,orofacial cleft 2 ,2p13,
,,,Orofacial cleft-2
,,,
OFC3,orofacial cleft 3 ,19q13,
,,,Orofacial cleft-3
,,,
OFC4,Orofacial cleft 4 ,4q21-q31,
,,,Orofacial cleft 4
,,,
OFC9,Orofacial cleft 9 ,13q33.1-q34,
,,,Orofacial cleft 9
,,,
OFD1,oral-facial-digital syndrome 1 ,Xp22.3-p22.2,
,,,Oral-facial-digital syndrome 1 [MIM:311200]
,,,"Simpson-Golabi-Behmel syndrome, type 2 [MIM:300209]"
,,,Joubert syndrome 10 [MIM:300804]
,,,
OGDH,oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) ,7p14-p13,
,,,Alpha-ketoglutarate dehydrogenase deficiency [MIM:203740]
,,,
OGG1,8-oxoguanine DNA glycosylase ,3p26.2,
,,,"Renal cell carcinoma, clear cell, somatic [MIM:144700]"
,,,
OGS2,"Opitz G syndrome, type II ",22q11.2,
,,,"Opitz G syndrome, type II"
,,,
OHDS,Orthostatic hypotensive disorder of Streeten ,18q,
,,,Orthostatic hypotensive disorder of Streeten
,,,
OLFM2,olfactomedin 2 ,?,
,,,mutations
,,,
OLR1,oxidized low density lipoprotein (lectin-like) receptor 1 ,12p13-p12,
,,,"Myocardial infarction, susceptibility to"
,,,
OMG,oligodendrocyte myelin glycoprotein ,17q11.2,
,,,mutations
,,,
OMP,olfactory marker protein ,11q13.4-q14.1,
,,,mutations
,,,
OMS,"otitis media, susceptibility to ",10q26.3,
,,,"Otitis media, susceptibility to"
,,,
OPA1,optic atrophy 1 (autosomal dominant) ,3q28-q29,
,,,Optic atrophy 1 [MIM:165500]
,,,"Glaucoma, normal tension, susceptibility to [MIM:606657]"
,,,Optic atrophy and deafness [MIM:125250]
,,,
OPA2,optic atrophy 2 (obscure) ,Xp11.4-p11.21,
,,,"Optic atrophy, X-linked"
,,,
OPA3,"optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) ",19q13.2-q13.3,
,,,"3-methylglutaconic aciduria, type III [MIM:258501]"
,,,Optic atrophy and cataract [MIM:165300]
,,,
OPA4,optic atrophy 4 (autosomal dominant) ,18q12.2-q12.3,
,,,Optic atrophy-4
,,,
OPA5,optic atrophy 5 (autosomal dominant) ,22q12.1-q13.1,
,,,Optic atrophy 5
,,,
OPA6,optic atrophy 6 (autosomal recessive) ,8q21-q22,
,,,Optic atrophy 6
,,,
OPCML,opioid binding protein/cell adhesion molecule-like ,11q25,
,,,"Ovarian cancer, somatic [MIM:167000]"
,,,
OPHN1,oligophrenin 1 ,Xq12,
,,,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance [MIM:300486]"
,,,
OPN1LW,"opsin 1 (cone pigments), long-wave-sensitive ",Xq28,
,,,"Colorblindness, protan [MIM:303900]"
,,,Blue cone monochromacy [MIM:303700]
,,,
OPN1MW,"opsin 1 (cone pigments), medium-wave-sensitive ",Xq28,
,,,"Colorblindness, deutan [MIM:303800]"
,,,Blue cone monochromacy [MIM:303700]
,,,
OPN1SW,"opsin 1 (cone pigments), short-wave-sensitive ",7q31.3-q32,
,,,"Colorblindness, tritan [MIM:190900]"
,,,
OPN4,opsin 4 ,?,
,,,mutations
,,,
OPRD1,"opioid receptor, delta 1 ",1p36.1-p34.3,
,,,mutations
,,,
OPRK1,"opioid receptor, kappa 1 ",8q11.2,
,,,mutations
,,,
OPRL1,opiate receptor-like 1 ,?,
,,,mutations
,,,
OPRM1,"opioid receptor, mu 1 ",6q24-q25,
,,,mutations
,,,
OPTC,opticin ,?,
,,,mutations
,,,
OPTN,optineurin ,10p15-p14,
,,,"Glaucoma 1, open angle, E [MIM:137760]"
,,,"Glaucoma, normal tension, susceptibility to [MIM:606657]"
,,,Amytrophic lateral sclerosis 12 [MIM:613435]
,,,
OR10C1,"olfactory receptor, family 10, subfamily C, member 1 ",?,
,,,mutations
,,,
OR10X1,"olfactory receptor, family 10, subfamily X, member 1 ",?,
,,,mutations
,,,
OR11H7,"olfactory receptor, family 11, subfamily H, member 7 (gene/pseudogene) ",?,
,,,mutations
,,,
OR12D2,"olfactory receptor, family 12, subfamily D, member 2 ",?,
,,,mutations
,,,
OR13G1,"olfactory receptor, family 13, subfamily G, member 1 ",1q44,
,,,mutations
,,,
OR1B1,"olfactory receptor, family 1, subfamily B, member 1 ",?,
,,,mutations
,,,
OR1P1,"olfactory receptor, family 1, subfamily P, member 1 (gene/pseudogene) ",?,
,,,mutations
,,,
OR1S1,"olfactory receptor, family 1, subfamily S, member 1 ",?,
,,,mutations
,,,
OR2J1,"olfactory receptor, family 2, subfamily J, member 1 (gene/pseudogene) ",?,
,,,mutations
,,,
OR2T5,"olfactory receptor, family 2, subfamily T, member 5 ",?,
,,,mutations
,,,
OR4A8P,"olfactory receptor, family 4, subfamily A, member 8 pseudogene ",?,
,,,mutations
,,,
OR4F5,"olfactory receptor, family 4, subfamily F, member 5 ",?,
,,,mutations
,,,
OR4X1,"olfactory receptor, family 4, subfamily X, member 1 ",?,
,,,mutations
,,,
OR51A2,"olfactory receptor, family 51, subfamily A, member 2 ",?,
,,,mutations
,,,
OR51F1,"olfactory receptor, family 51, subfamily F, member 1 ",?,
,,,mutations
,,,
OR51G1,"olfactory receptor, family 51, subfamily G, member 1 ",?,
,,,mutations
,,,
OR52B4,"olfactory receptor, family 52, subfamily B, member 4 ",?,
,,,mutations
,,,
OR52H1,"olfactory receptor, family 52, subfamily H, member 1 ",?,
,,,mutations
,,,
OR52N4,"olfactory receptor, family 52, subfamily N, member 4 ",?,
,,,mutations
,,,
OR5AC2,"olfactory receptor, family 5, subfamily AC, member 2 ",?,
,,,mutations
,,,
OR5AL1,"olfactory receptor, family 5, subfamily AL, member 1 (gene/pseudogene) ",?,
,,,mutations
,,,
OR5H6,"olfactory receptor, family 5, subfamily H, member 6 ",?,
,,,mutations
,,,
OR6Q1,"olfactory receptor, family 6, subfamily Q, member 1 ",?,
,,,mutations
,,,
OR7D4,"olfactory receptor, family 7, subfamily D, member 4 ",19p13.2,
,,,mutations
,,,
OR8K3,"olfactory receptor, family 8, subfamily K, member 3 ",?,
,,,mutations
,,,
ORAI1,ORAI calcium release-activated calcium modulator 1 ,12q24,
,,,Immune dysfunction with T-cell inactivation due to calcium entry defect 1 [MIM:612782]
,,,
ORC1,"origin recognition complex, subunit 1 ",1p32,
,,,mutations
,,,
ORC4,"origin recognition complex, subunit 4 ",2q22-q23,
,,,mutations
,,,
ORC6,"origin recognition complex, subunit 6 ",16q12,
,,,mutations
,,,
ORMDL3,ORM1-like 3 (S. cerevisiae) ,17q21.1,
,,,mutations
,,,
ORW3,Osler-Rendu-Weber syndrome 3 ,5q31.3-q32,
,,,"Telangiectasia, hereditary hemorrhagic, type 3"
,,,
OS6,Osteoarthritis susceptibility 6 ,3p24.3,
,,,Osteoarthritis susceptibility 6
,,,
OSMR,oncostatin M receptor ,5p13.1,
,,,"Amyloidosis, primary localized cutaneous [MIM:105250]"
,,,
OSR1,odd-skipped related 1 (Drosophila) ,2p24,
,,,mutations
,,,
OSTM1,osteopetrosis associated transmembrane protein 1 ,6q21,
,,,"Osteopetrosis, autosomal recessive 5 [MIM:259720]"
,,,
OTC,ornithine carbamoyltransferase ,Xp21.1,
,,,Ornithine transcarbamylase deficiency [MIM:311250]
,,,
OTOA,otoancorin ,16p12.2,
,,,"Deafness, autosomal recessive 22 [MIM:607039]"
,,,
OTOF,otoferlin ,2p23-p22,
,,,"Deafness, autosomal recessive 9 [MIM:601071]"
,,,"Auditory neuropathy, autosomal recessive, 1 [MIM:601071]"
,,,
OTOR,otoraplin ,20p11,
,,,mutations
,,,
OTSC1,otosclerosis 1 ,15q26.1-qter,
,,,Otosclerosis 1
,,,
OTSC2,otosclerosis 2 ,7q34-q36,
,,,Otosclerosis 2
,,,
OTSC3,otosclerosis 3 ,6p22.3-p21.3,
,,,Otosclerosis 3
,,,
OTSC4,otosclerosis 4 ,16q22.1-q23.1,
,,,Otosclerosis 4
,,,
OTSC5,otosclerosis 5 ,3q22-q24,
,,,Otosclerosis 5
,,,
OTSC7,otosclerosis 7 ,6q13-q16.1,
,,,Otosclerosis 7
,,,
OTSC8,otosclerosis 8 ,9p13.1-q21.11,
,,,Otosclerosis 8
,,,
OTX2,orthodenticle homeobox 2 ,14q21-q22,
,,,"Microphthalmia, syndromic 5 [MIM:610125]"
,,,
OVCAS1,"Ovarian cancer, epithelial, susceptibility to ",3p25-p22,
,,,"Ovarian cancer, susceptibility to"
,,,
OVCH2,ovochymase 2 (gene/pseudogene) ,?,
,,,mutations
,,,
OVGP1,"oviductal glycoprotein 1, 120kDa ",?,
,,,mutations
,,,
OXCT1,3-oxoacid CoA transferase 1 ,5p13,
,,,Succinyl CoA:3-oxoacid CoA transferase deficiency [MIM:245050]
,,,
OXTR,oxytocin receptor ,3p26.2,
,,,mutations
,,,
P2RX1,"purinergic receptor P2X, ligand-gated ion channel, 1 ",17p13.3,
,,,Bleeding disorder due to P2RX1 defect
,,,
P2RX4,"purinergic receptor P2X, ligand-gated ion channel, 4 ",12q24.32,
,,,mutations
,,,
P2RX5,"purinergic receptor P2X, ligand-gated ion channel, 5 ",?,
,,,mutations
,,,
P2RX7,"purinergic receptor P2X, ligand-gated ion channel, 7 ",12q24,
,,,mutations
,,,
P2RY11,"purinergic receptor P2Y, G-protein coupled, 11 ",19p13,
,,,mutations
,,,
P2RY12,"purinergic receptor P2Y, G-protein coupled, 12 ",3q24-q25,
,,,Bleeding disorder due to P2RY12 defect [MIM:609821]
,,,
P2RY4,"pyrimidinergic receptor P2Y, G-protein coupled, 4 ",Xq13,
,,,mutations
,,,
PABPC4L,"poly(A) binding protein, cytoplasmic 4-like ",?,
,,,mutations
,,,
PABPN1,"poly(A) binding protein, nuclear 1 ",14q11.2-q13,
,,,Oculopharyngeal muscular dystrophy [MIM:164300]
,,,
PACRG,PARK2 co-regulated ,6q25-q27,
,,,mutations
,,,
PADI4,"peptidyl arginine deiminase, type IV ",1p36.13,
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,
PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) ",17p13.3,
,,,Lissencephaly-1 [MIM:607432]
,,,Subcortical laminar heterotopia
,,,
PAFAH1B3,"platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) ",19q13.1,
,,,mutations
,,,
PAFC,"Preauricular fistulae, congenital ",8q11.1-q13.3,
,,,"Preauricular fistulae, congenital"
,,,
PAH,phenylalanine hydroxylase ,12q24.1,
,,,Phenylketonuria [MIM:261600]
,,,"Hyperphenylalaninemia, non-PKU mild [MIM:261600]"
,,,
PAK3,p21 protein (Cdc42/Rac)-activated kinase 3 ,Xq21.3-q24,
,,,"Mental retardation, X-linked 30 [MIM:300558]"
,,,
PAK7,p21 protein (Cdc42/Rac)-activated kinase 7 ,?,
,,,mutations
,,,
PALB2,partner and localizer of BRCA2 ,16p12,
,,,"Fanconi anemia, complementation group N [MIM:610832]"
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,"Pancreatic cancer, susceptibility to, 3 [MIM:613348]"
,,,
PALLD,"palladin, cytoskeletal associated protein ",4q32.3,
,,,"Pancreatic cancer, susceptibility to, 1 [MIM:606856]"
,,,
PAND1,Panic disorder 1 ,13q22-q32,
,,,Panic disorder syndrome 1
,,,
PAND2,panic disorder 2 ,9q31,
,,,Panic disorder 2
,,,
PAND3,panic disorder 3 ,4q31-q34,
,,,Panic disorder 3
,,,
PANK2,pantothenate kinase 2 ,20p13-p12.3,
,,,Neurodegeneration with brain iron accumulation 1 [MIM:234200]
,,,HARP syndrome [MIM:607236]
,,,
PAOD1,Peripheral arterial occlusive disease 1 ,1p31,
,,,Peripheral arterial occlusive disease 1
,,,
PAPA2,"postaxial polydactyly, type A2 ",13q21-q32,
,,,"Postaxial polydactyly, type A2"
,,,
PAPA3,"Polydactyly, postaxial, type A3 ",19p13.2-p13.1,
,,,"Polydactyly, postaxial, type A3"
,,,
PAPA4,"Polydactyly, postaxial, type A4 ",7q22,
,,,"Polydactyly, postaxial, type A4"
,,,
PAPD7,PAP associated domain containing 7 ,5p15,
,,,mutations
,,,
PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2 ,10q22-q24,
,,,"SEMD, Pakistani type [MIM:612847]"
,,,
PARD3B,par-3 partitioning defective 3 homolog B (C. elegans) ,?,
,,,mutations
,,,
PARD6A,par-6 partitioning defective 6 homolog alpha (C. elegans) ,?,
,,,mutations
,,,
PARK10,Parkinson disease 10 (susceptibility) ,1p32,
,,,Parkinson disease 10
,,,
PARK11,"Parkinson disease 11 (autosomal recessive, early onset) ",2q37.1,
,,,Parkinson disease 11 [MIM:607688]
,,,
PARK12,Parkinson disease 12 (susceptibility) ,Xq21-q25,
,,,Parkinson disease 12
,,,
PARK16,Parkinson disease 16 (susceptibility) ,1q32,
,,,Parkinson disease-16
,,,
PARK2,"parkinson protein 2, E3 ubiquitin protein ligase (parkin) ",6q25.2-q27,
,,,"Parkinson disease, juvenile, type 2 [MIM:600116]"
,,,"Adenocarcinoma of lung, somatic [MIM:211980]"
,,,"Adenocarcinoma, ovarian, somatic [MIM:604370]"
,,,"Leprosy, susceptibility to [MIM:607572]"
,,,
PARK3,"Parkinson disease 3 (autosomal dominant, Lewy body) ",2p13,
,,,Parkinson disease 3
,,,
PARK4,"Parkinson disease (autosomal dominant, Lewy body) 4 ",?,
,,,"Parkinson disease,with Lewi bodies segregating with postural tremor"
,,,
PARK7,parkinson protein 7 ,1p36,
,,,"Parkinson disease 7, autosomal recessive early-onset [MIM:606324]"
,,,Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2
,,,
PARL,"presenilin associated, rhomboid-like ",3q27,
,,,mutations
,,,
PARP1,poly (ADP-ribose) polymerase 1 ,1q42,
,,,Xeroderma pigmentosum
,,,
PARP2,poly (ADP-ribose) polymerase 2 ,14q11.2,
,,,mutations
,,,
PASK,PAS domain containing serine/threonine kinase ,2q37.3,
,,,mutations
,,,
PAWR,"PRKC, apoptosis, WT1, regulator ",12q21,
,,,mutations
,,,
PAX1,paired box 1 ,20p11.2,
,,,mutations
,,,
PAX2,paired box 2 ,10q24.3-q25.1,
,,,Optic nerve coloboma with renal disease [MIM:120330]
,,,"Renal hypoplasia, isolated"
,,,
PAX3,paired box 3 ,2q35,
,,,"Waardenburg syndrome, type 1 [MIM:193500]"
,,,"Waardenburg syndrome, type 3 [MIM:148820]"
,,,Craniofacial-deafness-hand syndrome [MIM:122880]
,,,"Rhabdomyosarcoma 2, alveolar [MIM:268220]"
,,,
PAX4,paired box 4 ,7q32,
,,,"Maturity-onset diabetes of the young, type IX [MIM:612225]"
,,,"Diabetes mellitus, type 2 [MIM:125853]"
,,,"Diabetes mellitus, ketosis-prone [MIM:612227]"
,,,
PAX5,paired box 5 ,9p13,
,,,Lymphoplasmacytoid lymphoma
,,,
PAX6,paired box 6 ,11p13,
,,,Aniridia [MIM:106210]
,,,Peters anomaly [MIM:604229]
,,,Cataract with late-onset corneal dystrophy [MIM:604219]
,,,Keratitis [MIM:148190]
,,,Foveal hyperplasia [MIM:136520]
,,,Morning glory disc anomaly [MIM:120430]
,,,Optic nerve hypoplasia [MIM:165550]
,,,"Coloboma, ocular [MIM:120200]"
,,,Coloboma of optic nerve [MIM:120430]
,,,Gillespie syndrome [MIM:206700]
,,,
PAX7,paired box 7 ,1p36.2-p36.12,
,,,"Rhabdomyosarcoma 2, alveolar [MIM:268220]"
,,,
PAX8,paired box 8 ,2q12-q14,
,,,"Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia [MIM:218700]"
,,,
PAX9,paired box 9 ,14q12-q13,
,,,"Tooth agenesis, selective, 3 [MIM:604625]"
,,,
PAXIP1,PAX interacting (with transcription-activation domain) protein 1 ,7q36,
,,,"Alzheimer disease, susceptibility to [MIM:104300]"
,,,
PBC2,"Biliary cirrhosis, primary, 2 ",6p21.3,
,,,"Biliary cirrhosis, primary, 2"
,,,
PBC3,"Biliary cirrhosis, primary, 3 ",1p31.2,
,,,"Biliary cirrhosis, primary, 3"
,,,
PBCA,"Pancreatic beta cell, agenesis of ",6p21.3,
,,,"Diabetes mellitus, insulin-dependent, neonatal"
,,,
PBCRA1,progressive bifocal chorioretinal atrophy 1 ,6q14-q16.2,
,,,"Chorioretinal atrophy, progressive bifocal"
,,,
PBX1,pre-B-cell leukemia homeobox 1 ,1q23,
,,,"Leukemia, acute pre-B-cell"
,,,
PCAP,predisposing for prostate cancer ,1q42.2-q43,
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
PCBD1,pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha ,10q22,
,,,"Hyperphenylalaninemia, BH4-deficient, D [MIM:264070]"
,,,
PCCA,"propionyl CoA carboxylase, alpha polypeptide ",13q32,
,,,Propionicacidemia [MIM:606054]
,,,
PCCB,"propionyl CoA carboxylase, beta polypeptide ",3q21-q22,
,,,Propionicacidemia [MIM:606054]
,,,
PCDH11X,protocadherin 11 X-linked ,Xq21.3,
,,,mutations
,,,
PCDH15,protocadherin-related 15 ,10q21-q22,
,,,"Usher syndrome, type 1F [MIM:602083]"
,,,"Deafness, autosomal recessive 23 [MIM:609533]"
,,,"Usher syndrome, type 1D/F digenic [MIM:601067]"
,,,
PCDH18,protocadherin 18 ,4q31,
,,,mutations
,,,
PCDH19,protocadherin 19 ,Xq22,
,,,"Epileptic encephalopathy, early infantile, 9 [MIM:300088]"
,,,
PCDHA10,protocadherin alpha 10 ,5q31,
,,,mutations
,,,
PCDHA13,protocadherin alpha 13 ,5q31,
,,,mutations
,,,
PCDHB4,protocadherin beta 4 ,5q31,
,,,mutations
,,,
PCK1,phosphoenolpyruvate carboxykinase 1 (soluble) ,?,
,,,mutations
,,,
PCLD,polycystic liver disease ,19p13.2-p13.1,
,,,Polycystic liver disease [MIM:174050]
,,,
PCM1,pericentriolar material 1 ,8p22-p21.3,
,,,"Thyroid carcinoma, papillary [MIM:188550]"
,,,
PCMT1,protein-L-isoaspartate (D-aspartate) O-methyltransferase ,6q22.3-q24,
,,,mutations
,,,
PCNT,pericentrin ,21q22.3,
,,,"Microcephalic osteodysplastic primordial dwarfism, type II [MIM:210720]"
,,,
PCOLCE,procollagen C-endopeptidase enhancer ,7q21.3-q22,
,,,mutations
,,,
PCSK1,proprotein convertase subtilisin/kexin type 1 ,5q15-q21,
,,,Obesity with impaired prohormone processing [MIM:600955]
,,,"Obesity, susceptibility to, BMIQ12 [MIM:612362]"
,,,
PCSK2,proprotein convertase subtilisin/kexin type 2 ,20p11.2,
,,,mutations
,,,
PCSK9,proprotein convertase subtilisin/kexin type 9 ,1p34.1-p32,
,,,"Hypercholesterolemia, familial, 3 [MIM:603776]"
,,,Low density lipoprotein cholesterol level QTL 1
,,,
PC,pyruvate carboxylase ,11q13.4-q13.5,
,,,Pyruvate carboxylase deficiency [MIM:266150]
,,,
PDB1,Paget disease of bone 1 ,6p21.3,
,,,Paget disease of bone
,,,
PDB2,Paget disease of bone 2 ,18q21-q22,
,,,Osteosarcoma [MIM:259500]
,,,
PDB4,Paget disease of bone 4 ,5q31,
,,,Paget disease of bone [MIM:602080]
,,,
PDCD10,programmed cell death 10 ,3q26.1,
,,,Cerebral cavernous malformations 3 [MIM:603285]
,,,
PDCD1,programmed cell death 1 ,2q37.3,
,,,"Systemic lupus erythematosus, susceptibility to, 2 [MIM:605218]"
,,,"Multiple sclerosis, disease progression, modifier of [MIM:126200]"
,,,
PDCD5,programmed cell death 5 ,?,
,,,mutations
,,,
PDE11A,phosphodiesterase 11A ,2q31.2,
,,,"Pigmented nodular adrenocortical disease, primary, 2 [MIM:610475]"
,,,
PDE4B,"phosphodiesterase 4B, cAMP-specific ",1p31,
,,,mutations
,,,
PDE4D,"phosphodiesterase 4D, cAMP-specific ",5q12,
,,,"Stroke, susceptibility to, 1 [MIM:606799]"
,,,
PDE6A,"phosphodiesterase 6A, cGMP-specific, rod, alpha ",5q31.2-q34,
,,,Retinitis pigmentosa-43
,,,
PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta ",4p16.3,
,,,"Night blindness, congenital stationary, autosomal dominant 2 [MIM:163500]"
,,,Retinitis pigmentosa-40
,,,
PDE6C,"phosphodiesterase 6C, cGMP-specific, cone, alpha prime ",10q24,
,,,Cone dystrophy 4 [MIM:613093]
,,,
PDE6G,"phosphodiesterase 6G, cGMP-specific, rod, gamma ",17q25,
,,,Retinitis pigmentosa 57 [MIM:613582]
,,,
PDE6H,"phosphodiesterase 6H, cGMP-specific, cone, gamma ",12p13,
,,,Retinal cone dystrophy 3 [MIM:610024]
,,,
PDE7B,phosphodiesterase 7B ,?,
,,,mutations
,,,
PDE8B,phosphodiesterase 8B ,5q13,
,,,"Pigmented nodular adrenocortical disease, primary, 3"
,,,"Striatal degeneration, autosomal dominant [MIM:609161]"
,,,
PDGFB,platelet-derived growth factor beta polypeptide ,22q12.3-q13.1,
,,,"Meningioma, SIS-related"
,,,Dermatofibrosarcoma protuberans
,,,Giant-cell fibroblastoma
,,,
PDGFC,platelet derived growth factor C ,4q32,
,,,mutations
,,,
PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide ",4q12,
,,,"Gastrointestinal stromal tumor, somatic [MIM:606764]"
,,,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib [MIM:607685]"
,,,
PDGFRB,"platelet-derived growth factor receptor, beta polypeptide ",5q31-q32,
,,,Myeloproliferative disorder with eosinophilia [MIM:131440]
,,,"Myelomonocytic leukemia, chronic"
,,,
PDGFRL,platelet-derived growth factor receptor-like ,8p22-p21.3,
,,,Hepatocellular cancer [MIM:114550]
,,,Colorectal cancer [MIM:114500]
,,,
PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1 ,Xp22.2-p22.1,
,,,Pyruvate dehydrogenase deficiency [MIM:312170]
,,,"Leigh syndrome, X-linked [MIM:308930]"
,,,
PDHB,pyruvate dehydrogenase (lipoamide) beta ,3p13-q23,
,,,Pyruvate dehydrogenase E1-beta deficiency
,,,
PDHX,"pyruvate dehydrogenase complex, component X ",11p13,
,,,Lacticacidemia due to PDX1 deficiency [MIM:245349]
,,,
PDLA,"Periodontitis, localized aggressive ",1q25,
,,,"Periodontitis, aggressive, 2"
,,,
PDLIM3,PDZ and LIM domain 3 ,4q35,
,,,mutations
,,,
PDLIM4,PDZ and LIM domain 4 ,5q31.1,
,,,"Osteoporosis, susceptibility to [MIM:166710]"
,,,
PDLIM5,PDZ and LIM domain 5 ,4q22,
,,,mutations
,,,
PDP1,pyruvate dehyrogenase phosphatase catalytic subunit 1 ,8q22.1,
,,,Pyruvate dehydrogenase phosphatase deficiency [MIM:608782]
,,,
PDPK1,3-phosphoinositide dependent protein kinase-1 ,16p13.3,
,,,mutations
,,,
PDR,"pigment disorder, reticulate ",Xp22-p21,
,,,"Pigment disorder, reticulate"
,,,
PDSS1,"prenyl (decaprenyl) diphosphate synthase, subunit 1 ",10p12.1,
,,,Coenzyme Q10 deficiency [MIM:607426]
,,,
PDSS2,"prenyl (decaprenyl) diphosphate synthase, subunit 2 ",6q21,
,,,Coenzyme Q10 deficiency [MIM:607426]
,,,
PDX1,pancreatic and duodenal homeobox 1 ,13q12.1,
,,,Pancreatic agenesis [MIM:260370]
,,,"MODY, type IV [MIM:606392]"
,,,"Diabetes mellitus, type II, susceptibility to [MIM:125853]"
,,,
PDXK,"pyridoxal (pyridoxine, vitamin B6) kinase ",21q22.3,
,,,mutations
,,,
PDYN,prodynorphin ,20p13,
,,,Spinocerebellar ataxia 23 [MIM:610245]
,,,
PDZD7,PDZ domain containing 7 ,10q24.3,
,,,mutations
,,,
PEAR1,platelet endothelial aggregation receptor 1 ,?,
,,,mutations
,,,
PECAM1,platelet/endothelial cell adhesion molecule 1 ,17q23,
,,,mutations
,,,
PECR,peroxisomal trans-2-enoyl-CoA reductase ,2q35,
,,,mutations
,,,
PEE1,preeclampsia/eclampsia 1 ,2p13,
,,,Preeclampsia/eclampsia 1
,,,
PEE2,Preeclampsia/eclampsia 2 ,2p25,
,,,Preeclampsia/eclampsia 2
,,,
PEE3,Preeclampsia/eclampsia 3 ,9p13,
,,,Preeclampsia/eclampsia 3
,,,
PEMT,phosphatidylethanolamine N-methyltransferase ,?,
,,,mutations
,,,
PENK,proenkephalin ,8q23-q24,
,,,mutations
,,,
PEPD,peptidase D ,19cen-q13.11,
,,,Prolidase deficiency [MIM:170100]
,,,
PER1,period homolog 1 (Drosophila) ,17p12,
,,,mutations
,,,
PER2,period homolog 2 (Drosophila) ,2q37.3,
,,,"Advanced sleep phase syndrome, familial [MIM:604348]"
,,,
PER3,period homolog 3 (Drosophila) ,?,
,,,mutations
,,,
PEX10,peroxisomal biogenesis factor 10 ,1p36.32,
,,,Zellweger syndrome [MIM:214100]
,,,"Adrenoleukodystrophy, neonatal [MIM:202370]"
,,,
PEX11B,peroxisomal biogenesis factor 11 beta ,?,
,,,mutations
,,,
PEX12,peroxisomal biogenesis factor 12 ,17,
,,,Peroxisome biogenesis factor 12
,,,
PEX13,peroxisomal biogenesis factor 13 ,2p15,
,,,Zellweger syndrome [MIM:214100]
,,,"Adrenoleukodystrophy, neonatal [MIM:202370]"
,,,
PEX14,peroxisomal biogenesis factor 14 ,1p36.2,
,,,Zellweger syndrome [MIM:214100]
,,,
PEX16,peroxisomal biogenesis factor 16 ,11p12-p11.2,
,,,"Zellweger syndrome, complementation group 9"
,,,
PEX19,peroxisomal biogenesis factor 19 ,1q22,
,,,Zellweger syndrome [MIM:214100]
,,,
PEX1,peroxisomal biogenesis factor 1 ,7q21-q22,
,,,Zellweger syndrome-1 [MIM:214100]
,,,"Adrenoleukodystrophy, neonatal [MIM:202370]"
,,,"Refsum disease, infantile [MIM:266510]"
,,,
PEX26,peroxisomal biogenesis factor 26 ,22q11.21,
,,,"Adrenoleukodystrophy, neonatal [MIM:202370]"
,,,"Refsum disease, infantile form [MIM:266510]"
,,,Zellweger syndrome [MIM:214100]
,,,
PEX2,peroxisomal biogenesis factor 2 ,8q21.1,
,,,Zellweger syndrome-3
,,,"Refsum disease, infantile form [MIM:266510]"
,,,
PEX3,peroxisomal biogenesis factor 3 ,6q23-q24,
,,,"Zellweger syndrome, complementation group G [MIM:214100]"
,,,
PEX5,peroxisomal biogenesis factor 5 ,12p13.3,
,,,"Adrenoleukodystrophy, neonatal [MIM:202370]"
,,,Zellweger syndrome [MIM:214100]
,,,
PEX6,peroxisomal biogenesis factor 6 ,6p21.1,
,,,"Peroxisomal biogenesis disorder, complementation group 4"
,,,"Peroxisomal biogenesis disorder, complementation group 6"
,,,
PEX7,peroxisomal biogenesis factor 7 ,6q22-q24,
,,,"Rhizomelic chondrodysplasia punctata, type 1 [MIM:215100]"
,,,Refsum disease [MIM:266500]
,,,
PFAS,phosphoribosylformylglycinamidine synthase ,17,
,,,mutations
,,,
PFBI,Plasmodium falciparum blood infection levels ,5q31-q33,
,,,"Malaria, intensity of infection"
,,,
PFKL,"phosphofructokinase, liver ",21q22.3,
,,,Hemolytic anemia due to phosphofructokinase deficiency
,,,
PFKM,"phosphofructokinase, muscle ",12q13.3,
,,,Glycogen storage disease VII [MIM:232800]
,,,
PGAM1,phosphoglycerate mutase 1 (brain) ,10q25.3,
,,,mutations
,,,
PGAM2,phosphoglycerate mutase 2 (muscle) ,7p13-p12.3,
,,,Glycogen storage disease X [MIM:261670]
,,,
PGAM5,phosphoglycerate mutase family member 5 ,?,
,,,mutations
,,,
PGBD1,piggyBac transposable element derived 1 ,?,
,,,mutations
,,,
PGC,progastricsin (pepsinogen C) ,6p21.3-p21.1,
,,,mutations
,,,
PGD,phosphogluconate dehydrogenase ,1p36.2-p36.13,
,,,mutations
,,,
PGK1P1,"phosphoglycerate kinase 1, pseudogene 1 ",Xq13,
,,,Phosphoglycerate kinase 1 deficiency [MIM:300653]
,,,
PGK1P2,"phosphoglycerate kinase 1, pseudogene 2 ",Xq13,
,,,Phosphoglycerate kinase 1 deficiency [MIM:300653]
,,,
PGK1,phosphoglycerate kinase 1 ,Xq13,
,,,Phosphoglycerate kinase 1 deficiency [MIM:300653]
,,,
PGM1,phosphoglucomutase 1 ,1p31,
,,,Glycogen storage disease XIV [MIM:612934]
,,,
PGRMC1,progesterone receptor membrane component 1 ,Xq22-q24,
,,,mutations
,,,
PGR,progesterone receptor ,11q22,
,,,Progesterone resistance [MIM:264080]
,,,
PHA2A,Pseudohypoaldosteronism type II (gene A) ,1q31-q42,
,,,"Pseudohypoaldosteronism, type II"
,,,
PHB,prohibitin ,17q21,
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,
PHEX,"phosphate regulating endopeptidase homolog, X-linked ",Xp22.2-p22.1,
,,,"Hypophosphatemic rickets, X-linked dominant [MIM:307800]"
,,,
PHF11,PHD finger protein 11 ,13q14.1,
,,,IgE levels QTL [MIM:147050]
,,,Asthma [MIM:600807]
,,,
PHF2,PHD finger protein 2 ,9q22,
,,,mutations
,,,
PHF3,PHD finger protein 3 ,6q12,
,,,mutations
,,,
PHF6,PHD finger protein 6 ,Xq26.3,
,,,Borjeson-Forssman-Lehmann syndrome [MIM:301900]
,,,
PHF8,PHD finger protein 8 ,Xp11.2,
,,,"Mental retardation syndrome, X-linked, Siderius type [MIM:300263]"
,,,
PHGDH,phosphoglycerate dehydrogenase ,1q12,
,,,Phosphoglycerate dehydrogenase deficiency [MIM:601815]
,,,
PHIP,pleckstrin homology domain interacting protein ,6q14,
,,,mutations
,,,
PHKA1,"phosphorylase kinase, alpha 1 (muscle) ",Xq13,
,,,Muscle glycogenosis [MIM:300559]
,,,
PHKA2,"phosphorylase kinase, alpha 2 (liver) ",Xp22.2-p22.1,
,,,"Glycogen storage disease, type IXa1 [MIM:306000]"
,,,"Glycogen storage disease, type IXa2 [MIM:306000]"
,,,
PHKB,"phosphorylase kinase, beta ",16q12-q13,
,,,"Phosphorylase kinase deficiency of liver and muscle, autosomal recessive [MIM:261750]"
,,,
PHKG2,"phosphorylase kinase, gamma 2 (testis) ",16p12.1-p11.2,
,,,Glycogen storage disease IXc [MIM:613027]
,,,Cirrhosis due to liver phosphorylase kinase deficiency
,,,
PHLDA2,"pleckstrin homology-like domain, family A, member 2 ",11p15.5,
,,,mutations
,,,
PHLPP2,PH domain and leucine rich repeat protein phosphatase 2 ,16q22.3,
,,,mutations
,,,
PHOBS,"Phobia, specific ",14,
,,,"Phobia, specific"
,,,
PHOX2A,paired-like homeobox 2a ,11q13.3-q13.4,
,,,"Fibrosis of extraocular muscles, congenital, 2 [MIM:602078]"
,,,
PHOX2B,paired-like homeobox 2b ,4p12,
,,,"Central hypoventilation syndrome, congenital [MIM:209880]"
,,,"Hirschsprung disease, short-segment [MIM:142623]"
,,,"Neuroblastoma, susceptibility to, 2 [MIM:613013]"
,,,
PHYH,phytanoyl-CoA 2-hydroxylase ,10pter-p11.2,
,,,Refsum disease [MIM:266500]
,,,
PI3,"peptidase inhibitor 3, skin-derived ",20q12-q13,
,,,mutations
,,,
PICALM,phosphatidylinositol binding clathrin assembly protein ,11q14,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,"Leukemia, acute T-cell lymphoblastic"
,,,
PICK1,protein interacting with PRKCA 1 ,22q12.3-q13.2,
,,,mutations
,,,
PIEZO2,piezo-type mechanosensitive ion channel component 2 ,18p11.22,
,,,mutations
,,,
PIF1,PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) ,15q22.31,
,,,mutations
,,,
PIGA,"phosphatidylinositol glycan anchor biosynthesis, class A ",Xp22.1,
,,,"Paroxysmal nocturnal hemoglobinuria, somatic [MIM:300818]"
,,,
PIGL,"phosphatidylinositol glycan anchor biosynthesis, class L ",17p12-p11.2,
,,,mutations
,,,
PIGM,"phosphatidylinositol glycan anchor biosynthesis, class M ",1q23.2,
,,,Glycosylphosphatidylinositol deficiency [MIM:610293]
,,,
PIGN,"phosphatidylinositol glycan anchor biosynthesis, class N ",18q21.2,
,,,mutations
,,,
PIGR,polymeric immunoglobulin receptor ,1q31-q42,
,,,"IgA nephropathy, susceptibility to [MIM:161950]"
,,,
PIGV,"phosphatidylinositol glycan anchor biosynthesis, class V ",1p36.11,
,,,mutations
,,,
PIK3C2G,"phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma ",12p12,
,,,mutations
,,,
PIK3C3,"phosphatidylinositol 3-kinase, catalytic subunit type 3 ",?,
,,,mutations
,,,
PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha ",3q26.3,
,,,"Ovarian cancer, somatic [MIM:604370]"
,,,"Breast cancer, somatic [MIM:114480]"
,,,"Colorectal cancer, somatic [MIM:114500]"
,,,"Gastric cancer, somatic [MIM:137215]"
,,,"Hepatocellular carcinoma, somatic [MIM:114550]"
,,,"Nonsmall cell lung cancer, somatic [MIM:211980]"
,,,"Keratosis, seborrheic, somatic [MIM:182000]"
,,,"Nevus, epidermal [MIM:162900]"
,,,
PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta ",3q22.3,
,,,mutations
,,,
PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta ",1p36.2,
,,,mutations
,,,
PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma ",7q22,
,,,mutations
,,,
PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha) ",5q13,
,,,mutations
,,,
PIK3R4,"phosphoinositide-3-kinase, regulatory subunit 4 ",?,
,,,mutations
,,,
PIK3R5,"phosphoinositide-3-kinase, regulatory subunit 5 ",?,
,,,mutations
,,,
PIKFYVE,"phosphoinositide kinase, FYVE finger containing ",2q35,
,,,Corneal fleck dystrophy [MIM:121850]
,,,
PIN1,"peptidylprolyl cis/trans isomerase, NIMA-interacting 1 ",19p13,
,,,mutations
,,,
PINK1,PTEN induced putative kinase 1 ,1p36,
,,,"Parkinson disease 6, early onset [MIM:605909]"
,,,
PIP4K2A,"phosphatidylinositol-5-phosphate 4-kinase, type II, alpha ",10p12.2,
,,,mutations
,,,
PIP5K1C,"phosphatidylinositol-4-phosphate 5-kinase, type I, gamma ",19p13.3,
,,,Lethal congenital contractural syndrome 3 [MIM:611369]
,,,
PIR,pirin (iron-binding nuclear protein) ,?,
,,,mutations
,,,
PITPNM3,PITPNM family member 3 ,17p13.1,
,,,Cone-rod dystrophy 5 [MIM:600977]
,,,
PITX1,paired-like homeodomain 1 ,5q31,
,,,"Clubfoot, congenital [MIM:119800]"
,,,
PITX2,paired-like homeodomain 2 ,4q25-q26,
,,,"Axenfeld-Rieger syndrome, type 1 [MIM:180500]"
,,,"Iridogoniodysgenesis, type 2 [MIM:137600]"
,,,Ring dermoid of cornea [MIM:180550]
,,,Peters anomaly [MIM:604229]
,,,
PITX3,paired-like homeodomain 3 ,10q25,
,,,Anterior segment mesenchymal dysgenesis [MIM:107250]
,,,"Cataract, posterior polar, 4 [MIM:610623]"
,,,"Cataract, congenital"
,,,"Cataract, posterior polar, 4, syndromic [MIM:610623]"
,,,
PIWIL3,piwi-like 3 (Drosophila) ,?,
,,,mutations
,,,
PKD1L1,polycystic kidney disease 1 like 1 ,7p13-p12,
,,,mutations
,,,
PKD1,polycystic kidney disease 1 (autosomal dominant) ,16p13.3-p13.12,
,,,"Polycystic kidney disease, adult type I [MIM:173900]"
,,,
PKD2,polycystic kidney disease 2 (autosomal dominant) ,4q21-q23,
,,,Polycystic kidney disease 2 [MIM:613095]
,,,
PKDTS,"polycystic kidney disease, infantile severe, with tuberous sclerosis ",16p13.3,
,,,"Polycystic kidney disease, infantile severe, with tuberous sclerosis"
,,,
PKHD1,polycystic kidney and hepatic disease 1 (autosomal recessive) ,6p21.1-p12,
,,,Polycystic kidney and hepatic disease [MIM:263200]
,,,
PKLR,"pyruvate kinase, liver and RBC ",1q21,
,,,Pyruvate kinase deficiency [MIM:266200]
,,,"Adenosine triphosphate, elevated, of erythrocytes [MIM:102900]"
,,,
PKN3,protein kinase N3 ,9q34.11,
,,,mutations
,,,
PKP1,plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) ,1q32,
,,,Ectodermal dysplasia/skin fragility syndrome [MIM:604536]
,,,
PKP2,plakophilin 2 ,12p11,
,,,"Arrhythmogenic right ventricular dysplasia, familial, 9 [MIM:609040]"
,,,
PLA2G10,"phospholipase A2, group X ",16p13.1-p12,
,,,mutations
,,,
PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid) ",1p35,
,,,Colorectal cancer [MIM:114500]
,,,
PLA2G2D,"phospholipase A2, group IID ",1p36.12,
,,,mutations
,,,
PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent) ",1q25,
,,,"Phospholipase A2, group IV A, deficiency of"
,,,
PLA2G4C,"phospholipase A2, group IVC (cytosolic, calcium-independent) ",19q13.3,
,,,mutations
,,,
PLA2G5,"phospholipase A2, group V ",1p36-p34,
,,,mutations
,,,
PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent) ",22q13.1,
,,,Infantile neuroaxonal dystrophy 1 [MIM:256600]
,,,Neurodegeneration with brain iron accumulation 2B [MIM:610217]
,,,Karak syndrome [MIM:610217]
,,,Parkinson disease 14 [MIM:612953]
,,,
PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) ",6p21.2-p12,
,,,Platelet-activating factor acetylhydrolase deficiency
,,,"Asthma, susceptibility to [MIM:600807]"
,,,"Atopy, susceptibility to [MIM:147050]"
,,,
PLAG1,pleiomorphic adenoma gene 1 ,8q12,
,,,"Adenomas, salivary gland pleomorphic [MIM:181030]"
,,,
PLAGL1,pleiomorphic adenoma gene-like 1 ,6q24,
,,,"Diabetes mellitus, transient neonatal [MIM:601410]"
,,,
PLAT,"plasminogen activator, tissue ",8p12,
,,,"Thrombophilia, familial, due to decreased release of PLAT [MIM:612348]"
,,,"Hyperfibrinolysis, familial, due to increased release of PLAT [MIM:612348]"
,,,
PLAUR,"plasminogen activator, urokinase receptor ",19q13,
,,,mutations
,,,
PLAU,"plasminogen activator, urokinase ",10q24,
,,,"Alzheimer disease, late-onset, susceptibility to [MIM:104300]"
,,,
PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific) ",20p12,
,,,"Epileptic encephalopathy, early infantile, 12 [MIM:613722]"
,,,
PLCB2,"phospholipase C, beta 2 ",15q15,
,,,Platelet PLC beta-2 deficiency
,,,
PLCB4,"phospholipase C, beta 4 ",20p12,
,,,mutations
,,,
PLCD1,"phospholipase C, delta 1 ",3p22-p21.3,
,,,mutations
,,,
PLCE1,"phospholipase C, epsilon 1 ",10q23,
,,,"Nephrotic syndrome, type 3 [MIM:610725]"
,,,
PLCG2,"phospholipase C, gamma 2 (phosphatidylinositol-specific) ",16q24.1,
,,,mutations
,,,
PLCZ1,"phospholipase C, zeta 1 ",12p12.3,
,,,mutations
,,,
PLD2,phospholipase D2 ,17p13.1,
,,,mutations
,,,
PLEC,plectin ,8q24,
,,,Muscular dystrophy with epidermolysis bullosa simplex [MIM:226670]
,,,"Epidermolysis bullosa simplex, Ogna type [MIM:131950]"
,,,Epidermolysis bullosa simplex with pyloric atresia [MIM:612138]
,,,"Muscular dystrophy, limb-girdle, type 2Q [MIM:613723]"
,,,
PLEKHA1,"pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 ",10q25.3-q26.2,
,,,"Age-related maculopathy, susceptibility to [MIM:603075]"
,,,
PLEKHG4,"pleckstrin homology domain containing, family G (with RhoGef domain) member 4 ",16q22.1,
,,,mutations
,,,
PLEKHG5,"pleckstrin homology domain containing, family G (with RhoGef domain) member 5 ",1p36,
,,,"Spinal muscular atrophy, distal, autosomal recessive, 4 [MIM:611067]"
,,,
PLEKHM1,"pleckstrin homology domain containing, family M (with RUN domain) member 1 ",17q21.3,
,,,"Osteopetrosis, autosomal recessive 6 [MIM:611497]"
,,,
PLF,Pulmonary function ,6q21-q22,
,,,Pulmonary function
,,,
PLG,plasminogen ,6q26,
,,,Plasminogen Tochigi disease
,,,"Thrombophilia, dysplasminogenemic"
,,,"Plasminogen deficiency, types I and II"
,,,"Conjunctivitis, ligneous [MIM:217090]"
,,,
PLIN1,perilipin 1 ,15q26,
,,,mutations
,,,
PLIN4,perilipin 4 ,19p13.3,
,,,mutations
,,,
PLN,phospholamban ,6q22.1,
,,,"Cardiomyopathy, dilated, 1P [MIM:609909]"
,,,
PLOD1,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 ",1p36.3-p36.2,
,,,"Ehlers-Danlos syndrome, type VI [MIM:225400]"
,,,Nevo syndrome [MIM:601451]
,,,
PLOD2,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 ",3q23-q24,
,,,Bruck syndrome 2 [MIM:609220]
,,,
PLOD3,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 ",7q22,
,,,Lysyl hydroxylase 3 deficiency [MIM:612394]
,,,
PLP1,proteolipid protein 1 ,Xq22,
,,,Pelizaeus-Merzbacher disease [MIM:312080]
,,,Spastic paraplegia-2 [MIM:312920]
,,,
PLP2,proteolipid protein 2 (colonic epithelium-enriched) ,Xp11.23-p11.22,
,,,mutations
,,,
PLSA1,"Primary lateral sclerosis, adult, 1 ",4p16,
,,,"Primary lateral sclerosis, adult, 1"
,,,
PLTP,phospholipid transfer protein ,20q12-q13.1,
,,,High density lipoprotein cholesterol level QTL 9
,,,
PLXND1,plexin D1 ,3q22,
,,,mutations
,,,
PMAIP1,phorbol-12-myristate-13-acetate-induced protein 1 ,?,
,,,mutations
,,,
PML,promyelocytic leukemia ,15q22,
,,,"Leukemia, acute promyelocytic, PML/RARA type"
,,,
PMM2,phosphomannomutase 2 ,16p13.3-p13.2,
,,,"Congenital disorder of glycosylation, type Ia [MIM:212065]"
,,,
PMP22,peripheral myelin protein 22 ,17p11.2,
,,,"Charcot-Marie-Tooth disease, type 1A [MIM:118220]"
,,,Dejerine-Sottas disease [MIM:145900]
,,,"Neuropathy, recurrent, with pressure palsies [MIM:162500]"
,,,"Charcot-Marie-Tooth disease, type 1E [MIM:118300]"
,,,Roussy-Levy syndrome [MIM:180800]
,,,
PMS1,PMS1 postmeiotic segregation increased 1 (S. cerevisiae) ,2q31-q33,
,,,"Colorectal cancer, hereditary nonpolyposis, type 3"
,,,
PMS2P3,postmeiotic segregation increased 2 pseudogene 3 ,?,
,,,mutations
,,,
PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae) ,7p22,
,,,Mismatch repair cancer syndrome [MIM:276300]
,,,"Colorectal cancer, hereditary nonpolyposis, type 4"
,,,
PNKD2,paroxysmal nonkinesigenic dyskinesia 2 ,2q31,
,,,Paroxysmal nonkinesigenic dyskinesia 2
,,,
PNKD,paroxysmal nonkinesigenic dyskinesia ,2q35,
,,,Paroxysmal nonkinesigenic dyskinesia [MIM:118800]
,,,
PNKP,polynucleotide kinase 3'-phosphatase ,19q13.4,
,,,"Epileptic encephalopathy, early infantile, 10 [MIM:613402]"
,,,
PNLIP,pancreatic lipase ,10q26.1,
,,,Pancreatic lipase deficiency
,,,
PNMT,phenylethanolamine N-methyltransferase ,17q21-q22,
,,,"Hypertension, essential [MIM:145500]"
,,,
PNPLA1,patatin-like phospholipase domain containing 1 ,6p21.31,
,,,mutations
,,,
PNPLA2,patatin-like phospholipase domain containing 2 ,11p15.5,
,,,Neutral lipid storage disease with myopathy [MIM:610717]
,,,
PNPLA3,patatin-like phospholipase domain containing 3 ,22q13,
,,,mutations
,,,
PNPLA6,patatin-like phospholipase domain containing 6 ,19p13.3,
,,,Spastic paraplegia 39 [MIM:612020]
,,,
PNPO,pyridoxamine 5'-phosphate oxidase ,17q21.32,
,,,Pyridoxamine 5'-phosphate oxidase deficiency [MIM:610090]
,,,
PNP,purine nucleoside phosphorylase ,14q13.1,
,,,Immunodeficiency due to purine nucleoside phosphorylase deficiency [MIM:613179]
,,,
POF1B,"premature ovarian failure, 1B ",Xq21,
,,,Premature ovarian failure 2B [MIM:300604]
,,,
POGZ,pogo transposable element with ZNF domain ,?,
,,,mutations
,,,
POLA1,"polymerase (DNA directed), alpha 1, catalytic subunit ",Xp22.3-p21.1,
,,,N syndrome [MIM:310465]
,,,
POLB,"polymerase (DNA directed), beta ",8p11.2,
,,,mutations
,,,
POLD1,"polymerase (DNA directed), delta 1, catalytic subunit ",19q13.3-q13.4,
,,,mutations
,,,
POLE2,"polymerase (DNA directed), epsilon 2, accessory subunit ",14q13-q21,
,,,mutations
,,,
POLG2,"polymerase (DNA directed), gamma 2, accessory subunit ",17q23-q24,
,,,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 [MIM:610131]"
,,,
POLG,"polymerase (DNA directed), gamma ",15q25,
,,,"Progressive external ophthalmoplegia, autosomal recessive [MIM:258450]"
,,,"Progressive external ophthalmoplegia, autosomal dominant [MIM:157640]"
,,,Mitochondrial DNA depletion syndrome 4B (MNGIE type) [MIM:613662]
,,,Mitochondrial DNA depletion syndrome 4A (Alpers type) [MIM:203700]
,,,Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE) [MIM:607459]
,,,
POLH,"polymerase (DNA directed), eta ",6p21.1-p12,
,,,"Xeroderma pigmentosum, variant type [MIM:278750]"
,,,
POLL,"polymerase (DNA directed), lambda ",10q23,
,,,mutations
,,,
POLR1C,"polymerase (RNA) I polypeptide C, 30kDa ",6p22.3,
,,,Treacher Collins syndrome 3 [MIM:248390]
,,,
POLR1D,"polymerase (RNA) I polypeptide D, 16kDa ",13q12.2,
,,,Treacher Collins syndrome 2 [MIM:613717]
,,,
POLR2E,"polymerase (RNA) II (DNA directed) polypeptide E, 25kDa ",19p13.3,
,,,mutations
,,,
POLR2M,polymerase (RNA) II (DNA directed) polypeptide M ,15q22.1,
,,,mutations
,,,
POLR3A,"polymerase (RNA) III (DNA directed) polypeptide A, 155kDa ",?,
,,,mutations
,,,
POLR3B,polymerase (RNA) III (DNA directed) polypeptide B ,?,
,,,mutations
,,,
POLRMT,polymerase (RNA) mitochondrial (DNA directed) ,19p13.3,
,,,mutations
,,,
POMC,proopiomelanocortin ,2p23.3,
,,,"Obesity, adrenal insufficiency, and red hair due to POMC deficiency [MIM:609734]"
,,,"Obesity, early-onset, susceptibility to [MIM:601665]"
,,,
POMGNT1,"protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase ",1p34-p33,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 [MIM:253280]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3 [MIM:613151]"
,,,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3 [MIM:613157]"
,,,
POMP,proteasome maturation protein ,13q12.3,
,,,Keratosis linearis with ichthyosis congenita and sclerosing keratoderma [MIM:601952]
,,,
POMT1,protein-O-mannosyltransferase 1 ,9q34.1,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 [MIM:236670]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1 [MIM:613155]"
,,,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1 [MIM:609308]"
,,,
POMT2,protein-O-mannosyltransferase 2 ,14q24.3,
,,,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2 [MIM:613150]"
,,,"Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2 [MIM:613156]"
,,,"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2 [MIM:613158]"
,,,
PON1,paraoxonase 1 ,7q21.3,
,,,"Coronary artery disease, susceptibility to"
,,,"Coronary artery spasm 2, susceptibility to"
,,,"Organophosphate poisoning, sensitivity to"
,,,Microvascular complications of diabetes 5 [MIM:612633]
,,,
PON2,paraoxonase 2 ,7q21.3,
,,,"Coronary artery disease, susceptibility to"
,,,
PON3,paraoxonase 3 ,7q21.3,
,,,mutations
,,,
POP1,"processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae) ",?,
,,,mutations
,,,
PORCN,porcupine homolog (Drosophila) ,Xp11.23,
,,,Focal dermal hypoplasia [MIM:305600]
,,,
POR,P450 (cytochrome) oxidoreductase ,7q11.2,
,,,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis [MIM:201750]
,,,Disordered steroidogenesis due to cytochrome P450 oxidoreductase [MIM:613571]
,,,
POU1F1,POU class 1 homeobox 1 ,3p11,
,,,"Pituitary hormone deficiency, combined, 1 [MIM:613038]"
,,,
POU3F4,POU class 3 homeobox 4 ,Xq21.1,
,,,"Deafness, X-linked 2 [MIM:304400]"
,,,
POU4F3,POU class 4 homeobox 3 ,5q31,
,,,"Deafness, autosomal dominant 15 [MIM:602459]"
,,,
POU5F1B,POU class 5 homeobox 1B ,?,
,,,mutations
,,,
POU5F1,POU class 5 homeobox 1 ,6p21.3,
,,,mutations
,,,
POU6F2,POU class 6 homeobox 2 ,7p14-p13,
,,,Wilms tumor susceptibility-5 [MIM:601583]
,,,
PPARA,peroxisome proliferator-activated receptor alpha ,22q12-q13.1,
,,,"Hyperapobetalipoproteinemia, susceptibility to"
,,,
PPARD,peroxisome proliferator-activated receptor delta ,6p21.2-p21.1,
,,,mutations
,,,
PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha ",4p15.1,
,,,mutations
,,,
PPARGC1B,"peroxisome proliferator-activated receptor gamma, coactivator 1 beta ",5q33,
,,,"Obesity, variation in [MIM:601665]"
,,,
PPARG,peroxisome proliferator-activated receptor gamma ,3p25,
,,,"Obesity, severe [MIM:601665]"
,,,"Obesity, resistance to"
,,,"Glioblastoma, susceptibility to [MIM:137800]"
,,,"Insulin resistance, severe, digenic [MIM:604367]"
,,,"Lipodystrophy, familial partial, type 3 [MIM:604367]"
,,,Carotid intimal medial thickness 1 [MIM:609338]
,,,"Diabetes, type 2 [MIM:125853]"
,,,
PPAT,phosphoribosyl pyrophosphate amidotransferase ,4q12,
,,,mutations
,,,
PPBP,pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) ,4q12-q13,
,,,"Spinocerebellar ataxia, autosomal recessive 10 [MIM:613726]"
,,,
PPIA,peptidylprolyl isomerase A (cyclophilin A) ,7p13,
,,,mutations
,,,
PPIB,peptidylprolyl isomerase B (cyclophilin B) ,15q21-q22,
,,,"Osteogenesis imperfecta, type IX [MIM:259440]"
,,,
PPIG,peptidylprolyl isomerase G (cyclophilin G) ,2q31.1,
,,,mutations
,,,
PPKB,"palmoplantar keratoderma, Bothnia type ",12q11-q13,
,,,"Palmoplantar keratoderma, Bothnia type"
,,,
PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent, 1D ",17q22-q23,
,,,Breast cancer [MIM:114480]
,,,
PPOX,protoporphyrinogen oxidase ,1q22,
,,,Porphyria variegata [MIM:176200]
,,,
PPP1R17,"protein phosphatase 1, regulatory subunit 17 ",7p15,
,,,"Hypercholesterolemia, susceptibility to [MIM:143890]"
,,,
PPP1R1A,"protein phosphatase 1, regulatory (inhibitor) subunit 1A ",12q13.2,
,,,mutations
,,,
PPP1R3A,"protein phosphatase 1, regulatory subunit 3A ",7q11.23-q21.11,
,,,"Insulin resistance, severe, digenic [MIM:604367]"
,,,
PPP1R3C,"protein phosphatase 1, regulatory subunit 3C ",10q23-q24,
,,,mutations
,,,
PPP2R1A,"protein phosphatase 2, regulatory subunit A, alpha ",19q13.4,
,,,mutations
,,,
PPP2R1B,"protein phosphatase 2, regulatory subunit A, beta ",11q22-q24,
,,,Lung cancer [MIM:211980]
,,,
PPP2R2B,"protein phosphatase 2, regulatory subunit B, beta ",5q31-q33,
,,,Spinocerebellar ataxia 12 [MIM:604326]
,,,
PPP2R2C,"protein phosphatase 2, regulatory subunit B, gamma ",4p16,
,,,mutations
,,,
PPPD1,"Porokeratosis, palmar, plantar, and disseminated 1 ",12q24.1-q24.2,
,,,"Porokeratosis, palmar, plantar, and disseminated 1"
,,,
PPR1,Photoparoxysmal response 1 ,6p21.1,
,,,Photoparoxysmal response 1
,,,
PPR2,Photoparoxysmal response 2 ,13q31.3,
,,,Photoparoxysmal response 2
,,,
PPR3,photoparoxysmal response 3 ,7q32,
,,,Photoparoxysmal response 3
,,,
PPT1,palmitoyl-protein thioesterase 1 ,1p32,
,,,"Ceroid lipofuscinosis, neuronal-1, infantile [MIM:256730]"
,,,"Ceroid lipofuscinosis, neuronal, variant juvenile type, with granular osmiophilic deposits"
,,,
PQBP1,polyglutamine binding protein 1 ,Xp11.23,
,,,Renpenning syndrome [MIM:309500]
,,,Golabi-Ito-Hall syndrome
,,,
PRB1,proline-rich protein BstNI subfamily 1 ,12p13.2,
,,,mutations
,,,
PRB3,proline-rich protein BstNI subfamily 3 ,12p13.2,
,,,mutations
,,,
PRB4,proline-rich protein BstNI subfamily 4 ,12p13.2,
,,,mutations
,,,
PRBNS,Pierre Robin syndrome ,17q24.3-q25.1,
,,,Pierre Robin syndrome
,,,
PRCC,papillary renal cell carcinoma (translocation-associated) ,1q21,
,,,"Renal cell carcinoma, papillary, 1 [MIM:605074]"
,,,
PRCD,progressive rod-cone degeneration ,17q22,
,,,Retinitis pigmentosa-36 [MIM:610599]
,,,
PRCP,prolylcarboxypeptidase (angiotensinase C) ,11q14,
,,,mutations
,,,
PRDM2,"PR domain containing 2, with ZNF domain ",1p36,
,,,mutations
,,,
PRDM5,PR domain containing 5 ,?,
,,,mutations
,,,
PRDM9,PR domain containing 9 ,5p14.2,
,,,mutations
,,,
PRED1,ENTREZGENE:  ,15q13.2,
,,,Legius syndrome [MIM:611431]
,,,
PREPL,prolyl endopeptidase-like ,2p21,
,,,mutations
,,,
PRF1,perforin 1 (pore forming protein) ,10q22,
,,,"Hemophagocytic lymphohistiocytosis, familial, 2 [MIM:603553]"
,,,"Lymphoma, non-Hodgkin [MIM:605027]"
,,,
PRG4,proteoglycan 4 ,1q24-q25,
,,,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome [MIM:208250]
,,,
PRICKLE1,prickle homolog 1 (Drosophila) ,12q12,
,,,"Epilepsy, progressive myoclonic 1B [MIM:612437]"
,,,
PRICKLE2,prickle homolog 2 (Drosophila) ,?,
,,,mutations
,,,
PRKAA2,"protein kinase, AMP-activated, alpha 2 catalytic subunit ",1p31,
,,,mutations
,,,
PRKACA,"protein kinase, cAMP-dependent, catalytic, alpha ",19p13.1,
,,,mutations
,,,
PRKAG2,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit ",7q36,
,,,Wolff-Parkinson-White syndrome [MIM:194200]
,,,"Cardiomyopathy, hypertrophic 6, with WPW [MIM:600858]"
,,,"Glycogen storage disease of heart, lethal congenital [MIM:261740]"
,,,
PRKAG3,"protein kinase, AMP-activated, gamma 3 non-catalytic subunit ",2q35,
,,,mutations
,,,
PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha ",17q23-q24,
,,,"Carney complex, type 1 [MIM:160980]"
,,,"Myxoma, intracardiac [MIM:255960]"
,,,"Thyroid carcinoma, papillary [MIM:188550]"
,,,"Pigmented adrenocortical disease, primary, 1 [MIM:610489]"
,,,"Adrenocortical tumor, somatic"
,,,
PRKCA,"protein kinase C, alpha ",17q22-q23.2,
,,,"Pituitary tumor, invasive"
,,,
PRKCB,"protein kinase C, beta ",16p11.2,
,,,mutations
,,,
PRKCG,"protein kinase C, gamma ",19q13.4,
,,,Spinocerebellar ataxia 14 [MIM:605361]
,,,
PRKCH,"protein kinase C, eta ",14q22-q23,
,,,"Cerebral infarction, susceptibility to [MIM:601367]"
,,,
PRKCSH,protein kinase C substrate 80K-H ,19p13.2-p13.1,
,,,Polycystic liver disease [MIM:174050]
,,,
PRKD3,protein kinase D3 ,2p21,
,,,mutations
,,,
PRKDC,"protein kinase, DNA-activated, catalytic polypeptide ",8q11,
,,,mutations
,,,
PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator ",2q31.3,
,,,Dystonia 16 [MIM:612067]
,,,
PRLHR,prolactin releasing hormone receptor ,10q25.3-q26,
,,,mutations
,,,
PRLR,prolactin receptor ,5p13-p12,
,,,mutations
,,,
PRL,prolactin ,6p22.2-p21.3,
,,,mutations
,,,
PRM1,protamine 1 ,16p13.3,
,,,mutations
,,,
PRM2,protamine 2 ,16p13.3,
,,,mutations
,,,
PRMT10,protein arginine methyltransferase 10 (putative) ,?,
,,,mutations
,,,
PRMT3,protein arginine methyltransferase 3 ,?,
,,,mutations
,,,
PRMT7,protein arginine methyltransferase 7 ,?,
,,,mutations
,,,
PRND,prion protein 2 (dublet) ,20pter-p12,
,,,mutations
,,,
PRNP,prion protein ,20pter-p12,
,,,Creutzfeldt-Jakob disease [MIM:123400]
,,,Gerstmann-Straussler disease [MIM:137440]
,,,"Insomnia, fatal familial [MIM:600072]"
,,,Prion disease with protracted course [MIM:606688]
,,,Huntington disease-like 1 [MIM:603218]
,,,
PROCR,"protein C receptor, endothelial ",20q11.2,
,,,mutations
,,,
PROC,protein C (inactivator of coagulation factors Va and VIIIa) ,2q13-q14,
,,,"Thrombophilia due to protein C deficiency, autosomal dominant [MIM:176860]"
,,,"Thrombophilia due to protein C deficiency, autosomal recessive [MIM:612304]"
,,,
PRODH2,proline dehydrogenase (oxidase) 2 ,22q11.2,
,,,"Hyperprolinemia, type I [MIM:239500]"
,,,"Schizophrenia, susceptibility to, 4 [MIM:600850]"
,,,
PRODH,proline dehydrogenase (oxidase) 1 ,22q11.2,
,,,"Hyperprolinemia, type I [MIM:239500]"
,,,"Schizophrenia, susceptibility to, 4 [MIM:600850]"
,,,
PROK1,prokineticin 1 ,1p21,
,,,mutations
,,,
PROK2,prokineticin 2 ,3p21.1,
,,,Kallmann syndrome 4 [MIM:610628]
,,,"Hypogonadism, hypogonadotropic [MIM:146110]"
,,,
PROKR1,prokineticin receptor 1 ,?,
,,,mutations
,,,
PROKR2,prokineticin receptor 2 ,20p13,
,,,Kallmann syndrome 3 [MIM:244200]
,,,
PROM1,prominin 1 ,4p15.3,
,,,Retinitis pigmentosa-41 [MIM:612095]
,,,Cone-rod dystrophy 12 [MIM:612657]
,,,Stargardt disease 4 [MIM:603786]
,,,"Macular dystrophy, retinal, 2 [MIM:608051]"
,,,
PROP1,PROP paired-like homeobox 1 ,5q,
,,,"Pituitary hormone deficiency, combined, 2 [MIM:262600]"
,,,
PROS1,protein S (alpha) ,3q11.2,
,,,Thrombophilia due to protein S deficiency [MIM:612336]
,,,
PROSP,protein S pseudogene (beta) ,3q11.2,
,,,Thrombophilia due to protein S deficiency [MIM:612336]
,,,
PROZ,"protein Z, vitamin K-dependent plasma glycoprotein ",?,
,,,"bleeding tendency,PROZ deficiency"
,,,
PRPF31,PRP31 pre-mRNA processing factor 31 homolog (S. cerevisiae) ,19q13.4,
,,,Retinitis pigmentosa-11 [MIM:600138]
,,,
PRPF3,PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae) ,1q21.2,
,,,Retinitis pigmentosa-18 [MIM:601414]
,,,
PRPF6,PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) ,?,
,,,mutations
,,,
PRPF8,PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) ,17p13.3,
,,,Retinitis pigmentosa-13 [MIM:600059]
,,,
PRPH2,"peripherin 2 (retinal degeneration, slow) ",6p21.1-cen,
,,,Retinitis pigmentosa-7 [MIM:608133]
,,,Retinitis punctata albescens [MIM:136880]
,,,"Macular dystrophy, patterned [MIM:169150]"
,,,"Macular dystrophy, vitelliform [MIM:608161]"
,,,"Foveomacular dystrophy, adult-onset, with choroidal neovascularization [MIM:608161]"
,,,Macular dystrophy
,,,"Retinitis pigmentosa, digenic [MIM:608133]"
,,,"Choriodal dystrophy, central areolar 2 [MIM:613105]"
,,,
PRPH,peripherin ,12q12-q13,
,,,"Amyotrophic lateral sclerosis, susceptibility to [MIM:105400]"
,,,
PRPS1,phosphoribosyl pyrophosphate synthetase 1 ,Xq22-q24,
,,,"Gout, PRPS-related [MIM:300661]"
,,,Phosphoribosylpyrophosphate synthetase superactivity [MIM:300661]
,,,"Charcot-Marie-Tooth disease, X-linked recessive, 5 [MIM:311070]"
,,,Arts syndrome [MIM:301835]
,,,"Deafness, X-linked 1 [MIM:304500]"
,,,
PRRC2A,proline-rich coiled-coil 2A ,6p21.3,
,,,mutations
,,,
PRRT2,proline-rich transmembrane protein 2 ,?,
,,,mutations
,,,
PRRX1,paired related homeobox 1 ,1q24,
,,,mutations
,,,
PRSS12,"protease, serine, 12 (neurotrypsin, motopsin) ",4q25-q26,
,,,"Mental retardation, autosomal recessive 1 [MIM:249500]"
,,,
PRSS1,"protease, serine, 1 (trypsin 1) ",7q35,
,,,Trypsinogen deficiency
,,,"Pancreatitis, hereditary [MIM:167800]"
,,,
PRSS2,"protease, serine, 2 (trypsin 2) ",7q35,
,,,"Pancreatitis, chronic, protection against"
,,,
PRSS56,"protease, serine, 56 ",?,
,,,mutations
,,,
PRSS8,"protease, serine, 8 ",16p11.2,
,,,mutations
,,,
PRS,Prieto X-linked mental retardation syndrome ,Xp11-q21,
,,,"Mental retardation, X-linked, syndromic-2, with dysmorphism and cerebral atrophy"
,,,
PRX,periaxin ,19q13.1-q13.2,
,,,"Dejerine-Sottas neuropathy, autosomal recessive [MIM:145900]"
,,,"Charcot-Marie-Tooth disease, type 4F [MIM:145900]"
,,,
PSAP,prosaposin ,10q22.1,
,,,Metachromatic leukodystrophy due to SAP-b deficiency [MIM:249900]
,,,"Gaucher disease, atypical [MIM:610539]"
,,,Combined SAP deficiency [MIM:611721]
,,,"Krabbe disease, atypical [MIM:611722]"
,,,
PSAT1,phosphoserine aminotransferase 1 ,9q21.31,
,,,Phosphoserine aminotransferase deficiency [MIM:610992]
,,,
PSCA,prostate stem cell antigen ,8q24.2,
,,,mutations
,,,
PSEN1,presenilin 1 ,14q24.3,
,,,"Alzheimer disease, type 3 [MIM:607822]"
,,,"Alzheimer disease, type 3, with spastic paraparesis and unusual plaques [MIM:607822]"
,,,"Alzheimer disease, type 3, with spastic paraparesis and apraxia [MIM:607822]"
,,,"Dementia, frontotemporal [MIM:600274]"
,,,Pick disease [MIM:172700]
,,,"Cardiomyopathy, dilated, 1U [MIM:613694]"
,,,"Acne inversa, familial, 3 [MIM:613737]"
,,,
PSEN2,presenilin 2 (Alzheimer disease 4) ,1q31-q42,
,,,Alzheimer disease-4 [MIM:606889]
,,,"Cardiomyopathy, dilated, 1V [MIM:613697]"
,,,
PSENEN,presenilin enhancer 2 homolog (C. elegans) ,19q13.1,
,,,"Acne inversa, familial, 2 [MIM:613736]"
,,,
PSHK2,"Pseudohyperkalemia, familial, 2, due to red cell leak ",2q35-q36,
,,,"Pseudohyperkalemia, familial, 2, due to red cell leak"
,,,
PSMA6,"proteasome (prosome, macropain) subunit, alpha type, 6 ",14q13,
,,,"Myocardial infarcation, susceptibility to"
,,,
PSMB8,"proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) ",6p21.3,
,,,mutations
,,,
PSMB9,"proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) ",6p21.3,
,,,mutations
,,,
PSMC3IP,PSMC3 interacting protein ,?,
,,,mutations
,,,
PSMD7,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 ",16q23-q24,
,,,mutations
,,,
PSNP2,"supranuclear palsy, progressive, 2 ",1q31.1,
,,,"Supranuclear palsy, progressive, 2"
,,,
PSNP3,"Supranuclear palsy, progressive, 3 ",11p12-p11,
,,,"Supranuclear palsy, progressive, 3"
,,,
PSORS10,psoriasis susceptibility 10 ,18p11.23,
,,,Psoriasis susceptibility 10
,,,
PSORS11,Psoriasis susceptibility 11 ,5q31.1-q33.1,
,,,Psoriasis susceptibility 11
,,,
PSORS1,psoriasis susceptibility 1 ,6p21.3,
,,,Psoriasis susceptibility 1 [MIM:177900]
,,,"HIV-1 viremia, susceptibility to [MIM:609423]"
,,,
PSORS2,psoriasis susceptibility 2 ,17q25,
,,,Psoriasis susceptibility 2
,,,
PSORS3,psoriasis susceptibility 3 ,4q,
,,,Psoriasis susceptibility 3
,,,
PSORS4,psoriasis susceptibility 4 ,1q21,
,,,Psoriasis susceptibility 4
,,,
PSORS5,psoriasis susceptibility 5 ,3q21,
,,,Psoriasis susceptibility 5
,,,
PSORS6,psoriasis susceptibility 6 ,19p13,
,,,Psoriasis susceptibility 6
,,,
PSORS7,psoriasis susceptibility 7 ,1p,
,,,Psoriasis susceptibility 7
,,,
PSORS8,psoriasis susceptibility 8 ,16q,
,,,Psoriasis susceptibility 8
,,,
PSORS9,psoriasis susceptibility 9 ,4q31-q34,
,,,Psoraisis susceptibility 9
,,,
PSPH,phosphoserine phosphatase ,7p15.2-p15.1,
,,,Phosphoserine phosphatase deficiency
,,,
PSPN,persephin ,19p13.3,
,,,mutations
,,,
PSS,Potocki-Shaffer syndrome ,11p11.2,
,,,Potocki-Shaffer syndrome
,,,
PSTPIP1,proline-serine-threonine phosphatase interacting protein 1 ,15q24-q25.1,
,,,"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne [MIM:604416]"
,,,
PTAFR,platelet-activating factor receptor ,1p35-p34.3,
,,,mutations
,,,
PTCD1,pentatricopeptide repeat domain 1 ,?,
,,,mutations
,,,
PTCH1,patched 1 ,9q22.3,
,,,Basal cell nevus syndrome [MIM:109400]
,,,"Basal cell carcinoma, somatic [MIM:605462]"
,,,Holoprosencephaly-7 [MIM:610828]
,,,
PTCH2,patched 2 ,1p32,
,,,Medulloblastoma [MIM:155255]
,,,"Basal cell carcinoma, somatic [MIM:605462]"
,,,
PTCHD1,patched domain containing 1 ,Xp22.11,
,,,mutations
,,,
PTCHD3,patched domain containing 3 ,10p12.1,
,,,mutations
,,,
PTCPRN,Papillary thyroid carcinoma with papillary renal neoplasia ,1q21,
,,,"Thyroid carcinoma, papillary, with papillary renal neoplasia"
,,,
PTCSC3,papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) ,?,
,,,mutations
,,,
PTEN,phosphatase and tensin homolog ,10q23.31,
,,,Cowden disease [MIM:158350]
,,,Lhermitte-Duclos syndrome [MIM:158350]
,,,Bannayan-Riley-Ruvalcaba syndrome [MIM:153480]
,,,Meningioma [MIM:607174]
,,,Glioma susceptibility 2 [MIM:613028]
,,,Macrocephaly/autism syndrome [MIM:605309]
,,,PTEN hamartoma tumor syndrome
,,,VATER association with macrocephaly and ventriculomegaly [MIM:276950]
,,,"Prostate cancer, somatic [MIM:176807]"
,,,"Thyroid carcinoma, follicular, somatic [MIM:188470]"
,,,"Malignant melanoma, somatic [MIM:155600]"
,,,"Endometrial carcinoma, somatic [MIM:608089]"
,,,"Squamous cell carcinoma, head and neck, somatic [MIM:275355]"
,,,
PTF1A,"pancreas specific transcription factor, 1a ",10p12.3,
,,,"Diabetes mellitus, permanent neonatal, with cerebellar agenesis [MIM:609069]"
,,,
PTGDR,prostaglandin D2 receptor (DP) ,14q22.1,
,,,"Asthma, susceptibility to, 1 [MIM:607277]"
,,,
PTGDS,prostaglandin D2 synthase 21kDa (brain) ,9q34.2-q34.3,
,,,mutations
,,,
PTGER2,"prostaglandin E receptor 2 (subtype EP2), 53kDa ",14q22,
,,,"Asthma, aspirin-induced, susceptibility to [MIM:208550]"
,,,
PTGER4,prostaglandin E receptor 4 (subtype EP4) ,5p13.1,
,,,mutations
,,,
PTGES2,prostaglandin E synthase 2 ,9q34.13,
,,,mutations
,,,
PTGIR,prostaglandin I2 (prostacyclin) receptor (IP) ,19q13.3,
,,,mutations
,,,
PTGIS,prostaglandin I2 (prostacyclin) synthase ,20q13.11-q13.13,
,,,"Hypertension, essential [MIM:145500]"
,,,
PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ,9q32-q33.3,
,,,mutations
,,,
PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) ,1q25.2-q25.3,
,,,mutations
,,,
PTH1R,parathyroid hormone 1 receptor ,3p22-p21.1,
,,,"Metaphyseal chondrodysplasia, Murk Jansen type [MIM:156400]"
,,,"Chondrodysplasia, Blomstrand type [MIM:215045]"
,,,Eiken syndrome [MIM:600002]
,,,"Failure of tooth eruption, primary [MIM:125350]"
,,,
PTHLH,parathyroid hormone-like hormone ,12p12.1-p11.2,
,,,Humoral hypercalcemia of malignancy
,,,"Brachydactyly, type E2 [MIM:613382]"
,,,
PTH,parathyroid hormone ,11p15.3-p15.1,
,,,"Hypoparathyroidism, autosomal dominant [MIM:146200]"
,,,"Hypoparathyroidism, autosomal recessive [MIM:146200]"
,,,
PTK7,PTK7 protein tyrosine kinase 7 ,6p21.1-p12.2,
,,,mutations
,,,
PTLAH,patella aplasia-hypoplasia ,17q21-q22,
,,,Patella aplasia or hypoplasia
,,,
PTLS,Potocki-Lupski syndrome ,17p11.2,
,,,Potocki-Lupski syndrome
,,,
PTOS1,"ptosis, congenital 1 (autosomal dominant) ",1p34.1-p32,
,,,"Ptosis, hereditary congenital, 1"
,,,
PTOS2,"Ptosis, hereditary congenital 2 ",Xq24-q27.1,
,,,"Ptosis, hereditary congenital 2"
,,,
PTPN11,"protein tyrosine phosphatase, non-receptor type 11 ",12q24.1,
,,,Noonan syndrome 1 [MIM:163950]
,,,LEOPARD syndrome 1 [MIM:151100]
,,,"Leukemia, juvenile myelomonocytic [MIM:607785]"
,,,Metachondromatosis [MIM:156250]
,,,
PTPN12,"protein tyrosine phosphatase, non-receptor type 12 ",7q11.23,
,,,Colon cancer
,,,
PTPN13,"protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) ",4q21.3,
,,,mutations
,,,
PTPN14,"protein tyrosine phosphatase, non-receptor type 14 ",1q32,
,,,Choanal atresia and lymphedema [MIM:613611]
,,,
PTPN1,"protein tyrosine phosphatase, non-receptor type 1 ",20q13.1-q13.2,
,,,"Insulin resistance, susceptibility to [MIM:125853]"
,,,
PTPN21,"protein tyrosine phosphatase, non-receptor type 21 ",?,
,,,mutations
,,,
PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid) ",1p13,
,,,"Diabetes, type 1, susceptibility to [MIM:222100]"
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,Systemic lupus erythematosus susceptibility to [MIM:152700]
,,,
PTPN2,"protein tyrosine phosphatase, non-receptor type 2 ",18p11.3-p11.2,
,,,mutations
,,,
PTPN6,"protein tyrosine phosphatase, non-receptor type 6 ",12p13,
,,,mutations
,,,
PTPRB,"protein tyrosine phosphatase, receptor type, B ",12q15-q21,
,,,mutations
,,,
PTPRCAP,"protein tyrosine phosphatase, receptor type, C-associated protein ",11q13.3,
,,,mutations
,,,
PTPRC,"protein tyrosine phosphatase, receptor type, C ",1q31-q32,
,,,"Hepatitic C virus, susceptibility to [MIM:609532]"
,,,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive [MIM:608971]"
,,,
PTPRD,"protein tyrosine phosphatase, receptor type, D ",9p24.3-p23,
,,,mutations
,,,
PTPRF,"protein tyrosine phosphatase, receptor type, F ",1p32,
,,,mutations
,,,
PTPRJ,"protein tyrosine phosphatase, receptor type, J ",11p11.2,
,,,"Colon cancer, somatic [MIM:114500]"
,,,
PTPRK,"protein tyrosine phosphatase, receptor type, K ",6q22.2-q22.3,
,,,mutations
,,,
PTPRO,"protein tyrosine phosphatase, receptor type, O ",12p13-p12,
,,,mutations
,,,
PTPRQ,"protein tyrosine phosphatase, receptor type, Q ",12q21.2,
,,,"Deafness, autosomal recessive 84 [MIM:613391]"
,,,
PTPRT,"protein tyrosine phosphatase, receptor type, T ",?,
,,,mutations
,,,
PTPRZ1,"protein tyrosine phosphatase, receptor-type, Z polypeptide 1 ",7q31.3,
,,,"H. pylori infection, susceptibility to [MIM:600263]"
,,,
PTRF,polymerase I and transcript release factor ,17q21,
,,,"Lipodystrophy, congenital generalized, type 4 [MIM:613327]"
,,,
PTS,6-pyruvoyltetrahydropterin synthase ,11q22.3-q23.3,
,,,"Hyperphenylalaninemia, BH4-deficient, A [MIM:261640]"
,,,
PUJO,pelviureteric junction obstruction ,6p,
,,,Pelviureteric junction obstruction
,,,
PURAQTL1,Polyunsaturated fatty acids plasma level QTL1 ,11q12-q13.1,
,,,Polyunsaturated fatty acids plasma level QTL1
,,,
PUS1,pseudouridylate synthase 1 ,12q24.33,
,,,Mitochondrial myopathy and sideroblastic anemia 1 [MIM:600462]
,,,
PVNH3,Periventricular nodular heterotopia 3 ,5p15.1,
,,,Periventricular nodular heterotopia 3
,,,
PVNH5,Periventricular nodular heterotopia 5 ,5q14.3-q15,
,,,Periventricular nodular heterotopia 5
,,,
PVOP1,"Pelvic organ prolapse, susceptibility to, 1 ",1q31,
,,,"Pelvic organ prolapse, susceptibility to, 1"
,,,
PVOP2,"Pelvic organ prolapse, susceptibility to, 2 ",9q21,
,,,"Pelvic organ prolapse, susceptibility to, 2"
,,,
PVRL1,poliovirus receptor-related 1 (herpesvirus entry mediator C) ,11q23-q24,
,,,Cleft lip/palate-ectodermal dysplasia syndrome [MIM:225060]
,,,Orofacial cleft 7 [MIM:225060]
,,,
PVRL3,poliovirus receptor-related 3 ,3q13,
,,,mutations
,,,
PVRL4,poliovirus receptor-related 4 ,1q23.3,
,,,Ectodermal dysplasia-syndactyly syndrome 1 [MIM:613573]
,,,
PVR,poliovirus receptor ,19q13.2-q13.3,
,,,"Polio, susceptibility to"
,,,
PVT1,Pvt1 oncogene (non-protein coding) ,8q24,
,,,Burkitt lymphoma variant/acute lymphoblastic leukemia with translocations t(2;8)(p12;q24);t(8;22)(q24;q11)
,,,
PXDN,peroxidasin homolog (Drosophila) ,2p25.3,
,,,mutations
,,,
PYCR1,pyrroline-5-carboxylate reductase 1 ,17q25.3,
,,,"Cutis laxa, autosomal recessive, type IIB [MIM:612940]"
,,,
PYCRL,pyrroline-5-carboxylate reductase-like ,?,
,,,mutations
,,,
PYGL,"phosphorylase, glycogen, liver ",?,
,,,mutations
,,,
PYGM,"phosphorylase, glycogen, muscle ",11q13,
,,,McArdle disease [MIM:232600]
,,,
PYY,peptide YY ,17q21,
,,,Obesity [MIM:601665]
,,,
PZP,pregnancy-zone protein ,12p13-p12.2,
,,,mutations
,,,
QDPR,quinoid dihydropteridine reductase ,4p15.31,
,,,"Hyperphenylalaninemia, BH4-deficient, C [MIM:261630]"
,,,
QKI,"QKI, KH domain containing, RNA binding ",?,
,,,mutations
,,,
QTV,"QT interval, variation in ",1q23.3,
,,,"QT interval, variation in"
,,,
RA6,Rheumatoid arthritis QTL 06 ,15q24.1,
,,,"Microphthalmia, syndromic 9 [MIM:601186]"
,,,
RA9,Rheumatoid arthritis QTL 09 ,11q13.3,
,,,"Pituitary adenoma, growth hormone-secreting [MIM:102200]"
,,,"Pituitary adenoma, prolactin-secreting [MIM:600634]"
,,,"Pituitary adenoma, ACTH-secreting [MIM:219090]"
,,,
RAB11FIP5,RAB11 family interacting protein 5 (class I) ,2p13-p12,
,,,mutations
,,,
RAB18,"RAB18, member RAS oncogene family ",10p12.1,
,,,mutations
,,,
RAB23,"RAB23, member RAS oncogene family ",6p11,
,,,Carpenter syndrome [MIM:201000]
,,,
RAB27A,"RAB27A, member RAS oncogene family ",15q21,
,,,"Griscelli syndrome, type 2 [MIM:607624]"
,,,
RAB28,"RAB28, member RAS oncogene family ",4p15.33,
,,,mutations
,,,
RAB2A,"RAB2A, member RAS oncogene family ",8q12.1,
,,,mutations
,,,
RAB39B,"RAB39B, member RAS oncogene family ",Xq28,
,,,"Mental retardation, X-linked-72 [MIM:300271]"
,,,
RAB3GAP1,RAB3 GTPase activating protein subunit 1 (catalytic) ,2q21.3,
,,,Warburg micro syndrome 1 [MIM:600118]
,,,
RAB3GAP2,RAB3 GTPase activating protein subunit 2 (non-catalytic) ,1q41,
,,,Martsolf syndrome [MIM:212720]
,,,
RAB40AL,"RAB40A, member RAS oncogene family-like ",Xq22.2,
,,,"Mental retardation, profound"
,,,
RAB7A,"RAB7A, member RAS oncogene family ",3q21,
,,,"Charcot-Marie-Tooth disease, type 2B [MIM:600882]"
,,,
RAB7L1,"RAB7, member RAS oncogene family-like 1 ",1q32,
,,,mutations
,,,
RABGGTA,"Rab geranylgeranyltransferase, alpha subunit ",14q11.2,
,,,mutations
,,,
RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) ",?,
,,,mutations
,,,
RAC2,"ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) ",22q12.3-q13.2,
,,,Neutrophil immunodeficiency syndrome [MIM:608203]
,,,
RAD21L1,RAD21-like 1 (S. pombe) ,?,
,,,mutations
,,,
RAD23B,RAD23 homolog B (S. cerevisiae) ,9,
,,,mutations
,,,
RAD50,RAD50 homolog (S. cerevisiae) ,5q31,
,,,Nijmegen breakage syndrome-like disorder [MIM:613078]
,,,
RAD51C,RAD51 homolog C (S. cerevisiae) ,17q22,
,,,"Fanconi anemia, complementation group 0 [MIM:613390]"
,,,"Breast-ovarian cancer, familial, susceptibility to, 3 [MIM:613399]"
,,,
RAD51D,RAD51 homolog D (S. cerevisiae) ,17q11,
,,,mutations
,,,
RAD51,RAD51 homolog (S. cerevisiae) ,15q15.1,
,,,"Breast cancer, susceptibility to [MIM:114480]"
,,,
RAD52,RAD52 homolog (S. cerevisiae) ,12p13-p12.2,
,,,mutations
,,,
RAD54B,RAD54 homolog B (S. cerevisiae) ,8q21.3-q22,
,,,"Lymphoma, non-Hodgkin"
,,,Colon adenocarcinoma
,,,
RAD54L,RAD54-like (S. cerevisiae) ,1p32,
,,,"Breast cancer, invasive ductal [MIM:114480]"
,,,"Lymphoma, non-Hodgkin, somatic [MIM:605027]"
,,,"Adenocarcinoma, colonic, somatic"
,,,
RAD9A,RAD9 homolog A (S. pombe) ,11q13.1-q13.2,
,,,mutations
,,,
RAET1L,retinoic acid early transcript 1L ,6q24.2-q25.3,
,,,mutations
,,,
RAF1,v-raf-1 murine leukemia viral oncogene homolog 1 ,3p25,
,,,Noonan syndrome 5 [MIM:611553]
,,,LEOPARD syndrome 2 [MIM:611554]
,,,
RAG1,recombination activating gene 1 ,11p13,
,,,"Severe combined immunodeficiency, B cell-negative [MIM:601457]"
,,,Omenn syndrome [MIM:603554]
,,,"Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity [MIM:609889]"
,,,Combined cellular and humoral immune defects with granulomas [MIM:233650]
,,,
RAG2,recombination activating gene 2 ,11p13,
,,,"Severe combined immunodeficiency, B cell-negative [MIM:601457]"
,,,Omenn syndrome [MIM:603554]
,,,Combined cellular and humoral immune defects with granulomas [MIM:233650]
,,,
RAI1,retinoic acid induced 1 ,17p11.2,
,,,Smith-Magenis syndrome [MIM:182290]
,,,
RALGAPA1,"Ral GTPase activating protein, alpha subunit 1 (catalytic) ",14q13.2,
,,,mutations
,,,
RALGDS,ral guanine nucleotide dissociation stimulator ,9q34,
,,,mutations
,,,
RANBP2,RAN binding protein 2 ,2q11-q13,
,,,"Encephalopathy, acute necrotizing 1 [MIM:608033]"
,,,
RANGRF,RAN guanine nucleotide release factor ,?,
,,,mutations
,,,
RAN,"RAN, member RAS oncogene family ",12q24.3,
,,,mutations
,,,
RAP1GDS1,"RAP1, GTP-GDP dissociation stimulator 1 ",4q21-q25,
,,,"Lymphocytic leukemia, acute T-cell"
,,,
RAPSN,receptor-associated protein of the synapse ,11p11.2-p11.1,
,,,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [MIM:608931]"
,,,"Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency [MIM:608931]"
,,,Fetal akinesia deformation sequence [MIM:208150]
,,,
RARA,"retinoic acid receptor, alpha ",17q21.1,
,,,"Leukemia, acute promyelocytic [MIM:612376]"
,,,
RARS2,"arginyl-tRNA synthetase 2, mitochondrial ",6q16.1,
,,,"Pontocerebellar hypoplasia, type 6 [MIM:611523]"
,,,
RASA1,RAS p21 protein activator (GTPase activating protein) 1 ,5q13.3,
,,,Parkes Weber slndrome [MIM:608355]
,,,Capillary malformation-arteriovenous malformation [MIM:608354]
,,,"Basal cell carcinoma, somatic [MIM:605462]"
,,,
RASGRP2,RAS guanyl releasing protein 2 (calcium and DAG-regulated) ,11q13,
,,,mutations
,,,
RASSF1,Ras association (RalGDS/AF-6) domain family member 1 ,3p21.3,
,,,Lung cancer [MIM:211980]
,,,
RAX2,retina and anterior neural fold homeobox 2 ,19p13.3,
,,,"Macular degeneration, age-related, 6"
,,,Cone-rod dystrophy 11 [MIM:610381]
,,,
RAX,retina and anterior neural fold homeobox ,18q21.3,
,,,"Microphthalmia, isolated 3 [MIM:611038]"
,,,
RB1CC1,RB1-inducible coiled-coil 1 ,8q11,
,,,"Breast cancer, somatic [MIM:114480]"
,,,
RB1,retinoblastoma 1 ,?,
,,,"retinoblastoma susceptibility,associated with a dysmorphic phenotype and mental retardation and/or motor impairment in patients with a constitutional 13q deletion"
,,,
RBBP8,retinoblastoma binding protein 8 ,18q11.2,
,,,"Pancreatic carcinoma, somatic"
,,,
RBFOX1,"RNA binding protein, fox-1 homolog (C. elegans) 1 ",16p13,
,,,mutations
,,,
RBM10,RNA binding motif protein 10 ,Xp11.23,
,,,TARP syndrome [MIM:311900]
,,,
RBM15,RNA binding motif protein 15 ,1p13,
,,,"Megakaryoblastic leukemia, acute"
,,,
RBM20,RNA binding motif protein 20 ,10q25.2,
,,,"Cardiomyopathy, dilated, 1DD [MIM:613172]"
,,,
RBM28,RNA binding motif protein 28 ,7q32.1,
,,,"Alopecia, neurologic defects, and endocrinopathy syndrome [MIM:612079]"
,,,
RBM8A,RNA binding motif protein 8A ,1q12,
,,,mutations
,,,
RBMXL2,"RNA binding motif protein, X-linked-like 2 ",11p15,
,,,mutations
,,,
RBP3,"retinol binding protein 3, interstitial ",10q11.2,
,,,mutations
,,,
RBP4,"retinol binding protein 4, plasma ",10q24,
,,,"Retinol binding protein, deficiency of"
,,,
RCBTB1,regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 ,13q14,
,,,Beta-glycopyranoside tasting
,,,"Alcohol dependence, susceptibility to [MIM:103780]"
,,,
RCD1,retinal cone dystrophy 1 ,6q25-q26,
,,,Retinal cone dystrophy-1
,,,
RCHTS,Roifman-Chitayat syndrome ,15q11-q21.1,
,,,Roifman-Chitayat syndrome
,,,
RCM2,"cardiomyopathy, familial restrictive, 2 ",10q23.3,
,,,"Cardiomyopathy, familial restrictive, 2"
,,,
RD3,retinal degeneration 3 ,1q32.3,
,,,Leber congenital amaurosis 12 [MIM:610612]
,,,
RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis) ,14q23.3,
,,,Leber congenital amaurosis 13 [MIM:612712]
,,,
RDH5,retinol dehydrogenase 5 (11-cis/9-cis) ,12q13-q14,
,,,Fundus albipunctatus [MIM:136880]
,,,
RDPA,"refsum disease, adult, with increased pipecolicacidemia ",10pter-p11.2,
,,,"Refsum disease, adult, with increased pipecolicacidemia"
,,,
RDX,radixin ,11q23,
,,,"Deafness, autosomal recessive, 24 [MIM:611022]"
,,,
RECQL4,RecQ protein-like 4 ,8q24.3,
,,,Rothmund-Thomson syndrome [MIM:268400]
,,,RAPADILINO syndrome [MIM:266280]
,,,Baller-Gerold syndrome [MIM:218600]
,,,
REEP1,receptor accessory protein 1 ,2p11.2,
,,,Spastic paraplegia 31 [MIM:610250]
,,,
RELN,reelin ,7q22,
,,,"Lissencephaly syndrome, Norman-Roberts type [MIM:257320]"
,,,
REL,v-rel reticuloendotheliosis viral oncogene homolog (avian) ,2p13-p12,
,,,mutations
,,,
REN,renin ,1q32,
,,,Hyperproreninemia
,,,Renal tubular dysgenesis [MIM:267430]
,,,"Hyperuricemic nephropathy, familial juvenile 2 [MIM:613092]"
,,,
REPS2,RALBP1 associated Eps domain containing 2 ,X,
,,,mutations
,,,
RETN,resistin ,19p13.2,
,,,"Diabetes mellitus, noninsulin-dependent, susceptibility to [MIM:125853]"
,,,"Hypertension, insulin resistance-related, susceptibility to [MIM:125853]"
,,,
RET,ret proto-oncogene ,10q11.2,
,,,Multiple endocrine neoplasia IIA [MIM:171400]
,,,Medullary thyroid carcinoma [MIM:155240]
,,,Multiple endocrine neoplasia IIB [MIM:162300]
,,,"Central hypoventilation syndrome, congenital [MIM:209880]"
,,,Pheochromocytoma [MIM:171300]
,,,Renal agenesis [MIM:191830]
,,,"Hirschsprung disease, susceptibility to, 1 [MIM:142623]"
,,,
REV3L,"REV3-like, polymerase (DNA directed), zeta, catalytic subunit ",6q21,
,,,mutations
,,,
RFC2,"replication factor C (activator 1) 2, 40kDa ",7q11.23,
,,,mutations
,,,
RFH1,"Renal failure, progressive, with hypertension ",1q21,
,,,Nephropathy-hypertension
,,,
RFMN,Roifman syndrome ,X,
,,,Roifman syndrome
,,,
RFT1,RFT1 homolog (S. cerevisiae) ,3p21.1,
,,,"Congenital disorder of glycosylation, type In [MIM:612015]"
,,,
RFWD2,"ring finger and WD repeat domain 2, E3 ubiquitin protein ligase ",1q24.1,
,,,mutations
,,,
RFX1,"regulatory factor X, 1 (influences HLA class II expression) ",19p13.1,
,,,"immunodeficiency,severe combined with defective expression of MHC class II gene"
,,,
RFX2,"regulatory factor X, 2 (influences HLA class II expression) ",19p13.3-p13.2,
,,,mutations
,,,
RFX5,"regulatory factor X, 5 (influences HLA class II expression) ",1q21.1-q21.3,
,,,"Bare lymphocyte syndrome, type II, complementation group C [MIM:209920]"
,,,"Bare lymphocyte syndrome, type II, complementation group E [MIM:209920]"
,,,
RFX6,"regulatory factor X, 6 ",6q22.2,
,,,mutations
,,,
RFX8,"regulatory factor X, 8 ",?,
,,,mutations
,,,
RFXANK,regulatory factor X-associated ankyrin-containing protein ,19p12,
,,,"MHC class II deficiency, complementation group B [MIM:209920]"
,,,
RFXAP,regulatory factor X-associated protein ,13q14,
,,,"Bare lymphocyte syndrome, type II, complementation group D [MIM:209920]"
,,,
RGMA,"RGM domain family, member A ",15q26.1,
,,,mutations
,,,
RGR,retinal G protein coupled receptor ,10q23,
,,,Retinitis pigmentosa-44
,,,
RGS2,"regulator of G-protein signaling 2, 24kDa ",1q31,
,,,mutations
,,,
RGS5,regulator of G-protein signaling 5 ,1q23,
,,,Blood pressure regulation QTL [MIM:145500]
,,,
RGS6,regulator of G-protein signaling 6 ,14q24.3,
,,,mutations
,,,
RGS7,regulator of G-protein signaling 7 ,?,
,,,mutations
,,,
RGS9BP,regulator of G protein signaling 9 binding protein ,19q13.11,
,,,Bradyopsia [MIM:608415]
,,,
RGS9,regulator of G-protein signaling 9 ,17q23-q24,
,,,Bradyopsia [MIM:608415]
,,,
RHAG,Rh-associated glycoprotein ,6p21.1-p11,
,,,"Anemia, hemolytic, Rh-null, regulator type [MIM:268150]"
,,,Rh-mod syndrome
,,,
RHBDF2,rhomboid 5 homolog 2 (Drosophila) ,?,
,,,mutations
,,,
RHCE,"Rh blood group, CcEe antigens ",1p36.2-p34,
,,,"Blood group, Rhesus"
,,,"Rh-null disease, amorph type"
,,,
RHDNS1,"Renal hypodysplasia, nonsyndromic, 1 ",1p33-p32,
,,,"Renal hypodysplasia, nonsyndromic, 1"
,,,
RHD,"Rh blood group, D antigen ",1p36.2-p34,
,,,Rh-negative blood type
,,,
RHOB,ras homolog family member B ,2pter-p12,
,,,mutations
,,,
RHOG,ras homolog family member G ,11p15.5-p15.4,
,,,mutations
,,,
RHO,rhodopsin ,3q21-q24,
,,,"Retinitis pigmentosa 4, autosomal dominant or recessive [MIM:613731]"
,,,"Night blindness, congenital stationery, autosomal dominant 1 [MIM:610445]"
,,,Retinitis punctata albescens [MIM:136880]
,,,
RHPN2,"rhophilin, Rho GTPase binding protein 2 ",?,
,,,mutations
,,,
RIEG2,Rieger syndrome 2 ,13q14,
,,,"Rieger syndrome, type 2"
,,,
RIMS1,regulating synaptic membrane exocytosis 1 ,6q12-q13,
,,,Cone-rod dystrophy 7 [MIM:603649]
,,,
RIMS3,regulating synaptic membrane exocytosis 3 ,1p34.1,
,,,mutations
,,,
RIN2,Ras and Rab interactor 2 ,20p11.22,
,,,"Macrocephaly, alopecia, cutis laxa, and scoliosis [MIM:613075]"
,,,
RIPK3,receptor-interacting serine-threonine kinase 3 ,14q11.2,
,,,mutations
,,,
RIPK4,receptor-interacting serine-threonine kinase 4 ,21q22.3,
,,,mutations
,,,
RJBS,Rajab syndrome ,2q36.2,
,,,Rajab syndrome
,,,
RLBP1,retinaldehyde binding protein 1 ,15q26,
,,,Fundus albipunctatus [MIM:136880]
,,,Retinitis punctata albescens [MIM:136880]
,,,Newfoundland rod-cone dystrophy [MIM:607476]
,,,Bothnia retinal dystrophy [MIM:607475]
,,,
RLS2,Restless legs syndrome 2 ,14q13-q21,
,,,Restless legs syndrome 2
,,,
RLS3,Restless legs syndrome 3 ,9p24-p22,
,,,Restless legs syndrome 3
,,,
RLS4,Restless legs syndrome 4 ,2q33,
,,,Restless legs syndrome 4
,,,
RLS5,"Restless legs syndrome, susceptibility to, 5 ",20p13,
,,,"Restless legs syndrome, susceptibility to, 5"
,,,
RLS6,"Restless legs syndrome, susceptibility to, 6 ",6p21,
,,,"Restless legs syndrome, susceptibility to, 6"
,,,
RLS7,Restless legs syndrome 7 ,2p14-p13,
,,,Restless legs syndrome 7
,,,
RLS,"Restless legs syndrome, susceptibility to ",12q12-q21,
,,,Restless legs syndrome 1
,,,
RMD1,rippling muscle disease 1 ,1q41,
,,,Rippling muscle disease-1 [MIM:606072]
,,,
RMI1,"RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) ",9q21.32,
,,,mutations
,,,
RMRP,RNA component of mitochondrial RNA processing endoribonuclease ,9p21-p12,
,,,Cartilage-hair hypoplasia [MIM:250250]
,,,Metaphyseal dysplasia without hypotrichosis [MIM:250460]
,,,Anauxetic dysplasia [MIM:607095]
,,,
RNANC,"Retinal nonattachment, nonsyndromic congenital ",10q21,
,,,"Retinal nonattachment, nonsyndromic congenital"
,,,
RNASE3,"ribonuclease, RNase A family, 3 ",14q11.2,
,,,mutations
,,,
RNASEH2A,"ribonuclease H2, subunit A ",19p13.13,
,,,Aicardi-Goutieres syndrome 4 [MIM:610333]
,,,
RNASEH2B,"ribonuclease H2, subunit B ",13q14.1,
,,,Aicardi-Goutieres syndrome 2 [MIM:610181]
,,,
RNASEH2C,"ribonuclease H2, subunit C ",11q13.2,
,,,Aicardi-Goutieres syndrome 3 [MIM:610329]
,,,
RNASEL,"ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) ",1q25,
,,,"Prostate cancer 1, 176807 [MIM:601518]"
,,,
RNASET2,ribonuclease T2 ,6q27,
,,,"Leukoencephalopathy, cystic, without megalencephaly [MIM:612951]"
,,,
RNF113A,ring finger protein 113A ,?,
,,,mutations
,,,
RNF114,ring finger protein 114 ,20q13,
,,,mutations
,,,
RNF135,ring finger protein 135 ,17q11,
,,,Overgrowth syndrome
,,,
RNF139,ring finger protein 139 ,8q24.1,
,,,Renal cell carcinoma [MIM:144700]
,,,
RNF168,"ring finger protein 168, E3 ubiquitin protein ligase ",3q29,
,,,RIDDLE syndrome [MIM:611943]
,,,
RNF170,ring finger protein 170 ,?,
,,,mutations
,,,
RNF212,ring finger protein 212 ,4p16.3,
,,,Recombination rate QTL 1 [MIM:612042]
,,,
RNF213,ring finger protein 213 ,?,
,,,mutations
,,,
RNF6,ring finger protein (C3H2C3 type) 6 ,13q12.11,
,,,"Esophageal carcinoma, somatic [MIM:133239]"
,,,
RNLS,"renalase, FAD-dependent amine oxidase ",10q23.33,
,,,mutations
,,,
RNU4ATAC,"RNA, U4atac small nuclear (U12-dependent splicing) ",?,
,,,mutations
,,,
ROBO1,"roundabout, axon guidance receptor, homolog 1 (Drosophila) ",3p12,
,,,mutations
,,,
ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila) ",3p12.3,
,,,Vesicoureteral reflux 2 [MIM:610878]
,,,
ROBO3,"roundabout, axon guidance receptor, homolog 3 (Drosophila) ",11q23-q25,
,,,"Gaze palsy, horizontal, with progressive scoliosis [MIM:607313]"
,,,
ROCK1,"Rho-associated, coiled-coil containing protein kinase 1 ",18q11.1,
,,,mutations
,,,
ROCK2,"Rho-associated, coiled-coil containing protein kinase 2 ",2p24,
,,,mutations
,,,
ROGDI,rogdi homolog (Drosophila) ,?,
,,,mutations
,,,
ROM1,retinal outer segment membrane protein 1 ,11q13,
,,,"Retinitis pigmentosa-7, digenic"
,,,
ROPN1L,rhophilin associated tail protein 1-like ,5p15.2,
,,,mutations
,,,
ROR2,receptor tyrosine kinase-like orphan receptor 2 ,9q22,
,,,"Brachydactyly, type B1 [MIM:113000]"
,,,"Robinow syndrome, autosomal recessive [MIM:268310]"
,,,
RORA,RAR-related orphan receptor A ,15q21-q22,
,,,mutations
,,,
ROS1,"c-ros oncogene 1 , receptor tyrosine kinase ",6q22,
,,,mutations
,,,
RP1L1,retinitis pigmentosa 1-like 1 ,8p23,
,,,Occult macular dystrophy [MIM:613587]
,,,
RP1,retinitis pigmentosa 1 (autosomal dominant) ,8q11-q13,
,,,Retinitis pigmentosa-1 [MIM:180100]
,,,"Hypertriglyceridemia, susceptibility to [MIM:145750]"
,,,
RP22,retinitis pigmentosa 22 (autosomal recessive) ,16p12.3-p12.1,
,,,Retinitis pigmentosa-22
,,,
RP23,retinitis pigmentosa 23 (X-linked recessive) ,Xp22,
,,,Retinitis pigmentosa-23
,,,
RP24,retinitis pigmentosa 24 (X-linked recessive) ,Xq26-q27,
,,,Retinitis pigmentosa-24
,,,
RP29,retinitis pigmentosa 29 (autosomal recessive) ,4q32-q34,
,,,Retinitis pigmentosa-29
,,,
RP2,retinitis pigmentosa 2 (X-linked recessive) ,Xp11.23,
,,,Retinitis pigmentosa-2 [MIM:312600]
,,,
RP32,retinitis pigmentosa 32 (autosomal recessive) ,1p21.3-p13.3,
,,,Retinitis pigmentosa-32
,,,
RP34,retinitis pigmentosa 34 (X-linked recessive) ,Xq28,
,,,Retinitis pigmentosa 34
,,,
RP35,retinitis pigmentosa 35 (autosomal dominant) ,1q22,
,,,Retinitis pigmentosa-35 [MIM:610282]
,,,Cone-rod dystrophy 10 [MIM:610283]
,,,
RP6,retinitis pigmentosa 6 (X-linked recessive) ,Xp21.3-p21.2,
,,,Retinitis pigmentosa-6
,,,
RP9,retinitis pigmentosa 9 (autosomal dominant) ,7p14.2,
,,,Retinitis pigmentosa-9 [MIM:180104]
,,,
RPA1,"replication protein A1, 70kDa ",17p13.3,
,,,mutations
,,,
RPA4,"replication protein A4, 30kDa ",Xq21.33,
,,,mutations
,,,
RPE65,retinal pigment epithelium-specific protein 65kDa ,1p31,
,,,Leber congenital amaurosis 2 [MIM:204100]
,,,Retinitis pigmentosa-20
,,,
RPGRIP1L,RPGRIP1-like ,16q12.2,
,,,Joubert syndrome 7 [MIM:611560]
,,,"Meckel syndrome, type 5 [MIM:611561]"
,,,COACH syndrome [MIM:216360]
,,,
RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1 ,14q11,
,,,Leber congenital amaurosis 6
,,,Cone-rod dystrophy 13 [MIM:608194]
,,,
RPGR,retinitis pigmentosa GTPase regulator ,Xp11.4,
,,,Retinitis pigmentosa-3 [MIM:300029]
,,,Cone-rod dystrophy-1 [MIM:304020]
,,,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness [MIM:300455]"
,,,"Macular degeneration, X-linked atrophic"
,,,
RPH3AL,rabphilin 3A-like (without C2 domains) ,17p13.3,
,,,mutations
,,,
RPIA,ribose 5-phosphate isomerase A ,2p11.2,
,,,Ribose 5-phosphate isomerase deficiency [MIM:608611]
,,,
RPL10,ribosomal protein L10 ,Xq28,
,,,mutations
,,,
RPL11,ribosomal protein L11 ,1p36.1-p35,
,,,Diamond-Blackfan anemia 7 [MIM:612562]
,,,
RPL21,ribosomal protein L21 ,13q,
,,,mutations
,,,
RPL35A,ribosomal protein L35a ,3q29-qter,
,,,Diamond-Blackfan anemia 5 [MIM:612528]
,,,
RPL36,ribosomal protein L36 ,5p15.3,
,,,mutations
,,,
RPL5,ribosomal protein L5 ,1p22.1,
,,,Diamond-Blackfan anemia 6 [MIM:612561]
,,,
RPN2,ribophorin II ,20q12-q13.1,
,,,mutations
,,,
RPS10,ribosomal protein S10 ,6p,
,,,Diamond-Blackfan anemia 9 [MIM:613308]
,,,
RPS14,ribosomal protein S14 ,5q32,
,,,"Macrocytic anemia, refractory, due to 5q deletion, somatic [MIM:153550]"
,,,
RPS15,ribosomal protein S15 ,19p,
,,,mutations
,,,
RPS17,ribosomal protein S17 ,15q,
,,,Diamond-Blackfan anemia 4 [MIM:612527]
,,,
RPS19,ribosomal protein S19 ,19q13.2,
,,,Diamond-Blackfan anemia 1 [MIM:105650]
,,,
RPS24,ribosomal protein S24 ,10q22-q23,
,,,Diamond-blackfan anemia [MIM:610629]
,,,
RPS26,ribosomal protein S26 ,12q,
,,,Diamond-Blackfan anemia 10 [MIM:613309]
,,,
RPS27A,ribosomal protein S27a ,?,
,,,mutations
,,,
RPS3,ribosomal protein S3 ,11q13.3-q13.5,
,,,mutations
,,,
RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3 ",Xp22.2-p22.1,
,,,Coffin-Lowry syndrome [MIM:303600]
,,,"Mental retardation, X-linked nonspecific, type 19"
,,,
RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1 ",17q23.1,
,,,mutations
,,,
RPS6KL1,ribosomal protein S6 kinase-like 1 ,?,
,,,mutations
,,,
RPS7,ribosomal protein S7 ,2p25,
,,,Diamond-Blackfan anemia 8 [MIM:612563]
,,,
RPSA,ribosomal protein SA ,3p21.3,
,,,Arrhythmogenic right ventricular dysplasia 5 [MIM:604400]
,,,
RPY,"Retinitis pigmentosa, Y-linked ",Y,
,,,"Retinitis pigmentosa, Y-linked"
,,,
RRAS2,related RAS viral (r-ras) oncogene homolog 2 ,11pter-p15.5,
,,,Ovarian carcinoma
,,,
RRDX,Radial ray deficiency ,Xq24-q25,
,,,Radial ray deficiency
,,,
RRH,retinal pigment epithelium-derived rhodopsin homolog ,4q,
,,,mutations
,,,
RRIS,Respiratory rhythmicity in sleep ,10q26,
,,,Respiratory rhythmicity in sleep
,,,
RRM1,ribonucleotide reductase M1 ,11p15.5,
,,,mutations
,,,
RRM2B,ribonucleotide reductase M2 B (TP53 inducible) ,8q23.1,
,,,Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) [MIM:612075]
,,,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5 [MIM:613077]"
,,,Mitochondrial DNA depletion syndrome 8B (MNGIE type) [MIM:612075]
,,,
RRP1B,ribosomal RNA processing 1 homolog B (S. cerevisiae) ,?,
,,,mutations
,,,
RS1,retinoschisin 1 ,?,
,,,"retinoschisis,juvenile form characterized by schisis or splitting of the nerve fiber and ganglion cell layers of the retina causing progressive blindness in males. Excluding the sporadic senile form"
,,,
RSCIS,"Radiation sensitivity/chromosome instability syndrome, autosomal dominant ",14q11.2,
,,,"Radiation sensitivity/chromosome instability syndrome, autosomal dominant"
,,,
RSPH4A,radial spoke head 4 homolog A (Chlamydomonas) ,6q22.1,
,,,"Ciliary dyskinesia, primary, 11 [MIM:612649]"
,,,
RSPH9,radial spoke head 9 homolog (Chlamydomonas) ,6p21.1,
,,,"Ciliary dyskinesia, primary, 12 [MIM:612650]"
,,,
RSPO1,R-spondin 1 ,1p34.3,
,,,Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal [MIM:610644]
,,,Palmoplantar hyperkeratosis and true hermaphroditism [MIM:610644]
,,,
RSPO4,R-spondin 4 ,20p13,
,,,Anonychia congenita [MIM:206800]
,,,
RSRC1,arginine/serine-rich coiled-coil 1 ,3q25.32,
,,,mutations
,,,
RSS,Russell Silver syndrome ,11p15.5,
,,,Beckwith-Wiedemann syndrome [MIM:130650]
,,,Silver-Russell syndrome [MIM:180860]
,,,Wilms tumor 2 [MIM:194071]
,,,
RSTSS,Chromosome 16p13.3 deletion syndrome ,16p13.3,
,,,Chromosome 16p13.3 deletion syndrome
,,,
RTN2,reticulon 2 ,19q13.3,
,,,mutations
,,,
RTN4R,reticulon 4 receptor ,22q11,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,
RUNX1,runt-related transcription factor 1 ,21q22.3,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,"Platelet disorder, familial, with associated myeloid malignancy [MIM:601399]"
,,,
RUNX2,runt-related transcription factor 2 ,6p21,
,,,Cleidocranial dysplasia [MIM:119600]
,,,"Dental anomalies, isolated"
,,,
RUNX3,runt-related transcription factor 3 ,1p36,
,,,mutations
,,,
RUVBL1,RuvB-like 1 (E. coli) ,3q21,
,,,mutations
,,,
RWS,Ragweed sensitivity ,6p21.3,
,,,Ragweed sensitivity
,,,
RXFP2,relaxin/insulin-like family peptide receptor 2 ,13q13.1,
,,,"Cryptorchidism, bilateral [MIM:219050]"
,,,
RXRG,"retinoid X receptor, gamma ",1q22-q23,
,,,mutations
,,,
RYK,receptor-like tyrosine kinase ,?,
,,,mutations
,,,
RYR1,ryanodine receptor 1 (skeletal) ,19q13.1,
,,,Malignant hyperthermia susceptibility 1 [MIM:145600]
,,,Central core disease [MIM:117000]
,,,Minicore myopathy with external ophthalmoplegia [MIM:255320]
,,,"Neuromuscular disease, congenital, with uniform type 1 fiber [MIM:117000]"
,,,
RYR2,ryanodine receptor 2 (cardiac) ,1q42.1-q43,
,,,"Ventricular tachycardia, catecholaminergic polymorphic, 1 [MIM:604772]"
,,,Arrhythmogenic right ventricular dysplasia 2 [MIM:600996]
,,,
RYR3,ryanodine receptor 3 ,15q14-q15,
,,,mutations
,,,
S100A14,S100 calcium binding protein A14 ,1q21,
,,,mutations
,,,
S100B,S100 calcium binding protein B ,21q22.2-q22.3,
,,,mutations
,,,
S11,surface antigen (X-linked) 2 ,Xq26-q27,
,,,"Mental retardation, X-linked, Shashi type"
,,,
S12,surface antigen (X-linked) 3 ,Xp11,
,,,"Mental retardation, X-linked, syndromic 12"
,,,
S1PR1,sphingosine-1-phosphate receptor 1 ,1p21,
,,,mutations
,,,
SAA1,serum amyloid A1 ,11p15.1,
,,,mutations
,,,
SAA2,serum amyloid A2 ,11p15.1,
,,,mutations
,,,
SACS,spastic ataxia of Charlevoix-Saguenay (sacsin) ,13q12,
,,,"Spastic ataxia, Charlevoix-Saguenay type [MIM:270550]"
,,,
SAGE1,sarcoma antigen 1 ,Xq28,
,,,mutations
,,,
SAG,S-antigen; retina and pineal gland (arrestin) ,2q37.1,
,,,Oguchi disease-1 [MIM:258100]
,,,Retinitis pigmentosa-47
,,,
SALL1,sal-like 1 (Drosophila) ,16q12.1,
,,,Townes-Brocks syndrome [MIM:107480]
,,,Townes-Brocks branchiootorenal-like syndrome [MIM:107480]
,,,
SALL4,sal-like 4 (Drosophila) ,20q13.13-q13.2,
,,,Duane-radial ray syndrome [MIM:607323]
,,,IVIC syndrome [MIM:147750]
,,,
SAMD9,sterile alpha motif domain containing 9 ,7q21,
,,,"Tumoral calcinosis, familial, normophosphatemic [MIM:610455]"
,,,
SAMHD1,SAM domain and HD domain 1 ,20q11.2,
,,,Aicardi-Goutieres syndrome 5 [MIM:612952]
,,,
SAR1B,SAR1 homolog B (S. cerevisiae) ,5q31.1,
,,,Chylomicron retention disease [MIM:246700]
,,,
SARDH,sarcosine dehydrogenase ,9q33-q34,
,,,Sarcosinemia [MIM:268900]
,,,
SARS2,"seryl-tRNA synthetase 2, mitochondrial ",19q13.2,
,,,mutations
,,,
SART1,squamous cell carcinoma antigen recognized by T cells ,11,
,,,mutations
,,,
SART3,squamous cell carcinoma antigen recognized by T cells 3 ,12q24.1,
,,,"Porokeratosis, disseminated superficial actinic, 1 [MIM:175900]"
,,,
SAT1,spermidine/spermine N1-acetyltransferase 1 ,Xp22.1,
,,,Keratosis follicularis spinulosa decalvans [MIM:308800]
,,,
SATB2,SATB homeobox 2 ,2q33,
,,,Cleft palate and mental retardation [MIM:119540]
,,,
SATL1,spermidine/spermine N1-acetyl transferase-like 1 ,?,
,,,mutations
,,,
SAX1,spastic ataxia 1 (autosomal dominant) ,12p13,
,,,"Spastic ataxia 1, autosomal dominant"
,,,
SAX2,spastic ataxia 2 (autosomal recessive) ,17p13,
,,,"Ataxia, spastic 2, autosomal recessive"
,,,
SBDS,Shwachman-Bodian-Diamond syndrome ,7q11,
,,,Shwachman-Bodian-Diamond syndrome [MIM:260400]
,,,
SBF2,SET binding factor 2 ,11p15,
,,,"Charcot-Marie-Tooth disease, type 4B2 [MIM:604563]"
,,,
SBNO1,strawberry notch homolog 1 (Drosophila) ,?,
,,,mutations
,,,
SC5DL,"sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like ",11q23.3,
,,,Lathosterolosis [MIM:607330]
,,,
SCA18,spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy) ,7q22-q32,
,,,Spinal cerebellar ataxia 18
,,,
SCA19,spinocerebellar ataxia 19 ,1p21-q21,
,,,Spinocerebellar ataxia 19
,,,
SCA20,spinocerebellar ataxia 20 ,11p13-q11,
,,,Spinocerebellar ataxia 20
,,,
SCA21,spinocerebellar ataxia 21 ,7p21.3-p15.1,
,,,Spinocerebellar ataxia 21
,,,
SCA25,spinocerebellar ataxia 25 ,2p21-p13,
,,,Spinocerebellar ataxia 25
,,,
SCA26,spinocerebellar ataxia 26 ,19p13.3,
,,,Spinocerebellar ataxia 26
,,,
SCA29,spinocerebellar ataxia 29 ,3p26,
,,,Spinocerebellar ataxia 29
,,,
SCA30,spinocerebellar ataxia 30 ,4q34.3-q35.1,
,,,Spinocerebellar ataxia 30
,,,
SCAP,SREBF chaperone ,3p21.31,
,,,mutations
,,,
SCAR2,"spinocerebellar ataxia, autosomal recessive 2 ",9q34-qter,
,,,"Spinocerebellar ataxia, autosomal recessive 2"
,,,
SCAR3,"spinocerebellar ataxia, autosomal recessive 3 ",6p23-p21,
,,,"Spinocerebellar ataxia, autosomal recessive 3"
,,,
SCAR6,"spinocerebellar ataxia, autosomal recessive 6 ",20q11-q13,
,,,"Spinocerebellar ataxia, autosomal recessive 6"
,,,
SCAR7,"spinocerebellar ataxia, autosomal recessive 7 ",11p15,
,,,"Spinocerebellar ataxia, autosomal recessive 7"
,,,
SCARB1,"scavenger receptor class B, member 1 ",12q24.31,
,,,High density lipoprotien cholesterol level QTL6 [MIM:610762]
,,,
SCARB2,"scavenger receptor class B, member 2 ",4q13-q21,
,,,Action myoclonus-renal failure syndrome [MIM:254900]
,,,
SCARF2,"scavenger receptor class F, member 2 ",22q11,
,,,mutations
,,,
SCASI,spinocerebellar ataxia with saccadic intrusions ,1p36,
,,,"Spinocerebellar ataxia, autosomal recessive 4"
,,,
SCAX1,"spinocerebellar ataxia, X-linked 1 ",Xp11.21-q21.3,
,,,"Spinocerebellar ataxia, X-linked 1"
,,,
SCAX5,"Spinocerebellar ataxia, X-linked 5 ",Xq25-q27.1,
,,,"Spinocerebellar ataxia, X-linked 5"
,,,
SCG2,secretogranin II ,2q35-q36,
,,,mutations
,,,
SCG3,secretogranin III ,15q21.3,
,,,mutations
,,,
SCGB1A1,"secretoglobin, family 1A, member 1 (uteroglobin) ",11q12.3-q13.1,
,,,"Asthma, susceptibility to [MIM:600807]"
,,,
SCGB1D2,"secretoglobin, family 1D, member 2 ",?,
,,,mutations
,,,
SCGB3A2,"secretoglobin, family 3A, member 2 ",5q31-q34,
,,,"Asthma, susceptibility to [MIM:600807]"
,,,
SCKL2,Seckel syndrome 2 ,18p11.31-q11.2,
,,,Seckel syndrome 2
,,,
SCKL3,Seckel syndrome 3 ,14q21-q22,
,,,Seckel syndrome 3
,,,
SCLC1,small cell cancer of the lung ,3p23-p21,
,,,Small-cell cancer of lung
,,,
SCLL,Chromosome 8p11 myeloproliferative syndrome ,8p11,
,,,Chromosome 8p11 myeloproliferative syndrome
,,,
SCN10A,"sodium channel, voltage-gated, type X, alpha subunit ",3p24.2-p22,
,,,mutations
,,,
SCN1A,"sodium channel, voltage-gated, type I, alpha subunit ",2q24,
,,,"Epilepsy, generalized, with febrile seizures plus, type 2 [MIM:604233]"
,,,Dravet syndrome [MIM:607208]
,,,"Migraine, familial hemiplegic, 3 [MIM:609634]"
,,,"Febrile convulsions, familial, 3A [MIM:604403]"
,,,
SCN1B,"sodium channel, voltage-gated, type I, beta subunit ",19q13.1,
,,,Generalized epilepsy with febrile seizures plus [MIM:604233]
,,,Brugada syndrome 5 [MIM:612838]
,,,"Cardiac conduction defect, nonspecific [MIM:612838]"
,,,
SCN2A,"sodium channel, voltage-gated, type II, alpha subunit ",2q23-q24.3,
,,,"Seizures, benign familial infantile, 3 [MIM:607745]"
,,,"Epileptic encephalopathy, early infantile, 11 [MIM:613721]"
,,,
SCN2B,"sodium channel, voltage-gated, type II, beta subunit ",11q23,
,,,mutations
,,,
SCN3A,"sodium channel, voltage-gated, type III, alpha subunit ",2q24,
,,,mutations
,,,
SCN3B,"sodium channel, voltage-gated, type III, beta subunit ",11q23.3,
,,,Brugada syndrome 7 [MIM:613120]
,,,
SCN4A,"sodium channel, voltage-gated, type IV, alpha subunit ",17q23.1-q25.3,
,,,"Hyperkalemic periodic paralysis, type 2 [MIM:613345]"
,,,Paramyotonia congenita [MIM:168300]
,,,"Myotonia congenita, atypical, acetazolamide-responsive [MIM:608390]"
,,,"Cramps, familial, potassium-aggravated"
,,,Myasthenic syndrome
,,,
SCN4B,"sodium channel, voltage-gated, type IV, beta subunit ",11q23,
,,,Long QT syndrome-10 [MIM:611819]
,,,
SCN5A,"sodium channel, voltage-gated, type V, alpha subunit ",3p21,
,,,Long QT syndrome-3 [MIM:603830]
,,,Brugada syndrome 1 [MIM:601144]
,,,"Heart block, progressive, type IA [MIM:113900]"
,,,"Heart block, nonprogressive [MIM:113900]"
,,,"Ventricular fibrillation, familial, 1 [MIM:603829]"
,,,Sick sinus syndrome 1 [MIM:608567]
,,,"Cardiomyopathy, dilated, 1E [MIM:601154]"
,,,"Sudden infant death syndrome, susceptibility to [MIM:272120]"
,,,
SCN8A,"sodium channel, voltage gated, type VIII, alpha subunit ",12q13,
,,,"Cerebellar atrophy, ataxia, and mental retardation"
,,,
SCN9A,"sodium channel, voltage-gated, type IX, alpha subunit ",2q24,
,,,"Erythermalgia, primary [MIM:133020]"
,,,"Insensitivity to pain, channelopathy-associated [MIM:243000]"
,,,Paroxysmal extreme pain disorder [MIM:167400]
,,,"Febrile convulsions, familial, 3B [MIM:604403]"
,,,
SCNN1A,"sodium channel, non-voltage-gated 1 alpha subunit ",12p13,
,,,"Pseudohypoaldosteronism, type I [MIM:264350]"
,,,Bronchiectasis with or without elevated sweat chloride 2 [MIM:613021]
,,,
SCNN1B,"sodium channel, non-voltage-gated 1, beta subunit ",16p13-p12,
,,,Liddle syndrome [MIM:177200]
,,,"Pseudohypoaldosteronism, type I [MIM:264350]"
,,,Bronchiectasis with or without elevated sweat chloride 1 [MIM:211400]
,,,
SCNN1G,"sodium channel, non-voltage-gated 1, gamma subunit ",16p13-p12,
,,,Liddle syndrome [MIM:177200]
,,,"Pseudohypoaldosteronism, type I [MIM:264350]"
,,,Bronchiectasis with or without elevated sweat chloride 3 [MIM:613071]
,,,
SCO1,SCO cytochrome oxidase deficient homolog 1 (yeast) ,17p13-p12,
,,,"Hepatic failure, early onset, and neurologic disorder"
,,,
SCO2,SCO cytochrome oxidase deficient homolog 2 (yeast) ,22q13,
,,,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency [MIM:604377]"
,,,
SCP2,sterol carrier protein 2 ,1p32,
,,,Leukoencephalopathy with dystonia and motor neuropathy [MIM:613724]
,,,
SCRIB,scribbled homolog (Drosophila) ,8,
,,,mutations
,,,
SCT,secretin ,11p15.5,
,,,mutations
,,,
SCUBE2,"signal peptide, CUB domain, EGF-like 2 ",11p15.5,
,,,mutations
,,,
SCZD10,schizophrenia disorder 10 (periodic catatonia) ,15q15,
,,,Schizophrenia [MIM:181500]
,,,
SCZD11,"Schizophrenia susceptibility locus, chromosome 10q-related ",10q22.3,
,,,Schizophrenia [MIM:181500]
,,,
SCZD12,schizophrenia 12 ,1p36.2,
,,,Schizophrenia 12 [MIM:181500]
,,,
SCZD13,schizophrenia 13 ,15q13,
,,,"Schizophrenia, susceptibility to, 13"
,,,
SCZD14,"schizophrenia, susceptibility to, 14 ",2q32.1,
,,,"Schizophrenia, susceptibility to, 14"
,,,
SCZD1,schizophrenia disorder 1 ,5q23-q35,
,,,Schizophrenia [MIM:181500]
,,,
SCZD2,schizophrenia disorder 2 ,11q14-q21,
,,,Schizophrenia [MIM:181500]
,,,
SCZD3,schizophrenia disorder 3 ,6p23,
,,,Schizophrenia [MIM:181500]
,,,
SCZD4,schizophrenia disorder 4 ,22q11.2,
,,,"Hyperprolinemia, type I [MIM:239500]"
,,,"Schizophrenia, susceptibility to, 4 [MIM:600850]"
,,,
SCZD5,schizophrenia disorder 5 ,6q13-q26,
,,,Schizophrenia [MIM:181500]
,,,
SCZD6,schizophrenia disorder 6 ,8p21,
,,,Schizophrenia [MIM:181500]
,,,
SCZD7,schizophrenia disorder 7 ,13q32,
,,,Schizophrenia [MIM:181500]
,,,
SCZD8,schizophrenia disorder 8 ,18p,
,,,Schizophrenia [MIM:181500]
,,,
SDC3,syndecan 3 ,1pter-p22.3,
,,,"Obesity, association with [MIM:601665]"
,,,
SDCCAG8,serologically defined colon cancer antigen 8 ,1q43-q44,
,,,mutations
,,,
SDHAF1,succinate dehydrogenase complex assembly factor 1 ,19q12-q13.2,
,,,Mitochondrial complex II deficiency [MIM:252011]
,,,
SDHAF2,succinate dehydrogenase complex assembly factor 2 ,11q13.1,
,,,Paragangliomas 2 [MIM:601650]
,,,
SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp) ",5p15,
,,,Leigh syndrome [MIM:256000]
,,,Mitochondrial respiratory chain complex II deficiency [MIM:252011]
,,,"Cardiomyopathy, dilated, 1GG [MIM:613642]"
,,,
SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip) ",1p36.1-p35,
,,,"Paraganglioma, familial chromaffin, 4 [MIM:115310]"
,,,Pheochromocytoma [MIM:171300]
,,,Paraganglioma and gastric stromal sarcoma [MIM:606864]
,,,Cowden-like syndrome [MIM:612359]
,,,
SDHC,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa ",1q21,
,,,"Paragangliomas, familial nonchromaffin, 3 [MIM:605373]"
,,,Paraganglioma and gastric stromal sarcoma [MIM:606864]
,,,
SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein ",11q23,
,,,"Paragangliomas, familial nonchromaffin, 1, with or without deafness [MIM:168000]"
,,,Pheochromocytoma [MIM:171300]
,,,"Carcinoid tumors, intestinal [MIM:114900]"
,,,"Merkel cell carcinoma, somatic"
,,,Paraganglioma and gastric stromal sarcoma [MIM:606864]
,,,Cowden-like syndrome [MIM:612359]
,,,
SDTY1,"Syndactyly, type I ",2q34-q36,
,,,"Syndactyly, type 1"
,,,
SEA,S13 erythroblastosis oncogene homolog (avian) ,11q13,
,,,mutations
,,,
SEC23A,Sec23 homolog A (S. cerevisiae) ,14q21.1,
,,,Craniolenticulosutural dysplasia [MIM:607812]
,,,
SEC23B,Sec23 homolog B (S. cerevisiae) ,20p11.2,
,,,"Anemia, dyserythropoietic congenital, type II [MIM:224100]"
,,,
SEC63,SEC63 homolog (S. cerevisiae) ,6q21,
,,,Polycystic liver disease [MIM:174050]
,,,
SECISBP2,SECIS binding protein 2 ,9q22.2,
,,,"Thyroid hormone metabolism, abnormal [MIM:609698]"
,,,
SEL1L,sel-1 suppressor of lin-12-like (C. elegans) ,14q31,
,,,mutations
,,,
SELE,selectin E ,1q23-q25,
,,,"IgA nephropathy, susceptibility to [MIM:161950]"
,,,"Atherosclerosis, susceptibility to"
,,,Blood pressure regulation QTL [MIM:145500]
,,,
SELL,selectin L ,1q23-q25,
,,,IgA nephropathy susceptibility to [MIM:161950]
,,,
SELPLG,selectin P ligand ,12q24,
,,,mutations
,,,
SELP,"selectin P (granule membrane protein 140kDa, antigen CD62) ",1q23-q25,
,,,Platelet alpha/delta storage pool deficiency
,,,"Atopy, susceptibility to [MIM:147050]"
,,,
SEMA3A,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A ",?,
,,,mutations
,,,
SEMA3E,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E ",7q21.11,
,,,CHARGE syndrome [MIM:214800]
,,,
SEMA4A,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A ",1q22,
,,,Retinitis pigmentosa-35 [MIM:610282]
,,,Cone-rod dystrophy 10 [MIM:610283]
,,,
SEMA4C,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C ",?,
,,,mutations
,,,
SEMA4G,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G ",?,
,,,mutations
,,,
SEMA6D,"sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D ",?,
,,,mutations
,,,
SEMA7A,"semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) ",15q22.2-q23,
,,,"Blood group, John-Milton-Hagen"
,,,
SEMG1,semenogelin I ,20q12-q13.1,
,,,mutations
,,,
SEN2,senescence (cellular)-related 2 ,3p25.1,
,,,Pontocerebellar hypoplasia type 2B [MIM:612389]
,,,
Sep-15,15 kDa selenoprotein ,1p31,
,,,mutations
,,,
SEPN1,"selenoprotein N, 1 ",1p36-p35,
,,,"Muscular dystrophy, rigid spine, 1 [MIM:602771]"
,,,
SEPP1,"selenoprotein P, plasma, 1 ",5p11,
,,,mutations
,,,
SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase ,4p15.2,
,,,mutations
,,,
Sep-12,septin 12 ,16p13.3,
,,,mutations
,,,
Sep-09,septin 9 ,17q25,
,,,"Leukemia, acute myeloid, therapy-related"
,,,Ovarian carcinoma
,,,"Amyotrophy, hereditary neuralgic [MIM:162100]"
,,,
SERPINA10,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 ",14q32.1,
,,,"Venous thrombosis, susceptibility to"
,,,
SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 ",14q32.1,
,,,Emphysema due to AAT deficiency [MIM:613490]
,,,"Emphysema-cirrhosis, due to AAT deficiency [MIM:613490]"
,,,Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh [MIM:613490]
,,,"Pulmonary disease, chronic obstructive, susceptibility to [MIM:606963]"
,,,
SERPINA3,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 ",14q32.1,
,,,Alpha-1-antichymotrypsin deficiency
,,,"Cerebrovascular disease, occlusive"
,,,
SERPINA6,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 ",14q32.1,
,,,Corticosteroid-binding globulin deficiency [MIM:611489]
,,,
SERPINA7,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 ",Xq22.2,
,,,Thyroxine-binding globulin deficiency
,,,
SERPINB11,"serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene) ",?,
,,,mutations
,,,
SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3 ",18q21.3,
,,,mutations
,,,
SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5 ",18q21.3,
,,,mutations
,,,
SERPINB6,"serpin peptidase inhibitor, clade B (ovalbumin), member 6 ",6p25,
,,,"Deafness, autosomal recessive 91 [MIM:613453]"
,,,
SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1 ",1q23-q25,
,,,Antithrombin III deficiency [MIM:613118]
,,,
SERPIND1,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1 ",22q11,
,,,Thrombophilia due to heparin cofactor II deficiency [MIM:612356]
,,,
SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 ",7q21.3-q22,
,,,"Plasminogen activator inhibitor, type I [MIM:613329]"
,,,"Transcription of plasminogen activator inhibitor, modulator of"
,,,
SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 ",17p13.3,
,,,mutations
,,,
SERPINF2,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 ",17pter-p12,
,,,Alpha-2-plasmin inhibitor deficiency [MIM:262850]
,,,
SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 ",11q11-q13.1,
,,,"Angioedema, hereditary, types I and II [MIM:106100]"
,,,"Complement component 4, partial deficiency of [MIM:120790]"
,,,
SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) ",11q13.5,
,,,"Preterm premature rupture of the membranes, susceptibility to [MIM:610504]"
,,,
SERPINI1,"serpin peptidase inhibitor, clade I (neuroserpin), member 1 ",3q26,
,,,"Encephalopathy, familial, with neuroserpin inclusion bodies [MIM:604218]"
,,,
SERPINI2,"serpin peptidase inhibitor, clade I (pancpin), member 2 ",3q26.1-q26.2,
,,,mutations
,,,
SERTAD1,SERTA domain containing 1 ,?,
,,,mutations
,,,
SESN2,sestrin 2 ,1p35.3,
,,,mutations
,,,
SETBP1,SET binding protein 1 ,18q21.1,
,,,"Leukemia, acute T-cell lymphoblastic"
,,,Schinzel-Giedion midface retraction syndrome [MIM:269150]
,,,
SETD2,SET domain containing 2 ,3p21.3-p21.2,
,,,mutations
,,,
SETD8,SET domain containing (lysine methyltransferase) 8 ,?,
,,,mutations
,,,
SETDB2,"SET domain, bifurcated 2 ",13q14,
,,,mutations
,,,
SETX,senataxin ,9q34,
,,,Ataxia-ocular apraxia-2 [MIM:606002]
,,,"Amyotrophic lateral sclerosis 4, juvenile [MIM:602433]"
,,,
SET,SET nuclear oncogene ,9q34,
,,,acute undifferentiated leukemia (AUL);see also CAN
,,,
SEZ6L2,seizure related 6 homolog (mouse)-like 2 ,?,
,,,mutations
,,,
SEZ6,seizure related 6 homolog (mouse) ,?,
,,,mutations
,,,
SF3B4,"splicing factor 3b, subunit 4, 49kDa ",1q12-q21,
,,,mutations
,,,
SFTPA1,surfactant protein A1 ,10q22.2-q23.1,
,,,"Pulmonary fibrosis, idiopathic, susceptibility to [MIM:178500]"
,,,
SFTPA2,surfactant protein A2 ,10q22-q23,
,,,"Pulmonary fibrosis, idiopathic [MIM:178500]"
,,,
SFTPB,surfactant protein B ,2p12-p11.2,
,,,"Surfactant metabolism dysfunction, pulmonary, 1 [MIM:265120]"
,,,
SFTPC,surfactant protein C ,8p21,
,,,"Surfactant metabolism dysfunction, pulmonary, 2 [MIM:610913]"
,,,
SFTPD,surfactant protein D ,10q23.3,
,,,mutations
,,,
SF,Stoltzfus blood group ,4q28-q31,
,,,"Blood group, Stoltzfus system"
,,,
SGCA,"sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) ",17q12-q21.33,
,,,"Muscular dystrophy, limb-girdle, type 2D [MIM:608099]"
,,,"Adhalinopathy, primary"
,,,
SGCB,"sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) ",4q12,
,,,"Muscular dystrophy, limb-girdle, type 2E [MIM:604286]"
,,,
SGCD,"sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) ",5q33,
,,,"Muscular dystrophy, limb-girdle, type 2F [MIM:601287]"
,,,"Cardiomyopathy, dilated, 1L [MIM:606685]"
,,,
SGCE,"sarcoglycan, epsilon ",7q21,
,,,"Dystonia-11, myoclonic [MIM:159900]"
,,,
SGCG,"sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) ",13q12,
,,,"Muscular dystrophy, limb-girdle, type 2C [MIM:253700]"
,,,
SGK110,putative uncharacterized serine/threonine-protein kinase SgK110-like ,?,
,,,mutations
,,,
SGK1,serum/glucocorticoid regulated kinase 1 ,6q23,
,,,mutations
,,,
SGSH,N-sulfoglucosamine sulfohydrolase ,17q25.3,
,,,Mucopolysaccharidisis type IIIA (Sanfilippo A) [MIM:252900]
,,,
SH2B1,SH2B adaptor protein 1 ,?,
,,,mutations
,,,
SH2B3,SH2B adaptor protein 3 ,12q24,
,,,mutations
,,,
SH2D1A,SH2 domain containing 1A ,Xq25,
,,,"Lymphoproliferative syndrome, X-linked [MIM:308240]"
,,,
SH3BP2,SH3-domain binding protein 2 ,4p16.3,
,,,Cherubism [MIM:118400]
,,,
SH3GL1,SH3-domain GRB2-like 1 ,19p13.3,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
SH3PXD2B,SH3 and PX domains 2B ,5q35.1,
,,,Frank-ter Haar syndrome [MIM:249420]
,,,
SH3TC2,SH3 domain and tetratricopeptide repeats 2 ,5q32,
,,,"Charcot-Marie-Tooth disease, type 4C [MIM:601596]"
,,,"Mononeuropathy of the median nerve, mild [MIM:613353]"
,,,
SHANK2,SH3 and multiple ankyrin repeat domains 2 ,11q13.3-q13.4,
,,,Autism susceptibility 17 [MIM:613436]
,,,
SHANK3,SH3 and multiple ankyrin repeat domains 3 ,22q13.3,
,,,Chromosome 22q13.3 deletion syndrome [MIM:606232]
,,,"Autism, chromosome 22q13.3 deletion syndrome-related"
,,,
SHBG,sex hormone-binding globulin ,17p13-p12,
,,,mutations
,,,
SHEP11,"Skin/hair/eye pigmentation 11, blue/nonblue eyes ",9p23,
,,,"Skin/hair/eye pigmentation 11, blue/nonblue eyes"
,,,
SHEP8,"Skin/hair/eye pigmentation 8, freckling ",6p25.3,
,,,"Skin/hair/eye pigmentation 8, freckling"
,,,
SHFL1,Split-hand/foot malformation with long bone deficiency 1 ,1q42.2-q43,
,,,Split-hand/foot malformation with long bone deficiency 1
,,,
SHFLD2,Split-hand/foot malformation with long deficiency 2 ,6q14.1,
,,,Split-hand/foot malformation with long deficiency 2
,,,
SHFLD3,Split-hand/foot malformation with long bone deficiency 3 ,17p13.3-p13.1,
,,,Split-hand/foot malformation with long bone deficiency 3
,,,
SHFM1,split hand/foot malformation (ectrodactyly) type 1 ,7q21.2-q21.3,
,,,Split hand/foot malformation 1
,,,
SHFM2,split hand/foot malformation (ectrodactyly) type 2 ,Xq26,
,,,Split hand/foot malformation 2
,,,
SHFM3,Split-hand/foot malformation 3 ,10q24,
,,,"Split-hand/foot malformation 3, gene duplication syndrome"
,,,
SHFM5,split hand/foot malformation (ectrodactyly) type 5 ,2q31,
,,,Split-hand/foot malformation 5
,,,
SHH,sonic hedgehog ,7q36,
,,,Holoprosencephaly-3 [MIM:142945]
,,,Solitary median maxillary central incisor [MIM:147250]
,,,"Coloboma, ocular [MIM:120200]"
,,,Microphthalmia with coloboma 5 [MIM:611638]
,,,
SHMT1,serine hydroxymethyltransferase 1 (soluble) ,17p11.2,
,,,mutations
,,,
SHOC2,soc-2 suppressor of clear homolog (C. elegans) ,10q25,
,,,Noonan-like syndrome with loose anagen hair [MIM:607721]
,,,
SHOX,short stature homeobox ,Xpter-p22.32,
,,,"Short stature, idiopathic familial [MIM:300582]"
,,,Leri-Weill dyschondrosteosis [MIM:127300]
,,,Langer mesomelic dysplasia [MIM:249700]
,,,
SHROOM3,shroom family member 3 ,4q21.1,
,,,mutations
,,,
SHROOM4,shroom family member 4 ,Xp11.2,
,,,Stocco dos Santos X-linked mental retardation syndrome [MIM:300434]
,,,
SIAE,sialic acid acetylesterase ,11q24,
,,,"Autoimmune disease, susceptibility to, 6 [MIM:613551]"
,,,
SIGLEC12,sialic acid binding Ig-like lectin 12 (gene/pseudogene) ,19q13.4,
,,,mutations
,,,
SIGLEC14,sialic acid binding Ig-like lectin 14 ,?,
,,,mutations
,,,
SIGLEC16,sialic acid binding Ig-like lectin 16 (gene/pseudogene) ,?,
,,,mutations
,,,
SIGMAR1,sigma non-opioid intracellular receptor 1 ,9p13,
,,,mutations
,,,
SIL1,"SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae) ",5q31,
,,,Marinesco-Sjogren syndrome [MIM:248800]
,,,
SIM1,single-minded homolog 1 (Drosophila) ,6q16.3-q21,
,,,"Obesity, severe [MIM:601665]"
,,,
SIPA1,signal-induced proliferation-associated 1 ,11q13.3,
,,,"Metastasis efficiency, modification of"
,,,
SIRT1,sirtuin 1 ,10q21.3,
,,,mutations
,,,
SIRT3,sirtuin 3 ,11p15.5,
,,,mutations
,,,
SIRT5,sirtuin 5 ,6p23,
,,,mutations
,,,
SIX1,SIX homeobox 1 ,14q23,
,,,Brachiootic syndrome 3 [MIM:608389]
,,,"Deafness, autosomal dominant 23 [MIM:605192]"
,,,
SIX2,SIX homeobox 2 ,2p16-p15,
,,,mutations
,,,
SIX3,SIX homeobox 3 ,2p21,
,,,Holoprosencephaly-2 [MIM:157170]
,,,
SIX5,SIX homeobox 5 ,19q13.3,
,,,Branchiootorenal syndrome 2 [MIM:610896]
,,,
SIX6,SIX homeobox 6 ,14q23,
,,,Microphthalmia with cataract 2 [MIM:212550]
,,,
SI,sucrase-isomaltase (alpha-glucosidase) ,3q25-q26,
,,,"Sucrase-isomaltase deficiency, congenital [MIM:222900]"
,,,
SKIV2L,superkiller viralicidic activity 2-like (S. cerevisiae) ,6p21,
,,,mutations
,,,
SKI,v-ski sarcoma viral oncogene homolog (avian) ,1p36.3,
,,,mutations
,,,
SLBP,stem-loop binding protein ,4p16.3,
,,,mutations
,,,
SLC10A1,"solute carrier family 10 (sodium/bile acid cotransporter family), member 1 ",14q24.1,
,,,mutations
,,,
SLC10A2,"solute carrier family 10 (sodium/bile acid cotransporter family), member 2 ",13q33,
,,,"Bile acid malabsorption, primary [MIM:613291]"
,,,
SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 ",2q35,
,,,"Mycobacterium tuberculosis, susceptibility to infection by [MIM:607948]"
,,,"Buruli ulcer, susceptibility to [MIM:610446]"
,,,
SLC11A2,"solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 ",12q13,
,,,"Anemia, hypochromic microcytic [MIM:206100]"
,,,
SLC12A1,"solute carrier family 12 (sodium/potassium/chloride transporters), member 1 ",15q15-q21.1,
,,,"Bartter syndrome, type 1 [MIM:601678]"
,,,
SLC12A3,"solute carrier family 12 (sodium/chloride transporters), member 3 ",16q13,
,,,Gitelman syndrome [MIM:263800]
,,,
SLC12A6,"solute carrier family 12 (potassium/chloride transporters), member 6 ",15q13-q14,
,,,Agenesis of the corpus callosum with peripheral neuropathy [MIM:218000]
,,,
SLC13A2,"solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 ",17p11.1-q11.1,
,,,mutations
,,,
SLC14A1,"solute carrier family 14 (urea transporter), member 1 (Kidd blood group) ",?,
,,,mutations
,,,
SLC14A2,"solute carrier family 14 (urea transporter), member 2 ",18q12.1-q21.1,
,,,mutations
,,,
SLC15A1,"solute carrier family 15 (oligopeptide transporter), member 1 ",13q33-q34,
,,,mutations
,,,
SLC16A12,"solute carrier family 16, member 12 (monocarboxylic acid transporter 12) ",10q23.3,
,,,"Cataract, juvenile, with microcornea and glucosuria [MIM:612018]"
,,,
SLC16A1,"solute carrier family 16, member 1 (monocarboxylic acid transporter 1) ",1p13.2-p12,
,,,Erythrocyte lactate transporter defect [MIM:245340]
,,,"Hyperinsulinemic hypoglycemia, familial, 7 [MIM:610021]"
,,,
SLC16A2,"solute carrier family 16, member 2 (thyroid hormone transporter) ",Xq13.2,
,,,Allan-Herndon-Dudley syndrome [MIM:300523]
,,,
SLC16A3,"solute carrier family 16, member 3 (monocarboxylic acid transporter 4) ",?,
,,,mutations
,,,
SLC17A1,"solute carrier family 17 (sodium phosphate), member 1 ",6p23-p21.3,
,,,mutations
,,,
SLC17A3,"solute carrier family 17 (sodium phosphate), member 3 ",6p21.3,
,,,Glycogen storage disease Ic [MIM:232240]
,,,
SLC17A5,"solute carrier family 17 (anion/sugar transporter), member 5 ",6q14-q15,
,,,Salla disease [MIM:604369]
,,,"Sialic acid storage disorder, infantile [MIM:269920]"
,,,
SLC17A8,"solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 ",12q23,
,,,"Deafness, autosomal dominant 25 [MIM:605583]"
,,,
SLC18A1,"solute carrier family 18 (vesicular monoamine), member 1 ",8p21.3,
,,,mutations
,,,
SLC19A1,"solute carrier family 19 (folate transporter), member 1 ",21q22.3,
,,,mutations
,,,
SLC19A2,"solute carrier family 19 (thiamine transporter), member 2 ",1q23.3,
,,,Thiamine-responsive megaloblastic anemia syndrome [MIM:249270]
,,,
SLC19A3,"solute carrier family 19, member 3 ",2q36.3,
,,,"Basal ganglia disease, biotin-responsive [MIM:607483]"
,,,"Encephalopathy, thiamine-responsive"
,,,
SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 ",9p24,
,,,Dicarboxylicaminoaciduria [MIM:222730]
,,,
SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2 ",11p13-p12,
,,,mutations
,,,
SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3 ",5p13,
,,,"Episodic ataxia, type 6 [MIM:612656]"
,,,
SLC20A2,"solute carrier family 20 (phosphate transporter), member 2 ",8p12-q12,
,,,mutations
,,,
SLC22A11,"solute carrier family 22 (organic anion/urate transporter), member 11 ",11q13,
,,,mutations
,,,
SLC22A12,"solute carrier family 22 (organic anion/urate transporter), member 12 ",11q13,
,,,"Hypouricemia, renal [MIM:220150]"
,,,
SLC22A14,"solute carrier family 22, member 14 ",?,
,,,mutations
,,,
SLC22A18,"solute carrier family 22, member 18 ",11p15.5,
,,,Breast cancer [MIM:114480]
,,,Rhabdomyosarcoma [MIM:268210]
,,,Lung cancer [MIM:211980]
,,,
SLC22A1,"solute carrier family 22 (organic cation transporter), member 1 ",6q26,
,,,mutations
,,,
SLC22A2,"solute carrier family 22 (organic cation transporter), member 2 ",6q26,
,,,mutations
,,,
SLC22A3,"solute carrier family 22 (extraneuronal monoamine transporter), member 3 ",6q27,
,,,mutations
,,,
SLC22A4,"solute carrier family 22 (organic cation/ergothioneine transporter), member 4 ",5q31,
,,,"Rheumatoid arthritis, susceptibility to [MIM:180300]"
,,,
SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5 ",5q31.1,
,,,"Carnitine deficiency, systemic primary [MIM:212140]"
,,,
SLC22A6,"solute carrier family 22 (organic anion transporter), member 6 ",11q13.1-q13.2,
,,,mutations
,,,
SLC22A9,"solute carrier family 22 (organic anion transporter), member 9 ",?,
,,,mutations
,,,
SLC23A1,"solute carrier family 23 (nucleobase transporters), member 1 ",5q31.2-q31.3,
,,,mutations
,,,
SLC24A1,"solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 ",15q22,
,,,mutations
,,,
SLC24A2,"solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 ",9p22,
,,,mutations
,,,
SLC24A4,"solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 ",14q32,
,,,"Skin/hair/eye pigmentation 6, blond/brown hair [MIM:210750]"
,,,"Skin/hair/eye pigmentation 6, blue/green eyes [MIM:210750]"
,,,
SLC24A5,"solute carrier family 24, member 5 ",15q21.1,
,,,"Skin/hair/eye pigmentation 4, fair/dark skin [MIM:113750]"
,,,
SLC25A12,"solute carrier family 25 (aspartate/glutamate carrier), member 12 ",2q24,
,,,"Hypomyelination, global cerebral [MIM:612949]"
,,,
SLC25A13,"solute carrier family 25 (aspartate/glutamate carrier), member 13 ",7q21.3,
,,,"Citrullinemia, adult-onset type II [MIM:603471]"
,,,"Citrullinemia, type II, neonatal-onset [MIM:605814]"
,,,
SLC25A15,solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 ,13q14,
,,,Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome [MIM:238970]
,,,
SLC25A19,"solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 ",17q25.3,
,,,"Microcephaly, Amish type [MIM:607196]"
,,,
SLC25A20,"solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 ",3p21.31,
,,,Carnitine-acylcarnitine translocase deficiency [MIM:212138]
,,,
SLC25A22,"solute carrier family 25 (mitochondrial carrier: glutamate), member 22 ",11p15.5,
,,,"Epileptic encephalopathy, early infantile, 3 [MIM:609304]"
,,,
SLC25A38,"solute carrier family 25, member 38 ",3p22.1,
,,,"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive [MIM:205950]"
,,,
SLC25A39,"solute carrier family 25, member 39 ",17q12,
,,,mutations
,,,
SLC25A3,"solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 ",12q23,
,,,Micochondrial phosphate carrier deficiency [MIM:610773]
,,,
SLC25A4,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 ",4q35,
,,,Progressive external ophthalmoplegia with mitochondrial DNA deletions 3 [MIM:609283]
,,,"Cardiomyopathy, familial hypertrophic [MIM:192600]"
,,,
SLC26A10,"solute carrier family 26, member 10 ",?,
,,,mutations
,,,
SLC26A1,"solute carrier family 26 (sulfate transporter), member 1 ",?,
,,,mutations
,,,
SLC26A2,"solute carrier family 26 (sulfate transporter), member 2 ",5q32-q33.1,
,,,Diastrophic dysplasia [MIM:222600]
,,,Atelosteogenesis II [MIM:256050]
,,,Achondrogenesis Ib [MIM:600972]
,,,"Epiphyseal dysplasia, multiple, 4 [MIM:226900]"
,,,"Diastrophic dysplasia, broad bone-platyspondylic variant [MIM:222600]"
,,,De la Chapelle dysplasia [MIM:256050]
,,,
SLC26A3,"solute carrier family 26, member 3 ",7q22-q31.1,
,,,Colon cancer
,,,"Chloride diarrhea, congenital, Finnish type [MIM:214700]"
,,,
SLC26A4,"solute carrier family 26, member 4 ",7q31,
,,,Pendred syndrome [MIM:274600]
,,,Enlarged vestibular aqueduct [MIM:600791]
,,,
SLC26A5,"solute carrier family 26, member 5 (prestin) ",7q22.1,
,,,"Deafness, autosomal recessive 61"
,,,
SLC26A6,"solute carrier family 26, member 6 ",3p21.3,
,,,mutations
,,,
SLC26A9,"solute carrier family 26, member 9 ",?,
,,,mutations
,,,
SLC27A4,"solute carrier family 27 (fatty acid transporter), member 4 ",9q34,
,,,Ichthyosis prematurity syndrome [MIM:608649]
,,,
SLC27A5,"solute carrier family 27 (fatty acid transporter), member 5 ",19q13.43,
,,,mutations
,,,
SLC28A1,"solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 ",15q25-q26,
,,,mutations
,,,
SLC28A2,"solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 ",15q15,
,,,mutations
,,,
SLC28A3,"solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 ",9q22.2,
,,,mutations
,,,
SLC29A1,"solute carrier family 29 (nucleoside transporters), member 1 ",6p21.2-p21.1,
,,,mutations
,,,
SLC29A2,"solute carrier family 29 (nucleoside transporters), member 2 ",11q13,
,,,mutations
,,,
SLC29A3,"solute carrier family 29 (nucleoside transporters), member 3 ",10q22.1,
,,,"Hyperpigmentation, cutaneous, with hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, and hypogonadism [MIM:612391]"
,,,
SLC29A4,"solute carrier family 29 (nucleoside transporters), member 4 ",?,
,,,mutations
,,,
SLC2A10,"solute carrier family 2 (facilitated glucose transporter), member 10 ",20q13.1,
,,,Arterial tortuosity syndrome [MIM:208050]
,,,
SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1 ",1p35-p31.3,
,,,GLUT1 deficiency syndrome 1 [MIM:606777]
,,,GLUT1 deficiency syndrome 2 [MIM:612126]
,,,
SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2 ",3q26.1-q26.3,
,,,"Diabetes mellitus, noninsulin-dependent"
,,,Fanconi-Bickel syndrome [MIM:227810]
,,,
SLC2A4,"solute carrier family 2 (facilitated glucose transporter), member 4 ",17p13,
,,,"Diabetes mellitus, noninsulin-dependent [MIM:125853]"
,,,
SLC2A9,"solute carrier family 2 (facilitated glucose transporter), member 9 ",4p16-p15.3,
,,,"Uric acid concentration, serum, QTL 2 [MIM:612076]"
,,,"Hypouricemia, renal, 2 [MIM:612076]"
,,,
SLC30A10,"solute carrier family 30, member 10 ",1q41,
,,,mutations
,,,
SLC30A2,"solute carrier family 30 (zinc transporter), member 2 ",1p36.11,
,,,mutations
,,,
SLC30A5,"solute carrier family 30 (zinc transporter), member 5 ",5q11.2,
,,,mutations
,,,
SLC30A8,"solute carrier family 30 (zinc transporter), member 8 ",8q24.11,
,,,"Diabetes mellitus, noninsulin-dependent, susceptibility to [MIM:125853]"
,,,
SLC31A1,"solute carrier family 31 (copper transporters), member 1 ",9q31-q32,
,,,mutations
,,,
SLC33A1,"solute carrier family 33 (acetyl-CoA transporter), member 1 ",3q25.31,
,,,Spastic paraplegia-42 [MIM:612539]
,,,
SLC34A1,"solute carrier family 34 (sodium phosphate), member 1 ",5q35,
,,,"Nephrolithiasis/osteoporosis, hypophosphatemic, 1 [MIM:612286]"
,,,Fanconi renotubular syndrome 2 [MIM:613388]
,,,
SLC34A2,"solute carrier family 34 (sodium phosphate), member 2 ",4p15.31-p15.2,
,,,Pulmonary alveolar microlithiasis [MIM:265100]
,,,Testicular microlithiasis [MIM:610441]
,,,
SLC34A3,"solute carrier family 34 (sodium phosphate), member 3 ",9q34,
,,,Hypophosphatemic rickets with hypercalciuria [MIM:241530]
,,,
SLC35A1,"solute carrier family 35 (CMP-sialic acid transporter), member A1 ",6q15,
,,,"Congenital disorder of glycosylation, type IIf [MIM:603585]"
,,,
SLC35C1,"solute carrier family 35, member C1 ",11p11.2,
,,,"Congenital disorder of glycosylation, type IIc [MIM:266265]"
,,,
SLC35D1,"solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 ",1p32-p31,
,,,Schneckenbecken dysplasia [MIM:269250]
,,,
SLC36A2,"solute carrier family 36 (proton/amino acid symporter), member 2 ",5q33.1,
,,,"Iminoglycinuria, digenic [MIM:242600]"
,,,Hyperglycinuria [MIM:138500]
,,,
SLC37A4,"solute carrier family 37 (glucose-6-phosphate transporter), member 4 ",11q23,
,,,Glycogen storage disease Ib [MIM:232220]
,,,Glycogen storage disease Ic [MIM:232240]
,,,
SLC39A13,"solute carrier family 39 (zinc transporter), member 13 ",11p11.2,
,,,"Spondylocheirodysplasia, Ehlers-Danlos syndrome-like [MIM:612350]"
,,,
SLC39A4,"solute carrier family 39 (zinc transporter), member 4 ",8q24.3,
,,,Acrodermatitis enteropathica [MIM:201100]
,,,
SLC3A1,"solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 ",2p16.3,
,,,Cystinuria [MIM:220100]
,,,
SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1 ",2q32,
,,,"Hemochromatosis, type 4 [MIM:606069]"
,,,
SLC41A1,"solute carrier family 41, member 1 ",1q31-q32,
,,,mutations
,,,
SLC44A2,"solute carrier family 44, member 2 ",19p13.1,
,,,mutations
,,,
SLC45A2,"solute carrier family 45, member 2 ",5p13.3,
,,,"Oculocutaneous albinism, type IV [MIM:606574]"
,,,"Skin/hair/eye pigmentation 5, black/nonblack hair [MIM:227240]"
,,,"Skin/hair/eye pigmentation 5, dark/fair skin [MIM:227240]"
,,,"Skin/hair/eye pigmentation 5, dark/light eyes [MIM:227240]"
,,,
SLC46A1,"solute carrier family 46 (folate transporter), member 1 ",17q11.1,
,,,"Folate malabsorption, hereditary [MIM:229050]"
,,,
SLC47A1,"solute carrier family 47, member 1 ",17p11.2,
,,,mutations
,,,
SLC47A2,"solute carrier family 47, member 2 ",17p11.2,
,,,mutations
,,,
SLC4A10,"solute carrier family 4, sodium bicarbonate transporter, member 10 ",2q23-q24,
,,,mutations
,,,
SLC4A11,"solute carrier family 4, sodium borate transporter, member 11 ",20p13-p12,
,,,Corneal endothelial dystrophy 2 [MIM:217700]
,,,Corneal endothelial dystrophy and perceptive deafness [MIM:217400]
,,,"Corneal dystrophy, Fuchs endothelial, 4 [MIM:613268]"
,,,
SLC4A1,"solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) ",17q21-q22,
,,,Ovalocytosis
,,,"Spherocytosis, type 4 [MIM:612653]"
,,,"Malaria, resistance to [MIM:611162]"
,,,"Renal tubular acidosis, distal, AD [MIM:179800]"
,,,"Renal tubular acidosis, distal, AR [MIM:611590]"
,,,"Blood group, Diego [MIM:110500]"
,,,"Blood group, Waldner [MIM:112010]"
,,,"Blood group, Wright [MIM:112050]"
,,,"Blood group, Froese [MIM:601551]"
,,,"Blood group, Swann [MIM:601550]"
,,,
SLC4A3,"solute carrier family 4, anion exchanger, member 3 ",2q36,
,,,mutations
,,,
SLC4A4,"solute carrier family 4, sodium bicarbonate cotransporter, member 4 ",4q21,
,,,"Renal tubular acidosis, proximal, with ocular abnormalities [MIM:604278]"
,,,
SLC52A3,"solute carrier family 52, riboflavin transporter, member 3 ",20p13,
,,,Brown-Vialetto-Van Laere syndrome [MIM:211530]
,,,Fazio-Londe disease [MIM:211500]
,,,
SLC5A11,"solute carrier family 5 (sodium/glucose cotransporter), member 11 ",?,
,,,mutations
,,,
SLC5A1,"solute carrier family 5 (sodium/glucose cotransporter), member 1 ",22q13.1,
,,,Glucose/galactose malabsorption [MIM:606824]
,,,
SLC5A2,"solute carrier family 5 (sodium/glucose cotransporter), member 2 ",16p11.2,
,,,Renal glucosuria [MIM:233100]
,,,
SLC5A5,"solute carrier family 5 (sodium iodide symporter), member 5 ",19p13.2-p12,
,,,Thyroid dyshormonogenesis 1 [MIM:274400]
,,,
SLC5A7,"solute carrier family 5 (choline transporter), member 7 ",?,
,,,mutations
,,,
SLC6A11,"solute carrier family 6 (neurotransmitter transporter, GABA), member 11 ",3p25.3,
,,,mutations
,,,
SLC6A12,"solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 ",12p13,
,,,mutations
,,,
SLC6A13,"solute carrier family 6 (neurotransmitter transporter, GABA), member 13 ",?,
,,,mutations
,,,
SLC6A14,"solute carrier family 6 (amino acid transporter), member 14 ",Xq23-q24,
,,,"Obesity, susceptibility to, BMIQ11 [MIM:300306]"
,,,
SLC6A18,"solute carrier family 6, member 18 ",5p15.33,
,,,mutations
,,,
SLC6A19,"solute carrier family 6 (neutral amino acid transporter), member 19 ",5p15.33,
,,,Hartnup disorder [MIM:234500]
,,,"Iminoglycinuria, digenic [MIM:242600]"
,,,Hyperglycinuria [MIM:138500]
,,,
SLC6A1,"solute carrier family 6 (neurotransmitter transporter, GABA), member 1 ",3p25-p24,
,,,mutations
,,,
SLC6A20,"solute carrier family 6 (proline IMINO transporter), member 20 ",3p21.3,
,,,Hyperglycinuria [MIM:138500]
,,,"Iminoglycinuria, digenic [MIM:242600]"
,,,
SLC6A2,"solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ",16q12.2,
,,,Orthostatic intolerance [MIM:604715]
,,,
SLC6A3,"solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 ",5p15.3,
,,,"Attention-deficit hyperactivity disorder, susceptibility to [MIM:143465]"
,,,"Nicotine dependence, protection against [MIM:188890]"
,,,Major affective disorder [MIM:125480]
,,,"Parkinsonism-dystonia, infantile [MIM:613135]"
,,,
SLC6A4,"solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 ",17q11.1-q12,
,,,Anxiety-related personality traits [MIM:607834]
,,,Obsessive-compulsive disorder 1 [MIM:164230]
,,,
SLC6A5,"solute carrier family 6 (neurotransmitter transporter, glycine), member 5 ",11p15.2-p15.1,
,,,Hyperekplexia [MIM:149400]
,,,
SLC6A8,"solute carrier family 6 (neurotransmitter transporter, creatine), member 8 ",Xq28,
,,,"Creatine deficiency syndrome, X-linked [MIM:300352]"
,,,
SLC7A10,"solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 ",?,
,,,mutations
,,,
SLC7A1,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 ",13q12.3,
,,,mutations
,,,
SLC7A2,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 ",8p22,
,,,mutations
,,,
SLC7A5,"solute carrier family 7 (amino acid transporter light chain, L system), member 5 ",16q24.3,
,,,mutations
,,,
SLC7A7,"solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 ",14q11.2,
,,,Lysinuric protein intolerance [MIM:222700]
,,,
SLC7A9,"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9 ",19q13.1,
,,,Cystinuria [MIM:220100]
,,,
SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1 ",2p23-p22,
,,,mutations
,,,
SLC9A3R1,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 ",17q25.1,
,,,"Nephrolithiasis/osteoporosis, hypophosphatemic, 2 [MIM:612287]"
,,,
SLC9A6,"solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 ",Xq26.3,
,,,"Mental retardation, X-linked syndromic, Christianson type [MIM:300243]"
,,,
SLC9A9,"solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 ",3q24,
,,,Autism susceptibility 16 [MIM:613410]
,,,
SLCO1A2,"solute carrier organic anion transporter family, member 1A2 ",12p12,
,,,mutations
,,,
SLCO1B1,"solute carrier organic anion transporter family, member 1B1 ",12p12,
,,,mutations
,,,
SLCO1B3,"solute carrier organic anion transporter family, member 1B3 ",?,
,,,mutations
,,,
SLCO1C1,"solute carrier organic anion transporter family, member 1C1 ",12p12,
,,,mutations
,,,
SLCO2A1,"solute carrier organic anion transporter family, member 2A1 ",3q21,
,,,mutations
,,,
SLCO2B1,"solute carrier organic anion transporter family, member 2B1 ",11,
,,,mutations
,,,
SLEB12,"Systemic lupus erythematosus, susceptibility to, 12 ",8p23.1,
,,,"Systemic lupus erythematosus, susceptibility to, 12"
,,,
SLEB13,"Systemic lupus erythematosus, susceptibility to, 13 ",6q23,
,,,"Systemic lupus erythematosus, susceptibility to, 13"
,,,
SLEB14,"Systemic lupus erythematosus, susceptiblity to, 14 ",1q21-q23,
,,,"Systemic lupus erythematosus, susceptibility to, 14"
,,,
SLEB15,"Systemic lupus erthematosus, susceptibility to, 15 ",Xq28,
,,,"Systemic lupus erthematosus, susceptibility to, 15"
,,,
SLEB3,systemic lupus erythematosus susceptibility 3 ,4p16-p15.2,
,,,"Systemic lupus erythematosus, susceptibility to, 3 [MIM:152700]"
,,,
SLEB4,"systemic lupus erythematosus, susceptibility to, 4 ",12q24,
,,,"Systemic lupus erythematosus, susceptibility to, 4"
,,,
SLEB5,"Systemic lupus erythematosus, susceptibility to, 5 ",13q32,
,,,"Systemic lupus erythematosus, susceptibility to, 5"
,,,
SLEB7,"Systemic lupus erythematosus, susceptibility to, 7 ",20p12,
,,,"Systemic lupus erythematosus, susceptibility to, 7"
,,,
SLEB8,"Systemic lupus erythematosus, susceptibility to, 8 ",20q13,
,,,"Systemic lupus erythematosus, susceptibility to, 8"
,,,
SLEH1,systemic lupus erythematosus with hemolytic anemia 1 ,11q14,
,,,Systemic lupus erythematosus with hemolytic anemia [MIM:152700]
,,,
SLEN1,systemic lupus erythematosus with nephritis 1 ,10q22.3,
,,,"Systemic lupus erythematosus with nephritis, susceptibility to, 1"
,,,
SLEN2,systemic lupus erythematosus with nephritis 2 ,2q34-q35,
,,,"Systemic lupus erythematosus with nephritis, susceptibility to, 2"
,,,
SLEN3,systemic lupus erythematosus with nephritis 3 ,11p15.5,
,,,"Systemic lupus erythematosus with nephritis, susceptibility to, 3"
,,,
SLEV1,"systemic lupus erythematosus, vitiligo-related 1 ",17p13,
,,,Vitiligo-associated multiple autoimmune disease susceptibility 1 [MIM:606579]
,,,
SLFN5,schlafen family member 5 ,?,
,,,mutations
,,,
SLI1,"Specific language impairment QTL, 1 ",16q,
,,,"Specific language impairment QTL, 1"
,,,
SLI2,"Specific language impairment QTL, 2 ",19q,
,,,"Specific language impairment QTL, 2"
,,,
SLI3,"Specific language impairment QTL, 3 ",13q21,
,,,"Specific language impairment QTL, 3"
,,,
SLI4,Specific language impairment 4 ,7q35-q36,
,,,Specific language impairment 4
,,,
SLIT3,slit homolog 3 (Drosophila) ,5q35,
,,,mutations
,,,
SLITRK1,"SLIT and NTRK-like family, member 1 ",13q31,
,,,Tourette syndrome [MIM:137580]
,,,Trichotillomania [MIM:613229]
,,,
SLSN3,Senior-Loken syndrome 3 ,3q22,
,,,Senior-Loken syndrome 3
,,,
SLURP1,secreted LY6/PLAUR domain containing 1 ,8qter,
,,,Meleda disease [MIM:248300]
,,,
SLX4,SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) ,16p13.3,
,,,mutations
,,,
SM1,"Schistosoma mansoni, susceptibility/resistance to ",5q31-q33,
,,,"Schistosoma mansoni infection, susceptibility/resistance to"
,,,
SM2,Hepatic fibrosis susceptibility due to Schistosoma mansoni infection ,6q22-q23,
,,,Hepatic fibrosis susceptibility due to Schistosoma mansoni infection
,,,
SMAD1,SMAD family member 1 ,4q28,
,,,mutations
,,,
SMAD2,SMAD family member 2 ,18q21,
,,,mutations
,,,
SMAD3,SMAD family member 3 ,15q21-q22,
,,,mutations
,,,
SMAD4,SMAD family member 4 ,18q21.1,
,,,Pancreatic cancer
,,,"Polyposis, juvenile intestinal [MIM:174900]"
,,,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome [MIM:175050]
,,,
SMAD6,SMAD family member 6 ,15q21-q22,
,,,mutations
,,,
SMAD7,SMAD family member 7 ,18q21.1,
,,,"Colorectal cancer, susceptibility to, 3 [MIM:612229]"
,,,
SMAD9,SMAD family member 9 ,13q12-q14,
,,,"Pulmonary hypertension, primary [MIM:178600]"
,,,
SMALED,"Spinal muscular atrophy, lower extremity, autosomal dominant ",14q32,
,,,"Spinal muscular atrophy, lower extremity, autosomal dominant"
,,,
SMAL,"spinal muscular atrophy, congenital nonprogressive, of lower limbs ",12q23-q24,
,,,"Spinal muscular atrophy, congenital nonprogressive, of lower limbs"
,,,
SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 ",9p24-p23,
,,,mutations
,,,
SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 ",19p13.2,
,,,Rhabdoid tumor predisposition syndrome 2 [MIM:613325]
,,,
SMARCAD1,"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 ",4q22-q23,
,,,mutations
,,,
SMARCAL1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 ",2q34-q36,
,,,Schimke immunoosseous dysplasia [MIM:242900]
,,,
SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 ",22q11,
,,,Rhabdoid tumors
,,,Rhabdoid predisposition syndrome 1 [MIM:609322]
,,,
SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 ",?,
,,,mutations
,,,
SMAR,"Spinal muscular atrophy, chronic distal, autosomal recessive ",11q13,
,,,"Spinal muscular atrophy, chronic distal, autosomal recessive"
,,,
SMC1A,structural maintenance of chromosomes 1A ,Xp11.22-p11.21,
,,,Cornelia de Lange syndrome 2 [MIM:300590]
,,,
SMC1B,structural maintenance of chromosomes 1B ,?,
,,,mutations
,,,
SMC3,structural maintenance of chromosomes 3 ,10q25,
,,,Cornelia de Lange syndrome 3 [MIM:610759]
,,,
SMG1,"smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) ",16p12,
,,,mutations
,,,
SMN1,"survival of motor neuron 1, telomeric ",5q12.2-q13.3,
,,,Spinal muscular atrophy-1 [MIM:253300]
,,,Spinal muscular atrophy-2 [MIM:253550]
,,,Spinal muscular atrophy-3 [MIM:253400]
,,,Spinal muscular atrophy-4 [MIM:271150]
,,,
SMN2,"survival of motor neuron 2, centromeric ",5q12.2-q13.3,
,,,"Spinal muscular atrophy, type III, modifier of [MIM:253400]"
,,,
SMOC1,SPARC related modular calcium binding 1 ,14q24.1,
,,,mutations
,,,
SMOC2,SPARC related modular calcium binding 2 ,6q72,
,,,mutations
,,,
SMO,"smoothened, frizzled family receptor ",7q31-q32,
,,,"Basal cell carcinoma, somatic"
,,,
SMPD1,"sphingomyelin phosphodiesterase 1, acid lysosomal ",11p15.4-p15.1,
,,,"Niemann-Pick disease, type A [MIM:257200]"
,,,"Niemann-Pick disease, type B [MIM:607616]"
,,,
SMPX,"small muscle protein, X-linked ",Xp22.1,
,,,mutations
,,,
SMS,spermine synthase ,Xp22.1,
,,,"Mental retardation, X-linked, Snyder-Robinson type [MIM:309583]"
,,,
SMUG1,single-strand-selective monofunctional uracil-DNA glycosylase 1 ,12q,
,,,mutations
,,,
SMYD3,SET and MYND domain containing 3 ,?,
,,,mutations
,,,
SNAI2,snail homolog 2 (Drosophila) ,8q11,
,,,"Waardenburg syndrome, type 2D [MIM:608890]"
,,,Piebaldism [MIM:172800]
,,,
SNAP29,"synaptosomal-associated protein, 29kDa ",22q11.2,
,,,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome [MIM:609528]"
,,,
SNAPC4,"small nuclear RNA activating complex, polypeptide 4, 190kDa ",?,
,,,mutations
,,,
SNAPC5,"small nuclear RNA activating complex, polypeptide 5, 19kDa ",?,
,,,mutations
,,,
SNAX1,sensory ataxia 1 (autosomal dominant) ,8p12-q12.1,
,,,"Ataxia, sensory, autosomal dominant"
,,,
SNCAIP,"synuclein, alpha interacting protein ",5q23.1-q23.3,
,,,mutations
,,,
SNCA,"synuclein, alpha (non A4 component of amyloid precursor) ",4q21,
,,,Parkinson disease 4 [MIM:605543]
,,,"Dementia, Lewy body [MIM:127750]"
,,,Parkinson disease 1 [MIM:168601]
,,,
SNCB,"synuclein, beta ",5q35,
,,,"Dementia, Lewy body [MIM:127750]"
,,,
SNIP1,Smad nuclear interacting protein 1 ,1p32.3-p32.2,
,,,mutations
,,,
SNORD116@,"small nucleolar RNA, C/D box 116 cluster ",?,
,,,mutations
,,,
SNORD50A,"small nucleolar RNA, C/D box 50A ",6q15,
,,,mutations
,,,
SNRK,SNF related kinase ,3p21,
,,,mutations
,,,
SNRNP200,small nuclear ribonucleoprotein 200kDa (U5) ,2q11.2,
,,,Retinitis pigmentosa 33 [MIM:610359]
,,,
SNRPN,small nuclear ribonucleoprotein polypeptide N ,15q12,
,,,Prader-Willi syndrome [MIM:176270]
,,,
SNTA1,"syntrophin, alpha 1 ",20q11.2,
,,,Long QT syndrome 12 [MIM:612955]
,,,
SNTG2,"syntrophin, gamma 2 ",?,
,,,mutations
,,,
SNURF,SNRPN upstream reading frame ,?,
,,,mutations
,,,
SNX10,sorting nexin 10 ,?,
,,,mutations
,,,
SNX19,sorting nexin 19 ,?,
,,,mutations
,,,
SNX3,sorting nexin 3 ,6q21,
,,,mutations
,,,
SOBP,sine oculis binding protein homolog (Drosophila) ,6q21,
,,,"Mental retardation, anterior maxillary protrusion, and strabismus [MIM:613671]"
,,,
SOCS1,suppressor of cytokine signaling 1 ,16p13.2,
,,,mutations
,,,
SOCS3,suppressor of cytokine signaling 3 ,17q25.3,
,,,mutations
,,,
SOD1,"superoxide dismutase 1, soluble ",21q22.1,
,,,"Amyotrophic lateral sclerosis, due to SOD1 deficiency [MIM:105400]"
,,,
SOD2,"superoxide dismutase 2, mitochondrial ",6q25.3,
,,,Microvascular complications of diabetes 6 [MIM:612634]
,,,
SOD3,"superoxide dismutase 3, extracellular ",4p15.3-p15.1,
,,,"Superoxide dismutase, elevated extracellular"
,,,
SOHLH1,spermatogenesis and oogenesis specific basic helix-loop-helix 1 ,?,
,,,mutations
,,,
SORBS1,sorbin and SH3 domain containing 1 ,10q23.3-q24.1,
,,,mutations
,,,
SORCS1,sortilin-related VPS10 domain containing receptor 1 ,10q23.3,
,,,mutations
,,,
SORD,sorbitol dehydrogenase ,15q15.3,
,,,"Cataract, congenital"
,,,
SORL1,"sortilin-related receptor, L(DLR class) A repeats containing ",11q23.2-q24.2,
,,,"Alzheimer disease, pathogenesis, association with [MIM:104300]"
,,,
SORT1,sortilin 1 ,1p21.3-p13.1,
,,,Low density lipoprotein cholesterol level QTL6 [MIM:613589]
,,,
SOS1,son of sevenless homolog 1 (Drosophila) ,2p22-p21,
,,,"Fibromatosis, gingival [MIM:135300]"
,,,Noonan syndrome 4 [MIM:610733]
,,,
SOST,sclerostin ,17q12-q21,
,,,Sclerosteosis [MIM:269500]
,,,Van Buchem disease [MIM:239100]
,,,
SOX10,SRY (sex determining region Y)-box 10 ,22q13,
,,,"Waardenburg syndrome, type 4C [MIM:613266]"
,,,"Waardenburg syndrome, type 2E, with or without neurologic involvement [MIM:611584]"
,,,PCWH syndrome [MIM:609136]
,,,
SOX17,SRY (sex determining region Y)-box 17 ,8q12-q13,
,,,Vesicoureteral reflux 3 [MIM:613674]
,,,
SOX18,SRY (sex determining region Y)-box 18 ,20q13.33,
,,,Hypotrichosis-lymphedema-telangiectasia syndrome [MIM:607823]
,,,
SOX2,SRY (sex determining region Y)-box 2 ,3q26.3-q27,
,,,"Microphthalmia, syndromic 3 [MIM:206900]"
,,,Optic nerve hypoplasia and abnormalities of the central nervous system [MIM:206900]
,,,
SOX3,SRY (sex determining region Y)-box 3 ,Xq26.3,
,,,"Mental retardation, X-linked, with isolated growth hormone deficiency [MIM:300123]"
,,,"Panhypopituitarism, X-linked [MIM:312000]"
,,,
SOX5,SRY (sex determining region Y)-box 5 ,12p12.1,
,,,mutations
,,,
SOX6,SRY (sex determining region Y)-box 6 ,11p15.3-p15.2,
,,,mutations
,,,
SOX8,SRY (sex determining region Y)-box 8 ,16p13.3,
,,,mutations
,,,
SOX9,SRY (sex determining region Y)-box 9 ,17q24.3-q25.1,
,,,Campomelic dysplasia with autosomal sex reversal [MIM:114290]
,,,Acampomelic campomelic dysplasia [MIM:114290]
,,,Campomelic dysplasia [MIM:114290]
,,,
SP100,SP100 nuclear antigen ,2q37.1,
,,,mutations
,,,
SP110,SP110 nuclear body protein ,2q37.1,
,,,Hepatic venoocclusive disease with immunodeficiency [MIM:235550]
,,,"Mycobacterium tuberculosis, susceptibility to [MIM:607948]"
,,,
SP7,Sp7 transcription factor ,?,
,,,mutations
,,,
SP8,Sp8 transcription factor ,7p21,
,,,mutations
,,,
SPAG16,sperm associated antigen 16 ,2q34,
,,,mutations
,,,
SPAG17,sperm associated antigen 17 ,?,
,,,mutations
,,,
SPANXN5,"SPANX family, member N5 ",?,
,,,mutations
,,,
SPAST,spastin ,2p22-p21,
,,,Spastic paraplegia-4 [MIM:182601]
,,,
SPATA13,spermatogenesis associated 13 ,13q12.12,
,,,mutations
,,,
SPATA16,spermatogenesis associated 16 ,3q26.3,
,,,Globozoospermia [MIM:102530]
,,,
SPATA21,spermatogenesis associated 21 ,?,
,,,mutations
,,,
SPATA7,spermatogenesis associated 7 ,14q31.3,
,,,Leber congenital amaurosis 3 [MIM:604232]
,,,"Retinitis pigmentosa, juvenile, autosomal recessive [MIM:268000]"
,,,
SPAX3,"Ataxia, spastic, 3, autosomal recessive ",2q33-q34,
,,,"Ataxia, spastic, 3, autosomal recessive"
,,,
SPD3,Synpolydactyly 3 ,14q11.2-q12,
,,,Synpolydactyly 3
,,,
SPDA2,"Spondyloarthropathy, susceptibility to, 2 ",9q31-q34,
,,,"Spondyloarthropathy, susceptibility to, 2"
,,,
SPDA3,"Spondylarthropathy, susceptibility to, 3 ",2q36.1-q36.3,
,,,"Spondylarthropathy, susceptibility to, 3"
,,,
SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1-like ,?,
,,,mutations
,,,
SPG11,spastic paraplegia 11 (autosomal recessive) ,15q21.1,
,,,Spastic paraplegia-11 [MIM:604360]
,,,
SPG14,spastic paraplegia 14 (autosomal recessive) ,3q27-q28,
,,,"Spastic paraplegia 14, autosomal recessive"
,,,
SPG16,"spastic paraplegia 16 (complicated, X-linked recessive) ",Xq11.2,
,,,"Spastic paraplegia-16, X-linked, complicated"
,,,
SPG18,spastic paraplegia 18 (autosomal dominant) ,8p12-p11.21,
,,,Spastic paraplegia-18
,,,
SPG19,spastic paraplegia 19 (autosomal dominant) ,9q,
,,,Spastic paraplegia-19
,,,
SPG20,spastic paraplegia 20 (Troyer syndrome) ,13q12.3,
,,,Troyer syndrome [MIM:275900]
,,,
SPG21,"spastic paraplegia 21 (autosomal recessive, Mast syndrome) ",15q21-q22,
,,,Mast syndrome [MIM:248900]
,,,
SPG24,spastic paraplegia 24 (autosomal recessive) ,13q14,
,,,Spastic paraplegia 24
,,,
SPG25,"spastic paraplegia 25 (autosomal recessive, with disc herniation) ",6q23-q24.1,
,,,Spastic paraplegia 25
,,,
SPG26,spastic paraplegia 26 ,12p11.1-q14,
,,,Spastic paraplegia 26
,,,
SPG27,spastic paraplegia 27 (autosomal recessive) ,10q22.1-q24.1,
,,,Spastic paraplegia-27
,,,
SPG28,spastic paraplegia 28 (autosomal recessive) ,14q21.3-q22.3,
,,,Spastic paraplegia-28
,,,
SPG29,spastic paraplegia 29 (autosomal dominant) ,1p31.1-p21.1,
,,,Spastic paraplegia-29
,,,
SPG32,spastic paraplegia 32 (autosomal recessive) ,14q12-q21,
,,,Spastic paraplegia-32
,,,
SPG34,spastic paraplegia 34 (autosomal dominant) ,Xq24-q25,
,,,"Spastic paraplegia 34, X-linked"
,,,
SPG36,spastic paraplegia 36 (autosomal dominant) ,12q23-q24,
,,,Spastic paraplegia-36
,,,
SPG37,spastic paraplegia 37 (autosomal dominant) ,8p21.1-q13.3,
,,,Spastic paraplegia-37
,,,
SPG38,"spastic paraplegia 38 (autosomal dominant, Silver syndrome) ",4p16-p15,
,,,Spastic paraplegia-38
,,,
SPG41,spastic paraplegia 41 (autosomal dominant) ,11p14.1-p11.2,
,,,Spastic paraplegia 41
,,,
SPG45,spastic paraplegia 45 (autosomal recessive) ,10q24.3-q25.1,
,,,Spastic paraplegia 45
,,,
SPG7,spastic paraplegia 7 (pure and complicated autosomal recessive) ,16q24.3,
,,,Spastic paraplegia-7 [MIM:607259]
,,,
SPG9,spastic paraplegia 9 (autosomal dominant) ,10q23.3-q24.1,
,,,Spastic paraplegia-9
,,,
SPI1,spleen focus forming virus (SFFV) proviral integration oncogene spi1 ,11p11.2,
,,,mutations
,,,
SPINK1,"serine peptidase inhibitor, Kazal type 1 ",5q32,
,,,"Pancreatitis, hereditary [MIM:167800]"
,,,"Fibrocalculous pancreatic diabetes, susceptibility to"
,,,Tropical calcific pancreatitis [MIM:608189]
,,,
SPINK5,"serine peptidase inhibitor, Kazal type 5 ",5q32,
,,,Netherton syndrome [MIM:256500]
,,,Atopy [MIM:147050]
,,,
SPINT2,"serine peptidase inhibitor, Kunitz type, 2 ",19q13.1,
,,,"Diarrhea 3, secretory sodium, congenital, syndromic [MIM:270420]"
,,,
SPOAN,"spastic paraplegia, optic atrophy, and neuropathy ",11q13,
,,,"Spastic paraplegia, optic atrophy, and neuropathy"
,,,
SPP1,secreted phosphoprotein 1 ,4q21-q25,
,,,mutations
,,,
SPRED1,"sprouty-related, EVH1 domain containing 1 ",15q13.2,
,,,Legius syndrome [MIM:611431]
,,,
SPRN,shadow of prion protein homolog (zebrafish) ,10q26.3,
,,,mutations
,,,
SPRR3,small proline-rich protein 3 ,1q21-q22,
,,,mutations
,,,
SPRY2,sprouty homolog 2 (Drosophila) ,13q31.1,
,,,mutations
,,,
SPRY3,sprouty homolog 3 (Drosophila) ,Xq28,
,,,mutations
,,,
SPR,"sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) ",2p14-p12,
,,,"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency [MIM:612716]"
,,,
SPTA1,"spectrin, alpha, erythrocytic 1 (elliptocytosis 2) ",1q21,
,,,Elliptocytosis-2 [MIM:130600]
,,,Pyropoikilocytosis [MIM:266140]
,,,"Spherocytosis, type 3 [MIM:270970]"
,,,
SPTAN1,"spectrin, alpha, non-erythrocytic 1 ",9q33-q34,
,,,"Epileptic encephalopathy, early infantile, 5 [MIM:613477]"
,,,
SPTBN2,"spectrin, beta, non-erythrocytic 2 ",11q13,
,,,Spinocerebellar ataxia-5 [MIM:600224]
,,,
SPTBN5,"spectrin, beta, non-erythrocytic 5 ",15q21,
,,,mutations
,,,
SPTB,"spectrin, beta, erythrocytic ",14q22-q23.2,
,,,Elliptocytosis-3
,,,"Spherocytosis, type 2"
,,,"Anemia, neonatal hemolytic, fatal and near-fatal"
,,,
SPTLC1,"serine palmitoyltransferase, long chain base subunit 1 ",9q22.1-q22.3,
,,,"Neuropathy, hereditary sensory and autonomic, type 1 [MIM:162400]"
,,,
SPTLC2,"serine palmitoyltransferase, long chain base subunit 2 ",14q24.3-q31,
,,,"Neuropathy, hereditary sensory/autonomic, type IC [MIM:613640]"
,,,
SQSTM1,sequestosome 1 ,5q35,
,,,Paget disease of bone [MIM:602080]
,,,
SQTL1,Smoking as a quantitative trait locus 1 ,10q22,
,,,Smoking as a quantitative trait locus 1
,,,
SQTL2,Smoking as a quantitative trait locus 2 ,22q12,
,,,Smoking as a quantitative trait locus 2
,,,
SRCAP,Snf2-related CREBBP activator protein ,16p11.2,
,,,mutations
,,,
SRC,v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) ,20q12-q13,
,,,"Colon cancer, advanced"
,,,
SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) ",2p23,
,,,Pseudovaginal perineoscrotal hypospadias [MIM:264600]
,,,
SRD5A3,steroid 5 alpha-reductase 3 ,4q12,
,,,"Congenital disorder of glycosylation, type Iq [MIM:612379]"
,,,
SREBF1,sterol regulatory element binding transcription factor 1 ,17p11.2,
,,,mutations
,,,
SREBF2,sterol regulatory element binding transcription factor 2 ,22q13,
,,,mutations
,,,
SREK1,splicing regulatory glutamine/lysine-rich protein 1 ,5q11.2-q12.1,
,,,mutations
,,,
SRGAP2,SLIT-ROBO Rho GTPase activating protein 2 ,1q32.1,
,,,mutations
,,,
SRGAP3,SLIT-ROBO Rho GTPase activating protein 3 ,3p25,
,,,mutations
,,,
SRI,sorcin ,7q21.1,
,,,mutations
,,,
SRP72,signal recognition particle 72kDa ,4q11,
,,,mutations
,,,
SRPX2,"sushi-repeat containing protein, X-linked 2 ",Xq21.33-q23,
,,,"Rolandic epilepsy, mental retardation, and speech dyspraxia [MIM:300643]"
,,,
SRPX,"sushi-repeat containing protein, X-linked ",Xp21.1,
,,,mutations
,,,
SRR,serine racemase ,17p13.3,
,,,mutations
,,,
SRY,sex determining region Y ,Yp11.3,
,,,46XY complete gonadal dysgenesis [MIM:400044]
,,,46XX true true hermaphroditism [MIM:400045]
,,,
SS18,"synovial sarcoma translocation, chromosome 18 ",18q11.2,
,,,"Sarcoma, synovial"
,,,
SS3,"Sarcoidosis, susceptibility to, 3 ",10q22.3,
,,,"Sarcoidosis, susceptibility to, 3"
,,,
SSD,Speech-sound disorder ,3p12-q13,
,,,Speech-sound disorder
,,,
SSH1,slingshot homolog 1 (Drosophila) ,12,
,,,mutations
,,,
SSTR2,somatostatin receptor 2 ,17q24,
,,,mutations
,,,
SSTR5,somatostatin receptor 5 ,16p13.3,
,,,"Somatostatin analog, resistance to [MIM:102200]"
,,,
SST,somatostatin ,3q28,
,,,mutations
,,,
SSX2,"synovial sarcoma, X breakpoint 2 ",Xp11.2,
,,,"Sarcoma, synovial"
,,,
SSX4,"synovial sarcoma, X breakpoint 4 ",Xp11.2,
,,,"Sarcoma, synovial"
,,,
SSX7,"synovial sarcoma, X breakpoint 7 ",?,
,,,mutations
,,,
ST11,suppression of tumorigenicity 11 (pancreas) ,3p25,
,,,Pancreatic endocrine tumors
,,,
ST14,suppression of tumorigenicity 14 (colon carcinoma) ,11q24-q25,
,,,Ichthyosis with hypotrichosis [MIM:610765]
,,,
ST2,suppression of tumorigenicity 2 ,11p14.3-p12,
,,,mutations
,,,
ST3GAL3,"ST3 beta-galactoside alpha-2,3-sialyltransferase 3 ",1p34.1,
,,,mutations
,,,
ST3GAL5,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5 ",2p11.2,
,,,Amish infantile epilepsy syndrome [MIM:609056]
,,,
ST3,suppression of tumorigenicity 3 ,11q13,
,,,Cervical carcinoma
,,,
ST5,suppression of tumorigenicity 5 ,11p15,
,,,mutations
,,,
ST8SIA2,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 ",15q26,
,,,mutations
,,,
ST8,suppression of tumorigenicity 8 (ovarian) ,6q26-q27,
,,,"Ovarian cancer, serous"
,,,
STAR,steroidogenic acute regulatory protein ,8p11.2,
,,,Lipoid adrenal hyperplasia [MIM:201710]
,,,
STAT1,"signal transducer and activator of transcription 1, 91kDa ",2q32.2-q32.3,
,,,"Mycobacterial infection, atypical, familial disseminated [MIM:209950]"
,,,"STAT1 deficiency, complete"
,,,
STAT3,signal transducer and activator of transcription 3 (acute-phase response factor) ,17q21,
,,,Hyper-IgE recurrent infection syndrome [MIM:147060]
,,,
STAT4,signal transducer and activator of transcription 4 ,2q32.2-q32.3,
,,,"Rheumatoid arthritis, association with [MIM:180300]"
,,,"Systemic lupus erythematous, association with susceptibility to, 11 [MIM:612253]"
,,,
STAT5B,signal transducer and activator of transcription 5B ,17q11.2,
,,,"Leukemia, acute promyelocytic, STAT5B/RARA type"
,,,Growth hormone insensitivity with immunodeficiency [MIM:245590]
,,,
STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced ",12q13,
,,,mutations
,,,
STBMS1,"Strabismus, susceptibility to, 1 ",7p22.1,
,,,"Strabismus, susceptibility to, 1"
,,,
STEAP3,"STEAP family member 3, metalloreductase ",2q14.2,
,,,mutations
,,,
STEAP4,STEAP family member 4 ,7q21,
,,,mutations
,,,
STHAG5,"tooth agenesis, selective, 5 ",10q11.2-q21,
,,,"Tooth agenesis, selective, 5"
,,,
STH,saitohin ,17q21.1,
,,,mutations
,,,
STIL,SCL/TAL1 interrupting locus ,1p32,
,,,"Microcephaly, primary autosomal recessive, 7 [MIM:612703]"
,,,
STIM1,stromal interaction molecule 1 ,11p15.5,
,,,"Immune dysfunction, with T-cell inactivation due to calcium entry defect 2 [MIM:612783]"
,,,
STK10,serine/threonine kinase 10 ,5q35.1,
,,,mutations
,,,
STK11,serine/threonine kinase 11 ,19p13.3,
,,,Peutz-Jeghers syndrome [MIM:175200]
,,,"Melanoma, malignant sporadic"
,,,"Pancreatic cancer, sporadic"
,,,"Testicular tumor, sporadic [MIM:273300]"
,,,
STK19,serine/threonine kinase 19 ,6p21.3,
,,,mutations
,,,
STK32A,serine/threonine kinase 32A ,?,
,,,mutations
,,,
STK33,serine/threonine kinase 33 ,11p15.3,
,,,mutations
,,,
STK39,serine threonine kinase 39 ,2q24.3,
,,,mutations
,,,
STK4,serine/threonine kinase 4 ,20q11.2-q13.2,
,,,mutations
,,,
STMN1,stathmin 1 ,1p36.1-p35,
,,,mutations
,,,
STOM,stomatin ,9q34.1,
,,,Stomatocytosis I [MIM:185000]
,,,
STOX1,storkhead box 1 ,10q22.1,
,,,Preeclampsia/eclampsia 4
,,,
STQTL10,Stature QTL 10 ,3q23,
,,,Stature QTL 10
,,,
STQTL11,Stature QTL 11 ,7q21,
,,,Stature QTL 11
,,,
STQTL12,Stature QTL 12 ,4q31,
,,,Stature QTL 12
,,,
STQTL13,Stature QTL 13 ,4p15.3,
,,,Stature QTL 13
,,,
STQTL14,Stature QTL 14 ,20q11.22,
,,,Stature QTL 14
,,,
STQTL15,Stature QTL 15 ,8q21.13,
,,,Stature QTL 15
,,,
STQTL16,Stature QTL 16 ,15q22.32,
,,,Stature QTL 16
,,,
STQTL17,Stature QTL 17 ,7p15,
,,,Stature QTL 17
,,,
STQTL18,Stature QTL 18 ,6p22.1,
,,,Stature QTL 18
,,,
STQTL19,Stature QTL 19 ,6p21.31,
,,,Stature QTL 19
,,,
STQTL20,Stature QTL 20 ,13q14.3,
,,,Stature QTL 20
,,,
STQTL21,Stature QTL 21 ,2q37.1,
,,,Stature QTL 21
,,,
STQTL22,Stature QTL 22 ,16q24,
,,,Stature QTL 22
,,,
STQTL23,Stature QTL 23 ,1p32,
,,,Stature QTL 23
,,,
STQTL24,Stature QTL 24 ,2p16,
,,,Stature QTL 24
,,,
STQTL2,stature quantitative trait locus 2 ,7q31.3,
,,,Stature QTL 2
,,,
STQTL3,stature quantitative trait locus 3 ,12p11.2-q14,
,,,Stature QTL 3
,,,
STQTL4,stature quantitative trait locus 4 ,13q32-q33,
,,,Stature QTL 4
,,,
STQTL5,stature quantitative trait locus 5 ,3p26,
,,,Stature QTL 5
,,,
STQTL6,stature quantitative trait locus 6 ,Xq24-q25,
,,,Stature QTL 6
,,,
STQTL7,stature quantitative trait locus 7 ,1p21,
,,,Stature QTL 7
,,,
STQTL8,stature quantitative trait locus 8 ,9q22,
,,,Stature QTL 8
,,,
STRA6,stimulated by retinoic acid gene 6 homolog (mouse) ,15q24.1,
,,,"Microphthalmia, syndromic 9 [MIM:601186]"
,,,
STRADA,STE20-related kinase adaptor alpha ,17q23.3,
,,,"Polyhydramnios, megalencephaly, and symptomatic epilepsy [MIM:611087]"
,,,
STRC,stereocilin ,15q15,
,,,"Deafness, autosomal recessive 16 [MIM:603720]"
,,,
STS,"steroid sulfatase (microsomal), isozyme S ",Xp22.32,
,,,"Ichthyosis, X-linked [MIM:308100]"
,,,
STUT1,"Stuttering, familial persistent 1 ",18p11.3-p11.2,
,,,"Stuttering, familial persistent 1"
,,,
STUT2,"Stuttering, familial persistent 2 ",12q24.1,
,,,"Stuttering, familial persistent 2"
,,,
STX11,syntaxin 11 ,6q24,
,,,"Hemophagocytic lymphohistiocytosis, familial, 4 [MIM:603552]"
,,,
STX16,syntaxin 16 ,20q13.32,
,,,"Pseudohypoparathyroidism, type IB [MIM:603233]"
,,,
STX1A,syntaxin 1A (brain) ,7q11.2,
,,,mutations
,,,
STXBP1,syntaxin binding protein 1 ,9q34.1,
,,,"Epileptic encephalopathy, early infantile, 4 [MIM:612164]"
,,,
STXBP2,syntaxin binding protein 2 ,19p13.3-p13.2,
,,,"Hemophagocytic lymphohistiocytosis, familial, 5"
,,,
STXBP5,syntaxin binding protein 5 (tomosyn) ,6q24.3,
,,,mutations
,,,
SUCLA2,"succinate-CoA ligase, ADP-forming, beta subunit ",13q12.2-q13,
,,,Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with methylmalonic aciduria) [MIM:612073]
,,,
SUCLG1,"succinate-CoA ligase, alpha subunit ",2p11.2,
,,,Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) [MIM:245400]
,,,
SUFU,suppressor of fused homolog (Drosophila) ,10q24-q25,
,,,"Medulloblastoma, desmoplastic [MIM:155255]"
,,,
SULF1,sulfatase 1 ,8q13.3,
,,,mutations
,,,
SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 ",16p12.1-p11.2,
,,,mutations
,,,
SULT1A3,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 ",16p11.2,
,,,mutations
,,,
SULT1C2,"sulfotransferase family, cytosolic, 1C, member 2 ",2q11.1-q11.2,
,,,mutations
,,,
SULT1E1,"sulfotransferase family 1E, estrogen-preferring, member 1 ",4q13.1,
,,,mutations
,,,
SULT2A1,"sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 ",19q13.3,
,,,mutations
,,,
SULT2B1,"sulfotransferase family, cytosolic, 2B, member 1 ",19q13.3,
,,,mutations
,,,
SULT4A1,"sulfotransferase family 4A, member 1 ",22q13.2-q13.31,
,,,mutations
,,,
SUMF1,sulfatase modifying factor 1 ,3p26,
,,,Multiple sulfatase deficiency [MIM:272200]
,,,
SUMO1,SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) ,2q32.2-q33,
,,,Orofacial cleft 10 [MIM:613705]
,,,
SUMO4,SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae) ,6q25,
,,,"Diabetes mellitus, insulin-dependent, 5 [MIM:600320]"
,,,
SUN2,Sad1 and UNC84 domain containing 2 ,?,
,,,mutations
,,,
SUOX,sulfite oxidase ,12,
,,,Sulfite oxidase deficiency [MIM:272300]
,,,
SUPT16H,suppressor of Ty 16 homolog (S. cerevisiae) ,?,
,,,mutations
,,,
SURF1,surfeit 1 ,9q34,
,,,"Leigh syndrome, due to COX deficiency [MIM:256000]"
,,,
SUV420H1,suppressor of variegation 4-20 homolog 1 (Drosophila) ,11q13,
,,,mutations
,,,
SUZ12,suppressor of zeste 12 homolog (Drosophila) ,17q11.2,
,,,Endometrial stromal tumors
,,,
SV2B,synaptic vesicle glycoprotein 2B ,?,
,,,mutations
,,,
SXGQTL1,Sex hormone-binding blobulin circulating level QTL 1 ,17p13,
,,,Sex hormone-binding blobulin circulating level QTL 1
,,,
SXI2,"X inactivation, familial skewed, 2 ",Xq25-q26,
,,,"X inactivation, familial skewed, 2"
,,,
SYCP3,synaptonemal complex protein 3 ,12q23,
,,,Azoospermia due to perturbations of meiosis [MIM:270960]
,,,
SYN1,synapsin I ,Xp11.4-p11.2,
,,,"Epilepsy, X-linked, with variable learning disabilities and behavior disorders [MIM:300491]"
,,,
SYN2,synapsin II ,3p25,
,,,"Schizophrenia, susceptibility to [MIM:181500]"
,,,
SYN3,synapsin III ,22q12.3,
,,,mutations
,,,
SYNE1,"spectrin repeat containing, nuclear envelope 1 ",6q25,
,,,"Spinocerebellar ataxia, autosomal recessive 8 [MIM:610743]"
,,,Emery-Dreifuss muscular dystrophy 4 [MIM:612998]
,,,
SYNE2,"spectrin repeat containing, nuclear envelope 2 ",14q23,
,,,Emery-Dreifuss muscular dystrophy 5 [MIM:612999]
,,,
SYNGAP1,synaptic Ras GTPase activating protein 1 ,6p21.3,
,,,"Mental retardation, autosomal dominant 5 [MIM:612621]"
,,,
SYNGR1,synaptogyrin 1 ,22q13,
,,,mutations
,,,
SYNM,"synemin, intermediate filament protein ",15,
,,,mutations
,,,
SYNPO,synaptopodin ,5q33.1,
,,,mutations
,,,
SYNSTH,Synesthesia ,2q24.1,
,,,Synesthesia
,,,
SYP,synaptophysin ,Xp11.23-p11.22,
,,,"Mental retardation, X-linked, with or without epilepsy [MIM:300802]"
,,,
SYT11,synaptotagmin XI ,?,
,,,mutations
,,,
SYT14,synaptotagmin XIV ,1q32.2,
,,,mutations
,,,
SYT2,synaptotagmin II ,1q,
,,,mutations
,,,
SYTL3,synaptotagmin-like 3 ,?,
,,,mutations
,,,
SYTL5,synaptotagmin-like 5 ,?,
,,,mutations
,,,
TAAR9,trace amine associated receptor 9 (gene/pseudogene) ,6q23.2,
,,,mutations
,,,
TAB2,TGF-beta activated kinase 1/MAP3K7 binding protein 2 ,6q25,
,,,"Congenital heart disease, nonsyndromic, 2 [MIM:612863]"
,,,
TAC3,tachykinin 3 ,12q13-q21,
,,,Hypogonadotropic hypogonadism [MIM:146110]
,,,
TACC3,"transforming, acidic coiled-coil containing protein 3 ",4p16.3,
,,,Bladder cancer susceptibility [MIM:109800]
,,,
TACO1,translational activator of mitochondrially encoded cytochrome c oxidase I ,17q22-q24.2,
,,,mutations
,,,
TACR3,tachykinin receptor 3 ,4q25,
,,,Hypogonadotropic hypogonadism [MIM:146110]
,,,
TACSTD2,tumor-associated calcium signal transducer 2 ,1p32,
,,,"Corneal dystrophy, gelatinous drop-like [MIM:204870]"
,,,
TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa ",17q11.1-q11.2,
,,,"Chondrosarcoma, extraskeletal myxoid [MIM:612237]"
,,,
TAF1C,"TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa ",16q24,
,,,mutations
,,,
TAF1L,"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like ",?,
,,,mutations
,,,
TAF1,"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa ",Xq13,
,,,"Dystonia-Parkinsonism, X-linked [MIM:314250]"
,,,
TAF2,"TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa ",?,
,,,mutations
,,,
TAF7L,"TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa ",X,
,,,mutations
,,,
TAG,tumor antigen gene ,16p,
,,,Mucolipidosis III gamma [MIM:252605]
,,,
TAL1,T-cell acute lymphocytic leukemia 1 ,1p32,
,,,"Leukemia-1, T-cell acute lymphocytic"
,,,
TAL2,T-cell acute lymphocytic leukemia 2 ,9q31,
,,,"Leukemia-2, T-cell acute lymphoblastic"
,,,
TALDO1,transaldolase 1 ,11p15.5-p15.4,
,,,Transaldolase deficiency [MIM:606003]
,,,
TAM,"Myeloproliferative syndrome, transient (transient abnormal ",21q11.2,
,,,"Leukemia, transient, of Down syndrome"
,,,
TAP1,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) ",6p21.3,
,,,"Bare lymphocyte syndrome, type I [MIM:604571]"
,,,
TAP2,"transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) ",6p21.3,
,,,"Bare lymphocyte syndrome, type I, due to TAP2 deficiency [MIM:604571]"
,,,Wegener-like granulomatosis
,,,
TAPBP,TAP binding protein (tapasin) ,6p21.3,
,,,"Bare lymphocyte syndrome, type I [MIM:604571]"
,,,
TAPVR1,total anomalous pulmonary venous return 1 ,4q12,
,,,Total anomalous pulmonary venous return
,,,
TARDBP,TAR DNA binding protein ,1p36.2,
,,,"Amyotrophic lateral sclerosis 10, with or without FTD [MIM:612069]"
,,,"Frontotemporal lobar degeneration, TARDBP-related [MIM:612069]"
,,,
TAR,Thrombocytopenia-absent radius syndrome ,1q21.1,
,,,Thrombocytopenia-absent radius syndrome
,,,
TAS1R1,"taste receptor, type 1, member 1 ",1p36,
,,,mutations
,,,
TAS1R2,"taste receptor, type 1, member 2 ",1p36,
,,,mutations
,,,
TAS1R3,"taste receptor, type 1, member 3 ",1p36.33,
,,,mutations
,,,
TAS2R16,"taste receptor, type 2, member 16 ",7q31,
,,,Alcohol dependence [MIM:103780]
,,,
TAS2R19,"taste receptor, type 2, member 19 ",?,
,,,mutations
,,,
TAS2R31,"taste receptor, type 2, member 31 ",12p13.2,
,,,mutations
,,,
TAS2R38,"taste receptor, type 2, member 38 ",7q35-q36,
,,,Phenylthiocarbamide tasting [MIM:171200]
,,,
TAS2R3,"taste receptor, type 2, member 3 ",7q31.3-q32,
,,,mutations
,,,
TAS2R43,"taste receptor, type 2, member 43 ",12p13.2,
,,,mutations
,,,
TAS2R45,"taste receptor, type 2, member 45 ",?,
,,,mutations
,,,
TAS2R46,"taste receptor, type 2, member 46 ",12p13.2,
,,,mutations
,,,
TAS2R50,"taste receptor, type 2, member 50 ",12p13.2,
,,,mutations
,,,
TAS2R9,"taste receptor, type 2, member 9 ",12p13,
,,,mutations
,,,
TAT,tyrosine aminotransferase ,16q22.1-q22.3,
,,,"Tyrosinemia, type II [MIM:277660]"
,,,
TAZ,tafazzin ,Xq28,
,,,Endocardial fibroelastosis-2
,,,Barth syndrome [MIM:302060]
,,,"Cardiomyopathy, dilated, 3A [MIM:300069]"
,,,"Left ventricular noncompaction, X-linked [MIM:300183]"
,,,
TBC1D1,"TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 ",4p15.1-q21,
,,,mutations
,,,
TBC1D23,"TBC1 domain family, member 23 ",?,
,,,mutations
,,,
TBC1D24,"TBC1 domain family, member 24 ",16p13.3,
,,,"Myoclonic epilepsy, infantile, familial [MIM:605021]"
,,,
TBC1D4,"TBC1 domain family, member 4 ",13q22.2,
,,,mutations
,,,
TBCE,tubulin folding cofactor E ,1q42-q43,
,,,Kenny-Caffey syndrome-1 [MIM:244460]
,,,Hypoparathyroidism-retardation-dysmorphism syndrome [MIM:241410]
,,,
TBK1,TANK-binding kinase 1 ,?,
,,,mutations
,,,
TBL1XR1,transducin (beta)-like 1 X-linked receptor 1 ,?,
,,,mutations
,,,
TBL1X,transducin (beta)-like 1X-linked ,Xp22.3,
,,,mutations
,,,
TBL1Y,"transducin (beta)-like 1, Y-linked ",Yp11.2,
,,,mutations
,,,
TBP,TATA box binding protein ,6q27,
,,,Spinocerebellar ataxia 17 [MIM:607136]
,,,"Parkinson disease, susceptibility to [MIM:168600]"
,,,
TBX10,T-box 10 ,11q13.1-q13.2,
,,,mutations
,,,
TBX15,T-box 15 ,1p13,
,,,Cousin syndrome [MIM:260660]
,,,
TBX19,T-box 19 ,1q23-q24,
,,,Adrenocorticotropic hormone deficiency [MIM:201400]
,,,
TBX1,T-box 1 ,22q11.2,
,,,Conotruncal anomaly face syndrome [MIM:217095]
,,,DiGeorge syndrome [MIM:188400]
,,,Velocardiofacial syndrome [MIM:192430]
,,,
TBX20,T-box 20 ,7p15-p14,
,,,Atrial septal defect 4 [MIM:611363]
,,,
TBX21,T-box 21 ,17q21.3,
,,,"Asthma, aspirin-induced, susceptibility to [MIM:208550]"
,,,Asthma and nasal polyps [MIM:208550]
,,,
TBX22,T-box 22 ,Xq12-q21,
,,,Cleft palate with ankyloglossia [MIM:303400]
,,,
TBX2,T-box 2 ,17q23,
,,,mutations
,,,
TBX3,T-box 3 ,12q24.1,
,,,Ulnar-mammary syndrome [MIM:181450]
,,,
TBX4,T-box 4 ,17q21-q22,
,,,Small patella syndrome [MIM:147891]
,,,
TBX5,T-box 5 ,12q24.1,
,,,Holt-Oram syndrome [MIM:142900]
,,,
TBX6,T-box 6 ,16p11.2,
,,,mutations
,,,
TBXA2R,thromboxane A2 receptor ,19p13.3,
,,,Bleeding disorder due to defective thromboxane A2 receptor
,,,
TBXAS1,thromboxane A synthase 1 (platelet) ,7q34,
,,,Thromboxane synthase deficiency
,,,Ghosal syndrome [MIM:231095]
,,,
TCAP,titin-cap (telethonin) ,17q12,
,,,"Muscular dystrophy, limb-girdle, type 2G [MIM:601954]"
,,,"Cardiomyopathy, dilated, 1N [MIM:607487]"
,,,
TCF21,transcription factor 21 ,6q23-q24,
,,,mutations
,,,
TCF3,transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) ,19p13.3,
,,,"Leukemia, acute lymphoblastic"
,,,
TCF4,transcription factor 4 ,18q21.2,
,,,Pitt-Hopkins syndrome [MIM:610954]
,,,
TCF7L1,"transcription factor 7-like 1 (T-cell specific, HMG-box) ",?,
,,,mutations
,,,
TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box) ",10q25.3,
,,,"Diabetes mellitus, type 2, susceptibility to [MIM:125853]"
,,,
TCF7,"transcription factor 7 (T-cell specific, HMG-box) ",5q31.1,
,,,mutations
,,,
TCIRG1,"T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 ",11q13.4-q13.5,
,,,"Osteopetrosis, recessive 1 [MIM:259700]"
,,,
TCL1A,T-cell leukemia/lymphoma 1A ,14q32.1,
,,,"Leukemia/lymphoma, T-cell"
,,,
TCL1B,T-cell leukemia/lymphoma 1B ,14q32.1,
,,,"Leukemia/lymphoma, T-cell"
,,,
TCL4,T-cell leukemia/lymphoma 4 ,2q34,
,,,"Leukemia/lymphoma, T-cell"
,,,
TCN1,"transcobalamin I (vitamin B12 binding protein, R binder family) ",11q11-q12,
,,,mutations
,,,
TCN2,transcobalamin II ,22q11.2-qter,
,,,Transcobalamin II deficiency [MIM:275350]
,,,
TCOF1,Treacher Collins-Franceschetti syndrome 1 ,5q32-q33.1,
,,,Treacher Collins syndrome 1 [MIM:154500]
,,,
TCO,"Thyroid carcinoma, nonmedullary, with cell oxyphilia ",19p13.2,
,,,"Thyroid carcinoma, nonmedullary, with cell oxyphilia"
,,,
TCP1,t-complex 1 ,6q25.3-q26,
,,,mutations
,,,
TCPT,"thrombocytopenia, Paris-Trousseau type ",11q23,
,,,"Thrombocytopenia, Paris-Trousseau type"
,,,
TCTE1,t-complex-associated-testis-expressed 1 ,6p21.3-cen,
,,,mutations
,,,
TCTE3,t-complex-associated-testis-expressed 3 ,6q27,
,,,mutations
,,,
TCTN1,tectonic family member 1 ,12q24.1,
,,,mutations
,,,
TCTN2,tectonic family member 2 ,?,
,,,mutations
,,,
TDGF1,teratocarcinoma-derived growth factor 1 ,3p23-p21,
,,,Forebrain defects
,,,
TDO2,"tryptophan 2,3-dioxygenase ",4q31-q32,
,,,mutations
,,,
TDP1,tyrosyl-DNA phosphodiesterase 1 ,14q31-q32,
,,,"Spinocerebellar ataxia, autosomal recessive with axonal neuropathy [MIM:607250]"
,,,
TDRD7,tudor domain containing 7 ,?,
,,,mutations
,,,
TEAD1,TEA domain family member 1 (SV40 transcriptional enhancer factor) ,11p15.2,
,,,Sveinsson choreoretinal atrophy [MIM:108985]
,,,
TECR,"trans-2,3-enoyl-CoA reductase ",?,
,,,mutations
,,,
TECTA,tectorin alpha ,11q22-q24,
,,,"Deafness, autosomal dominant 8/12 [MIM:601543]"
,,,"Deafness, autosomal recessive 21 [MIM:603629]"
,,,
TEKT2,tektin 2 (testicular) ,?,
,,,mutations
,,,
TEK,"TEK tyrosine kinase, endothelial ",9p21,
,,,"Venous malformations, multiple cutaneous and mucosal [MIM:600195]"
,,,
TELM,"telomere length, mean leukocyte ",14q23.2,
,,,"Telomere length, mean leukocyte"
,,,
TEP1,telomerase-associated protein 1 ,14q11.2,
,,,mutations
,,,
TERC,telomerase RNA component ,3q21-q28,
,,,"Dyskeratosis congenita, autosomal dominant [MIM:127550]"
,,,Aplastic anemia [MIM:609135]
,,,"Pulmonary fibrosis, idiopathic, susceptibility to [MIM:178500]"
,,,
TERT,telomerase reverse transcriptase ,5p15.33,
,,,"Aplastic anemia, susceptibility to [MIM:609135]"
,,,"Pulmonary fibrosis,idiopathic, susceptibility to [MIM:178500]"
,,,Dyskeratosis congenita [MIM:127550]
,,,
TET1,tet methylcytosine dioxygenase 1 ,10q22,
,,,mutations
,,,
TEX14,testis expressed 14 ,17,
,,,mutations
,,,
TFAM,"transcription factor A, mitochondrial ",10q21,
,,,mutations
,,,
TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) ,6p24,
,,,Branchiooculofacial syndrome [MIM:113620]
,,,
TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta) ,6p12,
,,,Char syndrome [MIM:169100]
,,,
TFB1M,"transcription factor B1, mitochondrial ",6q25,
,,,mutations
,,,
TFCP2,transcription factor CP2 ,12q13,
,,,mutations
,,,
TFE3,transcription factor binding to IGHM enhancer 3 ,Xp11.22,
,,,"Renal cell carcinoma, papillary, 1 [MIM:605074]"
,,,
TFF1,trefoil factor 1 ,21q22.3,
,,,mutations
,,,
TFG,TRK-fused gene ,3q11-q12,
,,,"Chondrosarcoma, extraskeletal myxoid [MIM:612237]"
,,,
TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) ,2q31-q32.1,
,,,mutations
,,,
TFR2,transferrin receptor 2 ,7q22,
,,,"Hemochromatosis, type 3 [MIM:604250]"
,,,
TFRC,"transferrin receptor (p90, CD71) ",3q29,
,,,mutations
,,,
TF,transferrin ,3q21,
,,,Atransferrinemia [MIM:209300]
,,,
TGCT1,testicular germ cell tumor susceptibility 1 ,Xq27,
,,,Testicular germ cell tumor
,,,
TGFB1,"transforming growth factor, beta 1 ",19q13.1,
,,,Camurati-Engelmann disease [MIM:131300]
,,,"Cystic fibrosis lung disease, modifier of [MIM:219700]"
,,,
TGFB2,"transforming growth factor, beta 2 ",1q41,
,,,mutations
,,,
TGFB3,"transforming growth factor, beta 3 ",14q24,
,,,Arrhythmogenic right ventricular dysplasia 1 [MIM:107970]
,,,
TGFBI,"transforming growth factor, beta-induced, 68kDa ",5q31,
,,,"Corneal dystrophy, Groenouw type I [MIM:121900]"
,,,"Corneal dystrophy, lattice type I [MIM:122200]"
,,,"Corneal dystrophy, Reis-Bucklers type [MIM:608470]"
,,,"Corneal dystrophy, Avellino type [MIM:607541]"
,,,"Corneal dystrophy, lattice type IIIA [MIM:608471]"
,,,"Corneal dystrophy, Thiel-Behnke type [MIM:602082]"
,,,"Corneal dystrophy, epithelial basement membrane [MIM:121820]"
,,,
TGFBR1,"transforming growth factor, beta receptor 1 ",9q22,
,,,"Loeys-Dietz syndrome, type 1A [MIM:609192]"
,,,"Loeys-Dietz syndrome, type 2A [MIM:608967]"
,,,
TGFBR2,"transforming growth factor, beta receptor II (70/80kDa) ",3p22,
,,,"Colorectal cancer, hereditary nonpolyposis, type 6"
,,,"Esophageal cancer, somatic [MIM:133239]"
,,,"Loeys-Dietz syndrome, type 1B [MIM:610168]"
,,,"Loeys-Dietz syndrome, type 2B [MIM:610380]"
,,,
TGFBR3,"transforming growth factor, beta receptor III ",1p33-p32,
,,,mutations
,,,
TGFBRAP1,"transforming growth factor, beta receptor associated protein 1 ",2q12.1,
,,,mutations
,,,
TGIF1,TGFB-induced factor homeobox 1 ,18p11.3,
,,,Holoprosencephaly-4 [MIM:142946]
,,,
TGM1,"transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) ",14q11.2,
,,,"Ichthyosis, lamellar, autosomal recessive [MIM:242300]"
,,,"Ichthyosiform erythroderma, congenital [MIM:242100]"
,,,Self-healing collodion baby [MIM:242300]
,,,
TGM2,"transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) ",20q11.2-q12,
,,,mutations
,,,
TGM5,transglutaminase 5 ,15q15.2,
,,,"Peeling skin syndrome, acral type [MIM:609796]"
,,,
TGM6,transglutaminase 6 ,?,
,,,mutations
,,,
TG,thyroglobulin ,8q24.2-q24.3,
,,,Thyroid dyshormonogenesis 3 [MIM:274700]
,,,"Autoimmune thyroid disease, susceptibility to 3 [MIM:608175]"
,,,
THADA,thyroid adenoma associated ,2p21,
,,,mutations
,,,
THAP1,"THAP domain containing, apoptosis associated protein 1 ",8p11.21,
,,,"Dystonia 6, torsion [MIM:602629]"
,,,
THAS,thoracoabdominal syndrome ,Xq25-q26.1,
,,,Thoracoabdominal syndrome
,,,
THBD,thrombomodulin ,20p11.2,
,,,Thrombophilia due to thrombomodulin defect
,,,"Myocardial infarction, susceptibility to"
,,,"Hemolytic uremic syndrome, atypical, susceptibility to, 6 [MIM:612926]"
,,,
THBS1,thrombospondin 1 ,15q15,
,,,mutations
,,,
THBS2,thrombospondin 2 ,6q27,
,,,"Lumbar disc herniation, susceptibility to [MIM:603932]"
,,,
THBS4,thrombospondin 4 ,?,
,,,mutations
,,,
THC2,thrombocytopenia 2 (autosomal dominant) ,10p12.1,
,,,Thrombocytopenia-2 [MIM:188000]
,,,
THCYTX,"Thrombocytosis, familial X-linked ",X,
,,,"Thrombocytosis, familial X-linked"
,,,
THMA,Tibial hemimelia ,8q24.1,
,,,Tibial hemimelia
,,,
THPO,thrombopoietin ,3q26.3-q27,
,,,"Thrombocythemia, essential [MIM:187950]"
,,,
THRA,"thyroid hormone receptor, alpha ",17q11.2,
,,,"hyperthyroxinemia,euthyroidal"
,,,
THRB,"thyroid hormone receptor, beta ",3p24.3,
,,,Thyroid hormone resistance [MIM:188570]
,,,"Thyroid hormone resistance, autosomal recessive [MIM:274300]"
,,,"Thyroid hormone resistance, selective pituitary [MIM:145650]"
,,,
THSD7A,"thrombospondin, type I, domain containing 7A ",7p21.3,
,,,mutations
,,,
TH,tyrosine hydroxylase ,11p15.5,
,,,"Segawa syndrome, recessive [MIM:605407]"
,,,
TICAM1,toll-like receptor adaptor molecule 1 ,19p13.3,
,,,mutations
,,,
TIMM44,translocase of inner mitochondrial membrane 44 homolog (yeast) ,19p13.3-p13.2,
,,,mutations
,,,
TIMM8A,translocase of inner mitochondrial membrane 8 homolog A (yeast) ,Xq22,
,,,"Deafness, X-linked 1, progressive"
,,,Mohr-Tranebjaerg syndrome [MIM:304700]
,,,Jensen syndrome [MIM:311150]
,,,
TIMP1,TIMP metallopeptidase inhibitor 1 ,Xp11.3-p11.23,
,,,mutations
,,,
TIMP2,TIMP metallopeptidase inhibitor 2 ,17q25,
,,,mutations
,,,
TIMP3,TIMP metallopeptidase inhibitor 3 ,22q12.1-q13.2,
,,,Sorsby fundus dystrophy [MIM:136900]
,,,
TINAG,tubulointerstitial nephritis antigen ,6p12-p11.2,
,,,mutations
,,,
TINF2,TERF1 (TRF1)-interacting nuclear factor 2 ,14q12,
,,,"Dyskeratosis congenita, autosomal dominant [MIM:127550]"
,,,Revesz syndrome [MIM:268130]
,,,
TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein ,11q23-q24,
,,,"Pneumococcal disease, invasive, protection against [MIM:610799]"
,,,"Bacteremia, protection against"
,,,"Malaria, protection against [MIM:611162]"
,,,"Tuberculosis, protection against [MIM:607948]"
,,,
TJP2,tight junction protein 2 ,9q12-q13,
,,,"Hypercholanemia, familial [MIM:607748]"
,,,
TK2,"thymidine kinase 2, mitochondrial ",16q22,
,,,Mitochondrial DNA depletion syndrome 2 (myopathic type) [MIM:609560]
,,,
TKCR,"torticollis, keloids, cryptorchidism and renal dysplasia ",Xq28,
,,,Goeminne TKCR syndrome
,,,
TLK1,tousled-like kinase 1 ,?,
,,,mutations
,,,
TLL1,tolloid-like 1 ,4q32-q33,
,,,Atrial septal defect 6 [MIM:613087]
,,,
TLR10,toll-like receptor 10 ,?,
,,,mutations
,,,
TLR1,toll-like receptor 1 ,4p14,
,,,"Leprosy, protection against [MIM:613223]"
,,,"Leprosy, susceptibility to, 5 [MIM:613223]"
,,,
TLR2,toll-like receptor 2 ,4q32,
,,,"Leprosy, susceptibility to [MIM:246300]"
,,,"Colorectal cancer, susceptibility to [MIM:114500]"
,,,
TLR3,toll-like receptor 3 ,4q35,
,,,"Herpes simplex encephalitis, susceptibility to, 2 [MIM:613002]"
,,,
TLR4,toll-like receptor 4 ,9q32-q33,
,,,Endotoxin hyporesponsiveness
,,,"Macular degeneration, age-related, 10 [MIM:611488]"
,,,"Colorectal cancer, susceptibility to [MIM:114500]"
,,,
TLR5,toll-like receptor 5 ,1q41-q42,
,,,"Legionaire disease, susceptibility to [MIM:608556]"
,,,"Systemic lupus erythematosus, resistance to [MIM:601744]"
,,,"Systemic lupus erythematosus, susceptibility to, 1 [MIM:601744]"
,,,
TLR6,toll-like receptor 6 ,4p14,
,,,mutations
,,,
TLR7,toll-like receptor 7 ,Xp22.3-p22.2,
,,,mutations
,,,
TLR8,toll-like receptor 8 ,Xp22.3-p22.2,
,,,mutations
,,,
TLR9,toll-like receptor 9 ,3p21.3,
,,,mutations
,,,
TLX1,T-cell leukemia homeobox 1 ,10q24,
,,,"Leukemia, T-cell acute lymphocytic"
,,,
TM4SF19,transmembrane 4 L six family member 19 ,?,
,,,mutations
,,,
TMC1,transmembrane channel-like 1 ,9q13-q21,
,,,"Deafness, autosomal recessive 7 [MIM:600974]"
,,,"Deafness, autosomal dominant 36 [MIM:606705]"
,,,
TMC6,transmembrane channel-like 6 ,17q25,
,,,Epidermodysplasia verruciformis [MIM:226400]
,,,
TMC8,transmembrane channel-like 8 ,17q25,
,,,Epidermodysplasia verruciformis [MIM:226400]
,,,
TMCO1,transmembrane and coiled-coil domains 1 ,?,
,,,mutations
,,,
TMEM114,transmembrane protein 114 ,16p13.3,
,,,mutations
,,,
TMEM126A,transmembrane protein 126A ,11q14.1-q21,
,,,Optic atrophy-7 [MIM:612989]
,,,
TMEM127,transmembrane protein 127 ,2q11,
,,,"Pheochromocytoma, susceptibility to [MIM:171300]"
,,,
TMEM135,transmembrane protein 135 ,?,
,,,mutations
,,,
TMEM138,transmembrane protein 138 ,?,
,,,mutations
,,,
TMEM173,transmembrane protein 173 ,5q31.2,
,,,mutations
,,,
TMEM187,transmembrane protein 187 ,Xq28,
,,,mutations
,,,
TMEM216,transmembrane protein 216 ,11q13,
,,,Joubert syndrome 2 [MIM:608091]
,,,
TMEM237,transmembrane protein 237 ,?,
,,,mutations
,,,
TMEM2,transmembrane protein 2 ,9q13-q21,
,,,mutations
,,,
TMEM39A,transmembrane protein 39A ,?,
,,,mutations
,,,
TMEM43,transmembrane protein 43 ,3p25,
,,,"Arrhythmogenic right ventricular dysplasia, familial, 5 [MIM:604400]"
,,,
TMEM67,transmembrane protein 67 ,8q21.13-q22.1,
,,,"Meckel syndrome, type 3 [MIM:607361]"
,,,Joubert syndrome 6 [MIM:610688]
,,,"Bardet-Biedl syndrome 14, modifier of [MIM:209900]"
,,,COACH syndrome [MIM:216360]
,,,Nephronophthisis 11 [MIM:613550]
,,,
TMEM70,transmembrane protein 70 ,8q21.11,
,,,"Encephalocardiomyopathy, neonatal, mitochondrial, due to ATP synthase deficiency [MIM:604273]"
,,,
TMEM8A,transmembrane protein 8A ,?,
,,,mutations
,,,
TMEM9,transmembrane protein 9 ,?,
,,,mutations
,,,
TMIE,transmembrane inner ear ,3p21,
,,,"Deafness, autosomal recessive 6 [MIM:600971]"
,,,
TMLHE,"trimethyllysine hydroxylase, epsilon ",Xq28,
,,,mutations
,,,
TMPO,thymopoietin ,12q22,
,,,"Cardiomyopathy, dilated, 1T [MIM:613740]"
,,,
TMPRSS11A,"transmembrane protease, serine 11A ",4q13.2,
,,,mutations
,,,
TMPRSS15,"transmembrane protease, serine 15 ",21q21,
,,,Enterokinase deficiency [MIM:226200]
,,,
TMPRSS3,"transmembrane protease, serine 3 ",21q22.3,
,,,"Deafness, autosomal recessive 8, childhood onset [MIM:601072]"
,,,"Deafness, autosomal recessive 10, congenital [MIM:605316]"
,,,
TMPRSS4,"transmembrane protease, serine 4 ",11q23.3,
,,,mutations
,,,
TMPRSS5,"transmembrane protease, serine 5 ",11q23.3,
,,,mutations
,,,
TMPRSS6,"transmembrane protease, serine 6 ",22q12-q13,
,,,Iron-refractory iron deficiency anemia [MIM:206200]
,,,
TNC,tenascin C ,9q33,
,,,mutations
,,,
TNFAIP2,"tumor necrosis factor, alpha-induced protein 2 ",14q32,
,,,mutations
,,,
TNFAIP3,"tumor necrosis factor, alpha-induced protein 3 ",6q23,
,,,mutations
,,,
TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a ",8p21,
,,,mutations
,,,
TNFRSF10B,"tumor necrosis factor receptor superfamily, member 10b ",8p22-p21,
,,,"Squamous cell carcinoma, head and neck [MIM:275355]"
,,,
TNFRSF11A,"tumor necrosis factor receptor superfamily, member 11a, NFKB activator ",18q22.1,
,,,"Osteolysis, familial expansile [MIM:174810]"
,,,Paget disease of bone [MIM:602080]
,,,"Osteopetrosis, autosomal recessive 7 [MIM:612301]"
,,,
TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b ",8q24,
,,,"Paget disease, juvenile [MIM:239000]"
,,,
TNFRSF13B,"tumor necrosis factor receptor superfamily, member 13B ",17p11.2,
,,,Immunoglobulin A deficiency 2 [MIM:609529]
,,,"Immunodeficiency, common variable, 2 [MIM:240500]"
,,,
TNFRSF13C,"tumor necrosis factor receptor superfamily, member 13C ",22q13.1-q13.31,
,,,"Immunodeficiency, common variable, 4 [MIM:613494]"
,,,
TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A ",12p13.2,
,,,"Periodic fever, familial [MIM:142680]"
,,,
TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B ",1p36.3-p36.2,
,,,mutations
,,,
TNFRSF25,"tumor necrosis factor receptor superfamily, member 25 ",1p36.3,
,,,mutations
,,,
TNFRSF4,"tumor necrosis factor receptor superfamily, member 4 ",1p36,
,,,mutations
,,,
TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10 ",3q26,
,,,mutations
,,,
TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11 ",13q14,
,,,"Osteopetrosis, autosomal recessive 2 [MIM:259710]"
,,,
TNFSF13B,"tumor necrosis factor (ligand) superfamily, member 13b ",13q32-q34,
,,,mutations
,,,
TNFSF14,"tumor necrosis factor (ligand) superfamily, member 14 ",19p13.3,
,,,mutations
,,,
TNFSF15,"tumor necrosis factor (ligand) superfamily, member 15 ",9q32,
,,,mutations
,,,
TNFSF4,"tumor necrosis factor (ligand) superfamily, member 4 ",1q25,
,,,"Myocardial infarction, susceptibility to [MIM:608446]"
,,,
TNFSF8,"tumor necrosis factor (ligand) superfamily, member 8 ",9q33,
,,,mutations
,,,
TNF,tumor necrosis factor ,6p21.3,
,,,"Malaria, cerebral, susceptibility to [MIM:611162]"
,,,"Septic shock, susceptibility to"
,,,"Asthma, susceptibility to [MIM:600807]"
,,,"Dementia, vascular, susceptibility to"
,,,"Migraine without aura, susceptibility to [MIM:157300]"
,,,
TNKS,"tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase ",8,
,,,mutations
,,,
TNNC1,troponin C type 1 (slow) ,3p21.3-p14.3,
,,,"Cardiomyopathy, dilated, 1Z [MIM:611879]"
,,,"Cardiomyopathy, familial hypertrophic, 13 [MIM:613243]"
,,,
TNNI2,"troponin I type 2 (skeletal, fast) ",11p15.5,
,,,"Arthrogryposis multiplex congenita, distal, type 2B [MIM:601680]"
,,,
TNNI3K,TNNI3 interacting kinase ,?,
,,,mutations
,,,
TNNI3,troponin I type 3 (cardiac) ,19q13.4,
,,,"Cardiomyopathy, familial hypertrophic, 7 [MIM:613690]"
,,,"Cardiomyopathy, familial restrictive [MIM:115210]"
,,,"Cardiomyopathy, dilated, 2A [MIM:611880]"
,,,"Cardiomyopathy, dilated, 1FF [MIM:613286]"
,,,
TNNT1,"troponin T type 1 (skeletal, slow) ",19q13.4,
,,,"Nemaline myopathy, Amish type [MIM:605355]"
,,,
TNNT2,troponin T type 2 (cardiac) ,1q32,
,,,"Cardiomyopathy, familial hypertrophic, 2 [MIM:115195]"
,,,"Cardiomyopathy, dilated, 1D [MIM:601494]"
,,,"Cardiomyopathy, familial restrictive, 3 [MIM:612422]"
,,,Left ventricular noncompaction 6 [MIM:601494]
,,,
TNNT3,"troponin T type 3 (skeletal, fast) ",11p15.5,
,,,"Arthyrgryposis, distal, type 2B [MIM:601680]"
,,,
TNP1,transition protein 1 (during histone to protamine replacement) ,2q35-q36,
,,,mutations
,,,
TNR,tenascin R ,1q24,
,,,mutations
,,,
TNS3,tensin 3 ,7p12.3,
,,,mutations
,,,
TNXB,tenascin XB ,6p21.3,
,,,Ehlers-Danlos due to tenascin X deficiency [MIM:606408]
,,,"Ehlers-Danlos syndrome, hypermobility type [MIM:130020]"
,,,
TOC,tylosis with oesophageal cancer ,17q25,
,,,Tylosis with esophageal cancer
,,,
TOMM40,translocase of outer mitochondrial membrane 40 homolog (yeast) ,19q13.2,
,,,mutations
,,,
TOP1MT,"topoisomerase (DNA) I, mitochondrial ",8q24.3,
,,,mutations
,,,
TOP1,topoisomerase (DNA) I ,20q12-q13.1,
,,,"DNA topoisomerase I, camptothecin-resistant"
,,,
TOP2A,topoisomerase (DNA) II alpha 170kDa ,17q21-q22,
,,,"DNA topoisomerase II, resistance to inhibition of, by amsacrine"
,,,
TOPBP1,topoisomerase (DNA) II binding protein 1 ,3q22.1,
,,,mutations
,,,
TOPORS,"topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase ",9p21,
,,,Retinitis pigmentosa-31 [MIM:609923]
,,,
TOR1A,"torsin family 1, member A (torsin A) ",9q34,
,,,"Dystonia-1, torsion [MIM:128100]"
,,,"Dystonia, early-onset atypical, with myoclonic features"
,,,"Dystonia-1, modifier of"
,,,
TOX3,TOX high mobility group box family member 3 ,?,
,,,mutations
,,,
TP53AIP1,tumor protein p53 regulated apoptosis inducing protein 1 ,11q24,
,,,mutations
,,,
TP53BP1,tumor protein p53 binding protein 1 ,15q15-q21,
,,,mutations
,,,
TP53I3,tumor protein p53 inducible protein 3 ,2p,
,,,mutations
,,,
TP53RK,TP53 regulating kinase ,?,
,,,mutations
,,,
TP53,tumor protein p53 ,17p13.1,
,,,Colorectal cancer [MIM:114500]
,,,Li-Fraumeni syndrome [MIM:151623]
,,,Hepatocellular carcinoma [MIM:114550]
,,,Osteosarcoma [MIM:259500]
,,,Choroid plexus papilloma [MIM:260500]
,,,Nasopharyngeal carcinoma [MIM:607107]
,,,Pancreatic cancer [MIM:260350]
,,,Adrenal cortical carcinoma [MIM:202300]
,,,Breast cancer [MIM:114480]
,,,Li-Fraumeni-like syndrome [MIM:151623]
,,,
TP63,tumor protein p63 ,3q27,
,,,"Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 [MIM:604292]"
,,,Split-hand/foot malformation 4 [MIM:605289]
,,,Hay-Wells syndrome [MIM:106260]
,,,ADULT syndrome [MIM:103285]
,,,Limb-mammary syndrome [MIM:603543]
,,,Rapp-Hodgkin syndrome [MIM:129400]
,,,Orofacial cleft 8 [MIM:129400]
,,,
TP73,tumor protein p73 ,1p36,
,,,Neuroblastoma
,,,
TPCN2,two pore segment channel 2 ,11q13.2,
,,,"Skin/hair/eye pigmentation 10, blond/brown hair [MIM:612267]"
,,,
TPH1,tryptophan hydroxylase 1 ,11p15.3-p14,
,,,mutations
,,,
TPH2,tryptophan hydroxylase 2 ,12q21.1,
,,,"Unipolar depression, susceptibility to [MIM:608516]"
,,,"Attention deficit-hyperactivity disorder, susceptibility to, 7 [MIM:613003]"
,,,
TPI1,triosephosphate isomerase 1 ,12p13,
,,,Hemolytic anemia due to triosephosphate isomerase deficiency
,,,
TPK1,thiamin pyrophosphokinase 1 ,7q34,
,,,mutations
,,,
TPM1,tropomyosin 1 (alpha) ,15q22.1,
,,,"Cardiomyopathy, familial hypertrophic, 3 [MIM:115196]"
,,,"Cardiomyopathy, dilated, 1Y [MIM:611878]"
,,,
TPM2,tropomyosin 2 (beta) ,9p13.2-p13.1,
,,,"Arthrogryposis multiplex congenita, distal, type 1 [MIM:108120]"
,,,Nemaline myopathy [MIM:609285]
,,,"Arthrogryposis, distal, type 2B [MIM:601680]"
,,,
TPM3,tropomyosin 3 ,1q22-q23,
,,,"Nemaline myopathy 1, autosomal dominant [MIM:609284]"
,,,
TPMT,thiopurine S-methyltransferase ,6p22.3,
,,,6-mercaptopurine sensitivity [MIM:610460]
,,,
TPO,thyroid peroxidase ,2p25,
,,,Thyroid dyshormonogenesis 2A [MIM:274500]
,,,
TPP1,tripeptidyl peptidase I ,11p15.5,
,,,"Ceroid-lipofuscinosis, neuronal 2, classic late infantile [MIM:204500]"
,,,
TPP2,tripeptidyl peptidase II ,13q32-q33,
,,,mutations
,,,
TPRN,taperin ,9q34.3,
,,,"Deafness, autosomal recessive 79 [MIM:613307]"
,,,
TPSB2,tryptase beta 2 (gene/pseudogene) ,16p13.3,
,,,mutations
,,,
TPTE,transmembrane phosphatase with tensin homology ,21p,
,,,mutations
,,,
TQDS,Chromosome 10q deletion syndrome ,10q26,
,,,Chromosome 10q26 deletion syndrome
,,,
TRA@,T cell receptor alpha locus ,14q11.2,
,,,"Leukemia/lymphoma, T-cell"
,,,
TRAC,T cell receptor alpha constant ,?,
,,,mutations
,,,
TRADD,TNFRSF1A-associated via death domain ,16q22,
,,,mutations
,,,
TRAF3IP1,TNF receptor-associated factor 3 interacting protein 1 ,2q37.3,
,,,mutations
,,,
TRAF3IP2,TRAF3 interacting protein 2 ,6q21,
,,,mutations
,,,
TRAF3,TNF receptor-associated factor 3 ,?,
,,,mutations
,,,
TRAF6,"TNF receptor-associated factor 6, E3 ubiquitin protein ligase ",11p12,
,,,mutations
,,,
TRAK2,"trafficking protein, kinesin binding 2 ",2q33-q34,
,,,mutations
,,,
TRAPPC2,trafficking protein particle complex 2 ,Xp22.2-p22.1,
,,,Spondyloepiphyseal dysplasia tarda [MIM:313400]
,,,
TRAPPC9,trafficking protein particle complex 9 ,8q24.3,
,,,"Mental retardation, autosomal recessive 13 [MIM:613192]"
,,,
TRB@,T cell receptor beta locus ,7q35,
,,,mutations
,,,
TRBV9,T cell receptor beta variable 9 ,?,
,,,mutations
,,,
TRD@,T cell receptor delta locus ,14q11.2,
,,,mutations
,,,
TRDN,triadin ,6q22-q23,
,,,mutations
,,,
TREH,trehalase (brush-border membrane glycoprotein) ,11q23,
,,,Trehalase deficiency [MIM:612119]
,,,
TREM2,triggering receptor expressed on myeloid cells 2 ,6p21.2,
,,,Nasu-Hakola disease [MIM:221770]
,,,
TRERF1,transcriptional regulating factor 1 ,?,
,,,mutations
,,,
TREX1,three prime repair exonuclease 1 ,3p21.3-p21.2,
,,,"Aicardi-Goutieres syndrome 1, dominant and recessive [MIM:225750]"
,,,Chilblain lupus [MIM:610448]
,,,"Vasculopathy, retinal, with cerebral leukodystrophy [MIM:192315]"
,,,"Systemic lupus erythematosus, susceptibility to [MIM:152700]"
,,,
TRHR,thyrotropin-releasing hormone receptor ,8q23,
,,,"Thyrotropin-releasing hormone resistance, generalized"
,,,
TRH,thyrotropin-releasing hormone ,?,
,,,thyrotropin releasing hormone deficiency
,,,
TRIB1,tribbles homolog 1 (Drosophila) ,?,
,,,mutations
,,,
TRIB3,tribbles homolog 3 (Drosophila) ,?,
,,,mutations
,,,
TRICY1,trichilemmal cyst 1 ,3p24-p21.2,
,,,Trichilemmal cyst 1
,,,
TRIL,TLR4 interactor with leucine-rich repeats ,7p14.3,
,,,mutations
,,,
TRIM17,tripartite motif containing 17 ,1q42,
,,,mutations
,,,
TRIM21,tripartite motif containing 21 ,11p15.5,
,,,mutations
,,,
TRIM22,tripartite motif containing 22 ,11p15,
,,,mutations
,,,
TRIM24,tripartite motif containing 24 ,7q32-q34,
,,,"Thyroid carcinoma, papillary [MIM:188550]"
,,,
TRIM32,tripartite motif containing 32 ,9q31-q34.1,
,,,"Muscular dystrophy, limb-girdle, type 2H [MIM:254110]"
,,,Bardet-Biedl syndrome 11 [MIM:209900]
,,,
TRIM33,tripartite motif containing 33 ,1p13,
,,,"Thyroid carcinoma, papillary [MIM:188550]"
,,,
TRIM37,tripartite motif containing 37 ,17q22-q23,
,,,Mulibrey nanism [MIM:253250]
,,,
TRIM5,tripartite motif containing 5 ,11p15,
,,,mutations
,,,
TRIOBP,TRIO and F-actin binding protein ,22q13.1,
,,,"Deafness, autosomal recessive 28 [MIM:609823]"
,,,
TRIO,trio Rho guanine nucleotide exchange factor ,5p15.1-p14,
,,,mutations
,,,
TRIP11,thyroid hormone receptor interactor 11 ,14q31-q32,
,,,"Achondrogenesis, type IA [MIM:200600]"
,,,
TRIP12,thyroid hormone receptor interactor 12 ,2q36.3,
,,,mutations
,,,
TRIP4Q32.1Q32.2,Chromosome 4q32.1-q32.2 triplication syndrome ,4q32.1-q32.2,
,,,Chromosome 4q32.1-q32.2 triplication syndrome
,,,
TRMT1,tRNA methyltransferase 1 homolog (S. cerevisiae) ,19p13.3,
,,,mutations
,,,
TRMU,tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase ,22q13,
,,,"Deafness, mitochondrial, modifier of [MIM:580000]"
,,,"Liver failure, acute infantile [MIM:613070]"
,,,
TROAP,trophinin associated protein (tastin) ,?,
,,,mutations
,,,
TROVE2,"TROVE domain family, member 2 ",1q31,
,,,mutations
,,,
TRO,trophinin ,Xp11.22-p11.21,
,,,mutations
,,,
TRPA1,"transient receptor potential cation channel, subfamily A, member 1 ",8q13,
,,,mutations
,,,
TRPC3,"transient receptor potential cation channel, subfamily C, member 3 ",?,
,,,mutations
,,,
TRPC4,"transient receptor potential cation channel, subfamily C, member 4 ",13q13.1-q13.2,
,,,mutations
,,,
TRPC5,"transient receptor potential cation channel, subfamily C, member 5 ",Xq23,
,,,mutations
,,,
TRPC6,"transient receptor potential cation channel, subfamily C, member 6 ",11q21-q22,
,,,"Glomerulosclerosis, focal segmental, 2 [MIM:603965]"
,,,
TRPM1,"transient receptor potential cation channel, subfamily M, member 1 ",15q13-q14,
,,,"Night blindness, congenital stationary, type IC [MIM:613216]"
,,,
TRPM2,"transient receptor potential cation channel, subfamily M, member 2 ",21q22.3,
,,,mutations
,,,
TRPM3,"transient receptor potential cation channel, subfamily M, member 3 ",9q21.12,
,,,mutations
,,,
TRPM4,"transient receptor potential cation channel, subfamily M, member 4 ",19q13.32,
,,,"Progressive familial heart block, type IB [MIM:604559]"
,,,
TRPM6,"transient receptor potential cation channel, subfamily M, member 6 ",9q22,
,,,Hypomagnesemia with secondary hypocalcemia [MIM:602014]
,,,
TRPM7,"transient receptor potential cation channel, subfamily M, member 7 ",15q21,
,,,"Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to [MIM:105500]"
,,,
TRPS1,trichorhinophalangeal syndrome I ,8q24.12,
,,,"Trichorhinophalangeal syndrome, type I [MIM:190350]"
,,,"Trichorhinophalangeal syndrome, type III [MIM:190351]"
,,,
TRPV1,"transient receptor potential cation channel, subfamily V, member 1 ",17p13,
,,,mutations
,,,
TRPV3,"transient receptor potential cation channel, subfamily V, member 3 ",17p13,
,,,mutations
,,,
TRPV4,"transient receptor potential cation channel, subfamily V, member 4 ",12q24.1,
,,,Brachyolmia type 3 [MIM:113500]
,,,"Spondylometaphyseal dysplasia, Kozlowski type [MIM:184252]"
,,,Metatropic dysplasia [MIM:156530]
,,,"Hereditary motor and sensory neuropathy, type IIc [MIM:606071]"
,,,Scapuloperoneal spinal muscular atrophy [MIM:181405]
,,,Sodium serum level QTL 1 [MIM:613508]
,,,Parastremmatic dwarfism [MIM:168400]
,,,"SED, Maroteaux type [MIM:184095]"
,,,
TRPV5,"transient receptor potential cation channel, subfamily V, member 5 ",7q35,
,,,mutations
,,,
TRRAP,transformation/transcription domain-associated protein ,7q21.2-q22.1,
,,,mutations
,,,
TSC1,tuberous sclerosis 1 ,9q34,
,,,Tuberous sclerosis-1 [MIM:191100]
,,,Lymphangioleiomyomatosis [MIM:606690]
,,,"Focal cortical dysplasia, Taylor balloon cell type [MIM:607341]"
,,,
TSC2,tuberous sclerosis 2 ,16p13.3,
,,,Tuberous sclerosis-2 [MIM:191100]
,,,"Lymphangioleiomyomatosis, somatic [MIM:606690]"
,,,
TSEN2,tRNA splicing endonuclease 2 homolog (S. cerevisiae) ,3p25.1,
,,,Pontocerebellar hypoplasia type 2B [MIM:612389]
,,,
TSEN34,tRNA splicing endonuclease 34 homolog (S. cerevisiae) ,19q13.4,
,,,Pontocerebellar hypoplasia type 2C [MIM:612390]
,,,
TSEN54,tRNA splicing endonuclease 54 homolog (S. cerevisiae) ,17q25.1,
,,,Pontocerebellar hypoplasia type 2A [MIM:277470]
,,,Pontocerebellar hypoplasia type 4 [MIM:225753]
,,,
TSFM,"Ts translation elongation factor, mitochondrial ",12q13-q14,
,,,Combined oxidative phosphorylation deficiency 3 [MIM:610505]
,,,
TSG101,tumor susceptibility gene 101 ,11p15.2-p15.1,
,,,Breast cancer
,,,
TSG11,Tumor suppressor gene on chromosome 11 ,11q23,
,,,Nonsmall cell lung cancer
,,,
TSHB,"thyroid stimulating hormone, beta ",1p13,
,,,"Hypothryoidism, congenital, nongoitrous 4 [MIM:275100]"
,,,
TSHQTL1,Thyroid-stimulating hormone level QTL 1 ,5q13,
,,,Thyroid-stimulating hormone level QTL 1
,,,
TSHR,thyroid stimulating hormone receptor ,14q31,
,,,"Hypothyroidism, congenital, nongoitrous, 1 [MIM:275200]"
,,,"Thyroid adenoma, hyperfunctioning, somatic"
,,,"Hyperthyroidism, nonautoimmune [MIM:609152]"
,,,Thyroid carcinoma with thyrotoxicosis
,,,"Hyperthyroidism, familial gestational [MIM:603373]"
,,,
TSHZ1,teashirt zinc finger homeobox 1 ,?,
,,,mutations
,,,
TSLP,thymic stromal lymphopoietin ,5q22.1,
,,,mutations
,,,
TSPAN12,tetraspanin 12 ,7q31,
,,,Exudative vitreoretinopathy 5 [MIM:613310]
,,,
TSPAN17,tetraspanin 17 ,?,
,,,mutations
,,,
TSPAN7,tetraspanin 7 ,Xq11,
,,,"Mental retardation, X-linked 58 [MIM:300210]"
,,,
TSPO,translocator protein (18kDa) ,22q13.31,
,,,mutations
,,,
TSPYL1,TSPY-like 1 ,6q22-q23,
,,,Sudden infant death with dysgenesis of the testes syndrome [MIM:608800]
,,,
TSSC4,tumor suppressing subtransferable candidate 4 ,11p15.5,
,,,mutations
,,,
TSSK2,testis-specific serine kinase 2 ,22q11.21,
,,,mutations
,,,
TSSK3,testis-specific serine kinase 3 ,1p35-p34,
,,,mutations
,,,
TSSK4,testis-specific serine kinase 4 ,14q11.2,
,,,mutations
,,,
TST1,"Tuberculin skin test reactivity, absence of ",11p14,
,,,"Tuberculin skin test reactivity, absence of"
,,,
TST2,Tuberculin skin test reactivity QTL ,5p15,
,,,Tuberculin skin test reactivity QTL
,,,
TST,thiosulfate sulfurtransferase (rhodanese) ,22q11.2-qter,
,,,mutations
,,,
TTBK2,tau tubulin kinase 2 ,15q15.2,
,,,Spinocerebellar ataxia-11 [MIM:604432]
,,,
TTC19,tetratricopeptide repeat domain 19 ,?,
,,,mutations
,,,
TTC21B,tetratricopeptide repeat domain 21B ,2q24.3,
,,,mutations
,,,
TTC37,tetratricopeptide repeat domain 37 ,?,
,,,mutations
,,,
TTC8,tetratricopeptide repeat domain 8 ,14q32.1,
,,,Bardet-Biedl syndrome 8 [MIM:209900]
,,,Retinitis pigmentosa 51 [MIM:613464]
,,,
TTI2,TELO2 interacting protein 2 ,?,
,,,mutations
,,,
TTLL11,"tubulin tyrosine ligase-like family, member 11 ",?,
,,,mutations
,,,
TTN,titin ,2q31,
,,,"Cardiomyopathy, familial hypertrophic, 9 [MIM:188840]"
,,,"Cardiomyopathy, dilated, 1G [MIM:604145]"
,,,"Tibial muscular dystrophy, tardive [MIM:600334]"
,,,"Muscular dystrophy, limb-girdle, type 2J [MIM:608807]"
,,,"Myopathy, proximal, with early respiratory muscle involvement [MIM:603689]"
,,,"Myopathy, early-onset, with fatal cardiomyopathy [MIM:611705]"
,,,
TTPA,tocopherol (alpha) transfer protein ,8q13.1-q13.3,
,,,Ataxia with isolated vitamin E deficiency [MIM:277460]
,,,
TTR,transthyretin ,18q11.2-q12.1,
,,,"Amyloidosis, hereditary, transthyretin-related [MIM:105210]"
,,,Dystransthyretinemic hyperthyroxinemia [MIM:145680]
,,,"Carpal tunnel syndrome, familial [MIM:115430]"
,,,
TTTY13,"testis-specific transcript, Y-linked 13 (non-protein coding) ",?,
,,,mutations
,,,
TUBA1A,"tubulin, alpha 1a ",12q12-q14,
,,,Lissencephaly 3 [MIM:611603]
,,,
TUBA8,"tubulin, alpha 8 ",22q11,
,,,Polymicrogyria with optic nerve hypoplasia [MIM:613180]
,,,
TUBB1,"tubulin, beta 1 class VI ",20q13.3,
,,,"Macrothrombocytopenia, autosomal dominant, TUBB1-related [MIM:613112]"
,,,
TUBB2A,"tubulin, beta 2A class IIa ",6p25.2,
,,,"Polymicrogyria, asymmetric [MIM:610031]"
,,,
TUBB2B,"tubulin, beta 2B class IIb ",6p25.2,
,,,"Polymicrogyria, asymmetric [MIM:610031]"
,,,
TUBB3,"tubulin, beta 3 class III ",16q24.3,
,,,"Fibrosis of extraocular muscles, congenital, 3A [MIM:600638]"
,,,
TUBGCP4,"tubulin, gamma complex associated protein 4 ",15q15,
,,,mutations
,,,
TUBGCP5,"tubulin, gamma complex associated protein 5 ",15q11.2,
,,,mutations
,,,
TUBGCP6,"tubulin, gamma complex associated protein 6 ",?,
,,,mutations
,,,
TUB,tubby homolog (mouse) ,?,
,,,mutations
,,,
TUFM,"Tu translation elongation factor, mitochondrial ",16p11.2,
,,,Combined oxidative phosphorylation deficiency 4 [MIM:610678]
,,,
TUKLS,Tukel syndrome ,21q22,
,,,Tukel syndrome
,,,
TULP1,tubby like protein 1 ,6p21.3,
,,,Retinitis pigmentosa-14 [MIM:600132]
,,,
TULP3,tubby like protein 3 ,12p13,
,,,mutations
,,,
TUSC3,tumor suppressor candidate 3 ,8p22,
,,,"Mental retardation, autosomal recessive 7 [MIM:611093]"
,,,
TWIST1,twist homolog 1 (Drosophila) ,7p21,
,,,Saethre-Chotzen syndrome [MIM:101400]
,,,Saethre-Chotzen syndrome with eyelid anomalies [MIM:101400]
,,,"Craniosynostosis, type 1 [MIM:123100]"
,,,
TWIST2,twist homolog 2 (Drosophila) ,2q37.3,
,,,mutations
,,,
TXN2,thioredoxin 2 ,?,
,,,mutations
,,,
TXNRD2,thioredoxin reductase 2 ,22q11.2,
,,,mutations
,,,
TYK2,tyrosine kinase 2 ,19p13.2,
,,,Tyrosine kinase 2 deficiency [MIM:611521]
,,,
TYMP,thymidine phosphorylase ,22q13.32-qter,
,,,Mitochondrial DNA depletion syndrome 1 (MNGIE type) [MIM:603041]
,,,
TYMS,thymidylate synthetase ,18p11.32,
,,,mutations
,,,
TYROBP,TYRO protein tyrosine kinase binding protein ,19q13.1,
,,,Nasu-Hakola disease [MIM:221770]
,,,
TYRP1,tyrosinase-related protein 1 ,9p23,
,,,"Albinism, oculocutaneous, type III [MIM:203290]"
,,,
TYR,tyrosinase (oculocutaneous albinism IA) ,11q14-q21,
,,,"Albinism, oculocutaneous, type IA [MIM:203100]"
,,,"Waardenburg syndrome/albinism, digenic [MIM:103470]"
,,,"Albinism, oculocutaneous, type IB [MIM:606952]"
,,,"Skin/hair/eye pigmentation 3, freckling [MIM:601800]"
,,,"Melanoma, cutaneous malignant, susceptibility to, 8 [MIM:601800]"
,,,
TYS,sclerotylosis ,4q23,
,,,Huriez syndrome
,,,
T,"T, brachyury homolog (mouse) ",6q27,
,,,"Neural tube defects, susceptibility to [MIM:182940]"
,,,
UAQTL3,"Uric acid concentration, serum, QTL3 ",4q22,
,,,"Uric acid concentration, serum, QTL3"
,,,
UAQTL4,"Uric acid concentration, serum, QTL4 ",6p21,
,,,"Uric acid concentration, serum, QTL4"
,,,
UBA1,ubiquitin-like modifier activating enzyme 1 ,Xp11.23,
,,,"Spinal muscular atrophy, X-linked 2, infantile [MIM:301830]"
,,,
UBA3,ubiquitin-like modifier activating enzyme 3 ,?,
,,,mutations
,,,
UBAC2,UBA domain containing 2 ,?,
,,,mutations
,,,
UBB,ubiquitin B ,17p12-p11.1,
,,,"Cleft palate, isolated [MIM:119540]"
,,,
UBD,ubiquitin D ,6p21.3,
,,,mutations
,,,
UBE2A,ubiquitin-conjugating enzyme E2A ,Xq24-q25,
,,,"Mental retardation, X-linked syndromic"
,,,
UBE2B,ubiquitin-conjugating enzyme E2B ,5q23-q31,
,,,Male infertility
,,,
UBE2I,ubiquitin-conjugating enzyme E2I ,16p13.3,
,,,mutations
,,,
UBE2NL,ubiquitin-conjugating enzyme E2N-like ,?,
,,,mutations
,,,
UBE3A,ubiquitin protein ligase E3A ,15q11-q13,
,,,Angelman syndrome [MIM:105830]
,,,
UBE3C,ubiquitin protein ligase E3C ,?,
,,,mutations
,,,
UBIAD1,UbiA prenyltransferase domain containing 1 ,1p36.3,
,,,"Corneal dystrophy, crystalline, of Schnyder [MIM:121800]"
,,,
UBM2,"Melanoma, uveal, susceptibility to, 2 ",3p25.2-p25.1,
,,,"Melanoma, uveal, susceptibility to, 2"
,,,
UBN2,ubinuclein 2 ,?,
,,,mutations
,,,
UBQLN2,ubiquilin 2 ,Xp11.23-p11.1,
,,,mutations
,,,
UBR1,ubiquitin protein ligase E3 component n-recognin 1 ,15q15-q21.1,
,,,Johanson-Blizzard syndrome [MIM:243800]
,,,
UBR3,ubiquitin protein ligase E3 component n-recognin 3 (putative) ,?,
,,,mutations
,,,
UBR7,ubiquitin protein ligase E3 component n-recognin 7 (putative) ,?,
,,,mutations
,,,
UCA1,urothelial cancer associated 1 (non-protein coding) ,1p34,
,,,Fucosidosis [MIM:230000]
,,,
UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) ,4p14,
,,,"Parkinson disease 5, susceptibility to [MIM:613643]"
,,,"Parkinson disease, resistance to [MIM:613643]"
,,,
UCP1,"uncoupling protein 1 (mitochondrial, proton carrier) ",4q31,
,,,"Obesity, susceptibility to [MIM:601665]"
,,,
UCP2,"uncoupling protein 2 (mitochondrial, proton carrier) ",11q13,
,,,"Obesity, susceptibility to, BMIQ4 [MIM:607447]"
,,,
UCP3,"uncoupling protein 3 (mitochondrial, proton carrier) ",11q13,
,,,"Obesity, severe, and type II diabetes [MIM:601665]"
,,,
UFD1L,ubiquitin fusion degradation 1 like (yeast) ,22q11.2,
,,,mutations
,,,
UGT1A10,"UDP glucuronosyltransferase 1 family, polypeptide A10 ",2q37,
,,,mutations
,,,
UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1 ",2q37,
,,,"Crigler-Najjar syndrome, type I [MIM:218800]"
,,,Gilbert syndrome [MIM:143500]
,,,"Crigler-Najjar syndrome, type II [MIM:606785]"
,,,"Hyperbilirubinemia, familial transcient neonatal [MIM:237900]"
,,,"Bilirubin, serum level of, QTL1 [MIM:601816]"
,,,
UGT1A3,"UDP glucuronosyltransferase 1 family, polypeptide A3 ",2q37,
,,,mutations
,,,
UGT1A4,"UDP glucuronosyltransferase 1 family, polypeptide A4 ",2q37,
,,,mutations
,,,
UGT1A5,"UDP glucuronosyltransferase 1 family, polypeptide A5 ",2q37,
,,,mutations
,,,
UGT1A6,"UDP glucuronosyltransferase 1 family, polypeptide A6 ",2q37,
,,,mutations
,,,
UGT1A7,"UDP glucuronosyltransferase 1 family, polypeptide A7 ",2q37,
,,,mutations
,,,
UGT1A8,"UDP glucuronosyltransferase 1 family, polypeptide A8 ",2q37,
,,,mutations
,,,
UGT1A9,"UDP glucuronosyltransferase 1 family, polypeptide A9 ",2q37,
,,,mutations
,,,
UGT2A1,"UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus ",4q13,
,,,mutations
,,,
UGT2A3,"UDP glucuronosyltransferase 2 family, polypeptide A3 ",?,
,,,mutations
,,,
UGT2B10,"UDP glucuronosyltransferase 2 family, polypeptide B10 ",?,
,,,mutations
,,,
UGT2B15,"UDP glucuronosyltransferase 2 family, polypeptide B15 ",4q13,
,,,mutations
,,,
UGT2B17,"UDP glucuronosyltransferase 2 family, polypeptide B17 ",4q13,
,,,mutations
,,,
UGT2B28,"UDP glucuronosyltransferase 2 family, polypeptide B28 ",4q13.2,
,,,mutations
,,,
UGT2B7,"UDP glucuronosyltransferase 2 family, polypeptide B7 ",4q13,
,,,mutations
,,,
UHRF1BP1,UHRF1 binding protein 1 ,?,
,,,mutations
,,,
UIMC1,ubiquitin interaction motif containing 1 ,5q35,
,,,mutations
,,,
UMOD,uromodulin ,16p12.3,
,,,"Hyperuricemic nephropathy, familial juvenile 1 [MIM:162000]"
,,,Medullary cystic kidney disease 2 [MIM:603860]
,,,Glomerulocystic kidney disease with hyperuricemia and isosthenuria [MIM:609886]
,,,
UMPS,uridine monophosphate synthetase ,?,
,,,orotic aciduria I (O5D & OPT deficiency)
,,,
UNC119,unc-119 homolog (C. elegans) ,17q11.2,
,,,Cone-rod dystrophy
,,,
UNC13D,unc-13 homolog D (C. elegans) ,17q25.1,
,,,"Hemophagocytic lymphohistiocytosis, familial, 3 [MIM:608898]"
,,,
UNC5CL,unc-5 homolog C (C. elegans)-like ,?,
,,,mutations
,,,
UNC5C,unc-5 homolog C (C. elegans) ,4q21-q23,
,,,mutations
,,,
UNC80,unc-80 homolog (C. elegans) ,2q35,
,,,mutations
,,,
UNC93A,unc-93 homolog A (C. elegans) ,6q27,
,,,mutations
,,,
UNC93B1,unc-93 homolog B1 (C. elegans) ,11q13,
,,,"Herpes simplex encephalitis, susceptibility to, 1 [MIM:610551]"
,,,
UNG,uracil-DNA glycosylase ,12q23-q24.1,
,,,"Immunodeficiency with hyper IgM, type 4 [MIM:608106]"
,,,
UNKL,unkempt homolog (Drosophila)-like ,?,
,,,mutations
,,,
UOX,"urate oxidase, pseudogene ",1p22,
,,,Urate oxidase deficiency
,,,
UPB1,"ureidopropionase, beta ",22q11.2,
,,,Beta-ureidopropionase deficiency [MIM:613161]
,,,
UPF3B,UPF3 regulator of nonsense transcripts homolog B (yeast) ,Xq25-q26,
,,,"Mental retardation, X-linked, syndromic 14 [MIM:300676]"
,,,
UPK3A,uroplakin 3A ,22q13.31,
,,,Renal adysplasia [MIM:191830]
,,,
UQCRB,ubiquinol-cytochrome c reductase binding protein ,8q22,
,,,Mitochondrial complex III deficiency [MIM:124000]
,,,
UQCRQ,"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa ",5q31.1,
,,,Mitochondrial complex III deficiency [MIM:124000]
,,,
UROC1,urocanate hydratase 1 ,3q21.3,
,,,Urocanase deficiency [MIM:276880]
,,,
UROD,uroporphyrinogen decarboxylase ,1p34,
,,,Porphyria cutanea tarda [MIM:176100]
,,,"Porphyria, hepatoerythropoietic [MIM:176100]"
,,,
UROS,uroporphyrinogen III synthase ,10q25.2-q26.3,
,,,"Porphyria, congenital erythropoietic [MIM:263700]"
,,,
USB1,U6 snRNA biogenesis 1 ,16q13,
,,,Poikiloderma with neutropenia [MIM:604173]
,,,
USF1,upstream transcription factor 1 ,1q22-q23,
,,,"Hyperlipidemia, familial combined, susceptibility to [MIM:602491]"
,,,
USH1C,"Usher syndrome 1C (autosomal recessive, severe) ",11p15.1,
,,,"Usher syndrome, type 1C [MIM:276904]"
,,,"Deafness, autosomal recessive 18 [MIM:602092]"
,,,
USH1E,"Usher syndrome 1E (autosomal recessive, severe) ",21q21,
,,,"Usher syndrome, type 1E"
,,,
USH1G,Usher syndrome 1G (autosomal recessive) ,17q24-q25,
,,,"Usher syndrome, type 1G [MIM:606943]"
,,,
USH1H,Usher syndrome 1H (autosomal recessive) ,15q22-q23,
,,,"Usher syndrome, type 1H"
,,,
USH2A,"Usher syndrome 2A (autosomal recessive, mild) ",1q41,
,,,"Usher syndrome, type 2A [MIM:276901]"
,,,Retinitis pigmentosa-39 [MIM:268000]
,,,
USP15,ubiquitin specific peptidase 15 ,?,
,,,mutations
,,,
USP24,ubiquitin specific peptidase 24 ,1p32.3,
,,,mutations
,,,
USP26,ubiquitin specific peptidase 26 ,Xq26.2,
,,,mutations
,,,
USP46,ubiquitin specific peptidase 46 ,4q12,
,,,mutations
,,,
USP7,ubiquitin specific peptidase 7 (herpes virus-associated) ,16p13.3,
,,,mutations
,,,
USP9X,"ubiquitin specific peptidase 9, X-linked ",Xp11.4,
,,,mutations
,,,
USP9Y,"ubiquitin specific peptidase 9, Y-linked ",Yq11.2,
,,,Azoospermia [MIM:415000]
,,,
UST,uronyl-2-sulfotransferase ,6q25.1,
,,,mutations
,,,
UTF1,undifferentiated embryonic cell transcription factor 1 ,10q26,
,,,mutations
,,,
UTRN,utrophin ,6q24,
,,,mutations
,,,
UTS2,urotensin 2 ,?,
,,,mutations
,,,
UVM1,"Melanoma, uveal, susceptibility to, 1 ",3q24-q26,
,,,"Melanoma, uveal, susceptibility to, 1"
,,,
VAMP7,vesicle-associated membrane protein 7 ,Xq28,
,,,mutations
,,,
VANGL1,"vang-like 1 (van gogh, Drosophila) ",1p13,
,,,Caudal regression syndrome [MIM:600145]
,,,Neural tube defects [MIM:182940]
,,,
VANGL2,"vang-like 2 (van gogh, Drosophila) ",1q21-q23,
,,,mutations
,,,
VAPB,VAMP (vesicle-associated membrane protein)-associated protein B and C ,20q13.3,
,,,Amyotrophic lateral sclerosis 8 [MIM:608627]
,,,"Spinal muscular atrophy, late-onset, Finkel type [MIM:182980]"
,,,
VAX1,ventral anterior homeobox 1 ,10q26.1,
,,,mutations
,,,
VCAM1,vascular cell adhesion molecule 1 ,1p32-p31,
,,,mutations
,,,
VCAN,versican ,5q12-q14,
,,,Wagner syndrome 1 [MIM:143200]
,,,
VCL,vinculin ,10q22.1-q23,
,,,"Cardiomyopathy, dilated, 1W [MIM:611407]"
,,,"Cardiomyopathy, familial hypertrophic, 15 [MIM:613255]"
,,,
VCP,valosin containing protein ,9p13-p12,
,,,Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia [MIM:167320]
,,,
VCX3A,"variable charge, X-linked 3A ",Xp22.3,
,,,mutations
,,,
VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor ",12q12-q14,
,,,"Rickets, vitamin D-resistant, type IIA [MIM:277440]"
,,,"Osteoporosis, involutional [MIM:166710]"
,,,
VEGFA,vascular endothelial growth factor A ,6p12,
,,,Microvascular complications of diabetes 1 [MIM:603933]
,,,
VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase ",3p26-p25,
,,,von Hippel-Lindau syndrome [MIM:193300]
,,,"Renal cell carcinoma, somatic [MIM:144700]"
,,,Pheochromocytoma [MIM:171300]
,,,"Hemangioblastoma, cerebellar, somatic"
,,,"Polycythemia, benign familial [MIM:263400]"
,,,
VIL1,villin 1 ,2q35-q36,
,,,"Cholestasis, progressive canalicular"
,,,
VIMP,VCP-interacting membrane protein ,15q26.3,
,,,"Inflammatory response, modulation of"
,,,
VIM,vimentin ,10p13,
,,,"Cataract, pulverulent, autosomal dominant"
,,,
VIPAS39,"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog ",14q24.3,
,,,"Arthrogryposis, renal dysfunction, and cholestasis 2 [MIM:613404]"
,,,
VIPR2,vasoactive intestinal peptide receptor 2 ,7q36.3,
,,,mutations
,,,
VIP,vasoactive intestinal peptide ,6q26-q27,
,,,mutations
,,,
VKORC1,"vitamin K epoxide reductase complex, subunit 1 ",16p11.2,
,,,"Vitamin K-dependent clotting factors, combined deficiency of, 2 [MIM:607473]"
,,,Warfarin resistance [MIM:122700]
,,,
VLDLR,very low density lipoprotein receptor ,9p24,
,,,Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1 [MIM:224050]
,,,
VMA21,VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) ,Xq28,
,,,"Myopathy, X-linked, with excessive autophagy"
,,,
VMD1,"vitelliform macular dystrophy, atypical ",8q24,
,,,"Macular dystrophy, atypical vitelliform"
,,,
VNN1,vanin 1 ,6q23-q24,
,,,High density lipoprotein cholesterol level QTL 8
,,,
VPREB1,pre-B lymphocyte 1 ,22q11.2,
,,,mutations
,,,
VPS13A,vacuolar protein sorting 13 homolog A (S. cerevisiae) ,9q21,
,,,Choreoacanthocytosis [MIM:200150]
,,,
VPS13B,vacuolar protein sorting 13 homolog B (yeast) ,8q22-q23,
,,,Cohen syndrome [MIM:216550]
,,,
VPS33B,vacuolar protein sorting 33 homolog B (yeast) ,15q26.1,
,,,"Arthrogryposis, renal dysfunction, and cholestasis 1 [MIM:208085]"
,,,
VPS35,vacuolar protein sorting 35 homolog (S. cerevisiae) ,16q12,
,,,mutations
,,,
VRK1,vaccinia related kinase 1 ,14q32,
,,,Pontocerebellar hypoplasia type 1 [MIM:607596]
,,,
VRNI,"vitreoretinopathy, neovascular inflammatory ",11q13,
,,,"Vitreoretinopathy, neovascular inflammatory"
,,,
VSIG4,V-set and immunoglobulin domain containing 4 ,Xq12,
,,,mutations
,,,
VSPA,Visuospatial/perceptual abilities ,Xp22.33,
,,,Turner syndrome-associated neurocognitive phenotype
,,,Visuospatial/perceptual abilities
,,,
VSX1,visual system homeobox 1 ,20p11.2,
,,,Keratoconus [MIM:148300]
,,,"Corneal dystrophy, hereditary polymorphous posterior [MIM:122000]"
,,,"Craniofacial anomalies, empty sella turcica, corneal endothelial changes, and abnormal retinal and auditory bipolar cells"
,,,
VSX2,visual system homeobox 2 ,14q24.3,
,,,Microphthalmia with coloboma 3 [MIM:610092]
,,,"Microphthalmia, isolated 2 [MIM:610093]"
,,,
VTLG,Vitiligo ,6p21.3,
,,,"Vitiligo, susceptibility to"
,,,
VTN,vitronectin ,17q11,
,,,mutations
,,,
VUR,Vesicoureteral reflux ,1p13,
,,,Vesicoureteral reflux
,,,
VWF,von Willebrand factor ,12p13.3,
,,,"von Willebrand disease, type 2A, 2B, 2M, and 2N [MIM:613554]"
,,,"von Willebrand disease, type 1 [MIM:193400]"
,,,"von Willibrand disease, type 3 [MIM:277480]"
,,,
WAGRO,WAGRO syndrome ,11p13-p12,
,,,WAGRO syndrome
,,,
WASF3,"WAS protein family, member 3 ",13q12,
,,,mutations
,,,
WAS,Wiskott-Aldrich syndrome ,Xp11.23-p11.22,
,,,Wiskott-Aldrich syndrome [MIM:301000]
,,,"Thrombocytopenia, X-linked [MIM:313900]"
,,,"Neutropenia, severe congenital, X-linked [MIM:300299]"
,,,"Thrombocytopenia, X-linked, intermittent [MIM:313900]"
,,,
WDFY3,WD repeat and FYVE domain containing 3 ,?,
,,,mutations
,,,
WDFY4,WDFY family member 4 ,10q11.22-q11.23,
,,,mutations
,,,
WDM,Welander distal myopathy ,2p13,
,,,Welander distal myopathy
,,,
WDPCP,WD repeat containing planar cell polarity effector ,2p15,
,,,Bardet-Biedl syndrome 15 [MIM:209900]
,,,
WDR11,WD repeat domain 11 ,10q26,
,,,mutations
,,,
WDR13,WD repeat domain 13 ,Xp11.23,
,,,mutations
,,,
WDR19,WD repeat domain 19 ,4p14-p11,
,,,mutations
,,,
WDR35,WD repeat domain 35 ,2p24.1,
,,,Cranioectodermal dysplasia 2 [MIM:613610]
,,,
WDR36,WD repeat domain 36 ,5q21.3-q22.1,
,,,"Glaucoma 1, open angle, G [MIM:609887]"
,,,
WDR45L,WDR45-like ,?,
,,,mutations
,,,
WDR4,WD repeat domain 4 ,21q22.3,
,,,mutations
,,,
WDR62,WD repeat domain 62 ,19q13.12,
,,,"Microcephaly, cortical malformations, and mental retardation [MIM:600176]"
,,,
WDR65,WD repeat domain 65 ,?,
,,,mutations
,,,
WDR72,WD repeat domain 72 ,15q21.3,
,,,"Amelogenesis imperfecta, hypomaturation type, IIA3 [MIM:613211]"
,,,
WDR81,WD repeat domain 81 ,?,
,,,mutations
,,,
WFS1,Wolfram syndrome 1 (wolframin) ,4p16.1,
,,,Wolfram syndrome [MIM:222300]
,,,"Deafness, autosomal dominant 6/14/38 [MIM:600965]"
,,,"Wolfram-like syndrome, autosomal dominant [MIM:222300]"
,,,"Diabetes mellitus, noninsulin-dependent, association with [MIM:125853]"
,,,
WG,Wegener granulomatosis ,6p21.3,
,,,Wegener granulomatosis
,,,
WHCR,Wolf-Hirschhorn syndrome chromosome region ,4p16.3,
,,,Wolf-Hirschhorn syndrome
,,,
WHSC1L1,Wolf-Hirschhorn syndrome candidate 1-like 1 ,8p12,
,,,"Leukemia, acute myeloid [MIM:601626]"
,,,
WHSC1,Wolf-Hirschhorn syndrome candidate 1 ,4p16.3,
,,,mutations
,,,
WHSC2,Wolf-Hirschhorn syndrome candidate 2 ,4p16.3,
,,,mutations
,,,
WIPF1,"WAS/WASL interacting protein family, member 1 ",?,
,,,mutations
,,,
WISP3,WNT1 inducible signaling pathway protein 3 ,6q22-q23,
,,,"Arthropathy, progressive pseudorheumatoid, of childhood [MIM:208230]"
,,,Spondyloepiphyseal dysplasia tarda with progressive arthropathy [MIM:208230]
,,,
WM1,"Macroglobulinemia, Waldenstrom, susceptibility to, 1 ",6p21.3,
,,,"Macroglobulinemia, Waldenstrom, susceptibility to, 1"
,,,
WM2,"Macroglobulinemia, Waldenstrom, susceptibility to, 2 ",4q,
,,,"Macroglobulinemia, Waldenstrom, susceptibility to, 2"
,,,
WNK1,WNK lysine deficient protein kinase 1 ,12p13,
,,,"Pseudohypoaldosteronism, type IIC [MIM:145260]"
,,,"Neuropathy, hereditary sensory and autonomic, type II [MIM:201300]"
,,,
WNK4,WNK lysine deficient protein kinase 4 ,17q21-q22,
,,,Pseudohypoaldosteronism type II [MIM:145260]
,,,
WNT10A,"wingless-type MMTV integration site family, member 10A ",2q35,
,,,Odontoonychodermal dysplasia [MIM:257980]
,,,Schopf-Schulz-Passarge syndrome [MIM:224750]
,,,
WNT10B,"wingless-type MMTV integration site family, member 10B ",12q13,
,,,Split-hand/foot malformation 6 [MIM:225300]
,,,
WNT3,"wingless-type MMTV integration site family, member 3 ",17q21,
,,,"Tetra-amelia, autosomal recessive [MIM:273395]"
,,,
WNT4,"wingless-type MMTV integration site family, member 4 ",1p35,
,,,SERKAL syndrome [MIM:611812]
,,,Mullerian aplasia and hyperandrogenism [MIM:158330]
,,,
WNT5A,"wingless-type MMTV integration site family, member 5A ",3p21-p14,
,,,mutations
,,,
WNT5B,"wingless-type MMTV integration site family, member 5B ",12p13.3,
,,,mutations
,,,
WNT7A,"wingless-type MMTV integration site family, member 7A ",3p25,
,,,"Ulna and fibula, absence of, with sever limb deficiency [MIM:276820]"
,,,Fuhrmann syndrome [MIM:228930]
,,,
WRAP53,"WD repeat containing, antisense to TP53 ",17p13,
,,,mutations
,,,
WRN,"Werner syndrome, RecQ helicase-like ",8p12-p11.2,
,,,Werner syndrome [MIM:277700]
,,,
WS2B,"Waardenburg syndrome, type 2B ",1p21-p13.3,
,,,"Waardenburg syndrome, type 2B"
,,,
WS2C,"Waardenburg syndrome, type IIC ",8p23,
,,,"Waardenburg syndrome, type 2C"
,,,
WSN,Waisman syndrome ,Xq28,
,,,Waisman parkinsonism-mental retardation syndrome
,,,
WT1-AS,WT1 antisense RNA ,?,
,,,mutations
,,,
WT1,Wilms tumor 1 ,11p13,
,,,"Wilms tumor, type 1 [MIM:194070]"
,,,Denys-Drash syndrome [MIM:194080]
,,,"Nephrotic syndrome, type 4 [MIM:256370]"
,,,Frasier syndrome [MIM:136680]
,,,Meacham syndrome [MIM:608978]
,,,
WT3,Wilms tumor-3 ,16q,
,,,"Wilms tumor, type 3"
,,,
WT4,Wilms tumor-4 ,17q12-q21,
,,,"Wilms tumor, type 4"
,,,
WTS,Wilson-Turner X-linked mental retardation syndrome ,Xp21.1-q22,
,,,"Mental retardation, X-linked, syndromic 6, with gynecomastia and obesity"
,,,
WWC1,WW and C2 domain containing 1 ,5q34-q35.2,
,,,"Memory, enhanced, association with"
,,,
WWOX,WW domain containing oxidoreductase ,16q23.3-q24.1,
,,,Esophageal squamous cell carcinoma [MIM:133239]
,,,
WWS,Wieacker-Wolff syndrome ,Xq13-q21,
,,,Wieacker-Wolff syndrome
,,,
XBP1,X-box binding protein 1 ,22q12,
,,,"Major affective disorder-7, susceptibility to [MIM:612371]"
,,,
XDH,xanthine dehydrogenase ,2p23-p22,
,,,"Xanthinuria, type I [MIM:278300]"
,,,
XECD,"Corneal dystrophy, endothelial, X-linked ",Xq25,
,,,"Corneal dystrophy, endothelial, X-linked"
,,,
XGPY,"Xg pseudogene, Y-linked ",Xpter-p22.32,
,,,"Blood group, XG system"
,,,
XG,Xg blood group ,?,
,,,Xg blood group
,,,
XIAP,X-linked inhibitor of apoptosis ,Xq25,
,,,"Lymphoproliferative syndrome, X-linked, 2 [MIM:300635]"
,,,
XIC,X chromosome inactivation center ,Xq13.2,
,,,"X-inactivation, familial skewed [MIM:300087]"
,,,
XIST,X (inactive)-specific transcript (non-protein coding) ,Xq13.2,
,,,"X-inactivation, familial skewed [MIM:300087]"
,,,
XKR4,"XK, Kell blood group complex subunit-related family, member 4 ",?,
,,,mutations
,,,
XK,X-linked Kx blood group (McLeod syndrome) ,Xp21.2-p21.1,
,,,McLeod syndrome
,,,McLeod syndrome with neuroacanthosis
,,,
XPA,"xeroderma pigmentosum, complementation group A ",9q22.3,
,,,"Xeroderma pigmentosum, group A [MIM:278700]"
,,,
XPC,"xeroderma pigmentosum, complementation group C ",3p25,
,,,"Xeroderma pigmentosum, group C [MIM:278720]"
,,,
XPNPEP2,"X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound ",Xq25,
,,,"Angioedema induced by ACE inhibitors, susceptibility to"
,,,
XPNPEP3,"X-prolyl aminopeptidase (aminopeptidase P) 3, putative ",22q13.31-q13.33,
,,,Nephronophthisis-like nephropathy 1 [MIM:613159]
,,,
XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1 ,19q13.2,
,,,mutations
,,,
XRCC2,X-ray repair complementing defective repair in Chinese hamster cells 2 ,7q36.1,
,,,mutations
,,,
XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3 ,14q32.3,
,,,"Melanoma, cutaneous malignant, susceptibility to, 6"
,,,"Breast cancer, susceptibility to"
,,,
XRCC4,X-ray repair complementing defective repair in Chinese hamster cells 4 ,5q13-q14,
,,,mutations
,,,
XRCC5,X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) ,2q35,
,,,mutations
,,,
XRCC6,X-ray repair complementing defective repair in Chinese hamster cells 6 ,22q11-q13,
,,,mutations
,,,
XYLT1,xylosyltransferase I ,16p13.1,
,,,"Pseudoxanthoma elasticum, modifier of severity of [MIM:264800]"
,,,
XYLT2,xylosyltransferase II ,17q21.3-q22,
,,,"Pseudoxanthoma elasticum, modifier of severity of [MIM:264800]"
,,,
YAP1,Yes-associated protein 1 ,11q13,
,,,mutations
,,,
YARS2,"tyrosyl-tRNA synthetase 2, mitochondrial ",12p11.21,
,,,"Myopathy, lactic acidosis, and sideroblastic anemia 2 [MIM:613561]"
,,,
YARS,tyrosyl-tRNA synthetase ,1p35,
,,,"Charcot-Marie-Tooth disease, dominant intermediate C [MIM:608323]"
,,,
YBX2,Y box binding protein 2 ,?,
,,,mutations
,,,
YTHDF2,"YTH domain family, member 2 ",1p35,
,,,mutations
,,,
YWHAE,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide ",17p13.3,
,,,mutations
,,,
YY1,YY1 transcription factor ,14q,
,,,mutations
,,,
ZAN,zonadhesin ,7q22,
,,,mutations
,,,
ZAP70,zeta-chain (TCR) associated protein kinase 70kDa ,2q12,
,,,Selective T-cell defect
,,,
ZBTB16,zinc finger and BTB domain containing 16 ,11q23.1,
,,,"Leukemia, acute promyelocytic, PL2F/RARA type"
,,,"Skeletal defects, genital hypoplasia, and mental retardation [MIM:612447]"
,,,
ZBTB24,zinc finger and BTB domain containing 24 ,?,
,,,mutations
,,,
ZBTB40,zinc finger and BTB domain containing 40 ,1p36,
,,,mutations
,,,
ZBTB41,zinc finger and BTB domain containing 41 ,?,
,,,mutations
,,,
ZC3H14,zinc finger CCCH-type containing 14 ,14q31.3,
,,,mutations
,,,
ZC3H3,zinc finger CCCH-type containing 3 ,?,
,,,mutations
,,,
ZC3HAV1,"zinc finger CCCH-type, antiviral 1 ",7q34,
,,,mutations
,,,
ZCCHC12,"zinc finger, CCHC domain containing 12 ",Xq24,
,,,mutations
,,,
ZCCHC13,"zinc finger, CCHC domain containing 13 ",?,
,,,mutations
,,,
ZCCHC8,"zinc finger, CCHC domain containing 8 ",?,
,,,mutations
,,,
ZD1,Zygodactyly 1 ,3p21.31,
,,,Zygodactyly 1
,,,
ZDHHC15,"zinc finger, DHHC-type containing 15 ",Xq13.3,
,,,"Mental retardation, X-linked-91 [MIM:300577]"
,,,
ZDHHC8,"zinc finger, DHHC-type containing 8 ",22q11.21,
,,,mutations
,,,
ZDHHC9,"zinc finger, DHHC-type containing 9 ",Xq26.1,
,,,"Mental retardation, X-linked, ZDHHC9-related [MIM:300799]"
,,,
ZEB1,zinc finger E-box binding homeobox 1 ,10p11.2,
,,,"Corneal dystrophy, posterior polymorphous, 3 [MIM:609141]"
,,,"Corneal dystrophy, Fuchs endothelial, 6 [MIM:613270]"
,,,
ZEB2,zinc finger E-box binding homeobox 2 ,2q22,
,,,Mowat-Wilson syndrome [MIM:235730]
,,,
ZFAT,zinc finger and AT hook domain containing ,8q23-q24,
,,,"Autoimmune thyroid disease, susceptibility to, 3 [MIM:608175]"
,,,
ZFHX3,zinc finger homeobox 3 ,16q22.3-q23.1,
,,,"Prostate cancer, susceptibility to [MIM:176807]"
,,,
ZFHX4,zinc finger homeobox 4 ,8q21.12,
,,,"Ptosis, congenital [MIM:178300]"
,,,
ZFP36L1,"zinc finger protein 36, C3H type-like 1 ",14q22-q24,
,,,mutations
,,,
ZFP36,"zinc finger protein 36, C3H type, homolog (mouse) ",19q13.1,
,,,mutations
,,,
ZFP57,zinc finger protein 57 homolog (mouse) ,6p22.1,
,,,"Diabetes mellitus, transient neonatal, 1 [MIM:601410]"
,,,
ZFP90,zinc finger protein 90 homolog (mouse) ,16q22.1,
,,,mutations
,,,
ZFPM2,"zinc finger protein, multitype 2 ",8q23,
,,,Tetralogy of Fallot [MIM:187500]
,,,Diaphragmatic hernia 3 [MIM:610187]
,,,
ZFYVE26,"zinc finger, FYVE domain containing 26 ",14q24.1,
,,,Spastic paraplegia 15 [MIM:270700]
,,,
ZFYVE27,"zinc finger, FYVE domain containing 27 ",10q24.2,
,,,Spastic paraplegia 33 [MIM:610244]
,,,
ZHX3,zinc fingers and homeoboxes 3 ,20q12,
,,,mutations
,,,
ZIC1,Zic family member 1 ,3q24,
,,,Dandy-Walker malformation [MIM:220200]
,,,
ZIC2,Zic family member 2 ,13q32,
,,,Holoprosencephaly-5 [MIM:609637]
,,,
ZIC3,Zic family member 3 ,Xq26.2,
,,,"Heterotaxy, visceral, 1, X-linked [MIM:306955]"
,,,"Congenital heart defects, nonsyndromic, 1, X-linked [MIM:306955]"
,,,
ZIC4,Zic family member 4 ,3q24,
,,,Dandy-Walker malformation [MIM:220200]
,,,
ZLS,Zimmerman-Laband Syndrome ,3p14.3,
,,,Zimmermann-Laband syndrome
,,,
ZMPSTE24,zinc metallopeptidase STE24 homolog (S. cerevisiae) ,1p34,
,,,Mandibuloacral dysplasia with type B lipodystrophy [MIM:608612]
,,,"Restrictive dermopathy, lethal [MIM:275210]"
,,,
ZMYND11,"zinc finger, MYND-type containing 11 ",?,
,,,mutations
,,,
ZNF148,zinc finger protein 148 ,3q21,
,,,Sertoli-cell-only syndrome [MIM:400042]
,,,
ZNF202,zinc finger protein 202 ,11q23.3,
,,,mutations
,,,
ZNF213,zinc finger protein 213 ,16p13.3,
,,,mutations
,,,
ZNF224,zinc finger protein 224 ,19q13.2-qter,
,,,mutations
,,,
ZNF233,zinc finger protein 233 ,?,
,,,mutations
,,,
ZNF238,zinc finger protein 238 ,1q44,
,,,mutations
,,,
ZNF24,zinc finger protein 24 ,18q12,
,,,mutations
,,,
ZNF335,zinc finger protein 335 ,20q11.2-q13.1,
,,,mutations
,,,
ZNF350,zinc finger protein 350 ,?,
,,,mutations
,,,
ZNF365,zinc finger protein 365 ,10q21.2,
,,,"Nephrolithiasis, uric acid, susceptibility to [MIM:605990]"
,,,
ZNF385B,zinc finger protein 385B ,2q31.2-q31.3,
,,,mutations
,,,
ZNF419,zinc finger protein 419 ,?,
,,,mutations
,,,
ZNF41,zinc finger protein 41 ,Xp22.1-cen,
,,,"Mental retardation, X-linked-89"
,,,
ZNF420,zinc finger protein 420 ,?,
,,,mutations
,,,
ZNF469,zinc finger protein 469 ,16q24,
,,,Brittle cornea syndrome [MIM:229200]
,,,
ZNF480,zinc finger protein 480 ,?,
,,,mutations
,,,
ZNF512B,zinc finger protein 512B ,?,
,,,mutations
,,,
ZNF513,zinc finger protein 513 ,2p24.1-p22.3,
,,,Retinitis pigmentosa 58 [MIM:613617]
,,,
ZNF526,zinc finger protein 526 ,?,
,,,mutations
,,,
ZNF577,zinc finger protein 577 ,?,
,,,mutations
,,,
ZNF592,zinc finger protein 592 ,15q25.3,
,,,"Spinocerebellar ataxia, autosomal recessive 5 [MIM:606937]"
,,,
ZNF600,zinc finger protein 600 ,?,
,,,mutations
,,,
ZNF624,zinc finger protein 624 ,?,
,,,mutations
,,,
ZNF627,zinc finger protein 627 ,19p13.2,
,,,mutations
,,,
ZNF642,zinc finger protein 642 ,?,
,,,mutations
,,,
ZNF644,zinc finger protein 644 ,?,
,,,mutations
,,,
ZNF674,zinc finger protein 674 ,Xp11,
,,,"Mental retardation, X-linked-92"
,,,
ZNF711,zinc finger protein 711 ,Xq21.1-q21.3,
,,,mutations
,,,
ZNF750,zinc finger protein 750 ,17q25.3,
,,,Seborrhea-like dermatitis with psoriasiform elements [MIM:610227]
,,,
ZNF75D,zinc finger protein 75D ,Xq26,
,,,mutations
,,,
ZNF778,zinc finger protein 778 ,?,
,,,mutations
,,,
ZNF799,zinc finger protein 799 ,?,
,,,mutations
,,,
ZNF80,zinc finger protein 80 ,3p12-qter,
,,,mutations
,,,
ZNF81,zinc finger protein 81 ,Xp22.1-p11,
,,,"Mental retardation, X-linked 45 [MIM:300498]"
,,,
ZNRF1,"zinc and ring finger 1, E3 ubiquitin protein ligase ",16q23.1,
,,,mutations
,,,
ZPBP2,zona pellucida binding protein 2 ,17q12-q21,
,,,mutations
,,,
ZPBP,zona pellucida binding protein ,?,
,,,mutations
,,,
ZPLD1,zona pellucida-like domain containing 1 ,?,
,,,mutations
,,,
